PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Aoi, T; Yae, K; Nakagawa, M; Ichisaka, T; Okita, K; Takahashi, K; Chiba, T; Yamanaka, S				Aoi, Takashi; Yae, Kojiro; Nakagawa, Masato; Ichisaka, Tomoko; Okita, Keisuke; Takahashi, Kazutoshi; Chiba, Tsutomu; Yamanaka, Shinya			Generation of pluripotent stem cells from adult mouse liver and stomach cells	SCIENCE			English	Article							FIBROBLASTS; EXPRESSION	Induced pluripotent stem ( iPS) cells have been generated from mouse and human fibroblasts by the retroviral transduction of four transcription factors. However, the cell origins and molecular mechanisms of iPS cell induction remain elusive. This report describes the generation of iPS cells from adult mouse hepatocytes and gastric epithelial cells. These iPS cell clones appear to be equivalent to embryonic stem cells in gene expression and are competent to generate germline chimeras. Genetic lineage tracings show that liver- derived iPS cells are derived from albumin-expressing cells. No common retroviral integration sites are found among multiple clones. These data suggest that iPS cells are generated by direct reprogramming of lineage- committed somatic cells and that retroviral integration into specific sites is not required.	[Aoi, Takashi; Yae, Kojiro; Nakagawa, Masato; Ichisaka, Tomoko; Okita, Keisuke; Takahashi, Kazutoshi; Yamanaka, Shinya] Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Aoi, Takashi; Chiba, Tsutomu] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto 6068507, Japan; [Ichisaka, Tomoko; Yamanaka, Shinya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Yamanaka, Shinya] Kyoto Univ, Ctr Induced Pluripotent StemiPS Cell Res & Applic, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes; Kyoto University	Yamanaka, S (corresponding author), Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020; Wilson, Matthew H/K-3193-2013	Takahashi, Kazutoshi/0000-0002-5329-8395; Okita, Keisuke/0000-0001-5806-1090				Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	17	758	953	1	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2008	321	5889					699	702		10.1126/science.1154884	http://dx.doi.org/10.1126/science.1154884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332IW	18276851	Green Submitted			2022-12-24	WOS:000258077700046
J	Goldberg, AV; Molik, S; Tsaousis, AD; Neumann, K; Kuhnke, G; Delbac, F; Vivares, CP; Hirt, RP; Lill, R; Embley, TM				Goldberg, Alina V.; Molik, Sabine; Tsaousis, Anastasios D.; Neumann, Karina; Kuhnke, Grit; Delbac, Frederic; Vivares, Christian P.; Hirt, Robert P.; Lill, Roland; Embley, T. Martin			Localization and functionality of microsporidian iron-sulphur cluster assembly proteins	NATURE			English	Article							GENOME SEQUENCE; ENCEPHALITOZOON-CUNICULI; TRICHOMONAS-VAGINALIS; MITOCHONDRIAL REMNANT; ENTAMOEBA-HISTOLYTICA; SCAFFOLD PROTEINS; FE/S PROTEINS; BIOGENESIS; MATURATION; ISU1P	Microsporidia are highly specialized obligate intracellular parasites of other eukaryotes ( including humans(1)) that show extreme reduction at the molecular, cellular and biochemical level(2,3). Although microsporidia have long been considered as early branching eukaryotes that lack mitochondria(4), they have recently been shown to contain a tiny mitochondrial remnant called a mitosome(2,5). The function of the mitosome is unknown, because microsporidians lack the genes for canonical mitochondrial functions, such as aerobic respiration and haem biosynthesis. However, microsporidial genomes encode several components of the mitochondrial iron - sulphur ( Fe - S) cluster assembly machinery. Here we provide experimental insights into the metabolic function and localization of these proteins. We cloned, functionally characterized and localized homologues of several central mitochondrial Fe - S cluster assembly components for the microsporidians Encephalitozoon cuniculi and Trachipleistophora hominis. Several microsporidial proteins can functionally replace their yeast counterparts in Fe - S protein biogenesis. In E. cuniculi, the iron ( frataxin) and sulphur ( cysteine desulphurase, Nfs1) donors and the scaffold protein ( Isu1) co- localize with mitochondrial Hsp70 to the mitosome, consistent with it being the functional site for Fe - S cluster biosynthesis. In T. hominis, mitochondrial Hsp70 and the essential sulphur donor ( Nfs1) are still in the mitosome, but surprisingly the main pools of Isu1 and frataxin are cytosolic, creating a conundrum of how these key components of Fe - S cluster biosynthesis coordinate their function. Together, our studies identify the essential biosynthetic process of Fe - S protein assembly as a key function of microsporidian mitosomes.	[Goldberg, Alina V.; Hirt, Robert P.; Embley, T. Martin] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Molik, Sabine; Neumann, Karina; Kuhnke, Grit; Lill, Roland] Univ Marburg, Inst Zytobiol & Zytopathol, D-35033 Marburg, Germany; [Tsaousis, Anastasios D.] Univ Newcastle, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Delbac, Frederic; Vivares, Christian P.] Univ Clermont Ferrand, LBP, CNRS, UMR 6023, F-63177 Aubiere, France	Newcastle University - UK; Philipps University Marburg; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Embley, TM (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Catherine Cookson Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Lill@staff.uni-marburg.de; Martin.Embley@ncl.ac.uk	Hirt, Robert/R-5429-2017	Hirt, Robert/0000-0002-3760-9958; Lill, Roland/0000-0002-8345-6518; Embley, Thomas Martin/0000-0002-1484-340X; Tsaousis, Anastasios/0000-0002-5424-1905				Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Ali V, 2004, J BIOL CHEM, V279, P16863, DOI 10.1074/jbc.M313314200; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Burri L, 2006, P NATL ACAD SCI USA, V103, P15916, DOI 10.1073/pnas.0604109103; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Dutkiewicz R, 2006, J BIOL CHEM, V281, P7801, DOI 10.1074/jbc.M513301200; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Emelyanov VV, 2003, FEMS MICROBIOL LETT, V226, P257, DOI 10.1016/S0378-1097(03)00598-6; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Molik S, 2007, METHOD CELL BIOL, V80, P261, DOI 10.1016/S0091-679X(06)80013-0; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; Taupin V, 2006, PARASITOL RES, V99, P708, DOI 10.1007/s00436-006-0231-y; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Vavra J, 2005, FOLIA PARASIT, V52, P193, DOI 10.14411/fp.2005.024; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949	30	162	182	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2008	452	7187					624	U7		10.1038/nature06606	http://dx.doi.org/10.1038/nature06606			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18311129				2022-12-24	WOS:000254567200044
J	Ross, SR; Lukas, KE; Lonsdorf, EV; Stoinski, TS; Hare, B; Shumaker, R; Goodall, J				Ross, S. R.; Lukas, K. E.; Lonsdorf, E. V.; Stoinski, T. S.; Hare, B.; Shumaker, R.; Goodall, J.			Science priorities - Inappropriate use and portrayal of chimpanzees	SCIENCE			English	Editorial Material									[Ross, S. R.; Lonsdorf, E. V.] Lincoln Pk Zoo, Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL 60614 USA; [Ross, S. R.] AZA, Chimpanzee Species Survival Plan SSP, Silver Spring, MD 20910 USA; [Lukas, K. E.] Cleveland Metropk Zoo, Cleveland, OH USA; [Lukas, K. E.] Case Western Reserve Univ, Cleveland, OH 44109 USA; [Lonsdorf, E. V.] Univ Chicago, Comm Evolut Biol, Chicago, IL 60637 USA; [Stoinski, T. S.] Zoo Atlanta, Atlanta, GA 30315 USA; [Stoinski, T. S.] AZA, Ape Taxon Advisory Grp TAG, Silver Spring, MD 20910 USA; [Hare, B.] Duke Univ, Durham, NC 27708 USA; [Shumaker, R.] Great Ape Trust Iowa, Des Moines, IA 50320 USA; [Shumaker, R.] Krasnow Inst Adv Study, Fairfax, VA 22030 USA; [Goodall, J.] Jane Goodall Inst, Arlington, VA 22203 USA	Case Western Reserve University; University of Chicago; Duke University	Ross, SR (corresponding author), Lincoln Pk Zoo, Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL 60614 USA.	sross@lpzoo.org						Tutin C., 2005, REGIONAL ACTION PLAN	1	35	35	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1487	1487		10.1126/science.1154490	http://dx.doi.org/10.1126/science.1154490			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339923				2022-12-24	WOS:000253943800022
J	Shinohara, M; Koga, T; Okamoto, K; Sakaguchi, S; Arai, K; Yasuda, H; Takai, T; Kodama, T; Morio, T; Geha, RS; Kitamura, D; Kurosaki, T; Ellmeier, W; Takayanagi, H				Shinohara, Masahiro; Koga, Takako; Okamoto, Kazuo; Sakaguchi, Shinya; Arai, Kimiko; Yasuda, Hisataka; Takai, Toshiyuki; Kodama, Tatsuhiko; Morio, Tomohiro; Geha, Raif S.; Kitamura, Daisuke; Kurosaki, Tomohiro; Ellmeier, Wilfried; Takayanagi, Hiroshi			Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals	CELL			English	Article							MICE LACKING; RAFTS PLAY; FAMILY; DEFICIENCY; ACTIVATION; PROTEIN; IMMUNE; OSTEOIMMUNOLOGY; PLC-GAMMA-2; SYSTEM	Certain autoimmune diseases result in abnormal bone homeostasis, but association of immunodeficiency with bone is poorly understood. Osteoclasts, which derive from bone marrow cells, are under the control of the immune system. Differentiation of osteoclasts is mainly regulated by signaling pathways activated by RANK and immune receptors linked to ITAM-harboring adaptors. However, it is unclear how the two signals merge to cooperate in osteoclast differentiation. Here we report that mice lacking the tyrosine kinases Btk and Tec show severe osteopetrosis caused by a defect in bone resorption. RANK and ITAM signaling results in formation of a Btk(Tec)/BLNK(SLP-76)-containing complex and PLC gamma-mediated activation of an essential calcium signal. Furthermore, Tec kinase inhibition reduces osteoclastic bone resorption in models of osteoporosis and inflammation-induced bone destruction. Thus, this study reveals the importance of the osteoclastogenic signaling complex composed of tyrosine kinases, which may provide the molecular basis for a new therapeutic strategy.	[Shinohara, Masahiro; Koga, Takako; Okamoto, Kazuo; Arai, Kimiko; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch, Dept Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; [Shinohara, Masahiro; Koga, Takako; Okamoto, Kazuo; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Ctr Excellence Program Frontier Res Mol Destruct, Bunkyo Ku, Tokyo 1138549, Japan; [Morio, Tomohiro] Tokyo Med & Dent Univ, Grad Sch, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo 1138549, Japan; [Sakaguchi, Shinya; Ellmeier, Wilfried] Med Univ Vienna, Inst Immunol, Ctr Physiol Pathophysiol & Immunol, A-1090 Vienna, Austria; [Arai, Kimiko] Tohoku Univ, Grad Sch Dent, Div Orthodont & Dentofacial Orthoped, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Takai, Toshiyuki] Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Yasuda, Hisataka] Oriental Yeast Co Ltd, Nagahama Inst Biochem Sci, Shiga 5260804, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Dept Mol Biol & Med, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; [Geha, Raif S.] Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Kitamura, Daisuke] Tokyo Univ Sci, Div Mol Biol, Res Inst Biol Sci, Nada Ku, Chiba 2780022, Japan; [Kurosaki, Tomohiro] RIKEN, Lab Lymphocyte Differentiat, Res Ctr Allergy & Immunol, RIKEN Yokohama Inst,Tsurumi Ku, Kanagawa 2300045, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Medical University of Vienna; Tohoku University; Tohoku University; Oriental Yeast Co., Ltd.; University of Tokyo; Harvard University; Boston Children's Hospital; Tokyo University of Science; RIKEN	Takayanagi, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Cell Signaling, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138549, Japan.	taka.csi@tmd.ac.jp	Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Ellmeier, Wilfried/0000-0001-8192-8481; Sakaguchi, Shinya/0000-0002-0591-2469; Morio, Tomohiro/0000-0002-9259-1025; Yasuda, Hisataka/0000-0003-3511-609X; Shinohara, Masahiro/0000-0002-5532-1042	Austrian Science Fund FWF [Y 163] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Aoki K, 2006, J CLIN INVEST, V116, P1525, DOI 10.1172/JCI22513; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; de Diego RP, 2006, J ALLERGY CLIN IMMUN, V117, P1462, DOI 10.1016/j.jaci.2006.01.037; Ellmeier W, 2000, J EXP MED, V192, P1611, DOI 10.1084/jem.192.11.1611; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Fernandes MJG, 2005, J LEUKOCYTE BIOL, V78, P524, DOI 10.1189/jlb.0804479; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Hashimoto S, 1999, BLOOD, V94, P2357, DOI 10.1182/blood.V94.7.2357.419k40_2357_2364; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hayashi K, 2003, IMMUNITY, V18, P825, DOI 10.1016/S1074-7613(03)00142-0; HORTON JE, 1972, SCIENCE, V177, P793, DOI 10.1126/science.177.4051.793; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jumaa H, 2003, NATURE, V423, P452, DOI 10.1038/nature01608; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KIRCHNER SG, 1985, RADIOLOGY, V156, P362, DOI 10.1148/radiology.156.2.4011897; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lopez-Granados E, 2007, P NATL ACAD SCI USA, V104, P5056, DOI 10.1073/pnas.0605715104; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; MANO H, 1995, BLOOD, V85, P343; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Pivniouk VI, 2000, CURR OPIN IMMUNOL, V12, P173, DOI 10.1016/S0952-7915(99)00068-0; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schmidt U, 2004, INT ARCH ALLERGY IMM, V134, P65, DOI 10.1159/000078339; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Wu YL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000586	44	233	259	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					794	806		10.1016/j.cell.2007.12.037	http://dx.doi.org/10.1016/j.cell.2007.12.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329366	Bronze			2022-12-24	WOS:000253818000017
J	Arimond, M; Daelmans, B; Dewey, K				Arimond, Mary; Daelmans, Bernadette; Dewey, Kathryn		Working Grp Infant & Young Child F	Indicators for feeding practices in children	LANCET			English	Editorial Material									[Daelmans, Bernadette] WHO, CH-1211 Geneva 27, Switzerland; [Arimond, Mary] Int Food Policy Res Inst, Washington, DC 20036 USA; [Dewey, Kathryn] Univ Calif Davis, Davis, CA 95616 USA	World Health Organization; CGIAR; International Food Policy Research Institute (IFPRI); University of California System; University of California Davis	Daelmans, B (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.							[Anonymous], GUID PRINC FEED NONB; [Anonymous], 2003, GUIDING PRINCIPLES C; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Ruel Marie T., 2003, Food and Nutrition Bulletin, V24, P289; *US AG INT DEV, 2006, INF YOUNG CHILDR FEE; WHO, IND ASS INF YOUNG CH; Working Group on Infant and Young Child Feeding Indicators, 2006, DEV VAL SIMPL IND DI; Working Group on Infant and Young Child Feeding Indicators, 2007, DEV VAL SIMPL IND DI; World Health Organization, 1991, WHOCDDSER9114	9	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					541	542		10.1016/S0140-6736(08)60250-0	http://dx.doi.org/10.1016/S0140-6736(08)60250-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280315				2022-12-24	WOS:000253202600009
J	Mouton, R; Finch, D; Davies, I; Binks, A; Zacharowski, K				Mouton, Ronelle; Finch, David; Davies, Ian; Binks, Andrea; Zacharowski, Kai			Effect of aprotinin on renal dysfunction in patients undergoing on-pump and off-pump cardiac surgery: a retrospective observational study	LANCET			English	Article							HIGH-DOSE APROTININ; BYPASS GRAFT-SURGERY; PROPENSITY SCORE; CORONARY REVASCULARIZATION; BLOOD-TRANSFUSION; TRANEXAMIC ACID; DOUBLE-BLIND; FAILURE; MULTICENTER; METAANALYSIS	Background Aprotinin is used during cardiac surgery for its blood-saving effects. However, reports suggest a possible association between use of this drug and increased renal dysfunction and mortality. We investigated the effect of aprotinin on renal dysfunction in cardiac surgery, considering the cofactors on-pump versus off-pump surgery and co-medication with angiotensin-converting enzyme (ACE) inhibitors. Methods Our analysis included 9875 patients undergoing on-pump or off-pump cardiac surgery from Jan 1, 2000, to Sept 30, 2007. Of these patients, 9106 were included in the retrospective observational study analysis. With propensity-adjusted, multivariate staged logistic regression, we analysed separately the incidence of renal dysfunction in patients receiving aprotinin, tranexamic acid, or no antifibrinolytic treatment in the presence or absence of preoperative ACE inhibitor treatment, for both on-pump and off-pump surgical techniques. Findings In 5434 patients undergoing on-pump cardiac surgery, the odds ratio (OR) between aprotinin and an increased risk of renal dysfunction without ACE inhibitor was 1. 81 (95% CI 0 . 79-4.13, p=0.162) and with ACE inhibitor 1.73 (0.56-5.32, p=0.342). In the 848 patients taking ACE inhibitors and undergoing off-pump cardiac surgery, aprotinin was associated with a greater than two-fold increase in the risk of renal dysfunction after off-pump cardiac surgery (OR 2.87 [1.25-6.58], p=0. 013). Interpretation Our results have shown that aprotinin seems to be safe during on-pump cardiac surgery. However, the combination of aprotinin and ACE inhibitors during off-pump cardiac surgery is associated with a significant risk of postoperative renal dysfunction.	[Mouton, Ronelle; Finch, David; Davies, Ian; Binks, Andrea; Zacharowski, Kai] Bristol Royal Infirm & Gen Hosp, Dept Anaesthesia, Bristol, Avon, England	Bristol Royal Infirmary	Zacharowski, K (corresponding author), Bristol Royal Infirm & Gen Hosp, Sir Humphry Davy Dept Anaesthesia, Upper Maudlin Rd, Bristol BS2 8HW, Avon, England.	kai.zacharowski@bristol.ac.uk	Mouton, Ronelle/A-9934-2012	Mouton, Ronelle/0000-0001-9562-8199				Alderman EL, 1998, J THORAC CARDIOV SUR, V116, P716, DOI 10.1016/S0022-5223(98)00431-0; Ascione R, 1999, ANN THORAC SURG, V68, P493, DOI 10.1016/S0003-4975(99)00566-4; Ascione R, 2001, ANN THORAC SURG, V72, P2020, DOI 10.1016/S0003-4975(01)03250-7; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2007, INTENS CARE MED, V33, P409, DOI 10.1007/s00134-006-0478-x; BLAUHUT B, 1991, J THORAC CARDIOV SUR, V101, P958; Brown JR, 2007, CIRCULATION, V115, P2801, DOI 10.1161/CIRCULATIONAHA.106.671222; Chertow GM, 1997, CIRCULATION, V95, P878; Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158; COSGROVE DM, 1992, ANN THORAC SURG, V54, P1031, DOI 10.1016/0003-4975(92)90066-D; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DAmbra MN, 1996, J THORAC CARDIOV SUR, V112, P1081, DOI 10.1016/S0022-5223(96)70110-1; Dietrich W, 2006, ANESTH ANALG, V103, P1074, DOI 10.1213/01.ane.0000238446.30034.c8; FEINDT PR, 1995, ANN THORAC SURG, V60, P1076, DOI 10.1016/0003-4975(95)00525-P; Furnary AP, 2007, CIRCULATION, V116, pI127, DOI 10.1161/CIRCULATIONAHA.106.681395; Godet G, 1997, ANESTH ANALG, V85, P1227, DOI 10.1097/00000539-199712000-00009; Henry DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub2; Hogue CW, 2006, ANESTH ANALG, V103, P1067, DOI 10.1213/01.ane.0000247881.20257.6d; Horl WH, 2000, BRIT J ANAESTH, V84, P3; Kapetanakis EI, 2006, CIRCULATION, V113, P1667, DOI 10.1161/CIRCULATIONAHA.105.571828; Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.x; Keogh B, 2004, 5 NATL ADULT CARDIAC; Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282; Kincaid EH, 2005, ANN THORAC SURG, V80, P1388, DOI 10.1016/j.athoracsur.2005.03.136; LEMMER JH, 1995, ANN THORAC SURG, V59, P132, DOI 10.1016/0003-4975(94)00813-M; LEVY JH, 1995, CIRCULATION, V92, P2236, DOI 10.1161/01.CIR.92.8.2236; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Mannucci PM, 1998, NEW ENGL J MED, V339, P245, DOI 10.1056/NEJM199807233390407; *MED HEALTHC PROD, 2007, APR TRAS SUSP UK MAR; MYERS BD, 1986, NEW ENGL J MED, V314, P97; O'Connor CJ, 1999, ANESTH ANALG, V89, P1101; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Royston D, 1992, J Cardiothorac Vasc Anesth, V6, P76, DOI 10.1016/1053-0770(91)90052-U; ROYSTON D, 1987, LANCET, V2, P1289; Royston D, 2006, ANESTH ANALG, V103, P1082, DOI 10.1213/01.ane.0000238447.74029.f5; Schweizer A, 2000, BRIT J ANAESTH, V84, P16, DOI 10.1093/oxfordjournals.bja.a013374; Sear JW, 2005, BRIT J ANAESTH, V95, P20, DOI 10.1093/bja/aei018; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P442, DOI 10.1016/j.jtcvs.2004.03.041; SOSLAU G, 1991, AM J HEMATOL, V38, P113, DOI 10.1002/ajh.2830380208; SUNDT TM, 1993, ANN THORAC SURG, V55, P1418, DOI 10.1016/0003-4975(93)91082-X; Textor SC, 1997, SEMIN NEPHROL, V17, P67; Tuttle KR, 2003, AM J KIDNEY DIS, V41, P76, DOI 10.1053/ajkd.2003.50025; *US FDA, 2007, FDA REQ MARK SUSP TR; van der Linden J, 2005, CIRCULATION, V112, pI276, DOI 10.1161/CIRCULATIONAHA.104.524611; VAN OW, 1987, ANN THORAC SURG, V44, P640; Watters MPR, 2001, EUR J CARDIO-THORAC, V19, P34, DOI 10.1016/S1010-7940(00)00603-5; Waxler B, 2003, CURR PHARM DESIGN, V9, P777, DOI 10.2174/1381612033455468; WESTABY S, 1994, EUR J CARDIO-THORAC, V8, P82, DOI 10.1016/1010-7940(94)90097-3; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	50	42	45	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2008	371	9611					475	482		10.1016/S0140-6736(08)60237-8	http://dx.doi.org/10.1016/S0140-6736(08)60237-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262039				2022-12-24	WOS:000253169200027
J	Zeng, N; Ding, YH; Pan, JH; Wang, HJ; Gregg, J				Zeng, Ning; Ding, Yihui; Pan, Jiahua; Wang, Huijun; Gregg, Jay			Sustainable development - Climate change - the Chinese challenge	SCIENCE			English	Editorial Material									[Zeng, Ning] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA; [Ding, Yihui] Chinese Meteorol Adm, Natl Climate Ctr, Beijing, Peoples R China; [Pan, Jiahua] Chinese Acad Social Sci, Res Ctr Sustainable Dev, Beijing, Peoples R China; [Wang, Huijun] Chinese Acad Sci, Inst Atmospher Phys, Beijing, Peoples R China; [Gregg, Jay] Univ Maryland, Dept Geog, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; China Meteorological Administration; Chinese Academy of Social Sciences; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; University System of Maryland; University of Maryland College Park	Zeng, N (corresponding author), Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA.	zeng@atmos.umd.edu	Zeng, Ning/A-3130-2008; Gregg, Jay Sterling/K-4242-2017	Zeng, Ning/0000-0002-7489-7629; Gregg, Jay Sterling/0000-0001-8759-9658				Committee of  China's National Assessment Report on Climate Change, 2007, CHINAS NATL ASSESSME; IEA, 2007, WORLD EN OUTL; IPCC, 2007, CLIM CHANG 2007 PHYS; Katzer J, 2007, THE FUTURE OF COAL; National Development and Reform Commission, 2019, CHIN NAT CLIM CHANG; NDRC, 2007, CHIN MED LONG TERM R; Peng CH, 2007, SCIENCE, V316, P546, DOI 10.1126/science.1134134; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Wang T., 2007, 23 TYND CTR; Wara M, 2007, NATURE, V445, P595, DOI 10.1038/445595a	10	96	116	9	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					730	731		10.1126/science.1153368	http://dx.doi.org/10.1126/science.1153368			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258882				2022-12-24	WOS:000252963000024
J	Wilbert-Lampen, U; Leistner, D; Greven, S; Pohl, T; Sper, S; Volker, C; Guthlin, D; Plasse, A; Knez, A; Kuchenhoff, H; Steinbeck, G				Wilbert-Lampen, Ute; Leistner, David; Greven, Sonja; Pohl, Tilmann; Sper, Sebastian; Voelker, Christoph; Guethlin, Denise; Plasse, Andrea; Knez, Andreas; Kuechenhoff, Helmut; Steinbeck, Gerhard			Cardiovascular events during World Cup Soccer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; EUROPEAN FOOTBALL CHAMPIONSHIP; SUDDEN CARDIAC DEATH; ENDOTHELIAL DYSFUNCTION; POTENTIAL LINK; VENTRICULAR ARRHYTHMIA; HORMONE CRH; MORTALITY; DISEASE; POPULATION	Background: The Federation Internationale de Football Association (FIFA) World Cup, held in Germany from June 9 to July 9, 2006, provided an opportunity to examine the relation between emotional stress and the incidence of cardiovascular events. Methods: Cardiovascular events occurring in patients in the greater Munich area were prospectively assessed by emergency physicians during the World Cup. We compared those events with events that occurred during the control period: May 1 to June 8 and July 10 to July 31, 2006, and May 1 to July 31 in 2003 and 2005. Results: Acute cardiovascular events were assessed in 4279 patients. On days of matches involving the German team, the incidence of cardiac emergencies was 2.66 times that during the control period (95% confidence interval [CI], 2.33 to 3.04; P<0.001); for men, the incidence was 3.26 times that during the control period (95% CI, 2.78 to 3.84; P<0.001), and for women, it was 1.82 times that during the control period (95% CI, 1.44 to 2.31; P<0.001). Among patients with coronary events on days when the German team played, the proportion with known coronary heart disease was 47.0%, as compared with 29.1% of patients with events during the control period. On those days, the highest average incidence of events was observed during the first 2 hours after the beginning of each match. A subanalysis of serious events during that period, as compared with the control period, showed an increase in the incidence of myocardial infarction with ST-segment elevation by a factor of 2.49 (95% CI, 1.47 to 4.23), of myocardial infarction without ST-segment elevation or unstable angina by a factor of 2.61 (95% CI, 2.22 to 3.08), and of cardiac arrhythmia causing major symptoms by a factor of 3.07 (95% CI, 2.32 to 4.06) (P<0.001 for all comparisons). Conclusions: Viewing a stressful soccer match more than doubles the risk of an acute cardiovascular event. In view of this excess risk, particularly in men with known coronary heart disease, preventive measures are urgently needed.	[Wilbert-Lampen, Ute; Leistner, David; Pohl, Tilmann; Sper, Sebastian; Voelker, Christoph; Plasse, Andrea; Knez, Andreas; Steinbeck, Gerhard] Univ Munich, Med Klin & Poliklin 1, D-81377 Munich, Germany; [Greven, Sonja; Guethlin, Denise; Kuechenhoff, Helmut] Univ Munich, Inst Stat, Stat Beratungslab, D-81377 Munich, Germany	University of Munich; University of Munich	Wilbert-Lampen, U (corresponding author), Univ Munich, Med Klin & Poliklin 1, Campus Grosshadern,Marchioninistr 15, D-81377 Munich, Germany.	ute.wilbert-lampen@med.uni-muenchen.de		Leistner, David/0000-0002-4351-420X; Kuchenhoff, Helmut/0000-0002-6372-2487				Akaike H, 1973, INT S INF THEOR, P267, DOI DOI 10.2307/2334537; [Anonymous], 2007, R LANG ENV STAT COMP; Berthier F, 2003, HEART, V89, P555, DOI 10.1136/heart.89.5.555; Brunekreef B, 2002, EPIDEMIOLOGY, V13, P491, DOI 10.1097/00001648-200207000-00022; Carroll D, 2002, BRIT MED J, V325, P1439, DOI 10.1136/bmj.325.7378.1439; Culic V, 2003, INT J CARDIOL, V90, P189, DOI 10.1016/S0167-5273(02)00563-6; Grima RS, 2005, REV ESP CARDIOL, V58, P587; Hemingway H, 2001, EUR HEART J, V22, P1082, DOI 10.1053/euhj.2000.2534; HUIKURI HV, 1994, CIRCULATION, V90, P121, DOI 10.1161/01.CIR.90.1.121; Kirkup W, 2003, J EPIDEMIOL COMMUN H, V57, P429, DOI 10.1136/jech.57.6.429; Lampert R, 2002, CIRCULATION, V106, P1800, DOI 10.1161/01.CIR.0000031733.51374.C1; Leor J, 1996, NEW ENGL J MED, V334, P413, DOI 10.1056/NEJM199602153340701; MEISEL SR, 1991, LANCET, V338, P660, DOI 10.1016/0140-6736(91)91234-L; Moecke H, 2000, ANAESTHESIST, V49, P211, DOI 10.1007/s001010050817; Schwartz J, 1999, EPIDEMIOLOGY, V10, P17, DOI 10.1097/00001648-199901000-00005; Strike PC, 2006, HEART, V92, P1035, DOI 10.1136/hrt.2005.077362; Tofler GH, 2006, CIRCULATION, V114, P1863, DOI 10.1161/CIRCULATIONAHA.105.596189; TOFLER GH, 1990, AM J CARDIOL, V66, P22, DOI 10.1016/0002-9149(90)90729-K; Toubiana L, 2001, BRIT MED J, V322, P1306, DOI 10.1136/bmj.322.7297.1306; Wilbert-Lampen U, 2007, ENDOTHELIUM-J ENDOTH, V14, P65, DOI 10.1080/10623320701346585; Wilbert-Lampen U, 2006, J CARDIOVASC PHARM, V47, P110, DOI 10.1097/01.fjc.0000196240.58641.d3; Wilbert-Lampen U, 2006, J PSYCHOSOM RES, V61, P453, DOI 10.1016/j.jpsychores.2006.07.001; Witte DR, 2000, BMJ-BRIT MED J, V321, P1552, DOI 10.1136/bmj.321.7276.1552; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	24	271	280	23	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					475	483		10.1056/NEJMoa0707427	http://dx.doi.org/10.1056/NEJMoa0707427			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18234752				2022-12-24	WOS:000252722900005
J	McMichael, AJ; Friel, S; Nyong, A; Corvalan, C				McMichael, A. J.; Friel, S.; Nyong, A.; Corvalan, C.			Global environmental change and health: impacts, inequalities, and the health sector	BRITISH MEDICAL JOURNAL			English	Editorial Material							CLIMATE-CHANGE; POPULATION HEALTH; BANGLADESH; CHALLENGE; AFRICA; ISSUES		[McMichael, A. J.; Friel, S.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Nyong, A.] Univ Jos, Ctr Environm Resources & Hazards Res, Dept Geog & Planning, Jos, Nigeria; [Corvalan, C.] WHO, CH-1211 Geneva, Switzerland	Australian National University; University of Jos; World Health Organization	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	tony.mcmichael@anu.edu.au		Friel, Sharon/0000-0002-8345-5435				Abdalla Abdalla Ahmed, 2006, ENV DEGRADATION CONF, P87; Barrios S, 2006, J URBAN ECON, V60, P357, DOI 10.1016/j.jue.2006.04.005; BAYLIS M, 2005, EFFECTS CLIMATE CHAN; Burnett J, 2007, BMJ-BRIT MED J, V334, P671; Butler CD, 2005, SOCIAL INJUSTICE PUB, V318-36; Corvalan C, 2005, ECOSYSTEMS HUMAN WEL; DESANKER P, 2001, CLIMATE CHANGE 2001, P433; Desanker PV, 2001, CLIM RES, V17, P93, DOI 10.3354/cr017093; Earth System Science Partnership, GLOB ENV CHANG HUM H; FRUMKIN H, IN PRESS AM J PUBLIC; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; Hassan MM, 2005, SOC SCI MED, V61, P2201, DOI 10.1016/j.socscimed.2005.04.021; Hirji R, 2002, DEFINING MAINSTREAM; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2006 IMP; Karim M, 2000, WATER RES, V34, P304, DOI 10.1016/S0043-1354(99)00128-1; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; McMichael AJ, 2006, HEALTH PROMOT INT, V21, P15, DOI 10.1093/heapro/dal047; McMichael AJ, 2006, EUR J PUBLIC HEALTH, V16, P579, DOI 10.1093/eurpub/ckl102; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Pruss-Ustun A., 2006, WORLD HEALTH; Stern Nicholas, 2006, STERN REV EC CLIMATE; *UN ENV PROGR, 2007, DARF POST CONFL ASS; United Nations, 2000, MILL DEV GOALS; *WHO UN JOINT MON, 2006, M MDG DRINK WAT SAN; World Health Organization, 2006, WHO HOUS EN DAT; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479	27	189	192	2	37	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 26	2008	336	7637					191	194		10.1136/bmj.39392.473727.AD	http://dx.doi.org/10.1136/bmj.39392.473727.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259KT	18219041	Green Submitted, Green Published			2022-12-24	WOS:000252938900041
J	Kawai, T; Cosimi, AB; Spitzer, TR; Tolkoff-Rubin, N; Suthanthiran, M; Saidman, SL; Shaffer, J; Preffer, FI; Ding, RC; Sharma, V; Fishman, JA; Dey, B; Ko, DSC; Hertl, M; Goes, NB; Wong, WC; Williams, WW; Colvin, RB; Sykes, M; Sachs, DH				Kawai, Tatsuo; Cosimi, A. Benedict; Spitzer, Thomas R.; Tolkoff-Rubin, Nina; Suthanthiran, Manikkam; Saidman, Susan L.; Shaffer, Juanita; Preffer, Frederic I.; Ding, Ruchuang; Sharma, Vijay; Fishman, Jay A.; Dey, Bimalangshu; Ko, Dicken S. C.; Hertl, Martin; Goes, Nelson B.; Wong, Waichi; Williams, Winfred W., Jr.; Colvin, Robert B.; Sykes, Megan; Sachs, David H.			Brief report: HLA-mismatched renal transplantation without maintenance immunosuppression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DONOR BONE-MARROW; ALLOGRAFT TOLERANCE; MIXED CHIMERISM; LYMPHOHEMATOPOIETIC CHIMERISM; CYNOMOLGUS MONKEYS; MULTIPLE-MYELOMA; BODY IRRADIATION; RECIPIENTS; INDUCTION; KIDNEY	Five patients with end-stage renal disease received combined bone marrow and kidney transplants from HLA single-haplotype mismatched living related donors, with the use of a nonmyeloablative preparative regimen. Transient chimerism and reversible capillary leak syndrome developed in all recipients. Irreversible humoral rejection occurred in one patient. In the other four recipients, it was possible to discontinue all immunosuppressive therapy 9 to 14 months after the transplantation, and renal function has remained stable for 2.0 to 5.3 years since transplantation. The T cells from these four recipients, tested in vitro, showed donor-specific unresponsiveness and in specimens from allograft biopsies, obtained after withdrawal of immunosuppressive therapy, there were high levels of P3 (FOXP3) messenger RNA (mRNA) but not granzyme B mRNA.	[Kawai, Tatsuo; Cosimi, A. Benedict; Tolkoff-Rubin, Nina; Fishman, Jay A.; Ko, Dicken S. C.; Hertl, Martin; Goes, Nelson B.; Wong, Waichi; Williams, Winfred W., Jr.] Massachusetts Gen Hosp, Transplantat Unit, Boston, MA 02114 USA; [Shaffer, Juanita; Sykes, Megan; Sachs, David H.] Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Boston, MA 02114 USA; [Spitzer, Thomas R.; Dey, Bimalangshu] Massachusetts Gen Hosp, Dept Med, Bone Marrow Transplantat Program, Boston, MA 02114 USA; [Saidman, Susan L.; Preffer, Frederic I.; Colvin, Robert B.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kawai, Tatsuo; Cosimi, A. Benedict; Spitzer, Thomas R.; Tolkoff-Rubin, Nina; Saidman, Susan L.; Shaffer, Juanita; Preffer, Frederic I.; Fishman, Jay A.; Dey, Bimalangshu; Ko, Dicken S. C.; Hertl, Martin; Goes, Nelson B.; Wong, Waichi; Williams, Winfred W., Jr.; Colvin, Robert B.; Sykes, Megan; Sachs, David H.] Harvard Univ, Sch Med, Boston, MA USA; [Suthanthiran, Manikkam; Ding, Ruchuang; Sharma, Vijay] New York Presbyterian Hosp Weill Cornell Med Ctr, Dept Med & Transplant Med, Div Nephrol, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cornell University; NewYork-Presbyterian Hospital	Sachs, DH (corresponding author), Massachusetts Gen Hosp, Transplantat Biol Res Ctr, 149 13th St, Charlestown, MA 02129 USA.		Suthanthiran, Manikkam/AAL-9104-2020; Spitzer, Thomas/AAR-7652-2020		NIAID NIH HHS [R01 AI037692-09, R01 AI037692-10, N01 AI015416, U19 AI102405, R01 AI037692, R21 AI037692, R21 AI037692-06, N01AI15416] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015416, U19AI102405, R21AI037692, R01AI037692] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARBER WH, 1991, TRANSPLANTATION, V51, P70, DOI 10.1097/00007890-199101000-00011; Buhler LH, 2002, TRANSPLANTATION, V74, P1405, DOI 10.1097/01.TP.0000034627.37442.A4; Ciancio G, 2002, TRANSPLANTATION, V74, P488, DOI 10.1097/00007890-200208270-00010; Corry RJ, 1999, ANN SURG, V230, P372, DOI 10.1097/00000658-199909000-00010; Fuchimoto Y, 2000, J CLIN INVEST, V105, P1779, DOI 10.1172/JCI8721; Fudaba Y, 2006, AM J TRANSPLANT, V6, P2121, DOI 10.1111/j.1600-6143.2006.01434.x; Haas M, 2006, AM J TRANSPLANT, V6, P1829, DOI 10.1111/j.1600-6143.2006.01356.x; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kawai T, 1999, TRANSPLANTATION, V68, P1767, DOI 10.1097/00007890-199912150-00022; Kawai T, 2004, AM J TRANSPLANT, V4, P1391, DOI 10.1111/j.1600-6143.2004.00523.x; KAWAI T, 1995, TRANSPLANTATION, V59, P256, DOI 10.1097/00007890-199501270-00018; Kimikawa M, 1997, TRANSPLANTATION, V64, P709, DOI 10.1097/00007890-199709150-00008; Kirk AD, 2005, TRANSPLANTATION, V80, P1051, DOI 10.1097/01.tp.0000174341.49741.8f; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Mengel M, 2005, AM J TRANSPLANT, V5, P1050, DOI 10.1111/j.1600-6143.2005.00788.x; Mezrich JD, 2003, TRANSPLANTATION, V76, P625, DOI 10.1097/01.TP.0000079926.80833.42; Millan TLT, 2002, TRANSPLANTATION, V73, P1386, DOI 10.1097/00007890-200205150-00005; MURRAY JE, 1960, SURGERY, V48, P272; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Sayegh MH, 1999, KIDNEY INT, V56, P1967, DOI 10.1046/j.1523-1755.1999.00751.x; SCHWARTZ DWM, 1995, VOX SANG, V68, P139, DOI 10.1111/j.1423-0410.1995.tb02571.x; Shapiro R, 2005, J AM COLL SURGEONS, V200, P505, DOI 10.1016/j.jamcollsurg.2004.12.024; SHARABI Y, 1989, J EXP MED, V169, P493, DOI 10.1084/jem.169.2.493; Spitzer TR, 1999, TRANSPLANTATION, V68, P480, DOI 10.1097/00007890-199908270-00006; Spitzer TR, 2001, BONE MARROW TRANSPL, V27, P893, DOI 10.1038/sj.bmt.1703015; Starzl TE, 1998, THEOR MED BIOETH, V19, P441, DOI 10.1023/A:1009924907775	28	787	842	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2008	358	4					353	361		10.1056/NEJMoa071074	http://dx.doi.org/10.1056/NEJMoa071074			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253GY	18216355	Green Accepted, Green Published, Green Submitted			2022-12-24	WOS:000252507900005
J	Riser, SC; Johnson, KS				Riser, Stephen C.; Johnson, Kenneth S.			Net production of oxygen in the subtropical ocean	NATURE			English	Article							METABOLIC BALANCE; RESPIRATION; NITROGEN; WATER	The question of whether the plankton communities in low-utrient regions of the ocean, comprising 80% of the global ocean surface area, are net producers or consumers of oxygen and fixed carbon is a key uncertainty in the global carbon cycle(1,2). Direct measurements in bottle experiments indicate net oxygen consumption in the sunlit zone(3-6), whereas geochemical evidence suggests that the upper ocean is a net source of oxygen(2). One possible resolution to this conflict is that primary production in the gyres is episodic(1,2,6) and thus difficult to observe: in this model, oligotrophic regions would be net consumers of oxygen during most of the year, but strong, brief events with high primary production rates might produce enough fixed carbon and dissolved oxygen to yield net production as an average over the annual cycle. Here we examine the balance of oxygen production over three years at sites in the North and South Pacific subtropical gyres using the new technique of oxygen sensors deployed on profiling floats. We find that mixing events during early winter homogenize the upper water column and cause low oxygen concentrations. Oxygen then increases below the mixed layer at a nearly constant rate that is similar to independent measures of net community production. This continuous oxygen increase is consistent with an ecosystem that is a net producer of fixed carbon ( net autotrophic) throughout the year, with episodic events not required to sustain positive oxygen production.	[Riser, Stephen C.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Johnson, Kenneth S.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	University of Washington; University of Washington Seattle; Monterey Bay Aquarium Research Institute	Riser, SC (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	riser@ocean.washington.edu; johnson@mbari.org	Johnson, Kenneth S/F-9742-2011	Johnson, Kenneth S/0000-0001-5513-5584				ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; DUARTE CM, 1999, SCIENCE, V284, P173; Emerson S, 2002, DEEP-SEA RES PT I, V49, P941, DOI 10.1016/S0967-0637(02)00004-3; Johnson KS, 2007, CHEM REV, V107, P623, DOI 10.1021/cr050354e; Karl DM, 2003, NATURE, V426, P32, DOI 10.1038/426032a; Keeling CD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002227; Kortzinger A, 2004, SCIENCE, V306, P1337, DOI 10.1126/science.1102557; Letelier RM, 2000, J GEOPHYS RES-OCEANS, V105, P28723, DOI 10.1029/1999JC000306; Roemmich D, 2004, MAR TECHNOL SOC J, V38, P21, DOI 10.4031/002533204787522802; Roemmich D., 2001, OBSERVING OCEANS 21, P248; Scharek R, 1999, MAR ECOL PROG SER, V182, P55, DOI 10.3354/meps182055; Schlitzer R., 2006, OCEAN DATA VIEW; SHULENBERGER E, 1981, DEEP-SEA RES, V28, P901, DOI 10.1016/0198-0149(81)90009-1; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9; Williams PJL, 2004, DEEP-SEA RES PT I, V51, P1563, DOI 10.1016/j.dsr.2004.07.001; WILLIAMS PJL, 1999, SCIENCE, V284, P173	20	151	156	5	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					323	U5		10.1038/nature06441	http://dx.doi.org/10.1038/nature06441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202655				2022-12-24	WOS:000252432100047
J	Beaulieu, JM; Marion, S; Rodriguiz, RM; Medvedev, IO; Sotnikova, TD; Ghisi, V; Wetsel, WC; Lefkowitz, RJ; Gainetdinov, RR; Caron, MG				Beaulieu, Jean-Martin; Marion, Sebastien; Rodriguiz, Ramona M.; Medvedev, Ivan O.; Sotnikova, Tatyana D.; Ghisi, Valentina; Wetsel, William C.; Lefkowitz, Robert J.; Gainetdinov, Raul R.; Caron, Marc G.			A beta-arrestin 2 signaling complex mediates lithium action on Behavior	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; MOUSE-BRAIN; KINASE-B; IN-VIVO; MICE; ACTIVATION; DESENSITIZATION; PHOSPHORYLATION	Besides their role in desensitization, b-arrestin 1 and 2 promote the formation of signaling complexes allowing G protein-coupled receptors (GPCR) to signal independently from G proteins. Here we show that lithium, a pharmacological agent used for the management of psychiatric disorders such as bipolar disorder, schizophrenia, and depression, regulates Akt/glycogen synthase kinase 3 (GSK3) signaling and related behaviors in mice by disrupting a signaling complex composed of Akt, beta-arrestin 2, and protein phosphatase 2A. When administered to beta-arrestin 2 knockout mice, lithium fails to affect Akt/GSK3 signaling and induce behavioral changes associated with GSK3 inhibition as it does in normal animals. These results point toward a pharmacological approach to modulating GPCR function that affects the formation of beta-arrestin-mediated signaling complexes.	[Beaulieu, Jean-Martin; Marion, Sebastien; Medvedev, Ivan O.; Sotnikova, Tatyana D.; Ghisi, Valentina; Wetsel, William C.; Gainetdinov, Raul R.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Lefkowitz, Robert J.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Wetsel, William C.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	m.caron@cellbio.duke.edu	Sotnikova, Tatyana D/T-9992-2017; Lefkowitz, Robert/AAW-2649-2021; Beaulieu, Jean-Martin/A-7598-2008; Gainetdinov, Raul R/G-5875-2011	Beaulieu, Jean-Martin/0000-0002-0446-7447; Gainetdinov, Raul R/0000-0003-2951-6038; Marion, Sebastien/0000-0002-3302-3845	NIMH NIH HHS [MH-73853, MH-40159] Funding Source: Medline; NINDS NIH HHS [NS-19576] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073853, P50MH040159, P30MH040159, R37MH073853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Beaulieu JM, 2007, INT J NEUROPSYCHOPH, V10, P3, DOI 10.1017/S1461145706006857; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2006, J BIOL CHEM, V281, P32072, DOI 10.1074/jbc.M606062200; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BIRCH NJ, 1974, LANCET, V2, P965; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; COX C, 1971, NATURE, V232, P336, DOI 10.1038/232336a0; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowley JJ, 2004, PHARMACOL BIOCHEM BE, V78, P269, DOI 10.1016/j.pbb.2004.03.014; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P2173, DOI 10.1038/sj.npp.1301338; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lavoie L, 1999, J BIOL CHEM, V274, P28279, DOI 10.1074/jbc.274.40.28279; Li XH, 2004, NEUROPSYCHOPHARMACOL, V29, P1426, DOI 10.1038/sj.npp.1300439; Li XH, 2007, INT J NEUROPSYCHOPH, V10, P7, DOI 10.1017/S1461145706006547; LOHSE MJ, 1989, P NATL ACAD SCI USA, V86, P3011, DOI 10.1073/pnas.86.9.3011; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Marion S, 2004, J BIOL CHEM, V279, P2945, DOI 10.1074/jbc.M308742200; Martinex A, 2006, NEUROBIOL AGING, V27, pS13; O'Brien WT, 2004, J NEUROSCI, V24, P6791, DOI 10.1523/JNEUROSCI.4753-03.2004; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; SMITH DF, 1980, PSYCHOPHARMACOLOGY, V68, P315, DOI 10.1007/BF00428123; Valenstein M, 2006, AM J PSYCHIAT, V163, P1219, DOI 10.1176/appi.ajp.163.7.1219; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613	52	273	285	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					125	136		10.1016/j.cell.2007.11.041	http://dx.doi.org/10.1016/j.cell.2007.11.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191226	Bronze			2022-12-24	WOS:000253427600021
J	Tanaka, JI; Horiike, Y; Matsuzaki, M; Miyazaki, T; Ellis-Davies, GCR; Kasai, H				Tanaka, Jun-ichi; Horiike, Yoshihiro; Matsuzaki, Masanori; Miyazaki, Takashi; Ellis-Davies, Graham C. R.; Kasai, Haruo			Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines	SCIENCE			English	Article							LONG-TERM POTENTIATION; LTP; POLYRIBOSOMES; LOCALIZATION; HIPPOCAMPUS; GEOMETRY; BDNF; RAT	Long- term potentiation ( LTP) at glutamatergic synapses is considered to underlie learning and memory and is associated with the enlargement of dendritic spines. Because the consolidation of memory and LTP require protein synthesis, it is important to clarify how protein synthesis affects spine enlargement. In rat brain slices, the repetitive pairing of postsynaptic spikes and two- photon uncaging of glutamate at single spines ( a spike- timing protocol) produced both immediate and gradual phases of spine enlargement in CA1 pyramidal neurons. The gradual enlargement was strongly dependent on protein synthesis and brain- derived neurotrophic factor ( BDNF) action, often associated with spine twitching, and was induced specifically at the spines that were immediately enlarged by the synaptic stimulation. Thus, this spike- timing protocol is an efficient trigger for BDNF secretion and induces protein synthesis- dependent long- term enlargement at the level of single spines.	[Tanaka, Jun-ichi; Horiike, Yoshihiro; Matsuzaki, Masanori; Miyazaki, Takashi; Kasai, Haruo] Univ Tokyo, Lab Struct Physiol, Ctr Dis Biol & Integrat Med, Grad Sch Med, Tokyo 1130033, Japan; [Tanaka, Jun-ichi; Horiike, Yoshihiro; Matsuzaki, Masanori; Miyazaki, Takashi; Kasai, Haruo] Univ Tokyo, Ctr Nanobio Integrat, Tokyo 1130033, Japan; [Tanaka, Jun-ichi; Matsuzaki, Masanori; Miyazaki, Takashi; Kasai, Haruo] Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448787, Japan; [Tanaka, Jun-ichi; Matsuzaki, Masanori; Miyazaki, Takashi; Kasai, Haruo] Grad Univ Adv Studies SOKENDAI, Okazaki, Aichi 4448787, Japan; [Matsuzaki, Masanori] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Ellis-Davies, Graham C. R.] Drexel Univ, Coll Med, Dept Pharmacol & Physiol, Philadelphia, PA 19102 USA	University of Tokyo; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Drexel University	Kasai, H (corresponding author), Univ Tokyo, Lab Struct Physiol, Ctr Dis Biol & Integrat Med, Grad Sch Med, Tokyo 1130033, Japan.	hkasai@m.u-tokyo.ac.jp		Kasai, Haruo/0000-0003-2327-9027; Matsuzaki, Masanori/0000-0003-3872-4322	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395, R24GM065473] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053395-12, R01 GM053395, R24 GM065473] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aicardi G, 2004, P NATL ACAD SCI USA, V101, P15788, DOI 10.1073/pnas.0406960101; Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Santamaria F, 2006, NEURON, V52, P635, DOI 10.1016/j.neuron.2006.10.025; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Squire L. R., 1987, MEMORY BRAIN; STEWARD O, 1982, J NEUROSCI, V2, P284; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	23	449	468	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1683	1687		10.1126/science.1152864	http://dx.doi.org/10.1126/science.1152864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18309046	Green Accepted			2022-12-24	WOS:000254172300046
J	Maisel, WH				Maisel, William H.			Semper Fidelis - Consumer protection for patients with implanted medical devices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Dept Med, Med Device Safety Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Maisel, WH (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Med Device Safety Inst, Boston, MA 02215 USA.							[Anonymous], 2007, URG MED DEV INF SPRI; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P161, DOI 10.1001/jama.295.2.161-b; Maisel WH, 2005, JAMA-J AM MED ASSOC, V294, P955, DOI 10.1001/jama.294.8.955; 2008, WALL STREET J   0102, pA10	4	76	76	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					985	987		10.1056/NEJMp0800495	http://dx.doi.org/10.1056/NEJMp0800495			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269JG	18322280	Bronze			2022-12-24	WOS:000253644700001
J	Harper, GR; Pfennig, DW				Harper, George R., Jr.; Pfennig, David W.			Selection overrides gene flow to break down maladaptive mimicry	NATURE			English	Article							BIASED DISPERSAL; MODEL; SNAKE; POPULATIONS; PATTERNS; PREDATORS; TOOLS	Predators typically avoid dangerous species, and batesian mimicry evolves when a palatable species ( the 'mimic') co- opts a warning signal from a dangerous species ( the 'model') and thereby deceives its potential predators(1,2). Because predators would not be under selection to avoid the model and any of its look- alikes in areas where the model is absent ( that is, allopatry)(2-5), batesian mimics should occur only in sympatry with their model. However, contrary to this expectation, batesian mimics often occur in allopatry(6-8). Here we focus on one such example - a coral snake mimic(3,8). Using indirect DNA- based methods, we provide evidence suggesting that mimics migrate from sympatry, where mimicry is favoured(3,9), to allopatry, where it is disfavoured(10). Such gene flow is much stronger in nuclear genes than in maternally inherited mitochondrial genes, indicating that dispersal by males may explain the presence of mimetic phenotypes in allopatry. Despite this gene flow, however, individuals from allopatry resemble the model less than do individuals from sympatry. We show that this breakdown of mimicry probably reflects predator- mediated selection acting against individuals expressing the more conspicuous mimetic phenotype in allopatry. Thus, although gene flow may explain why batesian mimics occur in allopatry, natural selection may often override such gene flow and promote the evolution of non- mimetic phenotypes in such areas.	[Harper, George R., Jr.; Pfennig, David W.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Pfennig, DW (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	dpfennig@unc.edu		Harper, George/0000-0001-5649-1206				Armstrong MP, 2001, J HERPETOL, V35, P688, DOI 10.2307/1565915; Bates HW., 1862, T LINN SOC LOND, V23, P495, DOI [DOI 10.1111/J.1096-3642.1860.TB00146.X, 10.1111/j.1096-3642.1860.tb00146.x]; Beerli P, 1999, GENETICS, V152, P763; Blouin-Demers G, 2002, CAN J ZOOL, V80, P1162, DOI 10.1139/Z02-096; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; BRODIE ED, 1993, EVOLUTION, V47, P227, DOI 10.1111/j.1558-5646.1993.tb01212.x; Brodie III ED, 2004, VENOMOUS REPTILES W, P617; BROWER LP, 1962, ECOLOGY, V43, P154; CLARKE C, 1975, PHILOS T ROY SOC B, V272, P229, DOI 10.1098/rstb.1975.0084; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; GREENE HW, 1981, SCIENCE, V213, P1207, DOI 10.1126/science.213.4513.1207; Harper GR, 2007, P R SOC B, V274, P1955, DOI 10.1098/rspb.2007.0558; HARPER GR, 2006, THESIS U N CAROLINA; Keogh JS, 2007, BIOL LETTERS, V3, P33, DOI 10.1098/rsbl.2006.0570; KING RB, 1995, EVOLUTION, V49, P885, DOI 10.1111/j.1558-5646.1995.tb02324.x; Nichols J., 2001, DISPERSAL; Palmer W. M., 1995, REPTILES N CAROLINA; Pfennig DW, 2007, BEHAV ECOL SOCIOBIOL, V61, P505, DOI 10.1007/s00265-006-0278-x; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SMITH SM, 1975, SCIENCE, V187, P759, DOI 10.1126/science.187.4178.759; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WALDBAUER GP, 1987, AM MIDL NAT, V118, P145, DOI 10.2307/2425637; Wallace Alfred Russel, 1870, CONTRIBUTIONS THEORY	29	47	48	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					1103	U6		10.1038/nature06532	http://dx.doi.org/10.1038/nature06532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305543				2022-12-24	WOS:000253453600041
J	Bell, KJL; Irwig, L; Craig, JC; Macaskill, P				Bell, Katy J. L.; Irwig, Les; Craig, Jonathan C.; Macaskill, Petra			Use of randomised trials to decide when to monitor response to new treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THERAPY		[Bell, Katy J. L.; Irwig, Les; Craig, Jonathan C.; Macaskill, Petra] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia	University of Sydney	Bell, KJL (corresponding author), Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Edward Ford Bldg A27, Sydney, NSW 2006, Australia.	katyb@health.usyd.edu.au	Craig, Jonathan/E-2813-2013; Bell, Katy/B-9650-2013	Craig, Jonathan/0000-0002-2548-4035; Bell, Katy/0000-0002-0137-3218; Macaskill, Petra/0000-0001-5879-6193				Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P1318, DOI 10.1001/jama.283.10.1318; Cummings SR, 2002, AM J MED, V112, P281, DOI 10.1016/S0002-9343(01)01124-X; Glasziou P, 2005, BMJ-BRIT MED J, V330, P644, DOI 10.1136/bmj.330.7492.644; GLASZIOU P, 2007, EVIDENCE BASED MED M, P245; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Morton V, 2005, J EVAL CLIN PRACT, V11, P59, DOI 10.1111/j.1365-2753.2004.00505.x; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Sellin L, 2005, J HYPERTENS, V23, P2083, DOI 10.1097/01.hjh.0000186022.74245.01; Senn S, 2001, DRUG INF J, V35, P1479, DOI 10.1177/009286150103500443; Tonkin A, 1998, NEW ENGL J MED, V339, P1349	11	24	25	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2008	336	7640					361	365		10.1136/bmj.39476.623611.25	http://dx.doi.org/10.1136/bmj.39476.623611.25			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268AP	18276713	Green Submitted, Green Published			2022-12-24	WOS:000253550600038
J	Monkhorst, K; Jonkers, I; Rentmeester, E; Grosveld, F; Gribnau, J				Monkhorst, Kim; Jonkers, Iris; Rentmeester, Eveline; Grosveld, Frank; Gribnau, Joost			X inactivation counting and choice is a stochastic process: Evidence for involvement of an X-linked activator	CELL			English	Article							CHROMOSOME INACTIVATION; XIST GENE; TSIX; TRANSCRIPTION; EXPRESSION; ANTISENSE; REGION; CELLS; XITE; MICE	Female mammalian cells achieve dosage compensation of X-encoded genes by X chromosome inactivation (XCI). This process is thought to involve X chromosome counting and choice. To explore how this process is initiated, we analyzed XCI in tetraploid XXXX, XXXY, and XXYY embryonic stem cells and found that every X chromosome within a single nucleus has an independent probability to initiate XCI. This finding suggests a stochastic mechanism directing XCI counting and choice. The probability is directly proportional to the X chromosome:ploidy ratio, indicating the presence of an X-encoded activator of XCI, that itself is inactivated by the XCI process. Deletion of a region including Xist, Tsix, and Xite still results in XCI on the remaining wild-type X chromosome in female cells. This result supports a stochastic model in which each X chromosome in a nucleus initiates XCI independently and positions an X-encoded trans-acting XCI-activator outside the deleted region.	[Monkhorst, Kim; Jonkers, Iris; Rentmeester, Eveline; Grosveld, Frank; Gribnau, Joost] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Monkhorst, Kim; Jonkers, Iris; Rentmeester, Eveline; Gribnau, Joost] Erasmus MC, Dept Reprod & Dev, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Gribnau, J (corresponding author), Erasmus MC, Dept Cell Biol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.gribnau@erasmusmc.nl						Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Burgoyne PS, 1995, PHILOS T R SOC B, V350, P253, DOI 10.1098/rstb.1995.0159; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gribnau J, 2005, J CELL BIOL, V168, P365, DOI 10.1083/jcb.200405117; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 2002, NAT GENET, V32, P195, DOI 10.1038/ng939; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; LYON MF, 1964, CYTOGENETICS, V3, P306, DOI 10.1159/000129820; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1999, GENE DEV, V13, P2624, DOI 10.1101/gad.13.20.2624; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Matveeva NM, 2005, MOL REPROD DEV, V71, P305, DOI 10.1002/mrd.20266; Mlynarczyk-Evans S, 2006, PLOS BIOL, V4, P906, DOI 10.1371/journal.pbio.0040159; Morey C, 2004, EMBO J, V23, P594, DOI 10.1038/sj.emboj.7600071; Nesterova TB, 2003, GENE DEV, V17, P2177, DOI 10.1101/gad.271203; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; TAKAGI N, 1993, GENETICA, V88, P107, DOI 10.1007/BF02424467; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103; WEBB S, 1992, GENET RES, V59, P205, DOI 10.1017/S0016672300030494; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	39	118	119	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					410	421		10.1016/j.cell.2007.12.036	http://dx.doi.org/10.1016/j.cell.2007.12.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267073	Bronze			2022-12-24	WOS:000253180700016
J	Alonso-Coello, P; Garcia-Franco, AL; Guyatt, G; Moynihan, R				Alonso-Coello, Pablo; Lopez Garcia-Franco, Alberto; Guyatt, Gordon; Moynihan, Ray			Drugs for pre-osteoporosis: prevention or disease mongering?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VERTEBRAL FRACTURE RISK; POSTMENOPAUSAL WOMEN; RALOXIFENE; METAANALYSIS; ALENDRONATE		[Alonso-Coello, Pablo] Univ Autonoma Barcelona, Hosp St Pau, Dept Clin Epidemiol & Publ Hlth, Iberoamer Cochrane Ctr, Barcelona 08041, Spain; [Lopez Garcia-Franco, Alberto] Serv Madrileno Salud, Madrid, Spain; [Guyatt, Gordon] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Guyatt, Gordon] McMaster Univ, Fac Hlth Sci, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Moynihan, Ray] Univ Newcastle, Fac Hlth, Callaghan, NSW, Australia	Autonomous University of Barcelona; McMaster University; McMaster University; University of Newcastle	Alonso-Coello, P (corresponding author), Univ Autonoma Barcelona, Hosp St Pau, Dept Clin Epidemiol & Publ Hlth, Iberoamer Cochrane Ctr, Barcelona 08041, Spain.	palonso@santpau.es	Moynihan, Ray/ABC-3010-2020					[Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cummings SR, 2006, JAMA-J AM MED ASSOC, V296, P2601, DOI 10.1001/jama.296.21.2601; Deeks JJ, 2002, STAT MED, V21, P1575, DOI 10.1002/sim.1188; *DEP HHS, 2004, ODS POSTM SAF REV; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; *EUR MED AG, 2007, EMEA REC CHANG PROD; International Osteoporosis Foundation, KEY STAT N AM; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2003, BONE, V33, P293, DOI 10.1016/S8756-3282(03)00200-X; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Miller PD, 2004, ARCH INTERN MED, V164, P1113, DOI 10.1001/archinte.164.10.1113; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2005, SELLING SICKNESS DRU; NELSON HD, 2001, OSTEOPOROSIS POSTMEN; O'Donnell S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005326.pub2; O'Neill TW, 2002, J BONE MINER RES, V17, P2214, DOI 10.1359/jbmr.2002.17.12.2214; Quandt SA, 2005, MAYO CLIN PROC, V80, P343, DOI 10.4065/80.3.343; Schousboe JT, 2005, ANN INTERN MED, V142, P734, DOI 10.7326/0003-4819-142-9-200505030-00008; SEEMAN E, 2007, J BONE MINER RE 1112; SIRIS ES, 2007, OSTEOPOROS INT  1030; STEVENSON M, 2007, HEALTH TECHNOL ASSES, P11; Valensi P, 2005, DIABETES METAB, V31, P606, DOI 10.1016/S1262-3636(07)70239-2	24	49	51	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2008	336	7636					126	129		10.1136/bmj.39435.656250.AD	http://dx.doi.org/10.1136/bmj.39435.656250.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257SS	18202066	Green Submitted, Green Published			2022-12-24	WOS:000252819400029
J	Prather, JF; Peters, S; Nowicki, S; Mooney, R				Prather, J. F.; Peters, S.; Nowicki, S.; Mooney, R.			Precise auditory-vocal mirroring in neurons for learned vocal communication	NATURE			English	Article							IDENTIFIED HVC NEURONS; ZEBRA FINCH; ACTION RECOGNITION; PREMOTOR CORTEX; EFFERENCE COPY; ADULT SONG; MECHANISMS; LANGUAGE; NUCLEUS; LESIONS	Brain mechanisms for communication must establish a correspondence between sensory and motor codes used to represent the signal. One idea is that this correspondence is established at the level of single neurons that are active when the individual performs a particular gesture or observes a similar gesture performed by another individual. Although neurons that display a precise auditory- vocal correspondence could facilitate vocal communication, they have yet to be identified. Here we report that a certain class of neurons in the swamp sparrow forebrain displays a precise auditory- vocal correspondence. We show that these neurons respond in a temporally precise fashion to auditory presentation of certain note sequences in this songbird's repertoire and to similar note sequences in other birds' songs. These neurons display nearly identical patterns of activity when the bird sings the same sequence, and disrupting auditory feedback does not alter this singing- related activity, indicating it is motor in nature. Furthermore, these neurons innervate striatal structures important for song learning, raising the possibility that singing- related activity in these cells is compared to auditory feedback to guide vocal learning.	[Prather, J. F.; Nowicki, S.; Mooney, R.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Peters, S.; Nowicki, S.] Duke Univ, Dept Biol, Durham, NC 27710 USA	Duke University; Duke University	Mooney, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	mooney@neuro.duke.edu	Nowicki, Stephen/Y-9690-2019; Galantucci, Bruno/E-5770-2010	Mooney, Richard/0000-0002-3308-1367	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002524] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002524] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; BELL CC, 1981, SCIENCE, V214, P450, DOI 10.1126/science.7291985; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Farries MA, 2002, J NEUROSCI, V22, P3776; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gentner TQ, 2000, J NEUROBIOL, V42, P117, DOI 10.1002/(SICI)1097-4695(200001)42:1<117::AID-NEU11>3.0.CO;2-M; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hyman J, 2003, ANIM BEHAV, V65, P1179, DOI 10.1006/anbe.2003.2175; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lewicki MS, 1996, J NEUROSCI, V16, P5854; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MARLER P, 1981, SCIENCE, V213, P780, DOI 10.1126/science.213.4509.780; MARLER P, 1984, ANIM BEHAV, V32, P673, DOI 10.1016/S0003-3472(84)80143-8; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; MARLER P, 1988, NATURE, V336, P770, DOI 10.1038/336770a0; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; Mooney R, 2001, P NATL ACAD SCI USA, V98, P12778, DOI 10.1073/pnas.221453298; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Okanoya K, 1997, J NEUROBIOL, V33, P343; Perkel DJ, 2002, BRAIN RES BULL, V57, P529, DOI 10.1016/S0361-9230(01)00690-6; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rosen MJ, 2003, NEURON, V39, P177, DOI 10.1016/S0896-6273(03)00357-X; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Wild JM, 2005, J COMP NEUROL, V483, P76, DOI 10.1002/cne.20403; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	43	277	281	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					305	U2		10.1038/nature06492	http://dx.doi.org/10.1038/nature06492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202651				2022-12-24	WOS:000252432100043
J	Palmer, TM; Stanton, ML; Young, TP; Goheen, JR; Pringle, RM; Karban, R				Palmer, Todd M.; Stanton, Maureen L.; Young, Truman P.; Goheen, Jacob R.; Pringle, Robert M.; Karban, Richard			Breakdown of an ant-plant mutualism follows the loss of large herbivores from an African Savanna	SCIENCE			English	Article							SWOLLEN-THORN ACACIAS; STABLE ISOTOPES; KENYA; COEXISTENCE; COMPETITION; ECOSYSTEM; LAIKIPIA; FOREST; GUILD	Mutualisms are key components of biodiversity and ecosystem function, yet the forces maintaining them are poorly understood. We investigated the effects of removing large mammals on an ant-Acacia mutualism in an African savanna. Ten years of large-herbivore exclusion reduced the nectar and housing provided by plants to ants, increasing antagonistic behavior by a mutualistic ant associate and shifting competitive dominance within the plant-ant community from this nectar-dependent mutualist to an antagonistic species that does not depend on plant rewards. Trees occupied by this antagonist suffered increased attack by stem-boring beetles, grew more slowly, and experienced doubled mortality relative to trees occupied by the mutualistic ant. These results show that large mammals maintain cooperation within a widespread symbiosis and suggest complex cascading effects of megafaunal extinction.	[Palmer, Todd M.; Goheen, Jacob R.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Palmer, Todd M.; Stanton, Maureen L.; Young, Truman P.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Stanton, Maureen L.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; [Palmer, Todd M.; Stanton, Maureen L.; Young, Truman P.; Goheen, Jacob R.; Pringle, Robert M.] Mpala Res Ctr, Nanyuki, Kenya; [Young, Truman P.] Univ Calif Davis, Dept Plant Environm Sci, Davis, CA 95616 USA; [Goheen, Jacob R.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Pringle, Robert M.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Karban, Richard] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	State University System of Florida; University of Florida; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of British Columbia; Stanford University; University of California System; University of California Davis	Palmer, TM (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.	tmpalmer@zoo.ufl.edu	Palmer, Todd/GRS-0639-2022; Stanton, Maureen L/E-1204-2012	Palmer, Todd/0000-0001-5710-9750				Brockerhoff EG, 2006, CAN J FOREST RES, V36, P263, DOI 10.1139/x06-013; BROWN WL, 1960, ECOLOGY, V41, P587, DOI 10.2307/1933346; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; Frederickson ME, 2005, OECOLOGIA, V143, P387, DOI 10.1007/s00442-004-1817-7; HARDY RWF, 1975, SCIENCE, V188, P633, DOI 10.1126/science.188.4188.633; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; HOCKING B, 1970, T ROY ENT SOC LONDON, V122, P211; Huntzinger M, 2004, ECOLOGY, V85, P609, DOI 10.1890/03-3056; JANZEN DANIEL H., 1967, UNIV KANS SCI SCI BULL, V47, P315; JANZEN DH, 1972, ECOLOGY, V53, P885, DOI 10.2307/1934304; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Ottichilo WK, 2000, AFR J ECOL, V38, P202, DOI 10.1046/j.1365-2028.2000.00242.x; Palmer TM, 2000, OECOLOGIA, V123, P425, DOI 10.1007/s004420051030; Palmer TM, 2003, ECOLOGY, V84, P2843, DOI 10.1890/02-0528; Palmer TM, 2002, OECOLOGIA, V133, P372, DOI 10.1007/s00442-002-1026-1; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Pringle RM, 2007, P NATL ACAD SCI USA, V104, P193, DOI 10.1073/pnas.0609840104; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Stanton ML, 1999, NATURE, V401, P578, DOI 10.1038/44119; Stanton ML, 2002, ECOL MONOGR, V72, P347, DOI 10.1890/0012-9615(2002)072[0347:CCTOIA]2.0.CO;2; Stapley L, 1998, OECOLOGIA, V115, P401, DOI 10.1007/s004420050534; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wheeler W.M., 1920, T AM PHIL SOC, V22, P235; Young T. P., 1997, African Journal of Range & Forage Science, V14, P94, DOI 10.1080/10220119.1997.9647929; Young TP, 1997, OECOLOGIA, V109, P98, DOI 10.1007/s004420050063; Young TP, 2003, OIKOS, V101, P171, DOI 10.1034/j.1600-0706.2003.12067.x	28	192	200	11	408	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					192	195		10.1126/science.1151579	http://dx.doi.org/10.1126/science.1151579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187652				2022-12-24	WOS:000252246400038
J	Shimizu, H; Iwamoto, M; Konno, T; Nihei, A; Sasaki, YC; Oiki, S				Shimizu, Hirofumi; Iwamoto, Masayuki; Konno, Takashi; Nihei, Amiko; Sasaki, Yuji C.; Oiki, Shigetoshi			Global twisting motion of single molecular KcsA potassium channel upon Gating	CELL			English	Article							FULL-LENGTH KCSA; K+-CHANNEL; X-RAYS; STREPTOMYCES-LIVIDANS; INTRACELLULAR GATE; CRYSTAL-STRUCTURE; ENERGY LANDSCAPE; ACTIVATION; F-1-ATPASE; MECHANISM	Ion channels are signal transduction molecules that switch ion permeation pathways on and off (gating). Crystal structures of several kinds of potassium channels have revealed open and closed conformations, which provide static pictures of gating status. Here we studied KcsA potassium channels undergoing conformational changes at the single-molecule level. A KcsA channel with a gold nanocrystal attached was irradiated by white X-rays and motions of the diffraction spot from the nanocrystal were tracked in real time. Upon gating, the KcsA channels twisted around the axis of the pore. These conformational changes were prevented by an open-channel blocker, tetrabuthylammonium. Random clockwise and counterclockwise twisting in the range of several tens of degrees originated in the transmembrane domain and was transmitted to the cytoplasmic domain. This coupling suggests a mechanical interplay between the transmembrane and cytoplasmic domains.	[Shimizu, Hirofumi; Iwamoto, Masayuki; Konno, Takashi; Sasaki, Yuji C.; Oiki, Shigetoshi] Japan Sci & Technol Corp, CREST Sasaki Team, Tokyo 1900012, Japan; [Shimizu, Hirofumi; Iwamoto, Masayuki; Konno, Takashi; Oiki, Shigetoshi] Univ Fukui, Fac Med Sci, Dept Physiol & Mol Biophys, Fukui 9101193, Japan; [Sasaki, Yuji C.] Japan Synchrotron Radiat Res Inst, Hyogo 6795198, Japan; [Nihei, Amiko] Sll NanoTechnol Inc, Engn Grp, Chiba 2702222, Japan	Japan Science & Technology Agency (JST); University of Fukui; Japan Synchrotron Radiation Research Institute	Oiki, S (corresponding author), Japan Sci & Technol Corp, CREST Sasaki Team, Tokyo 1900012, Japan.	oiki-fki@umin.ac.jp	SASAKI, Yuji/N-6880-2016	SASAKI, Yuji/0000-0003-3403-237X; Iwamoto, Masayuki/0000-0001-9505-2652				Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Bragg WH, 1913, P R SOC LOND A-CONTA, V88, P428, DOI 10.1098/rspa.1913.0040; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Faraldo-Gomez JD, 2007, J MOL BIOL, V365, P649, DOI 10.1016/j.jmb.2006.09.069; FRIEDRICH W, 1912, P BAV AC SCI, P303; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Iwamoto M, 2006, J BIOL CHEM, V281, P28379, DOI 10.1074/jbc.M602018200; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Kelly BL, 2003, NAT STRUCT BIOL, V10, P280, DOI 10.1038/nsb908; KUO RL, 2003, WORLD J SURG ONCOL, V1, P1; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Okumura Y, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021917; Okumura Y, 2005, THIN SOLID FILMS, V471, P91, DOI 10.1016/j.tsf.2004.04.033; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Sasaki YC, 2000, PHYS REV E, V62, P3843, DOI 10.1103/PhysRevE.62.3843; Sasaki YC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.248102; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Sigg D, 2003, P NATL ACAD SCI USA, V100, P7611, DOI 10.1073/pnas.1332409100; Sigg D, 2003, BIOPHYS J, V84, P3703, DOI 10.1016/S0006-3495(03)75099-1; Terada T, 1913, NATURE, V91, P213, DOI 10.1038/091213b0; Terada T, 1913, NATURE, V91, P135, DOI 10.1038/091135c0; Terada T., 1913, P TOKYO MATH PHYS SO, V7, P60; Thomas D. D, 1986, TECHNIQUES ANAL MEMB; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zimmer J, 2006, BIOPHYS J, V90, P1752, DOI 10.1529/biophysj.105.071175	40	90	91	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2008	132	1					67	78		10.1016/j.cell.2007.11.040	http://dx.doi.org/10.1016/j.cell.2007.11.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191221	Bronze, Green Submitted			2022-12-24	WOS:000253427600016
J	Tripp, HJ; Kitner, JB; Schwalbach, MS; Dacey, JWH; Wilhelm, LJ; Giovannoni, SJ				Tripp, H. James; Kitner, Joshua B.; Schwalbach, Michael S.; Dacey, John W. H.; Wilhelm, Larry J.; Giovannoni, Stephen J.			SAR11 marine bacteria require exogenous reduced sulphur for growth	NATURE			English	Article							DISSOLVED DIMETHYLSULFONIOPROPIONATE; BACTERIOPLANKTON COMMUNITIES; NORTH-ATLANTIC; SULFATE; REDUCTION; OCEAN; MICROORGANISMS; METABOLISM; GENOMICS; SEQUENCE	Sulphur is a universally required cell nutrient found in two amino acids and other small organic molecules. All aerobic marine bacteria are known to use assimilatory sulphate reduction to supply sulphur for biosynthesis, although many can assimilate sulphur from organic compounds that contain reduced sulphur atoms(1-3). An analysis of three complete 'Candidatus Pelagibacter ubique' genomes, and public ocean metagenomic data sets, suggested that members of the ubiquitous and abundant SAR11 alphaproteobacterial clade are deficient in assimilatory sulphate reduction genes. Here we show that SAR11 requires exogenous sources of reduced sulphur, such as methionine or 3-dimethylsulphoniopropionate (DMSP) for growth. Titrations of the algal osmolyte DMSP in seawater medium containing all other macronutrients in excess showed that 1.5 x 10(8) SAR11 cells are produced per nanomole of DMSP. Although it has been shown that other marine alphaproteobacteria use sulphur from DMSP in preference to sulphate(1,2), our results indicate that 'Cand. P. ubique' relies exclusively on reduced sulphur compounds that originate from other plankton.	[Tripp, H. James; Kitner, Joshua B.; Schwalbach, Michael S.; Wilhelm, Larry J.; Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Dacey, John W. H.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Oregon State University; Woods Hole Oceanographic Institution	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, 220 Nash Hall, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	van den Berg, Constant MG/A-7065-2012	van den Berg, Constant MG/0000-0003-2234-9345				Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; Bernal A, 2001, NUCLEIC ACIDS RES, V29, P126, DOI 10.1093/nar/29.1.126; Berndt C, 2004, J BIOL CHEM, V279, P7850, DOI 10.1074/jbc.M309332200; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; CUHEL RL, 1982, APPL ENVIRON MICROB, V43, P151, DOI 10.1128/AEM.43.1.151-159.1982; DANIELS L, 1986, APPL ENVIRON MICROB, V51, P703, DOI 10.1128/AEM.51.4.703-709.1986; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glaeser J, 1999, ARCH MICROBIOL, V171, P405, DOI 10.1007/s002030050727; HEINZINGER NK, 1995, J BACTERIOL, V177, P2813, DOI 10.1128/jb.177.10.2813-2820.1995; Hou SB, 2004, P NATL ACAD SCI USA, V101, P18036, DOI 10.1073/pnas.0407638102; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kiene RP, 2000, GEOCHIM COSMOCHIM AC, V64, P2797, DOI 10.1016/S0016-7037(00)00399-9; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; LIPPERT KD, 1969, ARCH MIKROBIOL, V65, P29, DOI 10.1007/BF00412063; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Neumann S, 2000, MOL BIOL REP, V27, P27, DOI 10.1023/A:1007058421714; Nicastro D., 2006, MICROSC MICROANAL, V12, P180, DOI [10.1017/S1431927606067456, DOI 10.1017/S1431927606067456]; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Ruckert C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-121; SCHUT F, 1993, APPL ENVIRON MICROB, V59, P2150, DOI 10.1128/AEM.59.7.2150-2160.1993; Simo R, 2002, LIMNOL OCEANOGR, V47, P53, DOI 10.4319/lo.2002.47.1.0053; Stingl U, 2007, ISME J, V1, P361, DOI 10.1038/ismej.2007.49; Street JH, 2005, MET IONS BIOL SYST, V43, P153; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; VENTURA S, 1988, ARCH MICROBIOL, V149, P273, DOI 10.1007/BF00411641; Zubkov MV, 2002, DEEP-SEA RES PT II, V49, P3017, DOI 10.1016/S0967-0645(02)00069-3	30	251	259	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					741	744		10.1038/nature06776	http://dx.doi.org/10.1038/nature06776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18337719				2022-12-24	WOS:000254792500043
J	Grabowsky, M				Grabowsky, Mark			The billion-dollar malaria moment	NATURE			English	Editorial Material							INSECTICIDE-TREATED BEDNETS; COVERAGE		Global Fund Fight AIDS TB & Malaria, CH-1214 Geneva, Switzerland		Grabowsky, M (corresponding author), Global Fund Fight AIDS TB & Malaria, 8 Chemin Blandonnet, CH-1214 Geneva, Switzerland.							Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Grabowsky M, 2005, B WORLD HEALTH ORGAN, V83, P195; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; *NAT AC BOARD GLOB, 2004, SAV LIV BUYING TIM E; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151	6	30	31	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					1051	1052		10.1038/4511051a	http://dx.doi.org/10.1038/4511051a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305524				2022-12-24	WOS:000253453600021
J	Higgs, DR				Higgs, Douglas R.			A new dawn for stem-cell therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DU, England	University of Oxford	Higgs, DR (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DU, England.			Higgs, Douglas/0000-0003-3579-8705	MRC [MC_U137961144] Funding Source: UKRI; Medical Research Council [MC_U137961144] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	5	11	12	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					964	966		10.1056/NEJMcibr0708823	http://dx.doi.org/10.1056/NEJMcibr0708823			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18305272				2022-12-24	WOS:000253430200015
J	Trounson, A; Klein, R; Murphy, R				Trounson, Alan; Klein, Robert; Murphy, Richard			Stem cell research in California: The game is on	CELL			English	Editorial Material								The California Initiative embodied in Proposition 71 was designed to boost embryonic stem cell research and its translation into cell therapies in the face of federal restrictions on such research. With funding starting to flow, the stem cell revolution is now underway.	[Trounson, Alan; Klein, Robert; Murphy, Richard] California Inst Regenerat Med, San Francisco, CA 94107 USA		Trounson, A (corresponding author), California Inst Regenerat Med, San Francisco, CA 94107 USA.	atrounson@cirm.ca.gov		Trounson, Alan/0000-0001-5469-0500				Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Seach N, 2007, CURR OPIN BIOTECH, V18, P441, DOI 10.1016/j.copbio.2007.07.001	2	6	6	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					522	524		10.1016/j.cell.2008.02.014	http://dx.doi.org/10.1016/j.cell.2008.02.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295567	Bronze			2022-12-24	WOS:000253817900009
J	Yang, XY; Ongusaha, PP; Miles, PD; Havstad, JC; Zhang, FX; So, WV; Kudlow, JE; Michell, RH; Olefsky, JM; Field, SJ; Evans, RM				Yang, Xiaoyong; Ongusaha, Pat P.; Miles, Philip D.; Havstad, Joyce C.; Zhang, Fengxue; So, W. Venus; Kudlow, Jeffrey E.; Michell, Robert H.; Olefsky, Jerrold M.; Field, Seth J.; Evans, Ronald M.			Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance	NATURE			English	Article							N-ACETYLGLUCOSAMINE; NUCLEOCYTOPLASMIC GLYCOSYLATION; CYTOSOLIC PROTEINS; ACTIVATION; MUSCLE; NUCLEAR; GLUCOSE; IDENTIFICATION; GLCNACYLATION; PHOSPHATASES	Glucose flux through the hexosamine biosynthetic pathway leads to the post-translational modification of cytoplasmic and nuclear proteins by O-linked beta-N-acetylglucosamine (O-GlcNAc). This tandem system serves as a nutrient sensor to couple systemic metabolic status to cellular regulation of signal transduction, transcription, and protein degradation. Here we show that O-GlcNAc transferase (OGT) harbours a previously unrecognized type of phosphoinositide-binding domain. After induction with insulin, phosphatidylinositol 3,4,5-trisphosphate recruits OGT from the nucleus to the plasma membrane, where the enzyme catalyses dynamic modification of the insulin signalling pathway by O-GlcNAc. This results in the alteration in phosphorylation of key signalling molecules and the attenuation of insulin signal transduction. Hepatic overexpression of OGT impairs the expression of insulin-responsive genes and causes insulin resistance and dyslipidaemia. These findings identify a molecular mechanism by which nutritional cues regulate insulin signalling through O-GlcNAc, and underscore the contribution of this modification to the aetiology of insulin resistance and type 2 diabetes.	[Yang, Xiaoyong; Havstad, Joyce C.; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Yang, Xiaoyong; Havstad, Joyce C.; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Ongusaha, Pat P.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Ongusaha, Pat P.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Miles, Philip D.; Olefsky, Jerrold M.; Field, Seth J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Zhang, Fengxue; Kudlow, Jeffrey E.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [So, W. Venus] Hoffmann La Roche Inc, Roche Grp Res Informat, Nutley, NJ 07110 USA; [Michell, Robert H.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Harvard University; Massachusetts General Hospital; Harvard University; University of California System; University of California San Diego; University of Alabama System; University of Alabama Birmingham; Roche Holding; University of Birmingham	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu	Michell, Robert H/AAT-4974-2020; Evans, Ronald/AAF-4001-2019	Michell, Robert H/0000-0001-9422-9858; Evans, Ronald/0000-0002-9986-5965; Field, Seth/0000-0002-8893-4806	NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA014195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Asante-Appiah E, 2003, AM J PHYSIOL-ENDOC M, V284, pE663, DOI 10.1152/ajpendo.00462.2002; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Joost HG, 2000, METH MOL B, V155, P77; Konrad RJ, 2002, INT J MOL MED, V10, P535; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Lazar DF, 2006, NAT REV DRUG DISCOV, V5, P333, DOI 10.1038/nrd2007; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Majumdar G, 2004, DIABETES, V53, P3184, DOI 10.2337/diabetes.53.12.3184; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Roos MD, 1998, P ASSOC AM PHYSICIAN, V110, P422; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Su KH, 2000, BIOCHEM J, V348, P281, DOI 10.1042/0264-6021:3480281; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whisenhunt TR, 2006, GLYCOBIOLOGY, V16, P551, DOI 10.1093/glycob/cwj096; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Yki-Jarvinen H, 1998, METABOLISM, V47, P449, DOI 10.1016/S0026-0495(98)90058-0; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	50	422	439	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					964	U1		10.1038/nature06668	http://dx.doi.org/10.1038/nature06668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288188				2022-12-24	WOS:000253313100042
J	Mettetal, JT; Muzzey, D; Gomez-Uribe, C; van Oudenaarden, A				Mettetal, Jerome T.; Muzzey, Dale; Gomez-Uribe, Carlos; van Oudenaarden, Alexander			The frequency dependence of osmo-adaptation in Saccharomyces cerevisiae	SCIENCE			English	Article							BACTERIAL CHEMOTAXIS; HIGH-OSMOLARITY; YEAST; STRESS; NETWORKS; GLYCEROL; ACCUMULATION; BIOLOGY; SYSTEMS; KINASE	The propagation of information through signaling cascades spans a wide range of time scales, including the rapid ligand- receptor interaction and the much slower response of downstream gene expression. To determine which dynamic range dominates a response, we used periodic stimuli to measure the frequency dependence of signal transduction in the osmo- adaptation pathway of Saccharomyces cerevisiae. We applied system identification methods to infer a concise predictive model. We found that the dynamics of the osmo- adaptation response are dominated by a fast-acting negative feedback through the kinase Hog1 that does not require protein synthesis. After large osmotic shocks, an additional, much slower, negative feedback through gene expression allows cells to respond faster to future stimuli.	[Mettetal, Jerome T.; Muzzey, Dale; Gomez-Uribe, Carlos; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Muzzey, Dale] Harvard Univ, Sch Med, Grad Biophys Program, Boston, MA 02115 USA; [Gomez-Uribe, Carlos] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957] Funding Source: NIH RePORTER; NIDDK NIH HHS [5 R90 DK071511-01, R90 DK071511] Funding Source: Medline; NIGMS NIH HHS [R01-GM068957, R01 GM068957-06, R01 GM068957-05, R01 GM068957] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; [Anonymous], 1983, SIGNALS SYSTEMS; BLOCK SM, 1982, CELL, V31, P215, DOI 10.1016/0092-8674(82)90421-4; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gennemark Peter, 2006, In Silico Biology, V6, P193; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Ingalls BP, 2004, J PHYS CHEM B, V108, P1143, DOI 10.1021/jp036567u; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Krantz M, 2004, EUKARYOT CELL, V3, P1381, DOI 10.1128/EC.3.6.1381-1390.2004; Lipan O, 2005, P NATL ACAD SCI USA, V102, P7063, DOI 10.1073/pnas.0403790102; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Samoilov M, 2002, J PHYS CHEM A, V106, P10205, DOI 10.1021/jp025846z; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; Sontag ED, 2005, EUR J CONTROL, V11, P396, DOI 10.3166/ejc.11.396-435; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Vance W, 2002, P NATL ACAD SCI USA, V99, P5816, DOI 10.1073/pnas.022049699; Westwick D. T., 2003, IDENTIFICATION NONLI; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	25	256	261	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					482	484		10.1126/science.1151582	http://dx.doi.org/10.1126/science.1151582			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218902	Green Accepted			2022-12-24	WOS:000252576600043
J	Deppmann, CD; Mihalas, S; Sharma, N; Lonze, BE; Niebur, E; Ginty, DD				Deppmann, Christopher D.; Mihalas, Stefan; Sharma, Nikhil; Lonze, Bonnie E.; Niebur, Ernst; Ginty, David D.			A model for neuronal competition during development	SCIENCE			English	Article							NERVE GROWTH-FACTOR; RECEPTOR GENE-EXPRESSION; SYMPATHETIC NEURONS; IN-VIVO; SENSORY NEURONS; SURVIVAL; NGF; DEATH; MICE	We report that developmental competition between sympathetic neurons for survival is critically dependent on a sensitization process initiated by target innervation and mediated by a series of feedback loops. Target- derived nerve growth factor ( NGF) promoted expression of its own receptor TrkA in mouse and rat neurons and prolonged TrkA- mediated signals. NGF also controlled expression of brain- derived neurotrophic factor and neurotrophin- 4, which, through the receptor p75, can kill neighboring neurons with low retrograde NGF- TrkA signaling whereas neurons with high NGF- TrkA signaling are protected. Perturbation of any of these feedback loops disrupts the dynamics of competition. We suggest that three target- initiated events are essential for rapid and robust competition between neurons: sensitization, paracrine apoptotic signaling, and protection from such effects.	[Deppmann, Christopher D.; Mihalas, Stefan; Sharma, Nikhil; Lonze, Bonnie E.; Niebur, Ernst; Ginty, David D.] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Deppmann, Christopher D.; Sharma, Nikhil; Lonze, Bonnie E.; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Mihalas, Stefan; Niebur, Ernst] Johns Hopkins Univ, Sch Med, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu		Lonze, Bonnie/0000-0002-0973-1657	NATIONAL EYE INSTITUTE [R01EY016281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034814, R01NS034814, F32NS053187, R37NS034814] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY016281, EY016281] Funding Source: Medline; NINDS NIH HHS [R01 NS034814, NS34814, NS053187, F32 NS053187, R37 NS034814] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; Campenot R B, 1979, Methods Enzymol, V58, P302; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Lei L, 2001, DEVELOPMENT, V128, P1147; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; MILLER FD, 1991, J CELL BIOL, V112, P303, DOI 10.1083/jcb.112.2.303; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; WYATT S, 1995, J CELL BIOL, V130, P1435, DOI 10.1083/jcb.130.6.1435; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004	21	122	124	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2008	320	5874					369	373		10.1126/science.1152677	http://dx.doi.org/10.1126/science.1152677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZZ	18323418	Green Accepted			2022-12-24	WOS:000255026100042
J	Alimohammadi, M; Bjorklund, P; Hallgren, A; Pontynen, N; Szinnai, G; Shikama, N; Keller, MP; Ekwall, O; Kinkel, SA; Husebye, ES; Gustafsson, J; Rorsman, F; Peltonen, L; Betterle, C; Perheentupa, J; Akerstrom, G; Westin, G; Scott, HS; Hollander, GA; Kampe, O				Alimohammadi, Mohammad; Bjorklund, Peyman; Hallgren, Asa; Pontynen, Nora; Szinnai, Gabor; Shikama, Noriko; Keller, Marcel P.; Ekwall, Olov; Kinkel, Sarah A.; Husebye, Eystein S.; Gustafsson, Jan; Rorsman, Fredrik; Peltonen, Leena; Betterle, Corrado; Perheentupa, Jaakko; Akerstrom, Goran; Westin, Gunnar; Scott, Hamish S.; Hollaender, Georg A.; Kampe, Olle			Autoimmune polyendocrine syndrome type 1 and NALP5, parathyroid autoantigen	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CANDIDIASIS-ECTODERMAL DYSTROPHY; CALCIUM-SENSING RECEPTOR; REGULATORY T-CELLS; SYNDROME TYPE-I; ADRENAL INSUFFICIENCY; EMBRYONIC-DEVELOPMENT; ACID DECARBOXYLASE; DISEASE; MICE; AUTOANTIBODIES	Background: Autoimmune polyendocrine syndrome type 1 (APS-1) is a multiorgan autoimmune disorder caused by mutations in AIRE, the autoimmune regulator gene. Though recent studies concerning AIRE deficiency have begun to elucidate the molecular pathogenesis of organ-specific autoimmunity in patients with APS-1, the autoantigen responsible for hypoparathyroidism, a hallmark of APS-1 and its most common autoimmune endocrinopathy, has not yet been identified. Methods: We performed immunoscreening of a human parathyroid complementary DNA library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with reactivity to the NACHT leucine-rich-repeat protein 5 (NALP5). Subsequently, serum samples from 87 patients with APS-1 and 293 controls, including patients with other autoimmune disorders, were used to determine the frequency and specificity of autoantibodies against NALP5. In addition, the expression of NALP5 was investigated in various tissues. Results: NALP5-specific autoantibodies were detected in 49% of the patients with APS-1 and hypoparathyroidism but were absent in all patients with APS-1 but without hypoparathyroidism, in all patients with other autoimmune endocrine disorders, and in all healthy controls. NALP5 was predominantly expressed in the cytoplasm of parathyroid chief cells. Conclusions: NALP5 appears to be a tissue-specific autoantigen involved in hypoparathyroidism in patients with APS-1. Autoantibodies against NALP5 appear to be highly specific and may be diagnostic for this prominent component of APS-1.	[Alimohammadi, Mohammad; Bjorklund, Peyman; Hallgren, Asa; Ekwall, Olov; Gustafsson, Jan; Rorsman, Fredrik; Akerstrom, Goran; Westin, Gunnar; Kampe, Olle] Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden; [Pontynen, Nora; Peltonen, Leena] Univ Helsinki, Helsinki, Finland; [Pontynen, Nora; Peltonen, Leena] Natl Publ Hlth Inst, Biomed Helsinki, Helsinki, Finland; [Perheentupa, Jaakko] Univ Helsinki Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Szinnai, Gabor; Shikama, Noriko; Keller, Marcel P.; Hollaender, Georg A.] Univ Basel, Lab Pediat Immunol, Basel, Switzerland; [Szinnai, Gabor; Shikama, Noriko; Keller, Marcel P.; Hollaender, Georg A.] Univ Childrens Hosp, Basel, Switzerland; [Kinkel, Sarah A.; Scott, Hamish S.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Kinkel, Sarah A.; Scott, Hamish S.] Univ Melbourne, Parkville, Vic 3052, Australia; [Husebye, Eystein S.] Univ Bergen, Inst Med, Bergen, Norway; Haukeland Hosp, N-5021 Bergen, Norway; [Betterle, Corrado] Univ Padua, Padua, Italy	Uppsala University; Uppsala University Hospital; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Basel; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Bergen; University of Padua	Kampe, O (corresponding author), Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden.	olle.kampe@medsci.uu.se	Scott, Hamish/B-2122-2009; Björklund, Peyman/A-1509-2014	Scott, Hamish/0000-0002-5813-631X; Björklund, Peyman/0000-0002-9398-4496; Ekwall, Olov/0000-0002-4506-9955; Kampe, Olle/0000-0001-6091-9914; Hollander, Georg/0000-0002-8790-0874; Szinnai, Gabor/0000-0003-0559-2597				AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; AHONEN P, 1987, J CLIN ENDOCR METAB, V64, P494, DOI 10.1210/jcem-64-3-494; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Betterle C, 2002, ENDOCR REV, V23, P579; Betterle C, 2002, ENDOCR REV, V23, P327, DOI 10.1210/er.23.3.327; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Eisenbarth GS, 2004, NEW ENGL J MED, V350, P2068, DOI 10.1056/NEJMra030158; Ekwall O, 1998, LANCET, V352, P279, DOI 10.1016/S0140-6736(97)11050-9; Falorni A, 2004, J CLIN ENDOCR METAB, V89, P1598, DOI 10.1210/jc.2003-030954; Gavalas NG, 2007, J CLIN ENDOCR METAB, V92, P2107, DOI 10.1210/jc.2006-2466; GebreMedhin G, 1997, FEBS LETT, V412, P439, DOI 10.1016/S0014-5793(97)00797-7; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Gillard GO, 2007, J IMMUNOL, V178, P3007, DOI 10.4049/jimmunol.178.5.3007; Gylling M, 2003, J CLIN ENDOCR METAB, V88, P4602, DOI 10.1210/jc.2003-030700; Kekalainen E, 2007, J IMMUNOL, V178, P1208, DOI 10.4049/jimmunol.178.2.1208; KOJIMA A, 1981, IMMUNOGENETICS, V14, P15, DOI 10.1007/BF00344296; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Li YX, 1996, J CLIN INVEST, V97, P910, DOI 10.1172/JCI118513; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Pennetier S, 2004, BIOL REPROD, V71, P1359, DOI 10.1095/biolreprod.104.030288; Perheentupa J, 2006, J CLIN ENDOCR METAB, V91, P2843, DOI 10.1210/jc.2005-2611; Skoldberg F, 2004, J CLIN ENDOCR METAB, V89, P1636, DOI 10.1210/jc.2003-031161; Soderbergh A, 2004, J CLIN ENDOCR METAB, V89, P557, DOI 10.1210/jc.2003-030279; TAGUCHI O, 1980, CLIN EXP IMMUNOL, V40, P540; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tung KSK, 2005, CURR TOP MICROBIOL, V293, P209; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; WINQVIST O, 1992, LANCET, V339, P1559, DOI 10.1016/0140-6736(92)91829-W	31	175	181	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					1018	1028		10.1056/NEJMoa0706487	http://dx.doi.org/10.1056/NEJMoa0706487			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18322283				2022-12-24	WOS:000253644700006
J	Chen, KM; Harjes, E; Gross, PJ; Fahmy, A; Lu, YJ; Shindo, K; Harris, RS; Matsuo, H				Chen, Kuan-Ming; Harjes, Elena; Gross, Phillip J.; Fahmy, Amr; Lu, Yongjian; Shindo, Keisuke; Harris, Reuben S.; Matsuo, Hiroshi			Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G	NATURE			English	Article							3-DIMENSIONAL NMR-SPECTROSCOPY; CYTIDINE DEAMINASE; CRYSTAL-STRUCTURE; SEDIMENTATION-VELOCITY; RETROVIRAL INFECTION; HIGH-SENSITIVITY; PROTEIN; RESONANCE; ASSIGNMENT; COMPLEX	The human APOBEC3G ( apolipoprotein B messenger- RNA-editing enzyme, catalytic polypeptide- like 3G) protein is a single-strand DNA deaminase that inhibits the replication of human immunodeficiency virus-1 (HIV-1), other retroviruses and retrotransposons(1-6). APOBEC3G anti- viral activity is circumvented by most retroelements, such as through degradation by HIV-1 Vif(7). APOBEC3G is a member of a family of polynucleotide cytosine deaminases, several of which also target distinct physiological substrates. For instance, APOBEC1 edits APOB mRNA and AID deaminates antibody gene DNA(8-10). Although structures of other family members exist, none of these proteins has elicited polynucleotide cytosine deaminase or anti- viral activity(11-16). Here we report a solution structure of the human APOBEC3G catalytic domain. Five alpha- helices, including two that form the zinc- coordinating active site, are arranged over a hydrophobic platform consisting of five beta-strands. NMR DNA titration experiments, computational modelling, phylogenetic conservation and Escherichia coli- based activity assays combine to suggest a DNA-binding model in which a brim of positively charged residues positions the target cytosine for catalysis. The structure of the APOBEC3G catalytic domain will help us to understand functions of other family members and interactions that occur with pathogenic proteins such as HIV- 1 Vif.	[Chen, Kuan-Ming; Harjes, Elena; Gross, Phillip J.; Lu, Yongjian; Shindo, Keisuke; Harris, Reuben S.; Matsuo, Hiroshi] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Chen, Kuan-Ming; Harjes, Elena; Gross, Phillip J.; Lu, Yongjian; Shindo, Keisuke; Harris, Reuben S.; Matsuo, Hiroshi] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Gross, Phillip J.; Shindo, Keisuke; Harris, Reuben S.] Univ Minnesota, Arnold & Mabel Beckman Ctr Genome Engn, Minneapolis, MN 55455 USA; [Fahmy, Amr] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School	Matsuo, H (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	rsh@umn.edu; matsu029@umn.edu		Harjes, Elena/0000-0002-3643-9432; Shindo, Keisuke/0000-0001-8793-8189; Chen, Kuan-Ming/0000-0003-1715-5319	NIAID NIH HHS [R21 AI073167] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073167] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P8172, DOI 10.1021/bi00487a027; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; Devany M, 2004, PROTEIN SCI, V13, P2252, DOI 10.1110/ps.04797104; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; GOLDSTEIN RF, 1994, BIOPHYS J, V66, P1335, DOI 10.1016/S0006-3495(94)80923-3; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KELLER R, 2004, THESIS SWISS FED I T; Kim S, 2001, BIOCHEMISTRY-US, V40, P6776, DOI 10.1021/bi002700m; Ko TP, 2003, J BIOL CHEM, V278, P19111, DOI 10.1074/jbc.M300874200; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Matsuo H, 1996, J MAGN RESON SER B, V111, P194, DOI 10.1006/jmrb.1996.0082; Matsuo H, 1996, J MAGN RESON SER B, V110, P112, DOI 10.1006/jmrb.1996.0018; Matsuo H, 1996, J MAGN RESON SER B, V113, P91, DOI 10.1006/jmrb.1996.0161; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Teh AH, 2006, BIOCHEMISTRY-US, V45, P7825, DOI 10.1021/bi060345f; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xiang SB, 1997, BIOCHEMISTRY-US, V36, P4768, DOI 10.1021/bi963091e; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	53	178	200	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					116	U16		10.1038/nature06638	http://dx.doi.org/10.1038/nature06638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18288108				2022-12-24	WOS:000253671900058
J	King, MT; Fayers, PM				King, Madeleine T.; Fayers, Peter M.			Making quality-of-life results more meaningful for clinicians	LANCET			English	Editorial Material							TRIALS		[King, Madeleine T.] Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW 2043, Australia; [Fayers, Peter M.] Univ Aberdeen, Dept Publ Hlth, Aberdeen, Scotland; [Fayers, Peter M.] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway	University of Technology Sydney; University of Aberdeen; Norwegian University of Science & Technology (NTNU)	King, MT (corresponding author), Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW 2043, Australia.	Madeleine.King@chere.uts.edu.au		Fayers, Peter/0000-0003-4778-1513				*CLIN TRIALS COOP, 1988, CANC THER EV PROGR G; Fayers P, 2002, EUR J CANCER, V38, pS125; Fayers P.M., 2001, EORTC QLQ C30 SCORIN, V3rd; FAYERS PM, 2000, QUALITY LIFE ASSESSM, P325; Guyatt G, 2007, QUAL LIFE RES, V16, P1097, DOI 10.1007/s11136-007-9223-3; JOHNSON JR, 1985, CANCER TREAT REP, V69, P1155; Medical Research Council, 1998, GUID GOOD CLIN PRACT; *MRC, 1998, VIRT CYCL WORK TOG H; Osoba D, 2005, EUR J CANCER, V41, P280, DOI 10.1016/j.ejca.2004.10.017; Osoba D, 1992, Qual Life Res, V1, P211, DOI 10.1007/BF00635620; Schunemann HJ, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-62; Wisloff F, 1996, BRIT J HAEMATOL, V94, P324, DOI 10.1046/j.1365-2141.1996.d01-1802.x	12	21	21	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					709	710		10.1016/S0140-6736(08)60324-4	http://dx.doi.org/10.1016/S0140-6736(08)60324-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313491				2022-12-24	WOS:000253596700011
J	Hellings, WE; Moll, FL; De Vries, JPPM; Ackerstaff, RGA; Seldenrijk, KA; Met, R; Velema, E; Derksen, WJM; De Kleijn, DPV; Pasterkamp, G				Hellings, Willem E.; Moll, Frans L.; De Vries, Jean-Paul P. M.; Ackerstaff, Rob G. A.; Seldenrijk, Kees A.; Met, Rosemarie; Velema, Evelyn; Derksen, Wouter J. M.; De Kleijn, Dominique P. V.; Pasterkamp, Gerard			Atherosclerotic plaque composition and occurrence of Restenosis after carotid endarterectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARTERY STENOSIS; CARDIOVASCULAR EVENTS; ELUTING STENTS; PREDICTORS; DIAGNOSIS; STROKE; IMPACT; RISK	Context Previous studies have assessed the predictive value of clinical and angiographic parameters for development of restenosis after vascular interventions. The composition of the atherosclerotic plaque at the intervention site has not been evaluated as a marker for restenosis. Objective To investigate the relationship between atherosclerotic plaque histology and the occurrence of restenosis after carotid endarterectomy. Design, Setting, and Patients The Athero- Express study is a longitudinal vascular biobank study that includes the collection of atherosclerotic plaques of patients undergoing primary carotid endarterectomy. Five hundred patients were prospectively followed up between April 1, 2002, and March 14, 2006, to assess carotid artery restenosis measured by duplex ultrasound 1 year after the intervention. Main Outcome Measures Risk of carotid restenosis in relation to predefined histological characteristics ( macrophage and smooth muscle cell infiltration, collagen, calcifications, intraplaque bleeding, luminal thrombus, and lipid core size), adjusted for clinical characteristics ( multivariate logistic regression analysis). Results At 1 year, 85 patients ( 17%) developed 50% or greater restenosis, including 40 patients ( 8%) who developed 70% or greater restenosis of the target vessel. Patients whose histological examination of the plaque revealed marked macrophage infiltration ( n= 286) had a lower risk than those with none or minor macrophage infiltration ( n= 214) of developing 50% or greater restenosis ( risk difference, 11.5% vs 24.3%; adjusted odds ratio [ OR], 0.43; 95% confidence interval [ CI], 0.26- 0.72) and a lower risk of developing 70% or greater restenosis ( risk difference, 4.5% vs 12.6%; adjusted OR, 0.36; 95% CI, 0.17- 0.74). Patients ( n= 177) with a plaque having a large lipid core size ( > 40%) had a lower risk than those ( n= 94) with a plaque having a lipid core size of less than 10% of developing 50% or greater restenosis ( risk difference, 11.3% vs 25.5%; adjusted OR, 0.40; 95% CI, 0.19- 0.81) and a lower risk of developing 70% or greater restenosis ( risk difference, 5.6% vs 14.9%; adjusted OR, 0.42; 95% CI, 0.17- 1.04), independent of clinical characteristics. Conclusions Plaque composition is an independent predictor of restenosis after carotid endarterectomy. The dissection of a lipid- rich, inflammatory plaque is associated with reduced risk of restenosis.	[Met, Rosemarie; Velema, Evelyn; Derksen, Wouter J. M.; De Kleijn, Dominique P. V.; Pasterkamp, Gerard] Univ Utrecht, Med Ctr, Expt Cardiol Lab, Div Heart & Lungs, NL-3584 CX Utrecht, Netherlands; [Hellings, Willem E.; Moll, Frans L.] Univ Utrecht, Med Ctr, Dept Vasc Surg, NL-3584 CX Utrecht, Netherlands; [De Vries, Jean-Paul P. M.] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [De Vries, Jean-Paul P. M.] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [Ackerstaff, Rob G. A.] St Antonius Hosp, Dept Clin Neurophysiol, Nieuwegein, Netherlands; [Seldenrijk, Kees A.] St Antonius Hosp, Dept Pathol, Nieuwegein, Netherlands	Utrecht University; Utrecht University; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht	Pasterkamp, G (corresponding author), Univ Utrecht, Med Ctr, Expt Cardiol Lab, Div Heart & Lungs, Heidelberglaan 100,Ste G02-523, NL-3584 CX Utrecht, Netherlands.	g.pasterkamp@umcutrecht.nl						CLAGETT GP, 1986, J VASC SURG, V3, P10; CLAGETT GP, 1983, SURGERY, V93, P313; Farb A, 2002, CIRCULATION, V105, P2974, DOI 10.1161/01.CIR.0000019071.72887.BD; Frericks H, 1998, STROKE, V29, P244, DOI 10.1161/01.STR.29.1.244; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Halliday A, 2004, LANCET, V363, P1491; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HEALY DA, 1989, J VASC SURG, V10, P662, DOI 10.1067/mva.1989.16374; Hellings WE, 2007, J VASC SURG, V46, P1147, DOI 10.1016/j.jvs.2007.08.018; Hellings WE, 2007, J VASC SURG, V45, P289, DOI 10.1016/j.jvs.2006.09.051; Hermiller JB, 2005, J AM COLL CARDIOL, V45, P1172, DOI 10.1016/j.jacc.2004.10.075; Higuchi Maria L., 2002, Arq. Bras. Cardiol., V79, P20, DOI 10.1590/S0066-782X2002001000003; Lee CW, 2006, AM J CARDIOL, V97, P506, DOI 10.1016/j.amjcard.2005.09.084; Lee SG, 1999, CATHETER CARDIO INTE, V47, P406, DOI 10.1002/(SICI)1522-726X(199908)47:4<406::AID-CCD5>3.3.CO;2-G; LENG GC, 1992, J CLIN EPIDEMIOL, V45, P1101, DOI 10.1016/0895-4356(92)90150-L; Liapis CD, 2002, EUR J VASC ENDOVASC, V24, P239, DOI 10.1053/ejvs.2002.1714; Lovett JK, 2004, CEREBROVASC DIS, V18, P117, DOI 10.1159/000079259; Marek JM, 1998, J SURG RES, V74, P27, DOI 10.1006/jsre.1997.5222; Mauri L, 2004, AM J CARDIOL, V93, P1340, DOI 10.1016/j.amjcard.2004.02.027; Moreno PR, 2002, CIRCULATION, V105, P2504, DOI 10.1161/01.CIR.0000017265.52501.37; Moussa I, 2004, CIRCULATION, V109, P2273, DOI 10.1161/01.CIR.0000129767.45513.71; Naylor R, 2004, J VASC SURG, V39, P985, DOI 10.1016/j.jvs.2004.01.037; Netuka D, 2006, ACTA NEUROCHIR, V148, P511, DOI 10.1007/s00701-006-0756-y; Pasterkamp G, 1998, J AM COLL CARDIOL, V32, P655, DOI 10.1016/S0735-1097(98)00304-0; Pasterkamp G, 2000, CARDIOVASC RES, V45, P843, DOI 10.1016/S0008-6363(99)00377-6; Pasterkamp G, 2000, ATHEROSCLEROSIS, V150, P245, DOI 10.1016/S0021-9150(99)00371-8; Post MJ, 1997, CIRCULATION, V96, P996; Puppini G, 2006, RADIOL MED, V111, P921, DOI 10.1007/s11547-006-0091-7; Reina-Gutierrez T, 2005, EUR J VASC ENDOVASC, V29, P334, DOI 10.1016/j.ejvs.2004.10.007; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Sabeti S, 2005, J ENDOVASC THER, V12, P6, DOI 10.1583/04-1359.1; Schulte-Altedorneburg G, 2005, J NEUROL, V252, P575, DOI 10.1007/s00415-005-0703-5; SCHWARCZ TH, 1987, J VASC SURG, V5, P280, DOI 10.1067/mva.1987.avs0050280; Trivedi RA, 2006, ARTERIOSCL THROM VAS, V26, P1601, DOI 10.1161/01.ATV.0000222920.59760.df; Valentine RJ, 1996, STROKE, V27, P1502, DOI 10.1161/01.STR.27.9.1502; Verhoeven B, 2005, J VASC SURG, V42, P1075, DOI 10.1016/j.jvs.2005.08.009; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WIKSTRAND J, 1994, J INTERN MED, V236, P555, DOI 10.1111/j.1365-2796.1994.tb00845.x	40	91	94	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					547	554		10.1001/jama.299.5.547	http://dx.doi.org/10.1001/jama.299.5.547			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252885	Bronze			2022-12-24	WOS:000252886100020
J	Steiner, MJ; Cates, W; Genuis, S				Steiner, Markus J.; Cates, Willard; Genuis, Stephen			Are condoms the answer to rising rates of non-HIV sexually transmitted infection?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Steiner, Markus J.; Cates, Willard] Family Hlth Int, Res Triangle Pk, NC 27709 USA; [Genuis, Stephen] Univ Alberta, Edmonton, AB T6K 4C1, Canada	University of Alberta	Steiner, MJ (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	wcates@fhi.org; sgenuis@ualberta.ca							0	9	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 26	2008	336	7637					184	185		10.1136/bmj.39402.488727.AD	http://dx.doi.org/10.1136/bmj.39402.488727.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259KT	18219036	Green Published			2022-12-24	WOS:000252938900037
J	Horton, R				Horton, Richard			Maternal and child undernutrition: an urgent opportunity	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9	1	68	76	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2008	371	9608					179	179		10.1016/S0140-6736(07)61869-8	http://dx.doi.org/10.1016/S0140-6736(07)61869-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207569				2022-12-24	WOS:000252471900004
J	Lim, KH; Ancrile, BB; Kashatus, DF; Counter, CM				Lim, Kian-Huat; Ancrile, Brooke B.; Kashatus, David F.; Counter, Christopher M.			Tumour maintenance is mediated by eNOS	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; KAPPA-B KINASE; PROTEIN S-NITROSYLATION; K-RAS; N-RAS; CELL-LINES; IN-VIVO; HA-RAS; ACTIVATION; CANCER	Tumour cells become addicted to the expression of initiating oncogenes like Ras, such that loss of oncogene expression in established tumours leads to tumour regression(1). HRas, NRas or KRas are mutated to remain in the active GTP- bound oncogenic state in many cancers(2). Although Ras activates several proteins to initiate human tumour growth, only PI3K, through activation of protein kinase B ( PKB; also known as AKT), must remain activated by oncogenic Ras to maintain this growth63. Here we show that blocking phosphorylation of the AKT substrate, endothelial nitric oxide synthase ( eNOS or NOS3), inhibits tumour initiation and maintenance. Moreover, eNOS enhances the nitrosylation and activation of endogenous wild- type Ras proteins, which are required throughout tumorigenesis. We suggest that activation of the PI3K - AKT - eNOS -( wild- type) Ras pathway by oncogenic Ras in cancer cells is required to initiate and maintain tumour growth.	[Lim, Kian-Huat; Ancrile, Brooke B.; Kashatus, David F.; Counter, Christopher M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Dept Radiat Oncol, Durham, NC 27710 USA.	count004@mc.duke.edu	Kashatus, David F/D-8299-2012	Kashatus, David F/0000-0001-8007-0612; Counter, Christopher M/0000-0003-0748-3079; Lim, Kian-Huat/0000-0002-2766-200X	NCI NIH HHS [R01 CA094184-04, R01 CA094184-03, R01 CA094184-02, R01 CA123031, R01 CA094184-01, R01 CA094184-05, R01 CA094184, R01 CA123031-01A2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA123031, R01CA094184] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Fotiadou PP, 2007, MOL CELL BIOL, V27, P6742, DOI 10.1128/MCB.00234-07; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Giuriato S, 2004, SEMIN CANCER BIOL, V14, P3, DOI 10.1016/j.semcancer.2003.11.002; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Hamilton M, 1998, ONCOGENE, V16, P1417, DOI 10.1038/sj.onc.1201653; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; HUANG DCS, 1993, MOL CELL BIOL, V13, P2420, DOI 10.1128/MCB.13.4.2420; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kita K, 1999, INT J CANCER, V80, P553, DOI 10.1002/(SICI)1097-0215(19990209)80:4<553::AID-IJC12>3.0.CO;2-6; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Li J, 2003, ONCOGENE, V22, P1243, DOI 10.1038/sj.onc.1206192; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Wan J, 2006, WORLD J GASTROENTERO, V12, P1033, DOI 10.3748/wjg.v12.i7.1037; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866	34	227	238	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2008	452	7187					646	U11		10.1038/nature06778	http://dx.doi.org/10.1038/nature06778			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18344980	Green Accepted, Bronze			2022-12-24	WOS:000254567200049
J	Bezemer, ID; Bare, LA; Doggen, CJM; Arellano, AR; Tong, C; Rowland, CM; Catanese, J; Young, BA; Reitsma, PH; Devlin, JJ; Rosendaal, FR				Bezemer, Irene D.; Bare, Lance A.; Doggen, Carine J. M.; Arellano, Andre R.; Tong, Carmen; Rowland, Charles M.; Catanese, Joseph; Young, Bradford A.; Reitsma, Pieter H.; Devlin, James J.; Rosendaal, Frits R.			Gene variants associated with deep vein thrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VENOUS THROMBOSIS; PROTEIN-C; FACTOR-XI; MYOCARDIAL-INFARCTION; RISK-FACTOR; SUSCEPTIBILITY; ACTIVATION; MUTATIONS; INCREASE; REGION	Context The genetic causes of deep vein thrombosis ( DVT) are not fully understood. Objective To identify single- nucleotide polymorphisms ( SNPs) associated with DVT. Design, Setting, and Patients We used 3 case- control studies of first DVT. A total of 19 682 gene- centric SNPs were genotyped in 443 cases and 453 controls from the Leiden Thrombophilia Study ( LETS, 1988- 1992). Twelve hundred six SNPs associated with DVT were reinvestigated in the Multiple Environmental and Genetic Assessment of Risk Factors for Venous Thrombosis study ( MEGA- 1, 1999- 2004) in a subset of 1398 cases and 1757 controls. Nine SNPs associated with DVT in both LETS and MEGA- 1 were investigated a third time in 1314 cases and 2877 controls from MEGA- 2, a second subset of MEGA. Additional SNPs close to one SNP in CYP4V2 were genotyped in LETS and MEGA- 1. Main Outcome Measure Odds ratios ( ORs) for DVT were estimated by logistic regression. False discovery rates served to investigate the effect of multiple hypothesis testing. Results Of 9 SNPs genotyped in MEGA- 2, 3 were strongly associated with DVT ( P <. 05; false discovery rate <=. 10): rs13146272 in CYP4V2 ( risk allele frequency, 0.64), rs2227589 in SERPINC1 ( risk allele frequency, 0.10), and rs1613662 in GP6 ( risk allele frequency, 0.84). The OR for DVT per risk allele was 1.24 ( 95% confidence interval [ 95% CI], 1.11- 1.37) for rs13146272, 1.29 ( 95% CI, 1.10- 1.49) for rs2227589, and 1.15 ( 95% CI, 1.01- 1.30) for rs1613662. In the region of CYP4V2, we identified 4 additional SNPs ( in CYP4V2, KLKB1, and F11) that were also associated with both DVT ( highest OR per risk allele, 1.39; 95% CI, 1.11- 1.74) and coagulation factor XI level ( highest increase per risk allele, 8%; 95% CI, 5%- 11%). Conclusions We identified SNPs in several genes that were associated with DVT. We also found SNPs in the region around the SNP in CYP4V2 ( rs13146272) that were associated with both DVT and factor XI levels. These results show that common genetic variation plays an important role in determining thrombotic risk.	[Bezemer, Irene D.; Doggen, Carine J. M.; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; [Reitsma, Pieter H.; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands; [Reitsma, Pieter H.; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, NL-2300 RC Leiden, Netherlands; [Bare, Lance A.; Arellano, Andre R.; Tong, Carmen; Rowland, Charles M.; Catanese, Joseph; Young, Bradford A.; Devlin, James J.] Celera, Alameda, CA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rosendaal, FR (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, C9-P,POB 9600, NL-2300 RC Leiden, Netherlands.	f.r.rosendaal@lumc.nl	Rosendaal, Frits/Q-3842-2017	Rosendaal, Frits/0000-0003-2558-7496				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Chung T, 2007, J THROMB HAEMOST, V5, P918, DOI 10.1111/j.1538-7836.2007.02461.x; Gallimore MJ, 2004, THROMB RES, V114, P91, DOI 10.1016/j.thromres.2004.05.005; Gerdes VEA, 2004, J THROMB HAEMOST, V2, P1015, DOI 10.1111/j.1538-7836.2004.00726.x; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Hasstedt SJ, 1998, AM J HUM GENET, V63, P569, DOI 10.1086/301947; Heit JA, 2001, THROMB HAEMOSTASIS, V86, P452, DOI 10.1161/ATVBAHA.108.162545; Iakoubova OA, 2006, ARTERIOSCL THROM VAS, V26, P2763, DOI 10.1161/01.ATV.0000247248.76409.8b; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; Larsen TB, 2003, EPIDEMIOLOGY, V14, P328, DOI 10.1097/00001648-200305000-00013; Lee J, 2001, INVEST OPHTH VIS SCI, V42, P1707; Li AR, 2004, AM J HUM GENET, V74, P817, DOI 10.1086/383228; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; MCGRAW RA, 1985, P NATL ACAD SCI USA, V82, P2847, DOI 10.1073/pnas.82.9.2847; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; MILETICH J, 1987, NEW ENGL J MED, V317, P991, DOI 10.1056/NEJM198710153171604; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Shiffman D, 2006, ARTERIOSCL THROM VAS, V26, P1613, DOI 10.1161/01.ATV.0000226543.77214.e4; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Stein PD, 2002, CHEST, V122, P960, DOI 10.1378/chest.122.3.960; Tarumi T, 2003, J THROMB HAEMOST, V1, P1854, DOI 10.1046/j.1538-7836.2003.00302.x; van Stralen KJ, 2008, ARCH INTERN MED, V168, P21, DOI 10.1001/archinternmed.2007.5; Vlieg AV, 2000, BLOOD, V95, P3678; Weir BS., 1996, GENETIC DATA ANAL	33	229	241	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1306	1314		10.1001/jama.299.11.1306	http://dx.doi.org/10.1001/jama.299.11.1306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349091	Bronze			2022-12-24	WOS:000254079100021
J	Hawkes, N				Hawkes, Nigel			There's no biological alternative, says Parliament	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes@thetimes.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 15	2008	336	7644					588	588		10.1136/bmj.39512.653727.59	http://dx.doi.org/10.1136/bmj.39512.653727.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18340072	Green Published			2022-12-24	WOS:000254364500029
J	Raya, RR				Raya, Rene R.			Philippine breastfeeding struggle continues	LANCET			English	Editorial Material									Act Econ Reforms, Quezon City 1101, Philippines		Raya, RR (corresponding author), Act Econ Reforms, Quezon City 1101, Philippines.	rrraya@gmail.com						CONDE CH, 2007, INT HEARLD TRIB 0717; DATINGUINOO VM, 2006, HLTH FILIPINO TEMPES; *DEM HLTH SURV, 2003, GEN TABL STATCOMPILE; *DEP HLTH, 1986, PHIL COD MARK BREAST; DONOHUE TJ, 2006, COMMUNICATION   0811; *FAO UN, 2004, ENT SAK OTH MICR POW; FEIST EM, 2006, COMMUNICATION   0130; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; MOUNTFORD M, 2006, COMMUNICATION   0620; *NAT ANT COMM, 2000, INF YOUNG CHILD FEED; RAMOS JG, 2007, CEASE DESIST ORDER I; *REP PHIL SUPR COU, 2007, PHARM HLTH CAR ASS P; WASSMER LP, 2006, COMMUNICATION   0112; World Health Organization, 1981, INT COD MARK BREAST	14	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 8	2008	371	9615					794	795		10.1016/S0140-6736(08)60358-X	http://dx.doi.org/10.1016/S0140-6736(08)60358-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272NQ	18328912				2022-12-24	WOS:000253866500008
J	Klein, DF				Klein, Donald F.			The loss of serendipity in psychopharmacology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MAJOR DEPRESSION; IMIPRAMINE; PREDICTORS; DISORDERS; RELAPSE		[Klein, Donald F.] NYU, Ctr Child Study, Phyllis Green & Randolph Cowen Inst Pediat Neuros, Med Ctr,Nathan S Kline Inst Psychiat Res, New York, NY 10016 USA; [Klein, Donald F.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA	Nathan Kline Institute for Psychiatric Research; New York University; Columbia University	Klein, DF (corresponding author), NYU, Ctr Child Study, Phyllis Green & Randolph Cowen Inst Pediat Neuros, Med Ctr,Nathan S Kline Inst Psychiat Res, Lexington Ave,14th Floor, New York, NY 10016 USA.	donaldk737@aol.com						Evins AE, 2003, J CLIN PSYCHIAT, V64, P9; KLEIN DF, 1967, ARCH GEN PSYCHIAT, V16, P118; McElroy SL, 2005, J CLIN PSYCHIAT, V66, P617, DOI 10.4088/JCP.v66n0512; McGrath PJ, 2006, AM J PSYCHIAT, V163, P1542, DOI 10.1176/appi.ajp.163.9.1542; McGrath PJ, 2000, J CLIN PSYCHIAT, V61, P518, DOI 10.4088/JCP.v61n0710; Ohlsen RI, 2005, J PSYCHOPHARMACOL, V19, P408, DOI 10.1177/0269881105053308; QUITKIN FM, 1989, ARCH GEN PSYCHIAT, V46, P787; UHLENHUTH EH, 1977, PSYCHOPHARMACOLOGY, V52, P79, DOI 10.1007/BF00426604; WIKLER A, 1953, J PHARMACOL EXP THER, V109, P8; ZITRIN CM, 1978, ARCH GEN PSYCHIAT, V35, P307	10	54	54	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2008	299	9					1063	1065		10.1001/jama.299.9.1063	http://dx.doi.org/10.1001/jama.299.9.1063			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JH	18319418				2022-12-24	WOS:000253644800026
J	Hecht, GA				Hecht, Gail A.			Inflammatory bowel disease - Live transmission	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Illinois, Sect Digest Dis & Nutr, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hecht, GA (corresponding author), Univ Illinois, Sect Digest Dis & Nutr, Chicago, IL 60680 USA.							Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Meduri GU, 1999, AM J RESP CRIT CARE, V160, P961, DOI 10.1164/ajrccm.160.3.9807080; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422	4	24	24	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					528	530		10.1056/NEJMcibr0707718	http://dx.doi.org/10.1056/NEJMcibr0707718			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18234759				2022-12-24	WOS:000252722900014
J	Doyle, MW; Stanley, EH; Havlick, DG; Kaiser, MJ; Steinbach, G; Graf, WL; Galloway, GE; Riggsbee, JA				Doyle, Martin W.; Stanley, Emily H.; Havlick, David G.; Kaiser, Mark J.; Steinbach, George; Graf, William L.; Galloway, Gerald E.; Riggsbee, J. Adam			Environmental science - Aging infrastructure and ecosystem restoration	SCIENCE			English	Editorial Material							OFFSHORE OIL		[Doyle, Martin W.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Stanley, Emily H.] Univ Wisconsin, Madison, WI USA; [Havlick, David G.] Univ Colorado, Colorado Springs, CO 80907 USA; [Kaiser, Mark J.] Louisiana State Univ, Ctr Energy Studies, Baton Rouge, LA 70803 USA; [Steinbach, George] Calif Artificial Reef Enhancement Program, Santa Barbara, CA USA; [Graf, William L.] Univ S Carolina, Columbia, SC 29208 USA; [Galloway, Gerald E.] Univ Maryland, College Pk, MD 20742 USA; [Riggsbee, J. Adam] Restorat Syst LLC, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado at Colorado Springs; Louisiana State University System; Louisiana State University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University System of Maryland; University of Maryland College Park	Doyle, MW (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	mwdoyle@email.unc.edu		Stanley, Emily/0000-0003-4922-8121; Havlick, David/0000-0002-6230-1584				ASCE, 2005, REP CARD AM INFR; *ASCE, 2007, NAT INV DAMS; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Doyle MW, 2005, GEOMORPHOLOGY, V71, P227, DOI 10.1016/j.geomorph.2004.04.011; Galat DL, 1998, BIOSCIENCE, V48, P721, DOI 10.2307/1313335; *HEINZ CTR, 2002, STAT NAT EC; Ihara D. M., 2003, REINVESTING JOBS COM; *INT LEV POL REV C, 2006, NAT LEV CHALL; Kaiser MJ, 2005, OCEAN DEV INT LAW, V36, P119, DOI 10.1080/00908320590943990; Leslie M., 1996, CONSERVING BIODIVERS; Love MS, 2006, FISH B-NOAA, V104, P383; National Research Council, 2001, COMP WETL LOSS CLEAN; National Research Council (NRC), 2005, ASS MAN EC IMP PAV R; *NCPWI, 1988, FRAG FDN FIN REP PRE; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; *NRC, 2006, PROGR REST EV; Patin S, 1999, ENV IMPACT OFFSHORE; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Schroeder DM, 2004, OCEAN COAST MANAGE, V47, P21, DOI 10.1016/j.ocecoaman.2004.03.002; TOBIN GA, 1995, WATER RESOUR BULL, V31, P359, DOI 10.1111/j.1752-1688.1995.tb04025.x; United States Environmental Protection Agency, 2002, CLEAN WAT DRINK WAT; *US FHA, 2007, FHA ANN HIGHW STAT; [No title captured]	23	76	76	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					286	287		10.1126/science.1149852	http://dx.doi.org/10.1126/science.1149852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202277				2022-12-24	WOS:000252436200021
J	Wakim, LM; Waithman, J; van Rooijen, N; Heath, WR; Carbone, FR				Wakim, Linda M.; Waithman, Jason; van Rooijen, Nico; Heath, William R.; Carbone, Francis R.			Dendritic cell-induced memory T cell activation in nonlymphoid tissues	SCIENCE			English	Article							HERPES-SIMPLEX-VIRUS; IN-VIVO; SENSORY GANGLIA; LYMPH-NODE; INFECTIONS; MONOCYTES; TYPE-1; DIFFERENTIATION; GENERATION; RESPONSES	Secondary lymphoid organs are dominant sites of T cell activation, although many T cells are subsequently retained within peripheral tissues. Currently, these nonlymphoid compartments are viewed as sites only of effector T cell function, without the involvement of renewed induction of immunity via the interactions with professional antigen- presenting cells. We describe a method of reactivation of herpes simplex virus to examine the stimulation of tissue- resident T cells during secondary challenge. The results revealed that memory CD8(+) T cell responses can be initiated within peripheral tissues through a tripartite interaction that includes CD4(+) T cells and recruited dendritic cells. These findings lend evidence for the existence of a sophisticated T cell response mechanism in extra- lymphoid tissues that can act to control localized infection.	[Heath, William R.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia; [Wakim, Linda M.; Waithman, Jason; Carbone, Francis R.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [van Rooijen, Nico] Vrije Univ Amsterdam, Fac Med, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Vrije Universiteit Amsterdam	Heath, WR (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia.	heath@wehi.edu.au; fcarbone@unimelb.edu.au	Carbone, Francis/ABF-2141-2020; Van Rooijen, Nico/Z-1578-2019	Heath, William/0000-0001-9670-259X; Wakim, Linda/0000-0003-1752-9579; Waithman, Jason/0000-0003-4940-0155				Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Freeman ML, 2007, J IMMUNOL, V179, P322, DOI 10.4049/jimmunol.179.1.322; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Harris NL, 2002, J EXP MED, V195, P317, DOI 10.1084/jem.20011558; Hikono H, 2006, IMMUNOL REV, V211, P119, DOI 10.1111/j.0105-2896.2006.00385.x; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; JENNINGS SR, 1991, CELL IMMUNOL, V133, P234, DOI 10.1016/0008-8749(91)90194-G; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Moyron-Quiroz JE, 2006, IMMUNITY, V25, P643, DOI 10.1016/j.immuni.2006.08.022; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; STEVENS JG, 1971, SCIENCE, V173, P843, DOI 10.1126/science.173.3999.843; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; TENSER RB, 1989, J VIROL, V63, P2861, DOI 10.1128/JVI.63.6.2861-2865.1989; van Lint AL, 2005, J VIROL, V79, P14843, DOI 10.1128/JVI.79.23.14843-14851.2005; van Panhuys N, 2005, TRENDS IMMUNOL, V26, P242, DOI 10.1016/j.it.2005.03.005; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005	25	325	353	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					198	202		10.1126/science.1151869	http://dx.doi.org/10.1126/science.1151869			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187654				2022-12-24	WOS:000252246400040
J	Martin, RW; Connell, PP; Bishop, DK				Martin, Richard W.; Connell, Philip P.; Bishop, Douglas K.			The Yin and Yang of treating BRCA-deficient tumors	CELL			English	Editorial Material							CANCER; RESISTANCE; CISPLATIN; CELLS; RAD51	The myriad changes that occur during the malignant progression of cancer cells present challenges to both clinicians and basic scientists. Two new studies in Nature underscore the central role of genome instability in tumor biology (Edwards et al., 2008; Sakai et al., 2008). These reports describe secondary changes in the BRCA2 locus that restore the wild-type reading frame and contribute to the development of resistance to chemotherapeutic agents.	[Martin, Richard W.; Bishop, Douglas K.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Connell, Philip P.; Bishop, Douglas K.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Bishop, DK (corresponding author), Univ Chicago, Cummings Life Sci Ctr, Comm Genet, Room 821A,920 E 58th St,Box 13, Chicago, IL 60637 USA.	dbishop@uchicago.edu						Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Foulkes WD, 2006, FAM CANCER, V5, P135, DOI 10.1007/s10689-005-2832-5; Martin RW, 2007, CANCER RES, V67, P9658, DOI 10.1158/0008-5472.CAN-07-0290; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087	10	7	8	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2008	132	6					919	920		10.1016/j.cell.2008.03.006	http://dx.doi.org/10.1016/j.cell.2008.03.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	278GR	18358803	Bronze			2022-12-24	WOS:000254273600009
J	Koch, CG; Li, L; Sessler, DI; Figueroa, P; Hoeltge, GA; Mihaljevic, T; Blackstone, EH				Koch, Colleen Gorman; Li, Liang; Sessler, Daniel I.; Figueroa, Priscilla; Hoeltge, Gerald A.; Mihaljevic, Tomislav; Blackstone, Eugene H.			Duration of red-cell storage and complications after cardiac surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIONAL-DEATH-INDEX; PLATELET-ACTIVATING-FACTOR; NEUTROPHIL NADPH OXIDASE; STORED-BLOOD COMPONENTS; CRITICALLY-ILL PATIENTS; LONG-TERM SURVIVAL; RHEOLOGICAL PROPERTIES; CLINICAL CONSEQUENCES; TRANSFUSED BLOOD; MORTALITY	Background: Stored red cells undergo progressive structural and functional changes over time. We tested the hypothesis that serious complications and mortality after cardiac surgery are increased when transfused red cells are stored for more than 2 weeks. Methods: We examined data from patients given red-cell transfusions during coronary-artery bypass grafting, heart-valve surgery, or both between June 30, 1998, and January 30, 2006. A total of 2872 patients received 8802 units of blood that had been stored for 14 days or less ("newer blood''), and 3130 patients received 10,782 units of blood that had been stored for more than 14 days ("older blood''). Multivariable logistic regression with propensity-score methods was used to examine the effect of the duration of storage on outcomes. Survival was estimated by the Kaplan-Meier method and Blackstone's decomposition method. Results: The median duration of storage was 11 days for newer blood and 20 days for older blood. Patients who were given older units had higher rates of in-hospital mortality (2.8% vs. 1.7%, P=0.004), intubation beyond 72 hours (9.7% vs. 5.6%, P<0.001), renal failure (2.7% vs. 1.6%, P=0.003), and sepsis or septicemia (4.0% vs. 2.8%, P=0.01). A composite of complications was more common in patients given older blood (25.9% vs. 22.4%, P=0.001). Similarly, older blood was associated with an increase in the risk-adjusted rate of the composite outcome (P=0.03). At 1 year, mortality was significantly less in patients given newer blood (7.4% vs. 11.0%, P<0.001). Conclusions: In patients undergoing cardiac surgery, transfusion of red cells that had been stored for more than 2 weeks was associated with a significantly increased risk of postoperative complications as well as reduced short-term and long-term survival.	[Koch, Colleen Gorman] Cleveland Clin Fdn, Dept Cardiothorac Anesthesia, Cleveland, OH 44195 USA; [Li, Liang] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Koch, Colleen Gorman; Sessler, Daniel I.] Cleveland Clin Fdn, Dept Outcomes Res, Cleveland, OH 44195 USA; [Figueroa, Priscilla; Hoeltge, Gerald A.] Cleveland Clin Fdn, Dept Lab Med & Clin Pathol, Cleveland, OH 44195 USA; [Mihaljevic, Tomislav; Blackstone, Eugene H.] Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Koch, CG (corresponding author), Cleveland Clin, Dept Cardiothorac Anesthesia, 9500 Euclid Ave G3, Cleveland, OH 44195 USA.	kochc@ccf.org	Sessler, Daniel/D-3504-2011	Sessler, Daniel/0000-0001-9932-3077	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061655] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 061655] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basran S, 2006, ANESTH ANALG, V103, P15, DOI 10.1213/01.ane.0000221167.58135.3d; Berezina TL, 2002, J SURG RES, V102, P6, DOI 10.1006/jsre.2001.6306; BLACKSTONE EH, 1986, J AM STAT ASSOC, V81, P615, DOI 10.2307/2288989; CALLE EE, 1993, AM J EPIDEMIOL, V137, P235, DOI 10.1093/oxfordjournals.aje.a116664; Chapman JF, 2004, VOX SANG, V87, P143, DOI 10.1111/j.1741-6892.2004.00472.x; d'Almeida MS, 2000, TRANSFUSION MED, V10, P291, DOI 10.1046/j.1365-3148.2000.00267.x; de Watering LV, 2006, TRANSFUSION, V46, P1712, DOI 10.1111/j.1537-2995.00958.x; Engoren MC, 2002, ANN THORAC SURG, V74, P1180, DOI 10.1016/S0003-4975(02)03766-9; Glynn SA, 2003, JAMA-J AM MED ASSOC, V289, P2246, DOI 10.1001/jama.289.17.2246; Hamasaki N, 2000, VOX SANG, V79, P191, DOI 10.1159/000056729; Ho J, 2003, CRIT CARE MED, V31, pS687, DOI 10.1097/01.CCM.0000099349.17094.A3; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kirkpatrick UJ, 1998, BRIT J HAEMATOL, V101, P364; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037; Koch CG, 2006, ANN THORAC SURG, V82, P1747, DOI 10.1016/j.athoracsur.2006.05.045; KOZAN E, 2003, INT J HEALTHCARE TEC, V3, P203; Kuduvalli M, 2005, EUR J CARDIO-THORAC, V27, P592, DOI 10.1016/j.ejcts.2005.01.030; Leal-Noval SM, 2001, CHEST, V119, P1461, DOI 10.1378/chest.119.5.1461; Leal-Noval SR, 2003, ANESTHESIOLOGY, V98, P815, DOI 10.1097/00000542-200304000-00005; MACMAHON B, 1983, AM J PUBLIC HEALTH, V73, P1247, DOI 10.2105/AJPH.73.11.1247; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; MARIK PE, 1993, JAMA-J AM MED ASSOC, V269, P3024, DOI 10.1001/jama.269.23.3024; McLellan SA, 2002, BRIT J ANAESTH, V89, P537, DOI 10.1093/bja/aef218; Murphy GJ, 2004, ANN THORAC SURG, V77, P1553, DOI 10.1016/j.athoracsur.2003.10.045; Mynster T, 2001, DIS COLON RECTUM, V44, P955, DOI 10.1007/BF02235483; Offner PJ, 2002, ARCH SURG-CHICAGO, V137, P711, DOI 10.1001/archsurg.137.6.711; Purdy FR, 1997, CAN J ANAESTH, V44, P1256, DOI 10.1007/BF03012772; Raat NJ, 2005, CRIT CARE MED, V33, P39, DOI 10.1097/01.CCM.0000150655.75519.02; Ranucci Marco, 1994, Perfusion, V9, P319, DOI 10.1177/026765919400900503; Robinson WP, 2005, J TRAUMA, V58, P437, DOI 10.1097/01.TA.0000153935.18997.14; SILLIMAN CC, 1993, LIPIDS, V28, P415, DOI 10.1007/BF02535939; SILLIMAN CC, 1992, VOX SANG, V63, P133, DOI 10.1111/j.1423-0410.1992.tb02500.x; SILLIMAN CC, 1994, J LAB CLIN MED, V124, P684; Spahn DR, 2002, ANESTHESIOLOGY, V97, P1338, DOI 10.1097/00000542-200212000-00004; Taylor RW, 2002, CRIT CARE MED, V30, P2249, DOI 10.1097/00003246-200210000-00012; Tinmouth A, 2001, TRANSFUS MED REV, V15, P91, DOI 10.1053/tmrv.2001.22613; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; VALERI CR, 1971, VOX SANG, V20, P397, DOI 10.1111/j.1423-0410.1971.tb01807.x; Vamvakas EC, 2000, TRANSFUSION, V40, P101, DOI 10.1046/j.1537-2995.2000.40010101.x; Walsh TS, 2004, CRIT CARE MED, V32, P364, DOI 10.1097/01.CCM.0000108878.23703.E0; Weiskopf RB, 2006, ANESTHESIOLOGY, V104, P911, DOI 10.1097/00000542-200605000-00005; WENTWORTH DN, 1983, AM J PUBLIC HEALTH, V73, P1270, DOI 10.2105/AJPH.73.11.1270; WHITAKER BI, 2006, 2005 NATIONWIDE BLOO; WOLFE LC, 1989, SEMIN HEMATOL, V26, P307; Yoshida T, 2007, VOX SANG, V92, P22, DOI 10.1111/j.1423-0410.2006.00860.x; Zacharias A, 1996, CHEST, V110, P1173, DOI 10.1378/chest.110.5.1173; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1	48	1026	1091	0	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1229	1239		10.1056/NEJMoa070403	http://dx.doi.org/10.1056/NEJMoa070403			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275TL	18354101				2022-12-24	WOS:000254094400004
J	Chatenoud, L				Chatenoud, Lucienne			Chemical immunosuppression in islet transplantation - Friend or foe?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MICE; REGENERATION; RECOVERY; ANTIBODY		Univ Paris 05, Paris, France; INSERM, Unite 580, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chatenoud, L (corresponding author), Univ Paris 05, Paris, France.							CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Sherry NA, 2007, ENDOCRINOLOGY, V148, P5136, DOI 10.1210/en.2007-0358; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989	5	22	23	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1192	1193		10.1056/NEJMcibr0708067	http://dx.doi.org/10.1056/NEJMcibr0708067			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337609				2022-12-24	WOS:000253877200014
J	Smetacek, V; Cloern, JE				Smetacek, Victor; Cloern, James E.			Oceans - On phytoplankton trends	SCIENCE			English	Editorial Material							LONG-TERM; PLANKTON; FALL; RISE; BAY		[Smetacek, Victor] Helmholtz Fdn, Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Smetacek, Victor] Univ Bremen, D-28334 Bremen, Germany; [Cloern, James E.] US Geol Survey, Menlo Pk, CA 94025 USA	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen; United States Department of the Interior; United States Geological Survey	Smetacek, V (corresponding author), Helmholtz Fdn, Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany.	Victor.Smetacek@awi.de; jecloern@usgs.gov	Cloern, James E/C-1499-2011	Cloern, James/0000-0002-5880-6862				*AM GEOPH UN, 2007, AM GEOPH UN CHAPM C; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Beninca E, 2008, NATURE, V451, P822, DOI 10.1038/nature06512; Cheke RA, 2007, SCIENCE, V318, P577, DOI 10.1126/science.1150636; Cloern JE, 2007, P NATL ACAD SCI USA, V104, P18561, DOI 10.1073/pnas.0706151104; HENSEN V, 1887, KOMM WISS UNTERS UNT, V12, P1; Kideys AE, 2002, SCIENCE, V297, P1482, DOI 10.1126/science.1073002; MABERLY SC, 1994, FRESHWATER BIOL, V31, P19, DOI 10.1111/j.1365-2427.1994.tb00835.x; Mills Eric., 1989, BIOL OCEANOGRAPHY EA; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; PACE ML, 1998, TREE, V14, P483; RILEY GORDON A., 1955, DEEP SEA RES, V3, P224; Sarno D, 2005, J PHYCOL, V41, P151, DOI 10.1111/j.1529-8817.2005.04067.x; Smayda TJ, 1998, ICES J MAR SCI, V55, P562, DOI 10.1006/jmsc.1998.0385; SMETACEK V, 1985, ESTUARIES, V8, P145, DOI 10.2307/1351864; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; WILTSHIRE K, CHAPM C LONG TIM SER	17	79	80	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1346	1348		10.1126/science.1151330	http://dx.doi.org/10.1126/science.1151330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323440				2022-12-24	WOS:000253712900029
J	Chaine, AS; Lyon, BE				Chaine, Alexis S.; Lyon, Bruce E.			Adaptive plasticity in female mate choice dampens sexual selection on male ornaments in the lark bunting	SCIENCE			English	Article								Theory on the evolution of ornamental male traits by sexual selection assumes consistency in selection over time. Temporal variation in female choice could dampen sexual selection, but scant information exists on the degree to which individual female preferences are flexible. Here we show that in lark buntings sexual selection on male traits varied dramatically across years and, in some cases, exhibited reversals in the direction of selection for a single trait. We show that these shifts are probably because of flexibility in mate choice by individual females and that they parallel shifts in the male traits that predict female reproductive success in a given year. Plasticity in choice and concomitant reversals in mating patterns across time may weaken the strength of sexual selection and could maintain genetic variation underlying multiple sexual ornaments.	[Chaine, Alexis S.; Lyon, Bruce E.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Chaine, Alexis S.] CNRS Moulis, Stn Ecol Expt, Lab Evolut & Divers Biol, USR 2936, F-09200 St Girons, France	University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS)	Chaine, AS (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	alexis.chaine@ecoex-moulis.cnrs.fr	Lyon, Bruce E/E-8491-2011; Chaine, Alexis S/B-4062-2012					Alonzo SH, 2001, BEHAV ECOL SOCIOBIOL, V49, P176, DOI 10.1007/s002650000265; Andersson Malte, 1994; BAKKER TCM, 1995, J EVOLUTION BIOL, V8, P129, DOI 10.1046/j.1420-9101.1995.8020129.x; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; CHAINE A, 2006, THESIS U CALIFORNIA; Darwin G., 1871, P423; Ellner S, 1996, B MATH BIOL, V58, P103, DOI 10.1007/BF02458284; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Hill GE, 1999, BEHAV ECOL, V10, P48, DOI 10.1093/beheco/10.1.48; JANETOS AC, 1980, BEHAV ECOL SOCIOBIOL, V7, P107, DOI 10.1007/BF00299515; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Mead LS, 2004, TRENDS ECOL EVOL, V19, P264, DOI 10.1016/j.tree.2004.03.003; Merila J, 2001, GENETICA, V112, P199, DOI 10.1023/A:1013391806317; O'Donald P., 1983, P53; Oh KP, 2006, P ROY SOC B-BIOL SCI, V273, P1913, DOI 10.1098/rspb.2006.3528; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; Qvarnstrom A, 2001, TRENDS ECOL EVOL, V16, P5, DOI 10.1016/S0169-5347(00)02030-9; REID ML, 1990, ANIM BEHAV, V40, P538, DOI 10.1016/S0003-3472(05)80534-2; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439	23	214	214	1	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					459	462		10.1126/science.1149167	http://dx.doi.org/10.1126/science.1149167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218896				2022-12-24	WOS:000252576600037
J	Lenz, G; Davis, RE; Ngo, VN; Lam, L; George, TC; Wright, GW; Dave, SS; Zhao, H; Xu, WH; Rosenwald, A; Ott, G; Muller-Hermelink, HK; Gascoyne, RD; Connors, JM; Rimsza, LM; Campo, E; Jaffe, ES; Delabie, J; Smeland, EB; Fisher, RI; Chan, WC; Staudt, LM				Lenz, Georg; Davis, R. Eric; Ngo, Vu N.; Lam, Lloyd; George, Thaddeus C.; Wright, George W.; Dave, Sandeep S.; Zhao, Hong; Xu, Weihong; Rosenwald, Andreas; Ott, German; Muller-Hermelink, Hans Konrad; Gascoyne, Randy D.; Connors, Joseph M.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Delabie, Jan; Smeland, Erlend B.; Fisher, Richard I.; Chan, Wing C.; Staudt, Louis M.			Oncogenic CARD11 mutations in human diffuse large B cell lymphoma	SCIENCE			English	Article							HODGKIN LYMPHOMA; ACTIVATION; CARMA1; PHOSPHORYLATION; PROLIFERATION; CHEMOTHERAPY; REQUIREMENT; SURVIVAL	The ability to select a better option from multiple acceptable ones is important for animals to optimize their resources. The mechanisms that underlie such decision- making processes are not well understood. We found that selection of egg- laying site in Drosophila melanogaster is a suitable system to probe the neural circuit that governs simple decision- making processes. First, Drosophila females pursue active probing of the environment before depositing each egg, apparently to evaluate site quality for every egg. Second, Drosophila females can either accept or reject a sucrose- containing medium, depending on the context. Last, communication of the "acceptability" of the sucrose- containing medium as an egg- laying option to the reproductive system depends on the function of a group of insulin- like peptide 7 ( ILP7)- producing neurons. These findings suggest that selection of egg- laying site involves a simple decision- making process and provide an entry point toward a systematic dissection of this process.	[Lenz, Georg; Davis, R. Eric; Ngo, Vu N.; Lam, Lloyd; Dave, Sandeep S.; Zhao, Hong; Xu, Weihong; Staudt, Louis M.] NCI, Metab Branch, Div Canc Treatment & Diag, Canc Res Ctr, Bethesda, MD 20892 USA; [George, Thaddeus C.] Amnis Corp, Seattle, WA 98121 USA; [Wright, George W.] NCI, Biometr Res Branch, Div Canc Treatment & Diag, Canc Res Ctr, Bethesda, MD 20892 USA; [Rosenwald, Andreas; Ott, German; Muller-Hermelink, Hans Konrad] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany; [Gascoyne, Randy D.; Connors, Joseph M.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Campo, Elias] Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Jaffe, Elaine S.] NCI, Pathol Lab, Div Canc Treatment & Diag, Canc Res Ctr, Bethesda, MD 20892 USA; [Delabie, Jan] Rikshosp Radiumhosp Med Ctr, Dept Immunol, N-0310 Oslo, Norway; [Smeland, Erlend B.] Rikshosp Univ Hosp, Inst Canc Res, N-0310 Oslo, Norway; [Smeland, Erlend B.] Norwegian Radium Hosp, Ctr Canc Biomed, Fac Div, N-0310 Oslo, Norway; [Fisher, Richard I.] SW Oncol Grp, Ann Arbor, MI 48106 USA; [Fisher, Richard I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Chan, Wing C.] Univ Nebraska, Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Chan, Wing C.] Univ Nebraska, Med Ctr, Dept Microbiol, Omaha, NE 68198 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wurzburg; Bosch; Robert Bosch Krankenhaus; British Columbia Cancer Agency; University of Arizona; University of Barcelona; Hospital Clinic de Barcelona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; Southwest Oncology Group; University of Rochester; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Staudt, LM (corresponding author), NCI, Metab Branch, Div Canc Treatment & Diag, Canc Res Ctr, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Gascoyne, Randy D/A-6009-2013; Smeland, Erlend/AAO-3214-2020; Lenz, Georg/I-6844-2012; Wright, George W/M-1660-2017; Staudt, Louis/AAC-5324-2019; Jaffe, Elaine/G-8981-2014; Connors, Joseph/AAF-5284-2019; Campo, Elias/AAC-5593-2019	Gascoyne, Randy D/0000-0002-2610-5690; Connors, Joseph/0000-0002-1361-7531; Campo, Elias/0000-0001-9850-9793; Ngo, Vu/0000-0002-9501-6990; Delabie, Jan/0000-0001-5023-0689	NATIONAL CANCER INSTITUTE [ZIABC011008, Z01BC011070, U01CA084967, ZIASC000550] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [UO1-CA84967] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chan WC, 1997, BLOOD, V89, P3909; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Tanner MJ, 2007, J BIOL CHEM, V282, P17141, DOI 10.1074/jbc.M700169200; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824	23	622	663	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1676	1679		10.1126/science.1153629	http://dx.doi.org/10.1126/science.1153629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18323416				2022-12-24	WOS:000254172300044
J	Lee, SH; Choi, JH; Lee, N; Lee, HR; Kim, JI; Yu, NK; Choi, SL; Lee, SH; Kim, H; Kaang, BK				Lee, Sue-Hyun; Choi, Jun-Hyeok; Lee, Nuribalhae; Lee, Hye-Ryeon; Kim, Jae-Ick; Yu, Nam-Kyung; Choi, Sun-Lim; Lee, Seung-Hee; Kim, Hyoung; Kaang, Bong-Kiun			Synaptic protein degradation underlies destabilization of retrieved fear memory	SCIENCE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; LONG-TERM FACILITATION; RECONSOLIDATION; EXTINCTION; CONSOLIDATION; EXPRESSION; PLASTICITY; GENES; MODULATION; STABILITY	Reactivated memory undergoes a rebuilding process that depends on de novo protein synthesis. This suggests that retrieval is dynamic and serves to incorporate new information into preexisting memories. However, little is known about whether or not protein degradation is involved in the reorganization of retrieved memory. We found that postsynaptic proteins were degraded in the hippocampus by polyubiquitination after retrieval of contextual fear memory. Moreover, the infusion of proteasome inhibitor into the CA1 region immediately after retrieval prevented anisomycin- induced memory impairment, as well as the extinction of fear memory. This suggests that ubiquitin- and proteasome-dependent protein degradation underlies destabilization processes after fear memory retrieval. It also provides strong evidence for the existence of reorganization processes whereby preexisting memory is disrupted by protein degradation, and updated memory is reconsolidated by protein synthesis.	[Lee, Sue-Hyun; Choi, Jun-Hyeok; Lee, Nuribalhae; Lee, Hye-Ryeon; Kim, Jae-Ick; Yu, Nam-Kyung; Choi, Sun-Lim; Lee, Seung-Hee; Kim, Hyoung; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Natl Creat Res Initiat Ctr Memory, Seoul 151747, South Korea	Seoul National University (SNU)	Kaang, BK (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Natl Creat Res Initiat Ctr Memory, San 56-1 Silim Dong, Seoul 151747, South Korea.	kaang@snu.ac.kr	Lee, Sue-Hyun/F-5490-2015; Kim, Jae-Ick/AAY-6005-2020; Lee, Seung-Hee/J-5971-2013; Kim, Jae-Ick/R-4007-2017	Lee, Sue-Hyun/0000-0002-5318-5657; Kim, Jae-Ick/0000-0001-9705-0394				Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Ferrell K, 1996, FEBS LETT, V381, P143, DOI 10.1016/0014-5793(96)00101-9; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Frankland PW, 2006, LEARN MEMORY, V13, P451, DOI 10.1101/lm.183406; Guo L, 2007, NEUROSCIENCE, V145, P100, DOI 10.1016/j.neuroscience.2006.11.042; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Ji JZ, 2007, HIPPOCAMPUS, V17, P749, DOI 10.1002/hipo.20331; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; Lee JA, 2006, J CELL BIOL, V174, P827, DOI 10.1083/jcb.200512066; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Wilensky AE, 2000, J NEUROSCI, V20, P7059, DOI 10.1523/JNEUROSCI.20-18-07059.2000	31	289	298	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1253	1256		10.1126/science.1150541	http://dx.doi.org/10.1126/science.1150541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18258863				2022-12-24	WOS:000253530600047
J	Orkin, SH; Zon, LI				Orkin, Stuart H.; Zon, Leonard I.			SnapShot: Hematopoiesis	CELL			English	Editorial Material							STEM-CELLS; LINEAGE COMMITMENT		[Orkin, Stuart H.; Zon, Leonard I.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Choi K, 1998, DEVELOPMENT, V125, P725; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005	9	46	47	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					712	U7		10.1016/j.cell.2008.02.013	http://dx.doi.org/10.1016/j.cell.2008.02.013			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295585	Bronze			2022-12-24	WOS:000253817900027
J	Mace, R				Mace, Ruth			Reproducing in cities	SCIENCE			English	Editorial Material							SUB-SAHARAN AFRICA; SEXUAL SELECTION; FERTILITY; POPULATION; ETHIOPIA; IMPACT	Reproducing in cities has always been costly, leading to lower fertility (that is, lower birth rates) in urban than in rural areas. Historically, although cities provided job opportunities, initially residents incurred the penalty of higher infant mortality, but as mortality rates fell at the end of the 19th century, European birth rates began to plummet. Fertility decline in Africa only started recently and has been dramatic in some cities. Here it is argued that both historical and evolutionary demographers are interpreting fertility declines across the globe in terms of the relative costs of child rearing, which increase to allow children to outcompete their peers. Now largely free from the fear of early death, postindustrial societies may create an environment that generates runaway parental investment, which will continue to drive fertility ever lower.	UCL, Dept Anthropol, London WC1H 0BW, England	University of London; University College London	Mace, R (corresponding author), UCL, Dept Anthropol, Taviton St, London WC1H 0BW, England.	r.mace@ucl.ac.uk		Mace, Ruth/0000-0002-6137-7739				Adler A., 1997, UNDERSTAND HUMAN NAT; Birchenall JA, 2007, WORLD DEV, V35, P543, DOI 10.1016/j.worlddev.2006.06.003; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; Boyd R., 1985, CULTURE EVOLUTIONARY; Central Statistical Agency, 2006, ETH DEM HLTH SURV; Cohen B, 1998, WORLD DEV, V26, P1431, DOI 10.1016/S0305-750X(98)00058-8; DOWNEY DB, 1995, AM SOCIOL REV, V60, P746, DOI 10.2307/2096320; Fisher R.A., 1930, GENETICAL THEORY NAT; Gibson MA, 2006, PLOS MED, V3, P476, DOI 10.1371/journal.pmed.0030087; Gregson S, 2007, P NATL ACAD SCI USA, V104, P14586, DOI 10.1073/pnas.0611540104; GURMU E, 2008, J BIOSOC SCI; Hrdy Sarah, 2000, MOTHER NATURE MATERN; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kristensen P, 2007, SCIENCE, V316, P1717, DOI 10.1126/science.1141493; Lack D., 1954, P143; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; Low BS, 2000, ADAPTATION HUMAN BEH, P323; Mace R, 1998, PHILOS T R SOC B, V353, P389, DOI 10.1098/rstb.1998.0217; Mace R, 1996, BEHAV ECOL SOCIOBIOL, V38, P75, DOI 10.1007/s002650050219; MACE R, 2007, OXFORD HDB EVOLUTION, P383; McNarmara John M., 2006, SOCIAL INFORM TRANSM, P59; Panter-Brick Catherine, 2000, ABANDONED CHILDREN; Pomiankowski A, 1998, P NATL ACAD SCI USA, V95, P5106, DOI 10.1073/pnas.95.9.5106; ROTH EA, 1993, AM ANTHROPOL, V95, P597, DOI 10.1525/aa.1993.95.3.02a00030; Sibanda A, 2003, STUD FAMILY PLANN, V34, P1, DOI 10.1111/j.1728-4465.2003.00001.x; Szreter Simon., 1996, FERTILITY CLASS GEND; Voland E, 1997, J BIOSOC SCI, V29, P355, DOI 10.1017/S0021932097003556	27	52	54	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					764	766		10.1126/science.1153960	http://dx.doi.org/10.1126/science.1153960			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259TE	18258904				2022-12-24	WOS:000252963000047
J	Williams, JM				Williams, Jill M.			Eliminating tobacco use in mental health facilities - Patients' rights, public health, and policy issues	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING BANS; NICOTINE; SCHIZOPHRENIA; SETTINGS; DISORDER; ILLNESS; SMOKERS		[Williams, Jill M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Addict Psychiat, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Williams, JM (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Addict Psychiat, 317 George St,Ste 105, New Brunswick, NJ 08901 USA.	jill.williams@umdnj.edu		Williams, Jill/0000-0001-8664-4373	NIMH NIH HHS [R01-MH076672-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076672] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Burke M, 2006, TECHNICAL REPORT SMO; Conners CK, 1996, PSYCHOPHARMACOL BULL, V32, P67; Covey LS, 1994, TOB CONTROL, V3, P222, DOI DOI 10.1136/TC.3.3.222; Dalack GW, 1999, NEUROPSYCHOPHARMACOL, V21, P195, DOI 10.1016/S0893-133X(98)00121-3; el-Guebaly N, 2002, PSYCHIATR SERV, V53, P1617, DOI 10.1176/appi.ps.53.12.1617; Freedman R, 2000, J CHEM NEUROANAT, V20, P299, DOI 10.1016/S0891-0618(00)00109-5; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; HAGMAN BT, 2002, ADDICT BEHAV; Henningfield J E, 1999, Nicotine Tob Res, V1 Suppl 2, pS31; KLEISS K, 2005, EDMONTON J      0707, pB3; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lawn S, 2005, AUST NZ J PSYCHIAT, V39, P866, DOI 10.1080/j.1440-1614.2005.01697.x; Longo DR, 1996, JAMA-J AM MED ASSOC, V275, P1252, DOI 10.1001/jama.275.16.1252; MARTINEAU K, 2007, HARTFORD COURAN 1002, pB9; Mauer B., 2006, MORBIDITY MORTALITY; Miller BJ, 2006, PSYCHIAT SERV, V57, P1482, DOI 10.1176/appi.ps.57.10.1482; *NEW JERS PROT ADV, HIGHL NJP AS ADV PAT; *PRES NEW FREED CO, 2003, DEP HHS PUBL; Prochaska J, 2004, PSYCHIAT SERV, V55, P1265, DOI 10.1176/appi.ps.55.11.1265; Russell MA, 1990, NICOTINE PSYCHOPHARM, P374; TYLER ML, 1998, GEORGETOWN LAW J, P86; Williams JM, 2005, SCHIZOPHR RES, V79, P323, DOI 10.1016/j.schres.2005.04.016; 2003, VENTURA COUNTY  0701	23	47	49	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					571	573		10.1001/jama.299.5.571	http://dx.doi.org/10.1001/jama.299.5.571			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252888				2022-12-24	WOS:000252886100024
J	Ke, YG; Lindsay, S; Chang, Y; Liu, Y; Yan, H				Ke, Yonggang; Lindsay, Stuart; Chang, Yung; Liu, Yan; Yan, Hao			Self-assembled water-soluble nucleic acid probe tiles for label-free RNA hybridization assays	SCIENCE			English	Article							DNA HYBRIDIZATION; MICROARRAY; PATTERNS; DESIGN	The DNA origami method, in which long, single- stranded DNA segments are folded into shapes by short staple segments, was used to create nucleic acid probe tiles that are molecular analogs of macroscopic DNA chips. One hundred trillion probe tiles were fabricated in one step and bear pairs of 20- nucleotide- long single- stranded DNA segments that act as probe sequences. These tiles can hybridize to their targets in solution and, after adsorption onto mica surfaces, can be examined by atomic force microscopy in order to quantify binding events, because the probe segments greatly increase in stiffness upon hybridization. The nucleic acid probe tiles have been used to study position-dependent hybridization on the nanoscale and have also been used for label- free detection of RNA.	[Ke, Yonggang; Lindsay, Stuart; Liu, Yan; Yan, Hao] Arizona State Univ, Ctr Single Mol Biophys, Tempe, AZ 85287 USA; [Chang, Yung] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Ke, Yonggang; Lindsay, Stuart; Liu, Yan; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Lindsay, Stuart] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Lindsay, Stuart] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Yan, H (corresponding author), Arizona State Univ, Ctr Single Mol Biophys, Tempe, AZ 85287 USA.	hao.yan@asu.edu	Liu, Yan/K-1999-2014	Liu, Yan/0000-0003-0906-2606				Bustin S. A., 2004, REAL TIME PCR ESSENT; Chang Y, 1999, P NATL ACAD SCI USA, V96, P191, DOI 10.1073/pnas.96.1.191; Chhabra R, 2007, J AM CHEM SOC, V129, P10304, DOI 10.1021/ja072410u; Gao Y, 2006, NUCLEIC ACIDS RES, V34, P3370, DOI 10.1093/nar/gkl422; Jacobsen EA, 2006, J IMMUNOL, V176, P6831, DOI 10.4049/jimmunol.176.11.6831; Lund K, 2005, J AM CHEM SOC, V127, P17606, DOI 10.1021/ja0568446; Meldrum DR, 2001, SCIENCE, V292, P515, DOI 10.1126/science.292.5516.515; MUELLER UR, 2004, MICROARRAY TECHNOLOG; Park SH, 2006, ANGEW CHEM INT EDIT, V45, P735, DOI 10.1002/anie.200503797; Peterson AW, 2001, NUCLEIC ACIDS RES, V29, P5163, DOI 10.1093/nar/29.24.5163; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	17	374	399	3	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					180	183		10.1126/science.1150082	http://dx.doi.org/10.1126/science.1150082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187649				2022-12-24	WOS:000252246400034
J	Priotto, G; Pinoges, L; Fursa, IB; Burke, B; Nicolay, N; Grillet, G; Hewison, C; Balasegaram, M				Priotto, Gerardo; Pinoges, Loretxu; Fursa, Isaac Badi; Burke, Barbara; Nicolay, Nathalie; Grillet, Guillaume; Hewison, Cathy; Balasegaram, Manica			Safety and effectiveness of first tine eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; PHASE-I TRIAL; ALPHA-DIFLUOROMETHYLORNITHINE; ORNITHINE-DECARBOXYLASE; MELARSOPROL TREATMENT; RISK-FACTORS; METABOLISM; INHIBITOR; DIAGNOSIS; ANGOLA		[Priotto, Gerardo; Pinoges, Loretxu; Nicolay, Nathalie] Epictr, F-75011 Paris, France; [Fursa, Isaac Badi; Burke, Barbara; Grillet, Guillaume; Hewison, Cathy; Balasegaram, Manica] Med Sans Frontieres, Paris, France	Doctors Without Borders	Priotto, G (corresponding author), Epictr, F-75011 Paris, France.	gpriotto@epicentre.msf.org	Priotto, Gerardo/AAS-9027-2021					ABELOFF MD, 1984, J CLIN ONCOL, V2, P124, DOI 10.1200/JCO.1984.2.2.124; [Anonymous], 1998, WHO TECHN REP SER, V881; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; BACCHI CJ, 1983, MOL BIOCHEM PARASIT, V7, P209, DOI 10.1016/0166-6851(83)90022-1; BAILEY JW, 1992, T ROY SOC TROP MED H, V86, P630, DOI 10.1016/0035-9203(92)90160-E; Burri C, 2001, TROP MED INT HEALTH, V6, P412, DOI 10.1046/j.1365-3156.2001.00725.x; Chappuis F, 2005, CLIN INFECT DIS, V41, P748, DOI 10.1086/432576; GRIFFIN CA, 1987, INVEST NEW DRUG, V5, P177; HAEGELE KD, 1981, CLIN PHARMACOL THER, V30, P210, DOI 10.1038/clpt.1981.150; Legros D, 1999, T ROY SOC TROP MED H, V93, P439, DOI 10.1016/S0035-9203(99)90151-7; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; MILORD F, 1993, T ROY SOC TROP MED H, V87, P473, DOI 10.1016/0035-9203(93)90044-Q; MILORD F, 1992, LANCET, V340, P652, DOI 10.1016/0140-6736(92)92180-N; *NCI CTEP NIH, 1999, COMM TOX CRIT VERS 2; PEPIN J, 1994, ADV PARASIT, V33, P1, DOI 10.1016/S0065-308X(08)60410-8; PEPIN J, 1995, T ROY SOC TROP MED H, V89, P92, DOI 10.1016/0035-9203(95)90673-8; Pepin J, 2000, B WORLD HEALTH ORGAN, V78, P1284; Schmid C, 2005, J INFECT DIS, V191, P1922, DOI 10.1086/429929; Stanghellini A, 2001, TROP MED INT HEALTH, V6, P330, DOI 10.1046/j.1365-3156.2001.00724.x; VANNIEUWENHOVE S, 1992, ANN SOC BELG MED TR, V72, P39; Woo P. T. K., 1970, Acta trop., V27, P384	22	53	55	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2008	336	7646					705	708A		10.1136/bmj.39485.592674.BE	http://dx.doi.org/10.1136/bmj.39485.592674.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZS	18321960	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000254675600029
J	Dosanjh, DPS; Hinks, TSC; Innes, JA; Deeks, JJ; Pasvol, G; Hackforth, S; Varia, H; Millington, KA; Gunatheesan, R; Guyot-Revol, V; Lalvani, A				Dosanjh, Davinder P. S.; Hinks, Timothy S. C.; Innes, John A.; Deeks, Jonathan J.; Pasvol, Geoffrey; Hackforth, Sarah; Varia, Hansa; Millington, Kerry A.; Gunatheesan, Rubamalar; Guyot-Revol, Valerie; Lalvani, Ajit			Improved diagnostic evaluation of suspected tuberculosis	ANNALS OF INTERNAL MEDICINE			English	Article							INTERFERON-GAMMA ASSAYS; LINKED IMMUNOSPOT ASSAY; CELL-BASED ASSAY; MYCOBACTERIUM-TUBERCULOSIS; T-CELLS; LIKELIHOOD RATIOS; SKIN-TEST; IMMUNOCOMPROMISED PATIENTS; INFECTED INDIVIDUALS; LOGISTIC-REGRESSION	Background: The role of new T-cell-based blood tests for tuberculosis in the diagnosis of active tuberculosis is unclear. Objective: To compare the performance of 2 interferon-gamma assays and tuberculin skin testing in adults with suspected tuberculosis. Design: Prospective study conducted in routine practice. Setting: 2 urban hospitals in the United Kingdom. Patients: 389 adults, predominantly of South Asian and black ethnicity, with moderate to high clinical suspicion of active tuberculosis. Intervention: Tuberculin skin testing, the enzyme-linked immuno-spot assay ( ELISpot) incorporating early secretory antigenic target-6 and culture filtrate protein-10 ( standard ELISpot), and ELISpot incorporating a novel antigen, Rv3879c ( ELISpot(PLUS)) were performed during diagnostic assessment by independent persons who were blinded to results of the other test. Measurements: Sensitivity, specificity, predictive values, and likelihood ratios. Results: 194 patients had a final diagnosis of active tuberculosis, of which 79% were culture-confirmed. Sensitivity for culture-confirmed and highly probable tuberculosis was 89% ( 95% CI, 84% to 93%) with ELISpot(PLUS), 85% ( CI, 79% to 90%) with standard ELISpot, 79% ( CI, 72% to 85%) with 15-mm threshold tuberculin skin testing, and 83% ( CI, 77% to 89%) with stratified thresholds of 15 and 10 mm in vaccinated and unvaccinated patients, respectively. The ELISpotPLUS assay was more sensitive than tuberculin skin testing with 15-mm cutoff points ( P = 0.01) but not with stratified cutoff points ( P = 0.10). The ELISpotPLUS assay had 4% higher diagnostic sensitivity than standard ELISpot ( P = 0.02). Combined sensitivity of ELISpotPLUS and tuberculin skin testing was 99% ( CI, 95% to 100%), conferring a negative likelihood ratio of 0.02 ( CI, 0 to 0.06) when both test results were negative. Limitations: Local standards for tuberculin skin testing differed from others used internationally. The study sample included few immunosuppressed patients. Conclusion: The ELISpotPLUS assay is more sensitive than standard ELISpot and, when used in combination with tuberculin skin testing, enables rapid exclusion of active infection in patients with moderate to high pretest probability of tuberculosis.	[Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Resp Med, TB Immunol Grp, London W2 1PG, England; Univ Oxford, Oxford OX1 2JD, England; Univ Birmingham, Birmingham B15 2TT, W Midlands, England; Birmingham Heartlands Hosp, Birmingham, W Midlands, England; Northwick Pk Hosp & Clin Res Ctr, Harrow HA1 3UJ, Middx, England	Imperial College London; University of Oxford; University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham; Imperial College London	Lalvani, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Resp Med, TB Immunol Grp, St Marys Campus,Norfolk Pl, London W2 1PG, England.	a.lalvani@imperial.ac.uk	Pasvol, Geoffrey/B-7113-2009; Dosanjh, Davinder/ABD-8895-2021; Deeks, Jon/AAV-5745-2020	Dosanjh, Davinder/0000-0002-9169-5607; Deeks, Jon/0000-0002-8850-1971; Hinks, Timothy/0000-0003-0699-2373; Lalvani, Ajit/0000-0002-2396-246X	Wellcome Trust [064353] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBERT A, 1982, CLIN CHEM, V28, P1113; [Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Barnes PF, 2001, AM J RESP CRIT CARE, V163, P807, DOI 10.1164/ajrccm.163.4.ed0201c; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Chan SF, 2008, J CLIN EPIDEMIOL, V61, P52, DOI 10.1016/j.jclinepi.2007.02.012; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Dheda K, 2005, AIDS, V19, P2038, DOI 10.1097/01.aids.0000191923.08938.5b; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; HMSO, 1996, IMM INF DIS; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kang YA, 2007, CHEST, V132, P959, DOI 10.1378/chest.06-2805; KNOTTNERUS JA, 1992, MED DECIS MAKING, V12, P93, DOI 10.1177/0272989X9201200202; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lee E, 2002, CLIN INFECT DIS, V34, P365, DOI 10.1086/338149; Lee JY, 2006, EUR RESPIR J, V28, P24, DOI 10.1183/09031936.06.00016906; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Liu XQ, 2004, INFECT IMMUN, V72, P2574, DOI 10.1128/IAI.72.5.2574-2581.2004; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; *NAT COLL CTR CHRO, 2006, TUB CLIN DIAGN MAN T; Ormerod P, 2000, THORAX, V55, P887; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Piana F, 2006, EUR RESPIR J, V28, P31, DOI 10.1183/09031936.06.00110205; Piana F, 2006, AM J RESP CRIT CARE, V173, P130, DOI 10.1164/ajrccm.173.1.130; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Richeldi L, 2006, THORAX, V61, P180, DOI 10.1136/thx.2005.049759; Richeldi L, 2004, AM J RESP CRIT CARE, V170, P288, DOI 10.1164/rccm.200403-307OC; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Rose AMC, 2001, THORAX, V56, P173, DOI 10.1136/thorax.56.3.173; Schluger NW, 2002, CHEST, V122, P597, DOI 10.1378/chest.122.2.597; Small PM, 2000, LANCET, V356, P1048, DOI 10.1016/S0140-6736(00)02724-0; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3	48	120	130	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2008	148	5					325	W72		10.7326/0003-4819-148-5-200803040-00003	http://dx.doi.org/10.7326/0003-4819-148-5-200803040-00003			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268SX	18316751	Green Accepted			2022-12-24	WOS:000253600800001
J	Mellman, DL; Gonzales, ML; Song, CH; Barlow, CA; Wang, P; Kendziorski, C; Anderson, RA				Mellman, David L.; Gonzales, Michael L.; Song, Chunhua; Barlow, Christy A.; Wang, Ping; Kendziorski, Christina; Anderson, Richard A.			A PtdIns4,5P(2)-regulatednuclear poly(A) polymerase controls expression of select mRNAs	NATURE			English	Article							POLYADENYLATION; COMPLEX; FAMILY; MECHANISM; KINASES; BINDING; REGION; DOMAIN; GAMMA; ENDS	Phosphoinositides are a family of lipid signalling molecules that regulate many cellular functions in eukaryotes. Phosphatidylinositol-4,5- bisphosphate ( PtdIns4,5P(2)), the central component in the phosphoinositide signalling circuitry, is generated primarily by type I phosphatidylinositol 4- phosphate 5- kinases ( PIPKI alpha, PIPKI beta and PIPKI gamma)(1). In addition to functions in the cytosol, phosphoinositides are present in the nucleus(2,3), where they modulate several functions(4-6); however, the mechanism by which they directly regulate nuclear functions remains unknown. PIPKIs regulate cellular functions through interactions with protein partners, often PtdIns4,5P(2) effectors, that target PIPKIs to discrete subcellular compartments, resulting in the spatial and temporal generation of PtdIns4,5P(2) required for the regulation of specific signalling pathways(1,7). Therefore, to determine roles for nuclear PtdIns4,5P(2) we set out to identify proteins that interacted with the nuclear PIPK, PIPKI alpha. Here we show that PIPKI alpha co- localizes at nuclear speckles and interacts with a newly identified non- canonical poly( A) polymerase, which we have termed Star- PAP ( nuclear speckle targeted PIPKIa regulated- poly( A) polymerase) and that the activity of Star- PAP can be specifically regulated by PtdIns4,5P(2). Star- PAP and PIPKIa function together in a complex to control the expression of select mRNAs, including the transcript encoding the key cytoprotective enzyme haem oxygenase- 1 ( refs 8, 9) and other oxidative stress response genes by regulating the 3 '-end formation of their mRNAs. Taken together, the data demonstrate a model by which phosphoinositide signalling works in tandem with complement pathways to regulate the activity of Star- PAP and the subsequent biosynthesis of its target mRNA. The results reveal a mechanism for the integration of nuclear phosphoinositide signals and a method for regulating gene expression.	[Mellman, David L.; Gonzales, Michael L.; Anderson, Richard A.] Univ Wisconsin, Sch Med, Mol & Cellular Biol Program, Madison, WI 53706 USA; [Song, Chunhua; Barlow, Christy A.; Anderson, Richard A.] Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53706 USA; [Wang, Ping; Kendziorski, Christina] Univ Wisconsin, Sch Med, Dept Biostat & Med Informat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Sch Med, Mol & Cellular Biol Program, 1300 Univ Ave, Madison, WI 53706 USA.	raanders@wisc.edu	song, chunhua/K-7882-2016; song, chunhua/K-7882-2016	song, chunhua/0000-0001-7563-0339; Anderson, Richard/0000-0001-6265-8359; song, chunhua/0000-0002-4081-2543; Barlow, Christy/0000-0002-1239-3767	NIGMS NIH HHS [R01 GM051968, R01 GM114386] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114386, R01GM051968] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; CHRISTOFORI G, 1988, CELL, V54, P875, DOI 10.1016/S0092-8674(88)91263-9; Cocco L, 2004, ADV ENZYME REGUL, V44, P51, DOI 10.1016/j.advenzreg.2003.11.009; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Gonzales ML, 2006, J CELL BIOCHEM, V97, P252, DOI 10.1002/jcb.20655; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hirose Y, 2000, GENE DEV, V14, P1415; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Kyriakopoulou CB, 2001, J BIOL CHEM, V276, P33504, DOI 10.1074/jbc.M104599200; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Nagaoka K, 2006, BBA-GENE STRUCT EXPR, V1759, P132, DOI 10.1016/j.bbaexp.2006.04.004; Osborne SL, 2001, J CELL SCI, V114, P2501; RAABE T, 1991, NATURE, V353, P229, DOI 10.1038/353229a0; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Trippe R, 2006, RNA, V12, P1494, DOI 10.1261/rna.87706; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	32	179	187	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					1013	U9		10.1038/nature06666	http://dx.doi.org/10.1038/nature06666			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288197				2022-12-24	WOS:000253313100053
J	Murayama, Y; Kurokawa, Y; Mayanagi, K; Iwasaki, H				Murayama, Yasuto; Kurokawa, Yumiko; Mayanagi, Kouta; Iwasaki, Hiroshi			Formation and branch migration of Holliday junctions mediated by eukaryotic recombinases	NATURE			English	Article							DNA STRAND EXCHANGE; ESCHERICHIA-COLI RECA; HUMAN RAD51 PROTEIN; HOMOLOGOUS RECOMBINATION; MEIOTIC RECOMBINATION; HETERODUPLEX FORMATION; ATP HYDROLYSIS; BREAK REPAIR; DUPLEX DNA; IN-VITRO	Holliday junctions ( HJs) are key intermediates in homologous recombination and are especially important for the production of crossover recombinants(1-4). Bacterial RecA family proteins promote the formation and branch migration of HJs in vitro by catalysing a reciprocal DNA- strand exchange reaction between two duplex DNA molecules, one of which contains a single- stranded DNA region that is essential for initial nucleoprotein filament formation(5). This activity has been reported only for prokaryotic RecA family recombinases(5), although eukaryotic homologues are also essential for HJ production in vivo(6,7). Here we show that fission yeast ( Rhp51) and human ( hRad51) RecA homologues promote duplex - duplex DNA- strand exchange in vitro. As with RecA, a HJ is formed between the two duplex DNA molecules, and reciprocal strand exchange proceeds through branch migration of the HJ. In contrast to RecA, however, strand exchange mediated by eukaryotic recombinases proceeds in the 3 '-->5 ' direction relative to the single- stranded DNA region of the substrate DNA. The opposite polarity of Rhp51 makes it especially suitable for the repair of DNA double- strand breaks, whose repair is initiated at the processed ends of breaks that have protruding 3 ' termini(1,2).	[Murayama, Yasuto; Kurokawa, Yumiko; Iwasaki, Hiroshi] Yokohama City Univ, Div Mol & Cellular Biol, Int Grad Sch Arts & Sci, Kanagawa 2300045, Japan; [Mayanagi, Kouta] Nagahama Inst Biosci & Technol, Dept Biosci, Shiga 5260829, Japan; [Mayanagi, Kouta] JST, BIRD, Shiga 5260829, Japan	Yokohama City University; Japan Science & Technology Agency (JST)	Iwasaki, H (corresponding author), Yokohama City Univ, Div Mol & Cellular Biol, Int Grad Sch Arts & Sci, 1-7-29 Suehirocho, Kanagawa 2300045, Japan.	iwasaki@tsurumi.yokohama-cu.ac.jp	Iwasaki, Hiroshi/Y-7946-2018	Iwasaki, Hiroshi/0000-0002-0153-6873				Baumann P, 1999, J MOL BIOL, V291, P363, DOI 10.1006/jmbi.1999.2954; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; CHOW SA, 1992, J MOL BIOL, V223, P79, DOI 10.1016/0022-2836(92)90717-X; Constantinou Angelos, 2004, Methods Mol Biol, V262, P239; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P6018, DOI 10.1073/pnas.78.10.6018; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; Gupta RC, 1998, P NATL ACAD SCI USA, V95, P9843, DOI 10.1073/pnas.95.17.9843; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Haruta N, 2008, DNA REPAIR, V7, P1, DOI 10.1016/j.dnarep.2007.07.004; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; JAIN SK, 1994, J BIOL CHEM, V269, P20653; KIM JI, 1992, J BIOL CHEM, V267, P16444; KMIEC EB, 1983, CELL, V33, P857, DOI 10.1016/0092-8674(83)90028-4; KONFORTI BB, 1987, P NATL ACAD SCI USA, V84, P690, DOI 10.1073/pnas.84.3.690; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; Namsaraev E, 1997, MOL CELL BIOL, V17, P5359, DOI 10.1128/MCB.17.9.5359; Namsaraev EA, 1998, P NATL ACAD SCI USA, V95, P10477, DOI 10.1073/pnas.95.18.10477; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shinagawa H, 1996, TRENDS BIOCHEM SCI, V21, P107, DOI 10.1016/0968-0004(96)10014-1; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; WEST SC, 1982, MOL GEN GENET, V187, P209, DOI 10.1007/BF00331119; Yoshikawa M, 2000, GENES CELLS, V5, P803, DOI 10.1046/j.1365-2443.2000.00371.x	33	38	38	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2008	451	7181					1018	U10		10.1038/nature06609	http://dx.doi.org/10.1038/nature06609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18256600				2022-12-24	WOS:000253313100054
J	Choi, HK; Curhan, G				Choi, Hyon K.; Curhan, Gary			Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE; CORONARY-HEART-DISEASE; ADENINE-NUCLEOTIDE TURNOVER; METABOLIC SYNDROME; INDUCED HYPERURICEMIA; VEGETABLE INTAKE; HEALTH-PROFESSIONALS; INSULIN-RESISTANCE; DIETARY FRUCTOSE; URATE PRODUCTION	Objective To examine the relation between intake of sugar sweetened soft drinks and fructose and the risk of incident gout in men. Design Prospective cohort over 12 years. Setting Health professionals follow-up study. Participants 46 393 men with no history of gout at baseline who provided information on intake of soft drinks and fructose through validated food frequency questionnaires. Main outcome measure Incident cases of gout meeting the American College of Rheumatology survey criteria for gout. Results During the 12 years of follow-up 755 confirmed incident cases of gout were reported. Increasing intake of sugar sweetened soft drinks was associated with an increasing risk of gout. Compared with consumption of less than one serving of sugar sweetened soft drinks a month the multivariate relative risk of gout for 5-6 servings a week was 1.29 (95% confidence interval 1.00 to 1.68), for one serving a day was 1.45 (1.02 to 2.08), and for two or more servings a day was 1.85 (1.08 to 3.16; P for trend=0.002). Diet soft drinks were not associated with risk of gout (P for trend=0.99). The multivariate relative risk of gout according to increasing fifths of fructose intake were 1.00, 1.29, 1.41, 1.84, and 2.02 (1.49 to 2.75; P for trend <0.001). Other major contributors to fructose intake such as total fruit juice or fructose rich fruits (apples and oranges) were also associated with a higher risk of gout (P values for trend (0.05). Conclusions Prospective data suggest that consumption of sugar sweetened soft drinks and fructose is strongly associated with an increased risk of gout in men. Furthermore, fructose rich fruits and fruit juices may also increase the risk. Diet soft drinks were not associated with the risk of gout.	[Choi, Hyon K.] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Arthrit Res Ctr Canada, Vancouver, BC V5Z 1L7, Canada; [Curhan, Gary] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA USA	University of British Columbia; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Choi, HK (corresponding author), Univ British Columbia, Vancouver Gen Hosp, Dept Med, Arthrit Res Ctr Canada, Vancouver, BC V5Z 1L7, Canada.	hchoi@arthritisresearch.ca			NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline; NIAAA NIH HHS [AA11181] Funding Source: Medline; NIDDK NIH HHS [DK58573] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABBOTT RD, 1988, J CLIN EPIDEMIOL, V41, P237, DOI 10.1016/0895-4356(88)90127-8; ANDERSON JW, 1989, DIABETES CARE, V12, P337, DOI 10.2337/diacare.12.5.337; Apovian CM, 2004, JAMA-J AM MED ASSOC, V292, P978, DOI 10.1001/jama.292.8.978; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Arromdee E, 2002, J RHEUMATOL, V29, P2403; BECKNIELSEN H, 1980, AM J CLIN NUTR, V33, P273, DOI 10.1093/ajcn/33.2.273; BLAKELY SR, 1981, J NUTR, V111, P307, DOI 10.1093/jn/111.2.307; Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Cho EY, 2004, ARCH OPHTHALMOL-CHIC, V122, P883, DOI 10.1001/archopht.122.6.883; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2005, CURR OPIN RHEUMATOL, V17, P341; CHOI HK, IN PRESS ARTHRITIS R; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P109, DOI 10.1002/art.22466; EMMERSON BT, 1974, ANN RHEUM DIS, V33, P276, DOI 10.1136/ard.33.3.276; Emmerson BT, 1996, NEW ENGL J MED, V334, P445, DOI 10.1056/NEJM199602153340707; FALLER J, 1982, NEW ENGL J MED, V307, P1598, DOI 10.1056/NEJM198212233072602; Fam AG, 2002, J RHEUMATOL, V29, P1350; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; FOX IH, 1987, NEW ENGL J MED, V317, P111, DOI 10.1056/NEJM198707093170209; FOX IH, 1972, METABOLISM, V21, P713, DOI 10.1016/0026-0495(72)90120-5; Gibson T, 1977, Adv Exp Med Biol, V76B, P46; GIBSON T, 1983, ANN RHEUM DIS, V42, P123, DOI 10.1136/ard.42.2.123; GOUT OW, 1893, PRINCIPLES PRACTICE, P287; Gross LS, 2004, AM J CLIN NUTR, V79, P774; HALLFRISCH J, 1983, J NUTR, V113, P1819, DOI 10.1093/jn/113.9.1819; HOCHBERG MC, 1995, ARTHRITIS RHEUM-US, V38, P628, DOI 10.1002/art.1780380508; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, AM J CLIN NUTR, V70, P221; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lee WY, 2004, DIABETES RES CLIN PR, V65, P143, DOI 10.1016/j.diabres.2003.12.007; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; MCGARRY JD, 1994, J CELL BIOCHEM, V55, P29, DOI 10.1002/jcb.240550005; Moeller SM, 2004, J NUTR, V134, P1812, DOI 10.1093/jn/134.7.1812; Nakagawa T, 2005, NAT CLIN PRACT NEPHR, V1, P80, DOI 10.1038/ncpneph0019; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; PERHEENT.J, 1967, LANCET, V2, P528; PUIG JG, 1984, J CLIN INVEST, V74, P936, DOI 10.1172/JCI111512; RAIVIO KO, 1975, METABOLISM, V24, P861, DOI 10.1016/0026-0495(75)90133-X; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIZKALLA SW, 1993, BRIT J NUTR, V70, P199, DOI 10.1079/BJN19930117; ROUBENOFF R, 1991, JAMA-J AM MED ASSOC, V266, P3004, DOI 10.1001/jama.266.21.3004; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Shadick NA, 2000, J RHEUMATOL, V27, P1708; SHARPE CR, 1984, CAN MED ASSOC J, V131, P563; STIRPE F, 1970, LANCET, V2, P1310; THORBURN AW, 1989, AM J CLIN NUTR, V49, P1155, DOI 10.1093/ajcn/49.6.1155; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; *USDA, 2005, DIET GUID AM; *USDA, 1993, COMP FOODS RAW PROC; Vainio H, 2003, IARC HDB CANC PREVEN; Vazquez-Mellado JV, 2004, JCR-J CLIN RHEUMATOL, V10, P105, DOI 10.1097/01.rhu.0000129082.42094.fc; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wu TY, 2004, AM J CLIN NUTR, V80, P1043, DOI 10.1093/ajcn/80.4.1043; ZAVARONI I, 1980, METABOLISM, V29, P970, DOI 10.1016/0026-0495(80)90041-4	66	352	384	5	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2008	336	7639					309	+		10.1136/bmj.39449.819271.BE	http://dx.doi.org/10.1136/bmj.39449.819271.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LR	18244959	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000253437400031
J	Heikens, GT; Amadi, BC; Manary, M; Rollins, N; Tomkins, A				Heikens, Geert Tom; Amadi, Beatrice C.; Manary, Mark; Rollins, Nigel; Tomkins, Andrew			Nutrition interventions need improved operational capacity	LANCET			English	Editorial Material							MALNOURISHED MALAWIAN CHILDREN; USE THERAPEUTIC FOOD; HOME-BASED THERAPY; TO-USE FOOD; SEVERE MALNUTRITION; CHALLENGES		[Heikens, Geert Tom] Univ Malawi, Coll Med, Dept Paediat, Blantyre 3, Malawi; [Manary, Mark] Univ Malawi, Coll Med, Dept Community Med, Blantyre 3, Malawi; [Amadi, Beatrice C.] Univ Teaching Hosp, Dept Paediat & Child Hlth, Lusaka, Zambia; [Manary, Mark] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Rollins, Nigel] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr Maternal & Child Hlth, Durban, South Africa; [Tomkins, Andrew] UCL, Inst Child Hlth, Ctr Int Hlth & Dev, London, England	University of Malawi; University of Malawi; University of Zambia; Washington University (WUSTL); University of Kwazulu Natal; University of London; University College London	Heikens, GT (corresponding author), Univ Malawi, Coll Med, Dept Paediat, Blantyre 3, Malawi.	theikens@medcol.mw		Manary, Mark/0000-0003-2733-9568				Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Briend A, 2006, FOOD NUTR BULL, V27, pS3, DOI 10.1177/15648265060273S301; BRYCE J, LANCET, DOI DOI 10.1016/S0140-6736(07)61694-8; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Heikens GT, 2007, PLOS MED, V4, P222, DOI 10.1371/journal.pmed.0040045; Heikens GT, 2007, LANCET, V369, P2159, DOI 10.1016/S0140-6736(07)61010-1; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Manary MJ, 2004, ARCH DIS CHILD, V89, P557, DOI 10.1136/adc.2003.034306; Murray CJL, 2007, LANCET, V370, P1018, DOI 10.1016/S0140-6736(07)61458-5; Sandige H, 2004, J PEDIATR GASTR NUTR, V39, P141, DOI 10.1097/00005176-200408000-00003; *WHO, 2006, WORLD HHLTH REP 2006; World Health Organization, 1999, MAN SEV MALN MAN PHY; [No title captured]	16	22	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2008	371	9608					181	182		10.1016/S0140-6736(07)61691-2	http://dx.doi.org/10.1016/S0140-6736(07)61691-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207567				2022-12-24	WOS:000252471900006
J	Kumar, PR; Yu, Y; Sternglanz, R; Johnston, SA; Joshua-Tor, L				Kumar, P. Rajesh; Yu, Yao; Sternglanz, Rolf; Johnston, Stephen Albert; Joshua-Tor, Leemor			NADP regulates the yeast GAL induction system	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-BINDING; ACTIVATION; REGULON; PROTEIN	Transcriptional regulation of the galactose- metabolizing genes in Saccharomyces cerevisiae depends on three core proteins: Gal4p, the transcriptional activator that binds to upstream activating DNA sequences (UAS(GAL)); Gal80p, a repressor that binds to the carboxyl terminus of Gal4p and inhibits transcription; and Gal3p, a cytoplasmic transducer that, upon binding galactose and adenosine 5 '-triphosphate, relieves Gal80p repression. The current model of induction relies on Gal3p sequestering Gal80p in the cytoplasm. However, the rapid induction of this system implies that there is a missing factor. Our structure of Gal80p in complex with a peptide from the carboxyl- terminal activation domain of Gal4p reveals the existence of a dinucleotide that mediates the interaction between the two. Biochemical and in vivo experiments suggests that nicotinamide adenine dinucleotide phosphate ( NADP) plays a key role in the initial induction event.	[Kumar, P. Rajesh; Joshua-Tor, Leemor] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Yu, Yao; Sternglanz, Rolf] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Johnston, Stephen Albert] Arizona State Univ, Ctr Innovat Med, Biodesign Inst, Sch Life Sci, Tempe, AZ 85287 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Arizona State University; Arizona State University-Tempe	Joshua-Tor, L (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu		Joshua-Tor, Leemor/0000-0001-8185-8049; Yu, Yao/0000-0003-0090-8193; Kumar, P. Rajesh/0000-0002-0576-6967	NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055641, R01GM074075] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30 CA045508] Funding Source: Medline; NIGMS NIH HHS [GM074075, R01 GM074075, GM55641, R01 GM074075-04] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhat PJ, 2001, MOL MICROBIOL, V40, P1059, DOI 10.1046/j.1365-2958.2001.02421.x; EINARSON MB, 2001, MOL CLONING LAB MANU; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Han Y, 2000, J BIOL CHEM, V275, P14979, DOI 10.1074/jbc.275.20.14979; JOHNSTON SA, 1987, CELL, V50, P143, DOI 10.1016/0092-8674(87)90671-4; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Peng G, 2000, MOL CELL BIOL, V20, P5140, DOI 10.1128/MCB.20.14.5140-5148.2000; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Thoden JB, 2007, J BIOL CHEM, V282, P1534, DOI 10.1074/jbc.C600285200; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	12	42	44	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1090	1092		10.1126/science.1151903	http://dx.doi.org/10.1126/science.1151903			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292341	Green Accepted			2022-12-24	WOS:000253311700043
J	Arnott, D; Joossens, L; Bianco, E; Assunta, M; Ogwell, A				Arnott, Deborah; Joossens, Luk; Bianco, Eduardo; Assunta, Mary; Ogwell, Ahmed			Smuggling treaty could reduce tobacco toll	LANCET			English	Editorial Material									[Arnott, Deborah] Act Smoking & Hlth, London E1 6JE, England; [Joossens, Luk; Bianco, Eduardo; Assunta, Mary; Ogwell, Ahmed] Framework Convent Alliance, Geneva, Switzerland		Arnott, D (corresponding author), Act Smoking & Hlth, London E1 6JE, England.	deborah.arnott@ash.org.uk						BEELMAN MS, 2001, TOBACCO CO LINKED CR; *BRIT AM TOB, 2007, BRIT AM TOB VIEWS FC; Clarke K., 2000, GUARDIAN 0203 GUARDIAN 0203; *FRAM CONV ALL, 2007, FCA EX SUMM COMM TEM; Framework Convention Alliance, 2007, BIG WAS ILL TOB TRAD; *HM REV CUST, 2006, ANN REP 2005 6 AUT P; Joossens L, 2000, BRIT MED J, V321, P947, DOI 10.1136/bmj.321.7266.947; Lee K, 2006, PLOS MED, V3, P1080, DOI 10.1371/journal.pmed.0030228; LEIGH D, 2000, GUARDIAN        0131; *TOB FREE IN WHO, WHY IS TOB PUBL HLTH; US General Accounting Office, 2003, TERR FIN US AG SHOUL; *WHO, 2007, 3 WHO COMM A; *WHO, 2007, TOB FREE IN TOB FACT; World Bank, 1999, CURB EP GOV EC TOB C	14	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2008	371	9611					458	460		10.1016/S0140-6736(08)60217-2	http://dx.doi.org/10.1016/S0140-6736(08)60217-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262028				2022-12-24	WOS:000253169200009
J	Thomson, WM; Poulton, R; Broadbent, JM; Moffitt, TE; Caspi, A; Beck, JD; Welch, D; Hancox, RJ				Thomson, W. Murray; Poulton, Richie; Broadbent, Jonathan M.; Moffitt, Terrie E.; Caspi, Avshalom; Beck, James D.; Welch, David; Hancox, Robert J.			Cannabis smoking and periodontal disease among young adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SELF-REPORTED SMOKING; CIGARETTE-SMOKING; NEW-ZEALAND; VALIDITY; INDEX	Context Tobacco smoking is a recognized behavioral risk factor for periodontal disease ( through its systemic effects), and cannabis smoking may contribute in a similar way. Objective To determine whether cannabis smoking is a risk factor for periodontal disease. Design and Setting Prospective cohort study of the general population, with cannabis use determined at ages 18, 21, 26, and 32 years and dental examinations conducted at ages 26 and 32 years. The most recent data collection ( at age 32 years) was completed in June 2005. Participants A complete birth cohort born in 1972 and 1973 in Dunedin, New Zealand, and assessed periodically ( with a 96% follow- up rate of the 1015 participants who survived to age 32 years). Complete data for this analysis were available from 903 participants ( comprising 89.0% of the surviving birth cohort). Main Outcome Measure Periodontal disease status at age 32 years ( and changes from ages 26 to 32 years) determined from periodontal combined attachment loss ( CAL) measured at 3 sites per tooth. Results Three cannabis exposure groups were determined: no exposure ( 293 individuals, or 32.3%), some exposure ( 428; 47.4%), and high exposure ( 182; 20.2%). At age 32 years, 265 participants ( 29.3%) had 1 or more sites with 4 mm or greater CAL, and 111 participants ( 12.3%) had 1 or more sites with 5 mm or greater CAL. Incident attachment loss between the ages of 26 and 32 years in the none, some, and high cannabis exposure groups was 6.5%, 11.2%, and 23.6%, respectively. After controlling for tobacco smoking ( measured in pack- years), sex, irregular use of dental services, and dental plaque, the relative risk estimates for the highest cannabis exposure group were as follows: 1.6 ( 95% confidence interval [ CI], 1.2- 2.2) for having 1 or more sites with 4 mm or greater CAL; 3.1 ( 95% CI, 1.5- 6.4) for having 1 or more sites with 5 mm or greater CAL; and 2.2 ( 95% CI, 1.2- 3.9) for having incident attachment loss ( in comparison with those who had never smoked cannabis). Tobacco smoking was strongly associated with periodontal disease experience, but there was no interaction between cannabis use and tobacco smoking in predicting the condition's occurrence. Conclusion Cannabis smoking may be a risk factor for periodontal disease that is independent of the use of tobacco.	[Thomson, W. Murray; Broadbent, Jonathan M.] Sir John Walsh Res Inst, Sch Dent, Dept Oral Sci, Dunedin, New Zealand; [Poulton, Richie; Welch, David; Hancox, Robert J.] Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; [Moffitt, Terrie E.; Caspi, Avshalom] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Moffitt, Terrie E.; Caspi, Avshalom] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Moffitt, Terrie E.; Caspi, Avshalom] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Moffitt, Terrie E.; Caspi, Avshalom] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Beck, James D.] Univ N Carolina, Sch Dent, Dept Dent Ecol, Chapel Hill, NC 27599 USA	University of Otago; University of London; King's College London; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Thomson, WM (corresponding author), Sir John Walsh Res Inst, Sch Dent, Dept Oral Sci, POB 647, Dunedin, New Zealand.	murray.thomson@otago.ac.nz	Broadbent, Jonathan M/R-9976-2019; Moffitt, Terrie E/D-5295-2011; caspi, avshalom/D-5294-2011; Hancox, Robert/G-4746-2011; Thomson, William Murray/AAC-8575-2019; Thomson, William Murray/A-4971-2008; caspi, avshalom/AAJ-5874-2020	Broadbent, Jonathan M/0000-0002-8905-398X; Moffitt, Terrie E/0000-0002-8589-6760; caspi, avshalom/0000-0003-0082-4600; Thomson, William Murray/0000-0003-0588-6843; caspi, avshalom/0000-0003-0082-4600	Medical Research Council [G0100527, G0601483] Funding Source: Medline; NIDCR NIH HHS [R01 DE-015260, R01 DE015260-01A1, R01 DE015260-03, R01 DE015260, R01 DE015260-02, R01 DE015260-04] Funding Source: Medline; NIMH NIH HHS [R01 MH077874, MH077874, R01 MH045070, MH49414, R01 MH049414, MH45070] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH049414, R01MH045070, R01MH077874, R01MH049414] Funding Source: NIH RePORTER; MRC [G0100527, G0601483] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aldington S, 2007, THORAX, V62, P1058, DOI 10.1136/thx.2006.077081; Ashton CH, 2001, BRIT J PSYCHIAT, V178, P101, DOI 10.1192/bjp.178.2.101; Dolcini MM, 2003, NICOTINE TOB RES, V5, P473, DOI 10.1080/1462220031000118586; Fendrich M, 2005, ADDICT BEHAV, V30, P175, DOI 10.1016/j.addbeh.2004.04.009; Gelskey SC, 1999, COMMUNITY DENT ORAL, V27, P16, DOI 10.1111/j.1600-0528.1999.tb01987.x; Gilthorpe MS, 2003, J DENT RES, V82, P200, DOI 10.1177/154405910308200310; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; Hujoel PP, 2003, COMMUNITY DENT ORAL, V31, P1, DOI 10.1034/j.1600-0528.2003.00061.x; IRVING JC, 1977, NEW ZEAL J EDUC STUD, V12, P154; Johnson GK, 2004, J PERIODONTOL, V75, P196, DOI 10.1902/jop.2004.75.2.196; Johnson N, 2001, J Dent Educ, V65, P328; Kinane DF, 2000, CRIT REV ORAL BIOL M, V11, P356, DOI 10.1177/10454411000110030501; Mak YW, 2005, ADDICT BEHAV, V30, P841, DOI 10.1016/j.addbeh.2004.08.008; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; PHIPPS KR, 1995, J PUBLIC HEALTH DENT, V55, P250, DOI 10.1111/j.1752-7325.1995.tb02377.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Silva P., 1996, CHILD ADULT DUNEDIN; Susin C, 2005, J PERIODONTOL, V76, P262, DOI 10.1902/jop.2005.76.2.262; Taylor DR, 2003, INTERN MED J, V33, P310, DOI 10.1046/j.1445-5994.2003.00401.x; Thomson WM, 2006, J PERIODONTOL, V77, P947, DOI 10.1902/jop.2006.050319; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Yoshie H, 2007, PERIODONTOL 2000, V43, P102, DOI 10.1111/j.1600-0757.2006.00164.x	22	82	85	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					525	531		10.1001/jama.299.5.525	http://dx.doi.org/10.1001/jama.299.5.525			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252882	Green Accepted, Green Submitted			2022-12-24	WOS:000252886100017
J	Claxton, K; Lindsay, AB; Buxton, MJ; Culyer, AJ; McCabe, C; Walker, S; Sculpher, MJ				Claxton, Karl; Lindsay, Andrew Briggs; Buxton, Martin J.; Culyer, Anthony J.; McCabe, Christopher; Walker, Simon; Sculpher, Mark J.			Value based pricing for NHS drugs: an opportunity not to be missed?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Claxton, Karl; Walker, Simon; Sculpher, Mark J.] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Claxton, Karl; Culyer, Anthony J.] Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England; [Lindsay, Andrew Briggs] Univ Glasgow, Glasgow, Lanark, Scotland; [Buxton, Martin J.] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England; [Culyer, Anthony J.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [McCabe, Christopher] Univ Leeds, Inst Hlth Sci, Leeds, W Yorkshire, England	University of York - UK; University of York - UK; University of Glasgow; Brunel University; University of Toronto; University of Leeds	Sculpher, MJ (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.	mjs23@york.ac.uk	McCabe, Christopher/E-2051-2016	Sculpher, Mark/0000-0003-3746-9913; Walker, Simon Mark/0000-0002-5750-3691	Medical Research Council [MC_U145079308] Funding Source: Medline; MRC [MC_U145079308] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2007, PHARM PRIC REG SCHEM; Claxton KP, 2006, PHARMACOECONOMICS, V24, P1055, DOI 10.2165/00019053-200624110-00003; Collier J, 2008, BRIT MED J, V336, P56, DOI 10.1136/bmj.39454.496748.80; Collier J, 2007, BRIT MED J, V334, P435, DOI 10.1136/bmj.39136.464421.BE; Culyer Anthony, 2007, J Health Serv Res Policy, V12, P56, DOI 10.1258/135581907779497567; *DEP BUS ENT REG R, 2007, INT GOV RESP OFF FAI; MARTIN S, 2007, 24 U YORK CTR HLTH E; *NIH CLIN EXC, 2008, HC27I STAT OFF NIH C; *NIH CLIN EXC, 2007, CLIN PUBL HLTH DIR P	9	129	133	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2008	336	7638					251	254		10.1136/bmj.39434.500185.25	http://dx.doi.org/10.1136/bmj.39434.500185.25			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261TM	18244997	Green Submitted, Green Published			2022-12-24	WOS:000253102900036
J	Ligi, I; Arnaud, F; Jouve, E; Tardieu, S; Sambuc, R; Simeoni, U				Ligi, Isabelle; Arnaud, Frederique; Jouve, Elisabeth; Tardieu, Sophie; Sambuc, Roland; Simeoni, Umberto			Iatrogenic events in admitted neonates: a prospective cohort study	LANCET			English	Article							INTENSIVE-CARE-UNIT; ADVERSE DRUG EVENTS; MEDICATION ERRORS; HOSPITALIZED-PATIENTS; QUALITY IMPROVEMENT; SYSTEM	Background Iatrogenic events are increasingly recognised as an important problem in all people admitted to hospital. However, few epidemiological data are available for iatrogenic events in neonatal high-risk units. We aimed to assess the incidence, nature, preventability, and severity of iatrogenic events in a neonatal Centre and to establish the association of patient characteristics with the occurrence of iatrogenic events in neonates. Methods We undertook an observational, prospective study from Jan 1, 2005, to Sept 1, 2005, including all neonates admitted in the Division of Neonatology of an academic, tertiary neonatal centre in southern France. Iatrogenic events were defined as any event that compromised the safety margin for the patient, in the presence or absence of harm. The report of an iatrogenic event was voluntary, anonymous, and non-punitive. The primary outcome was the rate of iatrogenic events per 1000 patient days. Findings A total of 388 patients were studied during 10436 patient days. We recorded 267 iatrogenic events in 116 patients. The incidence of iatrogenic events was 25.6 per 1000 patient days. 92 (34%) were preventable and 78 (29%) were severe. Two iatrogenic events (1%) were fatal, but neither was preventable. The most severe iatrogenic events were nosocomial infections (49/62 [79%]) and respiratory events (nine of 26 [35%]). Cutaneous injuries were frequent (n=94) but generally minor (89 [95%]), as were medication errors (15/19 [76%]). Most medication errors occurred during administration stage (12/19 [63%]) and were ten-fold errors (nine of 19 [47%]). The major risk factors were low birthweight and gestational age (both p<0.0001), length of stay (p<0.0001), a central venous line (p<0. 0001), mechanical ventilation (p=0. 0021), and support with continuous positive airwary pressure (p=0. 0076). Interpretation Iatrogenic events occur frequently and are often serious in neonates, especially in infants of low birthweight. Improved knowledge of the incidence and characteristics of iatrogenic events, and continuous monitoring could help to improve quality of health care for this vulnerable population.	[Ligi, Isabelle; Arnaud, Frederique; Simeoni, Umberto] La Concept Hosp, AP HM, Div Neonatol, F-13385 Marseille, France; [Jouve, Elisabeth; Tardieu, Sophie; Sambuc, Roland] Univ Mediterranee, Med Evaluat Dept, Dept Publ Hlth, Fac Med,Assistance Publ Hop Marseille,EA 3279, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Simeoni, U (corresponding author), La Concept Hosp, AP HM, Div Neonatol, 147 Blvd Baille, F-13385 Marseille, France.	umberto.simeoni@ap-hm.fr	Jouve, Elisabeth/GSN-9120-2022; Simeoni, Umberto/GRO-6971-2022; SIMEONI, Umberto/AAQ-1870-2021	Jouve, Elisabeth/0000-0002-4873-6522; Simeoni, Umberto/0000-0003-0730-9337; SIMEONI, Umberto/0000-0003-0730-9337				Ahluwalia J, 2005, SEMIN FETAL NEONAT M, V10, P31, DOI 10.1016/j.siny.2004.09.012; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Beckmann U, 2003, CRIT CARE MED, V31, P1006, DOI 10.1097/01.CCM.0000060016.21525.3C; Beckmann U, 1996, ANAESTH INTENS CARE, V24, P314, DOI 10.1177/0310057X9602400303; Branch WT, 2005, J GEN INTERN MED, V20, P1063, DOI 10.1111/j.1525-1497.2005.00231.x; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Capuzzo M, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-3; Chappell K, 2004, ARCH DIS CHILD-FETAL, V89, pF483, DOI 10.1136/adc.2003.041608; Fox PE, 1998, EARLY HUM DEV, V51, P171, DOI 10.1016/S0378-3782(97)00112-6; Frey B, 2000, INTENS CARE MED, V26, P69, DOI 10.1007/s001340050014; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; HARTWIG SC, 1991, AM J HOSP PHARM, V48, P2611, DOI 10.1093/ajhp/48.12.2611; *INT NEON NETW, 1993, CRIB CLIN RISK IND B, V342, P193; Kanter David E, 2004, Pediatr Crit Care Med, V5, P119; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; Leape LL, 2002, NEW ENGL J MED, V347, P1633, DOI 10.1056/NEJMNEJMhpr011493; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Leroy B, 1971, Rev Fr Gynecol Obstet, V66, P391; Michel P, 2004, BMJ-BRIT MED J, V328, P1; RAJU TNK, 1989, LANCET, V2, P374; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; Sadowski R, 2004, PEDIATRICS, V114, P628, DOI 10.1542/peds.2003-0735-L; Sharek PJ, 2006, PEDIATRICS, V118, P1332, DOI 10.1542/peds.2006-0565; Simpson JH, 2004, ARCH DIS CHILD-FETAL, V89, pF480, DOI 10.1136/adc.2003.044438; Thomas EJ, 2000, INT J QUAL HEALTH C, V12, P371, DOI 10.1093/intqhc/12.5.371; Veldman A, 2006, PEDIATR ANESTH, V16, P968, DOI 10.1111/j.1460-9592.2006.01902.x; Woods D, 2005, PEDIATRICS, V115, P155, DOI 10.1542/peds.2004-0410	28	69	76	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2008	371	9610					404	410		10.1016/S0140-6736(08)60204-4	http://dx.doi.org/10.1016/S0140-6736(08)60204-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242414				2022-12-24	WOS:000252992700030
J	Moore, CB; Bergstralh, DT; Duncan, JA; Lei, Y; Morrison, TE; Zimmermann, AG; Accavitti-Loper, MA; Madden, VJ; Sun, LJ; Ye, ZM; Lich, JD; Heise, MT; Chen, ZJ; Ting, JPY				Moore, Chris B.; Bergstralh, Daniel T.; Duncan, Joseph A.; Lei, Yu; Morrison, Thomas E.; Zimmermann, Albert G.; Accavitti-Loper, Mary A.; Madden, Victoria J.; Sun, Lijun; Ye, Zhengmao; Lich, John D.; Heise, Mark T.; Chen, Zhijian; Ting, Jenny P-Y.			NLRX1 is a regulator of mitochondrial antiviral immunity	NATURE			English	Article							NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; LRR PROTEINS; RESPONSES; CATERPILLER; FAMILY; DEFENSE; PATHWAY; SIGNALS	The RIG- like helicase ( RLH) family of intracellular receptors detect viral nucleic acid and signal through the mitochondrial antiviral signalling adaptor MAVS ( also known as Cardif, VISA and IPS- 1) during a viral infection(1-6). MAVS activation leads to the rapid production of antiviral cytokines, including type 1 interferons. Although MAVS is vital to antiviral immunity, its regulation from within the mitochondria remains unknown. Here we describe human NLRX1, a highly conserved nucleotide- binding domain ( NBD)- and leucine- rich- repeat ( LRR)- containing family member ( known as NLR) that localizes to the mitochondrial outer membrane and interacts with MAVS. Expression of NLRX1 results in the potent inhibition of RLH- and MAVS- mediated interferon-beta promoter activity and in the disruption of virus- induced RLH-MAVS interactions. Depletion of NLRX1 with small interference RNA promotes virus- induced type I interferon production and decreases viral replication. This work identifies NLRX1 as a check against mitochondrial antiviral responses and represents an intersection of three ancient cellular processes: NLR signalling, intracellular virus detection and the use of mitochondria as a platform for anti- pathogen signalling. This represents a conceptual advance, in that NLRX1 is a modulator of pathogen- associated molecular pattern receptors rather than a receptor, and identifies a key therapeutic target for enhancing antiviral responses.	[Moore, Chris B.; Lei, Yu; Zimmermann, Albert G.; Ye, Zhengmao; Lich, John D.; Ting, Jenny P-Y.] Univ N Carolina, Dept Microbiol Immunol, Chapel Hill, NC 27599 USA; [Moore, Chris B.; Bergstralh, Daniel T.; Lei, Yu; Zimmermann, Albert G.; Ye, Zhengmao; Lich, John D.; Ting, Jenny P-Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Duncan, Joseph A.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Morrison, Thomas E.; Heise, Mark T.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Morrison, Thomas E.; Heise, Mark T.] Univ N Carolina, Carolina Vaccine Inst, Chapel Hill, NC 27599 USA; [Madden, Victoria J.] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; [Accavitti-Loper, Mary A.] Univ Alabama, Birmingham, AL 35294 USA; [Sun, Lijun; Chen, Zhijian] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ting, JPY (corresponding author), Univ N Carolina, Dept Microbiol Immunol, Chapel Hill, NC 27599 USA.	jenny_ting@med.unc.edu	Chen, Zhijian/C-6039-2012; Sun, Lijun/ABD-4470-2021; Ariel, Pablo/AGJ-4118-2022; Lei, Yu Leo/ABF-1293-2020	Chen, Zhijian/0000-0002-8475-8251; Lei, Yu Leo/0000-0002-9868-9824; Bergstralh, Dan/0000-0003-1689-3715				Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Marathe R, 2003, MOL CELL, V11, P284, DOI 10.1016/S1097-2765(03)00072-8; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	25	430	457	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2008	451	7178					573	U8		10.1038/nature06501	http://dx.doi.org/10.1038/nature06501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18200010	Bronze			2022-12-24	WOS:000252739900042
J	Coates, AL				Coates, Allan L.			Guiding aerosol deposition in the lung	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DELIVERY		Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Coates, AL (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada.							COATES AL, 2006, KENDIGS DISORDERS RE, P268; Dames P, 2007, NAT NANOTECHNOL, V2, P495, DOI 10.1038/nnano.2007.217; Koehler DR, 2005, J GENE MED, V7, P1409, DOI 10.1002/jgm.797; Laube BL, 2000, CHEST, V118, P1069, DOI 10.1378/chest.118.4.1069; SMALDONE GC, 1991, AM REV RESPIR DIS, V143, P727, DOI 10.1164/ajrccm/143.4_Pt_1.727	5	23	24	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					304	305		10.1056/NEJMcibr0707489	http://dx.doi.org/10.1056/NEJMcibr0707489			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199871				2022-12-24	WOS:000252375600015
J	Nagamune, K; Hicks, LM; Fux, B; Brossier, F; Chini, EN; Sibley, LD				Nagamune, Kisaburo; Hicks, Leslie M.; Fux, Blima; Brossier, Fabien; Chini, Eduardo N.; Sibley, L. David			Abscisic acid controls calcium-dependent egress and development in Toxoplasma gondii	NATURE			English	Article							CYCLIC ADP-RIBOSE; MICRONEME SECRETION; BIOSYNTHESIS; PATHWAY; ACCUMULATION; REVEALS; STRAINS	Calcium controls a number of critical events, including motility, secretion, cell invasion and egress by apicomplexan parasites(1). Compared to animal(2) and plant cells(3), the molecular mechanisms that govern calcium signalling in parasites are poorly understood. Here we show that the production of the phytohormone abscisic acid ( ABA) controls calcium signalling within the apicomplexan parasite Toxoplasma gondii, an opportunistic human pathogen. In plants, ABA controls a number of important events, including environmental stress responses, embryo development and seed dormancy(4,5). ABA induces production of the second- messenger cyclic ADP ribose ( cADPR), which controls release of intracellular calcium stores in plants(6). cADPR also controls intracellular calcium release in the protozoan parasite T. gondii(7,8); however, previous studies have not revealed the molecular basis of this pathway(9). We found that addition of exogenous ABA induced formation of cADPR in T. gondii, stimulated calcium- dependent protein secretion, and induced parasite egress from the infected host cell in a density- dependent manner. Production of endogenous ABA within the parasite was confirmed by purification ( using high- performance liquid chromatography) and analysis ( by gas chromatography- mass spectrometry). Selective disruption of ABA synthesis by the inhibitor fluridone delayed egress and induced development of the slow- growing, dormant cyst stage of the parasite. Thus, ABA- mediated calcium signalling controls the decision between lytic and chronic stage growth, a developmental switch that is central in pathogenesis and transmission. The pathway for ABA production was probably acquired with an algal endosymbiont that was retained as a non- photosynthetic plastid known as the apicoplast. The plant- like nature of this pathway may be exploited therapeutically, as shown by the ability of a specific inhibitor of ABA synthesis to prevent toxoplasmosis in the mouse model.	[Nagamune, Kisaburo; Fux, Blima; Brossier, Fabien; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Hicks, Leslie M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Chini, Eduardo N.] Mayo Clin & Mayo Fdn, Dept Anesthesiol, Rochester, MN 55905 USA	Washington University (WUSTL); Donald Danforth Plant Science Center; Mayo Clinic	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	sibley@wustl.edu	Hicks, Leslie M/E-8015-2010; Fux, Blima/AAO-2941-2020; Sibley, L. David/C-4616-2008	Hicks, Leslie M/0000-0002-8008-3998; Fux, Blima/0000-0002-5038-3551	NIAID NIH HHS [R21 AI067051-02, R01 AI034036-16, R01 AI034036, R21 AI067051] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067051, R01AI034036] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bothwell JHF, 2005, NEW PHYTOL, V166, P21, DOI 10.1111/j.1469-8137.2004.01312.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Chini EN, 2005, BIOCHEM J, V389, P269, DOI 10.1042/BJ20041971; COWAN AK, 1991, PLANT PHYSIOL, V97, P798, DOI 10.1104/pp.97.2.798; Almeida Julieta Andrea Silva de, 2005, Braz. J. Plant Physiol., V17, P391, DOI 10.1590/S1677-04202005000400007; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Fux B, 2007, INFECT IMMUN, V75, P2580, DOI 10.1128/IAI.00085-07; HIRSCH R, 1989, BOT ACTA, V102, P326, DOI 10.1111/j.1438-8677.1989.tb00113.x; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kobayashi M, 1997, PLANT GROWTH REGUL, V22, P79, DOI 10.1023/A:1005862809711; Leef J.L., 1999, Carotenoid synthesis inhibiting herbicides and fatty acid synthesis oxime herbicides as anti-apicomplexa protozoan parasite agents, Patent No. 847932; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Puce S, 2004, J BIOL CHEM, V279, P39783, DOI 10.1074/jbc.M405348200; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Rodrigues CO, 2002, J BIOL CHEM, V277, P48650, DOI 10.1074/jbc.M208990200; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Schwartz SH, 2003, PLANT PHYSIOL, V131, P1591, DOI 10.1104/pp.102.017921; Tian L, 2004, PHYSIOL PLANTARUM, V122, P314, DOI 10.1111/j.1399-3054.2004.00409.x; Walter RF, 2005, CURR ISSUES MOL BIOL, V7, P57, DOI 10.21775/cimb.007.057; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Zhang YW, 1999, MOL MICROBIOL, V31, P691, DOI 10.1046/j.1365-2958.1999.01210.x; Zhang YW, 2001, INFECT IMMUN, V69, P501, DOI 10.1128/IAI.69.1.501-507.2001; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	30	169	178	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					207	U11		10.1038/nature06478	http://dx.doi.org/10.1038/nature06478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185591	Green Accepted			2022-12-24	WOS:000252214400046
J	Dentin, R; Hedrick, S; Xie, JX; Yates, J; Montminy, M				Dentin, Renaud; Hedrick, Susan; Xie, Jianxin; Yates, John, III; Montminy, Marc			Hepatic glucose sensing via the CREB coactivator CRTC2	SCIENCE			English	Article							O-GLYCOSYLATION; GENE-EXPRESSION; TORC2; PHOSPHORYLATION; PROTEINS; GLCNAC	Chronic hyperglycemia contributes to the development of diabetes- associated complications. Increases in the concentration of circulating glucose activate the hexosamine biosynthetic pathway ( HBP) and promote the O- glycosylation of proteins by O- glycosyl transferase ( OGT). We show that OGT triggered hepatic gluconeogenesis through the O- glycosylation of the transducer of regulated cyclic adenosine monophosphate response element - binding protein ( CREB) 2 ( TORC2 or CRTC2). CRTC2 was O- glycosylated at sites that normally sequester CRTC2 in the cytoplasm through a phosphorylation- dependent mechanism. Decreasing amounts of O- glycosylated CRTC2 by expression of the deglycosylating enzyme O- GlcNAcase blocked effects of glucose on gluconeogenesis, demonstrating the importance of the HBP in the development of glucose intolerance.	[Dentin, Renaud; Hedrick, Susan; Montminy, Marc] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Xie, Jianxin] Cell Signalling Technol, Danvers, MA 01923 USA; [Yates, John, III] Scripps Res Inst, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute	Montminy, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Dentin, Renaud/AAV-5818-2020	Dentin, Renaud/0000-0003-0988-4458	NIGMS NIH HHS [R01 GM037828, R37 GM037828] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037828] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Hakim AK, 2005, J CELL SCI, V118, P5661, DOI 10.1242/jcs.02670; Argaud D, 1997, J BIOL CHEM, V272, P12854, DOI 10.1074/jbc.272.19.12854; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kim JK, 2001, J CLIN INVEST, V108, P153, DOI 10.1172/JCI10294; Konrad RJ, 2000, BIOCHEM BIOPH RES CO, V267, P26, DOI 10.1006/bbrc.1999.1895; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Pedersen KB, 2007, AM J PHYSIOL-ENDOC M, V292, pE788, DOI 10.1152/ajpendo.00510.2006; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9	15	246	260	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1402	1405		10.1126/science.1151363	http://dx.doi.org/10.1126/science.1151363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323454				2022-12-24	WOS:000253712900047
J	Bryce, J; Coitinho, D; Darnton-Hill, I; Pelletier, D; Pinstrup-Andersen, P				Bryce, Jennifer; Coitinho, Denise; Darnton-Hill, Ian; Pelletier, David; Pinstrup-Andersen, Per		Maternal & Child Undernutr Study G	Maternal and Child Undernutrition 4 - Maternal and child undernutrition: effective action at national level	LANCET			English	Article							NUTRITIONAL-STATUS; HEALTH-SERVICES; YOUNG-CHILDREN; MORTALITY; SURVIVAL; INTERVENTIONS; INFANTS; PROGRAM; AFRICA; IMPACT	80% of the world's undernourished children live in just 20 countries. Intensified nutrition action in these countries can lead to achievement of the first Millennium Development Goal (MDG) and greatly increase the chances of achieving goals for child and maternal mortality (MDGs 4 and 5). Despite isolated successes in specific countries or for interventions-eg, iodised salt and vitamin A supplementation-most countries with high rates of undernutrition are failing to reach undernourished mothers and children with effective interventions supported by appropriate policies. This paper reports on an assessment of actions addressing undernutrition in the countries with the highest burden of undernutrition, drawing on systematic reviews and best-practice reports. Seven key Challenges for addressing undernutrition at national level are defined and reported on: getting nutrition on the list of priorities, and keeping it there; doing the right things; not doing the wrong things; acting at scale; reaching those in need; data-based decisionmaking; and building strategic and operational capacity. Interventions with proven effectiveness that are selected by countries should be rapidly implemented at scale. The period from pregnancy to 24 months of age is a crucial window of opportunity for reducing undernutrition and its adverse effects. Programme efforts, as well as monitoring and assessment, should focus on this segment of the continuum of care. Nutrition resources should not be used to support actions unlikely to be effective in the context of country or local realities. Nutrition resources should not be used to support actions that have not been proven to have a direct effect on undernutrition, such as stand-alone growth monitoring or school feeding programmes. In addition to health and nutrition interventions, economic and social policies addressing poverty, trade, and agriculture that have been associated with rapid improvements in nutritional status should be implemented. There is a reservoir of important experience and expertise in individual countries about how to build commitment, develop and monitor nutrition programmes, move toward acting at scale, reform or phase-out ineffective programmes, and other challenges. This resource needs to be formalised, shared, and used as the basis for setting priorities in problem-solving research for nutrition.	[Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Coitinho, Denise] WHO, CH-1211 Geneva, Switzerland; [Darnton-Hill, Ian] UNICEF, New York, NY USA; [Pelletier, David; Pinstrup-Andersen, Per] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; UNICEF; Cornell University	Bryce, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	jbryce@jhsph.edu	Hallal, Pedro C/A-3249-2011	Hallal, Pedro C/0000-0003-1470-6461; Kirkwood, Betty/0000-0001-5274-6072	Medical Research Council [U1475000003] Funding Source: researchfish; Medical Research Council [G0400519, U.1475.00.004.00005.01 (85821), MC_U147585821, G0400519(71108)] Funding Source: Medline; MRC [MC_U147585821, G0400519] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aguayo VM, 2003, BRIT MED J, V326, P127, DOI 10.1136/bmj.326.7381.127; Allen L.H., 2001, WHAT WORKS REV EFFIC; Allen LH, GUIDELINES FOOD FORT; [Anonymous], DEM HLTH SURV; [Anonymous], EM DAT OFDA CRED INT; ASHWORTH A, IN PRESS J MAT CHILD; Barrett CB, 2005, FOOD AID 50 YEARS RE; BERG A, 1993, AM J CLIN NUTR, V57, P3, DOI 10.1093/ajcn/57.1.3; BHUTTA ZA, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61693-6; Birn AE, 2005, LANCET, V366, P514, DOI 10.1016/S0140-6736(05)66479-3; Bishai D, 2002, ECON DEV CULT CHANGE, V51, P37, DOI 10.1086/345361; *BRAZ MIN HLTH, 2005, AV PROGR BOLS AL 2 F; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Carpenter KJ, 2005, J NUTR, V135, P675, DOI 10.1093/jn/135.4.675; CHOWDHURY N, 2006, 92 MTID INT FOOD POL; Darnton-Hill I, 1998, PUBLIC HEALTH NUTR, V1, P23, DOI 10.1079/PHN19980005; De Pee S., 2005, PREVENTIVE NUTR COMP, P689; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; GILLESPIE D, 2007, SCALING HLTH TECHNOL; Gitau R, 2005, PUBLIC HEALTH NUTR, V8, P837, DOI 10.1079/PHN2005746; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Heaver R., 2005, STRENGTHENING COUNTR; Hossain SMM, 2005, HEALTH POLICY PLANN, V20, P35, DOI 10.1093/heapol/czi004; *INT BAB FOOD ACT, 2004, BREAK RUL STRETCH RU; *JOINT UN PROGR HI, REP GLOB AIDS EP 200; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Krause VM, 1998, J NUTR, V128, P860, DOI 10.1093/jn/128.5.860; Leroy JL, 2007, J NUTR, V137, P2311, DOI 10.1093/jn/137.10.2311; LEVINSON J, 2002, SEARCHING HOME I ISS; Marek T, 1999, HEALTH POLICY PLANN, V14, P382, DOI 10.1093/heapol/14.4.382; Martin-Prevel Y, 2000, B WORLD HEALTH ORGAN, V78, P108; Montagu D, 2002, HEALTH POLICY PLANN, V17, P121, DOI 10.1093/heapol/17.2.121; MORRIS SS, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61695-X; Orr J.B., 1936, FOOD HLTH INCOME; Palmer N, 2006, BMJ-BRIT MED J, V332, P718, DOI 10.1136/bmj.332.7543.718; PINSTRUPANDERSE.P, 2006, POVERTY INEQUALITY D; PINSTRUPANDERSE.P, 2000, SEEDS CONTENTION WOR; PINSTRUPANDERSE.P, RURAL INFRASTRUCTURE; PINSTRUPANDERSE.P, 2006, 26 C INT ASS AGR EC; PORTER R, PACKAGED FOODS COMPL; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; *ROCK FDN, ALL GREE REV AFR AGR; ROKZ D, 2000, WHO SOULD IMPLEMENT; Sachs J., 2001, MACROECONOMICS HLTH; Selwitz Robert H, LANCET, V369, P51, DOI [10.1016/s0140-6736(07)60031-2, DOI 10.1016/S0140-6736(07)60031-2, DOI 10.1016/S0140-6736(07)61690-0]; Sen Amartya, 1995, INEQUALITY REEXAMINE; SHARMA RR, INTRO ADVOCACY; SHEKAR M, 2005, MAINSTREAMING NUTR P; Shiffman J, 2007, AM J PUBLIC HEALTH, V97, P796, DOI 10.2105/AJPH.2006.095455; SHRIMPTON R, 2007, SCN NEWS, V34, P32; *SIPRI, 2007, SIPRI YB 2006 ARM DI; The World Bank, POVCALNET; Torlesse H, 2003, J NUTR, V133, P1320; TRUSSELL J, 1992, POP STUD-J DEMOG, V46, P285, DOI 10.1080/0032472031000146246; *UN C TRAD DEV, 2002, LEAST DEV COUNTR REP; *UN MILL PROJ 2005, 2005, HALV HUNG IT CAN BE; *UN STAND COMM NUT, 5 UN STAND COMM NUTR; UNICEF, MON SIT CHILDR WOM; UNICEF, 2007, STAT WORLDS CHILDR 2; UNICEF, 2005, ACC CHILD SURV DEV R; United Nations Children's Fund (UNICEF), 2007, VIT A SUPPL DEC PROG; Utting P, 2005, DEV PRACT, V15, P375, DOI 10.1080/09614520500075797; Victora CG, 2005, HEALTH POLICY PLANN, V20, pI18, DOI 10.1093/heapol/czi050; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; VICTORA CG, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61692-4; Webster J, 2007, HEALTH POLICY PLANN, V22, P277, DOI 10.1093/heapol/czm021; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; *WHO, NAT HLTH ACC; *WHO, HLTH METR NETW; *WHO UNICEF, 2004, UNICEF WHO M JUN 17; *WORLD BANK, COUNTR CLASS; World Bank, 2006, REP NUTR CENTR DEV S; *WORLD BANK, 2007, WORLD DEV REP 2004 M	79	258	266	1	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2008	371	9611					510	526		10.1016/S0140-6736(07)61694-8	http://dx.doi.org/10.1016/S0140-6736(07)61694-8			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18206224				2022-12-24	WOS:000253169200031
J	Koentges, G				Koentges, Georgy			Evolution of anatomy and gene control	NATURE			English	Article							TRANSGENIC ANALYSIS; HIGH-THROUGHPUT; EXPRESSION; PATTERNS; ORIGINS; NOISE		[Koentges, Georgy] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England	University of Warwick	Koentges, G (corresponding author), Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England.	g.koentges@warwick.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Akam M, 1998, CURR BIOL, V8, pR676, DOI 10.1016/S0960-9822(98)70433-6; Alon U., 2006, INTRO SYSTEMS BIOL D; Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Beckers J, 1996, DEV BIOL, V180, P543, DOI 10.1006/dbio.1996.0327; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Carr JL, 1998, J EXP ZOOL, V280, P73, DOI 10.1002/(SICI)1097-010X(19980101)280:1<73::AID-JEZ9>3.0.CO;2-E; Chen JCJ, 2002, DEV BIOL, V245, P213, DOI 10.1006/dbio.2002.0638; Damle S, 2006, DEV BIOL, V299, P543, DOI 10.1016/j.ydbio.2006.06.016; Davidson EH, 2006, REG GEN GEN REG; Donoghue PCJ, 2006, NATURE, V442, P680, DOI 10.1038/nature04890; Faro-Trindade I, 2006, BIOCHEM SOC T, V34, P1133, DOI 10.1042/BST0341133; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gehring WJ, 2001, ZOOL-ANAL COMPLEX SY, V104, P171, DOI 10.1078/0944-2006-00022; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hansen Annika, 2004, Genome Inform, V15, P141; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Huang RJ, 2000, DEVELOPMENT, V127, P3789; Istrail S, 2005, P NATL ACAD SCI USA, V102, P4954, DOI 10.1073/pnas.0409624102; Janvier P., 1996, EARLY VERTEBRATES; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kontges G, 1996, DEVELOPMENT, V122, P3229; Larsen CW, 2001, J NEUROSCI, V21, P4699, DOI 10.1523/JNEUROSCI.21-13-04699.2001; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Nicodemi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108104; Ogino H, 2006, NAT PROTOC, V1, P1703, DOI 10.1038/nprot.2006.208; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pournara I, 2004, BIOINFORMATICS, V20, P2934, DOI 10.1093/bioinformatics/bth337; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Raff RA, 2007, NAT REV GENET, V8, P911, DOI 10.1038/nrg2225; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Roure A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000916; RUMI MJ, 1925, MATHNAWI YIMA NAWI M, V3, P1259; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Trinajstic K, 2007, BIOL LETTERS, V3, P197, DOI 10.1098/rsbl.2006.0604; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140	60	20	20	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					658	663		10.1038/451658a	http://dx.doi.org/10.1038/451658a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256661				2022-12-24	WOS:000252929500030
J	Rosasco-Nitcher, SE; Lan, WJ; Khorasanizadeh, S; Stukenberg, PT				Rosasco-Nitcher, Sara E.; Lan, Weijie; Khorasanizadeh, Sepideh; Stukenberg, P. Todd			Centromeric Aurora-B activation requires TD-60, microtubules, and substrate priming phosphorylation	SCIENCE			English	Article							CHROMOSOME SEGREGATION; MITOTIC CENTROMERE; CLEAVAGE FURROW; CENTRAL SPINDLE; REGULATES MCAK; INCENP BINDS; KINASE; HASPIN; TARGET; SITES	The chromosome passenger complex ( CPC) controls chromosome congression, kinetochore- microtubule attachments, and spindle checkpoint signaling during mitosis. Aurora- B kinase is the catalytic subunit of the CPC. To understand how a single kinase can regulate such diverse events, we have investigated the activation of Aurora- B and describe two distinct activation mechanisms. First, Aurora- B activation in vitro requires two cofactors, telophase disc-60kD ( TD-60) and microtubules. TD-60 is critical to localize both the CPC and Haspin kinase activity to centromeres and thus regulates Aurora- B at several levels. Second, Aurora- B substrates can inhibit kinase activation, and this is relieved by phosphorylation of these substrates by the centromeric kinases Plk1 and Haspin. These regulatory mechanisms suggest models for phosphorylation by Aurora- B of centromeric substrates at unaligned chromosomes and merotelic attachments.	[Rosasco-Nitcher, Sara E.; Lan, Weijie; Khorasanizadeh, Sepideh; Stukenberg, P. Todd] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Stukenberg, PT (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	pts7h@virginia.edu		Stukenberg, Todd/0000-0002-6788-2111	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063045] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM063045-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Dai J, 2005, CELL CYCLE, V4, P665, DOI 10.4161/cc.4.5.1683; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; MACKAY AM, 1993, J CELL BIOL, V123, P373, DOI 10.1083/jcb.123.2.373; Mollinari C, 2003, DEV CELL, V5, P295, DOI 10.1016/S1534-5807(03)00205-3; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; Zhang X, 2007, MOL BIOL CELL, V18, P3264, DOI 10.1091/mbc.E07-01-0086	20	119	128	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					469	472		10.1126/science.1148980	http://dx.doi.org/10.1126/science.1148980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218899				2022-12-24	WOS:000252576600040
J	Porter, P				Porter, Peggy			"Westernizing" women's risks? Breast cancer in lower-income countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SHANGHAI		[Porter, Peggy] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Porter, Peggy] Univ Washington, Sch Med, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Porter, P (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.							Anderson BO, 2006, BREAST J, V12, pS3, DOI 10.1111/j.1075-122X.2006.00199.x; Cui XH, 2007, CANCER EPIDEM BIOMAR, V16, P1443, DOI 10.1158/1055-9965.EPI-07-0059; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	5	344	356	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					213	216		10.1056/NEJMp0708307	http://dx.doi.org/10.1056/NEJMp0708307			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	251LS	18199859				2022-12-24	WOS:000252375600001
J	Jones, OAH; Maguire, ML; Griffin, JL				Jones, Oliver A. H.; Maguire, Mahon L.; Griffin, Julian L.			Environmental pollution and diabetes: a neglected association	LANCET			English	Editorial Material							PERSISTENT ORGANIC POLLUTANTS; SERUM CONCENTRATIONS; INSULIN-RESISTANCE; TOXICITY; VETERANS; EXPOSURE; BURDEN; DIOXIN		[Jones, Oliver A. H.; Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Maguire, Mahon L.] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, British Heart Fdn Magnet Resonance Unit, Oxford OX3 7BN, England	University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics	Jones, OAH (corresponding author), Univ Cambridge, Dept Biochem, Hopkins Bldg, Cambridge CB2 1QW, England.	oahj2@mole.bio.cam.ac.uk	Jones, Oliver A.H./B-9778-2008	Jones, Oliver A.H./0000-0002-4541-662X				Azmi J, 2005, XENOBIOTICA, V35, P839, DOI 10.1080/00498250500297940; Cranmer M, 2000, TOXICOL SCI, V56, P431, DOI 10.1093/toxsci/56.2.431; Fierens S, 2003, BIOMARKERS, V8, P529, DOI 10.1080/1354750032000158420; Fujiyoshi PT, 2006, ENVIRON HEALTH PERSP, V114, P1677, DOI 10.1289/ehp.9262; Griffin JL, 2007, J PROTEOME RES, V6, P54, DOI 10.1021/pr0601640; Henriksen GL, 1997, EPIDEMIOLOGY, V8, P252, DOI 10.1097/00001648-199705000-00005; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Jones OAH, 2007, COMP BIOCHEM PHYS D, V2, P316, DOI 10.1016/j.cbd.2007.06.003; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Porta M, 2006, LANCET, V368, P558, DOI 10.1016/S0140-6736(06)69174-5; Remillard RBJ, 2002, ENVIRON HEALTH PERSP, V110, P853, DOI 10.1289/ehp.02110853; Rylander Lars, 2005, Environ Health, V4, P28, DOI 10.1186/1476-069X-4-28	13	53	53	2	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2008	371	9609					287	288		10.1016/S0140-6736(08)60147-6	http://dx.doi.org/10.1016/S0140-6736(08)60147-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254VQ	18294985				2022-12-24	WOS:000252616500010
J	Nadler, JW; Angelaki, DE; DeAngelis, GC				Nadler, Jacob W.; Angelaki, Dora E.; DeAngelis, Gregory C.			A neural representation of depth from motion parallax in macaque visual cortex	NATURE			English	Article							MIDDLE TEMPORAL AREA; BINOCULAR DISPARITY; STEREOSCOPIC DEPTH; CORTICAL AREA; FUNCTIONAL-PROPERTIES; EYE-MOVEMENTS; MT NEURONS; PERCEPTION; MONKEY; DISCRIMINATION	Perception of depth is a fundamental challenge for the visual system, particularly for observers moving through their environment. The brain makes use of multiple visual cues to reconstruct the three- dimensional structure of a scene. One potent cue, motion parallax, frequently arises during translation of the observer because the images of objects at different distances move across the retina with different velocities. Human psychophysical studies have demonstrated that motion parallax can be a powerful depth cue(1-5), and motion parallax seems to be heavily exploited by animal species that lack highly developed binocular vision(6-8). However, little is known about the neural mechanisms that underlie this capacity. Here we show, by using a virtual- reality system to translate macaque monkeys ( Macaca mulatta) while they viewed motion parallax displays that simulated objects at different depths, that many neurons in the middle temporal area ( area MT) signal the sign of depth ( near versus far) from motion parallax in the absence of other depth cues. To achieve this, neurons must combine visual motion with extra- retinal ( non- visual) signals related to the animal's movement. Our findings suggest a new neural substrate for depth perception and demonstrate a robust interaction of visual and non- visual cues in area MT. Combined with previous studies that implicate area MT in depth perception based on binocular disparities(9-12), our results suggest that area MT contains a more general representation of three- dimensional space that makes use of multiple cues.	[Nadler, Jacob W.; Angelaki, Dora E.; DeAngelis, Gregory C.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [DeAngelis, Gregory C.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	Washington University (WUSTL); University of Rochester	DeAngelis, GC (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	gdeangelis@cvs.rochester.edu		DeAngelis, Gregory/0000-0002-1635-1273	NEI NIH HHS [T32 EY013360, R01 EY013644-07, R01 EY013644, R01 EY017866, R01 EY017866-02] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY013360, R01EY013644, R01EY017866] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Bradshaw MF, 1996, VISION RES, V36, P3457, DOI 10.1016/0042-6989(96)00072-7; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Cao A, 2003, VISUAL NEUROSCI, V20, P77, DOI 10.1017/S0952523803201085; DeAngelis GC, 2003, J NEUROPHYSIOL, V89, P1094, DOI 10.1152/jn.00717.2002; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; ELLARD CG, 1984, BEHAV BRAIN RES, V14, P29, DOI 10.1016/0166-4328(84)90017-2; FARBER JM, 1979, J EXP PSYCHOL HUMAN, V5, P494, DOI 10.1037/0096-1523.5.3.494; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Kral K, 2003, BEHAV PROCESS, V64, P1, DOI 10.1016/S0376-6357(03)00054-8; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Nawrot M, 2003, VISION RES, V43, P1553, DOI 10.1016/S0042-6989(03)00144-5; Nawrot M, 2006, VISION RES, V46, P4709, DOI 10.1016/j.visres.2006.07.006; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Nguyenkim JD, 2003, J NEUROSCI, V23, P7117, DOI 10.1523/JNEUROSCI.23-18-07117.2003; Nover H, 2005, J NEUROSCI, V25, P10049, DOI 10.1523/JNEUROSCI.1661-05.2005; ROGERS B, 1982, VISION RES, V22, P261, DOI 10.1016/0042-6989(82)90126-2; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; Rogers B J, 1993, Rev Oculomot Res, V5, P119; ROGERS BJ, 1989, Q J EXP PSYCHOL-A, V41, P697, DOI 10.1080/14640748908402390; ROGERS S, 1992, PERCEPT PSYCHOPHYS, V52, P446, DOI 10.3758/BF03206704; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2003, J NEUROSCI, V23, P3515; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; van der Willigen RF, 2002, J COMP PHYSIOL A, V187, P997, DOI 10.1007/s00359-001-0271-9	30	69	70	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2008	452	7187					642	U10		10.1038/nature06814	http://dx.doi.org/10.1038/nature06814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18344979	Green Accepted			2022-12-24	WOS:000254567200048
J	Talley, NJ				Talley, Nicholas J.			Commentary: Controversies in NICE guidance on irritable bowel syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									Mayo Clin, Jacksonville, FL 32082 USA	Mayo Clinic	Talley, NJ (corresponding author), Mayo Clin, 4500 San Pablo Rd, Jacksonville, FL 32082 USA.	talley.nicholas@mayo.edu	Talley, Nicholas J/D-5399-2013	Talley, Nicholas J/0000-0003-2537-3092				Brandt LJ, 2002, AM J GASTROENTEROL, V97, pS7; FRANCIS CY, 1994, LANCET, V344, P39, DOI 10.1016/S0140-6736(94)91055-3; Hammer J, 2004, GUT, V53, P666, DOI 10.1136/gut.2003.021857; Sanders DS, 2001, LANCET, V358, P1504, DOI 10.1016/S0140-6736(01)06581-3; Tack J, 2006, GUT, V55, P1095, DOI 10.1136/gut.2005.077503; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1288, DOI 10.1001/jama.289.10.1288; Whitehead WE, 2006, ALIMENT PHARM THER, V24, P137, DOI 10.1111/j.1365-2036.2006.02956.x	7	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 8	2008	336	7643					558	559		10.1136/bmj.39504.409329.AD	http://dx.doi.org/10.1136/bmj.39504.409329.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JV	18325968	Green Published			2022-12-24	WOS:000253998500034
J	Goldston, D				Goldston, David			The scientist delusion	NATURE			English	Editorial Material									[Goldston, David] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA	Harvard University	Goldston, D (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	partyofonecolumn@gmail.com							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					17	17		10.1038/452017a	http://dx.doi.org/10.1038/452017a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322497	Bronze			2022-12-24	WOS:000253671900013
J	Iyengar, R; Diverse-Pierluissi, MA; Jenkins, SL; Chan, AM; Devi, LA; Sobie, EA; Ting, AT; Weinstein, DC				Iyengar, Ravi; Diverse-Pierluissi, Maria A.; Jenkins, Sherry L.; Chan, Andrew M.; Devi, Lakshmi A.; Sobie, Eric A.; Ting, Adrian T.; Weinstein, Daniel C.			Inquiry learning - Integrating content detail and critical reasoning by peer review	SCIENCE			English	Editorial Material									[Iyengar, Ravi; Diverse-Pierluissi, Maria A.; Jenkins, Sherry L.; Devi, Lakshmi A.; Sobie, Eric A.; Weinstein, Daniel C.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Chan, Andrew M.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Ting, Adrian T.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Iyengar, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ravi.iyengar@mssm.edu	Chan, Andrew Man-Lok/J-9497-2013; Devi P, Lakshmi/GXM-5982-2022; Chan, Andrew/AAC-1145-2020	Chan, Andrew Man-Lok/0000-0001-9923-5464; Devi P, Lakshmi/0000-0001-9274-4776; Chan, Andrew/0000-0001-9923-5464; Jenkins, Sherry/0000-0003-1730-0977; Weinstein, Daniel/0000-0001-7832-9285	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM062754-01, T32GM062754, T32 GM062754] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Branon RF., 2001, TECHTRENDS TECH TREN, V45, P36, DOI DOI 10.1007/BF02763377; Edelson DC, 1999, J LEARN SCI, V8, P391, DOI 10.1207/s15327809jls0803&4_3; Guilford WH, 2001, ADV PHYSIOL EDUC, V25, P167, DOI 10.1152/advances.2001.25.3.167; IYENGAR R, 2005, SCI STKE, pTR3; IYENGAR R, 2008, SCI STKE         FEB; Jenkins SL, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.19tr2; JOHNSON GM, 2007, ANN C AM ED RES ASS; Lightfoot JT, 1998, ADV PHYSIOL EDUC, V19, pS57, DOI 10.1152/advances.1998.274.6.S57; Teikmanis M, 2001, Comput Nurs, V19, P75; WEINSTEIN DC, 2005, SCI STKE, pTR24	10	12	12	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1189	1190		10.1126/science.1149875	http://dx.doi.org/10.1126/science.1149875			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309063	Green Accepted			2022-12-24	WOS:000253530600019
J	Matsuo, N; Reijmers, L; Mayford, M				Matsuo, Naoki; Reijmers, Leon; Mayford, Mark			Spine-type-specific recruitment of newly synthesized AMPA receptors with learning	SCIENCE			English	Article							GLUTAMATE RECEPTORS; SURFACE EXPRESSION; DENDRITIC SPINES; MEMORY FORMATION; HIPPOCAMPUS; SYNAPSES; FEAR; LTP; REDISTRIBUTION; TRAFFICKING	The stabilization of long- term memories requires de novo protein synthesis. How can proteins, synthesized in the soma, act on specific synapses that participate in a given memory? We studied the dynamics of newly synthesized AMPA- type glutamate receptors ( AMPARs) induced with learning using transgenic mice expressing the GluR1 subunit fused to green fluorescent protein ( GFP- GluR1) under control of the c- fos promoter. We found learning- associated recruitment of newly synthesized GFP- GluR1 selectively to mushroom- type spines in adult hippocampal CA1 neurons 24 hours after fear conditioning. Our results are consistent with a "synaptic tagging" model to allow activated synapses to subsequently capture newly synthesized receptor and also demonstrate a critical functional distinction in the mushroom spines with learning.	[Matsuo, Naoki; Reijmers, Leon; Mayford, Mark] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Matsuo, Naoki; Reijmers, Leon; Mayford, Mark] Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Matsuo, N (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan.	n-matsuo@fujita-hu.ac.jp; mmayford@scripps.edu	Matsuo, Naoki/B-9929-2008	Matsuo, Naoki/0000-0003-0988-4706; Mayford, Mark/0000-0002-9001-5024	NIMH NIH HHS [R01 MH057368, MH57368, R21 MH070020, MH070020, R01 MH057368-04, R01 MH057368-03, R21 MH070020-02, R21 MH070020-03, R21 MH070020-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057368, R21MH070020] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Archibald K, 1998, NEUROPHARMACOLOGY, V37, P1345, DOI 10.1016/S0028-3908(98)00135-X; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Knafo S, 2004, HIPPOCAMPUS, V14, P819, DOI 10.1002/hipo.10219; Leuner B, 2003, J NEUROSCI, V23, P659, DOI 10.1523/JNEUROSCI.23-02-00659.2003; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J NEUROSCI, V17, P7351; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McCormack SG, 2006, NEURON, V50, P75, DOI 10.1016/j.neuron.2006.02.027; Milanovic S, 1998, BRAIN RES, V784, P37, DOI 10.1016/S0006-8993(97)01266-3; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	29	222	227	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1104	1107		10.1126/science.1149967	http://dx.doi.org/10.1126/science.1149967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292343	Green Accepted			2022-12-24	WOS:000253311700047
J	Clark, CM; Tilman, D				Clark, Christopher M.; Tilman, David			Loss of plant species after chronic low-level nitrogen deposition to prairie grasslands	NATURE			English	Article							NUTRIENT-ENRICHMENT; ECOSYSTEM RECOVERY; VEGETATION; DIVERSITY; HEATHLAND; FERTILIZATION; ACIDIFICATION; PRODUCTIVITY; COMMUNITIES; LIMITATION	Rates of atmospheric deposition of biologically active nitrogen ( N) are two to seven times the pre- industrial rates in many developed nations because of combustion of fossil fuels and agricultural fertilization(1,2). They are expected to increase similarly over the next 50 years in industrializing nations of Asia and South America(2). Although the environmental impacts of high rates of nitrogen addition have been well studied(3-8), this is not so for the lower, chronic rates that characterize much of the globe. Here we present results of the first multi- decadal experiment to examine the impacts of chronic, experimental nitrogen addition as low as 10 kg N ha(-1) yr(-1) above ambient atmospheric nitrogen deposition ( 6 kg N ha(-1) yr(-1) at our site). This total input rate is comparable to terrestrial nitrogen deposition in many industrialized nations(2). We found that this chronic low- level nitrogen addition rate reduced plant species numbers by 17% relative to controls receiving ambient N deposition. Moreover, species numbers were reduced more per unit of added nitrogen at lower addition rates, suggesting that chronic but low- level nitrogen deposition may have a greater impact on diversity than previously thought. A second experiment showed that a decade after cessation of nitrogen addition, relative plant species number, although not species abundances, had recovered, demonstrating that some effects of nitrogen addition are reversible.	[Clark, Christopher M.; Tilman, David] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Clark, CM (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 100 Ecol,1987 Upper Buford Circle, St Paul, MN 55108 USA.	clark134@umn.edu	Tilman, David/ABD-5309-2021					Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; BOBBINK R, 1991, J APPL ECOL, V28, P28, DOI 10.2307/2404111; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; BOBBINK R, 2002, MANUAL METHODOLOGIES, P40; Bouwman AF, 2002, WATER AIR SOIL POLL, V141, P349, DOI 10.1023/A:1021398008726; Boxman AW, 1998, FOREST ECOL MANAG, V101, P155, DOI 10.1016/S0378-1127(97)00132-1; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; INOUYE RS, 1995, ECOLOGY, V76, P1872, DOI 10.2307/1940720; MILCHUNAS DG, 1995, ECOL APPL, V5, P452, DOI 10.2307/1942035; MOUNTFORD JO, 1993, J APPL ECOL, V30, P321, DOI 10.2307/2404634; Mountford JO, 1996, J VEG SCI, V7, P219, DOI 10.2307/3236322; NILSSON J, 1988, WORKSH HELD STOKH SW; Power SA, 2006, GLOBAL CHANGE BIOL, V12, P1241, DOI 10.1111/j.1365-2486.2006.01161.x; Roem WJ, 2002, J APPL ECOL, V39, P937, DOI 10.1046/j.1365-2664.2002.00768.x; Smart SM, 2005, BIOL CONSERV, V124, P355, DOI 10.1016/j.biocon.2004.12.013; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Strengbom J, 2001, FUNCT ECOL, V15, P451, DOI 10.1046/j.0269-8463.2001.00538.x; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; TILMAN D, 1993, ECOLOGY, V74, P2179, DOI 10.2307/1939572; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; TILMAN D, 1992, OECOLOGIA, V89, P257, DOI 10.1007/BF00317226; van den Berg LJL, 2005, ENVIRON POLLUT, V138, P77, DOI 10.1016/j.envpol.2005.02.024; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; Williams MW, 2000, ECOL APPL, V10, P1648, DOI 10.1890/1051-0761(2000)010[1648:CLFIND]2.0.CO;2	28	670	791	37	692	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					712	715		10.1038/nature06503	http://dx.doi.org/10.1038/nature06503			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256670				2022-12-24	WOS:000252929500040
J	Kufer, SK; Puchner, EM; Gumpp, H; Liedl, T; Gaub, HE				Kufer, S. K.; Puchner, E. M.; Gumpp, H.; Liedl, T.; Gaub, H. E.			Single-molecule cut-and-paste surface assembly	SCIENCE			English	Article							DNA; SPECTROSCOPY; CELLS	We introduce a method for the bottom- up assembly of biomolecular structures that combines the precision of the atomic force microscope ( AFM) with the selectivity of DNA hybridization. Functional units coupled to DNA oligomers were picked up from a depot area by means of a complementary DNA strand bound to an AFM tip. These units were transferred to and deposited on a target area to create basic geometrical structures, assembled from units with different functions. Each of these cut- and- paste events was characterized by single- molecule force spectroscopy and single- molecule fluorescence microscopy. Transport and deposition of more than 5000 units were achieved, with less than 10% loss in transfer efficiency.	[Kufer, S. K.; Puchner, E. M.; Gumpp, H.; Gaub, H. E.] Univ Munich, Ctr Nanosci, D-80799 Munich, Germany; [Kufer, S. K.; Puchner, E. M.; Gumpp, H.; Gaub, H. E.] Univ Munich, Dept Phys, D-80799 Munich, Germany; [Liedl, T.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Liedl, T.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	University of Munich; University of Munich; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Kufer, SK (corresponding author), Univ Munich, Ctr Nanosci, Amalienstr 54, D-80799 Munich, Germany.		Liedl, Tim/O-7539-2014	Liedl, Tim/0000-0002-0040-0173; Puchner, Elias M./0000-0002-7129-2309				Albrecht C, 2003, SCIENCE, V301, P367, DOI 10.1126/science.1084713; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Collier CP, 2000, SCIENCE, V289, P1172, DOI 10.1126/science.289.5482.1172; Cuberes MT, 1996, APPL PHYS LETT, V69, P3016, DOI 10.1063/1.116824; Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Griessl SJH, 2004, J PHYS CHEM B, V108, P11556, DOI 10.1021/jp049521p; Grzybowski BA, 2000, NATURE, V405, P1033, DOI 10.1038/35016528; HANSMA PK, 1988, SCIENCE, V242, P209, DOI 10.1126/science.3051380; Jaschke M, 1996, BIOSENS BIOELECTRON, V11, P601, DOI 10.1016/0956-5663(96)83295-7; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Morfill J, 2007, BIOPHYS J, V93, P2400, DOI 10.1529/biophysj.107.106112; Neuert G, 2007, BIOPHYS J, V93, P1215, DOI 10.1529/biophysj.106.100511; NIEMEYER CM, 1994, NUCLEIC ACIDS RES, V22, P5530, DOI 10.1093/nar/22.25.5530; Pellegrino T, 2005, SMALL, V1, P48, DOI 10.1002/smll.200400071; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Quake SR, 2000, SCIENCE, V290, P1536, DOI 10.1126/science.290.5496.1536; RADMACHER M, 1992, SCIENCE, V257, P1900, DOI 10.1126/science.1411505; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Ringler M, 2007, NANO LETT, V7, P2753, DOI 10.1021/nl0712466; Schitter G, 2007, IEEE T CONTR SYST T, V15, P906, DOI 10.1109/TCST.2007.902953; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Strunz T, 1999, P NATL ACAD SCI USA, V96, P11277, DOI 10.1073/pnas.96.20.11277; Tinnefeld P, 2005, ANGEW CHEM INT EDIT, V44, P2642, DOI 10.1002/anie.200300647; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Vettiger P, 2000, IBM J RES DEV, V44, P323, DOI 10.1147/rd.443.0323	33	229	237	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					594	596		10.1126/science.1151424	http://dx.doi.org/10.1126/science.1151424			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239119				2022-12-24	WOS:000252772000033
J	Silva, JM; Marran, K; Parker, JS; Silva, J; Golding, M; Schlabach, MR; Elledge, SJ; Hannon, GJ; Chang, K				Silva, Jose M.; Marran, Krista; Parker, Joel S.; Silva, Javier; Golding, Michael; Schlabach, Michael R.; Elledge, Stephen J.; Hannon, Gregory J.; Chang, Kenneth			Profiling essential genes in human mammary cells by multiplex RNAi screening	SCIENCE			English	Article							MAMMALIAN-CELLS; SHRNA LIBRARIES; CANCER-CELLS; IN-VIVO; INTERFERENCE; IDENTIFICATION; CHECKPOINT; APOPTOSIS; PATHWAY; PROTEIN	By virtue of their accumulated genetic alterations, tumor cells may acquire vulnerabilities that create opportunities for therapeutic intervention. We have devised a massively parallel strategy for screening short hairpin RNA ( shRNA) collections for stable loss- of- function phenotypes. We assayed from 6000 to 20,000 shRNAs simultaneously to identify genes important for the proliferation and survival of five cell lines derived from human mammary tissue. Lethal shRNAs common to these cell lines targeted many known cell- cycle regulatory networks. Cell line - specific sensitivities to suppression of protein complexes and biological pathways also emerged, and these could be validated by RNA interference ( RNAi) and pharmacologically. These studies establish a practical platform for genome- scale screening of complex phenotypes in mammalian cells and demonstrate that RNAi can be used to expose genotype- specific sensitivities.	[Silva, Jose M.; Marran, Krista; Silva, Javier; Golding, Michael; Hannon, Gregory J.; Chang, Kenneth] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Schlabach, Michael R.; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst,Brigham & Womens Hosp, Ctr Genet & Genom,Dept Genet, Boston, MA 02115 USA; [Parker, Joel S.] Express Anal Inc, Durham, NC 27713 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Parker, Joel/AAG-1108-2019; Hannon, Gregory/AAB-3568-2019	GOLDING, MICHAEL/0000-0003-1631-2175	NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA013106-36, P01 CA013106, P01 CA013106-37] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Farah Mohamed H., 2007, Current Drug Delivery, V4, P161, DOI 10.2174/156720107780362276; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Moyer JD, 1997, CANCER RES, V57, P4838; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Natt F, 2007, CURR OPIN MOL THER, V9, P242; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Scherer L, 2004, CURR PHARM BIOTECHNO, V5, P355, DOI 10.2174/1389201043376724; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Snove O, 2006, NAT METHODS, V3, P689, DOI 10.1038/NMETH927; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	29	235	252	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					617	620		10.1126/science.1149185	http://dx.doi.org/10.1126/science.1149185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239125	Green Accepted, Green Submitted			2022-12-24	WOS:000252772000040
J	Collaco, JM; Vanscoy, L; Bremer, L; McDougal, K; Blackman, SM; Bowers, A; Naughton, K; Jennings, J; Ellen, J; Cutting, GR				Collaco, J. Michael; Vanscoy, Lori; Bremer, Lindsay; McDougal, Kathryn; Blackman, Scott M.; Bowers, Amanda; Naughton, Kathleen; Jennings, Jacky; Ellen, Jonathan; Cutting, Garry R.			Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PASSIVE SMOKING; SOCIOECONOMIC-STATUS; CHILDREN; EXPOSURE; POLYMORPHISMS; ASSOCIATION; DECLINE; MODIFIERS; SEVERITY	Context Disease variation can be substantial even in conditions with a single gene etiology such as cystic fibrosis ( CF). Simultaneously studying the effects of genes and environment may provide insight into the causes of variation. Objective To determine whether secondhand smoke exposure is associated with lung function and other outcomes in individuals with CF, whether socioeconomic status affects the relationship between secondhand smoke exposure and lung disease severity, and whether specific gene- environment interactions influence the effect of secondhand smoke exposure on lung function. Design, Setting, and Participants Retrospective assessment of lung function, stratified by environmental and genetic factors. Data were collected by the US Cystic Fibrosis Twin and Sibling Study with missing data supplemented by the Cystic Fibrosis Foundation Data Registry. All participants were diagnosed with CF, were recruited between October 2000 and October 2006, and were primarily from the United States. Main Outcome Measures Disease- specific cross- sectional and longitudinal measures of lung function. Results Of 812 participants with data on secondhand smoke in the home, 188 ( 23.2%) were exposed. Of 780 participants with data on active maternal smoking during gestation, 129 ( 16.5%) were exposed. Secondhand smoke exposure in the home was associated with significantly lower cross- sectional ( 9.8 percentile point decrease; P <. 001) and longitudinal lung function ( 6.1 percentile point decrease; P=. 007) compared with those not exposed. Regression analysis demonstrated that socioeconomic status did not confound the adverse effect of secondhand smoke exposure on lung function. Interaction between gene variants and secondhand smoke exposure resulted in significant percentile point decreases in lung function, namely in CFTR non- Delta F508 homozygotes ( 12.8 percentile point decrease; P=. 001), TGF beta 1-509 TT homozygotes ( 22.7 percentile point decrease; P=. 006), and TGF beta 1 codon 10 CC homozygotes ( 20.3 percentile point decrease; P=. 005). Conclusions Any exposure to secondhand smoke adversely affects both cross-sectional and longitudinal measures of lung function in individuals with CF. Variations in the gene that causes CF ( CFTR) and a CF- modifier gene ( TGF beta 1) amplify the negative effects of secondhand smoke exposure.	[Collaco, J. Michael; Vanscoy, Lori; Bremer, Lindsay; McDougal, Kathryn; Blackman, Scott M.; Bowers, Amanda; Naughton, Kathleen; Jennings, Jacky; Ellen, Jonathan; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Cutting, GR (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, 733 N Broadway,Broadway Res Bldg,Ste 551, Baltimore, MD 21205 USA.	gcutting@jhmi.edu		Blackman, Scott/0000-0002-4532-6421; Jennings PhD MPH, Jacky/0000-0002-3789-5122	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068927] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL68927, R01 HL068927-06A1, R01 HL068927] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arkwright PD, 2000, THORAX, V55, P459, DOI 10.1136/thorax.55.6.459; Beydon N, 2002, AM J RESP CRIT CARE, V166, P1099, DOI 10.1164/rccm.200205-421OC; Blackman SM, 2006, GASTROENTEROLOGY, V131, P1030, DOI 10.1053/j.gastro.2006.07.016; BOYER PH, 1955, PEDIATRICS, V16, P778; Brazova J, 2006, CLIN IMMUNOL, V121, P350, DOI 10.1016/j.clim.2006.08.015; Buranawuti K, 2007, J MED GENET, V44, P209, DOI 10.1136/jmg.2006.046318; CAMPBELL PW, 1992, J PEDIATR-US, V120, P261, DOI 10.1016/S0022-3476(05)80438-X; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Celedon JC, 2004, HUM MOL GENET, V13, P1649, DOI 10.1093/hmg/ddh171; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Duffy DL, 1997, AM J HUM GENET, V61, pA197; Festini F, 2005, J PEDIATR-US, V147, P316, DOI 10.1016/j.jpeds.2005.04.031; GILLJAM H, 1990, RESP MED, V84, P289, DOI 10.1016/S0954-6111(08)80055-8; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Kohler E, 1999, HUM EXP TOXICOL, V18, P212, DOI 10.1191/096032799678839932; Konstan MW, 2007, J PEDIATR-US, V151, P134, DOI 10.1016/j.jpeds.2007.03.006; KOVESI T, 1993, AM REV RESPIR DIS, V148, P1266, DOI 10.1164/ajrccm/148.5.1266; Kulich M, 2005, AM J RESP CRIT CARE, V172, P885, DOI 10.1164/rccm.200410-1335OC; Li HL, 2007, HUM GENET, V121, P529, DOI 10.1007/s00439-007-0337-z; Mak JCW, 2006, J ALLERGY CLIN IMMUN, V117, P92, DOI 10.1016/j.jaci.2005.08.049; Moritsugu KP, 2007, AM J PREV MED, V32, P542, DOI 10.1016/j.amepre.2007.02.026; Muller AE, 1999, EUR J PEDIATR, V158, P264, DOI 10.1007/s004310051065; O'Connor GT, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e333; Pulleyn LJ, 2001, HUM GENET, V109, P623, DOI 10.1007/s00439-001-0617-y; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; RUBIN BK, 1990, NEW ENGL J MED, V323, P782, DOI 10.1056/NEJM199009203231203; Salam MT, 2007, AM J RESP CRIT CARE, V176, P1192, DOI 10.1164/rccm.200704-561OC; Schechter MS, 1998, J PEDIATR-US, V132, P260, DOI 10.1016/S0022-3476(98)70442-1; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Schluchter MD, 2002, STAT MED, V21, P1271, DOI 10.1002/sim.1104; Silverman ES, 2004, AM J RESP CRIT CARE, V169, P214, DOI 10.1164/rccm.200307-973OC; SMYTH A, 1994, ARCH DIS CHILD, V71, P353, DOI 10.1136/adc.71.4.353; Smyth A, 2001, PEDIATR PULM, V31, P133, DOI 10.1002/1099-0496(200102)31:2<133::AID-PPUL1021>3.0.CO;2-8; Strausbaugh SD, 2007, CLIN CHEST MED, V28, P279, DOI 10.1016/j.ccm.2007.02.011; Su ZG, 2005, ACTA PHARMACOL SIN, V26, P714, DOI 10.1111/j.1745-7254.2005.00084.x; *US BUR CENS, CENS DAT 2000; *US CDCP, BOD MASS IND Z SCOR; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wu L, 2004, THORAX, V59, P126, DOI 10.1136/thorax.2003.005769	41	103	104	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 30	2008	299	4					417	424		10.1001/jama.299.4.417	http://dx.doi.org/10.1001/jama.299.4.417			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256JK	18230779	Green Accepted, Bronze			2022-12-24	WOS:000252724500019
J	Christofk, HR; Vander Heiden, MG; Wu, N; Asara, JM; Cantley, LC				Christofk, Heather R.; Vander Heiden, Matthew G.; Wu, Ning; Asara, John M.; Cantley, Lewis C.			Pyruvate kinase M2 is a phosphotyrosine-binding protein	NATURE			English	Article							ALLOSTERIC REGULATION; RECEPTOR KINASE; CELL-GROWTH; PHOSPHORYLATION; INHIBITION; ENZYMES	Growth factors stimulate cells to take up excess nutrients and to use them for anabolic processes. The biochemical mechanism by which this is accomplished is not fully understood but it is initiated by phosphorylation of signalling proteins on tyrosine residues. Using a novel proteomic screen for phosphotyrosine- binding proteins, we have made the observation that an enzyme involved in glycolysis, the human M2 ( fetal) isoform of pyruvate kinase ( PKM2), binds directly and selectively to tyrosine- phosphorylated peptides. We show that binding of phosphotyrosine peptides to PKM2 results in release of the allosteric activator fructose- 1,6- bisphosphate, leading to inhibition of PKM2 enzymatic activity. We also provide evidence that this regulation of PKM2 by phosphotyrosine signalling diverts glucose metabolites from energy production to anabolic processes when cells are stimulated by certain growth factors. Collectively, our results indicate that expression of this phosphotyrosine- binding form of pyruvate kinase is critical for rapid growth in cancer cells.	[Christofk, Heather R.; Vander Heiden, Matthew G.; Wu, Ning; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center	Cantley, LC (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	lcantley@hms.harvard.edu	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Christofk, Heather/0000-0002-8662-4425	NCI NIH HHS [T32 CA009172] Funding Source: Medline; NIGMS NIH HHS [R01 GM056203] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; PRESEK P, 1988, FEBS LETT, V242, P194, DOI 10.1016/0014-5793(88)81014-7; REISS N, 1986, BIOCHEM J, V239, P691, DOI 10.1042/bj2390691; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; SALE EM, 1987, J CELL BIOCHEM, V33, P15, DOI 10.1002/jcb.240330103; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	17	738	790	4	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					181	U27		10.1038/nature06667	http://dx.doi.org/10.1038/nature06667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337815				2022-12-24	WOS:000253925600033
J	Ives, AR; Einarsson, A; Jansen, VAA; Gardarsson, A				Ives, Anthony R.; Einarsson, Arni; Jansen, Vincent A. A.; Gardarsson, Arnthor			High-amplitude fluctuations and alternative dynamical states of midges in Lake Myvatn	NATURE			English	Article							POPULATION-DYNAMICS; DIPTERA; CHAOS; PREDATORS; STABILITY; SYSTEMS; LIMITS	Complex dynamics are often shown by simple ecological models(1,2) and have been clearly demonstrated in laboratory(3,4) and natural systems(5-9). Yet many classes of theoretically possible dynamics are still poorly documented in nature. Here we study long- term time- series data of a midge, Tanytarsus gracilentus ( Diptera: Chironomidae), in Lake Myvatn, Iceland. The midge undergoes density fluctuations of almost six orders of magnitude. Rather than regular cycles, however, these fluctuations have irregular periods of 4 - 7 years, indicating complex dynamics. We fit three consumer - resource models capable of qualitatively distinct dynamics to the data. Of these, the best- fitting model shows alternative dynamical states in the absence of environmental variability; depending on the initial midge densities, the model shows either fluctuations around a fixed point or high- amplitude cycles. This explains the observed complex population dynamics: high-amplitude but irregular fluctuations occur because stochastic variability causes the dynamics to switch between domains of attraction to the alternative states. In the model, the amplitude of fluctuations depends strongly on minute resource subsidies into the midge habitat. These resource subsidies may be sensitive to human- caused changes in the hydrology of the lake, with human impacts such as dredging leading to higher- amplitude fluctuations. Tanytarsus gracilentus is a key component of the Myvatn ecosystem, representing two- thirds of the secondary productivity of the lake(10) and providing vital food resources to fish and to breeding bird populations(11,12). Therefore the high- amplitude, irregular fluctuations in midge densities generated by alternative dynamical states dominate much of the ecology of the lake.	[Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Einarsson, Arni; Gardarsson, Arnthor] Univ Iceland, Myvatn Res Stn, IS-101 Reykjavik, Iceland; [Einarsson, Arni; Gardarsson, Arnthor] Univ Iceland, Inst Biol, IS-101 Reykjavik, Iceland; [Jansen, Vincent A. A.] Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England	University of Wisconsin System; University of Wisconsin Madison; University of Iceland; University of Iceland; University of London; Royal Holloway University London	Ives, AR (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	arives@wisc.edu	Ives, Anthony/A-5698-2008; Jansen, Vincent A A/C-8353-2009	Ives, Anthony/0000-0001-9375-9523; Jansen, Vincent A.A./0000-0002-6518-2090				Becks L, 2005, NATURE, V435, P1226, DOI 10.1038/nature03627; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Carpenter S R, 2003, REGIME SHIFTS LAKE E; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Dwyer G, 2004, NATURE, V430, P341, DOI 10.1038/nature02569; Einarsson A, 2002, J ANIM ECOL, V71, P832, DOI 10.1046/j.1365-2656.2002.00648.x; Gardarsson A, 2004, AQUAT ECOL, V38, P285, DOI 10.1023/B:AECO.0000032058.83651.2c; Gardarsson A, 2004, AQUAT ECOL, V38, P209, DOI 10.1023/B:AECO.0000032051.14118.e1; Gudbergsson G, 2004, AQUAT ECOL, V38, P271, DOI 10.1023/B:AECO.0000032100.28896.81; HANSKI I, 1993, NATURE, V364, P232, DOI 10.1038/364232a0; Harvey A. C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; HASTINGS A, 1993, ANNU REV ECOL SYST, V24, P1, DOI 10.1146/annurev.es.24.110193.000245; Henson SM, 2002, OIKOS, V98, P17, DOI 10.1034/j.1600-0706.2002.980102.x; Ingvason HR, 2004, AQUAT ECOL, V38, P231, DOI 10.1023/B:AECO.0000032053.67992.03; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Ives AR, 2000, ECOLOGY, V81, P3330, DOI 10.2307/177497; JANSEN VAA, 1995, OIKOS, V74, P172, DOI 10.2307/3545688; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; King AA, 1999, J MATH BIOL, V39, P439, DOI 10.1007/s002850050174; Kjaran SP, 2004, AQUAT ECOL, V38, P145, DOI 10.1023/B:AECO.0000032049.94886.5a; KLEBANOFF A, 1994, J MATH BIOL, V32, P427, DOI 10.1007/BF00160167; LINDEGAARD C, 1979, OIKOS, V32, P202, DOI 10.2307/3544228; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; McGovern TH, 2006, ENVIRON ARCHAEOL, V11, P187, DOI 10.1179/174963106x123205; NOYMEIR I, 1975, J ECOL, V63, P459, DOI 10.2307/2258730; Persson L, 2007, SCIENCE, V316, P1743, DOI 10.1126/science.1141412; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Turchin Peter, 2003, Monographs in Population Biology, V35, pi	30	79	82	2	88	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					84	87		10.1038/nature06610	http://dx.doi.org/10.1038/nature06610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322533				2022-12-24	WOS:000253671900051
J	Stepens, A; Logina, I; Liguts, V; Aldins, P; Eksteina, I; Platkajis, A; Martinsone, I; Terauds, E; Rozentale, B; Donaghy, M				Stepens, Ainars; Logina, Inara; Liguts, Viesturs; Aldins, Pauls; Eksteina, Ilze; Platkajis, Ardis; Martinsone, Inese; Terauds, Elmars; Rozentale, Baiba; Donaghy, Michael			A Parkinsonian syndrome in methcathinone users and the role of manganese	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INITIAL MANIFESTATION; MOVEMENT-DISORDERS; T1-WEIGHTED MRI; HIV-INFECTION; LIVER-FAILURE; EXPOSURE; AIDS; ENCEPHALOPATHY; HYPERINTENSITY; INTOXICATION	Background: A distinctive extrapyramidal syndrome has been observed in intravenous methcathinone (ephedrone) users in Eastern Europe and Russia. Methods: We studied 23 adults in Latvia who had extrapyramidal symptoms and who had injected methcathinone for a mean (+/-SD) of 6.7+/-5.1 years. The methcathinone was manufactured under home conditions by potassium permanganate oxidation of ephedrine or pseudoephedrine. All patients were positive for hepatitis C virus, and 20 were also positive for the human immunodeficiency virus (HIV). Results: The patients reported that the onset of their first neurologic symptoms (gait disturbance in 20 and hypophonia in 3) occurred after a mean of 5.8+/-4.5 years of methcathinone use. At the time of neurologic evaluation, all 23 patients had gait disturbance and difficulty walking backward; 11 patients were falling daily, and 1 of these patients used a wheelchair. Twenty-one patients had hypophonic speech in addition to gait disturbance, and one of these patients was mute. No patient reported decline in cognitive function. T-1-weighted magnetic resonance imaging (MRI) showed symmetric hyperintensity in the globus pallidus and in the substantia nigra and innominata in all 10 active methcathinone users. Among the 13 former users (2 to 6 years had passed since the last use), lesser degrees of change in the MRI signal were noted. Whole-blood manganese levels (normal level, <209 nmol per liter) averaged 831 nmol per liter (range, 201 to 2102) in the active methcathinone users and 346 nmol per liter (range, 114 to 727) in former users. The neurologic deficits did not resolve after patients discontinued methcathinone use. Conclusions: Our observation of a distinctive extrapyramidal syndrome, changes in the MRI signal in the basal ganglia, and elevated blood manganese levels in methcathinone users suggests that manganese in the methcathinone solution causes a persistent neurologic disorder.	[Donaghy, Michael] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England; [Stepens, Ainars; Logina, Inara] Riga Stradins Univ, Dept Neurol, Riga, Latvia; [Liguts, Viesturs] Riga Stradins Univ, Dept Anesthesiol & Intens Care, Riga, Latvia; [Aldins, Pauls; Eksteina, Ilze; Rozentale, Baiba] Riga Stradins Univ, Dept Class Infectol TB & AIDS, Riga, Latvia; [Platkajis, Ardis] Riga Stradins Univ, Dept Radiol, Riga, Latvia; [Martinsone, Inese] Riga Stradins Univ, Inst Occupat & Environm Hlth, Riga, Latvia; [Terauds, Elmars] Riga Stradins Univ, Dept Psychiat & Addict, Riga, Latvia	University of Oxford; Riga Stradins University; Riga Stradins University; Riga Stradins University; Riga Stradins University; Riga Stradins University; Riga Stradins University	Donaghy, M (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Level 3,West Wing, Oxford OX3 9DU, England.	joanna.wilkinson@clneuro.ox.ac.uk	Stepens, Ainars/C-7751-2018; Stepens, Ainars/C-7746-2018; Mārtiņsone, Inese/C-5668-2017; Platkajis, Ardis/AFS-1138-2022	Stepens, Ainars/0000-0002-6621-0196; Stepens, Ainars/0000-0002-6621-0196; Mārtiņsone, Inese/0000-0001-6923-5316; 				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; Bader M, 1999, INT ARCH OCC ENV HEA, V72, P521, DOI 10.1007/s004200050410; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P293, DOI 10.1081/CLT-100102427; Bouffard JP, 2003, MOVEMENT DISORD, V18, P1354, DOI 10.1002/mds.10546; Burkhard PR, 2003, ARCH NEUROL-CHICAGO, V60, P521, DOI 10.1001/archneur.60.4.521; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; COOK DG, 1974, ARCH NEUROL-CHICAGO, V30, P59, DOI 10.1001/archneur.1974.00490310061010; Cox G, 2003, ADV PSYCHIAT TREAT, V9, P456, DOI [10.1192/apt.9.6.456, DOI 10.1192/APT.9.6.456]; de Mattos JP, 2002, ARQ NEURO-PSIQUIAT, V60, P525, DOI 10.1590/S0004-282X2002000400002; EJIMA A, 1992, LANCET, V339, P426, DOI 10.1016/0140-6736(92)90109-G; EMERSON TS, 1993, ANN EMERG MED, V22, P1897, DOI 10.1016/S0196-0644(05)80419-6; EMERSON TS, 1994, ANN EMERG MED, V23, P790; Fahn S, 1987, RECENT DEV PARKINSON; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gillingham FJ., 1969, 3 S PARK DIS; Gygi MP, 1997, J PHARMACOL EXP THER, V283, P1350; Hersh BP, 2001, NEUROLOGY, V56, P278, DOI 10.1212/WNL.56.2.278; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUANG CC, 1993, NEUROLOGY, V43, P1479, DOI 10.1212/WNL.43.8.1479; Jankovic J, 2005, NEUROLOGY, V64, P2021, DOI 10.1212/01.WNL.0000166916.40902.63; Josephs KA, 2005, NEUROLOGY, V64, P2033, DOI 10.1212/01.WNL.0000167411.93483.A1; Kim YH, 2004, IND HEALTH, V42, P111, DOI 10.2486/indhealth.42.111; Klos KJ, 2006, NEUROLOGY, V67, P1984, DOI 10.1212/01.wnl.0000247037.37807.76; Koller WC, 2004, NEUROLOGY, V62, P730, DOI 10.1212/01.WNL.0000113726.34734.15; Koutsilieri E, 2002, J NEURAL TRANSM, V109, P767, DOI 10.1007/s007020200063; Levin OS, 2005, Z NEVROL PSIKHIATRII, V105, P12; Maggi P, 2000, NEUROL SCI, V21, P173, DOI 10.1007/s100720070093; McMillan Grant, 2005, Toxicol Rev, V24, P237, DOI 10.2165/00139709-200524040-00004; Mirsattari SM, 1998, MOVEMENT DISORD, V13, P684, DOI 10.1002/mds.870130413; Murakami T, 2000, INTERNAL MED, V39, P1111, DOI 10.2169/internalmedicine.39.1111; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; PUJOL A, 1993, NEUROLOGY, V43, P65, DOI 10.1212/WNL.43.1_Part_1.65; Racette BA, 2001, NEUROLOGY, V56, P8, DOI 10.1212/WNL.56.1.8; Rose C, 1999, GASTROENTEROLOGY, V117, P640, DOI 10.1016/S0016-5085(99)70457-9; Schaumburg, 2006, NEUROLOGY, V67, P1902; Schaumburg HH, 2006, NEUROLOGY, V67, P322, DOI 10.1212/01.wnl.0000225179.21282.58; Shulman LM, 2003, NEUROLOGY, V60, P519, DOI 10.1212/WNL.60.3.519; Tanaka M, 2000, MOVEMENT DISORD, V15, P1032, DOI 10.1002/1531-8257(200009)15:5<1032::AID-MDS1049>3.0.CO;2-X; Tse W, 2004, PARKINSONISM RELAT D, V10, P323, DOI 10.1016/j.parkreldis.2004.03.001; VANLOON JC, 1986, CHEM ANAL, P176; Wu A.H.B., 2006, TIETZ CLIN GUIDE LAB; ZHINGEL KY, 1991, J FORENSIC SCI, V36, P915	42	136	140	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					1009	1017		10.1056/NEJMoa072488	http://dx.doi.org/10.1056/NEJMoa072488			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18322282				2022-12-24	WOS:000253644700005
J	Xu, Y; Feng, L; Jeffrey, PD; Shi, YG; Morel, FMM				Xu, Yan; Feng, Liang; Jeffrey, Philip D.; Shi, Yigong; Morel, Francois M. M.			Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms	NATURE			English	Article							ACTIVE-SITE; CRYSTAL-STRUCTURE; PROTON-TRANSFER; ENZYME; ZINC; BINDING; PHYTOPLANKTON; WATERS; CO2; IDENTIFICATION	Carbonic anhydrase, a zinc enzyme found in organisms from all kingdoms, catalyses the reversible hydration of carbon dioxide and is used for inorganic carbon acquisition by phytoplankton. In the oceans, where zinc is nearly depleted, diatoms use cadmium as a catalytic metal atom in cadmium carbonic anhydrase ( CDCA). Here we report the crystal structures of CDCA in four distinct forms: cadmium- bound, zinc- bound, metal- free and acetate- bound. Despite lack of sequence homology, CDCA is a structural mimic of a functional beta- carbonic anhydrase dimer, with striking similarity in the spatial organization of the active site residues. CDCA readily exchanges cadmium and zinc at its active site - an apparently unique adaptation to oceanic life that is explained by a stable opening of the metal coordinating site in the absence of metal. Given the central role of diatoms in exporting carbon to the deep sea, their use of cadmium in an enzyme critical for carbon acquisition establishes a remarkable link between the global cycles of cadmium and carbon.	[Morel, Francois M. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Xu, Yan] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Feng, Liang; Jeffrey, Philip D.; Shi, Yigong] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Morel, FMM (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	yshi@princeton.edu; morel@princeton.edu		Jeffrey, Philip/0000-0002-4351-5341; Shi, Yigong/0000-0003-2030-168X				AHNER BA, 1994, P NATL ACAD SCI USA, V91, P8433, DOI 10.1073/pnas.91.18.8433; Alber BE, 1999, BIOCHEMISTRY-US, V38, P13119, DOI 10.1021/bi9828876; Badger M, 2003, PHOTOSYNTH RES, V77, P83, DOI 10.1023/A:1025821717773; BOYLE EA, 1976, NATURE, V263, P42, DOI 10.1038/263042a0; BRULAND KW, 1978, LIMNOL OCEANOGR, V23, P618, DOI 10.4319/lo.1978.23.4.0618; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; COLEMAN JE, 1965, BIOCHEMISTRY-US, V4, P2644, DOI 10.1021/bi00888a014; COLEMAN JE, 1967, NATURE, V214, P193, DOI 10.1038/214193a0; Cox EH, 2000, BIOCHEMISTRY-US, V39, P12128, DOI 10.1021/bi001416s; Cronk JD, 2006, BIOCHEMISTRY-US, V45, P4351, DOI 10.1021/bi052272q; Ejnik J, 1999, J BIOL INORG CHEM, V4, P784, DOI 10.1007/s007750050351; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fisher SZ, 2007, BIOCHEMISTRY-US, V46, P3803, DOI 10.1021/bi602620k; FRIDBORG K, 1967, J MOL BIOL, V25, P505, DOI 10.1016/0022-2836(67)90202-1; Gans P, 1996, TALANTA, V43, P1739, DOI 10.1016/0039-9140(96)01958-3; HAKANSSON K, 1992, J MOL BIOL, V227, P1192, DOI 10.1016/0022-2836(92)90531-N; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KANNAN KK, 1971, COLD SPRING HARB SYM, V36, P221, DOI 10.1101/SQB.1972.036.01.030; Kimber MS, 2000, EMBO J, V19, P1407, DOI 10.1093/emboj/19.7.1407; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuss J, 1999, MAR CHEM, V68, P71, DOI 10.1016/S0304-4203(99)00066-3; Lane TW, 2000, P NATL ACAD SCI USA, V97, P4627, DOI 10.1073/pnas.090091397; Lane TW, 2005, NATURE, V435, P42, DOI 10.1038/435042a; LILJAS A, 1972, NATURE-NEW BIOL, V235, P131, DOI 10.1038/newbio235131a0; Liu JB, 2005, BIOCHEMISTRY-US, V44, P5159, DOI 10.1021/bi0476275; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mitsuhashi S, 2000, J BIOL CHEM, V275, P5521, DOI 10.1074/jbc.275.8.5521; MOREL FMM, 1994, NATURE, V369, P740, DOI 10.1038/369740a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Okoniewska M, 2000, BIOCHEM J, V349, P169, DOI 10.1042/0264-6021:3490169; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2007, ENVIRON MICROBIOL, V9, P403, DOI 10.1111/j.1462-2920.2006.01151.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P2045, DOI 10.1021/bi00551a006; PRICE NM, 1990, NATURE, V344, P658, DOI 10.1038/344658a0; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Roberts SB, 1997, J PHYCOL, V33, P845, DOI 10.1111/j.0022-3646.1997.00845.x; Satoh D, 2001, PLANT PHYSIOL, V126, P1459, DOI 10.1104/pp.126.4.1459; Sawaya MR, 2006, J BIOL CHEM, V281, P7546, DOI 10.1074/jbc.M510464200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Sotoj AR, 2006, APPL ENVIRON MICROB, V72, P5500, DOI 10.1128/AEM.00237-06; Strop P, 2001, J BIOL CHEM, V276, P10299, DOI 10.1074/jbc.M009182200; TIBELL L, 1984, BIOCHIM BIOPHYS ACTA, V788, P110, DOI 10.1016/0167-4838(84)90302-9; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200	47	398	406	16	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					56	U3		10.1038/nature06636	http://dx.doi.org/10.1038/nature06636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322527				2022-12-24	WOS:000253671900045
J	Fargione, J; Hill, J; Tilman, D; Polasky, S; Hawthorne, P				Fargione, Joseph; Hill, Jason; Tilman, David; Polasky, Stephen; Hawthorne, Peter			Land clearing and the biofuel carbon debt	SCIENCE			English	Article							CLIMATE POLICY; SWITCHGRASS; CONSERVATION; AMAZON; LEGUME; FUEL	Increasing energy use, climate change, and carbon dioxide ( CO2) emissions from fossil fuels make switching to low- carbon fuels a high priority. Biofuels are a potential low- carbon energy source, but whether biofuels offer carbon savings depends on how they are produced. Converting rainforests, peatlands, savannas, or grasslands to produce food crop - based biofuels in Brazil, Southeast Asia, and the United States creates a "biofuel carbon debt" by releasing 17 to 420 times more CO2 than the annual greenhouse gas ( GHG) reductions that these biofuels would provide by displacing fossil fuels. In contrast, biofuels made from waste biomass or from biomass grown on degraded and abandoned agricultural lands planted with perennials incur little or no carbon debt and can offer immediate and sustained GHG advantages.	[Hill, Jason; Tilman, David; Polasky, Stephen; Hawthorne, Peter] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Fargione, Joseph] Nature Conservancy, Minneapolis, MN 55415 USA; [Hill, Jason; Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; Nature Conservancy; University of Minnesota System; University of Minnesota Twin Cities	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu	Tilman, David/ABD-5309-2021; Molina, Carolina/E-3898-2015; Polasky, Stephen/AAC-5341-2019; Hill, Jason/A-8919-2008	Molina, Carolina/0000-0001-6659-994X; Hill, Jason/0000-0001-7609-6713; Hawthorne, Peter/0000-0003-1125-5239; Fargione, Joseph/0000-0002-0636-5380				Basiron Y, 2007, EUR J LIPID SCI TECH, V109, P289, DOI 10.1002/ejlt.200600223; Cerri CEP, 2007, AGR ECOSYST ENVIRON, V122, P58, DOI 10.1016/j.agee.2007.01.008; Eggleston HS., 2006, EM LIV MAN MAN, DOI DOI 10.35-10.49; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; George JR, 1995, AGRON J, V87, P1147, DOI 10.2134/agronj1995.00021962008700060018x; Graham DJ, 2002, J TRANSP ECON POLICY, V36, P1; Graham RL, 2007, AGRON J, V99, P1, DOI 10.2134/agronj2005.0222; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Hammerschlag R, 2006, ENVIRON SCI TECHNOL, V40, P1744, DOI 10.1021/es052024h; Hooijer A., 2006, PEAT CO2 ASSESSMENT; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; JUNG GA, 1985, AGRON J, V77, P846, DOI 10.2134/agronj1985.00021962007700060005x; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Robles MD, 1997, ECOL APPL, V7, P345, DOI 10.1890/1051-0761(1997)007[0345:LGACRP]2.0.CO;2; SAMPLE DW, 1989, THESIS U WISCONSIN; Schlesinger WH., 1997, BIOGEOCHEMISTRY; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; SECCHI S, 2007, 07WP447 IOW STAT U C; Silver WL, 2001, OECOLOGIA, V129, P407, DOI 10.1007/s004420100740; Solomon BD, 2007, BIOMASS BIOENERG, V31, P416, DOI 10.1016/j.biombioe.2007.01.023; Sterner T, 2007, ENERG POLICY, V35, P3194, DOI 10.1016/j.enpol.2006.10.025; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; West TO, 2004, ENVIRON MANAGE, V33, P507, DOI 10.1007/s00267-003-9108-3; Winjum JK, 1998, FOREST SCI, V44, P272	28	2479	2530	31	1439	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1235	1238		10.1126/science.1152747	http://dx.doi.org/10.1126/science.1152747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18258862				2022-12-24	WOS:000253530600041
J	Ravi, M; Marimuthu, MPA; Siddiqi, I				Ravi, Maruthachalam; Marimuthu, Mohan P. A.; Siddiqi, Imran			Gamete formation without meiosis in Arabidopsis	NATURE			English	Article							THALIANA PLANTS; APOMIXIS; GENE; MARKERS; IDENTIFICATION; PROGRESSION; STRATEGIES; TRIPSACUM; EVOLUTION; APOSPORY	Apomixis, the formation of asexual seeds in plants, leads to populations that are genetically uniform maternal clones. The transfer of apomixis to crop plants holds great promise in plant breeding for fixation of heterozygosity and hybrid vigour because it would allow the propagation of hybrids over successive generations(1,2). Apomixis involves the production of unreduced ( diploid) female gametes that retain the genotype of the parent plant ( apomeiosis), followed by parthenogenetic development of the egg cell into an embryo and the formation of functional endosperm(3). The molecular mechanisms underlying apomixis are unknown. Here we show that mutation of the Arabidopsis gene DYAD/ SWITCH1 (SWI1)(4,5), a regulator of meiotic chromosome organization, leads to apomeiosis. We found that most fertile ovules in dyad plants form seeds that are triploid and that arise from the fertilization of an unreduced female gamete by a haploid male gamete. The unreduced female gametes fully retain parental heterozygosity across the genome, which is characteristic of apomeiosis. Our results show that the alteration of a single gene in a sexual plant can bring about functional apomeiosis, a major component of apomixis.	[Ravi, Maruthachalam; Marimuthu, Mohan P. A.; Siddiqi, Imran] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Siddiqi, I (corresponding author), Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	imran@ccmb.res.in		Maruthachalam, Ravi/0000-0003-0036-3330				Agashe B, 2002, DEVELOPMENT, V129, P3935; ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; ALTMANN T, 1994, PLANT CELL REP, V13, P652, DOI 10.1007/BF00232939; BARONE A, 1995, THEOR APPL GENET, V91, P98, DOI 10.1007/BF00220864; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Blakey CA, 2001, GENOME, V44, P222, DOI 10.1139/gen-44-2-222; BRETAGNOLLE F, 1995, NEW PHYTOL, V129, P1, DOI 10.1111/j.1469-8137.1995.tb03005.x; Chen KY, 2007, SCIENCE, V318, P643, DOI 10.1126/science.1148428; CURTIS CA, 1992, J HERED, V83, P335, DOI 10.1093/oxfordjournals.jhered.a111227; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dilkes BP, 2004, PLANT CELL, V16, P3174, DOI 10.1105/tpc.104.161230; DOUCHES DS, 1988, EUPHYTICA, V38, P247, DOI 10.1007/BF00023528; FINCH RA, 1979, HEREDITY, V43, P87, DOI 10.1038/hdy.1979.62; Grimanelli D, 1998, HEREDITY, V80, P33, DOI 10.1046/j.1365-2540.1998.00263.x; Guitton AE, 2005, CURR BIOL, V15, P750, DOI 10.1016/j.cub.2005.02.066; Hamant O, 2006, ANNU REV PLANT BIOL, V57, P267, DOI 10.1146/annurev.arplant.57.032905.105255; Huanca-Mamani W, 2005, P NATL ACAD SCI USA, V102, P17231, DOI 10.1073/pnas.0508186102; Koltunow AM, 2003, ANNU REV PLANT BIOL, V54, P547, DOI 10.1146/annurev.arplant.54.110901.160842; KOLTUNOW AM, 1995, PLANT PHYSIOL, V108, P1345, DOI 10.1104/pp.108.4.1345; Mercier R, 2001, GENE DEV, V15, P1859, DOI 10.1101/gad.203201; MOGIE M, 1988, BIOL J LINN SOC, V35, P127, DOI 10.1111/j.1095-8312.1988.tb00462.x; Noyes RD, 2005, HEREDITY, V94, P193, DOI 10.1038/sj.hdy.6800597; Ozias-Akins P, 1998, P NATL ACAD SCI USA, V95, P5127, DOI 10.1073/pnas.95.9.5127; Pessino SC, 1998, HEREDITAS, V128, P153, DOI 10.1111/j.1601-5223.1998.00153.x; Pupilli F, 2004, MOL GENET GENOMICS, V270, P539, DOI 10.1007/s00438-003-0949-5; RHOADES MM, 1966, GENETICS, V54, P505; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Savidan Y., 2000, Plant Breeding Reviews, V18, P13; Siddiqi I, 2000, DEVELOPMENT, V127, P197; Spielman M, 2001, TRENDS GENET, V17, P705, DOI 10.1016/S0168-9525(01)02519-7; Spillane C, 2001, SEX PLANT REPROD, V14, P179, DOI 10.1007/s00497-001-0117-1; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; VORSA L, 1997, J HERED, V8, P423	33	150	165	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					1121	U10		10.1038/nature06557	http://dx.doi.org/10.1038/nature06557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18272967				2022-12-24	WOS:000253453600045
J	Schetter, AJ; Leung, SY; Sohn, JJ; Zanetti, KA; Bowman, ED; Yanaihara, N; Yuen, ST; Chan, TL; Kwong, DLW; Au, GKH; Liu, CG; Calin, GA; Croce, CM; Harris, CC				Schetter, Aaron J.; Leung, Suet Yi; Sohn, Jane J.; Zanetti, Krista A.; Bowman, Elise D.; Yanaihara, Nozomu; Yuen, Siu Tsan; Chan, Tsun Leung; Kwong, Dora L. W.; Au, Gordon K. H.; Liu, Chang-Gong; Calin, George A.; Croce, Carlo M.; Harris, Curtis C.			MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANCER; DIFFERENTIATION; SIGNATURE; PATTERNS; ENCODES; RNA	Context MicroRNAs have potential as diagnostic biomarkers and therapeutic targets in cancer. No study has evaluated the association between microRNA expression patterns and colon cancer prognosis or therapeutic outcome. Objective To identify microRNA expression patterns associated with colon adenocarcinomas, prognosis, or therapeutic outcome. Design, Setting, and Patients MicroRNA microarray expression profiling of tumors and paired nontumorous tissues was performed on a US test cohort of 84 patients with incident colon adenocarcinoma, recruited between 1993 and 2002. We evaluated associations with tumor status, TNM staging, survival prognosis, and response to adjuvant chemotherapy. Associations were validated in a second, independent Chinese cohort of 113 patients recruited between 1991 and 2000, using quantitative reverse transcription polymerase chain reaction assays. The final date of follow- up was December 31, 2005, for the Maryland cohort and August 16, 2004, for the Hong Kong cohort. Main Outcome Measures MicroRNAs that were differentially expressed in tumors and microRNA expression patterns associated with survival using cancer-specific death as the end point. Results Thirty- seven microRNAs were differentially expressed in tumors from the test cohort. Selected for validation were miR- 20a, miR- 21, miR- 106a, miR- 181b, and miR- 203, and all 5 were enriched in tumors from the validation cohort ( P <. 001). Higher miR- 21 expression was present in adenomas ( P =.006) and in tumors with more advanced TNM staging ( P <. 001). In situ hybridization demonstrated miR- 21 to be expressed at high levels in colonic carcinoma cells. The 5- year cancer- specific survival rate was 57.5% for the Maryland cohort and was 49.5% for the Hong Kong cohort. High miR- 21 expression was associated with poor survival in both the training ( hazard ratio, 2.5; 95% confidence interval, 1.2- 5.2) and validation cohorts ( hazard ratio, 2.4; 95% confidence interval, 1.4- 3.9), independent of clinical covariates, including TNM staging, and was associated with a poor therapeutic outcome. Conclusions Expression patterns of microRNAs are systematically altered in colon adenocarcinomas. High miR- 21 expression is associated with poor survival and poor therapeutic outcome.	[Schetter, Aaron J.; Sohn, Jane J.; Zanetti, Krista A.; Bowman, Elise D.; Yanaihara, Nozomu; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Schetter, Aaron J.; Zanetti, Krista A.] NCI, Canc Prevent Fellowship Program, Off Prevent Oncol, NIH, Bethesda, MD 20892 USA; [Leung, Suet Yi; Yuen, Siu Tsan; Chan, Tsun Leung] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Pokfulam, Hong Kong, Peoples R China; [Kwong, Dora L. W.; Au, Gordon K. H.] Univ Hong Kong, Queen Mary Hosp, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China; [Liu, Chang-Gong; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Hong Kong; University of Hong Kong; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center	Harris, CC (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bldg 37,Room 3068A, Bethesda, MD 20892 USA.	Curtis_Harris@nih.gov	Young, Richard A/F-6495-2012; Leung, Suet Yi/C-4340-2009; Yuen, Siu/K-6311-2014; Calin, George/E-9390-2011; Vickers, Michael M/E-4095-2010; Leung, Suet Yi/T-9620-2019	Young, Richard A/0000-0001-8855-8647; Calin, George/0000-0001-6704-5615; Leung, Suet Yi/0000-0001-8614-4619	NATIONAL CANCER INSTITUTE [Z01BC010878, ZIABC010878, ZIABC005480, Z01BC005480] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC005480-22] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aaltonen LA, 2000, PATHOLOGY GENETICS T, P130; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brosens LAA, 2007, CURR MOL MED, V7, P29; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Goldman E, 2006, ARCH MED RES, V37, P548, DOI 10.1016/j.arcmed.2005.09.013; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; HILL AB, 1971, STAT EVIDENCE INFERE; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kang HJ, 2005, DIS COLON RECTUM, V48, P1161, DOI 10.1007/s10350-004-0932-1; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mattes J, 2007, AM J RESP CELL MOL, V36, P8, DOI 10.1165/rcmb.2006-0227TR; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Michael MZ, 2003, MOL CANCER RES, V1, P882; Rodriguez-Bigas MA, 2006, HOLLAND FREI CANC ME, P1369; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Waldman SA, 2007, JAMA-J AM MED ASSOC, V297, P1923, DOI 10.1001/jama.297.17.1923; Wang CL, 2006, P NATL ACAD SCI USA, V103, P18680, DOI 10.1073/pnas.0609030103; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wurdinger T, 2007, PHARMACOGENOMICS J, V7, P297, DOI 10.1038/sj.tpj.6500429; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	43	1327	1472	1	114	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 30	2008	299	4					425	436		10.1001/jama.299.4.425	http://dx.doi.org/10.1001/jama.299.4.425			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256JK	18230780	Green Accepted, Bronze			2022-12-24	WOS:000252724500020
J	Barabas, O; Ronning, DR; Guynet, C; Hickman, AB; Ton-Hoang, B; Chandler, M; Dyda, F				Barabas, Orsolya; Ronning, Donald R.; Guynet, Catherine; Hickman, Alison Burgess; Ton-Hoang, Bao; Chandler, Michael; Dyda, Fred			Mechanism of IS200/IS605 family DNA transposases: Activation and transposon-directed target site selection	CELL			English	Article							CRYSTAL-STRUCTURE; HELICOBACTER-PYLORI; INSERTION; BINDING; ISHP608; DOMAIN	The smallest known DNA transposases are those from the IS200/IS605 family. Here we show how the interplay of protein and DNA activates TnpA, the Helicobacter pylori IS608 transposase, for catalysis. First, transposon end binding causes a conformational change that aligns catalytically important protein residues within the active site. Subsequent precise cleavage at the left and right ends, the steps that liberate the transposon from its donor site, does not involve a site-specific DNA-binding domain. Rather, cleavage site recognition occurs by complementary base pairing with a TnpA-bound subterminal transposon DNA segment. Thus, the enzyme active site is constructed from elements of both protein and DNA, reminiscent of the interdependence of protein and RNA in the ribosome. Our structural results explain why the transposon ends are asymmetric and how the transposon selects a target site for integration, and they allow us to propose a molecular model for the entire transposition reaction.	[Barabas, Orsolya; Ronning, Donald R.; Hickman, Alison Burgess; Dyda, Fred] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Guynet, Catherine; Ton-Hoang, Bao; Chandler, Michael] Natl Rech Sci, Microbiol Lab, F-31062 Toulouse, France; [Guynet, Catherine; Ton-Hoang, Bao; Chandler, Michael] Natl Rech Sci, Ctr Mol Genet, F-31062 Toulouse, France	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dyda, F (corresponding author), NIDDK, Mol Biol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	fred.dyda@nih.gov	Barabas, Orsolya/F-3961-2012; Guynet, Catherine/A-4815-2011; Guynet, Catherine/GPX-0917-2022	Barabas, Orsolya/0000-0002-2873-5872; Ronning, Donald/0000-0003-2583-8849; Chandler, Michael/0000-0002-0292-6662	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036154] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK036154-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bao TH, 2005, EMBO J, V24, P3325, DOI 10.1038/sj.emboj.7600787; Belfort Marlene, 2002, P761; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; Debets-Ossenkopp YJ, 1999, ANTIMICROB AGENTS CH, V43, P2657, DOI 10.1128/AAC.43.11.2657; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Garcillan-Barcia MD, 2001, MOL MICROBIOL, V39, P494, DOI 10.1046/j.1365-2958.2001.02261.x; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Guasch A, 2003, NAT STRUCT BIOL, V10, P1002, DOI 10.1038/nsb1017; GUYNET C, 2008, IN PRESS MOL CELL; Hickman AB, 2002, MOL CELL, V10, P327, DOI 10.1016/S1097-2765(02)00592-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Karberg M, 2001, NAT BIOTECHNOL, V19, P1162, DOI 10.1038/nbt1201-1162; Kersulyte D, 2002, J BACTERIOL, V184, P992, DOI 10.1128/jb.184.4.992-1002.2002; KOONIN EV, 1993, BIOSYSTEMS, V30, P241, DOI 10.1016/0303-2647(93)90074-M; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin C, 2005, STRUCTURE, V13, P1533, DOI 10.1016/j.str.2005.06.013; Lee HH, 2006, J BIOL CHEM, V281, P4261, DOI 10.1074/jbc.M511567200; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Mennecier S, 2006, MOL MICROBIOL, V59, P317, DOI 10.1111/j.1365-2958.2005.04936.x; Miskey C, 2005, CELL MOL LIFE SCI, V62, P629, DOI 10.1007/s00018-004-4232-7; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; Otwinowski Z, 1997, PROCESSING XRAY DIFF, V276; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	32	85	87	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					208	220		10.1016/j.cell.2007.12.029	http://dx.doi.org/10.1016/j.cell.2007.12.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243097	Green Accepted, Bronze			2022-12-24	WOS:000253427700008
J	Strand, AE; Pritchard, SG; McCormack, ML; Davis, MA; Oren, R				Strand, Allan E.; Pritchard, Seth G.; McCormack, M. Luke; Davis, Micheal A.; Oren, Ram			Irreconcilable differences: Fine-root life spans and soil carbon persistence	SCIENCE			English	Article							ELEVATED CO2; NITROGEN DEPOSITION; FOREST; TURNOVER; MORTALITY; SEQUESTRATION; MINIRHIZOTRON; TEMPERATURE; DYNAMICS	The residence time of fine- root carbon in soil is one of the least understood aspects of the global carbon cycle, and fine- root dynamics are one of the least understood aspects of plant function. Most recent studies of these belowground dynamics have used one of two methodological strategies. In one approach, based on analysis of carbon isotopes, the persistence of carbon is inferred; in the other, based on direct observations of roots with cameras, the longevity of individual roots is measured. We show that the contribution of fine roots to the global carbon cycle has been overstated because observations of root lifetimes systematically overestimate the turnover of fine- root biomass. On the other hand, isotopic techniques systematically underestimate the turnover of individual roots. These differences, by virtue of the separate processes or pools measured, are irreconcilable.	[Strand, Allan E.; Pritchard, Seth G.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [McCormack, M. Luke] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Davis, Micheal A.] Univ So Mississippi, Dept Biol, Hattiesburg, MS 39406 USA; [Oren, Ram] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA	College of Charleston; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Southern Mississippi; Duke University	Pritchard, SG (corresponding author), Coll Charleston, Dept Biol, Charleston, SC 29424 USA.	pritchards@cofc.edu	Oren, Ram/AAC-5326-2019	Oren, Ram/0000-0002-5654-1733; McCormack, Michael Luke/0000-0002-8300-5215				Eissenstat DM, 2000, NEW PHYTOL, V147, P33, DOI 10.1046/j.1469-8137.2000.00686.x; Fitter A, 2005, CURR BIOL, V15, pR185, DOI 10.1016/j.cub.2005.03.002; Guo DL, 2008, NEW PHYTOL, V177, P443, DOI 10.1111/j.1469-8137.2007.02242.x; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Johnson MG, 2006, NEW PHYTOL, V170, P345, DOI 10.1111/j.1469-8137.2006.01658.x; Johnson MG, 2001, ENVIRON EXP BOT, V45, P263, DOI 10.1016/S0098-8472(01)00077-6; Joslin JD, 2006, NEW PHYTOL, V172, P523, DOI 10.1111/j.1469-8137.2006.01847.x; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; LUO Y, 2004, SCIENCE, V304, P945; Luo YQ, 2003, GLOBAL CHANGE BIOL, V9, P1118, DOI 10.1046/j.1365-2486.2003.00642.x; Matamala R, 2003, SCIENCE, V302, P1385, DOI 10.1126/science.1089543; Nadelhoffer KJ, 2000, NEW PHYTOL, V147, P131, DOI 10.1046/j.1469-8137.2000.00677.x; Norby RJ, 2004, P NATL ACAD SCI USA, V101, P9689, DOI 10.1073/pnas.0403491101; Phillips DL, 2006, GLOBAL CHANGE BIOL, V12, P61, DOI 10.1111/j.1365-2486.2005.01085.x; Phillips DL, 2006, OECOLOGIA, V148, P517, DOI 10.1007/s00442-006-0392-5; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Schlesinger WH, 2006, ECOL STU AN, V187, P197; Tierney GL, 2002, CAN J FOREST RES, V32, P1692, DOI [10.1139/x02-123, 10.1139/X02-123]; Tingey DT, 2005, FOREST ECOL MANAG, V204, P359, DOI 10.1016/j.foreco.2004.09.010; Trumbore SE, 2003, SCIENCE, V302, P1344, DOI 10.1126/science.1091841; Wells CE, 2002, AM J BOT, V89, P79, DOI 10.3732/ajb.89.1.79	23	175	185	5	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					456	458		10.1126/science.1151382	http://dx.doi.org/10.1126/science.1151382			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218895				2022-12-24	WOS:000252576600036
J	Grol, R; Berwick, D; Wensing, M				Grol, Richard; Berwick, Donald; Wensing, Michel			On the trail of quality and safety in health care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SERVICES RESEARCH; IMPROVEMENT		[Grol, Richard; Wensing, Michel] Ctr Qual Care Res, NL-6500 HB Nijmegen, Netherlands; [Berwick, Donald] Inst Healthcare Improvement, Cambridge, MA 02138 USA	Radboud University Nijmegen; Institute for Healthcare Improvement	Grol, R (corresponding author), Ctr Qual Care Res, POB 9101,114, NL-6500 HB Nijmegen, Netherlands.	r.grol@kwazo.umcn.nl	Wensing, Michel/D-3998-2009; Grol, Richard/C-8523-2013; Wensing, Michel/H-8113-2014	Wensing, Michel/0000-0001-6569-8137				Berwick DM, 2005, HEALTH SERV RES, V40, P317, DOI 10.1111/j.1475-6773.2005.0n359.x; Dash P, 2003, BRIT MED J, V327, P1339, DOI 10.1136/bmj.327.7427.1339; Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; GROL IR, 2005, IMPROVING PATIENT CA; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Grol R BR, 2004, QUALITY IMPROVEMENT; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Institute of Medicine, 2006, PERF MEAS ACC IMPR; Leatherman Sheila, 2004, BMJ, V328, pE288, DOI 10.1136/bmj.328.7445.E288; Lomas J, 2003, BMJ-BRIT MED J, V327, P1301, DOI 10.1136/bmj.327.7427.1301; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Rosenberg RN, 2003, JAMA-J AM MED ASSOC, V289, P1305, DOI 10.1001/jama.289.10.1305; Schoen C, 2006, HEALTH AFFAIR, V25, pW457, DOI 10.1377/hlthaff.25.w457; Seddon ME, 2001, QUAL HEALTH CARE, V10, P152, DOI 10.1136/qhc.0100152..; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; TETROE J, IN PRESS MILBANK Q; van Roosmalen MS, 2007, QUAL SAF HEALTH CARE, V16, P105, DOI 10.1136/qshc.2006.018580	21	88	89	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2008	336	7635					74	76		10.1136/bmj.39413.486944.AD	http://dx.doi.org/10.1136/bmj.39413.486944.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	253BX	18187724	Green Published			2022-12-24	WOS:000252494800027
J	Niessen, F; Schaffner, F; Furlan-Freguia, C; Pawlinski, R; Bhattacharjee, G; Chun, J; Derian, CK; Andrade-Gordon, P; Rosen, H; Ruf, W				Niessen, Frank; Schaffner, Florence; Furlan-Freguia, Christian; Pawlinski, Rafal; Bhattacharjee, Gourab; Chun, Jerold; Derian, Claudia K.; Andrade-Gordon, Patricia; Rosen, Hugh; Ruf, Wolfram			Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation	NATURE			English	Article							PROTEASE-ACTIVATED RECEPTORS; TISSUE FACTOR; SPHINGOSINE 1-PHOSPHATE; POLYMICROBIAL SEPSIS; P2X(7) RECEPTOR; MICE DEFICIENT; LYMPH-NODES; MOUSE MODEL; RESPONSES; ENDOTOXEMIA	Defining critical points of modulation across heterogeneous clinical syndromes may provide insight into new therapeutic approaches. Coagulation initiated by the cytokine- receptor family member known as tissue factor is a hallmark of systemic inflammatory response syndromes in bacterial sepsis and viral haemorrhagic fevers(1,2), and anticoagulants can be effective in severe sepsis with disseminated intravascular coagulation(3). The precise mechanism coupling coagulation and inflammation remains unresolved(4-7). Here we show that protease- activated receptor 1 ( PAR1) signalling sustains a lethal inflammatory response that can be interrupted by inhibition of either thrombin or PAR1 signalling. The sphingosine 1- phosphate ( S1P) axis is a downstream component of PAR1 signalling, and by combining chemical and genetic probes for S1P receptor 3 ( S1P3) we show a critical role for dendritic cell PAR1 - S1P3 cross- talk in regulating amplification of inflammation in sepsis syndrome. Conversely, dendritic cells sustain escalated systemic coagulation and are the primary hub at which coagulation and inflammation intersect within the lymphatic compartment. Loss of dendritic cell PAR1 - S1P3 signalling sequesters dendritic cells and inflammation into draining lymph nodes, and attenuates dissemination of interleukin-1 beta to the lungs. Thus, activation of dendritic cells by coagulation in the lymphatics emerges as a previously unknown mechanism that promotes systemic inflammation and lethality in decompensated innate immune responses.	[Niessen, Frank; Schaffner, Florence; Furlan-Freguia, Christian; Pawlinski, Rafal; Bhattacharjee, Gourab; Rosen, Hugh; Ruf, Wolfram] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Chun, Jerold] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Rosen, Hugh] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Derian, Claudia K.; Andrade-Gordon, Patricia] Johnson & Johnson PRD, Spring House, PA 19477 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Johnson & Johnson; Johnson & Johnson USA	Ruf, W (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ruf@scripps.edu	Chun, Jerold/Y-4670-2019; PAwlinski, Rafal/AAD-6090-2022					Ahamed J, 2007, BLOOD, V109, P5251, DOI 10.1182/blood-2006-10-051334; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Baroni M, 2007, FASEB J, V21, P1926, DOI 10.1096/fj.06-7238com; Camerer E, 2006, BLOOD, V107, P3912, DOI 10.1182/blood-2005-08-3130; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Don AS, 2007, J BIOL CHEM, V282, P15833, DOI 10.1074/jbc.M609124200; Efron PA, 2004, J IMMUNOL, V173, P3035, DOI 10.4049/jimmunol.173.5.3035; Esmon CT, 2004, TRENDS IMMUNOL, V25, P536, DOI 10.1016/j.it.2004.08.003; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fujita S, 2006, BLOOD, V107, P3656, DOI 10.1182/blood-2005-10-4190; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maeda Y, 2007, J IMMUNOL, V178, P3437, DOI 10.4049/jimmunol.178.6.3437; Ohteki T, 2006, J EXP MED, V203, P2329, DOI 10.1084/jem.20061297; Opal SM, 2004, J ENDOTOXIN RES, V10, P125, DOI 10.1179/0968051042255004022; Pan SF, 2006, CHEM BIOL, V13, P1227, DOI 10.1016/j.chembiol.2006.09.017; Pawlinski R, 2004, BLOOD, V103, P1342, DOI 10.1182/blood-2003-09-3051; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Ruf W, 2004, TRENDS IMMUNOL, V25, P461, DOI 10.1016/j.it.2004.07.002; Scumpia PO, 2005, J IMMUNOL, V175, P3282, DOI 10.4049/jimmunol.175.5.3282; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Singleton PA, 2007, AM J RESP CELL MOL, V37, P222, DOI 10.1165/rcmb.2006-0327OC; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Taylor FB, 2001, CRIT CARE MED, V29, pS78, DOI 10.1097/00003246-200107001-00026; Xu H, 2006, J PATHOL, V210, P488, DOI 10.1002/path.2073	30	229	250	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2008	452	7187					654	658		10.1038/nature06663	http://dx.doi.org/10.1038/nature06663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18305483	Bronze			2022-12-24	WOS:000254567200051
J	Richmond, BG; Jungers, WL				Richmond, Brian G.; Jungers, William L.			Orrorin tugenensis femoral morphology and the evolution of hominin bipedalism	SCIENCE			English	Article							ORIGIN; FEMUR; ENERGETICS; LUKEINO; MIOCENE	Bipedalism is a key human adaptation and a defining feature of the hominin clade. Fossil femora discovered in Kenya and attributed to Orrorin tugenensis, at 6 million years ago, purportedly provide the earliest postcranial evidence of hominin bipedalism, but their functional and phylogenetic affinities are controversial. We show that the O. tugenensis femur differs from those of apes and Homo and most strongly resembles those of Australopithecus and Paranthropus, indicating that O. tugenensis was bipedal but is not more closely related to Homo than to Australopithecus. Femoral morphology indicates that O. tugenensis shared distinctive hip biomechanics with australopiths, suggesting that this complex evolved early in human evolution and persisted for almost 4 million years until modifications of the hip appeared in the late Pliocene in early Homo.	[Richmond, Brian G.] George Washington Univ, Ctr Adv Study Hominid Paleobiol, Dept Anthropol, Washington, DC 20052 USA; [Richmond, Brian G.] Smithsonian Inst, Natl Museum Amer Hist, Human Origins Program, Washington, DC 20560 USA; [Jungers, William L.] SUNY Stony Brook, Dept Anatom Sci, Stony Brook, NY 11794 USA	George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Richmond, BG (corresponding author), George Washington Univ, Ctr Adv Study Hominid Paleobiol, Dept Anthropol, 2110 G St NW, Washington, DC 20052 USA.	brich@gwu.edu						Aiello LC, 2001, NATURE, V410, P526, DOI 10.1038/35069164; Begun DR, 2004, SCIENCE, V303, P1478, DOI 10.1126/science.1095516; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; Cela-Conde CJ, 2003, P NATL ACAD SCI USA, V100, P7684, DOI 10.1073/pnas.0832372100; DAY MH, 1969, NATURE, V221, P230, DOI 10.1038/221230a0; Deino AL, 2002, J HUM EVOL, V42, P117, DOI 10.1006/jhev.2001.0521; Galik K, 2004, SCIENCE, V305, P1450, DOI 10.1126/science.1098807; JENKINS FA, 1972, SCIENCE, V178, P877, DOI 10.1126/science.178.4063.877; JUNGERS WL, 1988, J HUM EVOL, V17, P247, DOI 10.1016/0047-2484(88)90056-5; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; MCHENRY HM, 1978, AM J PHYS ANTHROPOL, V49, P473, DOI 10.1002/ajpa.1330490407; Nakatsukasa M, 2007, PRIMATES, V48, P171, DOI 10.1007/s10329-007-0040-7; Ohman JC, 2005, SCIENCE, V307, P845; Pickford M, 2002, C R PALEVOL, V1, P191, DOI 10.1016/S1631-0683(02)00028-3; Richmond BG, 2002, J HUM EVOL, V43, P529, DOI 10.1006/jhev.2002.0594; Richmond BG, 2001, YEARB PHYS ANTHROPOL, V44, P70, DOI 10.1002/ajpa.10019; Ruff C, 1998, PRIMATE LOCOMOTION, P449; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; STERN JT, 1981, AM J PHYS ANTHROPOL, V55, P153, DOI 10.1002/ajpa.1330550203; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Steudel-Numbers KL, 2006, J HUM EVOL, V51, P445, DOI 10.1016/j.jhevol.2006.05.001; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; WALKER A, 1973, J HUM EVOL, V2, P545, DOI 10.1016/0047-2484(73)90132-2; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; Wood B, 2000, J ANAT, V197, P19, DOI 10.1046/j.1469-7580.2000.19710019.x; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	31	146	153	3	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2008	319	5870					1662	1665		10.1126/science.1154197	http://dx.doi.org/10.1126/science.1154197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356526				2022-12-24	WOS:000254172300040
J	Satoh, T; Arii, J; Suenaga, T; Wang, J; Kogure, A; Uehori, J; Arase, N; Shiratori, I; Tanaka, S; Kawaguchi, Y; Spear, PG; Lanier, LL; Arase, H				Satoh, Takeshi; Arii, Jun; Suenaga, Tadahiro; Wang, Jing; Kogure, Amane; Uehori, Junji; Arase, Noriko; Shiratori, Ikuo; Tanaka, Shinya; Kawaguchi, Yasushi; Spear, Patricia G.; Lanier, Lewis L.; Arase, Hisashi			PILR alpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B	CELL			English	Article							CELL-SURFACE RECEPTORS; HEPARAN-SULFATE; ARTIFICIAL CHROMOSOME; CRYSTAL-STRUCTURE; TYPE-1; PROTEIN; CONSTRUCTION; FUSION; BETA; HERPES-SIMPLEX-VIRUS-1	Glycoprotein B(gB) is one of the essential components for infection by herpes simplex virus-1 (HSV-1). Although several cellular receptors that associate with glycoprotein D(gD), such as herpes virus entry mediator (HVEM) and Nectin-1, have been identified, specific molecules that mediate HSV-1 infection by associating with gB have not been elucidated. Here, we found that paired immunoglobulin-like type 2 receptor (PILR) alpha associates with gB, and cells transduced with PILR alpha become susceptible to HSV-1 infection. Furthermore, HSV-1 infection of human primary cells expressing both HVEM and PILR alpha was blocked by either anti-PILR alpha or anti-HVEM antibody. Our results demonstrate that cellular receptors for both gB and gD are required for HSV-1 infection and that PILR alpha plays an important role in HSV-1 infection as a coreceptor that associates with gB. These findings uncover a crucial aspect of the mechanism underlying HSV-1 infection.	[Arase, Hisashi] Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3320012, Japan; [Satoh, Takeshi; Suenaga, Tadahiro; Wang, Jing; Kogure, Amane; Uehori, Junji; Arase, Noriko; Shiratori, Ikuo; Arase, Hisashi] Osaka Univ, Dept Immunochem, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Satoh, Takeshi; Suenaga, Tadahiro; Arase, Hisashi] Osaka Univ, WPI Immunl Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Arii, Jun; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Infect Dis Control,Minato Ku, Tokyo 1088639, Japan; [Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Lab Mol & Cellular Pathol, Sapporo, Hokkaido 0608638, Japan; [Spear, Patricia G.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lanier, Lewis L.] Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA	Japan Science & Technology Agency (JST); Osaka University; Osaka University; University of Tokyo; Hokkaido University; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Arase, H (corresponding author), Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3320012, Japan.	arase@biken.osaka-u.ac.jp	Lanier, Lewis L/E-2139-2014; Arase, Hisashi/C-8442-2009; Tanaka, Shinya/D-3586-2011; Satoh, Takeshi/O-3549-2014	Lanier, Lewis L/0000-0003-1308-3952; Arase, Hisashi/0000-0002-1153-3166; Satoh, Takeshi/0000-0001-8544-7423; Arase, Noriko/0000-0003-3966-3437; Wang, Jing/0000-0001-8758-1693; Shiratori, Ikuo/0000-0003-3713-4910; Kawaguchi, Yasushi/0000-0001-8232-6925	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036293, R01AI068129, P01AI064520, R01AI036293] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI036293-10, AI36293, R37 AI036293-08, R37 AI036293-13, R37 AI036293, R01 AI068129-08, R37 AI036293-12, R01 AI068129-06, R37 AI036293-06, AI64520, P01 AI064520, R01 AI068129-07, R37 AI036293-07, R37 AI036293-09, R37 AI036293-15, R37 AI036293-14, R37 AI036293-11, R01 AI068129] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Bender FC, 2005, J VIROL, V79, P11588, DOI 10.1128/JVI.79.18.11588-11597.2005; CAL WH, 1988, J VIROL, V62, P2596, DOI 10.1128/JVI.62.8.2596-2604.1988; Chapman TL, 1999, J BIOL CHEM, V274, P6911, DOI 10.1074/jbc.274.11.6911; de Zarate IBO, 2004, J VIROL, V78, P1540, DOI 10.1128/JVI.78.3.1540-1551-2004; FORRESTER A, 1992, J VIROL, V66, P341, DOI 10.1128/JVI.66.1.341-348.1992; Fournier N, 2000, J IMMUNOL, V165, P1197, DOI 10.4049/jimmunol.165.3.1197; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gianni T, 2005, J VIROL, V79, P2931, DOI 10.1128/JVI.79.5.2931-2940.2005; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; HEROLD BC, 1994, J GEN VIROL, V75, P1211, DOI 10.1099/0022-1317-75-6-1211; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Kawaguchi Y, 1997, J VIROL, V71, P7328, DOI 10.1128/JVI.71.10.7328-7336.1997; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Laquerre S, 1998, J VIROL, V72, P6119, DOI 10.1128/JVI.72.7.6119-6130.1998; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Mousseau DD, 2000, J BIOL CHEM, V275, P4467, DOI 10.1074/jbc.275.6.4467; Narayanan K, 1999, GENE THER, V6, P442, DOI 10.1038/sj.gt.3300901; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shiratori I, 2005, J IMMUNOL, V175, P4441, DOI 10.4049/jimmunol.175.7.4441; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; Tanaka M, 2005, VIROLOGY, V341, P301, DOI 10.1016/j.virol.2005.07.010; Tanaka M, 2004, MICROBES INFECT, V6, P485, DOI 10.1016/j.micinf.2004.01.011; Tanaka M, 2003, J VIROL, V77, P1382, DOI 10.1128/JVI.77.2.1382-1391.2003; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Wilson MD, 2006, PHYSIOL GENOMICS, V27, P201, DOI 10.1152/physiolgenomics.00284.2005	35	210	234	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 21	2008	132	6					935	944		10.1016/j.cell.2008.01.043	http://dx.doi.org/10.1016/j.cell.2008.01.043			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	278GR	18358807	Green Accepted, Bronze			2022-12-24	WOS:000254273600013
J	Yuan, ZQ; Becker, EBE; Merlo, P; Yamada, T; DiBacco, S; Konishi, Y; Schaefer, EM; Bonni, A				Yuan, Zengqiang; Becker, Esther B. E.; Merlo, Paola; Yamada, Tomoko; DiBacco, Sara; Konishi, Yoshiyuki; Schaefer, Erik M.; Bonni, Azad			Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons	SCIENCE			English	Article							ALZHEIMERS-DISEASE BRAIN; PHOSPHORYLATION; EXPRESSION; DEATH	Activation of cyclin- dependent kinase 1 ( Cdk1) has been linked to cell death of postmitotic neurons in brain development and disease. We found that Cdk1 phosphorylated the transcription factor FOXO1 at Ser(249) in vitro and in vivo. The phosphorylation of FOXO1 at Ser(249) disrupted FOXO1 binding with 14- 3- 3 proteins and thereby promoted the nuclear accumulation of FOXO1 and stimulated FOXO1-dependent transcription, leading to cell death in neurons. In proliferating cells, Cdk1 induced FOXO1 Ser(249) phosphorylation at the G(2)/M phase of the cell cycle, resulting in FOXO1- dependent expression of the mitotic regulator Polo- like kinase ( Plk). These findings define a conserved signaling link between Cdk1 and FOXO1 that may have a key role in diverse biological processes, including the degeneration of postmitotic neurons.	[Yuan, Zengqiang; Becker, Esther B. E.; Merlo, Paola; Yamada, Tomoko; DiBacco, Sara; Konishi, Yoshiyuki; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Schaefer, Erik M.] Invitrogen Corp, Ctr Signal Transduct, Cellular Anal Business Unit, Biodiscovery Div, Hopkinton, MA 01748 USA	Harvard University; Harvard Medical School; Thermo Fisher Scientific	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	Merlo, Paola/K-5330-2014; Yuan, Zengqiang/G-5245-2017	Merlo, Paola/0000-0003-0105-7044; Becker, Esther B E/0000-0002-5238-4902; Yuan, Zengqiang/0000-0001-5739-2867	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047188] Funding Source: NIH RePORTER; NINDS NIH HHS [NS047188] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Busser J, 1998, J NEUROSCI, V18, P2801; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kurita M, 2006, J NEUROSCI, V26, P12003, DOI 10.1523/JNEUROSCI.3002-06.2006; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vincent I, 1997, J NEUROSCI, V17, P3588	8	137	143	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1665	1668		10.1126/science.1152337	http://dx.doi.org/10.1126/science.1152337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356527	Green Submitted			2022-12-24	WOS:000254172300041
J	Johnson, KG; Jackson, JBC; Budd, AF				Johnson, Kenneth G.; Jackson, Jeremy B. C.; Budd, Ann F.			Caribbean reef development was independent of coral diversity over 28 million years	SCIENCE			English	Article							EXTINCTION; NEOGENE; PRODUCTIVITY; TEMPERATURE; TURNOVER; CLOSURE	The relationship between natural variations in coral species diversity, reef development, and ecosystem function on coral reefs is poorly understood. Recent coral diversity varies 10- fold among geographic regions, but rates of reef growth are broadly similar, suggesting that diversity is unimportant for reef development. Differences in diversity may reflect regional differences in long- term biotic history in addition to environmental conditions. Using a combination of new and published fossil and stratigraphic data, we compared changes in coral diversity and reef development within the tropical western Atlantic over the past 28 million years. Reef development was unrelated to coral diversity, and the largest reef tracts formed after extinction had reduced diversity by 50%. High diversity is thus not essential for the growth and persistence of coral reefs.	[Johnson, Kenneth G.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Jackson, Jeremy B. C.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Jackson, Jeremy B. C.] Smithsonian Trop Res Inst, Balboa, Panama; [Budd, Ann F.] Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA	Natural History Museum London; University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Iowa	Johnson, KG (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	K.Johnson@nhm.ac.uk						Allmon WD, 2001, PALAEOGEOGR PALAEOCL, V166, P9, DOI 10.1016/S0031-0182(00)00199-1; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bosellini FR, 2008, PALAEOGEOGR PALAEOCL, V258, P71, DOI 10.1016/j.palaeo.2007.10.028; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Budd AF, 1999, PALEOBIOLOGY, V25, P188, DOI 10.1017/S009483730002649X; Budd AF, 2000, CORAL REEFS, V19, P25, DOI 10.1007/s003380050222; BUDD AF, 1994, J PALEONTOL, V68, P951, DOI 10.1017/S0022336000026585; Budd AF, 1998, PALAIOS, V13, P170, DOI 10.2307/3515488; Dullo WC, 2005, FACIES, V51, P33, DOI 10.1007/s10347-005-0060-y; EDINGER EN, 1995, PALEOBIOLOGY, V21, P200, DOI 10.1017/S0094837300013208; EDINGER EN, 1994, PALAIOS, V9, P576, DOI 10.2307/3515129; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Glynn PW, 1996, CORAL REEFS, V15, P71; Hallock P, 2001, T GEOBIOL, V17, P387; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; HATCHER BG, 1990, TRENDS ECOL EVOL, V5, P149, DOI 10.1016/0169-5347(90)90221-X; JACKSON JBC, 1991, BIOSCIENCE, V41, P475, DOI 10.2307/1311805; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JACKSON JBC, 1994, SCIENCE, V264, P1412, DOI 10.1126/science.264.5164.1412; Jain S, 2007, MAR MICROPALEONTOL, V63, P57, DOI 10.1016/j.marmicro.2006.11.003; JOHNSON KG, 2007, FOSSIL CORALS SPONGE, P471; Kiessling W, 2005, NATURE, V433, P410, DOI 10.1038/nature03152; Kleypas JA, 1999, AM ZOOL, V39, P146; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; O'Dea A, 2007, P NATL ACAD SCI USA, V104, P5501, DOI 10.1073/pnas.0610947104; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; Perrin C., 2002, SEPM SPECIAL PUBLICA, V72, P587; Schneider B, 2006, EARTH PLANET SC LETT, V246, P367, DOI 10.1016/j.epsl.2006.04.028; Schuster F., 2002, P199; Vaughan T.W., 1919, US NATL MUSEUM B, V103, P180, DOI DOI 10.5962/BHL.TITLE.46527; Vennin E, 2004, PALAEOGEOGR PALAEOCL, V213, P163, DOI 10.1016/j.palaeo.2004.07.014; Veron J.E.N., 2000, CORALS WORLD, V1-3; von der Heydt A, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001149; WELLS JW, 1957, TREATISE MARINE ECOL, V67	36	88	90	5	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1521	1523		10.1126/science.1152197	http://dx.doi.org/10.1126/science.1152197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339937				2022-12-24	WOS:000253943800037
J	DeBose, JL; Lema, SC; Nevitt, GA				DeBose, Jennifer L.; Lema, Sean C.; Nevitt, Gabrielle A.			Dimethylsulfoniopropionate as a foraging cue for reef fishes	SCIENCE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; DIMETHYLSULFIDE		[DeBose, Jennifer L.; Nevitt, Gabrielle A.] Univ Calif Davis, Bodega Marine Lab, Davis, CA 95616 USA; [Lema, Sean C.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28403 USA	University of California System; University of California Davis; University of North Carolina; University of North Carolina Wilmington	Nevitt, GA (corresponding author), Univ Calif Davis, Bodega Marine Lab, Davis, CA 95616 USA.	ganevitt@ucdavis.edu		Lema, Sean/0000-0002-2564-8992				Broadbent AD, 2004, MAR FRESHWATER RES, V55, P849, DOI 10.1071/MF04114; DACEY JWH, 1994, MAR ECOL PROG SER, V112, P67, DOI 10.3354/meps112067; Iida H., 1988, B TOKAI TEG FISH RES, V124, P35; Jones GB, 2005, MAR FRESHWATER RES, V56, P85, DOI 10.1071/MF04097; Lieske E., 1994, CORAL REEF FISHES; Steinke M, 2006, LIMNOL OCEANOGR, V51, P1925, DOI 10.4319/lo.2006.51.4.1925	6	70	73	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1356	1356		10.1126/science.1151109	http://dx.doi.org/10.1126/science.1151109			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323445	Green Submitted			2022-12-24	WOS:000253712900034
J	Dalbeth, N; Arroll, B				Dalbeth, Nicola; Arroll, Bruce			Commentary: controversies in NICE guidance on osteoarthritis	BRITISH MEDICAL JOURNAL			English	Editorial Material							KNEE OSTEOARTHRITIS		[Arroll, Bruce] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand; [Dalbeth, Nicola] Univ Auckland, Dept Med, Auckland 1, New Zealand	University of Auckland; University of Auckland	Arroll, B (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand.	b.arroll@auckland.ac.nz						Dehaan MN, 2007, J RHEUMATOL, V34, P2099; Herrero-Beaumont G, 2007, ARTHRITIS RHEUM-US, V56, P555, DOI 10.1002/art.22371; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Scheiman JM, 2006, AM J GASTROENTEROL, V101, P701, DOI 10.1111/j.1572-0241.2006.00499.x; Sullivan T, 1998, ARTHRIT CARE RES, V11, P228, DOI 10.1002/art.1790110403	5	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 1	2008	336	7642					504	504		10.1136/bmj.39496.451898.AD	http://dx.doi.org/10.1136/bmj.39496.451898.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18310006	Green Published			2022-12-24	WOS:000253997500045
J	Campbell, BH				Campbell, Bruce H.			Listening to Leviticus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												bcampbel@mcw.edu						*BIBLE, LEVITICUS, V17, P10	1	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2008	299	8					879	880		10.1001/jama.299.8.879	http://dx.doi.org/10.1001/jama.299.8.879			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266DZ	18314424				2022-12-24	WOS:000253413200001
J	Wald, HS				Wald, Hedy S.			In the here and now	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												hedy_wald@brown.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2008	299	6					613	614		10.1001/jama.299.6.613	http://dx.doi.org/10.1001/jama.299.6.613			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261QN	18270345				2022-12-24	WOS:000253095200001
J	Middaugh, JP				Middaugh, John P.			Pandemic influenza preparedness and community resiliency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTERVENTIONS		[Middaugh, John P.] Florida Dept Hlth, Tallahassee, FL 32399 USA	Florida Department of Health	Middaugh, JP (corresponding author), Florida Dept Hlth, 4052 Bald Cypress Way,Bin A07, Tallahassee, FL 32399 USA.	john_middaugh@doh.state.fl.us						*AM AC PED, 2003, RED BOOK REP COMM IN; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; BENENSON AS, 1980, CONTROL COMMUNICABLE; BLENDON RJ, 2006, FOR MICR THREATS SEP; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; *CDCP, 2006, INFL PAND OP PLAN OP; Centers for Disease Control and Prevention, 2007, INT PREP PLANN GUID; *COMM MOD CONT PAN, 2006, MOD COMM CONT PAND I; CROSBY AW, 1989, AM FORGOTTEN PANDEMI, P115; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Heymann DL, 2004, CONTROL COMMUNICABLE, V18th; Inglesby TV, 2006, BIOSECUR BIOTERROR, V4, P366, DOI 10.1089/bsp.2006.4.366; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; NOWAK G, 2005, THREAT PANDEMIC INFL; Reissman DB, 2006, J HOMEL SECUR EMERG, V3	18	9	9	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					566	568		10.1001/jama.299.5.566	http://dx.doi.org/10.1001/jama.299.5.566			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252886				2022-12-24	WOS:000252886100022
J	Schlabach, MR; Luo, J; Solimini, NL; Hu, G; Xu, QK; Li, MZ; Zhao, ZM; Smogorzewska, A; Sowa, ME; Ang, XLL; Westbrook, TF; Liang, AC; Chang, K; Hackett, JA; Harper, JW; Hannon, GJ; Elledge, SJ				Schlabach, Michael R.; Luo, Ji; Solimini, Nicole L.; Hu, Guang; Xu, Qikai; Li, Mamie Z.; Zhao, Zhenming; Smogorzewska, Agata; Sowa, Mathew E.; Ang, Xiaolu L.; Westbrook, Thomas F.; Liang, Anthony C.; Chang, Kenneth; Hackett, Jennifer A.; Harper, J. Wade; Hannon, Gregory J.; Elledge, Stephen J.			Cancer proliferation gene discovery through functional Genomics	SCIENCE			English	Article							COLORECTAL CANCERS; HUMAN BREAST; P53 PATHWAY; SCREEN; PHOSPHATASE; CELLS; MDM2	Retroviral short hairpin RNA (shRNA) - mediated genetic screens in mammalian cells are powerful tools for discovering loss- of- function phenotypes. We describe a highly parallel multiplex methodology for screening large pools of shRNAs using half- hairpin barcodes for microarray deconvolution. We carried out dropout screens for shRNAs that affect cell proliferation and viability in cancer cells and normal cells. We identified many shRNAs to be antiproliferative that target core cellular processes, such as the cell cycle and protein translation, in all cells examined. Moreover, we identified genes that are selectively required for proliferation and survival in different cell lines. Our platform enables rapid and cost- effective genome-wide screens to identify cancer proliferation and survival genes for target discovery. Such efforts are complementary to the Cancer Genome Atlas and provide an alternative functional view of cancer cells.	[Schlabach, Michael R.; Luo, Ji; Solimini, Nicole L.; Hu, Guang; Xu, Qikai; Li, Mamie Z.; Zhao, Zhenming; Smogorzewska, Agata; Westbrook, Thomas F.; Liang, Anthony C.; Hackett, Jennifer A.; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Schlabach, Michael R.; Luo, Ji; Solimini, Nicole L.; Hu, Guang; Xu, Qikai; Li, Mamie Z.; Zhao, Zhenming; Smogorzewska, Agata; Westbrook, Thomas F.; Liang, Anthony C.; Hackett, Jennifer A.; Elledge, Stephen J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Genet & Genom,Dept Genet, Boston, MA 02115 USA; [Smogorzewska, Agata] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sowa, Mathew E.; Ang, Xiaolu L.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chang, Kenneth; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Luo, Ji/G-5693-2017; Hu, Guang/E-7474-2016; Hannon, Gregory/AAB-3568-2019; Cambronne, Xiaolu Ang/GRY-7149-2022; Smogorzewska, Agata/B-8891-2011	Luo, Ji/0000-0001-5063-1626; Hu, Guang/0000-0003-0437-4723; Cambronne, Xiaolu Ang/0000-0002-3547-448X; Harper, Jeffrey/0000-0002-6944-7236; Smogorzewska, Agata/0000-0001-6285-1562	NATIONAL CANCER INSTITUTE [P01CA013106, T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA013106-36, P01 CA013106, T32CA09216, T32 CA009216, P01 CA013106-37] Funding Source: Medline; NIA NIH HHS [R01 AG011085] Funding Source: Medline; NINDS NIH HHS [F31 NS054507-01, F31 NS054507] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Draviam VM, 2007, NAT CELL BIOL, V9, P556, DOI 10.1038/ncb1569; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	18	298	312	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					620	624		10.1126/science.1149200	http://dx.doi.org/10.1126/science.1149200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239126	Green Accepted			2022-12-24	WOS:000252772000041
J	Sheeran, J				Sheeran, Josette			The challenge of hunger	LANCET			English	Editorial Material									UN, World Food Programme, I-00148 Rome, Italy		Sheeran, J (corresponding author), UN, World Food Programme, I-00148 Rome, Italy.	nancy.roman@wfp.org						Collier P.., 2007, RISK MANAGEMENT ACCO; *FOOD AGR ORG UN, 2006, STAT FOOD INS WORLD; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; *UN EC COMM LAT AM, 2007, COST HAMBR IMP EC SO; United Nations, 2000, MILL DEV GOALS REP 2	5	20	20	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					180	181		10.1016/S0140-6736(07)61870-4	http://dx.doi.org/10.1016/S0140-6736(07)61870-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207568				2022-12-24	WOS:000252471900005
J	Gratten, J; Wilson, AJ; McRae, AF; Beraldi, D; Visscher, PM; Pemberton, JM; Slate, J				Gratten, J.; Wilson, A. J.; McRae, A. F.; Beraldi, D.; Visscher, P. M.; Pemberton, J. M.; Slate, J.			A localized negative genetic correlation constrains microevolution of coat color in wild sheep	SCIENCE			English	Article							SELECTION; EVOLUTION; DISEQUILIBRIUM; POPULATION; PHENOTYPE; GROWTH; TYRP1	The evolutionary changes that occur over a small number of generations in natural populations often run counter to what is expected on the basis of the heritability of traits and the selective forces acting upon them. In Soay sheep, dark coat color is associated with large size, which is heritable and positively correlated with fitness, yet the frequency of dark sheep has decreased. This unexpected microevolutionary trend is explained by genetic linkage between the causal mutation underlying the color polymorphism and quantitative trait loci with antagonistic effects on size and fitness. As a consequence, homozygous dark sheep are large, but have reduced fitness relative to phenotypically indistinguishable dark heterozygotes and light sheep. This result demonstrates the importance of understanding the genetic basis of fitness variation when making predictions about the microevolutionary consequences of selection.	[Gratten, J.; Slate, J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Wilson, A. J.; Beraldi, D.; Pemberton, J. M.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [McRae, A. F.; Visscher, P. M.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia	University of Sheffield; University of Edinburgh; QIMR Berghofer Medical Research Institute	Gratten, J (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Wilson, Alastair/F-3118-2010; McRae, Allan F/J-2644-2014; Visscher, Peter/ABB-6151-2020; Pemberton, Josephine M/F-3100-2010; Gratten, Jacob/G-1485-2011; Slate, Jon/D-2925-2012	McRae, Allan F/0000-0001-5286-5485; Visscher, Peter/0000-0002-2143-8760; Gratten, Jacob/0000-0003-1293-409X; Slate, Jon/0000-0003-3356-5123; Wilson, Alastair/0000-0002-5045-2051; Beraldi, Dario/0000-0003-1504-5212	Natural Environment Research Council [NER/T/S/2002/00189, NE/D008883/1, NE/F001371/1] Funding Source: researchfish; NERC [NE/F001371/1, NE/D008883/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], ISLAND SURVIVORS ECO; Clutton-Brock T.H., 2004, SOAY SHEEP DYNAMICS; CluttonBrock TH, 1997, PHILOS T R SOC B, V352, P839, DOI 10.1098/rstb.1997.0064; Coltman DW, 2003, MOL ECOL, V12, P733, DOI 10.1046/j.1365-294X.2003.01762.x; Coltman DW, 1999, AM NAT, V154, P730, DOI 10.1086/303274; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; ELWES HJ, 1912, SCOTT NATURALIST, V1, P25; Gratten J, 2007, P ROY SOC B-BIOL SCI, V274, P619, DOI 10.1098/rspb.2006.3762; Hernandez-Sanchez J, 2003, GENETICS, V164, P637; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Merila J, 2001, GENETICA, V112, P199, DOI 10.1023/A:1013391806317; Murisier F, 2006, DEV BIOL, V298, P644, DOI 10.1016/j.ydbio.2006.05.011; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Slate J, 2002, GENETICS, V160, P1587; Smyth IM, 2006, P NATL ACAD SCI USA, V103, P3704, DOI 10.1073/pnas.0600199103; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Wilson AJ, 2007, EVOL ECOL, V21, P337, DOI 10.1007/s10682-006-9106-z; Wilson AJ, 2005, J EVOLUTION BIOL, V18, P405, DOI 10.1111/j.1420-9101.2004.00824.x; Wilson AJ, 2005, EVOLUTION, V59, P451; Yagyu H, 2002, J BIOL CHEM, V277, P10037, DOI 10.1074/jbc.M109966200; ZDARSKY E, 1990, GENETICS, V126, P443	23	91	92	0	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					318	320		10.1126/science.1151182	http://dx.doi.org/10.1126/science.1151182			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202287				2022-12-24	WOS:000252436200034
J	Fries, M; Steele, A				Fries, Marc; Steele, Andrew			Graphite whiskers in CV3 meteorites	SCIENCE			English	Article							ACCELERATING UNIVERSE; BACKGROUND-RADIATION; POLYHEDRAL CRYSTALS; INTERSTELLAR-MEDIUM; METALLIC NEEDLES; DARK INCLUSIONS; DUST MODELS; EXTINCTION; SUPERNOVAE; CONES	Graphite whiskers ( GWs), an allotrope of carbon that has been proposed to occur in space, have been discovered in three CV- type carbonaceous chondrites via Raman imaging and electron microscopy. The GWs are associated with high- temperature calcium- aluminum inclusion ( CAI) rims and interiors, with the rim of a dark inclusion, and within an inclusion inside an unusual chondrule that bears mineralogy and texture indicative of high- temperature processing. Current understanding of CAI formation places their condensation, and that of associated GWs, relatively close to the Sun and early in the condensation sequence of protoplanetary disk materials. If this is the case, then it is a possibility that GWs are expelled from any young solar system early in its history, thus populating interstellar space with diffuse GWs. Graphite whiskers have been postulated to play a role in the near- infrared ( near- IR) dimming of type Ia supernovae, as well as in the thermalization of both the cosmic IR and microwave background and in galactic center dimming between 3 and 9 micrometers. Our observations, along with the further possibility that GWs could be manufactured during supernovae, suggest that GWs may have substantial effects in observational astronomy.	[Fries, Marc; Steele, Andrew] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA	Carnegie Institution for Science	Fries, M (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	Marc.D.Fries@jpl.nasa.gov	Steele, Andrew/A-3573-2013	Steele, Andrew/0000-0001-9643-2841				Aguirre A, 1999, ASTROPHYS J, V525, P583, DOI 10.1086/307945; Aguirre AN, 2000, ASTROPHYS J, V533, P1, DOI 10.1086/308660; Aguirre AN, 1999, ASTROPHYS J, V512, pL19, DOI 10.1086/311862; AMELINCKX S, 1992, J CRYST GROWTH, V121, P543, DOI 10.1016/0022-0248(92)90561-V; BACON R, 1960, J APPL PHYS, V31, P283, DOI 10.1063/1.1735559; Brenker FE, 2004, AM MINERAL, V89, P1280; DIMOVSKI S, 2006, NANOTUBES NANOFIBERS, P109; Dong J, 2002, APPL PHYS LETT, V80, P3733, DOI 10.1063/1.1481783; Dwek E, 2004, ASTROPHYS J, V611, pL109, DOI 10.1086/423893; Dwek E, 2004, ASTROPHYS J, V607, P848, DOI 10.1086/382653; Gogotsi Y, 2000, SCIENCE, V290, P317, DOI 10.1126/science.290.5490.317; GROSSMAN L, 1972, GEOCHIM COSMOCHIM AC, V36, P597, DOI 10.1016/0016-7037(72)90078-6; Henning T, 1998, SCIENCE, V282, P2204, DOI 10.1126/science.282.5397.2204; HOYLE F, 1984, ASTROPHYS SPACE SCI, V103, P371, DOI 10.1007/BF00653751; Jaszczak JA, 2003, CARBON, V41, P2085, DOI 10.1016/S0008-6223(03)00214-8; Jaszczak JA, 2007, CAN MINERAL, V45, P379, DOI 10.2113/gscanmin.45.2.379; JOHNSON CA, 1990, GEOCHIM COSMOCHIM AC, V54, P819, DOI 10.1016/0016-7037(90)90376-V; KROT AN, 1995, METEORITICS, V30, P748, DOI 10.1111/j.1945-5100.1995.tb01173.x; Li A, 2001, ASTROPHYS J, V550, pL213, DOI 10.1086/319640; Li AG, 2003, ASTROPHYS J, V584, P593, DOI 10.1086/345753; Narlikar JV, 2002, PUBL ASTRON SOC PAC, V114, P1092, DOI 10.1086/342374; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Robaina AR, 2007, ASTRON ASTROPHYS, V464, P465, DOI 10.1051/0004-6361:20065292; Saito Y, 2007, CARBON, V45, P248, DOI 10.1016/j.carbon.2006.10.002; SEARS GW, 1959, J CHEM PHYS, V31, P358, DOI 10.1063/1.1730358; SHU F, 1994, ASTROPHYS J, V429, P781, DOI 10.1086/174363; Shu FH, 1997, SCIENCE, V277, P1475, DOI 10.1126/science.277.5331.1475; SIVARAM C, 1985, ASTROPHYS SPACE SCI, V117, P199, DOI 10.1007/BF00660923; Tan PH, 2004, PHILOS T R SOC A, V362, P2289, DOI 10.1098/rsta.2004.1442; Tan PH, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevLett.87.214301; WICKRAMASINGHE NC, 1994, ASTROPHYS SPACE SCI, V213, P143, DOI 10.1007/BF00627786; Wickramasinghe NC, 1996, ASTROPHYS SPACE SCI, V240, P157, DOI 10.1007/BF00640203; Zubko V, 2004, ASTROPHYS J SUPPL S, V152, P211, DOI 10.1086/382351	35	36	36	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2008	320	5872					91	93		10.1126/science.1153578	http://dx.doi.org/10.1126/science.1153578			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18309047				2022-12-24	WOS:000254633000037
J	Wen, JD; Lancaster, L; Hodges, C; Zeri, AC; Yoshimura, SH; Noller, HF; Bustamante, C; Tinoco, I				Wen, Jin-Der; Lancaster, Laura; Hodges, Courtney; Zeri, Ana-Carolina; Yoshimura, Shige H.; Noller, Harry F.; Bustamante, Carlos; Tinoco, Ignacio, Jr.			Following translation by single ribosomes one codon at a time	NATURE			English	Article							INITIATOR TRANSFER-RNA; ELONGATION-FACTOR TU; MESSENGER-RNA; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; OPTICAL TWEEZERS; FORCE; TRANSLOCATION; COMPLEXES	We have followed individual ribosomes as they translate single messenger RNA hairpins tethered by the ends to optical tweezers. Here we reveal that translation occurs through successive translocation- and- pause cycles. The distribution of pause lengths, with a median of 2.8 s, indicates that at least two rate- determining processes control each pause. Each translocation step measures three bases - one codon - and occurs in less than 0.1 s. Analysis of the times required for translocation reveals, surprisingly, that there are three substeps in each step. Pause lengths, and thus the overall rate of translation, depend on the secondary structure of the mRNA; the applied force destabilizes secondary structure and decreases pause durations, but does not affect translocation times. Translocation and RNA unwinding are strictly coupled ribosomal functions.	[Wen, Jin-Der; Bustamante, Carlos; Tinoco, Ignacio, Jr.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Lancaster, Laura; Noller, Harry F.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Lancaster, Laura; Noller, Harry F.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Hodges, Courtney; Bustamante, Carlos] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Zeri, Ana-Carolina] Brazilian Synchrotron Light Lab, BR-13083970 Campinas, SP, Brazil; [Yoshimura, Shige H.] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Phys & Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; Laboratorio Nacional de Luz Sincrotron (LNLS); Kyoto University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tinoco, I (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	intinoco@lbl.gov	Zeri, Ana/AAY-4799-2021; Yoshimura, Shige H./AAF-5463-2019; Wen, Jin-Der/A-3159-2014	Zeri, Ana/0000-0003-4169-4523; Yoshimura, Shige H./0000-0001-6033-1301; Hodges, H. Courtney/0000-0003-4441-497X; Bustamante, Carlos/0000-0002-2970-0073; Wen, Jin-Der/0000-0001-8317-4329	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM010840, R01 GM010840-49, R01 GM010840-50] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SL, 1999, P NATL ACAD SCI USA, V96, P14177, DOI 10.1073/pnas.96.25.14177; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; BOON K, 1992, EUR J BIOCHEM, V210, P177, DOI 10.1111/j.1432-1033.1992.tb17406.x; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; Culver GM, 2000, METHOD ENZYMOL, V318, P446; DOTY P., 1959, PROC NATL ACAD SCI, V45, P482, DOI 10.1073/pnas.45.4.482; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; FAVRE A, 1975, EUR J BIOCHEM, V57, P147, DOI 10.1111/j.1432-1033.1975.tb02285.x; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2003, BIOPOLYMERS, V68, P223, DOI 10.1002/bip.10210; Horan LH, 2007, P NATL ACAD SCI USA, V104, P4881, DOI 10.1073/pnas.0700762104; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Moore PB, 2003, ANNU REV BIOCHEM, V72, P813, DOI 10.1146/annurev.biochem.72.110601.135450; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Onoa B, 2003, SCIENCE, V299, P1892, DOI 10.1126/science.1081338; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tinoco I, 2004, ANNU REV BIOPH BIOM, V33, P363, DOI 10.1146/annurev.biophys.33.110502.140418; Tinoco I, 2006, Q REV BIOPHYS, V39, P325, DOI 10.1017/S0033583506004446; Traub P, 1981, RNA PROTEIN SYNTHESI, P521; Uemura S, 2007, NATURE, V446, P454, DOI 10.1038/nature05625; Vanzi F, 2005, BIOPHYS J, V89, P1909, DOI 10.1529/biophysj.104.056283; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Wen JD, 2007, BIOPHYS J, V92, P2996, DOI 10.1529/biophysj.106.094052; Wilson KS, 1998, CELL, V92, P131, DOI 10.1016/S0092-8674(00)80905-8; Wintermeyer W, 2004, BIOCHEM SOC T, V32, P733, DOI 10.1042/BST0320733; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	44	362	369	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2008	452	7187					598	603		10.1038/nature06716	http://dx.doi.org/10.1038/nature06716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18327250	Green Accepted			2022-12-24	WOS:000254567200038
J	Fisk, NM; Atun, R				Fisk, Nicholas M.; Atun, Rifat			Public-private partnership in cord blood banking	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSPLANTATION; ADULTS; UNITS		[Fisk, Nicholas M.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Tanaka Business Sch, London SW7 2AZ, England	Imperial College London; Imperial College London	Fisk, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England.	nfisk@uq.edu.au	Fisk, Nicholas M/B-2126-2009; Atun, Rifat/AAH-5537-2021	Fisk, Nicholas M/0000-0003-0031-7975; Atun, Rifat/0000-0002-1531-5983				Annas GJ, 1999, NEW ENGL J MED, V340, P1521, DOI 10.1056/NEJM199905133401923; [Anonymous], 2007, LANCET, V369, P437; [Anonymous], 2002, RCM Midwives, V5, P422; Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Cairo MS, 2007, PEDIATRICS, V119, P165, DOI 10.1542/peds.2006-2901; Council of Europa, 1997, CONV PROT HUM RIGHTS; Davey S, 2004, BRIT J HAEMATOL, V125, P358, DOI 10.1111/j.1365-2141.2004.04923.x; Edozien LC, 2006, BMJ-BRIT MED J, V333, P801, DOI 10.1136/bmj.38950.628519.68; *EUR GROUP ETH SCI, ETH ASP UMB CORD BLO; Fisk NM, 2005, PLOS MED, V2, P87, DOI 10.1371/journal.pmed.0020044; Hayani A, 2007, PEDIATRICS, V119, pE296, DOI 10.1542/peds.2006-1009; HIGHFIELD R, 2005, DAILY TELEGRAPH 0222; *HUM TISS AUTH, 2006, COD PRACT 6 DON ALL; Johnson FL, 1997, J PEDIAT HEMATOL ONC, V19, P183, DOI 10.1097/00043426-199705000-00001; Proctor SJ, 2001, BMJ-BRIT MED J, V323, P60, DOI 10.1136/bmj.323.7304.60; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; *ROYAL COLL OBST G, 2006, UMB CORD BLOOD BANK; Smythe J, 2007, STEM CELLS, V25, P2087, DOI 10.1634/stemcells.2007-0063; *VIRG HLTH BANK, 2007, STEM CELL STOR; WARWICK R, 2004, STEM CELLS OBSTET GY, V995, P1011	21	21	24	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2008	336	7645					642	644		10.1136/bmj.39489.454699.AD	http://dx.doi.org/10.1136/bmj.39489.454699.AD			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RH	18356233	Green Published			2022-12-24	WOS:000254443400023
J	Osterloo, MM; Hamilton, VE; Bandfield, JL; Glotch, TD; Baldridge, AM; Christensen, PR; Tornabene, LL; Anderson, FS				Osterloo, M. M.; Hamilton, V. E.; Bandfield, J. L.; Glotch, T. D.; Baldridge, A. M.; Christensen, P. R.; Tornabene, L. L.; Anderson, F. S.			Chloride-bearing materials in the southern highlands of Mars	SCIENCE			English	Article							THERMAL EMISSION SPECTROMETER; SURFACE; SPECTROSCOPY; MINERALS; BRINES	Chlorides commonly precipitate during the evaporation of surface water or groundwater and during volcanic outgassing. Spectrally distinct surface deposits consistent with chloride- bearing materials have been identified and mapped using data from the 2001 Mars Odyssey Thermal Emission Imaging System. These deposits are found throughout regions of low albedo in the southern highlands of Mars. Geomorphologic evidence from orbiting imagery reveals these deposits to be light- toned relative to their surroundings and to be polygonally fractured. The deposits are small (< similar to 25 km(2)) but globally widespread, occurring in middle to late Noachian terrains with a few occurrences in early Hesperian terrains. The identification of chlorides in the ancient southern highlands suggests that near- surface water was available and widespread in early Martian history.	[Osterloo, M. M.; Hamilton, V. E.; Anderson, F. S.] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Bandfield, J. L.; Baldridge, A. M.; Christensen, P. R.] Arizona State Univ, Sch Earth & Planetary Explorat, Tempe, AZ 85287 USA; [Glotch, T. D.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Tornabene, L. L.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Hawaii System; Arizona State University; Arizona State University-Tempe; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Arizona	Osterloo, MM (corresponding author), Univ Hawaii, Hawaii Inst Geophys & Planetol, 1680 East West Rd, Honolulu, HI 96822 USA.	osterloo@higp.hawaii.edu	Glotch, Timothy/B-6829-2008	Bandfield, Joshua/0000-0003-3571-3716; Tornabene, Livio Leonardo/0000-0002-1479-6711				Baldridge AM, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002315; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002289; Bandfield JL, 2003, ICARUS, V161, P47, DOI 10.1016/S0019-1035(02)00025-8; Bandfield JL, 2007, NATURE, V447, P64, DOI 10.1038/nature05781; BRASS GW, 1980, ICARUS, V42, P20, DOI 10.1016/0019-1035(80)90237-7; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9735, DOI 10.1029/1998JE000624; Christensen PR, 2004, SPACE SCI REV, V110, P85, DOI 10.1023/B:SPAC.0000021008.16305.94; CHRISTENSEN PR, 1999, CALIBRATION REPORT T; Eugster HP., 1978, LAKES, P237, DOI [10.1007/978-1-4757-1152-3_8, DOI 10.1007/978-1-4757-1152-3_8]; Farmer JD, 1999, J GEOPHYS RES-PLANET, V104, P26977, DOI 10.1029/1998JE000540; Farmer V.C., 1974, INFRARED SPECTRA MIN, P331; Goodall TM, 2000, SEDIMENTOLOGY, V47, P99, DOI 10.1046/j.1365-3091.2000.00279.x; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Knauth LP, 2002, ICARUS, V158, P267, DOI 10.1006/icar.2002.6866; Lane MD, 1998, ICARUS, V135, P528, DOI 10.1006/icar.1998.5998; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; MCEWEN AS, 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; PALLUCONI FD, 1981, ICARUS, V45, P415, DOI 10.1016/0019-1035(81)90044-0; Presley MA, 1997, J GEOPHYS RES-PLANET, V102, P6551, DOI 10.1029/96JE03303; Ruff SW, 1997, J GEOPHYS RES-SOL EA, V102, P14899, DOI 10.1029/97JB00593; Ruff SW, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001580; Tosca NJ, 2006, EARTH PLANET SC LETT, V241, P21, DOI 10.1016/j.epsl.2005.10.021; ZUBER MT, 1992, J GEOPHYS RES-PLANET, V97, P7781, DOI 10.1029/92JE00341	26	335	342	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2008	319	5870					1651	1654		10.1126/science.1150690	http://dx.doi.org/10.1126/science.1150690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356522				2022-12-24	WOS:000254172300036
J	Gaziano, TA; Young, CR; Fitzmaurice, G; Atwood, S; Gaziano, JM				Gaziano, Thomas A.; Young, Cynthia R.; Fitzmaurice, Garrett; Atwood, Sidney; Gaziano, J. Michael			Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort	LANCET			English	Article							CORONARY-HEART-DISEASE; SERUM-CHOLESTEROL CONCENTRATION; MIDDLE-INCOME COUNTRIES; C-REACTIVE PROTEIN; GLOBAL BURDEN; PREDICTION; POPULATION; HYPERTENSION; PREVENTION; EVENTS	Background Around 80% of all cardiovascular deaths occur in developing countries. Assessment of those patients at high risk is an important strategy for prevention. Since developing countries have limited resources for prevention strategies that require laboratory testing, we assessed if a risk prediction method that did not require any laboratory tests could be as accurate as one requiring laboratory information. Methods The National Health and Nutrition Examination Survey (NHANES) was a prospective cohort study of 14407 US participants aged between 25-74 years at the time they were first examined (between 1971 and 1975). Our follow-up study population included participants with complete information on these surveys who did not report a history of cardiovascular disease (myocardial infarction, heart failure, stroke, angina) or cancer, yielding an analysis dataset N=6186. We compared how well either method could predict first-time fatal and non-fatal cardiovascular disease events in this cohort. For the laboratory-based model, which required blood testing, we used standard risk factors to assess risk of cardiovascular disease: age, systolic blood pressure, smoking status, total cholesterol, reported diabetes status, and current treatment for hypertension. For the non-laboratory-based model, we substituted body-mass index for cholesterol. Findings in the cohort of 6186, there were 1529 first-time cardiovascular events and 578 (38%) deaths due to cardiovascular disease over 21 years. In women, the laboratory-based model was 0.831. In men, the results were similar (0.784 for the laboratory-based model and 0.783 for the non-laboratory-based model). Results were similar between the laboratory-based and non-laboratory-based models in both men and women when restricted to fatal events only. Interpretation A method that uses non-laboratory-based risk factors predicted cardiovascular events as accurately as one that relied on laboratory-based values. This approach could simplify risk assessment in situations where laboratory testing is inconvenient or unavailable.	[Gaziano, Thomas A.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Atwood, Sidney] Brigham & Womens Hosp, Div Social Med & Hlth Inequal, Boston, MA 02115 USA; [Young, Cynthia R.] Harvard Univ, Sch Med, Boston, MA USA; [Fitzmaurice, Garrett] McLean Hosp, Lab Psychiat Biostat, Belmont, MA 02178 USA; [Gaziano, Thomas A.] Brigham & Womens Hosp, VA Boston Healthcare Syst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; McLean Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Gaziano, TA (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	tgaziano@partners.org		Atwood, Sidney/0000-0001-8865-6300	FIC NIH HHS [1K01TW007141-01, K01 TW007141-03, K01 TW007141-02, K01 TW007141, K01 TW007141-04, K01 TW007141-01] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [K01TW007141] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Assmann G, 2002, CIRCULATION, V105, P900, DOI 10.1161/hh0702.105723; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Cohen B.B., 1987, PLAN OPERATION NHANE; Collinson P, 1998, HEART, V80, P215, DOI 10.1136/hrt.80.3.215; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cox C.S., 1992, PLAN OPERATION NHANE; COX CS, 1997, PLAN OPERATION NHANE; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Ferrario M, 2005, INT J EPIDEMIOL, V34, P413, DOI 10.1093/ije/dyh405; Finucane F.F., 1990, PLAN OPERATION NHANE; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Gaziano TA, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P645; GOFMAN JW, 1950, SCIENCE, V111, P166, DOI 10.1126/science.111.2877.166; Greenland P, 2005, ARCH INTERN MED, V165, P2454, DOI 10.1001/archinte.165.21.2454; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Jha P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P869; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; LAW MR, 1994, BMJ-BRIT MED J, V308, P363, DOI 10.1136/bmj.308.6925.363; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lindholm LH, 2007, LANCET, V370, P720, DOI 10.1016/S0140-6736(07)61356-7; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MADANS JH, 1995, STAT MED, V14, P643, DOI 10.1002/sim.4780140521; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; *NAT HLTH COMM, 1995, GUID MAN MILD RAIS B; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Rodgers A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P851; *US DHHS, 1971, 1 NAT HLTH NUTR EX S; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; World Bank, 2021, WORLD DEV IND 2021; World Health Organization, 2007, PREV CARD DIS GUID A; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	242	260	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2008	371	9616					923	931		10.1016/S0140-6736(08)60418-3	http://dx.doi.org/10.1016/S0140-6736(08)60418-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342687	Green Accepted			2022-12-24	WOS:000254056800029
J	Ohsugi, M; Adachi, K; Horai, R; Kakuta, S; Sudo, K; Kotaki, H; Tokai-Nishizumi, N; Sagara, H; Iwakura, Y; Yamamoto, T				Ohsugi, Miho; Adachi, Kenjiro; Horai, Reiko; Kakuta, Shigeru; Sudo, Katsuko; Kotaki, Hayato; Tokai-Nishizumi, Noriko; Sagara, Hiroshi; Iwakura, Yoichiro; Yamamoto, Tadashi			Kid-mediated chromosome compaction ensures proper nuclear envelope formation	CELL			English	Article							CHROMOKINESIN KID; XENOPUS-EMBRYOS; MOUSE EMBRYO; RAN; SPINDLE; TRANSITION; ALIGNMENT; DYNAMICS; ANAPHASE; GTPASE	Toward the end of mitosis, neighboring chromosomes gather closely to form a compact cluster. This is important for reassembling the nuclear envelope around the entire chromosome mass but not individual chromosomes. By analyzing mice and cultured cells lacking the expression of chromokinesin Kid/kinesin-10, we show that Kid localizes to the boundaries of anaphase and telophase chromosomes and contributes to the shortening of the anaphase chromosome mass along the spindle axis. Loss of Kid-mediated anaphase chromosome compaction often causes the formation of multinucleated cells, specifically at oocyte meiosis II and the first couple of mitoses leading to embryonic death. In contrast, neither male meiosis nor somatic mitosis after the morula-stage is affected by Kid deficiency. These data suggest that Kid-mediated anaphase/telophase chromosome compaction prevents formation of multinucleated cells. This protection is especially important during the very early stages of development, when the embryonic cells are rich in ooplasm.	[Ohsugi, Miho; Tokai-Nishizumi, Noriko; Yamamoto, Tadashi] Univ Tokyo, Div Oncol, Dept Canc Biol, Minato Ku, Tokyo 1088639, Japan; [Adachi, Kenjiro; Horai, Reiko; Kakuta, Shigeru; Sudo, Katsuko; Kotaki, Hayato; Iwakura, Yoichiro] Univ Tokyo, Div Cell Biol, Ctr Med Expt, Minato Ku, Tokyo 1088639, Japan; [Sagara, Hiroshi] Univ Tokyo, Lab Proteom, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Yamamoto, T (corresponding author), Univ Tokyo, Div Oncol, Dept Canc Biol, Minato Ku, Tokyo 1088639, Japan.	tyamamot@ims.u-tokyo.ac.jp	Kakuta, Shigeru/L-2241-2018; Iwakura, Yoichiro/E-5457-2011; Ohsugi, Miho/AAY-9339-2020; Sagara, Hiroshi/GRX-7740-2022	Kakuta, Shigeru/0000-0002-5900-1425; Iwakura, Yoichiro/0000-0002-9934-5775; Ohsugi, Miho/0000-0003-0288-3428; Sagara, Hiroshi/0000-0001-8456-8362				Adachi K, 2007, MOL CELL BIOL, V27, P2202, DOI 10.1128/MCB.01908-06; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; BACHVAROVA R, 1980, DEV BIOL, V74, P1, DOI 10.1016/0012-1606(80)90048-2; Bamba C, 2002, CURR BIOL, V12, P503, DOI 10.1016/S0960-9822(02)00741-8; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; Clute P, 1997, DEV BIOL, V185, P1, DOI 10.1006/dbio.1997.8540; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hinkle B, 2002, J CELL SCI, V115, P4685, DOI 10.1242/jcs.00136; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; MONTAG M, 1988, CHROMOSOMA, V96, P187, DOI 10.1007/BF00302357; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Munne S, 1998, HUM REPROD UPDATE, V4, P842, DOI 10.1093/humupd/4.6.842; Nagy A., 2003, MANIPULATING MOUSE E; NEWPORT J, 1989, J CELL SCI, P149; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Ohsugi M, 2003, EMBO J, V22, P2091, DOI 10.1093/emboj/cdg208; Onishi M, 1996, EXP HEMATOL, V24, P324; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Shiroguchi K, 2003, J BIOL CHEM, V278, P22460, DOI 10.1074/jbc.M212274200; SIRACUSA G, 1980, J EMBRYOL EXP MORPH, V60, P71; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Yamagata K, 2005, GENESIS, V43, P71, DOI 10.1002/gene.20158; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 2001, CURR BIOL, V11, P208, DOI 10.1016/S0960-9822(01)00053-7; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	35	69	69	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					771	782		10.1016/j.cell.2008.01.029	http://dx.doi.org/10.1016/j.cell.2008.01.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329364	Bronze			2022-12-24	WOS:000253818000015
J	Palacios, G; Druce, J; Du, L; Tran, T; Birch, C; Briese, T; Conlan, S; Quan, P; Hui, J; Marshall, J; Simons, JF; Egholm, M; Paddock, CD; Shieh, W; Goldsmith, CS; Zaki, SR; Catton, M; Lipkin, WI				Palacios, Gustavo; Druce, Julian; Du, Lei; Tran, Thomas; Birch, Chris; Briese, Thomas; Conlan, Sean; Quan, Phenix-Lan; Hui, Jeffrey; Marshall, John; Simons, Jan Fredrik; Egholm, Michael; Paddock, Christopher D.; Shieh, Wun-Ju; Goldsmith, Cynthia S.; Zaki, Sherif R.; Catton, Mike; Lipkin, W. Ian			A new arenavirus in a cluster of fatal transplant-associated diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SEQUENCE; PROGRAM	Background: Three patients who received visceral-organ transplants from a single donor on the same day died of a febrile illness 4 to 6 weeks after transplantation. Culture, polymerase-chain-reaction (PCR) and serologic assays, and oligonucleotide microarray analysis for a wide range of infectious agents were not informative. Methods: We evaluated RNA obtained from the liver and kidney transplant recipients. Unbiased high-throughput sequencing was used to identify microbial sequences not found by means of other methods. The specificity of sequences for a new candidate pathogen was confirmed by means of culture and by means of PCR, immunohistochemical, and serologic analyses. Results: High-throughput sequencing yielded 103,632 sequences, of which 14 represented an Old World arenavirus. Additional sequence analysis showed that this new arenavirus was related to lymphocytic choriomeningitis viruses. Specific PCR assays based on a unique sequence confirmed the presence of the virus in the kidneys, liver, blood, and cerebrospinal fluid of the recipients. Immunohistochemical analysis revealed arenavirus antigen in the liver and kidney transplants in the recipients. IgM and IgG antiviral antibodies were detected in the serum of the donor. Seroconversion was evident in serum specimens obtained from one recipient at two time points. Conclusions: Unbiased high-throughput sequencing is a powerful tool for the discovery of pathogens. The use of this method during an outbreak of disease facilitated the identification of a new arenavirus transmitted through solid-organ transplantation.	[Palacios, Gustavo; Briese, Thomas; Conlan, Sean; Quan, Phenix-Lan; Hui, Jeffrey; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Druce, Julian; Tran, Thomas; Birch, Chris; Marshall, John; Catton, Mike] Victorian Infect Dis Reference Lab, Carlton, Vic 3053, Australia; [Du, Lei; Simons, Jan Fredrik; Egholm, Michael] 454 Life Sci, Branford, CT USA; [Paddock, Christopher D.; Shieh, Wun-Ju; Goldsmith, Cynthia S.; Zaki, Sherif R.] Ctr Dis Control & Prevent, Atlanta, GA USA	Columbia University; Victorian Infectious Diseases Reference Laboratory; Centers for Disease Control & Prevention - USA	Lipkin, WI (corresponding author), Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, 722 W 168th St, New York, NY 10032 USA.	mike.catton@mh.org.au; wil2001@columbia.edu	Conlan, Sean/B-4401-2008; Palacios, Gustavo/I-7773-2015; Lipkin, W. Ian/ABE-6216-2020	Conlan, Sean/0000-0001-6848-3465; Palacios, Gustavo/0000-0001-5062-1938; Lipkin, W. Ian/0000-0002-8768-9386; Druce, Julian/0000-0002-3521-3298	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC1AI062705, U54AI057158, U01AI070411] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL083850] Funding Source: Medline; NIAID NIH HHS [U54AI57158, AI062705, U01AI070411] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSHUL SF, 1997, NUCLEIC ACIDS RES, V25, P402; BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; Fischer SA, 2006, NEW ENGL J MED, V354, P2235, DOI 10.1056/NEJMoa053240; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ike F, 2007, COMPARATIVE MED, V57, P272; Jabado OJ, 2006, NUCLEIC ACIDS RES, V34, P6605, DOI 10.1093/nar/gkl966; Jamieson DJ, 2006, AM J OBSTET GYNECOL, V194, P1532, DOI 10.1016/j.ajog.2005.11.040; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lecompte E, 2007, VIROLOGY, V364, P178, DOI 10.1016/j.virol.2007.02.008; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LIPKIN WI, 2007, GLOBAL INFECT DIS SU, P177; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MERITET JF, 2006, HUMAN FETAL LYMPHOCY; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857	16	473	511	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					991	998		10.1056/NEJMoa073785	http://dx.doi.org/10.1056/NEJMoa073785			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18256387	Green Published, Bronze			2022-12-24	WOS:000253644700003
J	Christner, BC; Morris, CE; Foreman, CM; Cai, RM; Sands, DC				Christner, Brent C.; Morris, Cindy E.; Foreman, Christine M.; Cai, Rongman; Sands, David C.			Ubiquity of biological ice nucleators in snowfall	SCIENCE			English	Article							PROTEINS; BACTERIA		[Christner, Brent C.; Cai, Rongman] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Morris, Cindy E.] INRA, Unite Pathol Vegetale UR407, F-84140 Montfavet, France; [Foreman, Christine M.] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA; [Foreman, Christine M.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Sands, David C.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	Louisiana State University System; Louisiana State University; INRAE; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Christner, BC (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	xner@lsu.edu	Cai, Rongman/C-5998-2015	Cai, Rongman/0000-0003-2404-4852; Foreman, Christine/0000-0003-0230-4692				Jaenicke R, 2005, SCIENCE, V308, P73, DOI 10.1126/science.1106335; Kawahara H, 2002, J BIOSCI BIOENG, V94, P492, DOI 10.1016/S1389-1723(02)80185-2; LINDOW SE, 1989, MOL PLANT MICROBE IN, V2, P262, DOI 10.1094/MPMI-2-262; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Morris CE, 2004, J PHYS IV, V121, P87, DOI 10.1051/jp4:2004121004; Vali G., 1995, BIOL ICE NUCL ITS AP	6	251	263	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1214	1214		10.1126/science.1149757	http://dx.doi.org/10.1126/science.1149757			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309078	Green Submitted			2022-12-24	WOS:000253530600034
J	Blow, N				Blow, Nathan			In search of common ground	NATURE			English	Editorial Material							STEM-CELL LINES											Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	3	12	17	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2008	451	7180					855	860		10.1038/451855a	http://dx.doi.org/10.1038/451855a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273022	Bronze			2022-12-24	WOS:000253191400048
J	Pedraza, JM; Paulsson, J				Pedraza, Juan M.; Paulsson, Johan			Effects of molecular memory and bursting on fluctuations in gene expression	SCIENCE			English	Article							SINGLE-CELL; PROTEIN EXPRESSION; NOISE; NETWORKS; DIFFERENTIATION; STOCHASTICITY; TURNOVER; LEVEL; TIME	Many cellular components are present in such low numbers per cell that random births and deaths of individual molecules can cause substantial "noise" in concentrations. But biochemical events do not necessarily occur in single steps of individual molecules. Some processes are greatly randomized when synthesis or degradation occurs in large bursts of many molecules during a short time interval. Conversely, each birth or death of a macromolecule could involve several small steps, creating a memory between individual events. We present a generalized theory for stochastic gene expression, formulating the variance in protein abundance in terms of the randomness of the individual gene expression events. We show that common types of molecular mechanisms can produce gestation and senescence periods that reduce noise without requiring higher abundances, shorter lifetimes, or any concentration- dependent control loops. We also show that most single- cell experimental methods cannot distinguish between qualitatively different stochastic principles, although this in turn makes such methods better suited for identifying which components introduce fluctuations. Characterizing the random events that give rise to noise in concentrations instead requires dynamic measurements with single- molecule resolution.	[Pedraza, Juan M.; Paulsson, Johan] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA; [Paulsson, Johan] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Paulsson, J (corresponding author), Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA.	johan_paulsson@hms.harvard.edu		Pedraza, Juan/0000-0002-1802-3337				Amir A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100113; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bortkewitsch L.v, 1898, MONATSHEFTE MATH PHY, V9, pA39; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hubner CG, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.093903; Korobkova EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058105; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	32	275	278	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2008	319	5861					339	343		10.1126/science.1144331	http://dx.doi.org/10.1126/science.1144331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202292				2022-12-24	WOS:000252436200041
J	Kathiresan, S; Melander, O; Anevski, D; Guiducci, C; Burtt, NP; Roos, C; Hirschhorn, JN; Berglund, G; Hedblad, B; Groop, L; Altshuler, DM; Newton-Cheh, C; Orho-Melander, M				Kathiresan, Sekar; Melander, Olle; Anevski, Dragi; Guiducci, Candace; Burtt, Noel P.; Roos, Charlotta; Hirschhorn, Joel N.; Berglund, Goran; Hedblad, Bo; Groop, Leif; Altshuler, David M.; Newton-Cheh, Christopher; Orho-Melander, Marju			Polymorphisms associated with cholesterol and risk of cardiovascular events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; HDL-CHOLESTEROL; HEPATIC LIPASE; TRIGLYCERIDES; LOCI; CONTRIBUTES; CURVE; MALMO; PCSK9	Background: Common single-nucleotide polymorphisms (SNPs) that are associated with blood low-density lipoprotein (LDL) or high-density lipoprotein (HDL) cholesterol modestly affect lipid levels. We tested the hypothesis that a combination of such SNPs contributes to the risk of cardiovascular disease. Methods: We studied SNPs at nine loci in 5414 subjects from the cardiovascular cohort of the Malmo Diet and Cancer Study. We first validated the association between SNPs and either LDL or HDL cholesterol and subsequently created a genotype score on the basis of the number of unfavorable alleles. We used Cox proportional-hazards models to determine the time to the first cardiovascular event in relation to the genotype score. Results: All nine SNPs showed replication of an association with levels of either LDL or HDL cholesterol. With increasing genotype scores, the level of LDL cholesterol increased from 152 mg to 171 mg per deciliter (3.9 to 4.4 mmol per liter), whereas HDL cholesterol decreased from 60 mg to 51 mg per deciliter (1.6 to 1.3 mmol per liter). During follow-up (median, 10.6 years), 238 subjects had a first cardiovascular event. The genotype score was associated with incident cardiovascular disease in models adjusted for covariates including baseline lipid levels (P<0.001). The use of the genotype score did not improve the clinical risk prediction, as assessed by the C statistic. However, there was a significant improvement in risk classification with the use of models that included the genotype score, as compared with those that did not include the genotype score. Conclusions: A genotype score of nine validated SNPs that are associated with modulation in levels of LDL or HDL cholesterol was an independent risk factor for incident cardiovascular disease. The score did not improve risk discrimination but did modestly improve clinical risk reclassification for individual subjects beyond standard clinical factors.	[Kathiresan, Sekar; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Dis Prevent Ctr, Div Cardiol, Boston, MA 02114 USA; [Altshuler, David M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Altshuler, David M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Kathiresan, Sekar; Altshuler, David M.; Newton-Cheh, Christopher] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Hirschhorn, Joel N.; Altshuler, David M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol & Genet, Boston, MA 02115 USA; [Kathiresan, Sekar; Guiducci, Candace; Burtt, Noel P.; Hirschhorn, Joel N.; Altshuler, David M.; Newton-Cheh, Christopher] MIT, Broad Inst, Cambridge, MA 02139 USA; [Kathiresan, Sekar; Guiducci, Candace; Burtt, Noel P.; Hirschhorn, Joel N.; Altshuler, David M.; Newton-Cheh, Christopher] Harvard Univ, Cambridge, MA 02138 USA; [Melander, Olle] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Hypertens & Cardiovasc Dis, Malmo, Sweden; [Anevski, Dragi; Roos, Charlotta; Groop, Leif; Orho-Melander, Marju] Lund Univ, Malmo Univ Hosp, Dept Endocrinol & Diabet, Malmo, Sweden; [Berglund, Goran] Lund Univ, Malmo Univ Hosp, Dept Internal Med, Malmo, Sweden; [Hedblad, Bo] Lund Univ, Malmo Univ Hosp, Dept Epidemiol Res, Malmo, Sweden; [Anevski, Dragi] Chalmers Univ Technol, S-41296 Gothenburg, Sweden; [Groop, Leif] Helsinki Univ Hosp, Helsinki, Finland	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Chalmers University of Technology; University of Helsinki; Helsinki University Central Hospital	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Dis Prevent Ctr, Div Cardiol, 25 New Chardon St,Suite 301, Boston, MA 02114 USA.	skathiresan@partners.org	Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; Melander, Olle/0000-0002-2581-484X	NHLBI NIH HHS [K23-HL080025, K23-HL083102] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL083102, K23HL080025] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTSHULER D, 2007, WHOLE GENOME SCANE T; Benn M, 2005, J CLIN ENDOCR METAB, V90, P5797, DOI 10.1210/jc.2005-0974; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Boekholdt SM, 2005, CIRCULATION, V111, P278, DOI 10.1161/01.CIR.0000153341.46271.40; Boright AP, 1998, J HUM GENET, V43, P153, DOI 10.1007/s100380050060; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cooper GR, 1997, JAMA-J AM MED ASSOC, V278, P478; COOPER GR, 1992, JAMA-J AM MED ASSOC, V267, P1652, DOI 10.1001/jama.267.12.1652; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frikke-Schmidt R, 2004, J CLIN INVEST, V114, P1343, DOI 10.1172/JCI200420361; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Guerra R, 1997, P NATL ACAD SCI USA, V94, P4532, DOI 10.1073/pnas.94.9.4532; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Humphries SE, 2007, CLIN CHEM, V53, P8, DOI 10.1373/clinchem.2006.074591; JERNTORP P, 1992, STROKE, V23, P357, DOI 10.1161/01.STR.23.3.357; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; MILLER NE, 1975, LANCET, V1, P1033, DOI 10.1016/S0140-6736(75)91977-7; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; Nettleton JA, 2007, ATHEROSCLEROSIS, V194, pE131, DOI 10.1016/j.atherosclerosis.2006.11.025; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PERO RW, 1993, J INTERN MED, V233, P63, DOI 10.1111/j.1365-2796.1993.tb00650.x; Rip J, 2006, ARTERIOSCL THROM VAS, V26, P1236, DOI 10.1161/01.ATV.0000219283.10832.43; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SING CF, 1985, AM J HUM GENET, V37, P268; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wittrup HH, 2006, J CLIN ENDOCR METAB, V91, P1438, DOI 10.1210/jc.2005-1725	36	543	561	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1240	1249		10.1056/NEJMoa0706728	http://dx.doi.org/10.1056/NEJMoa0706728			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275TL	18354102				2022-12-24	WOS:000254094400005
J	Wilt, TJ				Wilt, Timothy J.			Commentary: controversies in NICE guidance on prostate cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material							GUIDELINES		[Wilt, Timothy J.] Minneapolis VA Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA		Wilt, TJ (corresponding author), Minneapolis VA Ctr Chron Dis Outcomes Res, 1 Vet Dr 111-O, Minneapolis, MN 55417 USA.	Tim.wilt@med.va.gov						Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Heidenreich A, 2008, EUR UROL, V53, P68, DOI 10.1016/j.eururo.2007.09.002; LUYAO G, 2008, GEN CANC S SAN FRANC; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; Wilt TJ, 2008, COMP EFFECTIVENSS RE	7	6	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 15	2008	336	7644					612	614		10.1136/bmj.39501.621690.AD	http://dx.doi.org/10.1136/bmj.39501.621690.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279OM	18340077	Green Published			2022-12-24	WOS:000254364500037
J	Xiao, H; Jiang, N; Schaffner, E; Stockinger, EJ; van der Knaap, E				Xiao, Han; Jiang, Ning; Schaffner, Erin; Stockinger, Eric J.; van der Knaap, Esther			A retrotransposon-mediated gene duplication underlies morphological variation of tomato fruit	SCIENCE			English	Article							ARABIDOPSIS; DOMESTICATION; BIOSYNTHESIS; TRYPTOPHAN; PROTEIN	Edible fruits, such as that of the tomato plant and other vegetable crops, are markedly diverse in shape and size. SUN, one of the major genes controlling the elongated fruit shape of tomato, was positionally cloned and found to encode a member of the IQ67 domain - containing family. We show that the locus arose as a result of an unusual 24.7- kilobase gene duplication event mediated by the long terminal repeat retrotransposon Rider. This event resulted in a new genomic context that increased SUN expression relative to that of the ancestral copy, culminating in an elongated fruit shape. Our discovery demonstrates that retrotransposons may be a major driving force in genome evolution and gene duplication, resulting in phenotypic change in plants.	[Xiao, Han; Schaffner, Erin; Stockinger, Eric J.; van der Knaap, Esther] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA; [Jiang, Ning] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Schaffner, Erin] Coll Wooster, Wooster, OH 44691 USA	University System of Ohio; Ohio State University; Michigan State University; College of Wooster	van der Knaap, E (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Hort & Crop Sci, Wooster, OH 44691 USA.	vanderknaap.1@osu.edu	Xiao, Han/C-3295-2012; van der Knaap, Esther/D-6307-2012; Jiang, Ning/G-6546-2012	Xiao, Han/0000-0001-5937-6510; van der Knaap, Esther/0000-0003-4963-7427				Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Ficcadenti N, 1999, MOL BREEDING, V5, P463, DOI 10.1023/A:1009665409959; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Lertpiriyapong K, 2003, PLANT MOL BIOL, V53, P581, DOI 10.1023/B:PLAN.0000019067.05185.d6; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; LEWIN B, 2008, GENES, V9; Majira A, 2002, PLANT MOL BIOL, V50, P551, DOI 10.1023/A:1019851913083; Mikkelsen MD, 2000, J BIOL CHEM, V275, P33712, DOI 10.1074/jbc.M001667200; Pandolfini Tiziana, 2002, BMC Biotechnology, V2, P1, DOI 10.1186/1472-6750-2-1; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Takada S, 2001, DEVELOPMENT, V128, P1127; van der Knaap E, 2004, GENETICS, V168, P2127, DOI 10.1534/genetics.104.031013; van der Knaap E, 2001, THEOR APPL GENET, V103, P353, DOI 10.1007/s001220100623; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	15	368	402	16	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1527	1530		10.1126/science.1153040	http://dx.doi.org/10.1126/science.1153040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339939				2022-12-24	WOS:000253943800039
J	Tato, CM; Cua, DJ				Tato, Cristina M.; Cua, Daniel J.			SnapShot: Cytokines III	CELL			English	Editorial Material							FAMILY-MEMBERS; LYMPHOTOXIN		[Tato, Cristina M.; Cua, Daniel J.] Schering Plough Biopharma, Palo Alto, CA 94304 USA	Merck & Company	Tato, CM (corresponding author), Schering Plough Biopharma, Palo Alto, CA 94304 USA.			Tato, Cristina M./0000-0002-0614-756X				Abe K, 2000, ANN NY ACAD SCI, V926, P52; Le Pottier L, 2007, ANN NY ACAD SCI, V1110, P426, DOI 10.1196/annals.1423.044; O'Shea JJ, 2008, CLIN IMMUNOLOGY; PAUL NL, 1988, ANNU REV IMMUNOL, V6, P407, DOI 10.1146/annurev.iy.06.040188.002203; Sun M, 2007, J IMMUNOL, V179, P4307, DOI 10.4049/jimmunol.179.7.4307; Tumanov AV, 2007, CURR MOL MED, V7, P567, DOI 10.2174/156652407781695701; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839	7	18	19	1	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					900	U12		10.1016/j.cell.2008.02.023	http://dx.doi.org/10.1016/j.cell.2008.02.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329374	Bronze			2022-12-24	WOS:000253818000025
J	Watts, G				Watts, Geoff			Europe seeks to boost research	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						European Federation of Pharmaceutical Industries and Associations, 2007, PHARM IND FIG; *INN MED IN, 2007, ASS EC SOC EFF; *INN MED IN, 2006, STRAT RES AG	3	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 1	2008	336	7642					474	475		10.1136/bmj.39475.547199.AD	http://dx.doi.org/10.1136/bmj.39475.547199.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18309998	Green Published			2022-12-24	WOS:000253997500035
J	Greenland, P; Lloyd-Jones, D				Greenland, Philip; Lloyd-Jones, Donald			Critical lessons from the ENHANCE trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHOLESTEROL; METAANALYSIS		[Greenland, Philip; Lloyd-Jones, Donald] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Greenland, Philip; Lloyd-Jones, Donald] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Greenland, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 750 N Lake Shore Dr,9th Floor, Chicago, IL 60611 USA.		Lloyd-Jones, Donald M/C-5899-2009; Greenland, Philip/ABD-5528-2021	Lloyd-Jones, Donald/0000-0003-0847-6110				Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Carey J, 2008, BUS WEEK, P52; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Kumar Amit, 2007, J Interv Cardiol, V20, P447, DOI 10.1111/j.1540-8183.2007.00298.x; Laine C, 2007, JAMA-J AM MED ASSOC, V298, P93, DOI 10.1001/jama.298.1.jed70037; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Parker-Pope T., 2008, NY TIMES, pD1; PARKERPOPE T, 2008, NY TIMES        0122, pD6; SAUL S, 2008, NY TIMES        0124, pC4; SAUL S, 2008, NY TIMES        0124, pC1; TAUBES G, 2008, NY TIMES        0127; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; WINSLOW R, 2008, WALL STREET J   0115, pA3	14	39	41	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2008	299	8					953	955		10.1001/jama.299.8.953	http://dx.doi.org/10.1001/jama.299.8.953			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266DZ	18314439				2022-12-24	WOS:000253413200025
J	Krishnakumar, R; Gamble, MJ; Frizzell, KM; Berrocal, JG; Kininis, M; Kraus, WL				Krishnakumar, Raga; Gamble, Matthew J.; Frizzell, Kristine M.; Berrocal, Jhoanna G.; Kininis, Miltiadis; Kraus, W. Lee			Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes	SCIENCE			English	Article							CHROMATIN-STRUCTURE; POLY(ADP-RIBOSYL)ATION; DISTINCT; DOMAINS; GENOME	Nucleosome- binding proteins act to modulate the promoter chromatin architecture and transcription of target genes. We used genomic and gene- specific approaches to show that two such factors, histone H1 and poly( ADP- ribose) polymerase- 1 ( PARP- 1), exhibit a reciprocal pattern of chromatin binding at many RNA polymerase II - transcribed promoters. PARP- 1 was enriched and H1 was depleted at these promoters. This pattern of binding was associated with actively transcribed genes. Furthermore, we showed that PARP- 1 acts to exclude H1 from a subset of PARP- 1 - stimulated promoters, suggesting a functional interplay between PARP- 1 and H1 at the level of nucleosome binding. Thus, although H1 and PARP- 1 have similar nucleosome- binding properties and effects on chromatin structure in vitro, they have distinct roles in determining gene expression outcomes in vivo.	[Krishnakumar, Raga; Gamble, Matthew J.; Frizzell, Kristine M.; Berrocal, Jhoanna G.; Kininis, Miltiadis; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Krishnakumar, Raga; Frizzell, Kristine M.; Berrocal, Jhoanna G.; Kraus, W. Lee] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Kininis, Miltiadis; Kraus, W. Lee] Cornell Univ, Grad Field Genet & Dev, Ithaca, NY 14853 USA; [Kraus, W. Lee] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Cornell University	Kraus, WL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 465 Biotechnol Bldg, Ithaca, NY 14853 USA.	wlk5@cornell.edu		Krishnakumar, Raga/0000-0002-2479-754X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058110, R56DK069710, R01DK069710] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK069710, R01 DK069710, DK058110] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; HULETSKY A, 1989, J BIOL CHEM, V264, P8878; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Vignali M, 1998, NAT STRUCT BIOL, V5, P1025, DOI 10.1038/4133; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3	17	308	316	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					819	821		10.1126/science.1149250	http://dx.doi.org/10.1126/science.1149250			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258916				2022-12-24	WOS:000252963000064
J	Gray, NJ				Gray, Nigel J.			Dilemmas over tobacco research	LANCET			English	Editorial Material									Canc Council Victoria, Hawthorn, Vic 3122, Australia	Cancer Council Victoria	Gray, NJ (corresponding author), Canc Council Victoria, Hawthorn, Vic 3122, Australia.	nigel@uicc.org						Schick SF, 2007, TOB CONTROL, V16, P157, DOI 10.1136/tc.2006.017186; *WHO STUD GROUP TO, 2007, SCI BAS TOB PROD REG; WILDE A, 2007, WALL STREET J   0621, pA1	3	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2008	371	9610					368	370		10.1016/S0140-6736(08)60182-8	http://dx.doi.org/10.1016/S0140-6736(08)60182-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242400				2022-12-24	WOS:000252992700009
J	Burguete, AS; Fenn, TD; Brunger, AT; Pfeffer, SR				Burguete, Alondra Schweizer; Fenn, Timothy D.; Brunger, Axel T.; Pfeffer, Suzanne R.			Rab and arl GTPase family members cooperate in the localization of the golgin GCC185	CELL			English	Article							GRIP DOMAIN PROTEIN; STRUCTURAL BASIS; TRANS-GOLGI; COILED-COIL; RECRUITMENT; EFFECTOR; SPECIFICITY; BINDS; VISUALIZATION; VESICLES	GCC185 is a large coiled-coil protein at the trans Golgi network that is required for receipt of transport vesicles inbound from late endosomes and for anchoring noncentrosomal microtubules that emanate from the Golgi. Here, we demonstrate that recruitment of GCC185 to the Golgi is mediated by two Golgi-localized small GTPases of the Rab and Arl families. GCC185 binds Rab6, and mutation of residues needed for Rab binding abolishes Golgi localization. The crystal structure of Rab6 bound to the GCC185 Rab-binding domain reveals that Rab6 recognizes a two-fold symmetric surface on a coiled coil immediately adjacent to a C-terminal GRIP domain. Unexpectedly, Rab6 binding promotes association of Arl1 with the GRIP domain. We present a structure-derived model for dual GTPase membrane attachment that highlights the potential ability of Rab GTPases to reach binding partners at a significant distance from the membrane via their unstructured and membrane-anchored, hypervariable domains.	[Burguete, Alondra Schweizer; Pfeffer, Suzanne R.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Burguete, Alondra Schweizer; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Burguete, Alondra Schweizer; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Neurol, Stanford, CA 94305 USA; [Burguete, Alondra Schweizer; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Struct Biol & Photon Sci, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	pfeffer@stanford.edu		Brunger, Axel/0000-0001-5121-2036; Schweizer Burguete, Alondra/0000-0003-0324-3334	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037332, R01DK037332, R37DK037332] Funding Source: NIH RePORTER; NIDDK NIH HHS [R56 DK037332, DK37332, R37 DK037332-19, R37 DK037332-22, R37 DK037332-21, R01 DK037332, R37 DK037332-20, R37 DK037332] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Bergbrede T, 2005, J STRUCT BIOL, V152, P235, DOI 10.1016/j.jsb.2005.10.001; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chattopadhyay D, 2000, ACTA CRYSTALLOGR D, V56, P937, DOI 10.1107/S0907444900007575; Derby MC, 2004, J CELL SCI, V117, P5865, DOI 10.1242/jcs.01497; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gilson PR, 2004, PLANTA, V219, P1050, DOI 10.1007/s00425-004-1311-9; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Latijnhouwers M, 2005, PLANT J, V44, P459, DOI 10.1111/j.1365-313X.2005.02542.x; Li BJ, 1996, J BIOL CHEM, V271, P16813, DOI 10.1074/jbc.271.28.16813; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Luke MR, 2005, BIOCHEM J, V388, P835, DOI 10.1042/BJ20041810; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Merithew E, 2001, J BIOL CHEM, V276, P13982, DOI 10.1074/jbc.M009771200; Neu M, 1997, PROTEINS, V27, P204, DOI 10.1002/(SICI)1097-0134(199702)27:2<204::AID-PROT6>3.0.CO;2-F; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Sato Y, 2007, STRUCTURE, V15, P245, DOI 10.1016/j.str.2007.01.003; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Siniossoglou S, 2001, EMBO J, V20, P5991, DOI 10.1093/emboj/20.21.5991; Stroupe C, 2000, J MOL BIOL, V304, P585, DOI 10.1006/jmbi.2000.4236; Sztul E, 2006, AM J PHYSIOL-CELL PH, V290, pC11, DOI 10.1152/ajpcell.00293.2005; Tsukada M, 1996, J CELL SCI, V109, P2471; WARREN G, 1984, EMBO J, V3, P2217, DOI 10.1002/j.1460-2075.1984.tb02119.x; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832	49	129	136	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					286	298		10.1016/j.cell.2007.11.048	http://dx.doi.org/10.1016/j.cell.2007.11.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243103	Green Accepted, Bronze			2022-12-24	WOS:000253427700014
J	Friedlingstein, P				Friedlingstein, Pierre			A steep road to climate stabilization	NATURE			English	Article									CEA Saclay, Inst Pierre Simon Laplace, Lab Climate & Environm Sci, F-91191 Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Friedlingstein, P (corresponding author), CEA Saclay, Inst Pierre Simon Laplace, Lab Climate & Environm Sci, F-91191 Gif Sur Yvette, France.	pierre.friedlingstein@lsce.ipsl.fr	Friedlingstein, Pierre/H-2700-2014	Friedlingstein, Pierre/0000-0003-3309-4739				Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6	4	33	34	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					297	298		10.1038/nature06593	http://dx.doi.org/10.1038/nature06593			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202648	Bronze, Green Submitted			2022-12-24	WOS:000252432100040
J	Sinclair, CA; Makin, JK				Sinclair, Craig A.; Makin, Jennifer K.			Medicine and the media - Sometimes it takes a loss of life to make a difference	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sinclair, Craig A.; Makin, Jennifer K.] Canc Council Victoria, Melbourne, Vic, Australia	Cancer Council Victoria	Sinclair, CA (corresponding author), Canc Council Victoria, Melbourne, Vic, Australia.	craig.sinclair@cancervic.org.au	Makin, Jen/AAE-6862-2020	Makin, Jen/0000-0001-7556-196X; Sinclair, Craig/0000-0002-6467-1191				Dobbinson S, 2006, EUR J CANCER PREV, V15, P424, DOI 10.1097/00008469-200610000-00007; 2007, AUST NZ J PUBLIC HLT, V31, P191	2	15	15	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 12	2008	336	7635					73	73		10.1136/bmj.39430.705752.94	http://dx.doi.org/10.1136/bmj.39430.705752.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	18187723	Green Published			2022-12-24	WOS:000252494800026
J	Romani, L; Fallarino, F; De Luca, A; Montagnoli, C; D'Angelo, C; Zelante, T; Vacca, C; Bistoni, F; Fioretti, MC; Grohmann, U; Segal, BH; Puccetti, P				Romani, Luigina; Fallarino, Francesca; De Luca, Antonella; Montagnoli, Claudia; D'Angelo, Carmen; Zelante, Teresa; Vacca, Carmine; Bistoni, Francesco; Fioretti, Maria C.; Grohmann, Ursula; Segal, Brahm H.; Puccetti, Paolo			Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease	NATURE			English	Article							DELTA-T-CELLS; NF-KAPPA-B; DENDRITIC CELLS; INDOLEAMINE 2,3-DIOXYGENASE; IL-17 PRODUCTION; HOST-DEFENSE; GAMMA; IDO; TOLERANCE; INFECTION	Half a century ago, chronic granulomatous disease ( CGD) was first described as a disease fatally affecting the ability of children to survive infections. Various milestone discoveries have since been made, from an insufficient ability of patients' leucocytes to kill microbes to the underlying genetic abnormalities(1). In this inherited disorder, phagocytes lack NADPH oxidase activity and do not generate reactive oxygen species, most notably superoxide anion, causing recurrent bacterial and fungal infections. Patients with CGD also suffer from chronic inflammatory conditions, most prominently granuloma formation in hollow viscera. The precise mechanisms of the increased microbial pathogenicity have been unclear(2), and more so the reasons for the exaggerated inflammatory response(3-6). Here we show that a superoxide- dependent step in tryptophan metabolism along the kynurenine pathway is blocked in CGD mice with lethal pulmonary aspergillosis, leading to unrestrained V gamma 1(+) gamma delta T- cell reactivity, dominant production of interleukin ( IL)- 17, defective regulatory T- cell activity and acute inflammatory lung injury. Although beneficial effects are induced by IL- 17 neutralization or gamma delta T- cell contraction, complete cure and reversal of the hyperinflammatory phenotype are achieved by replacement therapy with a natural kynurenine distal to the blockade in the pathway. Effective therapy, which includes co-administration of recombinant interferon-gamma ( IFN-gamma), restores production of downstream immunoactive metabolites and enables the emergence of regulatory V gamma 4(+) gamma delta and Foxp3(+) alpha beta T cells. Therefore, paradoxically, the lack of reactive oxygen species contributes to the hyperinflammatory phenotype associated with NADPH oxidase deficiencies, through a dysfunctional kynurenine pathway of tryptophan catabolism. Yet, this condition can be reverted by reactivating the pathway downstream of the superoxide- dependent step.	[Romani, Luigina; Fallarino, Francesca; De Luca, Antonella; Montagnoli, Claudia; D'Angelo, Carmen; Zelante, Teresa; Vacca, Carmine; Bistoni, Francesco; Fioretti, Maria C.; Grohmann, Ursula; Puccetti, Paolo] Univ Perugia, Dept Expt Med, I-06126 Perugia, Italy; [Segal, Brahm H.] Roswell Pk Canc Inst, Div Infect Dis, Buffalo, NY 14263 USA	University of Perugia; Roswell Park Cancer Institute	Romani, L (corresponding author), Univ Perugia, Dept Expt Med, I-06126 Perugia, Italy.	iromani@unipg.it; plopcc@tin.it	Segal, Brahm/AAW-2706-2020; zelante, teresa/F-7933-2017; Vacca, Carmine/AAE-7046-2019; Romani, Luigina/O-9987-2018; Grohmann, Ursula/T-6545-2019; Fallarino, Francesca/O-3358-2013	zelante, teresa/0000-0002-7071-0302; Vacca, Carmine/0000-0002-3799-8164; Fallarino, Francesca/0000-0002-8501-2136; Puccetti, Paolo/0000-0001-6674-2128; Romani, Luigina/0000-0002-1356-525X; Grohmann, Ursula/0000-0001-7952-1850; DE LUCA, ANTONELLA/0000-0002-6866-5530				Andrew EM, 2005, J IMMUNOL, V175, P1741, DOI 10.4049/jimmunol.175.3.1741; Andrew EM, 2005, MICROBES INFECT, V7, P529, DOI 10.1016/j.micinf.2004.12.010; Assari Tracy, 2006, Med Immunol, V5, P4, DOI 10.1186/1476-9433-5-4; Belladonna ML, 2006, J IMMUNOL, V177, P130, DOI 10.4049/jimmunol.177.1.130; Bellocchio S, 2004, J IMMUNOL, V173, P7406, DOI 10.4049/jimmunol.173.12.7406; Born WK, 2006, CURR OPIN IMMUNOL, V18, P31, DOI 10.1016/j.coi.2005.11.007; Bylund J, 2007, EUR J IMMUNOL, V37, P1087, DOI 10.1002/eji.200636651; Chang YC, 1998, J CLIN INVEST, V101, P1843, DOI 10.1172/JCI2301; De Luca A, 2007, J IMMUNOL, V179, P5999, DOI 10.4049/jimmunol.179.9.5999; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Hizawa N, 2006, CLIN EXP ALLERGY, V36, P1109, DOI 10.1111/j.1365-2222.2006.02550.x; Hultqvist M, 2007, J IMMUNOL, V179, P1431, DOI 10.4049/jimmunol.179.3.1431; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jackson SH, 2001, J INTERF CYTOK RES, V21, P567, DOI 10.1089/10799900152547821; Kirby AC, 2007, J PATHOL, V212, P29, DOI 10.1002/path.2149; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Marciano BE, 2004, CLIN INFECT DIS, V39, P692, DOI 10.1086/422993; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Montagnoli C, 2006, J IMMUNOL, V176, P1712, DOI 10.4049/jimmunol.176.3.1712; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; PETERMAN GM, 1993, J IMMUNOL, V151, P6546; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Popov A, 2006, J CLIN INVEST, V116, P3160, DOI 10.1172/JCI28996; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romani L, 2006, BLOOD, V108, P2265, DOI 10.1182/blood-2006-02-004762; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Tramonti D, 2006, EUR J IMMUNOL, V36, P1729, DOI 10.1002/eji.200635959	39	436	449	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					211	U12		10.1038/nature06471	http://dx.doi.org/10.1038/nature06471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185592				2022-12-24	WOS:000252214400047
J	Robicsek, A; Beaumont, JL; Paule, SM; Hacek, DM; Thomson, RB; Kaul, KL; King, P; Peterson, LR				Robicsek, Ari; Beaumont, Jennifer L.; Paule, Suzanne M.; Hacek, Donna M.; Thomson, Richard B., Jr.; Kaul, Karen L.; King, Peggy; Peterson, Lance R.			Universal surveillance for methicillin-resistant Staphylocloccus aureus in 3 affiliated hospitals	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL RESISTANCE; ACTIVE SURVEILLANCE; CONTACT ISOLATION; US HOSPITALS; BACTEREMIA; RISK; IMPACT	Background: The effect of large-scale expanded surveillance for methicillin-resistant Staphylococcus aureus (MRSA) on health careassociated MRSA disease is not known. Objective: To examine the effect of 2 expanded surveillance interventions on MRSA disease. Design: Observational study comparing rates of MRSA clinical disease during and after hospital admission in 3 consecutive periods: baseline (12 months), MRSA surveillance for all admissions to the intensive care unit (ICU) (12 months), and universal MRSA surveillance for all hospital admissions (21 months). Setting: A 3-hospital, 850-bed organization with approximately 40 000 annual admissions. Intervention: Polymerase chain reaction-based nasal surveillance for MRSA followed by topical decolonization therapy and contact isolation of patients who tested positive for MRSA. Measurements: Poisson and segmented regression models were used to compare prevalence density of hospital-associated clinical MRSA disease (bloodstream, respiratory, urinary tract, and surgical site) in each period. Rates of bloodstream disease with methicillin-susceptible S. aureus were used as a control. Results: The prevalence density of aggregate hospital-associated MRSA disease (all body sites) per 10 000 patient-days at baseline, during ICU surveillance, and during universal surveillance was 8.9 (95% Cl, 7.6 to 10.4), 7.4 (Cl, 6.1 to 9.0; P = 0.15 compared with baseline), and 3.9 (Cl, 3.2 to 4.7; P < 0.001 compared with baseline and ICU surveillance), respectively. During universal surveillance, the prevalence density of MRSA infection at each body site had a statistically significant decrease compared with baseline. The methicillin-susceptible S. aureus bacteremia rate did not statistically significantly change during the 3 periods. In a segmented regression model, the aggregate hospital-associated MRSA disease prevalence density changed by -36.2% (Cl, -65.4% to 9.8%; P= 0.17) from baseline to ICU surveillance and by -69.6% (Cl, -89.2% to -19.6%]; P = 0.03) from baseline to universal surveillance. During universal surveillance, the MRSA disease rate decreased during hospitalization and in the 30 days after discharge; no further reduction occurred thereafter. Surveillance with clinical cultures would have identified 17.8% of actual MRSA patient-days, and ICU-based surveillance with polymerase chain reaction would have identified 33.3%. Limitation: The findings rely on observational data. Conclusion: The introduction of universal admission surveillance for MRSA was associated with a large reduction in MRSA disease during admission and 30 days after discharge.	Evanston Northwestern Healthcare, Dept Pathol & Lab Med, Evanston, IL 60201 USA; Northwestern Univ, Feinberg Sch Med, Evanston, IL USA	NorthShore University Health System; Northwestern University; Feinberg School of Medicine	Peterson, LR (corresponding author), Evanston Northwestern Healthcare, Dept Pathol & Lab Med, 2650 Ridge Ave, Evanston, IL 60201 USA.	ari.robicsek@gmail.com; lancer@northwestern.edu	Beaumont, Jennifer/AAA-2825-2020	Beaumont, Jennifer/0000-0002-1484-260X				Clancy M, 2006, INFECT CONT HOSP EP, V27, P1009, DOI 10.1086/507915; *CONS UN, HELP STOP DANG SUP B; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Efron B., 1994, INTRO BOOTSTRAP; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Farr BM, 2006, INFECT CONT HOSP EP, V27, P999, DOI 10.1086/508672; Fridkin SK, 2002, EMERG INFECT DIS, V8, P697, DOI 10.3201/eid0807.010427; Girou E, 1998, CLIN INFECT DIS, V27, P543, DOI 10.1086/514695; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; Harbarth S, 2006, CRIT CARE, V10, DOI 10.1186/cc3982; *HEALTHC COST UT P, COM SOFTW VERS 3 2; *HLTH PROT AG, MRSA SURV SYST RES; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Jernigan JA, 1996, AM J EPIDEMIOL, V143, P496, DOI 10.1093/oxfordjournals.aje.a008770; JOHNSON S, 1990, LANCET, V336, P97, DOI 10.1016/0140-6736(90)91605-A; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; MCCAUGHEY B, 2006, NY TIMES, P11; Pan A, 2005, INFECT CONT HOSP EP, V26, P127, DOI 10.1086/502515; Paule SM, 2004, J MOL DIAGN, V6, P191, DOI 10.1016/S1525-1578(10)60509-0; Paule SM, 2007, J CLIN MICROBIOL, V45, P2993, DOI 10.1128/JCM.00670-07; Peterson LR, 2007, JT COMM J QUAL PATIE, V33, P732, DOI 10.1016/S1553-7250(07)33088-2; ROBICSEK A, 2006, 46 INT C ANT AG CHEM; Salgado CD, 2006, INFECT CONT HOSP EP, V27, P116, DOI 10.1086/500624; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shardell M, 2007, CLIN INFECT DIS, V45, P901, DOI 10.1086/521255; Shitrit P, 2006, INFECT CONT HOSP EP, V27, P1004, DOI 10.1086/507914; Siegel JD, 2006, MANAGEMENT MULTIDRUG; Warren DK, 2007, CRIT CARE MED, V35, P430, DOI 10.1097/01.CCM.0000253813.98431.28; West TE, 2006, INFECT CONT HOSP EP, V27, P233, DOI 10.1086/500372; 2007, GEN ASS PENNS HOUS B	34	334	335	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2008	148	6					409	418		10.7326/0003-4819-148-6-200803180-00003	http://dx.doi.org/10.7326/0003-4819-148-6-200803180-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279KT	18347349				2022-12-24	WOS:000254354800001
J	Debler, EW; Kaufmann, GF; Meijler, MM; Heine, A; Mee, JM; Pljevaljcic, G; Di Bilio, AJ; Schultz, PG; Millar, DP; Janda, KD; Wilson, IA; Gray, HB; Lerner, RA				Debler, Erik W.; Kaufmann, Gunnar F.; Meijler, Michael M.; Heine, Andreas; Mee, Jenny M.; Pljevaljcic, Goran; Di Bilio, Angel J.; Schultz, Peter G.; Millar, David P.; Janda, Kim D.; Wilson, Ian A.; Gray, Harry B.; Lerner, Richard A.			Deeply inverted electron-hole recombination in a luminescent antibody-stilbene complex	SCIENCE			English	Article							BLUE-FLUORESCENT-ANTIBODIES; PROTEINS; SENSOR	The blue- emissive antibody EP2-19G2 that has been elicited against trans- stilbene has unprecedented ability to produce bright luminescence and has been used as a biosensor in various applications. We show that the prolonged luminescence is not stilbene fluorescence. Instead, the emissive species is a charge- transfer excited complex of an anionic stilbene and a cationic, parallel pi-stacked tryptophan. Upon charge recombination, this complex generates exceptionally bright blue light. Complex formation is enabled by a deeply penetrating ligand-binding pocket, which in turn results from a noncanonical interface between the two variable domains of the antibody.	[Di Bilio, Angel J.; Gray, Harry B.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA; [Debler, Erik W.; Heine, Andreas; Pljevaljcic, Goran; Millar, David P.; Wilson, Ian A.; Lerner, Richard A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Debler, Erik W.; Kaufmann, Gunnar F.; Meijler, Michael M.; Mee, Jenny M.; Schultz, Peter G.; Janda, Kim D.; Wilson, Ian A.; Lerner, Richard A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Kaufmann, Gunnar F.; Meijler, Michael M.; Mee, Jenny M.; Schultz, Peter G.; Janda, Kim D.; Lerner, Richard A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Kaufmann, Gunnar F.; Janda, Kim D.] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Janda, Kim D.] Scripps Res Inst, Worm Inst Res & Med, La Jolla, CA 92037 USA	California Institute of Technology; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Gray, HB (corresponding author), CALTECH, Beckman Inst, Pasadena, CA 91125 USA.	hbgray@caltech.edu; rlerner@scripps.edu	Debler, Erik/D-1794-2013	Debler, Erik/0000-0002-2587-2150; Meijler, Michael/0000-0001-7095-1467	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK019038, R01DK019038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056528, R01GM038273, R29GM038273] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK19038] Funding Source: Medline; NIGMS NIH HHS [GM56528, R01 GM038273, GM38273] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BIRKS JB, 1970, PHOTOPHYSICS AROMATI, P420; Chen DW, 2001, J ORG CHEM, V66, P1725, DOI 10.1021/jo001676f; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; DENZIN LK, 1993, MOL IMMUNOL, V30, P1331, DOI 10.1016/0161-5890(93)90094-R; Di Bilio AJ, 2001, J AM CHEM SOC, V123, P3181, DOI 10.1021/ja0043183; Gotz M, 2002, BIOCHEMISTRY-US, V41, P4156, DOI 10.1021/bi015888y; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Kaufmann GF, 2005, ANGEW CHEM INT EDIT, V44, P2144, DOI 10.1002/anie.200461143; LEWIS FD, 1979, ACCOUNTS CHEM RES, V12, P152, DOI 10.1021/ar50136a007; Matsushita H, 2005, MOL BIOSYST, V1, P303, DOI 10.1039/b511408j; Matsushita M, 2005, ORG LETT, V7, P4943, DOI 10.1021/ol051919w; Matsushita M, 2003, ANGEW CHEM INT EDIT, V42, P5984, DOI 10.1002/anie.200352793; Murza A, 2000, BIOCHEMISTRY-US, V39, P10557, DOI 10.1021/bi000583p; NOVOTNY J, 1985, P NATL ACAD SCI USA, V82, P4592, DOI 10.1073/pnas.82.14.4592; RUOFF RS, 1995, J PHYS CHEM-US, V99, P8843, DOI 10.1021/j100021a060; Saltiel J., 1980, REARRANGEMENTS GROUN, P25, DOI DOI 10.1016/B978-0-12-481303-8.50007-X; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Simeonov A, 2000, SCIENCE, V290, P307, DOI 10.1126/science.290.5490.307; Tian T, 2006, ANGEW CHEM INT EDIT, V45, P7763, DOI 10.1002/anie.200602720; Tommos C, 1999, BIOCHEMISTRY-US, V38, P9495, DOI 10.1021/bi990609g; TURRO NJ, 1991, MODERN MOL PHOTOCHEM, P137; Wang Q, 2003, BIOCONJUGATE CHEM, V14, P38, DOI 10.1021/bc025587g; WHITLOW M, 1995, PROTEIN ENG, V8, P749, DOI 10.1093/protein/8.8.749; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11867, DOI 10.1073/pnas.211440398	27	40	43	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1232	1235		10.1126/science.1153445	http://dx.doi.org/10.1126/science.1153445			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309081				2022-12-24	WOS:000253530600040
J	Auerbach, PS				Auerbach, Paul S.			Physicians and the environment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stanford Univ, Sch Med, Dept Surg, Div Emergency Med, Palo Alto, CA 94304 USA	Stanford University	Auerbach, PS (corresponding author), Stanford Univ, Sch Med, Dept Surg, Div Emergency Med, 701 Welch Rd,Ste C, Palo Alto, CA 94304 USA.	auerbach@stanford.edu						*BBC WEATH CTR, CLIM CHANG; BOTKIN DB, 2007, WALL STREET J   1017, pA19; Campbell-Lendrum D, 2007, B WORLD HEALTH ORGAN, V85, P235, DOI 10.2471/BLT.06.039503; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Collins W, 2007, SCI AM, V297, P64, DOI 10.1038/scientificamerican0807-64; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; LONGSTRETH J, 1998, ENV EFFECTS OZONE DE; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; National Oceanic and Atmospheric Administration, TRENDS ATM CARB DIOX; Nelson SM, 2002, GEND ARCHAEOL SERIES, V1, P1; NICKLEN P, 2007, NATL GEOGR, V211, P12; Parry M. L., 2007, CLIMATE CHANGE 2007; Patz JA, 2000, ENVIRON HEALTH PERSP, V108, P367, DOI 10.2307/3454357; SACHS JD, CLIMATE CHANGE REFUG; Trenberth K, 2007, SCI AM, V297, P44, DOI 10.1038/scientificamerican0707-44; *UN WAT LIF, FACT SHEET WAT SAN; van der Linden P.J, 2007, CLIMATE CHANGE 2007, P391; Wiedinmyer Christine, 2007, Carbon Balance Manag, V2, P10, DOI 10.1186/1750-0680-2-10; *WORLD BANK GROUP, PIL PROGR CONS BRAZ; *WORLD WAT COUNC, WAT CRIS	21	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2008	299	8					956	958		10.1001/jama.299.8.956	http://dx.doi.org/10.1001/jama.299.8.956			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266DZ	18314440				2022-12-24	WOS:000253413200026
J	Bonetta, L				Bonetta, Laura			European stem cell patents: Taking the moral high road?	CELL			English	Editorial Material								A European law that prevents the patenting of discoveries that contravene morality is causing confusion when it comes to human embryonic stem cells. The ensuing debate is markedly different from the one in the United States, where the scope of stem cell patents and their licensing are under challenge.											0	6	7	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					514	516		10.1016/j.cell.2008.02.012	http://dx.doi.org/10.1016/j.cell.2008.02.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295565	Bronze			2022-12-24	WOS:000253817900007
J	Hainaut, P; Boyle, P				Hainaut, Pierre; Boyle, Peter			Curbing the liver cancer epidemic in Africa	LANCET			English	Editorial Material							HEPATITIS-B; WEST-AFRICA; INFECTION; GAMBIA		[Hainaut, Pierre; Boyle, Peter] Int Agcy Res Canc, F-69372 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	Boyle, P (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	director@iarc.fr	Boyle, Peter/A-4380-2014; Hainaut, Pierre/B-6018-2012	Boyle, Peter/0000-0001-6251-0610; Hainaut, Pierre/0000-0002-1303-1610				Boyle P, 2006, LANCET, V368, P629, DOI 10.1016/S0140-6736(06)69225-8; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kirk GD, 2006, CARCINOGENESIS, V27, P2070, DOI 10.1093/carcin/bgl060; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Raza SA, 2007, BRIT J CANCER, V96, P1127, DOI 10.1038/sj.bjc.6603649; Turner PC, 2005, LANCET, V365, P1950, DOI 10.1016/S0140-6736(05)66661-5; VANDERSANDE MA, PLOS ONE, V2, pE753; Viviani S, 1999, VACCINE, V17, P2946, DOI 10.1016/S0264-410X(99)00178-4	8	36	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2008	371	9610					367	368		10.1016/S0140-6736(08)60181-6	http://dx.doi.org/10.1016/S0140-6736(08)60181-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	260ED	18242399				2022-12-24	WOS:000252992700008
J	Hajkova, P; Ancelin, K; Waldmann, T; Lacoste, N; Lange, UC; Cesari, F; Lee, C; Almouzni, G; Schneider, R; Surani, MA				Hajkova, Petra; Ancelin, Katia; Waldmann, Tanja; Lacoste, Nicolas; Lange, Ulrike C.; Cesari, Francesca; Lee, Caroline; Almouzni, Genevieve; Schneider, Robert; Surani, M. Azim			Chromatin dynamics during epigenetic reprogramming in the mouse germ line	NATURE			English	Article							HISTONE ARGININE METHYLATION; REPAIR; NAP1; SPECIFICATION; DEMETER; BLIMP1	A unique feature of the germ cell lineage is the generation of totipotency. A critical event in this context is DNA demethylation and the erasure of parental imprints in mouse primordial germ cells ( PGCs) on embryonic day 11.5 ( E11.5) after they enter into the developing gonads(1,2). Little is yet known about the mechanism involved, except that it is apparently an active process. We have examined the associated changes in the chromatin to gain further insights into this reprogramming event. Here we show that the chromatin changes occur in two steps. The first changes in nascent PGCs at E8.5 establish a distinctive chromatin signature that is reminiscent of pluripotency. Next, when PGCs are residing in the gonads, major changes occur in nuclear architecture accompanied by an extensive erasure of several histone modifications and exchange of histone variants. Furthermore, the histone chaperones HIRA and NAP- 1 ( NAP111), which are implicated in histone exchange, accumulate in PGC nuclei undergoing reprogramming. We therefore suggest that the mechanism of histone replacement is critical for these chromatin rearrangements to occur. The marked chromatin changes are intimately linked with genome- wide DNA demethylation. On the basis of the timing of the observed events, we propose that if DNA demethylation entails a DNA repair- based mechanism, the evident histone replacement would represent a repair- induced response event rather than being a prerequisite.	[Hajkova, Petra; Ancelin, Katia; Lange, Ulrike C.; Cesari, Francesca; Lee, Caroline; Surani, M. Azim] Univ Cambridge, Welcome Trust Canc Res UK Gordon Inst Canc & Dev, Cambridge CB2 1QN, England; [Schneider, Robert] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Almouzni, Genevieve] Inst Curie, CNRS, F-75248 Paris 05, France	University of Cambridge; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Surani, MA (corresponding author), Univ Cambridge, Welcome Trust Canc Res UK Gordon Inst Canc & Dev, Tennis Court Rd, Cambridge CB2 1QN, England.	as10021@mole.bio.cam.ac.uk	Waldmann, Tanja/A-5145-2010; Almouzni, Genevieve/ABG-1029-2021; Ancelin, Katia/R-1719-2019	Waldmann, Tanja/0000-0001-9276-1592; Almouzni, Genevieve/0000-0001-5570-0723; Hajkova, Petra/0000-0003-4145-1468; Ancelin, Katia/0000-0002-2117-9754; Surani, Azim/0000-0002-8640-4318	Wellcome Trust [083089] Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Durcova-Hills G, 2006, P NATL ACAD SCI USA, V103, P11184, DOI 10.1073/pnas.0602621103; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Kaufman Paul D., 2006, V47, P121; Kepert JF, 2005, J BIOL CHEM, V280, P34063, DOI 10.1074/jbc.M507322200; Lee JD, 2002, DEVELOPMENT, V129, P5697, DOI 10.1242/dev.00159; Levchenko V, 2004, BIOCHEMISTRY-US, V43, P2359, DOI 10.1021/bi035737q; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Saitou M, 2003, PHILOS T R SOC B, V358, P1363, DOI 10.1098/rstb.2003.1324; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Surani MA, 2004, COLD SPRING HARB SYM, V69, P1, DOI 10.1101/sqb.2004.69.40; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Walfridsson J, 2007, EMBO J, V26, P2868, DOI 10.1038/sj.emboj.7601728; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0	30	460	482	1	59	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 17	2008	452	7189					877	U6		10.1038/nature06714	http://dx.doi.org/10.1038/nature06714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18354397	Green Accepted			2022-12-24	WOS:000255026000049
J	Milner, JD; Brenchley, JM; Laurence, A; Freeman, AF; Hill, BJ; Elias, KM; Kanno, Y; Spalding, C; Elloumi, HZ; Paulson, ML; Davis, J; Hsu, A; Asher, AI; O'Shea, J; Holland, SM; Paul, WE; Douek, DC				Milner, Joshua D.; Brenchley, Jason M.; Laurence, Arian; Freeman, Alexandra F.; Hill, Brenna J.; Elias, Kevin M.; Kanno, Yuka; Spalding, Christine; Elloumi, Houda Z.; Paulson, Michelle L.; Davis, Joie; Hsu, Amy; Asher, Ava I.; O'Shea, John; Holland, Steven M.; Paul, William E.; Douek, Daniel C.			Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome	NATURE			English	Article							HELPER T-CELLS; NEUTROPHIL RECRUITMENT; HOST-DEFENSE; IL-21; GENERATION; STAT3; ACTIVATION; EXPRESSION; CYTOKINE; INTERLEUKIN-17	The autosomal dominant hyper-IgE syndrome (HIES, 'Job's syndrome') is characterized by recurrent and often severe pulmonary infections, pneumatoceles, eczema, staphylococcal abscesses, mucocutaneous candidiasis, and abnormalities of bone and connective tissue(1,2). Mutations presumed to underlie HIES have recently been identified in stat3, the gene encoding STAT3 (signal transducer and activator of transcription 3) (refs 3, 4). Although impaired production of interferon-gamma and tumour-necrosis factor by T cells(5), diminished memory T-cell populations, decreased delayed-type-hypersensitivity responses and decreased in vitro lymphoproliferation in response to specific antigens(6) have variably been described, specific immunological abnormalities that can explain the unique susceptibility to particular infections seen in HIES have not yet been defined. Here we show that interleukin (IL)-17 production by T cells is absent in HIES individuals. We observed that ex vivo T cells from subjects with HIES failed to produce IL-17, but not IL-2, tumour-necrosis factor or interferon-gamma, on mitogenic stimulation with staphylococcal enterotoxin B or on antigenic stimulation with Candida albicans or streptokinase. Purified naive T cells were unable to differentiate into IL-17-producing (T(H)17) T helper cells in vitro and had lower expression of retinoid-related orphan receptor (ROR)-gamma t, which is consistent with a crucial role for STAT3 signalling in the generation of T(H)17 cells(7-14). T(H)17 cells have emerged as an important subset of helper T cells(15) that are believed to be critical in the clearance of fungal(16) and extracellular bacterial(17) infections. Thus, our data suggest that the inability to produce T(H)17 cells is a mechanism underlying the susceptibility to the recurrent infections commonly seen in HIES.	[Brenchley, Jason M.; Hill, Brenna J.; Asher, Ava I.; Douek, Daniel C.] NIAMSD, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Milner, Joshua D.; Paul, William E.] NIAMSD, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Laurence, Arian; Elias, Kevin M.; Kanno, Yuka; O'Shea, John] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Freeman, Alexandra F.; Spalding, Christine; Elloumi, Houda Z.; Paulson, Michelle L.; Davis, Joie; Hsu, Amy; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Elias, Kevin M.] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vanderbilt University	Douek, DC (corresponding author), NIAMSD, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	ddouek@nih.gov	Laurence, Arian/H-5534-2019; Laurence, Arian/A-8770-2009; Brenchley, Jason/AAC-5085-2019; Kanno, Yuka/B-5802-2013	Laurence, Arian/0000-0003-0942-8292; Laurence, Arian/0000-0003-0942-8292; Kanno, Yuka/0000-0001-5668-9319; Brenchley, Jason/0000-0001-8357-2984; Elias, Kevin/0000-0003-1502-5553	Intramural NIH HHS [Z99 AI999999] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001029, ZIAAI000493, ZIAAI000646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIAAR041167] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; BUCKLEY RH, 1972, PEDIATRICS, V49, P59; Buckley RH, 2001, CLIN REV ALLERG IMMU, V20, P139, DOI 10.1385/CRIAI:20:1:139; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; DELPRETE G, 1989, J CLIN INVEST, V84, P1830, DOI 10.1172/JCI114368; Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; KING CL, 1991, J IMMUNOL, V146, P1478; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Tanaka T, 2005, CLIN EXP IMMUNOL, V140, P524, DOI 10.1111/j.1365-2249.2005.02805.x; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	30	864	898	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					773	U11		10.1038/nature06764	http://dx.doi.org/10.1038/nature06764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18337720	Green Accepted			2022-12-24	WOS:000254792500050
J	Pearson, TA; Manolio, TA				Pearson, Thomas A.; Manolio, Teri A.			How to interpret a genome-wide association study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FALSE DISCOVERY RATE; POPULATION STRATIFICATION; CROHN-DISEASE; SUSCEPTIBILITY VARIANT; CONFER SUSCEPTIBILITY; COLORECTAL-CANCER; COMMON DISEASES; RISK LOCUS; ERROR RATE; GENE	Genome- wide association ( GWA) studies use high- throughput genotyping technologies to assay hundreds of thousands of single- nucleotide polymorphisms ( SNPs) and relate them to clinical conditions and measurable traits. Since 2005, nearly 100 loci for as many as 40 common diseases and traits have been identified and replicated in GWA studies, many in genes not previously suspected of having a role in the disease under study, and some in genomic regions containing no known genes. GWA studies are an important advance in discovering genetic variants influencing disease but also have important limitations, including their potential for false- positive and false- negative results and for biases related to selection of study participants and genotyping errors. Although these studies are clearly many steps removed from actual clinical use, and specific applications of GWA findings in prevention and treatment are actively being pursued, at present these studies mainly represent a valuable discovery tool for examining genomic function and clarifying pathophysiologic mechanisms. This article describes the design, interpretation, application, and limitations of GWA studies for clinicians and scientists for whom this evolving science may have great relevance.	[Pearson, Thomas A.; Manolio, Teri A.] NHGRI, Off Populat Genom, NIH, Bethesda, MD 20892 USA; [Pearson, Thomas A.] Univ Rochester, Med Ctr, Clin & Translat Sci Inst, Rochester, NY 14642 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Rochester	Manolio, TA (corresponding author), NHGRI, Off Populat Genom, NIH, 31 Ctr Dr,Room 4B-09,MSC 2154, Bethesda, MD 20892 USA.	manolio@nih.gov			NCRR NIH HHS [UL1 RR024160, RR024160] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Christensen K, 2007, NEW ENGL J MED, V356, P1094, DOI 10.1056/NEJMp068126; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Cupples LA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Frayling TM, 2007, DIABETOLOGIA, V50, P2229, DOI 10.1007/s00125-007-0825-7; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; GORDIS L, 2000, EPIDEMIOLOGY, P165; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoover RN, 2007, EPIDEMIOLOGY, V18, P13, DOI 10.1097/01.ede.0000249532.81073.b2; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Khoury MJ, 2007, INT J EPIDEMIOL, V36, P439, DOI 10.1093/ije/dyl253; LAST J, 1983, DICT EPIDEMIOLOGY, P7; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Moskvina V, 2006, HUM HERED, V61, P55, DOI 10.1159/000092553; Mueller PW, 2006, J AM SOC NEPHROL, V17, P1782, DOI 10.1681/ASN.2005080822; *NAT LIB MED NAT C, DAT SINGL NUCL POL; Patterson M, 2005, PLOS BIOL, V3, P1511, DOI 10.1371/journal.pbio.0030327; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sabatti C, 2003, GENETICS, V164, P829; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SLATER EE, 1988, DRUGS, V36, P72, DOI 10.2165/00003495-198800363-00016; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yang Q, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S134; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821; 2007, FED REG, V72, P49290	73	610	652	3	81	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1335	1344		10.1001/jama.299.11.1335	http://dx.doi.org/10.1001/jama.299.11.1335			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349094				2022-12-24	WOS:000254079100024
J	van Meurs, JBJ; Trikalinos, TA; Ralston, SH; Balcells, S; Brandi, ML; Brixen, K; Kiel, DP; Langdahl, BL; Lips, P; Ljunggren, O; Lorenc, R; Obermayer-Pietsch, B; Ohlsson, C; Pettersson, U; Reid, DM; Rousseau, F; Scollen, S; Van Hul, W; Agueda, L; Akesson, K; Benevolenskaya, LI; Ferrari, SL; Hallmans, G; Hofman, A; Husted, LB; Kruk, M; Kaptoge, S; Karasik, D; Karlsson, MK; Lorentzon, M; Masi, L; McGuigan, FEA; Mellstrom, D; Mosekilde, L; Nogues, X; Pols, HAP; Reeve, J; Renner, W; Rivadeneira, F; van Schoor, NM; Weber, K; Ioannidis, JPA; Uitterlinden, AG				van Meurs, Joyce B. J.; Trikalinos, Thomas A.; Ralston, Stuart H.; Balcells, Susana; Brandi, Maria Luisa; Brixen, Kim; Kiel, Douglas P.; Langdahl, Bente L.; Lips, Paul; Ljunggren, Osten; Lorenc, Roman; Obermayer-Pietsch, Barbara; Ohlsson, Claes; Pettersson, Ulrika; Reid, David M.; Rousseau, Francois; Scollen, Serena; Van Hul, Wim; Agueda, Lidia; Akesson, Kristina; Benevolenskaya, Lidia I.; Ferrari, Serge L.; Hallmans, Goran; Hofman, Albert; Husted, Lise Bjerre; Kruk, Marcin; Kaptoge, Stephen; Karasik, David; Karlsson, Magnus K.; Lorentzon, Mattias; Masi, Laura; McGuigan, Fiona E. A.; Mellstrom, Dan; Mosekilde, Leif; Nogues, Xavier; Pols, Huibert A. P.; Reeve, Jonathan; Renner, Wilfried; Rivadeneira, Fernando; van Schoor, Natasja M.; Weber, Kurt; Ioannidis, John P. A.; Uitterlinden, Andre G.		GENOMOS Study	Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECEPTOR-RELATED PROTEIN-5; BONE-MINERAL DENSITY; COMMON GENETIC-VARIATION; FRACTURE RISK; INDEPENDENT PREDICTOR; FREE TESTOSTERONE; ODENSE ANDROGEN; CLINICAL-TRIALS; JAPANESE WOMEN; POLYMORPHISMS	Context Mutations in the low- density lipoprotein receptor - related protein 5 ( LRP5) gene cause rare syndromes characterized by altered bone mineral density ( BMD). More common LRP5 variants may affect osteoporosis risk in the general population. Objective To generate large- scale evidence on whether 2 common variants of LRP5 ( Val667Met,Ala1330Val) and 1 variant of LRP6( Ile1062Val) are associated with BMD and fracture risk. Design and Setting Prospective, multicenter, collaborative study of individual-level data on 37 534 individuals from 18 participating teams in Europe and North America. Data were collected between September 2004 and January 2007; analysis of the collected data was performed between February and May 2007. Bone mineral density was assessed by dual- energy x- ray absorptiometry. Fractures were identified via questionnaire, medical records, or radiographic documentation; incident fracture data were available for some cohorts, ascertained via routine surveillance methods, including radiographic examination for vertebral fractures. Main Outcome Measures Bone mineral density of the lumbar spine and femoral neck; prevalence of all fractures and vertebral fractures. Results The Met667 allele of LRP5 was associated with reduced lumbar spine BMD ( n= 25 052 [ number of participants with available data]; 20- mg/ cm(2) lower BMD per Met667 allele copy; P= 3.3 x 10(-8)), as was the Val1330 allele ( n= 24 812; 14- mg/ cm(2) lower BMD per Val1330 copy; P= 2.6 x 10(-9)). Similar effects were observed for femoral neck BMD, with a decrease of 11 mg/ cm(2) ( P= 3.8 x 10(-5)) and 8 mg/ cm2 ( P= 5.0 x 10(-6)) for the Met667 and Val1330 alleles, respectively ( n= 25 193). Findings were consistent across studies for both LRP5 alleles. Both alleles were associated with vertebral fractures ( odds ratio [ OR], 1.26; 95% confidence interval [ CI], 1.08-1.47 for Met667 [ 2001 fractures among 20 488 individuals] and OR, 1.12; 95% CI, 1.01- 1.24 for Val1330 [ 1988 fractures among 20 096 individuals]). Risk of all fractures was also increased with Met667 ( OR, 1.14; 95% CI, 1.05- 1.24 per allele [ 7876 fractures among 31 435 individuals)]) and Val1330 ( OR, 1.06; 95% CI, 1.01- 1.12 per allele [ 7802 fractures among 31 199 individuals]). Effects were similar when adjustments were made for age, weight, height, menopausal status, and use of hormone therapy. Fracture risks were partly attenuated by adjustment for BMD. Haplotype analysis indicated that Met667 and Val1330 variants both independently affected BMD. The LRP6 Ile1062Val polymorphism was not associated with any osteoporosis phenotype. All aforementioned associations except that between Val1330 and all fractures and vertebral fractures remained significant after multiple-comparison adjustments. Conclusions Common LRP5 variants are consistently associated with BMD and fracture risk across different white populations. The magnitude of the effect is modest. LRP5 may be the first gene to reach a genome- wide significance level ( a conservative level of significance [ herein, unadjusted P < 10(-7)] that accounts for the many possible comparisons in the human genome) for a phenotype related to osteoporosis.	[Trikalinos, Thomas A.; Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [van Meurs, Joyce B. J.; Pols, Huibert A. P.; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Trikalinos, Thomas A.; Ioannidis, John P. A.] Tufts Univ, New England Med Ctr, Ctr Clin Evidence Synth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Trikalinos, Thomas A.] Tufts Univ, New England Med Ctr, Ctr Genet Epidemiol & Modeling, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; [Ralston, Stuart H.] Univ Edinburgh, Rheumat Dis Unit, Edinburgh, Midlothian, Scotland; [Balcells, Susana; Agueda, Lidia] Univ Barcelona, Dept Genet, CIBERER, IBUB, Barcelona, Spain; [Brandi, Maria Luisa; Masi, Laura] Univ Florence, Dept Internal Med, Florence, Italy; [Brixen, Kim] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Ohlsson, Claes; Lorentzon, Mattias; Mellstrom, Dan] Shlgrenska Acad, Dept Internal Med, Ctr Bone Res, Gothenburg, Sweden; [Kiel, Douglas P.; Karasik, David] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA; [Kiel, Douglas P.; Karasik, David] Harvard Univ, Sch Med, Boston, MA USA; [Langdahl, Bente L.; Husted, Lise Bjerre; Mosekilde, Leif] Aarhus Univ Hosp, Dept Endocrinol, DK-8000 Aarhus, Denmark; [Lips, Paul; van Schoor, Natasja M.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Amsterdam, Netherlands; [Ljunggren, Osten] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lorenc, Roman; Kruk, Marcin] Childrens Mem Hlth Inst, Dept Biochem & Expt Med, Warsaw, Poland; [Obermayer-Pietsch, Barbara; Renner, Wilfried] Med Univ Graz, Dept Internal Med, Graz, Austria; [Pettersson, Ulrika] Umea Univ, Dept Pharmacol & Neurosci, Umea, Sweden; [Pettersson, Ulrika] Umea Univ, Dept Sports Med, Umea, Sweden; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Reid, David M.; McGuigan, Fiona E. A.] Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland; [Rousseau, Francois] Ctr Hosp Univ Quebec, Unite Rech Genet Humaine & Mol, Ctr Rech Hop St Francois Assise, Quebec City, PQ, Canada; [Scollen, Serena; Kaptoge, Stephen; Reeve, Jonathan] Univ Cambridge, Strangeways Res Lab, Cambridge, England; [Van Hul, Wim] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; [Akesson, Kristina; Karlsson, Magnus K.] Lund Univ, Dept Orthoped, Malmo Univ Hosp, Lund, Sweden; [Benevolenskaya, Lidia I.] Russian Acad Med Sci, Inst Rheumatol, Moscow 109801, Russia; [Ferrari, Serge L.] Univ Hosp Geneva, Div Bone Dis, Geneva, Switzerland; [Hofman, Albert; Pols, Huibert A. P.; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands; [Nogues, Xavier] UAB, Hosp del Mar, IMIM, Barcelona, Spain; [Weber, Kurt] Univ Hosp, Dept Med, Graz, Austria	University of Ioannina; Erasmus University Rotterdam; Erasmus MC; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Tufts University; University of Edinburgh; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Florence; University of Southern Denmark; Odense University Hospital; Harvard University; Hebrew SeniorLife; Harvard University; Harvard Medical School; Aarhus University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Uppsala University; Children's Memorial Health Institute; Medical University of Graz; Umea University; Umea University; Umea University; University of Aberdeen; Laval University; University of Cambridge; University of Antwerp; Lund University; Skane University Hospital; Russian Academy of Medical Sciences; University of Geneva; Erasmus University Rotterdam; Erasmus MC; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	van Leeuwen, Johannes/D-5015-2014; Rivadeneira, Fernando/O-5385-2015; Balcells, Susana/C-5222-2017; Ohlsson, Claes/AGP-3544-2022; Andersen, Marianne Skovsager/AAE-1751-2019; Trikalinos, Thomas A/A-1217-2009; Grinberg, Daniel/F-3641-2010; Ioannidis, John P. A./G-9836-2011; Duncan, Emma L/L-1224-2013; Reeve, Jonathan/C-7551-2012; Lorentzon, Mattias/W-7878-2019; Cannata-Andía, Jorge B L/L-2260-2013; Lewinski, Andrzej/N-3971-2014; Ferrari, Serge/ABD-2730-2020; Da Silva, Jose/K-9769-2018	van Leeuwen, Johannes/0000-0002-2282-4006; Rivadeneira, Fernando/0000-0001-9435-9441; Balcells, Susana/0000-0003-1211-1907; Ohlsson, Claes/0000-0002-9633-2805; Andersen, Marianne Skovsager/0000-0002-4603-9504; Grinberg, Daniel/0000-0001-9859-2590; Duncan, Emma L/0000-0002-8143-4403; Reeve, Jonathan/0000-0002-4364-2682; Lorentzon, Mattias/0000-0003-0749-1431; Cannata-Andía, Jorge B L/0000-0001-6543-9960; Ferrari, Serge/0000-0002-1372-4417; Kiel, Douglas/0000-0001-8474-0310; Nogues, Xavier/0000-0001-8201-9933; Bergdahl, Ingvar/0000-0003-1227-6859; van Meurs, Joyce/0000-0001-6245-2123; Scollen, Serena/0000-0002-9311-1337; Nordstrom, Peter/0000-0003-2924-508X; Pettersson Kymmer, Ulrika/0000-0002-0557-9803; Diez-Perez, Adolfo/0000-0001-8162-0209; van Schoor, Natasja/0000-0002-0870-0795; Armas, Jacome/0000-0001-7671-6521; Nogues, Xavier/0000-0002-5537-1859; Da Silva, Jose/0000-0002-2782-6780; Van Hul, Wim/0000-0002-5065-7858; Karasik, David/0000-0002-8826-0530; Eiken, Pia/0000-0001-7278-5968; Jensen, Jens-Erik Beck/0000-0003-4290-0480; Van Duijn, Cornelia/0000-0002-2374-9204	Medical Research Council [U1475000001] Funding Source: researchfish; MRC [G0400491] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050066, R01AR041398] Funding Source: NIH RePORTER; Medical Research Council [G0401527, G0400491, MC_UP_A620_1014] Funding Source: Medline; NHLBI NIH HHS [N01-HC-25195, N01HC25195] Funding Source: Medline; NIAMS NIH HHS [R01 AR041398-17, R01-AR050066, R01 AR050066, R01 AR041398] Funding Source: Medline; NIA NIH HHS [AR/AG41398] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abrahamsen B, 2006, BONE, V38, P215, DOI 10.1016/j.bone.2005.08.005; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bollerslev J, 2005, BONE, V36, P599, DOI 10.1016/j.bone.2005.01.006; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brixen K, 2007, CALCIFIED TISSUE INT, V81, P421, DOI 10.1007/s00223-007-9088-z; Brown BW, 1997, STAT MED, V16, P2511, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2511::AID-SIM693>3.0.CO;2-4; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bustamante M, 2007, OSTEOPOROSIS INT, V18, P235, DOI 10.1007/s00198-006-0225-8; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; Deeg DJH, 2002, J CLIN EPIDEMIOL, V55, P319, DOI 10.1016/S0895-4356(01)00475-9; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dobnig H, 2006, J CLIN ENDOCR METAB, V91, P3355, DOI 10.1210/jc.2006-0460; EVANS RA, 1988, ANN INTERN MED, V109, P870, DOI 10.7326/0003-4819-109-11-870; Ezura Y, 2007, BONE, V40, P997, DOI 10.1016/j.bone.2005.06.025; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Ferrari SL, 2004, AM J HUM GENET, V74, P866, DOI 10.1086/420771; Ferrari SL, 2005, CURR OPIN LIPIDOL, V16, P207, DOI 10.1097/01.mol.0000162326.62419.e4; Giroux S, 2007, BONE, V40, P1299, DOI 10.1016/j.bone.2007.01.004; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grundberg E, 2008, OSTEOPOROSIS INT, V19, P829, DOI 10.1007/s00198-007-0512-z; Gugatschka M, 2005, QJM-INT J MED, V98, P857, DOI 10.1093/qjmed/hci140; Hallmans G, 2003, SCAND J PUBLIC HEALT, V31, P18, DOI 10.1080/14034950310001432; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Kiel DP, 2007, BONE, V40, P587, DOI 10.1016/j.bone.2006.09.029; Koay MA, 2007, CALCIFIED TISSUE INT, V81, P1, DOI 10.1007/s00223-007-9024-2; Koay MA, 2004, J BONE MINER RES, V19, P1619, DOI 10.1359/JBMR.040704; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Koller DL, 2005, J BONE MINER RES, V20, P75, DOI 10.1359/JBMR.041019; Kruk M, 2007, CALCIFIED TISSUE INT, V80, pS100; Langdahl BL, 2002, J BONE MINER RES, V17, P1245, DOI 10.1359/jbmr.2002.17.7.1245; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lorentzon M, 2005, J BONE MINER RES, V20, P1334, DOI 10.1359/JBMR.050404; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Masi L, 2001, J CLIN ENDOCR METAB, V86, P2263, DOI 10.1210/jc.86.5.2263; MCCLOSKEY EV, 1993, OSTEOPOROSIS INT, V3, P138, DOI 10.1007/BF01623275; McGuigan FEA, 2007, J BONE MINER RES, V22, P195, DOI [10.1359/jbmr.061016, 10.1359/JBMR.061016]; Mellstrom D, 2006, J BONE MINER RES, V21, P529, DOI 10.1359/JBMR.060110; MELTON LJ, 1993, J BONE MINER RES, V8, P1227; Moonesinghe R, 2008, P NATL ACAD SCI USA, V105, P617, DOI 10.1073/pnas.0705554105; Mosekilde L, 1999, MATURITAS, V31, P207, DOI 10.1016/S0378-5122(99)00006-7; Obermayer-Pietsch BM, 2004, J BONE MINER RES, V19, P42, DOI 10.1359/JBMR.0301207; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Ralston SH, 2005, HUM MOL GENET, V14, P943, DOI 10.1093/hmg/ddi088; Ralston SH, 2006, PLOS MED, V3, P515, DOI 10.1371/journal.pmed.0030090; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROUSSET F, 1995, GENETICS, V140, P1413; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Saarinen A, 2007, BONE, V40, P1006, DOI 10.1016/j.bone.2006.11.010; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Uitterlinden AG, 2006, ANN INTERN MED, V145, P936, DOI 10.7326/0003-4819-145-12-200612190-00021; UITTERLINDEN AG, 2001, OSTEOPOROSIS, P639; Uitterlinden AG, 2006, ANN INTERN MED, V145, P255, DOI 10.7326/0003-4819-145-4-200608150-00005; Urano T, 2004, J BONE MINER METAB, V22, P341, DOI 10.1007/s00774-003-0492-9; Urano T, 2007, SPINE, V32, P25, DOI 10.1097/01.brs.0000251003.62212.5b; van Meurs JBJ, 2006, J BONE MINER RES, V21, P141, DOI 10.1359/JBMR.050904; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Xiong DH, 2007, J BONE MINER RES, V22, P385, DOI 10.1359/JBMR.061116; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang ZL, 2005, ACTA PHARMACOL SIN, V26, P1111, DOI 10.1111/j.1745-7254.2005.00173.x	67	194	202	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1277	1290		10.1001/jama.299.11.1277	http://dx.doi.org/10.1001/jama.299.11.1277			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349089	Green Accepted			2022-12-24	WOS:000254079100019
J	D'Ardenne, K; McClure, SM; Nystrom, LE; Cohen, JD				D'Ardenne, Kimberlee; McClure, Samuel M.; Nystrom, Leigh E.; Cohen, Jonathan D.			BOLD responses reflecting dopaminergic signals in the human ventral tegmental area	SCIENCE			English	Article							TEMPORAL DIFFERENCE MODELS; PARKINSONS-DISEASE; REWARD; MIDBRAIN; NEURONS; PREDICTION; NOVELTY; ACTIVATION; MEMORY; HIPPOCAMPUS	Current theories hypothesize that dopamine neuronal firing encodes reward prediction errors. Although studies in nonhuman species provide direct support for this theory, functional magnetic resonance imaging ( fMRI) studies in humans have focused on brain areas targeted by dopamine neurons [ ventral striatum ( VStr)] rather than on brainstem dopaminergic nuclei [ ventral tegmental area ( VTA) and substantia nigra]. We used fMRI tailored to directly image the brainstem. When primary rewards were used in an experiment, the VTA blood oxygen level - dependent ( BOLD) response reflected a positive reward prediction error, whereas the VStr encoded positive and negative reward prediction errors. When monetary gains and losses were used, VTA BOLD responses reflected positive reward prediction errors modulated by the probability of winning. We detected no significant VTA BOLD response to nonrewarding events.	[D'Ardenne, Kimberlee] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [D'Ardenne, Kimberlee; McClure, Samuel M.; Nystrom, Leigh E.; Cohen, Jonathan D.] Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA; [McClure, Samuel M.; Nystrom, Leigh E.; Cohen, Jonathan D.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Cohen, Jonathan D.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Princeton University; Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	D'Ardenne, K (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	dardenne@princeton.edu			NIMH NIH HHS [P50 MH062196, F32 MH072141, T32 MH065214] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196, F32MH072141, T32MH065214] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Braver TS, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P713; Bunzeck N, 2007, CEREB CORTEX, V17, P2940, DOI 10.1093/cercor/bhm020; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dreher JC, 2006, CEREB CORTEX, V16, P561, DOI 10.1093/cercor/bhj004; Dunckley P, 2005, J NEUROSCI, V25, P7333, DOI 10.1523/JNEUROSCI.1100-05.2005; Duvernoy HM, 1995, HUMAN BRAIN STEM CER; Eckert T, 2004, NEUROIMAGE, V21, P229, DOI 10.1016/j.neuroimage.2003.08.028; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Napadow V, 2006, NEUROIMAGE, V32, P1113, DOI 10.1016/j.neuroimage.2006.05.050; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Oikawa H, 2002, AM J NEURORADIOL, V23, P1747; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; Schneider KA, 2005, J NEUROPHYSIOL, V94, P2491, DOI 10.1152/jn.00288.2005; Schneider KA, 2004, J NEUROSCI, V24, P8975, DOI 10.1523/JNEUROSCI.2413-04.2004; Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Schott BH, 2007, BRAIN, V130, P2412, DOI 10.1093/brain/awm147; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Tobler PN, 2007, NEURON, V54, P167, DOI 10.1016/j.neuron.2007.03.004; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Wittmann BC, 2007, NEUROIMAGE, V38, P194, DOI 10.1016/j.neuroimage.2007.06.038	42	479	480	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1264	1267		10.1126/science.1150605	http://dx.doi.org/10.1126/science.1150605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309087				2022-12-24	WOS:000253530600050
J	Dial, KP; Jackson, BE; Segre, P				Dial, Kenneth P.; Jackson, Brandon E.; Segre, Paolo			A fundamental avian wing-stroke provides a new perspective on the evolution of flight	NATURE			English	Article							MANEUVERING FLIGHT; WIDE-RANGE; ORIGIN; AERODYNAMICS; KINEMATICS; BIRDS	The evolution of avian flight remains one of biology's major controversies, with a long history of functional interpretations of fossil forms given as evidence for either an arboreal or cursorial origin of flight. Despite repeated emphasis on the 'wing-stroke' as a necessary avenue of investigation for addressing the evolution of flight(1-4), no empirical data exist on wing-stroke dynamics in an experimental evolutionary context. Here we present the first comparison of wing-stroke kinematics of the primary locomotor modes (descending flight and incline flap- running) that lead to level- flapping flight in juvenile ground birds throughout development (Fig. 1). We offer results that are contrary both to popular perception and inferences from other studies(5-7). Starting shortly after hatching and continuing through adulthood, ground birds use a wing- stroke confined to a narrow range of less than 20 degrees, when referenced to gravity, that directs aerodynamic forces about 40 degrees above horizontal, permitting a 180 degrees range in the direction of travel. Based on our results, we put forth an ontogenetic- transitional wing hypothesis that posits that the incremental adaptive stages leading to the evolution of avian flight correspond behaviourally and morphologically to transitional stages observed in ontogenetic forms.	[Dial, Kenneth P.; Jackson, Brandon E.; Segre, Paolo] Univ Montana, Div Biol Sci, Flight Lab, Missoula, MT 59812 USA	University of Montana System; University of Montana	Dial, KP (corresponding author), Univ Montana, Div Biol Sci, Flight Lab, 32 Campus Dr, Missoula, MT 59812 USA.	kdial@mso.umt.edu	Jackson, Brandon/H-3869-2012; Segre, Paolo/A-7865-2011					Bundle MW, 2003, J EXP BIOL, V206, P4553, DOI 10.1242/jeb.00673; Dial KP, 2006, BIOSCIENCE, V56, P437, DOI 10.1641/0006-3568(2006)056[0437:WUIHAW]2.0.CO;2; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; FEDUCCIA A, 1979, SCIENCE, V203, P1021, DOI 10.1126/science.203.4384.1021; Garner JP, 1999, P ROY SOC B-BIOL SCI, V266, P1259, DOI 10.1098/rspb.1999.0772; Gatesy SM, 2005, PALEOBIOLOGY, V31, P382, DOI 10.1666/0094-8373(2005)031[0382:TOOTAF]2.0.CO;2; Gauthier J., 1985, P185; Hedrick TL, 2007, J EXP BIOL, V210, P1897, DOI 10.1242/jeb.002055; Hedrick TL, 2002, J EXP BIOL, V205, P1389; JENKINS FA, 1993, AM J SCI, V293A, P253, DOI 10.2475/ajs.293.A.253; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Norberg U.M., 1985, P293; Ostrom J.H., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P1; PADIAN K, 1985, PALAEONTOLOGY, V28, P413; Padian K, 2005, NATURE, V438, pE3, DOI 10.1038/nature04354; Padian K, 1998, SCI AM, V278, P38, DOI 10.1038/scientificamerican0298-38; Park KJ, 2001, J EXP BIOL, V204, P2741; SPEAKMAN JR, 1995, NATURE, V374, P221, DOI 10.1038/374221b0; Tobalske BW, 2007, J EXP BIOL, V210, P1742, DOI 10.1242/jeb.001701; Tobalske BW, 1996, J EXP BIOL, V199, P263; Warrick DR, 1998, J EXP BIOL, V201, P655; Witmer Lawrence M., 2002, P3; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; [No title captured]; [No title captured]	25	67	69	2	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					985	U3		10.1038/nature06517	http://dx.doi.org/10.1038/nature06517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18216784	Green Published			2022-12-24	WOS:000253313100047
J	Furuike, S; Hossain, MD; Maki, Y; Adachi, K; Suzuki, T; Kohori, A; Itoh, H; Yoshida, M; Kinosita, K				Furuike, Shou; Hossain, Mohammad Delawar; Maki, Yasushi; Adachi, Kengo; Suzuki, Toshiharu; Kohori, Ayako; Itoh, Hiroyasu; Yoshida, Masasuke; Kinosita, Kazuhiko, Jr.			Axle-less F-1-ATPase rotates in the correct direction	SCIENCE			English	Article							ATP SYNTHASE; F-1 MOTOR; F1-ATPASE; RESOLUTION; MITOCHONDRIA; CATALYSIS; MECHANISM	F-1- adenosine triphosphatase ( ATPase) is an ATP- driven rotary molecular motor in which the central gamma subunit rotates inside a cylinder made of three alpha and three beta subunits alternately arranged. The rotor shaft, an antiparallel alpha- helical coiled coil of the amino and carboxyl termini of the gamma subunit, deeply penetrates the central cavity of the stator cylinder. We truncated the shaft step by step until the remaining rotor head would be outside the cavity and simply sat on the concave entrance of the stator orifice. All truncation mutants rotated in the correct direction, implying torque generation, although the average rotary speeds were low and short mutants exhibited moments of irregular motion. Neither a fixed pivot nor a rigid axle was needed for rotation of F-1- ATPase.	[Furuike, Shou; Hossain, Mohammad Delawar; Adachi, Kengo; Kohori, Ayako; Kinosita, Kazuhiko, Jr.] Waseda Univ, Dept Phys, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Hossain, Mohammad Delawar] Shahjalal Univ Sci & Technol, Dept Phys, Sch Phys Sci, Sylhet 3114, Bangladesh; [Maki, Yasushi] Osaka Med Coll, Dept Phys, Osaka 5698686, Japan; [Suzuki, Toshiharu; Yoshida, Masasuke] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; [Suzuki, Toshiharu; Yoshida, Masasuke] Japan Sci & Technol Agcy, ATP Synth Regulat Project, ICORP, Tokyo 1350064, Japan; [Itoh, Hiroyasu] Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan; [Itoh, Hiroyasu] CREST Format Soft Nanomachines Team 13, Tsukuba, Ibaraki 3002635, Japan	Waseda University; Shahjalal University of Science & Technology (SUST); Osaka Medical College; Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Hamamatsu Photonics; Japan Science & Technology Agency (JST)	Kinosita, K (corresponding author), Waseda Univ, Dept Phys, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan.	kazuhiko@waseda.jp						ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Boyer P.D., 1981, PRESENT STATUS BINDI, P231; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Hossain MD, 2006, BIOPHYS J, V90, P4195, DOI 10.1529/biophysj.105.079087; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; MIWA K, 1989, P NATL ACAD SCI USA, V86, P6484, DOI 10.1073/pnas.86.17.6484; Muller M, 2002, J BIOL CHEM, V277, P23308, DOI 10.1074/jbc.M201998200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; OHTA S, 1988, BIOCHIM BIOPHYS ACTA, V933, P141, DOI 10.1016/0005-2728(88)90064-3; Okada Y, 2003, NATURE, V424, P574, DOI 10.1038/nature01804; Oosawa F, 1986, Adv Biophys, V22, P151, DOI 10.1016/0065-227X(86)90005-5; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	22	88	88	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					955	958		10.1126/science.1151343	http://dx.doi.org/10.1126/science.1151343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276891				2022-12-24	WOS:000253165700047
J	Kirkwood, TBL				Kirkwood, Thomas B. L.			A systematic look at an old problem	NATURE			English	Article							MITOCHONDRIAL-DNA DELETIONS; SUBSTANTIA-NIGRA NEURONS; LIFE-SPAN; CAENORHABDITIS-ELEGANS; C-ELEGANS; STRESS; DISEASE; GENES; AGE; RESTRICTION		Univ Newcastle, Integrated Syst Biol Ageing & Nutr, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Newcastle University - UK	Kirkwood, TBL (corresponding author), Univ Newcastle, Integrated Syst Biol Ageing & Nutr, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	tom.kirkwood@ncl.ac.uk			Biotechnology and Biological Sciences Research Council [BB/C008200/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Esiri MM, 2001, LANCET, V357, P169; Finch C, 2000, CHANCE DEV AGING; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Kirkwood TBL, 2003, NAT REV MOL CELL BIO, V4, P243, DOI 10.1038/nrm1051; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kirkwood TBL, 2002, NATURE, V419, P794, DOI 10.1038/419794a; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KIRKWOOD TBL, 1982, HUM GENET, V60, P101, DOI 10.1007/BF00569695; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Peto R, 1997, BRIT MED J, V315, P1030, DOI 10.1136/bmj.315.7115.1030; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Shanley DP, 2006, BIOGERONTOLOGY, V7, P165, DOI 10.1007/s10522-006-9006-1; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Sozou PD, 2001, J THEOR BIOL, V213, P573, DOI 10.1006/jtbi.2001.2432; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003	30	224	241	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					644	647		10.1038/451644a	http://dx.doi.org/10.1038/451644a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256658				2022-12-24	WOS:000252929500027
J	Gawande, A; Denno, DW; Truog, RD; Waisel, D				Gawande, Atul; Denno, Deborah W.; Truog, Robert D.; Waisel, David			Perspective roundtable: Physicians and execution - Highlights from a discussion of lethal injection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gawande, Atul; Truog, Robert D.; Waisel, David] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gawande, Atul] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Gawande, Atul] Brigham & Womens Hosp, Boston, MA 02115 USA; [Denno, Deborah W.] Fordham Univ, Sch Law, Bronx, NY 10458 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Fordham University	Gawande, A (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.			Waisel, David/0000-0002-5307-4092; Gawande, Atul/0000-0002-1824-9176					0	17	17	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2008	358	5					448	451		10.1056/NEJMp0800378	http://dx.doi.org/10.1056/NEJMp0800378			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256IW	18216349				2022-12-24	WOS:000252722900002
J	Zhao, WH; Kruse, JP; Tang, Y; Jung, SY; Qin, J; Gu, W				Zhao, Wenhui; Kruse, Jan-Philipp; Tang, Yi; Jung, Sung Yun; Qin, Jun; Gu, Wei			Negative regulation of the deacetylase SIRT1 by DBC1	NATURE			English	Article							TRANSCRIPTION FACTORS; CELL-SURVIVAL; LIFE-SPAN; P53; RESVERATROL; ACTIVATION; ACETYLATION; PGC-1-ALPHA; CANDIDATE; APOPTOSIS	SIRT1 is an NAD- dependent deacetylase critically involved in stress responses, cellular metabolism and, possibly, ageing(1-15). The tumour suppressor p53 represents the first non- histone substrate functionally regulated by acetylation and deacetylation(16,17); we and others previously found that SIRT1 promotes cell survival by deacetylating p53 ( refs 4-6). These results were further supported by the fact that p53 hyperacetylation and increased radiation- induced apoptosis were observed in Sirt1- deficient mice(10). Nevertheless, SIRT1-mediated deacetylase function is also implicated in p53- independent pathways under different cellular contexts, and its effects on transcriptional factors such as members of the FOXO family and PGC-1 alpha directly modulate metabolic responses(1-15). These studies validate the importance of the deacetylase activity of SIRT1, but how SIRT1 activity is regulated in vivo is not well understood. Here we show that DBC1 ( deleted in breast cancer 1) acts as a native inhibitor of SIRT1 in human cells. DBC1- mediated repression of SIRT1 leads to increasing levels of p53 acetylation and upregulation of p53-mediated function. In contrast, depletion of endogenous DBC1 by RNA interference ( RNAi) stimulates SIRT1- mediated deacetylation of p53 and inhibits p53- dependent apoptosis. Notably, these effects can be reversed in cells by concomitant knockdown of endogenous SIRT1. Our study demonstrates that DBC1 promotes p53- mediated apoptosis through specific inhibition of SIRT1.	[Zhao, Wenhui; Kruse, Jan-Philipp; Tang, Yi; Gu, Wei] Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Zhao, Wenhui; Kruse, Jan-Philipp; Tang, Yi; Gu, Wei] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	Columbia University; Columbia University; Baylor College of Medicine; Baylor College of Medicine	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu		ZHAO, WENHUI/0000-0002-7703-7106; Jung, Sung Yun/0000-0003-1521-7977; Tang, Yi/0000-0002-3561-8447	NCI NIH HHS [R01 CA098821-06A1, R01 CA098821, R01 CA085533] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098821, R01CA085533] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Greene Warner C, 2004, Novartis Found Symp, V259, P208; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Knowles MA, 2005, CANCER LETT, V225, P121, DOI 10.1016/j.canlet.2004.10.047; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mai A, 2005, J MED CHEM, V48, P7789, DOI 10.1021/jm050100l; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Olaharski AJ, 2005, PLOS GENET, V1, P689, DOI 10.1371/journal.pgen.0010077; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sundararajan R, 2005, ONCOGENE, V24, P4908, DOI 10.1038/sj.onc.1208681; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	30	375	396	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					587	U11		10.1038/nature06515	http://dx.doi.org/10.1038/nature06515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235502	Green Accepted			2022-12-24	WOS:000252739900045
J	Buesseler, KO; Doney, SC; Karl, DM; Boyd, PW; Caldeira, K; Chai, F; Coale, KH; de Baar, HJW; Falkowski, PG; Johnson, KS; Lampitt, RS; Michaels, AF; Naqvi, SWA; Smetacek, V; Takeda, S; Watson, AJ				Buesseler, Ken O.; Doney, Scott C.; Karl, David M.; Boyd, Philip W.; Caldeira, Ken; Chai, Fei; Coale, Kenneth H.; de Baar, Hein J. W.; Falkowski, Paul G.; Johnson, Kenneth S.; Lampitt, Richard S.; Michaels, Anthony F.; Naqvi, S. W. A.; Smetacek, Victor; Takeda, Shigenobu; Watson, Andrew J.			Environment - Ocean iron fertilization - Moving forward in a sea of uncertainty	SCIENCE			English	Editorial Material									[Buesseler, Ken O.; Doney, Scott C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Karl, David M.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Boyd, Philip W.] Univ Otago, Natl Inst Water & Atmospher Res, Ctr Chem & Phys Oceanog, Dept Chem, Dunedin, New Zealand; [Caldeira, Ken] Carnegie Inst, Dept Global Ecol, Stanford, CA USA; [Chai, Fei] Univ Maine, Sch Marine Sci, Orono, ME USA; [Coale, Kenneth H.] Moss Landing Marine Labs, Moss Landing, CA 95039 USA; [de Baar, Hein J. W.] Royal Netherlands Inst Res, Isle Texel, Netherlands; [Falkowski, Paul G.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Johnson, Kenneth S.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Lampitt, Richard S.] Natl Oceanog Ctr, Southampton, Hants, England; [Michaels, Anthony F.] Univ So Calif, Wrigley Inst Environm Studies, Los Angeles, CA USA; [Naqvi, S. W. A.] Natl Inst Oceanog, Goa, India; [Smetacek, Victor] Alfred Wegener Inst Polar & Marine Res, D-2850 Bremerhaven, Germany; [Takeda, Shigenobu] Univ Tokyo, Dept Aquat Biosci, Tokyo, Japan; [Watson, Andrew J.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Woods Hole Oceanographic Institution; University of Hawaii System; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Otago; Carnegie Institution for Science; University of Maine System; University of Maine Orono; Moss Landing Marine Laboratories; Rutgers State University New Brunswick; Monterey Bay Aquarium Research Institute; NERC National Oceanography Centre; University of Southern California; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Tokyo; University of East Anglia	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu	Caldeira, Ken/E-7914-2011; Boyd, Philip W/J-7624-2014; Johnson, Kenneth S/F-9742-2011; Karl, David/AFP-3837-2022; Doney, Scott C/F-9247-2010	Caldeira, Ken/0000-0002-4591-643X; Boyd, Philip W/0000-0001-7850-1911; Johnson, Kenneth S/0000-0001-5513-5584; Doney, Scott C/0000-0002-3683-2437; Takeda, Shigenobu/0000-0002-4997-1583; Watson, Andrew/0000-0002-9654-8147; Karl, David/0000-0002-6660-6721	Natural Environment Research Council [soc010008] Funding Source: researchfish; NERC [soc010008] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; DEBAAR JHW, 2005, J GEOPHYS RES, V110, DOI UNSP C09816; Dilling L, 2003, ANNU REV ENV RESOUR, V28, P521, DOI 10.1146/annurev.energy.28.011503.163443; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103	4	124	127	5	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					162	162		10.1126/science.1154305	http://dx.doi.org/10.1126/science.1154305			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187642				2022-12-24	WOS:000252246400024
J	Cayirlioglu, P; Kadow, IG; Zhan, XL; Okamura, K; Suh, GSB; Gunning, D; Lai, EC; Zipursky, SL				Cayirlioglu, Pelin; Kadow, Ilona Grunwald; Zhan, Xiaoli; Okamura, Katsutomo; Suh, Greg S. B.; Gunning, Dorian; Lai, Eric C.; Zipursky, S. Lawrence			Hybrid neurons in a microRNA mutant are putative evolutionary intermediates in insect CO2 sensory systems	SCIENCE			English	Article							CENTRAL PROJECTIONS; RECEPTOR NEURONS; AEDES-AEGYPTI; DROSOPHILA; MAXILLARY; SENSILLA; MOTHS	Carbon dioxide ( CO2) elicits different olfactory behaviors across species. In Drosophila, neurons that detect CO2 are located in the antenna, form connections in a ventral glomerulus in the antennal lobe, and mediate avoidance. By contrast, in the mosquito these neurons are in the maxillary palps ( MPs), connect to medial sites, and promote attraction. We found in Drosophila that loss of a microRNA, miR- 279, leads to formation of CO2 neurons in the MPs. miR- 279 acts through down- regulation of the transcription factor Nerfin- 1. The ectopic neurons are hybrid cells. They express CO2 receptors and form connections characteristic of CO2 neurons, while exhibiting wiring and receptor characteristics of MP olfactory receptor neurons ( ORNs). We propose that this hybrid ORN reveals a cellular intermediate in the evolution of species- specific behaviors elicited by CO2.	[Cayirlioglu, Pelin; Kadow, Ilona Grunwald; Zhan, Xiaoli; Gunning, Dorian; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Okamura, Katsutomo; Lai, Eric C.] Sloan Kettering Inst, Rockefeller Res Labs 521, New York, NY 10021 USA; [Suh, Greg S. B.] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; California Institute of Technology	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu	Suh, Seong Bae/K-2434-2016; Lai, Eric/AAO-1143-2021; Lai, Eric C/A-3412-2008	Lai, Eric/0000-0002-8432-5851; Grunwald Kadow, Ilona/0000-0002-9085-4274; Zipursky, Stephen/0000-0001-5630-7181	Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [DC006485] Funding Source: Medline; NIGMS NIH HHS [R01 GM083300] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006485] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Anton S, 2003, ARTHROPOD STRUCT DEV, V32, P319, DOI 10.1016/j.asd.2003.09.002; BOGNER F, 1986, J COMP PHYSIOL A, V158, P741, DOI 10.1007/BF01324818; BOGNER F, 1992, PHYSIOL ENTOMOL, V17, P1992; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Distler PG, 1997, J EXP BIOL, V200, P1873; Grant AJ, 1996, CIBA F SYMP, V200, P233; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Ignell R, 2005, J COMP NEUROL, V493, P207, DOI 10.1002/cne.20800; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Kuzin A, 2005, DEV BIOL, V277, P347, DOI 10.1016/j.ydbio.2004.09.027; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2	19	85	89	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1256	1260		10.1126/science.1149483	http://dx.doi.org/10.1126/science.1149483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309086	Green Accepted, Green Submitted			2022-12-24	WOS:000253530600048
J	Muijres, FT; Johansson, LC; Barfield, R; Wolf, M; Spedding, GR; Hedenstrom, A				Muijres, F. T.; Johansson, L. C.; Barfield, R.; Wolf, M.; Spedding, G. R.; Hedenstrom, A.			Leading-edge vortex improves lift in slow-flying bats	SCIENCE			English	Article							PARTICLE IMAGE VELOCIMETRY; LOW REYNOLDS-NUMBERS; ANGLE-OF-ATTACK; INSECT FLIGHT; GENERATING MECHANISMS; DRAGONFLY FLIGHT; AERODYNAMICS; WINGS; FLOW; HAWKMOTH	Staying aloft when hovering and flying slowly is demanding. According to quasi - steady- state aerodynamic theory, slow- flying vertebrates should not be able to generate enough lift to remain aloft. Therefore, unsteady aerodynamic mechanisms to enhance lift production have been proposed. Using digital particle image velocimetry, we showed that a small nectar- feeding bat is able to increase lift by as much as 40% using attached leading- edge vortices ( LEVs) during slow forward flight, resulting in a maximum lift coefficient of 4.8. The airflow passing over the LEV reattaches behind the LEV smoothly to the wing, despite the exceptionally large local angles of attack and wing camber. Our results show that the use of unsteady aerodynamic mechanisms in flapping flight is not limited to insects but is also used by larger and heavier animals.	[Muijres, F. T.; Johansson, L. C.; Barfield, R.; Wolf, M.; Hedenstrom, A.] Lund Univ, Dept Theoret Ecol, SE-22362 Lund, Sweden; [Spedding, G. R.] Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90089 USA	Lund University; University of Southern California	Hedenstrom, A (corresponding author), Lund Univ, Dept Theoret Ecol, SE-22362 Lund, Sweden.	anders.hedenstrom@teorekol.lu.se	Johansson, Christoffer/B-2189-2013; Hedenström, Anders/F-5377-2010; Spedding, Geoffrey R/A-1860-2010; Wolf, Marta/B-4599-2013; Muijres, Florian Titus/N-6483-2015	Johansson, Christoffer/0000-0002-1851-3635; Hedenström, Anders/0000-0002-1757-0945; Spedding, Geoffrey R/0000-0003-3033-7897; Muijres, Florian Titus/0000-0002-5668-0653				Anderson John D, 1991, FUNDAMENTALS AERODYN; Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Birch JM, 2004, J EXP BIOL, V207, P1063, DOI 10.1242/jeb.00848; Bomphrey RJ, 2006, EXP FLUIDS, V40, P546, DOI 10.1007/s00348-005-0094-5; Bomphrey RJ, 2005, J EXP BIOL, V208, P1079, DOI 10.1242/jeb.01471; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; DICKINSON MH, 1993, J EXP BIOL, V174, P45; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P1, DOI 10.1098/rstb.1984.0049; Hedenstrom A, 2007, SCIENCE, V316, P894, DOI 10.1126/science.1142281; Laitone EV, 1997, EXP FLUIDS, V23, P405, DOI 10.1007/s003480050128; Lehmann FO, 2004, NATURWISSENSCHAFTEN, V91, P101, DOI 10.1007/s00114-004-0502-3; Luttges M., 1989, FRONTIERS EXPT FLUID, P429; MAXWORTHY T, 1979, J FLUID MECH, V93, P47, DOI 10.1017/S0022112079001774; Maxworthy T, 2007, J FLUID MECH, V587, P471, DOI 10.1017/S0022112007007616; Norberg U.M., 1975, SWIMMING FLYING NATU, P869, DOI DOI 10.1007/978-1-4757-1326-8_26; Read DA, 2003, J FLUID STRUCT, V17, P163, DOI 10.1016/S0889-9746(02)00115-9; SOMPS C, 1985, SCIENCE, V228, P1326, DOI 10.1126/science.228.4705.1326; Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223; Swartz SM, 1996, J ZOOL, V239, P357, DOI 10.1111/j.1469-7998.1996.tb05455.x; Thomas ALR, 2004, J EXP BIOL, V207, P4299, DOI 10.1242/jeb.01262; VandenBerg C, 1997, PHILOS T ROY SOC B, V352, P329, DOI 10.1098/rstb.1997.0024; Videler JJ, 2004, SCIENCE, V306, P1960, DOI 10.1126/science.1104682; Vogel S, 1994, LIFE MOVING FLUIDS; Warrick DR, 2005, NATURE, V435, P1094, DOI 10.1038/nature03647; WEISFOGH T, 1973, J EXP BIOL, V59, P169; Willmott AP, 1997, J EXP BIOL, V200, P2693	27	224	233	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1250	1253		10.1126/science.1153019	http://dx.doi.org/10.1126/science.1153019			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309085				2022-12-24	WOS:000253530600046
J	Futahashi, R; Fujiwara, H				Futahashi, Ryo; Fujiwara, Haruhiko			Juvenile hormone regulates butterfly larval pattern switches	SCIENCE			English	Article									[Futahashi, Ryo; Fujiwara, Haruhiko] Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Chiba 2778562, Japan; [Futahashi, Ryo] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan	Fujiwara, H (corresponding author), Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Biosci Bldg 501, Chiba 2778562, Japan.	haruh@k.u-tokyo.ac.jp	Futahashi, Ryo/I-2825-2018	Futahashi, Ryo/0000-0003-4791-7054				Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888	3	51	57	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1061	1061		10.1126/science.1149786	http://dx.doi.org/10.1126/science.1149786			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292334				2022-12-24	WOS:000253311700034
J	Thadhani, R				Thadhani, Ravi			Activated vitamin D sterols in kidney disease	LANCET			English	Editorial Material							HEMODIALYSIS; MORTALITY; SURVIVAL		[Thadhani, Ravi] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Renal Unit, Boston, MA 02114 USA; [Thadhani, Ravi] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr D Receptor Activat Res, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Thadhani, R (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Renal Unit, Boston, MA 02114 USA.	thadhani.ravi@mgh.harvard.edu			NCRR NIH HHS [M01 RR00088] Funding Source: Medline; NIDDK NIH HHS [DK 76116, DK 071674] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076116, R21DK071674] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Bodyak N, 2007, P NATL ACAD SCI USA, V104, P16810, DOI 10.1073/pnas.0611202104; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Garg AX, 2008, CLIN J AM SOC NEPHRO, V3, P253, DOI 10.2215/CJN.01430307; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; GRAY R, 1971, SCIENCE, V172, P1232, DOI 10.1126/science.172.3989.1232; HAMDY NAT, 1995, BRIT MED J, V310, P358, DOI 10.1136/bmj.310.6976.358; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; MORINIERE P, 1985, NEPHRON, V39, P309, DOI 10.1159/000183396; Palmer SC, 2007, ANN INTERN MED, V147, P840, DOI 10.7326/0003-4819-147-12-200712180-00004; PRZEDLACKI J, 1995, NEPHRON, V69, P433, DOI 10.1159/000188515; Steddon S, 2005, LANCET, V365, P2237, DOI 10.1016/S0140-6736(05)66782-7; Temple R, 1999, JAMA-J AM MED ASSOC, V282, P790, DOI 10.1001/jama.282.8.790; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Tonelli M, 2007, ANN INTERN MED, V147, P880, DOI 10.7326/0003-4819-147-12-200712180-00009; Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451	19	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					542	544		10.1016/S0140-6736(08)60251-2	http://dx.doi.org/10.1016/S0140-6736(08)60251-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18280316				2022-12-24	WOS:000253202600010
J	Garau, J; Calbo, E				Garau, Javier; Calbo, Esther			Community-acquired pneumonia	LANCET			English	Editorial Material							ADULTS; GUIDELINES; MANAGEMENT; EFFICACY; AZITHROMYCIN; OUTCOMES; CLARITHROMYCIN; LEVOFLOXACIN; METAANALYSIS; TOLERANCE		[Garau, Javier; Calbo, Esther] Univ Barcelona, Dept Med, Hosp Mutua Terrassa, Barcelona 08221, Spain; [Garau, Javier; Calbo, Esther] Univ Barcelona, Infect Dis Unit, Hosp Mutua Terrassa, Barcelona 08221, Spain	Hospital Universitario Mutua Terrassa; University of Barcelona; Hospital Universitario Mutua Terrassa; University of Barcelona	Garau, J (corresponding author), Univ Barcelona, Dept Med, Hosp Mutua Terrassa, Barcelona 08221, Spain.	jgarau@garmar.e.telefonica.net		Calbo, Esther/0000-0001-7750-5347				Arnold FW, 2007, AM J RESP CRIT CARE, V175, P1086, DOI 10.1164/rccm.200603-350OC; Barlow G, 2007, THORAX, V62, P67, DOI 10.1136/thx.2005.056689; Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953; Dunbar LM, 2003, CLIN INFECT DIS, V37, P752, DOI 10.1086/377539; el Moussaoui R, 2006, BMJ-BRIT MED J, V332, P1355, DOI 10.1136/bmj.332.7554.1355; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Kanwar M, 2007, CHEST, V131, P1865, DOI 10.1378/chest.07-0164; Li JZ, 2007, AM J MED, V120, P783, DOI 10.1016/j.amjmed.2007.04.023; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARIE TJ, 1990, SEMIN RESP INFECT, V5, P260; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; O'Doherty B, 1998, EUR J CLIN MICROBIOL, V17, P828, DOI 10.1007/s100960050201; Plouffe JF, 2003, CLIN INFECT DIS, V37, P1475, DOI 10.1086/379329; Sopena N, 2004, J CHEMOTHERAPY, V16, P102, DOI 10.1179/joc.2004.16.1.102; Yu VL, 2004, CHEST, V125, P2135, DOI 10.1378/chest.125.6.2135	20	30	33	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2008	371	9611					455	458		10.1016/S0140-6736(08)60216-0	http://dx.doi.org/10.1016/S0140-6736(08)60216-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262SV	18262027				2022-12-24	WOS:000253169200008
J	Chen, JM; Smith, J; Wolfe, J				Chen, Jer Ming; Smith, John; Wolfe, Joe			Experienced saxophonists learn to tune their vocal tracts	SCIENCE			English	Article							ACOUSTIC-IMPEDANCE SPECTRA; RESONANCE; CLARINET		[Chen, Jer Ming; Smith, John; Wolfe, Joe] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Wolfe, J (corresponding author), Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia.	J.Wolfe@unsw.edu.au	Chen, Jer-Ming/AAM-9842-2021; Smith, John/GYJ-1302-2022; Smith, John/Y-2316-2019	Chen, Jer-Ming/0000-0002-2500-0969; Smith, John/0000-0001-6885-1117; Wolfe, Joe/0000-0001-8030-0561				BACKUS J, 1985, J ACOUST SOC AM, V78, P17, DOI 10.1121/1.392556; CLINCH PG, 1982, ACUSTICA, V50, P280; Dickens P, 2007, J ACOUST SOC AM, V121, P1471, DOI 10.1121/1.2434764; Fritz C, 2005, J ACOUST SOC AM, V118, P3306, DOI 10.1121/1.2041287; Titze I. R., 1985, VOCAL FOLD PHYSL BIO, P425; Wolfe J, 2001, J SOUND VIB, V243, P127, DOI 10.1006/jsvi.2000.3346	6	17	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					776	776		10.1126/science.1151411	http://dx.doi.org/10.1126/science.1151411			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258908	Green Submitted			2022-12-24	WOS:000252963000051
J	Perillo, B; Ombra, MN; Bertoni, A; Cuozzo, C; Sacchetti, S; Sasso, A; Chiariotti, L; Malorni, A; Abbondanza, C; Avvedimento, EV				Perillo, Bruno; Ombra, Maria Neve; Bertoni, Alessandra; Cuozzo, Concetta; Sacchetti, Silvana; Sasso, Annarita; Chiariotti, Lorenzo; Malorni, Antonio; Abbondanza, Ciro; Avvedimento, Enrico V.			DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression	SCIENCE			English	Article							RECEPTOR-REGULATED TRANSCRIPTION; HISTONE; LSD1; PROMOTER; CELLS	Modifications at the N- terminal tails of nucleosomal histones are required for efficient transcription in vivo. We analyzed how H3 histone methylation and demethylation control expression of estrogen- responsive genes and show that a DNA- bound estrogen receptor directs transcription by participating in bending chromatin to contact the RNA polymerase II recruited to the promoter. This process is driven by receptor- targeted demethylation of H3 lysine 9 at both enhancer and promoter sites and is achieved by activation of resident LSD1 demethylase. Localized demethylation produces hydrogen peroxide, which modifies the surrounding DNA and recruits 8- oxoguanine- DNA glycosylase 1 and topoisomerase II beta, triggering chromatin and DNA conformational changes that are essential for estrogen- induced transcription. Our data show a strategy that uses controlled DNA damage and repair to guide productive transcription.	[Perillo, Bruno; Ombra, Maria Neve; Malorni, Antonio] CNR, Ist Sci Alimentaz, I-83100 Avellino, Italy; [Bertoni, Alessandra; Sasso, Annarita; Chiariotti, Lorenzo; Avvedimento, Enrico V.] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol L Calif, I-80131 Naples, Italy; [Cuozzo, Concetta; Sacchetti, Silvana] Ctr Ingn Genet CEINGE, Naples Oncogenom Ctr, I-80131 Naples, Italy; [Abbondanza, Ciro] Univ Naples 2, Dipartimento Patol Gen, I-80138 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Naples Federico II; Universita della Campania Vanvitelli	Perillo, B (corresponding author), CNR, Ist Sci Alimentaz, I-83100 Avellino, Italy.	perillo@unina.it; avvedim@unina.it	Chiariotti, Lorenzo/AAC-5262-2022; Hu, Ruogu/B-2203-2008	Perillo, Bruno/0000-0001-8935-0370; OMBRA, MARIA NEVE/0000-0002-2437-9276; CHIARIOTTI, Lorenzo/0000-0001-6097-4171; ABBONDANZA, Ciro/0000-0001-5346-4835	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Felty Q, 2005, BIOCHEMISTRY-US, V44, P6900, DOI 10.1021/bi047629p; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; KROEGER PE, 1993, J BIOL CHEM, V268, P16449; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Rajapakse N, 2005, ENVIRON MOL MUTAGEN, V45, P397, DOI 10.1002/em.20104; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; RUSSO MT, 2004, CANCER RES, V64, P1111; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shanmugam M, 1999, MOL CELL ENDOCRINOL, V148, P109, DOI 10.1016/S0303-7207(98)00229-9; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Vaute O, 2002, NUCLEIC ACIDS RES, V30, P475, DOI 10.1093/nar/30.2.475; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; YOUNG RL, 1993, MOL CELL BIOL, V13, P3686, DOI 10.1128/MCB.13.6.3686; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306	25	396	407	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					202	206		10.1126/science.1147674	http://dx.doi.org/10.1126/science.1147674			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187655				2022-12-24	WOS:000252246400041
J	Nakao, N; Ono, H; Yamamura, T; Anraku, T; Takagi, T; Higashi, K; Yasuo, S; Katou, Y; Kageyama, S; Uno, Y; Kasukawa, T; Iigo, M; Sharp, PJ; Iwasawa, A; Suzuki, Y; Sugano, S; Niimi, T; Mizutani, M; Namikawa, T; Ebihara, S; Ueda, HR; Yoshimura, T				Nakao, Nobuhiro; Ono, Hiroko; Yamamura, Takashi; Anraku, Tsubasa; Takagi, Tsuyoshi; Higashi, Kumiko; Yasuo, Shinobu; Katou, Yasuhiro; Kageyama, Saburo; Uno, Yumiko; Kasukawa, Takeya; Iigo, Masayuki; Sharp, Peter J.; Iwasawa, Atsushi; Suzuki, Yutaka; Sugano, Sumio; Niimi, Teruyuki; Mizutani, Makoto; Namikawa, Takao; Ebihara, Shizufumi; Ueda, Hiroki R.; Yoshimura, Takashi			Thyrotrophin in the pars tuberalis triggers photoperiodic response	NATURE			English	Article							II IODOTHYRONINE DEIODINASE; COTURNIX-COTURNIX-JAPONICA; JAPANESE-QUAIL; CHICKEN THYROTROPIN; GENE-EXPRESSION; CIRCADIAN CLOCK; BETA-SUBUNIT; HORMONE; RECEPTOR; BRAIN	Molecular mechanisms regulating animal seasonal breeding in response to changing photoperiod are not well understood. Rapid induction of gene expression of thyroid- hormone- activating enzyme ( type 2 deiodinase, DIO2) in the mediobasal hypothalamus ( MBH) of the Japanese quail ( Coturnix japonica) is the earliest event yet recorded in the photoperiodic signal transduction pathway. Here we show cascades of gene expression in the quail MBH associated with the initiation of photoinduced secretion of luteinizing hormone. We identified two waves of gene expression. The first was initiated about 14 h after dawn of the first long day and included increased thyrotrophin ( TSH) beta- subunit expression in the pars tuberalis; the second occurred approximately 4 h later and included increased expression of DIO2. Intracerebroventricular ( ICV) administration of TSH to short- day quail stimulated gonadal growth and expression of DIO2 which was shown to be mediated through a TSH receptor - cyclic AMP ( cAMP) signalling pathway. Increased TSH in the pars tuberalis therefore seems to trigger long- day photoinduced seasonal breeding.	[Nakao, Nobuhiro; Ono, Hiroko; Yamamura, Takashi; Anraku, Tsubasa; Takagi, Tsuyoshi; Higashi, Kumiko; Yasuo, Shinobu; Katou, Yasuhiro; Kageyama, Saburo; Uno, Yumiko; Ebihara, Shizufumi; Yoshimura, Takashi] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Div Biomodelling, Nagoya, Aichi 4648601, Japan; [Kasukawa, Takeya; Ueda, Hiroki R.] RIKEN, Funct Genom Subunit, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Iigo, Masayuki] Utsunomiya Univ, Fac Agr, Dept Appl Biochem, Utsunomiya, Tochigi 3218505, Japan; [Sharp, Peter J.] Univ Edinburgh, Div Genet & Genom, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Sharp, Peter J.] Univ Edinburgh, Div Genet & Genom, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland; [Iwasawa, Atsushi] Gifu Univ, Lab Comparat Biochem, Grad Sch Appl Biol Sci, Gifu 5011193, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Minato Ku, Tokyo 1088639, Japan; [Niimi, Teruyuki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Div Biofunct Dev, Nagoya, Aichi 4648601, Japan; [Mizutani, Makoto; Namikawa, Takao; Ebihara, Shizufumi; Yoshimura, Takashi] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Avian Biosci Res Ctr, Nagoya, Aichi 4648601, Japan; [Ueda, Hiroki R.] RIKEN, Lab Syst Biol, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Yoshimura, Takashi] Nagoya Univ, Chikusa Ku, Inst Adv Res, Nagoya, Aichi 4648601, Japan	Nagoya University; RIKEN; Utsunomiya University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Gifu University; University of Tokyo; Nagoya University; Nagoya University; RIKEN; Nagoya University	Yoshimura, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Div Biomodelling, Furo Cho, Nagoya, Aichi 4648601, Japan.	takashiy@agr.nagoya-u.ac.jp	Kasukawa, Takeya/N-5070-2015; Iigo, Masayuki/I-7110-2013; Yoshimura, Takashi/C-8306-2012; Ueda, Hiroki R/C-5037-2014	Kasukawa, Takeya/0000-0001-5085-0802; Yoshimura, Takashi/0000-0001-7018-9652; Ueda, Hiroki R/0000-0001-8342-9176; Niimi, Teruyuki/0000-0003-3981-0177; Iigo, Masayuki/0000-0001-8251-4141				Bockmann J, 1997, ENDOCRINOLOGY, V138, P1019, DOI 10.1210/en.138.3.1019; Bockmann J, 1997, BIOCHEM BIOPH RES CO, V238, P173, DOI 10.1006/bbrc.1997.7268; Crisanti P, 2001, ENDOCRINOLOGY, V142, P812, DOI 10.1210/en.142.2.812; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Follett B, 1998, BIOL RHYTHMS PHOTOPE; FOLLETT BK, 1988, J COMP PHYSIOL B, V157, P837, DOI 10.1007/BF00691016; Ganong WF, 2000, CLIN EXP PHARMACOL P, V27, P422, DOI 10.1046/j.1440-1681.2000.03259.x; Grommen SVH, 2006, ENDOCRINOLOGY, V147, P3943, DOI 10.1210/en.2005-1223; HOJVAT S, 1982, NEUROENDOCRINOLOGY, V34, P327, DOI 10.1159/000123322; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Iwasawa A, 2002, J REPROD DEVELOP, V48, P197, DOI 10.1262/jrd.48.197; JUSS TS, 1993, P ROY SOC B-BIOL SCI, V254, P21, DOI 10.1098/rspb.1993.0121; JUSS TS, 1993, AVIAN ENDOCRINOLOGY, P47; Klosen P, 2002, J HISTOCHEM CYTOCHEM, V50, P1647, DOI 10.1177/002215540205001209; KRISHNAN KA, 2004, COMP BIOCH PHYSL B, V108, P253; Lincoln GA, 2006, SCIENCE, V314, P1941, DOI 10.1126/science.1132009; MARUYAMA K, 1994, GENE, V138, P171; MATZUK MM, 1988, MOL ENDOCRINOL, V2, P95, DOI 10.1210/mend-2-2-95; Morgan P J, 1996, Rev Reprod, V1, P153, DOI 10.1530/revreprod/1.3.153; Murakami M, 2001, ENDOCRINOLOGY, V142, P2961, DOI 10.1210/en.142.7.2961; Murakami M, 2001, ENDOCRINOLOGY, V142, P1195, DOI 10.1210/en.142.3.1195; NICHOLLS TJ, 1983, J ENDOCRINOL, V97, P121, DOI 10.1677/joe.0.0970121; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Rebay I, 2005, TRENDS GENET, V21, P163, DOI 10.1016/j.tig.2005.01.005; SCHAUB C, 1977, J NEUROL SCI, V31, P123, DOI 10.1016/0022-510X(77)90010-7; SHARP PJ, 1972, Z ZELLFORSCH MIK ANA, V127, P552, DOI 10.1007/BF00306871; SHARP PJ, 1969, NEUROENDOCRINOLOGY, V5, P205, DOI 10.1159/000121861; SILVER R, 1988, CELL TISSUE RES, V253, P189; Takagi T, 2007, ENDOCRINOLOGY, V148, P2788, DOI 10.1210/en.2007-0112; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Turnbull AV, 1998, ENDOCRINOLOGY, V139, P128, DOI 10.1210/en.139.1.128; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; WADA M, 1979, GEN COMP ENDOCR, V39, P141, DOI 10.1016/0016-6480(79)90219-3; WITTKOWSKI W, 1988, CELL TISSUE RES, V251, P183, DOI 10.1007/BF00215463; Wittkowski W, 1999, INT REV CYTOL, V185, P157; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Yasuo S, 2003, ENDOCRINOLOGY, V144, P3742, DOI 10.1210/en.2003-0435; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117	39	358	372	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					317	U1		10.1038/nature06738	http://dx.doi.org/10.1038/nature06738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354476				2022-12-24	WOS:000254117400039
J	Masciari, S; Van den Abbeele, AD; Diller, LR; Rastarhuyeva, I; Yap, J; Schneider, K; Digianni, L; Li, FP; Fraumeni, JF; Syngal, S; Garber, JE				Masciari, Serena; Van den Abbeele, Annick D.; Diller, Lisa R.; Rastarhuyeva, Iryna; Yap, Jeffrey; Schneider, Katherine; Digianni, Lisa; Li, Frederick P.; Fraumeni, Joseph F., Jr.; Syngal, Sapna; Garber, Judy E.			F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SOFT-TISSUE SARCOMA; P53 MUTATIONS; F-18 FLUORODEOXYGLUCOSE; FDG-PET; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; COLORECTAL-CANCER; FAMILIAL SYNDROME; RATIONAL APPROACH; DOSE REDUCTION	Context Individuals with Li-Fraumeni syndrome ( LFS) have an inherited cancer predisposition to a diverse array of malignancies beginning early in life; survivors of one cancer have a markedly elevated risk of additional primary tumors. The underlying genetic defect in the majority of the families is a germline mutation in the TP53 tumor suppressor gene. The diversity of tumors and rarity of families have contributed to the difficulty in devising effective screening recommendations for members of LFS kindreds. Objective To gather preliminary data with which to evaluate F18- fluorodeoxyglucose positron emission tomography/ computed tomography ( FDG- PET/ CT) imaging as a potential surveillance modality to detect early malignancies in asymptomatic members of LFS kindreds. Design, Setting, and Participants Members of LFS families with documented germline TP53 mutations or obligate carrier status, no history of cancer within 5 years of enrollment, and no symptoms of cancer or ill- health were offered FDG-PET/ CT scanning as a screening test in a comprehensive US cancer center from 2006 to 2007. Scans were initially reviewed clinically, then centrally reviewed by an expert radiologist. Main OutcomeMeasure The primary outcome was the detection of new primary cancers using FDG- PET/ CT scanning. Results Of 15 individuals, baseline FDG- PET/ CT scan identified asymptomatic cancers in 3 ( 20%). Two individuals had papillary thyroid cancers ( stage II and stage III) and one individual had stage II esophageal adenocarcinoma. Conclusions These preliminary data provide the first evidence for a potential cancer surveillance strategy that may be worthy of further investigation for patients with LFS. Concerns about radiation exposure and other challenges inherent in screening high-risk patients will require further consideration.	[Masciari, Serena; Schneider, Katherine; Digianni, Lisa; Li, Frederick P.; Syngal, Sapna; Garber, Judy E.] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA; [Van den Abbeele, Annick D.; Rastarhuyeva, Iryna; Yap, Jeffrey] Dana Farber Canc Inst, Dept Radiol, Boston, MA 02115 USA; [Diller, Lisa R.] Dana Farber Canc Inst, Perini Family Survivors Ctr, Boston, MA 02115 USA; [Fraumeni, Joseph F., Jr.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Syngal, Sapna] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital	Garber, JE (corresponding author), Dana Farber Canc Inst, Div Populat Sci, 44 Binney St,SM 209, Boston, MA 02115 USA.	judy_garber@dfci.harvard.edu	Van den Abbeele, Annick/AAK-9792-2020; Pinheiro, Maísa/E-7424-2012	Yap, Jeffrey/0000-0001-5306-2860				Al-Sugair A, 1998, SEMIN NUCL MED, V28, P303, DOI 10.1016/S0001-2998(98)80035-4; American Association of Physicists in Medicine, 96 AAPM; Avril N, 2000, J CLIN ONCOL, V18, P3495, DOI 10.1200/JCO.2000.18.20.3495; BIRCH JM, 1994, CANCER RES, V54, P1298; Boone JM, 2003, RADIOLOGY, V228, P352, DOI 10.1148/radiol.2282020471; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Chao ST, 2001, INT J CANCER, V96, P191, DOI 10.1002/ijc.1016.abs; Chen YK, 2004, ANTICANCER RES, V24, P4103; Chodick G, 2007, ISR MED ASSOC J, V9, P584; Delbeke D, 1999, J NUCL MED, V40, P591; DICHIRO G, 1987, INVEST RADIOL, V22, P360; Eeles RA, 1995, CANCER SURV, V25, P101; Folpe AL, 2000, CLIN CANCER RES, V6, P1279; GARBER JE, 1991, CANCER RES, V51, P6094; Hisada M, 1998, JNCI-J NATL CANCER I, V90, P606, DOI 10.1093/jnci/90.8.606; Hwang SJ, 2003, AM J HUM GENET, V72, P975, DOI 10.1086/374567; Ioannidis JPA, 2003, J NUCL MED, V44, P717; Kalra MK, 2004, RADIOLOGY, V233, P649, DOI 10.1148/radiol.2333031150; Kleihues P, 1997, AM J PATHOL, V150, P1; LI FP, 1988, CANCER RES, V48, P5358; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; LI FP, 1992, J NATL CANCER I, V84, P1156, DOI 10.1093/jnci/84.15.1156; Limacher JM, 2001, INT J CANCER, V96, P238, DOI 10.1002/ijc.1021; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Nichols KE, 2001, CANCER EPIDEM BIOMAR, V10, P83; Oehr P, 1999, J INVEST MED, V47, P452; Shankar LK, 2006, J NUCL MED, V47, P1059; Varley JM, 1997, CANCER RES, V57, P3245; Varley JM, 1997, BRIT J CANCER, V76, P1, DOI 10.1038/bjc.1997.328; Wilting JE, 2001, EUR RADIOL, V11, P2627, DOI 10.1007/s003300101039; Wong P, 2006, GASTROENTEROLOGY, V130, P73, DOI 10.1053/j.gastro.2005.10.014; Yasuda S, 2000, BRIT J CANCER, V83, P1607, DOI 10.1054/bjoc.2000.1496; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4	35	66	69	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1315	1319		10.1001/jama.299.11.1315	http://dx.doi.org/10.1001/jama.299.11.1315			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349092	Bronze			2022-12-24	WOS:000254079100022
J	Raices, M; Verdun, RE; Compton, SA; Haggblom, CI; Griffith, JD; Dillin, A; Karlseder, J				Raices, Marcela; Verdun, Ramiro E.; Compton, Sarah A.; Haggblom, Candy I.; Griffith, Jack D.; Dillin, Andrew; Karlseder, Jan			C-elegans telomeres contain G-strand and C-strand overhangs that are bound by distinct proteins	CELL			English	Article							HUMAN-CHROMOSOMES; CAENORHABDITIS-ELEGANS; BINDING PROTEIN; MOUSE CELLS; DNA-DAMAGE; T-LOOPS; CDC13; END; POT1; MAINTENANCE	Single-strand extensions of the G strand of telomeres are known to be critical for chromosome-end protection and length regulation. Here, we report that in C. elegans, chromosome termini possess 30 G-strand overhangs as well as 50 C-strand overhangs. C tails are as abundant as G tails and are generated by a well-regulated process. These two classes of overhangs are bound by two single-stranded DNA binding proteins, CeOB1 and CeOB2, which exhibit specificity for G-rich or C-rich telomeric DNA. Strains of worms deleted for CeOB1 have elongated telomeres as well as extended G tails, whereas CeOB2 deficiency leads to telomere-length heterogeneity. Both CeOB1 and CeOB2 contain OB (oligo-saccharide/oligo-nucleotide binding) folds, which exhibit structural similarity to the second and first OB folds of the mammalian telomere binding protein hPOT1, respectively. Our results suggest that C. elegans telomere homeostasis relies on a novel mechanism that involves 50 and 30 single-stranded termini.	[Raices, Marcela; Verdun, Ramiro E.; Haggblom, Candy I.; Dillin, Andrew; Karlseder, Jan] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Compton, Sarah A.; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA	Salk Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Karlseder, J (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	karlseder@salk.edu			NIA NIH HHS [AG025837] Funding Source: Medline; NIEHS NIH HHS [ES13773] Funding Source: Medline; NIGMS NIH HHS [GM31819, GM06525] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025837] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Anderson EM, 2002, NUCLEIC ACIDS RES, V30, P4305, DOI 10.1093/nar/gkf554; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Booth C, 2001, NUCLEIC ACIDS RES, V29, P4414, DOI 10.1093/nar/29.21.4414; BRENNER S, 1974, GENETICS, V77, P71; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; Cheung I, 2004, NUCLEIC ACIDS RES, V32, P3383, DOI 10.1093/nar/gkh661; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 2001, EMBO J, V20, P6127, DOI 10.1093/emboj/20.21.6127; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; GRAY HB, 1975, NUCLEIC ACIDS RES, V2, P1459, DOI 10.1093/nar/2.9.1459; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; GUBLER U, 1987, METHOD ENZYMOL, V152, P330; Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hope IA., 1999, C ELEGANS PRACTICAL; Jacob NK, 2003, MOL CELL, V11, P1021, DOI 10.1016/S1097-2765(03)00131-X; Jacob NK, 2001, EMBO J, V20, P4299, DOI 10.1093/emboj/20.15.4299; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Lei M, 2002, BIOCHEMISTRY-US, V41, P14560, DOI 10.1021/bi026674z; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Meier B, 2006, PLOS GENET, V2, P187, DOI 10.1371/journal.pgen.0020018; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nakamura M, 2005, MOL CELL BIOL, V25, P11073, DOI 10.1128/MCB.25.24.11073-11088.2005; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Raices M, 2005, PLOS GENET, V1, P295, DOI 10.1371/journal.pgen.0010030; Riha K, 2000, PLANT J, V23, P633, DOI 10.1046/j.1365-313x.2000.00831.x; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; Theobald DL, 2004, STRUCTURE, V12, P1877, DOI 10.1016/j.str.2004.07.015; TRAVERS AA, 2000, DNA PROTEIN INTERACT; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x	53	92	97	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					745	757		10.1016/j.cell.2007.12.039	http://dx.doi.org/10.1016/j.cell.2007.12.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329362	Green Submitted, Bronze			2022-12-24	WOS:000253818000013
J	Minton, J; Clayton, J; Sandoe, J; Mc Gann, H; Wilcox, M				Minton, Jane; Clayton, James; Sandoe, Jonathan; Mc Gann, Hugh; Wilcox, Mark			Quality improvement report - Improving early management of bloodstream infection: a quality improvement project	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMPREHENSIVE ANALYSIS; CLINICAL-SIGNIFICANCE; 500 EPISODES; BACTEREMIA; FUNGEMIA; CULTURES; THERAPY; ADULTS; SEPSIS	Problem Bloodstream infection is a common but serious illness with high mortality and morbidity, which is seen in many clinical specialties. Errors such as delay in diagnosis and lack of effective treatment often occur. Design Initial observational study followed by prospective study before and after intervention in a high risk clinical area. Setting 1400 bed teaching hospital in the United Kingdom where the initial management of all inpatients with bloodstream infections was surveyed over six weeks. This showed 55 major errors in 46 (30%) of 157 episodes of bloodstream infection. Most (44) were in general areas of the hospital without a specific protocol for managing sepsis. 29 of the 55 errors were caused by delay in giving effective antibiotics to critically ill patients. In 19 cases, effective antibiotics were still not given despite advice from infection services based on blood culture results. A diagnosis of bloodstream infection had not been considered in 7 patients already in hospital despite clear signs of sepsis for more than 48 hours. Strategy for improvement Development of guidelines for recognition and initial management of patients with severe sepsis and bloodstream infection, implementation of an education programme on clinical standards for managing sepsis, and introduction of a bacteraemia service that included feedback. Key measure of improvement Reduction in incidence of major errors in early management of bloodstream infection. Effects of change In the second part of the study, major errors were found in 11 of 37 episodes (30%) immediately before the intervention in the main high risk area (medical wards), whereas such errors were found in 6 of 79 episodes (8%) after the intervention. Lessons learnt The early management of patients with bloodstream infection was often suboptimal. The underlying factors included failure to recognise patients with serious infection; delays in giving antibiotics as a result of poor communication between medical, nursing, and pharmacy teams; and lack of understanding of empirical antimicrobial selection. Introduction of improvement measures was associated with considerable improvement in the early management of severe sepsis caused by bloodstream infection.	[Minton, Jane; Mc Gann, Hugh] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Clayton, James; Sandoe, Jonathan; Wilcox, Mark] Leeds Gen Infirm, Dept Microbiol, Old Med Sch, Leeds LS1 3EX, W Yorkshire, England	Saint James's University Hospital; Leeds General Infirmary; University of Leeds	Minton, J (corresponding author), St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.	jane.minton@leedsth.nhs.uk	Sandoe, Jonathan/AAL-2117-2020	Sandoe, Jonathan/0000-0003-0193-8677				BATES DW, 1995, ARCH INTERN MED, V155, P593, DOI 10.1001/archinte.155.6.593; DAVEY PG, 1995, J ANTIMICROB CHEMOTH, V36, P561, DOI 10.1093/jac/36.3.561; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; DUNAGAN WC, 1989, AM J MED, V87, P253; ISPAHANI P, 1987, Q J MED, V63, P427; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lin MT, 2004, CRIT CARE MED, V32, P569, DOI 10.1097/01.CCM.0000110878.49476.42; MILLER PJ, 1987, J INFECT DIS, V156, P471, DOI 10.1093/infdis/156.3.471; Nathwani D, 1996, QJM-MON J ASSOC PHYS, V89, P789, DOI 10.1093/qjmed/89.10.789; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P54; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35	12	25	25	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2008	336	7641					440	443		10.1136/bmj.39454.634502.80	http://dx.doi.org/10.1136/bmj.39454.634502.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18292170	Green Published			2022-12-24	WOS:000253664000041
J	Bonderer, LJ; Studart, AR; Gauckler, LJ				Bonderer, Lorenz J.; Studart, Andre R.; Gauckler, Ludwig J.			Bioinspired design and assembly of platelet reinforced polymer films	SCIENCE			English	Article							MECHANICAL-PROPERTIES; NACRE; NANOCOMPOSITES; COMPOSITES; STIFFNESS; MOTHER; PEARL; MODEL	Although strong and stiff human- made composites have long been developed, the microstructure of today's most advanced composites has yet to achieve the order and sophisticated hierarchy of hybrid materials built up by living organisms in nature. Clay- based nanocomposites with layered structure can reach notable stiffness and strength, but these properties are usually not accompanied by the ductility and flaw tolerance found in the structures generated by natural hybrid materials. By using principles found in natural composites, we showed that layered hybrid films combining high tensile strength and ductile behavior can be obtained through the bottom- up colloidal assembly of strong submicrometer- thick ceramic platelets within a ductile polymer matrix.	[Bonderer, Lorenz J.; Studart, Andre R.; Gauckler, Ludwig J.] ETH, Dept Mat, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Studart, AR (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Dept Phys, Expt Soft Condensed Matter Grp, Cambridge, MA 02138 USA.	studart@seas.harvard.edu; ludwig.gauckler@mat.ethz.ch	Studart, Andre R/A-2550-2008; Gauckler, Ludwig Julius/C-2784-2009; Gauckler, Ludwig/AAM-5856-2020	Gauckler, Ludwig Julius/0000-0003-4668-4025; 				Almqvist N, 1999, MAT SCI ENG C-BIO S, V7, P37, DOI 10.1016/S0928-4931(98)00072-1; BALLARD DGH, 1983, J MATER SCI, V18, P545, DOI 10.1007/BF00560644; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Chasiotis I, 2005, EXP MECH, V45, P507, DOI 10.1177/0014485105059992; COX HL, 1952, BRIT J APPL PHYS, V3, P72, DOI 10.1088/0508-3443/3/3/302; CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050; Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; GLAVINCHEVSKI B, 1973, J MATER SCI, V8, P1373, DOI 10.1007/BF00551660; Hull D., 1996, INTRO COMPOSITE MAT; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Jager I, 2000, BIOPHYS J, V79, P1737, DOI 10.1016/S0006-3495(00)76426-5; KLEINFELD ER, 1994, SCIENCE, V265, P370, DOI 10.1126/science.265.5170.370; LANDIS WJ, 1995, J BONE MINER RES, V10, P859, DOI 10.1002/jbmr.5650100606; Lowenstam H.A., 1989, BIOMINERALIZATION, DOI [10.1093/oso/9780195049770.001.0001, DOI 10.1093/OSO/9780195049770.001.0001]; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; MESSERSMITH PB, 1994, CHEM MATER, V6, P1719, DOI 10.1021/cm00046a026; Nassif N, 2005, P NATL ACAD SCI USA, V102, P12653, DOI 10.1073/pnas.0502577102; Okada A, 1995, MAT SCI ENG C-BIOMIM, V3, P109, DOI 10.1016/0928-4931(95)00110-7; PADAWER GE, 1970, POLYM ENG SCI, V10, P185, DOI 10.1002/pen.760100310; Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176; REXER J, 1979, POLYM ENG SCI, V19, P1, DOI 10.1002/pen.760190102; SANO H, 1994, J DENT RES, V73, P1205, DOI 10.1177/00220345940730061201; Schmidt D, 2002, CURR OPIN SOLID ST M, V6, P205, DOI 10.1016/S1359-0286(02)00049-9; Sheng N, 2004, POLYMER, V45, P487, DOI 10.1016/j.polymer.2003.10.100; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; WAGNER HD, 1992, J BIOMECH, V25, P1311, DOI 10.1016/0021-9290(92)90286-A; Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340	28	821	843	31	984	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1069	1073		10.1126/science.1148726	http://dx.doi.org/10.1126/science.1148726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292337				2022-12-24	WOS:000253311700037
J	Rossant, J				Rossant, Janet			Stem cells and early lineage development	CELL			English	Article							PRIMORDIAL GERM-CELLS; SELF-RENEWAL; PLURIPOTENCY; DIFFERENTIATION; FIBROBLASTS; GENERATION; DERIVATION; EPIBLAST; INDUCTION	The recent derivation of pluripotent stem cell lines from a number of different sources, including reprogrammed adult somatic cells, raises the issue of the developmental equivalence of these different pluripotent states. At least two different states representing the epiblast progenitors in the blastocyst and the pluripotent progenitors of the later gastrulating embryo have been recognized. Understanding the initial developmental status of the different pluripotent lines is critical for defining starting conditions for differentiation toward therapeutically relevant cell types.	Univ Toronto, Dept Mol Genet, Hosp Sick Children, Res Inst,Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Rossant, J (corresponding author), Univ Toronto, Dept Mol Genet, Hosp Sick Children, Res Inst,Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	janet.rossant@sickkids.ca						Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Nichols J, 2001, DEVELOPMENT, V128, P2333; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rossant J, 2001, STEM CELLS, V19, P477, DOI 10.1634/stemcells.19-6-477; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	28	230	245	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					527	531		10.1016/j.cell.2008.01.039	http://dx.doi.org/10.1016/j.cell.2008.01.039			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295568	Bronze			2022-12-24	WOS:000253817900010
J	Rubin, LL				Rubin, Lee L.			Stem cells and drug discovery: The beginning of a new era?	CELL			English	Article							DIRECTED DIFFERENTIATION; SMALL MOLECULES; SELF-RENEWAL; MIDBRAIN; NEURONS; OSTEOGENESIS; ACTIVATION	Much of the attention focused on stem cells relates to their use in cell replacement therapy; however, stem cells may also transform the way in which therapeutics are discovered and validated.	[Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Rubin, Lee L.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University	Rubin, LL (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	lee_rubin@harvard.edu		Rubin, Lee/0000-0002-8658-841X				Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Chen SB, 2007, P NATL ACAD SCI USA, V104, P10482, DOI 10.1073/pnas.0704360104; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Duckmanton A, 2005, CHEM BIOL, V12, P1117, DOI 10.1016/j.chembiol.2005.07.011; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Rosania GR, 2000, NAT BIOTECHNOL, V18, P304, DOI 10.1038/73753; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SAXE J, 2007, J CHEM BIOL, V14, P1019; Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i; Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908	26	104	120	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					549	552		10.1016/j.cell.2008.02.010	http://dx.doi.org/10.1016/j.cell.2008.02.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295572	Bronze			2022-12-24	WOS:000253817900014
J	Lee, C; Morton, CC				Lee, Charles; Morton, Cynthia C.			Structural genomic variation and personalized medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MAP		[Lee, Charles; Morton, Cynthia C.] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Morton, Cynthia C.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lee, C (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA.							Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	6	41	43	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2008	358	7					740	741		10.1056/NEJMcibr0708452	http://dx.doi.org/10.1056/NEJMcibr0708452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262CX	18272898				2022-12-24	WOS:000253127700014
J	Acar, M; Jafar-Nejad, H; Takeuchi, H; Rajan, A; Ibrani, D; Rana, NA; Pan, H; Haltiwanger, RS; Bellen, HJ				Acar, Melih; Jafar-Nejad, Hamed; Takeuchi, Hideyuki; Rajan, Akhila; Ibrani, Dafina; Rana, Nadia A.; Pan, Hongling; Haltiwanger, Robert S.; Bellen, Hugo J.			Rumi is a CAP10 domain glycosyltransferase that modifies notch and is required for notch signaling	CELL			English	Article							GROWTH FACTOR-LIKE; THROMBOSPONDIN TYPE-1 REPEATS; O-FUCOSYL-TRANSFERASE; UNFOLDED PROTEIN RESPONSE; DROSOPHILA NOTCH; CELL FATE; CRYPTOCOCCUS-NEOFORMANS; LIGAND ENDOCYTOSIS; DELTA INTERACTIONS; ALAGILLE-SYNDROME	Notch signaling is broadly used to regulate cell-fate decisions. We have identified a gene, rumi, with a temperature-sensitive Notch phenotype. At 28 degrees C-30 degrees C, rumi clones exhibit a full-blown loss of Notch signaling in all tissues tested. However, at 18 degrees C only a mild Notch phenotype is evident. In vivo analyses reveal that the target of Rumi is the extracellular domain of Notch. Notch accumulates intracellularly and at the cell membrane of rumi cells but fails to be properly cleaved, despite normal binding to Delta. Rumi is an endoplasmic reticulum-retained protein with a highly conserved CAP10 domain. Our studies show that Rumi is a protein O-glucosyltransferase, capable of adding glucose to serine residues in Notch EGF repeats with the consensus C-1-X-S-X-P-C-2 sequence. These data indicate that by O-glucosylating Notch in the ER, Rumi regulates its folding and/or trafficking and allows signaling at the cell membrane.	[Acar, Melih; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Acar, Melih; Jafar-Nejad, Hamed; Rajan, Akhila; Ibrani, Dafina; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pan, Hongling; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Takeuchi, Hideyuki; Rana, Nadia A.; Haltiwanger, Robert S.] SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Jafar-Nejad, Hamed/B-9216-2008; Takeuchi, Hideyuki/AAZ-9210-2020	Bellen, Hugo/0000-0001-5992-5989	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [P30 HD024064] Funding Source: Medline; NIGMS NIH HHS [5R01GM061126-07, R01 GM061126, R01 GM084135, R01 GM084135-01] Funding Source: Medline; PHS HHS [T32-GMO7526] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084135, R01GM061126] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Carlson ME, 2007, CURR OPIN PHARMACOL, V7, P303, DOI 10.1016/j.coph.2007.02.004; Chang YC, 1999, J BACTERIOL, V181, P5636, DOI 10.1128/JB.181.18.5636-5643.1999; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; deCelis JF, 1997, DEVELOPMENT, V124, P1919; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kidd S, 2002, MECH DEVELOP, V115, P41, DOI 10.1016/S0925-4773(02)00120-X; Lai EC, 2004, DEV BIOL, V269, P1, DOI 10.1016/j.ydbio.2004.01.032; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nita-Lazar A, 2006, METHOD ENZYMOL, V417, P93, DOI 10.1016/S0076-6879(06)17008-1; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Okabayashi K, 2007, MYCOPATHOLOGIA, V163, P1, DOI 10.1007/s11046-006-0083-0; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Parks AL, 2000, DEVELOPMENT, V127, P1373; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Shao L, 2003, CELL MOL LIFE SCI, V60, P241, DOI 10.1007/s000180300019; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Teng Y, 2006, GENE, V371, P7, DOI 10.1016/j.gene.2005.08.027; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100	70	221	226	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					247	258		10.1016/j.cell.2007.12.016	http://dx.doi.org/10.1016/j.cell.2007.12.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243100	Green Accepted, Bronze			2022-12-24	WOS:000253427700011
J	Plikus, MV; Mayer, JA; de la Cruz, D; Baker, RE; Maini, PK; Maxson, R; Chuong, CM				Plikus, Maksim V.; Mayer, Julie Ann; de la Cruz, Damon; Baker, Ruth E.; Maini, Philip K.; Maxson, Robert; Chuong, Cheng-Ming			Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration	NATURE			English	Article							SELF-RENEWAL; SKIN; GROWTH; INDUCTION; FOLLICLES; NICHE; DIFFERENTIATION; MODULATION; ALOPECIA; HEDGEHOG	In the age of stem cell engineering it is critical to understand how stem cell activity is regulated during regeneration. Hairs are mini-organs that undergo cyclic regeneration throughout adult life(1,) and are an important model for organ regeneration. Hair stem cells located in the follicle bulge(2) are regulated by the surrounding microenvironment, or niche(3). The activation of such stem cells is cyclic, involving periodic beta-catenin activity(4-7). In the adult mouse, regeneration occurs in waves in a follicle population, implying coordination among adjacent follicles and the extrafollicular environment. Here we show that unexpected periodic expression of bone morphogenetic protein 2 ( Bmp2) and Bmp4 in the dermis regulates this process. This BMP cycle is out of phase with the WNT/beta-catenin cycle, thus dividing the conventional telogen into new functional phases: one refractory and the other competent for hair regeneration, characterized by high and low BMP signalling, respectively. Overexpression of noggin, a BMP antagonist, in mouse skin resulted in a markedly shortened refractory phase and faster propagation of the regenerative wave. Transplantation of skin from this mutant onto a wild- type host showed that follicles in donor and host can affect their cycling behaviours mutually, with the outcome depending on the equilibrium of BMP activity in the dermis. Administration of BMP4 protein caused the competent region to become refractory. These results show that BMPs may be the long- sought 'chalone' inhibitors of hair growth postulated by classical experiments. Taken together, results presented in this study provide an example of hierarchical regulation of local organ stem cell homeostasis by the inter- organ macro-environment. The expression of Bmp2 in subcutaneous adipocytes indicates physiological integration between these two thermoregulatory organs. Our findings have practical importance for studies using mouse skin as a model for carcinogenesis, intracutaneous drug delivery and stem cell engineering studies, because they highlight the acute need to differentiate supportive versus inhibitory regions in the host skin.	[Plikus, Maksim V.; Mayer, Julie Ann; de la Cruz, Damon; Chuong, Cheng-Ming] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Baker, Ruth E.; Maini, Philip K.] Math Inst, Ctr Math Biol, Oxford OX1 3LB, England; [Maini, Philip K.] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; [Maxson, Robert] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Southern California; University of Oxford; University of Oxford; University of Southern California	Chuong, CM (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	cmchuong@usc.edu		Plikus, Maksim/0000-0002-8845-2559; Baker, Ruth/0000-0002-6304-9333	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042177, R01AR047364] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR042177-13, R01 AR042177, R01 AR047364-05, R01 AR047364, R01 AR047364-06, R01 AR042177-14] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; CHASE HB, 1954, PHYSIOL REV, V34, P113, DOI 10.1152/physrev.1954.34.1.113; DURWARD A, 1949, J ANAT, V83, P325; EBLING FJ, 1961, J EMBRYOL EXP MORPH, V9, P285; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Iguchi M, 2001, J INVEST DERMATOL, V117, P1349, DOI 10.1046/j.0022-202x.2001.01606.x; JOHNSON E, 1958, J ENDOCRINOL, V16, P351, DOI 10.1677/joe.0.0160351; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Ma L, 2003, DEVELOPMENT, V130, P379, DOI 10.1242/dev.00201; Maurer M, 1997, AM J PATHOL, V150, P1433; Militzer K, 2001, CELLS TISSUES ORGANS, V168, P285, DOI 10.1159/000047845; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; PAUS R, 1990, BRIT J DERMATOL, V122, P777, DOI 10.1111/j.1365-2133.1990.tb06266.x; Plikus M, 2004, AM J PATHOL, V164, P1099, DOI 10.1016/S0002-9440(10)63197-5; PLIKUS MV, 2007, IN PRESS J INVEST DE; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P9680, DOI 10.1073/pnas.1731184100; Wu P, 2004, INT J DEV BIOL, V48, P249, DOI 10.1387/ijdb.15272390; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x	30	489	522	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					340	U8		10.1038/nature06457	http://dx.doi.org/10.1038/nature06457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202659	Green Accepted, Green Submitted			2022-12-24	WOS:000252432100051
J	Droser, ML; Gehling, JG				Droser, Mary L.; Gehling, James G.			Synchronous aggregate growth in an abundant new Ediacaran tubular organism	SCIENCE			English	Article							REPRODUCTION; FOSSILS	The most abundant taxon of the Neoproterozoic soft- bodied biota near Ediacara, South Australia, occurs as clusters of similarly sized individuals, which suggests synchronous aggregate growth by spatfall. Tubes of Funisia dorothea gen. et sp. nov. were anchored within the shallow, sandy sea bed and lived in dense, typically monospecific concentrations. Tubes were composed of modular, serially repeating elements. Individuals grew by adding serial elements to the tubular body and by branching of tubes. Their construction and close- packed association imply likely affinity within the Porifera or Cnidaria. These data suggest that several of the most successful marine invertebrate ecological strategies known today were in place in Earth's oldest known metazoan ecosystems before the advent of skeletonization and widespread predation.	[Droser, Mary L.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Gehling, James G.] S Australian Museum, Adelaide, SA 5000, Australia	University of California System; University of California Riverside	Droser, ML (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	Mary.droser@ucr.edu						Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; BENGSTON S, 1992, SCIENCE, V257, P1645; CRISP DJ, 1979, BIOL SYSTEMATICS COL, P319; Droser ML, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P125; Droser ML, 2006, PALAEOGEOGR PALAEOCL, V232, P131, DOI 10.1016/j.palaeo.2005.12.015; Fautin DG, 2002, CAN J ZOOL, V80, P1735, DOI 10.1139/Z02-133; Gehling JG, 2000, PALAEONTOLOGY, V43, P427, DOI 10.1111/j.0031-0239.2000.00134.x; Gehling JG, 1999, PALAIOS, V14, P40, DOI 10.2307/3515360; Gehling JG, 2000, PRECAMBRIAN RES, V100, P65, DOI 10.1016/S0301-9268(99)00069-8; GEHLING JG, 2005, EDIACARA ORGANISMS R; GLAESSNER MF, 1969, LETHAIA, V2, P369, DOI 10.1111/j.1502-3931.1969.tb01258.x; HOLTS LJ, 1993, MAR BIOL, V116, P129, DOI 10.1007/BF00350740; JACKSON JBC, 1983, BIOTIC INTERACTIONS, V3, P39; Jacobs DK, 2005, EVOL DEV, V7, P498, DOI 10.1111/j.1525-142X.2005.05055.x; Peterson KJ, 2003, INTEGR COMP BIOL, V43, P127, DOI 10.1093/icb/43.1.127; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377	16	81	84	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1660	1662		10.1126/science.1152595	http://dx.doi.org/10.1126/science.1152595			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356525				2022-12-24	WOS:000254172300039
J	Williams, B; Ruff, TA				Williams, Bill; Ruff, Tilman A.			Getting nuclear-bomb fuel out of radiopharmaceuticals	LANCET			English	Editorial Material									[Williams, Bill; Ruff, Tilman A.] Int Campaign Abolish Nucl Weap, Melbourne, Vic, Australia; [Ruff, Tilman A.] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic 3010, Australia	University of Melbourne	Ruff, TA (corresponding author), Int Campaign Abolish Nucl Weap, Melbourne, Vic, Australia.	tar@unimelb.edu.au						Bunn M, 2006, ANN AM ACAD POLIT SS, V607, P133, DOI 10.1177/0002716206290260; Collier R, 2008, CAN MED ASSOC J, V178, P536, DOI 10.1503/cmaj.080154; GOLDEMBERG J, 2006, MINIMISATION HIGHLY; Helfand I, 2002, BRIT MED J, V324, P356, DOI 10.1136/bmj.324.7333.356; *IAEA, INT VER SER, V3; *IAEA, 2005, ILL NUCL TRAFF FACTS; Kahn Laura H, 2007, J Am Coll Radiol, V4, P248, DOI 10.1016/j.jacr.2006.12.012; Kuperman AJ, 2006, B ATOM SCI, V62, P44, DOI 10.2968/062002012; *NAT AC SCI, MED IS PROD HIGHL EN; National Research Council, 2002, MAK NAT SAF ROL SCI; Williams Bill, 2007, Med Confl Surviv, V23, P267, DOI 10.1080/13623690701596692	11	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2008	371	9615					795	797		10.1016/S0140-6736(08)60359-1	http://dx.doi.org/10.1016/S0140-6736(08)60359-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272NQ	18328913				2022-12-24	WOS:000253866500009
J	Chao, JR; Parganas, E; Boyd, K; Hong, CY; Opferman, JT; Ihle, JN				Chao, Jyh-Rong; Parganas, Evan; Boyd, Kelli; Hong, Cheol Yi; Opferman, Joseph T.; Ihle, James N.			Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons	NATURE			English	Article							TROPHIC FACTOR DEPRIVATION; SERINE-PROTEASE HTRA2/OMI; APOPTOTIC PROTEIN; CYTOCHROME-C; CELL-DEATH; BAX; FAMILY; PHOSPHORYLATION; HAX-1; MICE	Cytokines affect a variety of cellular functions, including regulation of cell numbers by suppression of programmed cell death(1). Suppression of apoptosis requires receptor signalling through the activation of Janus kinases and the subsequent regulation of members of the B- cell lymphoma 2 ( Bcl- 2) family. Here we demonstrate that a Bcl- 2- family- related protein, Hax1, is required to suppress apoptosis in lymphocytes and neurons. Suppression requires the interaction of Hax1 with the mitochondrial proteases Parl ( pre-senilin-associated, rhomboid- like) and HtrA2 ( high- temperature-regulated A2, also known as Omi). These interactions allow Hax1 to present HtrA2 to Parl, and thereby facilitates the processing of HtrA2 to the active protease localized in the mitochondrial intermembrane space. In mouse lymphocytes, the presence of processed HtrA2 prevents the accumulation of mitochondrial-outer-membrane- associated activated Bax, an event that initiates apoptosis. Together, the results identify a previously unknown sequence of interactions involving a Bcl- 2- family- related protein and mitochondrial proteases in the ability to resist the induction of apoptosis when cytokines are limiting.	[Chao, Jyh-Rong; Parganas, Evan; Hong, Cheol Yi; Opferman, Joseph T.; Ihle, James N.] St Jude Childrens Hosp, Dept Biochem, Memphis, TN 38105 USA; [Boyd, Kelli] St Jude Childrens Hosp, Anim Resources Ctr, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Ihle, JN (corresponding author), St Jude Childrens Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.ihle@stjude.org	Opferman, Joseph T/M-5331-2018	Opferman, Joseph T/0000-0002-1147-5621				Carlsson G, 2001, ACTA PAEDIATR, V90, P757, DOI 10.1080/080352501750315663; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Deckwerth TL, 1998, EXP NEUROL, V152, P150, DOI 10.1006/exnr.1998.6846; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Letai A, 2006, MOL CELL, V21, P728, DOI 10.1016/j.molcel.2006.03.005; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Matsubara K, 2007, HAEMATOLOGICA, V92, pE123, DOI 10.3324/haematol.11973; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Seward RJ, 2003, MOL IMMUNOL, V39, P983, DOI 10.1016/S0161-5890(03)00047-6; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Vaux DL, 2003, CELL, V115, P251, DOI 10.1016/S0092-8674(03)00851-1; Wei MC, 2000, GENE DEV, V14, P2060; White FA, 1998, J NEUROSCI, V18, P1428; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281	27	189	191	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					98	U10		10.1038/nature06604	http://dx.doi.org/10.1038/nature06604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18288109				2022-12-24	WOS:000253671900054
J	Rousseau, P				Rousseau, Paul			Sammy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												palliativedoc@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2008	299	7					736	736		10.1001/jama.299.7.736	http://dx.doi.org/10.1001/jama.299.7.736			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263OR	18285581				2022-12-24	WOS:000253226900001
J	Birmingham, CL; Canadien, V; Kaniuk, NA; Steinberg, BE; Higgins, DE; Brumell, JH				Birmingham, Cheryl L.; Canadien, Veronica; Kaniuk, Natalia A.; Steinberg, Benjamin E.; Higgins, Darren E.; Brumell, John H.			Listeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles	NATURE			English	Article							PHOSPHOLIPASES-C; LYSOSOME FUSION; CELLS; INFECTION; PH; PATHOGENESIS; MATURATION; AUTOPHAGY; SURVIVAL; PROTEIN	Listeria monocytogenes is an intracellular bacterial pathogen that replicates rapidly in the cytosol of host cells during acute infection(1). Surprisingly, these bacteria were found to occupy vacuoles in liver granuloma macrophages during persistent infection of severe combined immunodeficient ( SCID) mice(2). Here we show that L. monocytogenes can replicate in vacuoles within macrophages. In livers of SCID mice infected for 21 days, we observed bacteria in large LAMP1(+) compartments that we termed spacious Listeria- containing phagosomes ( SLAPs). SLAPs were also observed in vitro, and were found to be non- acidic and non-degradative compartments that are generated in an autophagy-dependent manner. The replication rate of bacteria in SLAPs was found to be reduced compared to the rate of those in the cytosol. Listeriolysin O ( LLO, encoded by hly), a pore- forming toxin essential for L. monocytogenes virulence(1), was necessary and sufficient for SLAP formation. A L. monocytogenes mutant with low LLO expression was impaired for phagosome escape but replicated slowly in SLAPs over a 72 h period. Therefore, our studies reveal a role for LLO in promoting L. monocytogenes replication in vacuoles and suggest a mechanism by which this pathogen can establish persistent infection in host macrophages.	[Birmingham, Cheryl L.; Canadien, Veronica; Kaniuk, Natalia A.; Steinberg, Benjamin E.; Brumell, John H.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Birmingham, Cheryl L.; Brumell, John H.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Steinberg, Benjamin E.; Brumell, John H.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Higgins, Darren E.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Harvard University; Harvard Medical School	Brumell, JH (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	john.brumell@sickkids.ca	Birmingham, Cheryl/AAF-6649-2020					Alberti-Segui C, 2007, CELL MICROBIOL, V9, P179, DOI 10.1111/j.1462-5822.2006.00780.x; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Bhardwaj V, 1998, J IMMUNOL, V160, P376; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cheng LW, 2003, CELL MICROBIOL, V5, P875, DOI 10.1046/j.1462-5822.2003.00327.x; DECHASTELLIER C, 1994, INFECT IMMUN, V62, P543, DOI 10.1128/IAI.62.2.543-553.1994; del Cerro-Vadillo E, 2006, J IMMUNOL, V176, P1321, DOI 10.4049/jimmunol.176.3.1321; Dramsi S, 1998, INFECT IMMUN, V66, P4461; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; Jankowski A, 2002, J BIOL CHEM, V277, P6059, DOI 10.1074/jbc.M110059200; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kayal S, 2006, FEMS MICROBIOL REV, V30, P514, DOI 10.1111/j.1574-6976.2006.00021.x; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; NATO F, 1991, INFECT IMMUN, V59, P4641, DOI 10.1128/IAI.59.12.4641-4646.1991; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; Skoble J, 2000, J CELL BIOL, V150, P527, DOI 10.1083/jcb.150.3.527; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	32	230	239	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					350	U13		10.1038/nature06479	http://dx.doi.org/10.1038/nature06479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202661				2022-12-24	WOS:000252432100053
J	Han, HJ; Russo, J; Kohwi, Y; Kohwi-Shigematsu, T				Han, Hye-Jung; Russo, Jose; Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi			SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis	NATURE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; CANCER METASTASIS; SIGNAL-TRANSDUCTION; BINDING PROTEIN; IN-VIVO; CHROMATIN; CELLS; PROGRESSION; ARCHITECTURE; APOPTOSIS	Mechanisms underlying global changes in gene expression during tumour progression are poorly understood. SATB1 is a genome organizer that tethers multiple genomic loci and recruits chromatin- remodelling enzymes to regulate chromatin structure and gene expression. Here we show that SATB1 is expressed by aggressive breast cancer cells and its expression level has high prognostic significance ( P < 0.0001), independent of lymph- node status. RNA- interference- mediated knockdown of SATB1 in highly aggressive ( MDA- MB- 231) cancer cells altered the expression of >1,000 genes, reversing tumorigenesis by restoring breast- like acinar polarity and inhibiting tumour growth and metastasis in vivo. Conversely, ectopic SATB1 expression in non- aggressive ( SKBR3) cells led to gene expression patterns consistent with aggressive- tumour phenotypes, acquiring metastatic activity in vivo. SATB1 delineates specific epigenetic modifications at target gene loci, directly upregulating metastasis- associated genes while downregulating tumour- suppressor genes. SATB1 reprogrammes chromatin organization and the transcription profiles of breast tumours to promote growth and metastasis; this is a new mechanism of tumour progression.	[Han, Hye-Jung; Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi] Univ Calif Berkeley, Div Life Sci, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Russo, Jose] Fox Chase Canc Ctr, Breast Canc Res Lab, Philadelphia, PA 19111 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Fox Chase Cancer Center	Kohwi-Shigematsu, T (corresponding author), Univ Calif Berkeley, Div Life Sci, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.	YKohwi@lbl.gov; Terumiks@lbl.gov						Alvarez JD, 2000, GENE DEV, V14, P521; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; de Bono JS, 2002, TRENDS MOL MED, V8, pS19, DOI 10.1016/S1471-4914(02)02306-7; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Drobic B, 2006, EXP SUPPL, V96, P25; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Galande S, 2000, J CELL BIOCHEM, P36; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Ince TA, 2002, CANCER CELL, V1, P15, DOI 10.1016/S1535-6108(02)00023-5; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kohwi-Shigematsu T, 1998, METHOD CELL BIOL, V53, P323; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mosesson Y, 2004, SEMIN CANCER BIOL, V14, P262, DOI 10.1016/j.semcancer.2004.04.005; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Parker BS, 2003, CANCER BIOL THER, V2, P14; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Salven P, 1998, AM J PATHOL, V153, P103, DOI 10.1016/S0002-9440(10)65550-2; Severgnini M, 2006, ANAL BIOCHEM, V353, P43, DOI 10.1016/j.ab.2006.03.023; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	50	417	468	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2008	452	7184					187	193		10.1038/nature06781	http://dx.doi.org/10.1038/nature06781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337816				2022-12-24	WOS:000253925600034
J	Mermin, J; Were, W; Ekwaru, JP; Moore, D; Downing, R; Behumbiize, P; Lule, JR; Coutinho, A; Tappero, J; Bunnell, R				Mermin, Jonathan; Were, Willy; Ekwaru, John Paul; Moore, David; Downing, Robert; Behumbiize, Prosper; Lule, John R.; Coutinho, Alex; Tappero, Jordan; Bunnell, Rebecca			Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study	LANCET			English	Article							SUB-SAHARAN AFRICA; COTRIMOXAZOLE PROPHYLAXIS; GENDER-DIFFERENCES; THERAPY; AIDS; PROGRESSION; LESSONS	Background Antiretroviral therapy (ART) is increasingly available in Africa, but physicians and clinical services are few. We therefore assessed the effect of a home-based ART programme in Uganda on mortality, hospital admissions, and orphanhood in people with HIV-1 and their household members. Methods In 2001, we enrolled and followed up 466 HIV-infected adults and 1481 HIV-uninfected household members in a prospective cohort study. After 5 months, we provided daily co-trimoxazole (160 mg trimethoprim and 800 mg sulfamethoxazole) prophylaxis to HIV-infected participants. Between May, 2003, and December, 2005, we followed up 138 infected adults who were eligible and 907 new HIV-infected participants and their HIV-negative household members in a study of ART (mainly stavudine, lamivudine, and nevirapine). Households were visited every week by lay providers, and no dinic visits were scheduled after enrolment. We compared rates of death, hospitalisation, and orphanhood during diffierent study periods and calculated the number needed to treat to prevent an outcome. Findings 233 (17%) of 1373 participants with HIV and 40 (1%) of 4601 HIV-uninfected household members died. During the first 16 weeks of ART and co-trimoxazole, mortality in HIV-infected participants was 55% lower than that during co-trimoxazole alone (14 vs 16 deaths per 100 person-years; adjusted hazard ratio 0 . 45, 95% CI 0 . 27-0.74, p=0.0018), and after 16 weeks, was reduced by 92% (3 vs 16 deaths per 100 person-years; 0 . 08, 0.06-0.13, p<0.0001). Compared with no intervention, ART and co-trimoxazole were associated with a 95% reduction in mortality in HIV-indected participants (5 vs 27 deaths per 100 person-years; 0.05, 0.03-0.08, p<0.0001), 81% reduction in mortality in their uninfected children younger than 10 years (0 . 2 vs 1 . 2 deaths per 100 person-years; 0 . 19, 0.06-0.59, p=0.004), and a 93% estimated reduction in orphanhood (0 . 9 vs 12.8 per 100 person-years of adults treated; 0.07, 0.04-0 . 13, p<0 . 0001). Interpretation Expansion of access to ART and co-trimoxazole prophylaxis could substantially reduce mortality and orphanhood among adults with HIV and their families living in resource-poor settings.	[Mermin, Jonathan] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, Coordinating Off Global Hlth, Nairobi, Kenya; [Mermin, Jonathan; Were, Willy; Ekwaru, John Paul; Moore, David; Downing, Robert; Behumbiize, Prosper; Lule, John R.; Tappero, Jordan; Bunnell, Rebecca] Ctr Dis Control & Prevent Uganda, Global AIDS Program, Natl Ctr HIV Viral Hepatitis Sexually Transmitted, Entebbe, Uganda; [Moore, David] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Coutinho, Alex] AIDS Support Org, Kampala, Uganda	Kenya Medical Research Institute; University of British Columbia	Mermin, J (corresponding author), Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, Coordinating Off Global Hlth, Mbagathi Rd, Nairobi, Kenya.	jhm7@cdc.gov	Mermin, Jonathan/J-9847-2012					Akileswaran C, 2005, CLIN INFECT DIS, V41, P376, DOI 10.1086/431482; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Braga P, 2007, AIDS PATIENT CARE ST, V21, P321, DOI 10.1089/apc.2006.0111; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Calmy A, 2004, AIDS, V18, P2353; Colebunders R, 2005, PLOS MED, V2, P941, DOI 10.1371/journal.pmed.0020276; El-Ghannam Ashraf Ragab, 2003, J Health Soc Policy, V16, P1, DOI 10.1300/J045v16n04_01; Hardin J., 2003, GEN ESTIMATING EQUAT; IWASA S, PLANNING HLTH INFRAS; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Laurent C, 2005, CLIN INFECT DIS, V41, P108, DOI 10.1086/430712; Losina E, 2007, ANTIVIR THER, V12, P543; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Nduati R, 2001, LANCET, V357, P1651, DOI 10.1016/S0140-6736(00)04820-0; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; PAPPAS G, 2006, AIDS PUBLIC POLICY J, V19, P75; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Spacek LA, 2006, CLIN INFECT DIS, V42, P252, DOI 10.1086/499044; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Walker AS, 2007, CLIN INFECT DIS, V44, P1361, DOI 10.1086/515396; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; WHO, WORK TOG HLTH WORLD; *WHO UNAIDS, AIDS EP UPD 2006; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea	33	144	149	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					752	759		10.1016/S0140-6736(08)60345-1	http://dx.doi.org/10.1016/S0140-6736(08)60345-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313504				2022-12-24	WOS:000253596700029
J	Hirata, A; Klein, BJ; Murakami, KS				Hirata, Akira; Klein, Brianna J.; Murakami, Katsuhiko S.			The X-ray crystal structure of RNA polymerase from Archaea	NATURE			English	Article							TRANSCRIPTION FACTORS; ANGSTROM RESOLUTION; INITIATION; SUBUNIT; TRANSLATION; MACHINERY; MECHANISM; COMPLEX; SYSTEM; ENZYME	The transcription apparatus in Archaea can be described as a simplified version of its eukaryotic RNA polymerase ( RNAP) II counterpart, comprising an RNAPII- like enzyme as well as two general transcription factors, the TATA- binding protein ( TBP) and the eukaryotic TFIIB orthologue TFB1,2. It has been widely understood that precise comparisons of cellular RNAP crystal structures could reveal structural elements common to all enzymes and that these insights would be useful in analysing components of each enzyme that enable it to perform domain- specific gene expression. However, the structure of archaeal RNAP has been limited to individual subunits(3,4). Here we report the first crystal structure of the archaeal RNAP from Sulfolobus solfataricus at 3.4 angstrom resolution, completing the suite of multi- subunit RNAP structures from all three domains of life. We also report the high-resolution ( at 1.76 angstrom) crystal structure of the D/ L subcomplex of archaeal RNAP and provide the first experimental evidence of any RNAP possessing an iron - sulphur ( Fe - S) cluster, which may play a structural role in a key subunit of RNAP assembly. The striking structural similarity between archaeal RNAP and eukaryotic RNAPII highlights the simpler archaeal RNAP as an ideal model system for dissecting the molecular basis of eukaryotic transcription.	[Hirata, Akira; Klein, Brianna J.; Murakami, Katsuhiko S.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Murakami, KS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	kum14@psu.edu		Murakami, Katsuhiko/0000-0003-2244-0501	NIGMS NIH HHS [R01 GM071897, R01 GM071897-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071897] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bell SD, 1998, TRENDS MICROBIOL, V6, P222, DOI 10.1016/S0966-842X(98)01281-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chlenov M, 2005, J MOL BIOL, V353, P138, DOI 10.1016/j.jmb.2005.07.073; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Geiduschek EP, 2005, MOL MICROBIOL, V56, P1397, DOI 10.1111/j.1365-2958.2005.04627.x; Goede B, 2006, J BIOL CHEM, V281, P30581, DOI 10.1074/jbc.M605209200; ISHIHAMA A, 1976, RNA POLYMERASE, P485; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murakami K, 1997, P NATL ACAD SCI USA, V94, P11274, DOI 10.1073/pnas.94.21.11274; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Naji S, 2007, J BIOL CHEM, V282, P11047, DOI 10.1074/jbc.M611674200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouhammouch M, 2004, J BIOL CHEM, V279, P51719, DOI 10.1074/jbc.C400446200; Rodriguez-Monge L, 1998, TRENDS BIOCHEM SCI, V23, P169, DOI 10.1016/S0968-0004(98)01203-1; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Todone F, 2001, MOL CELL, V8, P1137, DOI 10.1016/S1097-2765(01)00379-3; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yee A, 2000, P NATL ACAD SCI USA, V97, P6311, DOI 10.1073/pnas.97.12.6311; ZALENSKAYA K, 1990, GENE, V89, P7, DOI 10.1016/0378-1119(90)90199-2; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; ZILLIG W, 1976, RNA POLYMERASE, P101	35	156	173	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					851	U12		10.1038/nature06530	http://dx.doi.org/10.1038/nature06530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18235446	Green Accepted			2022-12-24	WOS:000253191400047
J	O'Gorman, C				O'Gorman, Carmel			We need better data on smoking in pregnancy	BRITISH MEDICAL JOURNAL			English	Editorial Material									Good Hope Hosp, Birmingham, W Midlands, England	Birmingham City University; Heart of England NHS Foundation Trust; Good Hope Hospital	O'Gorman, C (corresponding author), Good Hope Hosp, Birmingham, W Midlands, England.	carmel.ogorman@heartofengland.nhs.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 9	2008	336	7639					330	330		10.1136/bmj.39479.677188.BD	http://dx.doi.org/10.1136/bmj.39479.677188.BD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LR	18258970	Green Published			2022-12-24	WOS:000253437400037
J	Kim, JE; Chen, JJ; Lou, ZK				Kim, Ja-Eun; Chen, Junjie; Lou, Zhenkun			DBC1 is a negative regulator of SIRT1	NATURE			English	Article							CALORIE RESTRICTION; CELL-SURVIVAL; LIFE-SPAN; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; DNA-DAMAGE; DEACETYLASE; CANCER; STRESS; NAD	The NAD- dependent protein deacetylase Sir2 ( silent information regulator 2) regulates lifespan in several organisms(1-3). SIRT1, the mammalian orthologue of yeast Sir2, participates in various cellular functions(4-7) and possibly tumorigenesis(8). Whereas the cellular functions of SIRT1 have been extensively investigated, less is known about the regulation of SIRT1 activity. Here we show that Deleted in Breast Cancer- 1 ( DBC1), initially cloned from a region ( 8p21) homozygously deleted in breast cancers(9), forms a stable complex with SIRT1. DBC1 directly interacts with SIRT1 and inhibits SIRT1 activity in vitro and in vivo. Downregulation of DBC1 expression potentiates SIRT1- dependent inhibition of apoptosis induced by genotoxic stress. Our results shed new light on the regulation of SIRT1 and have important implications in understanding the molecular mechanism of ageing and cancer.	[Kim, Ja-Eun; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Lou, Zhenkun] Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA	Yale University; Mayo Clinic	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	Junjie.Chen@yale.edu; Lou.Zhenkun@mayo.edu	Kim, Ja-Eun/AAI-1896-2020	Kim, Ja-Eun/0000-0002-9132-1277				Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Lim CS, 2006, MED HYPOTHESES, V67, P341, DOI 10.1016/j.mehy.2006.01.050; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; PRUITT K, 2006, PLOS GENET, V2, P344, DOI ARTN e40; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sundararajan R, 2005, ONCOGENE, V24, P4908, DOI 10.1038/sj.onc.1208681; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	30	394	409	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2008	451	7178					583	U10		10.1038/nature06500	http://dx.doi.org/10.1038/nature06500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235501				2022-12-24	WOS:000252739900044
J	Savage, PA; Vosseller, K; Kang, CH; Larimore, K; Riedel, E; Wojnoonski, K; Jungbluth, AA; Allison, JP				Savage, Peter A.; Vosseller, Keith; Kang, Chulho; Larimore, Kevin; Riedel, Elyn; Wojnoonski, Kathleen; Jungbluth, Achim A.; Allison, James P.			Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8(+) T lymphocytes	SCIENCE			English	Article							TRANSGENIC MOUSE; MELANOMA; CELLS; MODEL	Substantial evidence exists that many tumors can be specifically recognized by CD8(+) T lymphocytes. The definition of antigens targeted by these cells is paramount for the development of effective immunotherapeutic strategies for treating human cancers. In a screen for endogenous tumor- associated T cell responses in a primary mouse model of prostatic adenocarcinoma, we identified a naturally arising CD8(+) T cell response that is reactive to a peptide derived from histone H4. Despite the ubiquitous nature of histones, T cell recognition of histone H4 peptide was specifically associated with the presence of prostate cancer in these mice. Thus, the repertoire of antigens recognized by tumor- infiltrating T cells is broader than previously thought and includes peptides derived from ubiquitous self antigens that are normally sequestered from immune detection.	[Savage, Peter A.; Wojnoonski, Kathleen; Allison, James P.] Mem Sloan Kettering Canc Ctr, Dept Immunol, Howard Hughes Med Inst, New York, NY 10021 USA; [Savage, Peter A.; Wojnoonski, Kathleen; Allison, James P.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, New York, NY 10021 USA; [Vosseller, Keith] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Kang, Chulho] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Larimore, Kevin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Riedel, Elyn] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Jungbluth, Achim A.] Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Drexel University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Memorial Sloan Kettering Cancer Center; Ludwig Institute for Cancer Research	Allison, JP (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Immunol, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10021 USA.	allisonj@mskcc.org		Allison, James/0000-0001-8980-5697				Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Foster BA, 1997, CANCER RES, V57, P3325; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Mortarini R, 2003, CANCER RES, V63, P2535; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Romero P, 2006, ADV IMMUNOL, V92, P187, DOI 10.1016/S0065-2776(06)92005-7; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	13	81	82	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					215	220		10.1126/science.1148886	http://dx.doi.org/10.1126/science.1148886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187659				2022-12-24	WOS:000252246400045
J	Rietjens, J; van Delden, J; Onwuteaka-Philipsen, B; Buiting, H; van der Maas, P; van der Heide, A				Rietjens, Judith; van Delden, Johannes; Onwuteaka-Philipsen, Bregje; Buiting, Hilde; van der Maas, Paul; van der Heide, Agnes			Continuous deep sedation for patients nearing death in the Netherlands: descriptive study	BRITISH MEDICAL JOURNAL			English	Article							PALLIATIVE SEDATION; TERMINAL SEDATION; EUTHANASIA; LIFE; SYMPTOMS	Objectives To study the practice of continuous deep sedation in 2005 in the Netherlands and compare it with findings from 2001. Design Questionnaire study about random samples of deaths reported to a central death registry in 2005 and 2001. Setting Nationwide physician study in the Netherlands. Participants Reporting physicians received a questionnaire about the medical decisions that preceded the patient's death; 78% (n=6860) responded in 2005 and 74% (n=5617) in 2001. Main outcome measures Characteristics of continuous deep sedation (attending physician, types of patients, drugs used, duration, estimated effect on shortening life, palliative consultation). Requests for euthanasia. Results The use of continuous deep sedation increased from 5.6% (95% confidence interval 5.0% to 6.2%) of deaths in 2001 to 7.1% (6.5% to 7.6%) in 2005, mostly in patients treated by general practitioners and in those with cancer (in 2005, 47% of sedated patients had cancer v 33% in 2001). In 83% of cases sedation was induced by benzodiazepines, and in 94% patients were sedated for periods of less than one week until death. Nine per cent of those who received continuous deep sedation had previously requested euthanasia but their requests were not granted. Nine percent of the physicians had consulted a palliative expert. Conclusions The increased use of continuous deep sedation for patients nearing death in the Netherlands and the limited use of palliative consultation suggests that this practice is increasingly considered as part of regular medical practice.	[Rietjens, Judith; Buiting, Hilde; van der Maas, Paul; van der Heide, Agnes] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [van Delden, Johannes] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Onwuteaka-Philipsen, Bregje] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Rietjens, J (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.rietjens@erasmusmc.nl						Chiu TY, 2001, J PAIN SYMPTOM MANAG, V21, P467, DOI 10.1016/S0885-3924(01)00286-X; De Graeff A, 2007, J PALLIAT MED, V10, P67, DOI 10.1089/jpm.2006.0139; Fainsinger RL, 2000, PALLIATIVE MED, V14, P257, DOI 10.1191/026921600666097479; Hasselaar JGJ, 2007, ARCH INTERN MED, V167, P1166, DOI 10.1001/archinte.167.11.1166; Miccinesi G, 2006, J PAIN SYMPTOM MANAG, V31, P122, DOI 10.1016/j.jpainsymman.2005.07.004; Muller-Busch H Christof, 2003, BMC Palliat Care, V2, P2, DOI 10.1186/1472-684X-2-2; Onwuteaka-Philipsen BD, 2003, LANCET, V362, P395, DOI 10.1016/S0140-6736(03)14029-9; Rietjens JAC, 2006, ARCH INTERN MED, V166, P749, DOI 10.1001/archinte.166.7.749; Rietjens JAC, 2004, ANN INTERN MED, V141, P178, DOI 10.7326/0003-4819-141-3-200408030-00006; *STICHT FARM KENG, 2006, PHARM WEEKBLAD, V141, P81; Stone P, 1997, PALLIATIVE MED, V11, P140, DOI 10.1177/026921639701100208; van der Heide A, 2007, NEW ENGL J MED, V356, P1957, DOI 10.1056/NEJMsa071143; Verkerk M, 2007, J PAIN SYMPTOM MANAG, V34, P666, DOI 10.1016/j.jpainsymman.2007.01.005	13	104	105	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR	2008	336	7648					810	813		10.1136/bmj.39504.531505.25	http://dx.doi.org/10.1136/bmj.39504.531505.25			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292ER	18344245	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000255249800043
J	Cook, B; Hardy, RW; McConnaughey, WB; Zuker, CS				Cook, Boaz; Hardy, Robert W.; McConnaughey, William B.; Zuker, Charles S.			Preserving cell shape under environmental stress	NATURE			English	Article							MECHANOSENSORY TRANSDUCTION; MECHANICAL-PROPERTIES; DROSOPHILA RETINA; CYTOCHALASIN-D; MECHANORECEPTORS; EYES	Maintaining cell shape and tone is crucial for the function and survival of cells and tissues. Mechanotransduction relies on the transformation of minuscule mechanical forces into high- fidelity electrical responses(1-3). When mechanoreceptors are stimulated, mechanically sensitive cation channels open and produce an inward transduction current that depolarizes the cell. For this process to operate effectively, the transduction machinery has to retain integrity and remain unfailingly independent of environmental changes. This is particularly challenging for poikilothermic organisms, where changes in temperature in the environment may impact the function of mechanoreceptor neurons. Thus, we wondered how insects whose habitat might quickly vary over several tens of degrees of temperature manage to maintain highly effective mechanical senses. We screened for Drosophila mutants with defective mechanical responses at elevated ambient temperatures, and identified a gene, spam, whose role is to protect the mechanosensory organ from massive cellular deformation caused by heat-induced osmotic imbalance. Here we show that Spam protein forms an extracellular shield that guards mechanosensory neurons from environmental insult. Remarkably, heterologously expressed Spam protein also endowed other cells with superb defence against physically and chemically induced deformation. We studied the mechanical impact of Spam coating and show that spam- coated cells are up to ten times stiffer than uncoated controls. Together, these results help explain how poikilothermic organisms preserve the architecture of critical cells during environmental stress, and illustrate an elegant and simple solution to such challenge.	[Cook, Boaz; Hardy, Robert W.; Zuker, Charles S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Cook, Boaz; Hardy, Robert W.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; [Cook, Boaz; Hardy, Robert W.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [McConnaughey, William B.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Washington University (WUSTL)	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	charles@flyeye.ucsd.edu			NATIONAL EYE INSTITUTE [R01EY006979] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY006979-18, R01 EY006979] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barth FG, 2004, CURR OPIN NEUROBIOL, V14, P415, DOI 10.1016/j.conb.2004.07.005; Colclasure J Chris, 2003, Gravit Space Biol Bull, V16, P61; Gibbs AG, 1998, J EXP BIOL, V201, P71; Gopfert MC, 2001, NATURE, V411, P908, DOI 10.1038/35082144; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; KERNAN M, 1995, CURR OPIN NEUROBIOL, V5, P443, DOI 10.1016/0959-4388(95)80003-4; KIGER A, 2003, J BIOL, V2; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Osorio D, 2007, BIOESSAYS, V29, P111, DOI 10.1002/bies.20533; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; ZAHALAK GI, 1990, J BIOMECH ENG-T ASME, V112, P283, DOI 10.1115/1.2891186; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	18	37	37	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					361	U9		10.1038/nature06603	http://dx.doi.org/10.1038/nature06603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18297055	Green Accepted			2022-12-24	WOS:000254117400049
J	Mantzouranis, EC				Mantzouranis, Eva C.			Taking your child's breath away - The extension of asthma's globel reach	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Crete, Iraklion, Greece	University of Crete	Mantzouranis, EC (corresponding author), Univ Crete, Iraklion, Greece.							Khaltaev N, 2007, GLOBAL SURVEILLANCE; Lodha Rakesh, 2003, Indian Pediatr, V40, P874; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mellon Michael, 2004, J Manag Care Pharm, V10, P130	4	8	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2008	358	12					1211	1213		10.1056/NEJMp0708621	http://dx.doi.org/10.1056/NEJMp0708621			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275TL	18354100				2022-12-24	WOS:000254094400002
J	Bhattacharyya, T; Nicholls, SJ; Topol, EJ; Zhang, RL; Yang, X; Schmitt, D; Fu, XM; Shao, MY; Brennan, DM; Ellis, SG; Brennan, ML; Allayee, H; Lusis, AJ; Hazen, SL				Bhattacharyya, Tamali; Nicholls, Stephen J.; Topol, Eric J.; Zhang, Renliang; Yang, Xia; Schmitt, David; Fu, Xiaoming; Shao, Mingyuan; Brennan, Danielle M.; Ellis, Stephen G.; Brennan, Marie-Luise; Allayee, Hooman; Lusis, Aldons J.; Hazen, Stanley L.			Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; SERUM PARAOXONASE; ARTERY-DISEASE; ATHEROSCLEROSIS; MICE; METAANALYSIS; ASSOCIATION; LIPOPROTEIN; PROTEIN; GENOME	Context Paraoxonase 1 ( PON1) is reported to have antioxidant and cardioprotective properties. The relationship between PON1 genotypes and functional activity with systemic measures of oxidative stress and cardiovascular disease ( CVD) risk in humans has not been systematically investigated. Objective To investigate the relationship of genetic and biochemical determinants of PON1 activity with systemic measures of oxidative stress and CVD risk in humans. Design, Setting, and Participants The association between systemic PON1 activity measures and a functional polymorphism ( Q192R) resulting in high PON1 activity with prevalent CVD and future major adverse cardiac events ( myocardial infarction, stroke, or death) was evaluated in 1399 sequential consenting patients undergoing diagnostic coronary angiography between September 2002 and November 2003 at the Cleveland Clinic. Patients were followed up until December 2006. Systemic levels of multiple structurally defined fatty acid oxidation products were also measured by mass spectrometry in 150 age-, sex-, and race- matched patients and compared with regard to PON1 genotype and activity. Main Outcome Measures Relationship between a functional PON1 polymorphism and PON1 activity with global indices of systemic oxidative stress and risk of CVD. Results The PON1 genotype demonstrated significant dose- dependent associations ( QQ192 > QR192 > RR192) with decreased levels of serum PON1 activity and with increased levels of systemic indices of oxidative stress. Compared with participants with either the PON1 RR192 or QR192 genotype, participants with the QQ192 genotype demonstrated an increased risk of all- cause mortality ( 43/ 681 deaths [ 6.75%] in RR192 and QR192 and 62/ 584 deaths [ 11.1%] in QQ192; adjusted hazard ratio, 2.05; 95% confidence interval [ CI], 1.32- 3.18) and of major adverse cardiac events ( 88/ 681 events [ 13.6%] in RR192 and QR192 and 102/ 584 events [ 18.0%] in QQ192; adjusted hazard ratio, 1.48; 95% CI, 1.09- 2.03; P=. 01). The incidence of major adverse cardiac events was significantly lower in participants in the highest PON1 activity quartile ( 23/ 315 [ 7.3%]) and 235/ 324 [ 7.7%] for paraoxonase and arylesterase, respectively) compared with those in the lowest activity quartile ( 78/ 311 [ 25.1%] and 75/ 319 [ 23.5%]; P <. 001 for paraoxonase and arylesterase, respectively). The adjusted hazard ratios for major adverse cardiac events between the highest and lowest PON1 activity quartiles were, for paraoxonase, 3.4 ( 95% CI, 2.1- 5.5; P <. 001) and for arylesterase, 2.9 ( 95% CI, 1.8- 4.7; P <. 001) and remained independent in multivariate analysis. Conclusion This study provides direct evidence for a mechanistic link between genetic determinants and activity of PON1 with systemic oxidative stress and prospective cardiovascular risk, indicating a potential mechanism for the atheroprotective function of PON1.	[Bhattacharyya, Tamali; Nicholls, Stephen J.; Zhang, Renliang; Schmitt, David; Fu, Xiaoming; Brennan, Danielle M.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Bhattacharyya, Tamali; Nicholls, Stephen J.; Zhang, Renliang; Schmitt, David; Fu, Xiaoming; Brennan, Marie-Luise; Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Nicholls, Stephen J.; Shao, Mingyuan; Brennan, Danielle M.; Ellis, Stephen G.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Topol, Eric J.] Scripps Res Inst & Scripps Clin, La Jolla, CA USA; [Yang, Xia; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90024 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Immunol, Los Angeles, CA 90024 USA; [Allayee, Hooman] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Scripps Research Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California	Hazen, SL (corresponding author), Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, 9500 Euclid Ave,NE-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021	Topol, Eric/0000-0002-1478-4729; Nicholls, Stephen/0000-0002-9668-4368	NATIONAL CANCER INSTITUTE [C06CA062528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR010600, C06RR014514, KL2RR024990] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018, P50HL077107, R01HL079353, P01HL076491, P01HL030568] Funding Source: NIH RePORTER; NCI NIH HHS [C06 CA062528, CA62528-01] Funding Source: Medline; NCRR NIH HHS [C06 RR10600-01, C06 RR014514, KL2 RR024990, 1KL2RR024990, RR14514-01] Funding Source: Medline; NHLBI NIH HHS [P01 HL077107, P50 HL077107, P01 HL030568, P01 HL30568, P01 HL087018, R01 HL079353, P01 HL030568-200009, P01 HL076491] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brophy VH, 2001, PHARMACOGENETICS, V11, P77, DOI 10.1097/00008571-200102000-00009; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; Gaidukov L, 2006, J LIPID RES, V47, P2492, DOI 10.1194/jlr.M600297-JLR200; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hegele RA, 1999, ANN MED, V31, P217, DOI 10.3109/07853899909115981; Kattan MW, 2006, CANCER, V107, P2523, DOI 10.1002/cncr.22314; Kattan MW, 2004, CLIN CANCER RES, V10, P822, DOI 10.1158/1078-0432.CCR-03-0061; Lawlor DA, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-17; Li HL, 2003, J MOL MED, V81, P766, DOI 10.1007/s00109-003-0481-4; Lusis AJ, 2004, CIRCULATION, V110, P1868, DOI 10.1161/01.CIR.0000143041.58692.CC; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Mackness M, 2004, FREE RADICAL BIO MED, V37, P1317, DOI 10.1016/j.freeradbiomed.2004.07.034; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542, DOI 10.1161/01.ATV.21.4.542; Robertson KS, 2003, BBA-MOL BASIS DIS, V1639, P203, DOI 10.1016/j.bbadis.2003.09.008; Rosenzweig A, 2007, NEW ENGL J MED, V357, P497, DOI 10.1056/NEJMe078121; Rozenberg O, 2003, FREE RADICAL BIO MED, V34, P774, DOI 10.1016/S0891-5849(02)01429-6; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Shishehbor MH, 2006, FREE RADICAL BIO MED, V41, P1678, DOI 10.1016/j.freeradbiomed.2006.09.001; Shriner D, 2007, SCIENCE, V316, P1840; Thukkani AK, 2003, CIRCULATION, V108, P3128, DOI 10.1161/01.CIR.0000104564.01539.6A; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; Watzinger N, 2002, CARDIOLOGY, V98, P116, DOI 10.1159/000066321; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	31	427	442	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2008	299	11					1265	1276		10.1001/jama.299.11.1265	http://dx.doi.org/10.1001/jama.299.11.1265			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275NO	18349088	Green Accepted, Bronze			2022-12-24	WOS:000254079100018
J	Wheeler, BW; Gunnell, D; Metcalfe, C; Stephens, P; Martin, RM				Wheeler, Benedict W.; Gunnell, David; Metcalfe, Chris; Stephens, Peter; Martin, Richard M.			The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IN-VITRO FERTILIZATION; RANDOMIZED CONTROLLED-TRIALS; ASSISTED REPRODUCTION; OOCYTE ASPIRATION; SYSTEMATIC REVIEWS; SSRI PRESCRIPTIONS; RELEVANT STANDARD; ANALGESIC METHOD; INFERTILE WOMEN; EFFICACY TRIALS	Objective To investigate the population impact on the incidence of suicide and non-fatal self harm of regulatory action in 2003 to restrict the use of selective serotonin reuptake inhibitors (SSRIs) in under 18s. Design Ecological time series study. Setting United Kingdom. Populations Young people in the UK aged 12-19 years (prescribing trends), in England and Wales aged 12-17 years (mortality), and in England aged 12-17 years (hospital admissions). Main outcome measures Deaths from suicide and hospital admissions for self harm. Results Antidepressant prescribing doubled between 1999 and 2003 but fell to the 1999 level between 2004 and 2005. These large changes in prescribing did not seem to be associated with temporal trends in suicide or self harm. In the years 1993 to 2005 the annual percentage reduction for suicide among 1 2-17 year olds was -3.9% (95% confidence interval -6.2% to -1.5%) in mates and -3.0% (-6.6% to 0.6%) in females, with no indication of a substantial change in this rate of decrease during that period. Similarly, hospital admission rates for self harm in the years 1999 to 2005 indicated an annual percentage increase for mates of 1.1% (-0.5% to 2.7%) and for females of 5.7% (3.6% to 7.8%), again with no statistical evidence of a change in rate after the regulatory action. Conclusions The noticeable reduction in prescribing of antidepressants since regulatory action in 2003 to restrict the use of SSRIs in under 18s does not seem to have been associated with changes in suicidal behaviour in young people. Specifically, these data for England do not indicate that reductions in antidepressant use have led to an increase in suicidal behaviour.	[Wheeler, Benedict W.; Gunnell, David; Metcalfe, Chris; Martin, Richard M.] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Stephens, Peter] IMS Hlth, London, England	University of Bristol	Wheeler, BW (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.	ben.wheeler@bristol.ac.uk	Gunnell, David/ABE-6653-2020; Wheeler, Benedict/G-1711-2012	Gunnell, David/0000-0002-0829-6470; Wheeler, Benedict/0000-0001-9404-5936; Martin, Richard/0000-0002-7992-7719; Metcalfe, Chris/0000-0001-8318-8907				Adamson GD, 2006, FERTIL STERIL, V85, P1586, DOI 10.1016/j.fertnstert.2006.01.011; ALDERSON P, 2002, COCHRANE COLLABORATI; Altman DG, 1996, BRIT MED J, V313, P570; Andersen AN, 2004, HUM REPROD, V19, P490, DOI 10.1093/humrep/deh129; [Anonymous], FREQ ASK QUEST INF; Arce JC, 2005, HUM REPROD, V20, P1757, DOI 10.1093/humrep/deh818; Benson MR, 2006, FERTIL STERIL, V86, pS135, DOI 10.1016/j.fertnstert.2006.07.362; BIRCH S, 2001, CLIN ACUPUNCT ORIENT, V2, P17; *CDCP, 2005, ASS REPR TECHN SUCC; Chang R, 2002, FERTIL STERIL, V78, P1149, DOI 10.1016/S0015-0282(02)04348-0; Cho ZH, 1998, P NATL ACAD SCI USA, V95, P2670, DOI 10.1073/pnas.95.5.2670; CLARKE J, 2006, MENSTRUAL DISORDERS; Collins J, 2006, FERTIL STERIL, V85, P1364, DOI 10.1016/j.fertnstert.2005.10.064; Daya S, 2003, HUM REPROD, V18, P1005, DOI 10.1093/humrep/deg238; Daya S, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004830, 10.1002/14651858.CD004830]; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; DEEKS JJ, 2005, COCHRANE HDB SYSTEMA; *DEP HLTH, 2007, HOSP EP STAT DAT; Dieterle S, 2006, FERTIL STERIL, V85, P1347, DOI 10.1016/j.fertnstert.2005.09.062; Domar AD, 2006, FERTIL STERIL, V86, pS378, DOI 10.1016/j.fertnstert.2006.07.1042; Domar AD, 2006, FERTIL STERIL, V85, P1359, DOI 10.1016/j.fertnstert.2005.10.063; Elden H, 2005, BMJ-BRIT MED J, V330, P761, DOI 10.1136/bmj.38397.507014.E0; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; FERIN M, 1984, EUR J OBSTET GYN R B, V18, P365, DOI 10.1016/0028-2243(84)90059-5; Gejervall AL, 2005, HUM REPROD, V20, P728, DOI 10.1093/humrep/deh665; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Glanville JM, 2006, J MED LIBR ASSOC, V94, P130; Griesinger G, 2004, HUM REPROD, V19, P1239, DOI 10.1093/humrep/deh237; Gunnell D, 2004, BRIT MED J, V329, P34, DOI 10.1136/bmj.329.7456.34; Gunnell D, 2003, SOC SCI MED, V57, P595, DOI 10.1016/S0277-9536(02)00408-2; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Humaidan P, 2004, HUM REPROD, V19, P1367, DOI 10.1093/humrep/deh229; *IMS HLTH, 2007, INT MED STAT; JOHNSON NP, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002125.PUB2; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kaptchuk TJ, 2003, BRIT MED J, V326, P1453, DOI 10.1136/bmj.326.7404.1453; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kvorning N, 2004, ACTA OBSTET GYN SCAN, V83, P246; Lee H, 2004, AM J OBSTET GYNECOL, V191, P1573, DOI 10.1016/j.ajog.2004.05.027; Libby AM, 2007, AM J PSYCHIAT, V164, P884, DOI 10.1176/appi.ajp.164.6.884; Lineberry TW, 2007, MAYO CLIN PROC, V82, P518, DOI 10.4065/82.4.518; Ludwig M, 2000, HUM REPROD, V15, P319, DOI 10.1093/humrep/15.2.319; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Maciocia G, 1997, OBSTET GYNECOLOGY CH; MacPherson H, 2001, BMJ-BRIT MED J, V323, P486, DOI 10.1136/bmj.323.7311.486; MAYER DJ, 1977, BRAIN RES, V121, P368, DOI 10.1016/0006-8993(77)90161-5; *MED HEALTHC PROD, 2005, SEL SER REUPT INH SS; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Murray ML, 2005, DRUG SAFETY, V28, P1151, DOI 10.2165/00002018-200528120-00009; Myers ER, 2006, FERTIL STERIL, V85, P1362, DOI 10.1016/j.fertnstert.2005.10.062; *NAT I HLTH CLIN E, 2005, 28 BRIT PSYCH SOC NA; *OFF NAT STAT, 2007, NAT STAT; Olfson M, 2003, ARCH GEN PSYCHIAT, V60, P978, DOI 10.1001/archpsyc.60.9.978; Olfson M, 2007, AM J PSYCHIAT, V164, P1907, DOI 10.1176/appi.ajp.2007.07091467; Paulus WE, 2003, HUM REPROD, V18, P18; Paulus WE, 2002, FERTIL STERIL, V77, P721, DOI 10.1016/S0015-0282(01)03273-3; PIANTADOSI S, 1997, TREATMENT ALLOCATION, P203; Pinborg A, 2004, HUM REPROD, V19, P1052, DOI 10.1093/humrep/deh228; Quintero R, 2004, FERTIL STERIL, V81, pS11; Sallam HN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004635.pub2; Sator-Katzenschlager SM, 2006, HUM REPROD, V21, P2114, DOI 10.1093/humrep/del110; Smith C, 2002, COMPLEMENT THER MED, V10, P78, DOI 10.1054/ctim.2002.0523; Smith CA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003521.pub2; Smith C, 2006, FERTIL STERIL, V85, P1352, DOI 10.1016/j.fertnstert.2005.12.015; Smith R, 1998, BMJ-BRIT MED J, V317, P291, DOI 10.1136/bmj.317.7154.291; Stener-Victorin E, 1999, HUM REPROD, V14, P2480, DOI 10.1093/humrep/14.10.2480; Stener-Victorin E, 2003, HUM REPROD, V18, P1454, DOI 10.1093/humrep/deg277; StenerVictorin E, 1996, HUM REPROD, V11, P1314; Udoff LC, 2006, FERTIL STERIL, V86, pS145, DOI 10.1016/j.fertnstert.2006.07.389; Vail A, 2003, HUM REPROD, V18, P1000, DOI 10.1093/humrep/deg133; [张明敏 Zhang Mingmin], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P3; Wedenberg K, 2000, ACTA OBSTET GYN SCAN, V79, P331, DOI 10.1034/j.1600-0412.2000.079005331.x; Westergaard LG, 2006, FERTIL STERIL, V85, P1341, DOI 10.1016/j.fertnstert.2005.08.070; White A, 2001, BRIT MED J, V323, P485, DOI 10.1136/bmj.323.7311.485; WOOD L, 2006, 14 COCHR C DUBL IR O; Zegers-Hochschild F, 2006, HUM REPROD, V21, P1968, DOI 10.1093/humrep/del171; Zhang M, 2001, FERTIL STERIL, V76, pS75, DOI 10.1016/S0015-0282(01)02231-2; [张民 Zhang Min], 2002, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V8, P507	80	63	63	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2008	336	7643					542	545		10.1136/bmj.39462.375613.BE	http://dx.doi.org/10.1136/bmj.39462.375613.BE			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JV	18276667	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000253998500029
J	Koralov, SB; Muljo, SA; Galler, GR; Krek, A; Chakraborty, T; Kanellopoulou, C; Jensen, K; Cobb, BS; Merkenschlager, M; Rajewsky, N; Rajewsky, K				Koralov, Sergei B.; Muljo, Stefan A.; Galler, Gunther R.; Krek, Azra; Chakraborty, Tirtha; Kanellopoulou, Chryssa; Jensen, Kari; Cobb, Bradley S.; Merkenschlager, Matthias; Rajewsky, Nikolaus; Rajewsky, Klaus			Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage	CELL			English	Article							TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; HEAVY-CHAIN; TRANSGENIC MICE; MESSENGER-RNAS; ENZYME DICER; MICRORNA; BIM; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION	To explore the role of Dicer-dependent control mechanisms in B lymphocyte development, we ablated this enzyme in early B cell progenitors. This resulted in a developmental block at the pro- to pre-B cell transition. Gene-expression profiling revealed a miR-17 similar to 92 signature in the 3'UTRs of genes upregulated in Dicer-deficient pro-B cells; a top miR-17 similar to 92 target, the proapoptotic molecule Bim, was highly upregulated. Accordingly, B cell development could be partially rescued by ablation of Bim or transgenic expression of the prosurvival protein Bcl-2. This allowed us to assess the impact of Dicer deficiency on the V(D)J recombination program in developing B cells. We found intact Ig gene rearrangements in immunoglobulin heavy (IgH) and kappa chain loci, but increased sterile transcription and usage of D-H elements of the DSP family in IgH, and increased N sequence addition in Ig kappa due to deregulated transcription of the terminal deoxynucleotidyl transferase gene.	[Koralov, Sergei B.; Muljo, Stefan A.; Galler, Gunther R.; Chakraborty, Tirtha; Jensen, Kari; Rajewsky, Klaus] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Koralov, Sergei B.; Muljo, Stefan A.; Galler, Gunther R.; Chakraborty, Tirtha; Jensen, Kari; Rajewsky, Klaus] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Krek, Azra; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Krek, Azra] NYU, Dept Phys, New York, NY 10003 USA; [Kanellopoulou, Chryssa] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Cobb, Bradley S.; Merkenschlager, Matthias] Univ London Imperial Coll Sci Technol & Med, Lymphocyte Dev Grp, MRC, Ctr Clin Sci, London W12 0NN, England	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine; New York University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Imperial College London	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 200 Longwood Ave, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu	Muljo, Stefan A/F-5671-2015	Muljo, Stefan A/0000-0003-1013-446X; Koralov, Sergei/0000-0002-4843-3791; Merkenschlager, Matthias/0000-0003-2889-3288; Rajewsky, Klaus/0000-0002-6633-6370; Galler, Gunther/0000-0003-4507-5957; Rajewsky, Nikolaus/0000-0002-4785-4332	MRC [MC_U120027516] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI060302] Funding Source: NIH RePORTER; Medical Research Council [MC_U120027516] Funding Source: Medline; NIAID NIH HHS [AI-060302] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bolland DJ, 2007, MOL CELL BIOL, V27, P5523, DOI 10.1128/MCB.02407-06; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hughes P, 2006, CURR DIRECT AUTOIMMU, V9, P74; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Koralov SB, 2006, IMMUNITY, V25, P43, DOI 10.1016/j.immuni.2006.04.016; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Oliver PM, 2004, J EXP MED, V200, P1179, DOI 10.1084/jem.20041129; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wasserman R, 1997, J IMMUNOL, V158, P1133; XIAO C, 2008, NAT IMMUNOL     0309; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	53	452	477	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					860	874		10.1016/j.cell.2008.02.020	http://dx.doi.org/10.1016/j.cell.2008.02.020			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329371	Bronze			2022-12-24	WOS:000253818000022
J	Ho, PM; Peterson, ED; Wang, L; Magid, DJ; Fihn, SD; Larsen, GC; Jesse, RA; Rumsfeld, JS				Ho, P. Michael; Peterson, Eric D.; Wang, Li; Magid, David J.; Fihn, Stephan D.; Larsen, Greg C.; Jesse, Robert A.; Rumsfeld, John S.			Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIPLATELET THERAPY; PLATELET ACTIVATION; ASPIRIN THERAPY; UNSTABLE ANGINA; DRUG-THERAPY; WITHDRAWAL; RISK; PREVENTION; HEPARIN; DISCONTINUATION	Context It is unknown whether patients are at increased short- term risk for adverse events following clopidogrel cessation. Objective To assess the rates of adverse events after stopping treatment with clopidogrel in a national sample of patients with acute coronary syndrome ( ACS). Design, Setting, and Patients Retrospective cohort study of 3137 patients with ACS discharged from 127 Veterans Affairs hospitals between October 1, 2003, and March 31, 2005, with posthospital treatment with clopidogrel. Main Outcome Measure Rate of all- cause mortality or acute myocardial infarction ( AMI) after stopping treatment with clopidogrel. Results Mean ( SD) follow- up after stopping treatment with clopidogrel was 196 ( 152) days for medically treated patients with ACS without stents ( n= 1568) and 203 ( 148) days for patients with ACS treated with percutaneous coronary intervention ( PCI) ( n= 1569). Among medically treated patients, mean ( SD) duration of clopidogrel treatment was 302 ( 151) days and death or AMI occurred in 17.1%( n= 268) of patients, with 60.8%( n= 163) of events occurring during 0 to 90 days, 21.3% ( n= 57) during 91 to 180 days, and 9.7% ( n= 26) during 181 to 270 days after stopping treatment with clopidogrel. In multivariable analysis including adjustment for duration of clopidogrel treatment, the first 90- day interval after stopping treatment with clopidogrel was associated with a significantly higher risk of adverse events ( incidence rate ratio [ IRR], 1.98; 95% confidence interval [ CI], 1.46- 2.69 vs the interval of 91- 180 days). Similarly, among PCI- treated patients with ACS, mean( SD) duration of clopidogrel treatment was 278 ( 169) days and death or AMI occurred in 7.9% ( n= 124) of patients, with 58.9% ( n= 73) of events occurring during 0 to 90 days, 23.4% ( n= 29) during 91 to 180 days, and 6.5% ( n= 8) during 181 to 270 days after stopping clopidogrel treatment. In multivariable analysis including adjustment for duration of clopidogrel treatment, the first 90- day interval after stopping clopidogrel treatment was associated with a significantly higher risk of adverse events ( IRR, 1.82; 95% CI, 1.17- 2.83). Conclusions We observed a clustering of adverse events in the initial 90 days after stopping clopidogrel among both medically treated and PCI- treated patients with ACS, supporting the possibility of a clopidogrel rebound effect. Additional studies are needed to confirm the clustering of events after stopping clopidogrel, including associations with cardiovascular mortality and reasons for stopping clopidogrel, as well as to determine the mechanism of this phenomenon, and to identify strategies to reduce early events after clopidogrel cessation.	[Ho, P. Michael; Rumsfeld, John S.] Denver VA Med Ctr, Denver, CO 80220 USA; [Ho, P. Michael; Magid, David J.; Rumsfeld, John S.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Peterson, Eric D.] Duke Clin Res Inst, Durham, NC USA; [Wang, Li; Fihn, Stephan D.] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Ho, P. Michael; Magid, David J.; Rumsfeld, John S.] Kaiser Permanente Colorado, Inst Hlth Res, Aurora, CO USA; [Larsen, Greg C.] VA Med Ctr, Portland, OR USA; [Jesse, Robert A.] Richmond VA Med Ctr, Richmond, VA USA; [Jesse, Robert A.] Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Kaiser Permanente; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University	Rumsfeld, JS (corresponding author), Denver VA Med Ctr, 111B,1055 Clermont St, Denver, CO 80220 USA.	John.Rumsfeld@va.gov	Fihn, Stephan/ABA-1040-2020; Peterson, Eric David/ABF-5033-2021					Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Angiolillo DJ, 2006, DIABETES, V55, P780, DOI 10.2337/diabetes.55.03.06.db05-1394; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P2667, DOI 10.1093/eurheartj/ehl334; Burger W, 2005, J INTERN MED, V257, P399, DOI 10.1111/j.1365-2796.2005.01477.x; Caetano PA, 2006, CLIN THER, V28, P1411, DOI 10.1016/j.clinthera.2006.09.021; Campo G, 2007, J AM COLL CARDIOL, V50, P1132, DOI 10.1016/j.jacc.2007.04.092; Collet JP, 2006, EUR HEART J SUPPL, V8, pG46, DOI 10.1093/eurheartj/sul055; Collet JP, 2004, CIRCULATION, V110, P2361, DOI 10.1161/01.CIR.0000145171.89690.B4; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Ferrari E, 2005, J AM COLL CARDIOL, V45, P456, DOI 10.1016/j.jacc.2004.11.041; GRANGER CB, 1995, CIRCULATION, V91, P1929, DOI 10.1161/01.CIR.91.7.1929; Grines CL, 2007, J AM DENT ASSOC, V138, P652, DOI 10.14219/jada.archive.2007.0237; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Holmes DR, 2007, J AM COLL CARDIOL, V50, P109, DOI 10.1016/j.jacc.2007.04.032; Lauer MA, 2001, CIRCULATION, V104, P2772, DOI 10.1161/hc4801.100358; Maulaz AB, 2005, ARCH NEUROL-CHICAGO, V62, P1217, DOI 10.1001/archneur.62.8.1217; Maynard C, 2006, ARCH INTERN MED, V166, P1410, DOI 10.1001/archinte.166.13.1410; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Serebruany VL, 2006, INT J CLIN PRACT, V60, P863, DOI 10.1111/j.1742-1241.2006.00999.x; Serebruany VL, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.11.007; Sohn Min-Woong, 2006, Popul Health Metr, V4, P7, DOI 10.1186/1478-7954-4-7; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; THEROUX P, 1992, NEW ENGL J MED, V327, P141, DOI 10.1056/NEJM199207163270301; Valgimigli M, 2007, J AM COLL CARDIOL, V50, P138, DOI 10.1016/j.jacc.2007.04.029; Xiao ZH, 1998, CIRCULATION, V97, P251, DOI 10.1161/01.CIR.97.3.251; Yusuf S, 2001, NEW ENGL J MED, V345, P494	33	289	307	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2008	299	5					532	539		10.1001/jama.299.5.532	http://dx.doi.org/10.1001/jama.299.5.532			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258RB	18252883	Bronze			2022-12-24	WOS:000252886100018
J	Park, SY; Lytton-Jean, AKR; Lee, B; Weigand, S; Schatz, GC; Mirkin, CA				Park, Sung Yong; Lytton-Jean, Abigail K. R.; Lee, Byeongdu; Weigand, Steven; Schatz, George C.; Mirkin, Chad A.			DNA-programmable nanoparticle crystallization	NATURE			English	Article							DISSIPATIVE PARTICLE DYNAMICS; ASYMMETRIC FUNCTIONALIZATION; COLLOIDAL CRYSTALS; GOLD NANOPARTICLES; BUILDING-BLOCKS; OLIGONUCLEOTIDES; SUPERLATTICES	It was first shown(1,2) more than ten years ago that DNA oligonucleotides can be attached to gold nanoparticles rationally to direct the formation of larger assemblies. Since then, oligonucleotide-functionalized nanoparticles have been developed into powerful diagnostic tools(3,4) for nucleic acids and proteins, and into intracellular probes(5) and gene regulators(6). In contrast, the conceptually simple yet powerful idea that functionalized nanoparticles might serve as basic building blocks that can be rationally assembled through programmable base- pairing interactions into highly ordered macroscopic materials remains poorly developed. So far, the approach has mainly resulted in polymerization, with modest control over the placement of, the periodicity in, and the distance between particles within the assembled material. That is, most of the materials obtained thus far are best classified as amorphous polymers(7-16), although a few examples of colloidal crystal formation exist(8,16). Here, we demonstrate that DNA can be used to control the crystallization of nanoparticle - oligonucleotide conjugates to the extent that different DNA sequences guide the assembly of the same type of inorganic nanoparticle into different crystalline states. We show that the choice of DNA sequences attached to the nanoparticle building blocks, the DNA linking molecules and the absence or presence of a non- bonding single- base flexor can be adjusted so that gold nanoparticles assemble into micrometresized face- centred- cubic or body- centred- cubic crystal structures. Our findings thus clearly demonstrate that synthetically programmable colloidal crystallization is possible, and that a single-component system can be directed to form different structures.	[Park, Sung Yong; Lytton-Jean, Abigail K. R.; Schatz, George C.; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Park, Sung Yong; Lytton-Jean, Abigail K. R.; Schatz, George C.; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Lee, Byeongdu] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Weigand, Steven] Northwestern Univ, DND CAT Synchrotron Res Ctr, Argonne, IL 60439 USA	Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Schatz, George C./ABF-1341-2020; Weigand, Steven/G-6181-2015; Lee, Byeongdu/AAO-8096-2020; Mirkin, Chad A/E-3911-2010	Weigand, Steven/0000-0003-3137-0672; Lee, Byeongdu/0000-0003-2514-8805; Lytton-Jean, Abigail/0000-0002-1582-0066; Mirkin, Chad/0000-0002-6634-7627				Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Bartlett P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.128302; Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; Cullity B. D., 1978, ELEMENTS XRAY DIFFRA; Donev A, 2004, J COMPUT PHYS, V197, P139, DOI 10.1016/j.jcp.2003.11.022; ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001; Frenkel D, 2006, NAT MATER, V5, P85, DOI 10.1038/nmat1572; HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001; Huo FW, 2006, ADV MATER, V18, P2304, DOI 10.1002/adma.200601178; Hurst SJ, 2006, ANAL CHEM, V78, P8313, DOI 10.1021/ac0613582; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808; Kim AJ, 2006, LANGMUIR, V22, P1991, DOI 10.1021/la0528955; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; MIRKIN CA, 1996, NATURE, V382, P609; Nykypanchuk D, 2007, LANGMUIR, V23, P6305, DOI 10.1021/la0637566; Ozin G.A., 2015, NANOCHEMISTRY CHEM A; Park SJ, 2001, ANGEW CHEM INT EDIT, V40, P2909, DOI 10.1002/1521-3773(20010803)40:15<2909::AID-ANIE2909>3.0.CO;2-O; Park SJ, 2004, J PHYS CHEM B, V108, P12375, DOI 10.1021/jp040242b; Park SY, 2006, J PHYS CHEM B, V110, P12673, DOI 10.1021/jp062212+; Park SY, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.224201; Park SY, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.212202; Redl FX, 2003, NATURE, V423, P968, DOI 10.1038/nature01702; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Seferos DS, 2007, J AM CHEM SOC, V129, P15477, DOI 10.1021/ja0776529; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Strable E, 2004, NANO LETT, V4, P1385, DOI 10.1021/nl0493850; Velev OD, 2006, SCIENCE, V312, P376, DOI 10.1126/science.1125800; Xu XY, 2006, J AM CHEM SOC, V128, P9286, DOI 10.1021/ja061980b	30	1258	1284	15	740	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					553	556		10.1038/nature06508	http://dx.doi.org/10.1038/nature06508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235497				2022-12-24	WOS:000252739900037
J	Vaia, R; Baur, J				Vaia, Richard; Baur, Jeffery			Adaptive composites	SCIENCE			English	Editorial Material							POLYMER		[Vaia, Richard; Baur, Jeffery] USAF, Mat & Mfg Directorate, Res Lab, Wright Patterson AFB, OH 45433 USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Vaia, R (corresponding author), USAF, Mat & Mfg Directorate, Res Lab, Wright Patterson AFB, OH 45433 USA.	richard.vaia@wpafb.af.mil; jeffery.baur@wpafb.af.mil						Barrett CJ, 2007, SOFT MATTER, V3, P1249, DOI 10.1039/b705619b; Buckley PR, 2006, IEEE T BIO-MED ENG, V53, P2075, DOI 10.1109/TBME.2006.877113; Cao AY, 2005, SCIENCE, V310, P1307, DOI 10.1126/science.1118957; Ebron VH, 2006, SCIENCE, V311, P1580, DOI 10.1126/science.1120182; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059; Kousourakis A, 2006, COMPOS STRUCT, V75, P610, DOI 10.1016/j.compstruct.2006.04.086; Kramer RM, 2007, NAT MATER, V6, P533, DOI 10.1038/nmat1930; Leo D.J., ENG ANAL SMART MAT S, P1; Mathger LM, 2007, CELL TISSUE RES, V329, P179, DOI 10.1007/s00441-007-0384-8; *NASA, 2007, NASA TECH BRIEFS, V31, P20; Nelson EC, 2007, SCIENCE, V318, P924, DOI 10.1126/science.1148009; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; STOY K, 2004, P 2004 IEEE RSJ INT, V2, P2062; Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934; Yakobson BI, 2006, J NANOPART RES, V8, P105, DOI 10.1007/s11051-005-8335-3	16	111	113	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2008	319	5862					420	421		10.1126/science.1152931	http://dx.doi.org/10.1126/science.1152931			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218885				2022-12-24	WOS:000252576600026
J	Goldberg, RB; Holman, R; Drucker, DJ				Goldberg, Ronald B.; Holman, Rury; Drucker, Daniel J.			Management of type 2 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRIPLE ORAL-THERAPY; RANDOMIZED-TRIAL; INSULIN GLARGINE; PLUS METFORMIN; SULFONYLUREA; PIOGLITAZONE; EXENATIDE; FAILURE		[Goldberg, Ronald B.] Univ Miami, Miller Sch Med, Diabet Res Inst, Div Endocrinol Diabet & Metab, Miami, FL 33152 USA; [Holman, Rury] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford, England; [Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Banting & Best Diabet Ctr, Toronto, ON M5G 1X5, Canada	University of Miami; University of Oxford; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Goldberg, RB (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, Div Endocrinol Diabet & Metab, Miami, FL 33152 USA.							Aljabri K, 2004, AM J MED, V116, P230, DOI 10.1016/j.amjmed.2003.07.023; [Anonymous], 1996, DIABETES; Dorkhan M, 2006, J INTERN MED, V260, P125, DOI 10.1111/j.1365-2796.2006.01665.x; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; HOLMAN RR, 1987, DIABETIC MED, V4, P457, DOI 10.1111/j.1464-5491.1987.tb00909.x; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Nathan DM, 2006, DIABETOLOGIA, V49, P2816, DOI 10.1007/s00125-006-0415-0; Nauck MA, 2007, DIABETOLOGIA, V50, P259, DOI 10.1007/s00125-006-0510-2; Nyback-Nakell A, 2007, DIABETIC MED, V24, P1424, DOI 10.1111/j.1464-5491.2007.02286.x; Rosenstock J, 2006, DIABETES CARE, V29, P554, DOI 10.2337/diacare.29.03.06.dc05-0695; Schwartz AV, 2006, J CLIN ENDOCR METAB, V91, P3349, DOI 10.1210/jc.2005-2226; Schwartz S, 2003, DIABETES CARE, V26, P2238, DOI 10.2337/diacare.26.8.2238; TURNER RC, 1995, DIABETES, V44, P1249	15	17	20	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					293	297						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199869				2022-12-24	WOS:000252375600013
J	Knabl, J; Witschi, R; Hosl, K; Reinold, H; Zeilhofer, UB; Ahmadi, S; Brockhaus, J; Sergejeva, M; Hess, A; Brune, K; Fritschy, JM; Rudolph, U; Mohler, H; Zeilhofer, HU				Knabl, Julia; Witschi, Robert; Hoesl, Katharina; Reinold, Heiko; Zeilhofer, Ulrike B.; Ahmadi, Seifollah; Brockhaus, Johannes; Sergejeva, Marina; Hess, Andreas; Brune, Kay; Fritschy, Jean-Marc; Rudolph, Uwe; Moehler, Hanns; Zeilhofer, Hanns Ulrich			Reversal of pathological pain through specific spinal GABA(A) receptor subtypes	NATURE			English	Article							SUPERFICIAL DORSAL HORN; PERIPHERAL-NERVE INJURY; NEUROPATHIC PAIN; ANION GRADIENT; RAT; HYPERALGESIA; CORD; INHIBITION; NEURONS; BENZODIAZEPINES	Inflammatory diseases and neuropathic insults are frequently accompanied by severe and debilitating pain, which can become chronic and often unresponsive to conventional analgesic treatment(1,2). A loss of synaptic inhibition in the spinal dorsal horn is considered to contribute significantly to this pain pathology(3-7). Facilitation of spinal gamma-aminobutyric acid ( GABA) ergic neurotransmission through modulation of GABA(A) receptors should be able to compensate for this loss(8,9). With the use of GABA(A)-receptor point- mutated knock- in mice in which specific GABA(A) receptor subtypes have been selectively rendered insensitive to benzodiazepine- site ligands(10-12), we show here that pronounced analgesia can be achieved by specifically targeting spinal GABA(A) receptors containing the alpha 2 and/ or alpha 3 subunits. We show that their selective activation by the non- sedative ('alpha 1- sparing') benzodiazepine- site ligand L- 838,417 ( ref. 13) is highly effective against inflammatory and neuropathic pain yet devoid of unwanted sedation, motor impairment and tolerance development. L- 838,417 not only diminished the nociceptive input to the brain but also reduced the activity of brain areas related to the associative- emotional components of pain, as shown by functional magnetic resonance imaging in rats. These results provide a rational basis for the development of subtype- selective GABAergic drugs for the treatment of chronic pain, which is often refractory to classical analgesics.	[Knabl, Julia; Hoesl, Katharina; Reinold, Heiko; Zeilhofer, Ulrike B.; Ahmadi, Seifollah; Sergejeva, Marina; Hess, Andreas; Brune, Kay; Zeilhofer, Hanns Ulrich] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Witschi, Robert; Brockhaus, Johannes; Fritschy, Jean-Marc; Rudolph, Uwe; Moehler, Hanns; Zeilhofer, Hanns Ulrich] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Moehler, Hanns; Zeilhofer, Hanns Ulrich] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Rudolph, Uwe] Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat,Lab Genet Neuropharmacol, Belmont, MA 02478 USA; [Moehler, Hanns] Collegium Helveticum, CH-8092 Zurich, Switzerland	University of Erlangen Nuremberg; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; McLean Hospital	Zeilhofer, HU (corresponding author), Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany.	zeilhofer@pharma.uzh.ch	Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Fritschy, Jean-Marc/0000-0002-8552-3702				Ahmadi S, 2002, NAT NEUROSCI, V5, P34, DOI 10.1038/nn778; Ator NA, 2005, CNS SPECTRUMS, V10, P31, DOI 10.1017/S1092852900009883; Barnard EA, 1998, PHARMACOL REV, V50, P291; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bohlhalter S, 1996, J NEUROSCI, V16, P283, DOI 10.1523/jneurosci.16-01-00283.1996; BONETTI EP, 1988, PHARMACOL BIOCHEM BE, V31, P733, DOI 10.1016/0091-3057(88)90259-6; Brooks J, 2005, J ANAT, V207, P19, DOI 10.1111/j.1469-7580.2005.00428.x; BUSHNELL MC, 2006, WALL MELZACKS TXB PA, P107; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; Depner UB, 2003, EUR J NEUROSCI, V17, P2381, DOI 10.1046/j.1460-9568.2003.02676.x; Dias R, 2005, J NEUROSCI, V25, P10682, DOI 10.1523/JNEUROSCI.1166-05.2005; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Enna SJ, 2006, ADV PHARMACOL, V54, P1, DOI 10.1016/S1054-3589(06)54001-3; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HARRIS JA, 1995, BEHAV NEUROSCI, V109, P295, DOI 10.1037/0735-7044.109.2.295; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hess A, 2007, EUR J PAIN, V11, P109, DOI 10.1016/j.ejpain.2006.01.005; Jasmin L, 2003, NATURE, V424, P316, DOI 10.1038/nature01808; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; MA W, 1993, J COMP NEUROL, V338, P337, DOI 10.1002/cne.903380303; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Sandkuhler J, 2000, PAIN, V88, P113, DOI 10.1016/S0304-3959(00)00424-3; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Scott-Stevens P, 2005, BIOPHARM DRUG DISPOS, V26, P13, DOI 10.1002/bdd.423; van Rijnsoever C, 2004, J NEUROSCI, V24, P6785, DOI 10.1523/JNEUROSCI.1067-04.2004; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zeilhofer HU, 1997, J PHYSIOL-LONDON, V503, P67, DOI 10.1111/j.1469-7793.1997.067bi.x	38	335	346	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					330	U6		10.1038/nature06493	http://dx.doi.org/10.1038/nature06493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202657				2022-12-24	WOS:000252432100049
J	Georgescu, RE; Kim, SS; Yurieva, O; Kuriyan, J; Kong, XP; O'Donnell, M				Georgescu, Roxana E.; Kim, Seung-Sup; Yurieva, Olga; Kuriyan, John; Kong, Xiang-Peng; O'Donnell, Mike			Structure of a sliding clamp on DNA	CELL			English	Article							CELL NUCLEAR ANTIGEN; POLYMERASE-III HOLOENZYME; ESCHERICHIA-COLI; PROCESSIVITY-CLAMP; CRYSTAL-STRUCTURE; REPLICATION; BETA; SUBUNIT; REPAIR; MECHANISM	The structure of the E. coli beta clamp polymerase processivity factor has been solved in complex with primed DNA. Interestingly, the clamp directly binds the DNA duplex and also forms a crystal contact with the ssDNA template strand, which binds into the protein-binding pocket of the clamp. We demonstrate that these clamp-DNA interactions function in clamp loading, perhaps by inducing the ring to close around DNA. Clamp binding to template ssDNA may also serve to hold the clamp at a primed site after loading or during switching of multiple factors on the clamp. Remarkably, the DNA is highly tilted as it passes through the b ring. The pronounced 22 degrees angle of DNA through b may enable DNA to switch between multiple factors bound to a single clamp simply by alternating from one protomer of the ring to the other.	[Georgescu, Roxana E.; Yurieva, Olga; O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Kim, Seung-Sup; Kong, Xiang-Peng] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Kuriyan, John] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA USA	Howard Hughes Medical Institute; Rockefeller University; New York University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	O'Donnell, M (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	odonnel@mail.rockefeller.edu	Georgescu, Roxana/B-9943-2011	Kong, Xiang-Peng/0000-0001-5773-2681; O'Donnell, Michael/0000-0001-9002-4214	NIGMS NIH HHS [GM45547, R37 GM038839-17, R37 GM038839, R01 GM045547, GM70841, R01 GM038839, R37 GM038839-18, GM38839, R01 GM070841, R37 GM038839-19, R37 GM038839-16] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045547, R01GM070841, R01GM038839, R37GM038839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson SG, 2007, J BIOL CHEM, V282, P7035, DOI 10.1074/jbc.M610136200; Argiriadi MA, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-2; Bloom LB, 2006, CRIT REV BIOCHEM MOL, V41, P179, DOI 10.1080/10409230600648751; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Burnouf DY, 2004, J MOL BIOL, V335, P1187, DOI 10.1016/j.jmb.2003.11.049; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; de Saro FJL, 2003, EMBO J, V22, P6408, DOI 10.1093/emboj/cdg603; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Dohrmann PR, 2005, J MOL BIOL, V350, P228, DOI 10.1016/j.jmb.2005.04.065; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Fujii S, 2004, EMBO J, V23, P4342, DOI 10.1038/sj.emboj.7600438; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Ivanov I, 2006, NUCLEIC ACIDS RES, V34, P6023, DOI 10.1093/nar/gkl744; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Maul RW, 2007, MOL MICROBIOL, V65, P811, DOI 10.1111/j.1365-2958.2007.05828.x; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Snyder AK, 2004, J BIOL CHEM, V279, P4386, DOI 10.1074/jbc.M310430200; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; Sutton MD, 2001, P NATL ACAD SCI USA, V98, P8342, DOI 10.1073/pnas.111036998; Sutton MD, 2005, MOL MICROBIOL, V55, P1751, DOI 10.1111/j.1365-2958.2005.04500.x; Sutton MD, 2006, DNA REPAIR, V5, P312, DOI 10.1016/j.dnarep.2005.10.011; Sutton MD, 2004, J BACTERIOL, V186, P6738, DOI 10.1128/JB.186.20.6738-6748.2004; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Yao N, 2000, J BIOL CHEM, V275, P1421, DOI 10.1074/jbc.275.2.1421	40	163	164	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					43	54		10.1016/j.cell.2007.11.045	http://dx.doi.org/10.1016/j.cell.2007.11.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191219	Bronze, Green Accepted			2022-12-24	WOS:000253427600014
J	Nakatsukasa, K; Huyer, G; Michaelis, S; Brodsky, JL				Nakatsukasa, Kunio; Huyer, Gregory; Michaelis, Susan; Brodsky, Jeffrey L.			Dissecting the ER-Associated degradation of a misfolded polytopic membrane protein	CELL			English	Article							RETICULUM-ASSOCIATED DEGRADATION; TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; UBIQUITIN-LIGASE; MOLECULAR CHAPERONES; CYSTIC-FIBROSIS; SACCHAROMYCES-CEREVISIAE; IN-VIVO; PROTEASOME	It remains unclear how misfolded membrane proteins are selected and destroyed during endoplasmic reticulum-associated degradation (ERAD). For example, chaperones are thought to solubilize aggregation-prone motifs, and some data suggest that these proteins are degraded at the ER. To better define how membrane proteins are destroyed, the ERAD of Ste6p*, a 12 transmembrane protein, was reconstituted. We found that specific Hsp70/40s act before ubiquitination and facilitate Ste6p* association with an E3 ubiquitin ligase, suggesting an active role for chaperones. Furthermore, polyubiquitination was a prerequisite for retrotranslocation, which required the Cdc48 complex and ATP. Surprisingly, the substrate was soluble, and extraction was independent of a ubiquitin chain extension enzyme (Ufd2p). However, Ufd2p increased the degree of ubiquitination and facilitated degradation. These data indicate that polytopic membrane proteins can be extracted from the ER, and define the point of action of chaperones and the requirement for Ufd2p during membrane protein quality control.	[Nakatsukasa, Kunio; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Huyer, Gregory; Michaelis, Susan] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu			NIGMS NIH HHS [R01 GM075061-02, GM75061, R01 GM051508, R01 GM075061, R01 GM075061-01A1, GM51508] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061, R01GM051508] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Akiyama Y, 2003, J BIOL CHEM, V278, P18146, DOI 10.1074/jbc.M302152200; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Becker J, 1996, MOL CELL BIOL, V16, P4378; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; DESHAIES RJ, 1995, EMBO J, V14, P303, DOI 10.1002/j.1460-2075.1995.tb07004.x; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wigley WC, 1999, J CELL BIOL, V145, P481; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	57	206	208	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					101	112		10.1016/j.cell.2007.11.023	http://dx.doi.org/10.1016/j.cell.2007.11.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191224	Green Accepted, Bronze			2022-12-24	WOS:000253427600019
J	Semba, RD; de Pee, S; Sun, K; Sari, M; Akhter, N; Bloem, MW				Semba, Richard D.; de Pee, Saskia; Sun, Kai; Sari, Mayang; Akhter, Nasima; Bloem, Martin W.			Effect of parental formal education on risk of child stunting in Indonesia and Bangladesh: a cross-sectional study	LANCET			English	Article							MALNUTRITION; COUNTRIES; NUTRITION; AGE	Background Child stunting is associated with poor child development and increased mortality. Our aim was to determine the effect of length of maternal and paternal education on stunting in children under the age of 5 years. Methods Data for indicators of child growth and of parental education and socioeconomic status were gathered from 590570 families in Indonesia and 395122 families in Bangladesh as part of major nutritional surveillance programmes. Findings The prevalence of stunting in families in Indonesia was 33.2%, while that in Bangladesh was 50.7%. In Indonesia, greater maternal formal education led to a decrease of between 4.4% and 5% in the odds of child stunting (odds ratio per year 0.950, 95% CI 0.946-0.954 in rural settings; 0.956, 0.950-0.961 in urban settings); greater paternal formal education led to a decrease of 3% in the odds of child stunting (0 . 970, 0 . 967-0.974). In Bangladesh, greater maternal formal education led to a 4.6% decrease in the odds of child stunting (0.954, 0 .951-0 .957), while greater paternal formal education led to a decrease of between 2.9% and 5.4% in the odds of child stunting (0 . 971, 0. 969-0.974 in rural settings; 0 . 946, 0.941-0.951 in urban settings). In Indonesia, high levels of maternal and paternal education were both associated with protective caregiving behaviours, including vitamin A capsule receipt, complete childhood immunisations, better sanitation, and use of iodised salt (all p<0. 0001). Interpretation Both maternal and paternal education are strong determinants of child stunting in families in Indonesia and Bangladesh.	[Semba, Richard D.; Sun, Kai] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [de Pee, Saskia; Bloem, Martin W.] World Food Programme, Policy Strategy & Programme Support Div, Nutr Serv, Rome, Italy; [Bloem, Martin W.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Bloem, Martin W.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Sari, Mayang] Helen Keller Int Asia Pacific, Phnom Penh, Cambodia; [Akhter, Nasima] Helen Keller Int Asia Pacific, Dhaka, Bangladesh	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tufts University	Semba, RD (corresponding author), Johns Hopkins Univ, Sch Med, 550 N Broadway,Suite 700, Baltimore, MD 21205 USA.	rdsemba@jhmi.edu	Ebot, Jane/B-6983-2012; Akhter, Nasima/AAL-3670-2020	Akhter, Nasima/0000-0002-5424-1593				Adair LS, 1997, J NUTR, V127, P314, DOI 10.1093/jn/127.2.314; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; *BANK CAN, EXCH RAT MONTHL AV R; Bushamuka Victor N., 2005, Food and Nutrition Bulletin, V26, P17; Chopra M, 2003, PUBLIC HEALTH NUTR, V6, P645, DOI 10.1079/PHN2003477; de Onis M, 2000, B WORLD HEALTH ORGAN, V78, P1222; de Onis M, 2004, INT J EPIDEMIOL, V33, P1260, DOI 10.1093/ije/dyh202; de Pee S, 2002, J NUTR, V132, P2215, DOI 10.1093/jn/132.8.2215; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; HABICHT JP, 1973, NUTR REP INT, V7, P533; KELLER W, 1988, LINEAR GROWTH RETARD; KHAN SR, 2001, SOCIOLEGAL STAT BENG; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; MARTORELL R, 1981, HUM BIOL, V53, P303; Mason JB, 1984, NUTR SURVEILLANCE; Milman A, 2005, J NUTR, V135, P1415, DOI 10.1093/jn/135.6.1415; Pee S. de, 2001, Nutrition and health in developing countries, P483; PELLETIER DL, 1993, AM J PUBLIC HEALTH, V83, P1130, DOI 10.2105/AJPH.83.8.1130; Pelletier DL, 2003, J NUTR, V133, P107, DOI 10.1093/jn/133.1.107; POLLITT E, 1992, MALNUTRITION INFECT; Rahman A, 2007, J BIOSOC SCI, V39, P161, DOI 10.1017/S0021932006001295; Ricci JA, 1996, AM J CLIN NUTR, V63, P966, DOI 10.1093/ajcn/63.6.966; Royston E, 1989, PREVENTING MATERNAL; Sakisaka K, 2006, PUBLIC HEALTH, V120, P400, DOI 10.1016/j.puhe.2005.10.018; SPURR GB, 1977, AM J CLIN NUTR, V30, P316, DOI 10.1093/ajcn/30.3.316; Wamani H, 2006, PUBLIC HEALTH NUTR, V9, P320, DOI 10.1079/PHN2006854; WHO, 2006, WHO CHILD GROWTH STA; [No title captured]	29	196	199	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2008	371	9609					322	328		10.1016/S0140-6736(08)60169-5	http://dx.doi.org/10.1016/S0140-6736(08)60169-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254VQ	18294999				2022-12-24	WOS:000252616500028
J	Minto, C; Myers, RA; Blanchard, W				Minto, Coilin; Myers, Ransom A.; Blanchard, Wade			Survival variability and population density in fish populations	NATURE			English	Article							MARINE DEMERSAL FISH; DEPENDENCE; RECRUITMENT; MORTALITY; TIME; COD; AGE	To understand the processes that regulate the abundance and persistence of wild populations is a fundamental goal of ecology and a prerequisite for the management of living resources. Variable abundance data, however, make the demonstration of regulation processes challenging(1-3). A previously overlooked aspect in understanding how populations are regulated(4-6) is the possibility that the pattern of variability - its strength as a function of population size - may be more than 'noise', thus revealing much about the characteristics of population regulation. Here we show that patterns in survival variability do provide evidence of regulation through density. Using a large, global compilation of marine, anadromous and freshwater fisheries data, we examine the relationship between the variability of survival and population abundance. The interannual variability in progeny survival increases at low adult abundance in an inversely density- dependent fashion. This pattern is consistent with models in which density dependence enters after the larval stage. The findings are compatible with very simple forms of density dependence: even a linear increase of juvenile mortality with adult density adequately explains the results. The model predictions explain why populations with strong regulation may experience large increases in variability at low densities(7). Furthermore, the inverse relationship between survival variability and the strength of density dependence has important consequences for fisheries management and recovery, and population persistence or extinction(8-10).	[Minto, Coilin] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Blanchard, Wade] Dalhousie Univ, Dept Math & Stat, Halifax, NS B3H 3J5, Canada	Dalhousie University; Dalhousie University	Minto, C (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.	mintoc@mathstat.dal.ca		Minto, Coilin/0000-0003-0630-6775				Berryman AA, 2002, OIKOS, V99, P600, DOI 10.1034/j.1600-0706.2002.12106.x; Boer PJ, 1996, REGULATION STABILIZA; DERISO RB, 1980, CAN J FISH AQUAT SCI, V37, P268, DOI 10.1139/f80-034; Drake JM, 2005, PLOS BIOL, V3, P1300, DOI 10.1371/journal.pbio.0030222; GODFRAY HCJ, 1992, NATURE, V359, P673, DOI 10.1038/359673a0; HASSELL MP, 1989, J ANIM ECOL, V58, P883, DOI 10.2307/5130; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; HUTCHINGS JA, 1993, CAN J FISH AQUAT SCI, V50, P2468, DOI 10.1139/f93-271; Lande R., 2003, OXFORD SERIES ECOLOG; LEIGH EG, 1981, J THEOR BIOL, V90, P213; Manly B., 1990, STAGE STRUCTURED POP; MAY RMC, 1973, STABILITY COMPLEXITY, pCH2; Mertz G., 1994, Fisheries Oceanography, V3, P236, DOI 10.1111/j.1365-2419.1994.tb00101.x; Mertz G, 1996, CAN J FISH AQUAT SCI, V53, P1618, DOI 10.1139/cjfas-53-7-1618; MERTZ G, 1995, FISH B-NOAA, V93, P657; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Murray BG, 1999, OIKOS, V84, P148, DOI 10.2307/3546875; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1591, DOI 10.1139/f93-180; MYERS RA, 1995, SCIENCE, V269, P1106, DOI 10.1126/science.269.5227.1106; Myers RA, 2001, ICES J MAR SCI, V58, P937, DOI 10.1006/jmsc.2001.1109; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; Myers RA, 1995, CAN TECH REP FISH AQ, V2024, P1; Ord K., 1987, KENDALLS ADV THEORY, V1; PETERMAN RM, 1981, CAN J FISH AQUAT SCI, V38, P1113, DOI 10.1139/f81-151; Rosenberg AA, 2005, FRONT ECOL ENVIRON, V3, P84, DOI 10.2307/3868514; Saether BE, 1998, AM NAT, V151, P441, DOI 10.1086/286131; Sale PF, 2000, OECOLOGIA, V124, P166, DOI 10.1007/s004420050003; SCHNUTE J, 1985, CAN J FISH AQUAT SCI, V42, P414, DOI 10.1139/f85-057; Shenk TM, 1998, ECOL MONOGR, V68, P445, DOI 10.1890/0012-9615(1998)068[0445:SVEODD]2.0.CO;2; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; WOLDA H, 1993, OECOLOGIA, V95, P581, DOI 10.1007/BF00317444	33	81	82	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					344	U6		10.1038/nature06605	http://dx.doi.org/10.1038/nature06605			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354480				2022-12-24	WOS:000254117400045
J	Suda, T; Arai, F				Suda, Toshio; Arai, Fumio			Wnt signaling in the niche	CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELL	There is much interest in understanding the signals in the bone marrow niche that keep hematopoietic stem cells (HSCs) in a quiescent state. In the current issue of Cell Stem Cell, Fleming et al. (2008) report that blocking Wnt signaling in the niche increases the number of proliferating HSCs and reduces their ability to reconstitute the hematopoietic system of irradiated recipient mice. These findings show that Wnt/beta-catenin activity is crucial for the maintenance of HSC quiescence in the bone marrow niche.	[Suda, Toshio; Arai, Fumio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Suda, T (corresponding author), Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	sudato@sc.itc.keio.ac.jp	Arai, Fumio/J-5241-2013	Arai, Fumio/0000-0003-1936-4907				Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Nishikawa SI, 2007, PIGM CELL RES, V20, P263, DOI 10.1111/j.1600-0749.2007.00388.x; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	10	38	43	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					729	730		10.1016/j.cell.2008.02.017	http://dx.doi.org/10.1016/j.cell.2008.02.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329358	Bronze			2022-12-24	WOS:000253818000009
J	Fitzpatrick, M				Fitzpatrick, Michael			Medicine and the media - From hero to zero	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												fitz@easynet.co.uk						Boyce T., 2008, HLTH RISK NEWS MMR V	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2008	336	7642					479	479		10.1136/bmj.39492.664225.0F	http://dx.doi.org/10.1136/bmj.39492.664225.0F			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	274JL	18310002	Green Published			2022-12-24	WOS:000253997500038
J	Parson, AB				Parson, Ann B.			Stem cell biotech: Seeking a piece of the action	CELL			English	Editorial Material								Venture capital groups and big pharma have largely held back from investing in biotech companies focused on regenerative medicine. Will it take a clinical bull's eye to bring venture capitalists and big pharma into the cell therapy arena?											0	22	28	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					511	513		10.1016/j.cell.2008.02.004	http://dx.doi.org/10.1016/j.cell.2008.02.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295564	Bronze			2022-12-24	WOS:000253817900006
J	Morris, SS; Cogill, B; Uauy, R				Morris, Saul S.; Cogill, Bruce; Uauy, Ricardo		Maternal & Child Undernutr Study G	Maternal and Child Undernutrition 5 - Effective international action against undernutrition: why has it proven so difficult and what can be done to accelerate progress?	LANCET			English	Article							HEALTH; EMERGENCY; PRIORITIES; PROGRAMS; QUALITY	Many transnational organisations work to support efforts to eliminate maternal and child undernutrition in high-burden countries. Financial, intellectual, and personal linkages bind these organisations loosely together as components of an international nutrition system. In this paper, we argue that such a system should deliver in four functional areas: stewardship, mobilisation of financial resources, direct provision of nutrition services at times of natural disaster or conflict, and human and institutional resource strengthening. We review quantitative and qualitative data from various sources to assess the performance of the system in each of these areas, and find substantial shortcomings. Fragmentation, lack of an evidence base for prioritised action, institutional inertia, and failure to join up with promising developments in parallel sectors are recurrent themes. Many of these weaknesses can be attributed to systemic problems affecting most organisations working in the field; these are analysed using a problem tree approach. We also make recommendations to overcome some of the most important problems, and we propose five priority actions for the development of a new international architecture.	[Morris, Saul S.; Uauy, Ricardo] Univ London London Sch Hyg & Trop Med, Nutr & Publ Hlth Intervent Res Unit, London WC1E 7HT, England; [Uauy, Ricardo] Int Union Nutr Sci, New York, NY USA; [Cogill, Bruce] UNICEF, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; UNICEF	Uauy, R (corresponding author), Univ London London Sch Hyg & Trop Med, Nutr & Publ Hlth Intervent Res Unit, Keppel St, London WC1E 7HT, England.	Ricardo.Uauy@LSHTM.ac.uk	Hallal, Pedro C/A-3249-2011	Hallal, Pedro C/0000-0003-1470-6461; Morris, Saul/0000-0002-9372-7342; Kirkwood, Betty/0000-0001-5274-6072	Medical Research Council [G0400519, MC_U147585821, G0400519(71108), U.1475.00.004.00005.01 (85821)] Funding Source: Medline; Medical Research Council [U1475000003] Funding Source: researchfish; MRC [G0400519, MC_U147585821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AGBLE R, 2005, PANAFRICAN NUTR INIT; Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], 2005, HUMANITARIAN RESPONS; AusAID, 2005, AUSGUIDELINE 3 3 LOG; BARRETT CB, 2002, 200243 CORN U; Barrett CB, 2005, FOOD AID 50 YEARS RE; BATE R, 2006, AM INTEREST, V1, P113; BERG E, 1993, RETHINKING TECHNICAL; Berruios R., 2000, CONTRACTING DEV ROLE; BHUTTA ZA, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61693-6; Bonnard P, 2002, REPORT FOOD AID FOOD; Bouis Howarth E., 2000, Food and Nutrition Bulletin, V21, P374; BRYCE J, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61694-8; Bryce J, 2006, LANCET, V368, P817, DOI 10.1016/S0140-6736(06)69299-4; Copeland R, 2002, FOOD NUTR TECHNICAL; Deitchler M, 2007, INT J EPIDEMIOL, V36, P858, DOI 10.1093/ije/dym092; DIAO XE, 2005, 84 MTID INT FOOD POL; Dixit A, 2002, J HUM RESOUR, V37, P696, DOI 10.2307/3069614; *DRN ADE BAAST ECO, 2005, JOINT EV EFF IMP EN; DUFFIELD A, REV PUBLISHED LIT IM; Easterly W., 2002, J POLICY REFORM, V5, P223, DOI DOI 10.1080/1384128032000096823; *EM NUTR NETW, IMPR EFF EM FOOD NJU; *FAO WORLD FOOD PR, 1997, TCPIRQ6713 FAO WORLD; Heaver R, 2006, GOOD WORK BUT NOT EN; Hofmann C.-A., 2004, 17 HPG OV DEV I; HOOGENDOORN A, 2005, OEDE20064 WORLD FOOD; *INT BAB ACT NETW, 2000, BREAK RUL STRETCH RU; *INT HLTH PARTN, GLOB COMP ACH HLTH M; JACOBSTEIN R, 2001, MIDTERM REV MOST PRO; KENNEDY E, 2002, MIDTERM PERFORMANCE; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; *LEAD EDG GROUP, INT IN IMP EV; Leroy JL, 2007, AM J PUBLIC HEALTH, V97, P219, DOI 10.2105/AJPH.2005.083287; Llanos A, 2008, PUBLIC HEALTH NUTR, V11, P466, DOI 10.1017/S1368980007000730; Maleta K., 2004, J PEDIAT GASTROENTER, V38, P143; Maluccio J, 2005, 141 IFPRI; Marchione TJ, 2002, J NUTR, V132, p2104S, DOI 10.1093/jn/132.7.2104S; MASON F, 2003, REV ADV CHALLENGES N; Maxwell D, 2003, DISASTERS, V27, P72, DOI 10.1111/1467-7717.00220; Mcmichael A.J., 2003, ATL HLTH CLIM; *MEST ASS CAN, 2006, STAK PERC AN 10 YEAR; Mukuria A.G., 2006, INFANT YOUNG CHILD F; Myatt M, 2005, B WORLD HEALTH ORGAN, V83, P20; National Academies Committee on Facilitating Interdisciplinary Research (CFIR) and Committee on Science Engineering and Public Policy (COSEPUP), 2005, FAC INT RES; Nielsen J, 2004, AM J CLIN NUTR, V80, P1036, DOI 10.1093/ajcn/80.4.1036; *OECD DEV ASS COMM, 2004, AN AID SUPP HIV AIDS; *ORG EC COOP DEV, 2006, DEV EFF FOOD AID DOE; *ORG EC COOP DEV, PEER REV DAC MEMB; Pelletier D. L., 1999, Agriculture and Human Values, V16, P401, DOI 10.1023/A:1007651801471; PELLETIER DL, 2002, NUTR FDN DEV; Pielemeier John, 2003, ASSESSMENT BASIC SUP; Prinzo ZW, 2002, P NUTR SOC, V61, P251, DOI 10.1079/PNS2002151; Robertson SE, 2006, SOC SCI MED, V63, P1648, DOI 10.1016/j.socscimed.2006.04.011; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; Saltman RB, 2000, B WORLD HEALTH ORGAN, V78, P732; Selwitz Robert H, LANCET, V369, P51, DOI [10.1016/s0140-6736(07)60031-2, DOI 10.1016/S0140-6736(07)60031-2, DOI 10.1016/S0140-6736(07)61690-0]; Shrimpton R, 2002, UNICEF NUTR PORTFOLI; Simondon KB, 1996, AM J CLIN NUTR, V64, P537, DOI 10.1093/ajcn/64.4.537; Skoufias E., 2005, 139 IFPRI; Slaughter S., 2004, ACAD CAPITALISM NEW; Smith L.C., 2000, EXPLAINING CHILD MAL; Sphere Project, HUM CHART MIN STAND; Spiegel PB, 2004, JAMA-J AM MED ASSOC, V292, P613, DOI 10.1001/jama.292.5.613; STODDARD A, 2003, EXTERNAL REV INTERAG; *UN, 2001, A56326 UN GEN ASS; *UN FAO, WORLD FOOD SUMM PLAN; *UN INT SECR INT S, 2006, GLOB SURV EARL WARN; *UN INT STAND COMM, NUTR CLUST; *UNICEF, GOALS CHILDR DEV 199; UNICEF data, 2006, PROGR CHILDR REP CAR; UNICEF WHO, 2003, GLOB STRAT INF YOUNG; *US GOV ACC OFF, 2007, FOOD ASS VAR CHALL I; Vautier F, 1999, TROP MED INT HEALTH, V4, P875, DOI 10.1046/j.1365-3156.1999.00495.x; VICTORA CG, 2008, LANCET          0117, DOI DOI 10.1016/S0140-6736(07)61692-4; *WHO, 2006, A5920 WHO WORLD HOLT; *WHO, MICR DEF INF SYST; WHO, 2003, INF YOUNG CHILD FEED; *WHO DEP IMM, 2007, WHO VACC POS PAP; WHO/FAO, 2005, UND COD AL; World Bank, 2012, WORLD DEV IND GLOB D; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, GLOB DAT BOD MASS IN; Young H, 2004, LANCET, V364, P1899, DOI 10.1016/S0140-6736(04)17447-3; 1997, FOOD NUTR B, V18, P4	84	157	161	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2008	371	9612					608	621		10.1016/S0140-6736(07)61695-X	http://dx.doi.org/10.1016/S0140-6736(07)61695-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FI	18206225				2022-12-24	WOS:000253202600028
J	Lee, S; Spencer, ND				Lee, Seunghwan; Spencer, Nicholas D.			Materials science - Sweet, hairy, soft, and slippery	SCIENCE			English	Editorial Material							POLYMER BRUSHES; LUBRICATION; FRICTION; SURFACES; HYDROGELS; FORCES; MUCIN		[Lee, Seunghwan; Spencer, Nicholas D.] ETH, Dept Mat, Surface Sci & Technol Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Lee, S (corresponding author), ETH, Dept Mat, Surface Sci & Technol Lab, CH-8093 Zurich, Switzerland.	spencer@mat.ethz.ch	Spencer, NIcholas D./A-5843-2008; Lee, Seunghwan/K-8382-2014; Spencer, Nicholas/M-9647-2019	Spencer, NIcholas D./0000-0002-7873-7905; Lee, Seunghwan/0000-0002-0797-1446; Spencer, Nicholas/0000-0002-7873-7905				BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223; Celli J, 2005, BIOMACROMOLECULES, V6, P1329, DOI 10.1021/bm0493990; DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009; Dowson D., 1998, HIST TRIBOLOGY; DROBEK T, 2007, LANGMUIR; Gong JP, 2006, SOFT MATTER, V2, P544, DOI 10.1039/b603209p; Han L, 2007, BIOPHYS J, V92, P1384, DOI 10.1529/biophysj.106.091397; Klein J, 2006, P I MECH ENG J-J ENG, V220, P691, DOI 10.1243/13506501JET143; Klein J, 1998, ACTA POLYM, V49, P617, DOI 10.1002/(SICI)1521-4044(199810)49:10/11<617::AID-APOL617>3.0.CO;2-8; KLEIN J, 1994, NATURE, V370, P634, DOI 10.1038/370634a0; Kobayashi M, 2007, SOFT MATTER, V3, P740, DOI 10.1039/b615780g; Lee S, 2005, TRIBOL INT, V38, P922, DOI 10.1016/j.triboint.2005.07.017; Lee S, 2008, LUBR SCI, V20, P21, DOI 10.1002/ls.50; Moore DF., 1972, FRICTION LUBRICATION, V9, P1; Muller M, 2003, TRIBOL LETT, V15, P395, DOI 10.1023/B:TRIL.0000003063.98583.bb; Raviv U, 2002, LANGMUIR, V18, P7482, DOI 10.1021/la020002s; Tanaka Y, 2005, PROG POLYM SCI, V30, P1, DOI 10.1016/j.progpolymsci.2004.11.003	17	184	191	7	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					575	576		10.1126/science.1153273	http://dx.doi.org/10.1126/science.1153273			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239111				2022-12-24	WOS:000252772000024
J	Montgomery, TA; Howell, MD; Cuperus, JT; Li, DW; Hansen, JE; Alexander, AL; Chapman, EJ; Fahlgren, N; Allen, E; Carrington, JC				Montgomery, Taiowa A.; Howell, Miya D.; Cuperus, Josh T.; Li, Dawei; Hansen, Jesse E.; Alexander, Amanda L.; Chapman, Elisabeth J.; Fahlgren, Noah; Allen, Edwards; Carrington, James C.			Specificity of ARGONAUTE7-miR390 interaction and dual functionality in TAS3 trans-acting siRNA formation	CELL			English	Article							DEPENDENT RNA-POLYMERASE; ARABIDOPSIS-THALIANA; MESSENGER-RNAS; BIOGENESIS; MICRORNAS; PATHWAY; PLANTS; MIRNA; SPECIALIZATION; IDENTIFICATION	Trans-acting siRNA form through a refined RNAi mechanism in plants. miRNA-guided cleavage triggers entry of precursor transcripts into an RNA-DEPENDENT RNA POLYMERASE6 pathway, and sets the register for phased tasiRNA formation by DICER-LIKE4. Here, we show that miR390-ARGONAUTE7 complexes function in distinct cleavage or noncleavage modes at two target sites in TAS3a transcripts. The AGO7 cleavage, but not the noncleavage, function could be provided by AGO1, the dominant miRNA-associated AGO, but only when AGO1 was guided to a modified target site through an alternate miRNA. AGO7 was highly selective for interaction with miR390, and miR390 in turn was excluded from association with AGO1 due entirely to an incompatible 50 adenosine. Analysis of AGO1, AGO2, and AGO7 revealed a potent 50 nucleotide discrimination function for some, although not all, ARGONAUTEs. miR390 and AGO7, therefore, evolved as a highly specific miRNA guide/effector protein pair to function at two distinct tasiRNA biogenesis steps.	[Montgomery, Taiowa A.; Howell, Miya D.; Cuperus, Josh T.; Hansen, Jesse E.; Alexander, Amanda L.; Chapman, Elisabeth J.; Fahlgren, Noah; Allen, Edwards; Carrington, James C.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Montgomery, Taiowa A.; Cuperus, Josh T.; Chapman, Elisabeth J.; Fahlgren, Noah] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA; [Howell, Miya D.; Allen, Edwards; Carrington, James C.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Li, Dawei] China Agr Univ, State Key Lab Agro Biotechnol, Beijing 100094, Peoples R China	Oregon State University; Oregon State University; Oregon State University; China Agricultural University	Carrington, JC (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	carrington@cgrb.oregonstate.edu	Li, Dawei/I-8751-2016; Carrington, James C/A-4656-2012; Fahlgren, Noah/D-4404-2011	Li, Dawei/0000-0003-4133-1263; Carrington, James C/0000-0003-3572-129X; Fahlgren, Noah/0000-0002-5597-4537; Cuperus, Josh/0000-0002-8019-7733; Allen, Edwards/0000-0002-8318-6319; Montgomery, Taiowa/0000-0001-7857-3253	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI043288, R01AI043288, R37AI043288] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43288] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Forsyth D, 1907, Q J MED, V1, P287; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hunter C, 2003, CURR BIOL, V13, P1734, DOI 10.1016/j.cub.2003.09.004; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Talmor-Neiman M, 2006, PLANT J, V48, P511, DOI 10.1111/j.1365-313X.2006.02895.x; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	48	556	602	6	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2008	133	1					128	141		10.1016/j.cell.2008.02.033	http://dx.doi.org/10.1016/j.cell.2008.02.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18342362	Bronze			2022-12-24	WOS:000254641300014
J	Colina, R; Costa-Mattioli, M; Dowling, RJO; Jaramillo, M; Tai, LH; Breitbach, CJ; Martineau, Y; Larsson, O; Rong, LW; Svitkin, YV; Makrigiannis, AP; Bell, JC; Sonenberg, N				Colina, Rodney; Costa-Mattioli, Mauro; Dowling, Ryan J. O.; Jaramillo, Maritza; Tai, Lee-Hwa; Breitbach, Caroline J.; Martineau, Yvan; Larsson, Ola; Rong, Liwei; Svitkin, Yuri V.; Makrigiannis, Andrew P.; Bell, John C.; Sonenberg, Nahum			Translational control of the innate immune response through IRF-7	NATURE			English	Article							DOUBLE-STRANDED-RNA; TARGETED DISRUPTION; INITIATION-FACTORS; RIG-I; INTERFERON; RECOGNITION; GENE; PHOSPHORYLATION; KINASE; CELLS	Transcriptional activation of cytokines, such as type-I interferons ( interferon ( IFN)- alpha and IFN- beta), constitutes the first line of antiviral defence. Here we show that translational control is critical for induction of type- I IFN production. In mouse embryonic fibroblasts lacking the translational repressors 4E- BP1 and 4E- BP2, the threshold for eliciting type- I IFN production is lowered. Consequently, replication of encephalomyocarditis virus, vesicular stomatitis virus, influenza virus and Sindbis virus is markedly suppressed. Furthermore, mice with both 4E- BP1 and 4E- BP2 genes ( also known as Eif4ebp1 and Eif4ebp2, respectively) knocked out are resistant to vesicular stomatitis virus infection, and this correlates with an enhanced type- I IFN production in plasmacytoid dendritic cells and the expression of IFN- regulated genes in the lungs. The enhanced type- I IFN response in 4E-BP1(-/-) 4E-BP2(-/-) double knockout mouse embryonic fibroblasts is caused by upregulation of interferon regulatory factor 7 ( Irf7) messenger RNA translation. These findings highlight the role of 4E- BPs as negative regulators of type- I IFN production, via translational repression of Irf7 mRNA.	[Colina, Rodney; Costa-Mattioli, Mauro; Dowling, Ryan J. O.; Jaramillo, Maritza; Martineau, Yvan; Larsson, Ola; Rong, Liwei; Svitkin, Yuri V.; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Tai, Lee-Hwa; Makrigiannis, Andrew P.] Univ Montreal, Inst Rech Clin Montreal, Lab Mol Immunol, Montreal, PQ H2W 1R7, Canada; [Breitbach, Caroline J.; Bell, John C.] Ottawa Hlth Res Inst, Ottawa, ON K1H 8L6, Canada	McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada.	mauro.costa-mattioli@mail.mcgill.ca; nahum.sonenberg@mcgill.ca	Jaramillo, Maritza/T-7467-2019; Martineau, Yvan/G-2387-2017; Larsson, Ola/F-8151-2013; Dowling, Ryan/Q-8912-2018	Jaramillo, Maritza/0000-0002-1910-5684; Martineau, Yvan/0000-0002-0575-4085; Dowling, Ryan/0000-0002-5381-8805; Colina, Rodney/0000-0003-3731-5383; Svitkin, Yuri/0000-0003-3819-2143; Larsson, Ola/0000-0003-1412-1308; Makrigiannis, Andrew/0000-0002-7258-9411	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BELKOWSKI LS, 1987, J VIROL, V61, P653, DOI 10.1128/JVI.61.3.653-660.1987; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; MATHEWS MB, 2007, COLD SPRING HARB MON, V48, P1; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; MOHR IJ, 2007, TRANSLATIONAL CONTRO, P545; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Poulin F, 2003, J BIOL CHEM, V278, P52290, DOI 10.1074/jbc.M310761200; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; SHATKIN AJ, 1985, CELL, V40, P223, DOI 10.1016/0092-8674(85)90132-1; SONENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843, DOI 10.1073/pnas.75.10.4843; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Stojdl DF, 2000, J VIROL, V74, P9580, DOI 10.1128/JVI.74.20.9580-9585.2000; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	44	241	244	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					323	U2		10.1038/nature06730	http://dx.doi.org/10.1038/nature06730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18272964	Green Published			2022-12-24	WOS:000254117400040
J	Abramson, JS; Almquist, JR; Jenkins, RR; Bocchini, JA; Davis, RM; Langston, EL; Hale, RW; Gall, SA				Abramson, Jon S.; Almquist, Jon R.; Jenkins, Renee R.; Bocchini, Joseph A., Jr.; Davis, Ronald M.; Langston, Edward L.; Hale, Ralph W.; Gall, Stanley A.			Prioritisation of routine vaccines: a mistake for the USA	LANCET			English	Editorial Material							UNITED-STATES; CHILDREN		[Almquist, Jon R.] Amer Acad Pediat, Task Force Immunizat, Elk Grove Village, IL 60007 USA; [Abramson, Jon S.] Wake Forest Univ, Dept Paediat, Winston Salem, NC 27109 USA; [Bocchini, Joseph A., Jr.] Amer Acad Pediat, Comm Infect Dis, Elk Grove Village, IL 60007 USA; [Davis, Ronald M.; Langston, Edward L.] Amer Med Assoc, Board Trustees, Chicago, IL 60610 USA; [Hale, Ralph W.; Gall, Stanley A.] Amer Coll Obstetricians & Gynecologists, Working Grp Immunizat, Washington, DC USA	American Academy of Pediatrics; Wake Forest University; American Academy of Pediatrics; American Medical Association	Almquist, JR (corresponding author), Amer Acad Pediat, Task Force Immunizat, Elk Grove Village, IL 60007 USA.	jonralmquist@msn.com						Davis MM, 2007, JAMA-J AM MED ASSOC, V298, P680, DOI 10.1001/jama.298.6.680; Freed GL, 2005, HEALTH AFFAIR, V24, P755, DOI 10.1377/hlthaff.24.3.755; Lee GM, 2007, JAMA-J AM MED ASSOC, V298, P638, DOI 10.1001/jama.298.6.638; Orenstein WA, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00290-X; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Wooten K. G., 2007, Morbidity and Mortality Weekly Report, V56, P880	6	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 15	2008	371	9616					881	882		10.1016/S0140-6736(08)60394-3	http://dx.doi.org/10.1016/S0140-6736(08)60394-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342670				2022-12-24	WOS:000254056800009
J	Hu, JJ; Shibata, Y; Voss, C; Shemesh, T; Li, ZL; Coughlin, M; Kozlov, MM; Rapoport, TA; Prinz, WA				Hu, Junjie; Shibata, Yoko; Voss, Christiane; Shemesh, Tom; Li, Zongli; Coughlin, Margaret; Kozlov, Michael M.; Rapoport, Tom A.; Prinz, William A.			Membrane proteins of the endoplasmic reticulum induce high-curvature tubules	SCIENCE			English	Article							MITOCHONDRIAL FUSION; DYNAMIN; DOMAIN; ENDOCYTOSIS; ENDOPHILIN; AMPHIPHYSIN; MECHANISM; FISSION; RINGS	The tubular structure of the endoplasmic reticulum ( ER) appears to be generated by integral membrane proteins, the reticulons and a protein family consisting of DP1 in mammals and Yop1p in yeast. Here, individual members of these families were found to be sufficient to generate membrane tubules. When we purified yeast Yop1p and incorporated it into proteoliposomes, narrow tubules (similar to 15 to 17 nanometers in diameter) were generated. Tubule formation occurred with different lipids; required essentially only the central portion of the protein, including its two long hydrophobic segments; and was prevented by mutations that affected tubule formation in vivo. Tubules were also formed by reconstituted purified yeast Rtn1p. Tubules made in vitro were narrower than normal ER tubules, due to a higher concentration of tubule- inducing proteins. The shape and oligomerization of the "morphogenic" proteins could explain the formation of the tubular ER.	[Hu, Junjie; Shibata, Yoko; Rapoport, Tom A.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Hu, Junjie; Shibata, Yoko; Li, Zongli; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Voss, Christiane; Prinz, William A.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Shemesh, Tom; Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Coughlin, Margaret] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu; wprinz@helix.nih.gov	Shemesh, Tom/J-5060-2013; Hu, Junjie/F-9713-2013; Li, Zongli/AAB-9100-2020		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK060105, ZIADK060105] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gallop JL, 2005, NATURE, V438, P675, DOI 10.1038/nature04136; Griffin EE, 2006, J BIOL CHEM, V281, P16599, DOI 10.1074/jbc.M601847200; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tolley N, 2008, TRAFFIC, V9, P94, DOI 10.1111/j.1600-0854.2007.00670.x; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047	23	310	315	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1247	1250		10.1126/science.1153634	http://dx.doi.org/10.1126/science.1153634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309084				2022-12-24	WOS:000253530600045
J	Calis, JCJ; Phiri, KS; Faragher, EB; Brabin, BJ; Bates, I; Cuevas, LE; de Haan, RJ; Phiri, AI; Malange, P; Khoka, M; Hulshof, PJM; van Lieshout, L; Beld, MGHM; Teo, YY; Rockett, KA; Richardson, A; Kwiatkowski, DP; Molyneux, ME; van Hensbroek, MB				Calis, Job C. J.; Phiri, Kamija S.; Faragher, E. Brian; Brabin, Bernard J.; Bates, Imelda; Cuevas, Luis E.; de Haan, Rob J.; Phiri, Ajib I.; Malange, Pelani; Khoka, Mirriam; Hulshof, Paul J. M.; van Lieshout, Lisette; Beld, Marcel G. H. M.; Teo, Yik Y.; Rockett, Kirk A.; Richardson, Anna; Kwiatkowski, Dominic P.; Molyneux, Malcolm E.; van Hensbroek, Michael Boele			Severe anemia in Malawian children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VITAMIN-A SUPPLEMENTATION; YOUNG-CHILDREN; SALMONELLA BACTEREMIA; PLASMODIUM-FALCIPARUM; ANCYLOSTOMA-DUODENALE; NECATOR-AMERICANUS; BLOOD-TRANSFUSION; SEVERE MALARIA; IRON STATUS; FOLIC-ACID	Background Severe anemia is a major cause of sickness and death in African children, yet the causes of anemia in this population have been inadequately studied. Methods We conducted a case-control study of 381 preschool children with severe anemia (hemoglobin concentration, <5.0 g per deciliter) and 757 preschool children without severe anemia in urban and rural settings in Malawi. Causal factors previously associated with severe anemia were studied. The data were examined by multivariate analysis and structural equation modeling. Results Bacteremia (adjusted odds ratio, 5.3; 95% confidence interval [CI], 2.6 to 10.9), malaria (adjusted odds ratio, 2.3; 95% CI, 1.6 to 3.3), hookworm (adjusted odds ratio, 4.8; 95% CI, 2.0 to 11.8), human immunodeficiency virus infection (adjusted odds ratio, 2.0; 95% CI, 1.0 to 3.8), the G6PD(sup -202/-376) genetic disorder (adjusted odds ratio, 2.4; 95% CI, 1.3 to 4.4), vitamin A deficiency (adjusted odds ratio, 2.8; 95% CI, 1.3 to 5.8), and vitamin B(sub 12) deficiency (adjusted odds ratio, 2.2; 95% CI, 1.4 to 3.6) were associated with severe anemia. Folate deficiency, sickle cell disease, and laboratory signs of an abnormal inflammatory response were uncommon. Iron deficiency was not prevalent in case patients (adjusted odds ratio, 0.37; 95% CI, 0.22 to 0.60) and was negatively associated with bacteremia. Malaria was associated with severe anemia in the urban site (with seasonal transmission) but not in the rural site (where malaria was holoendemic). Seventy-six percent of hookworm infections were found in children under 2 years of age. Conclusions There are multiple causes of severe anemia in Malawian preschool children, but folate and iron deficiencies are not prominent among them. Even in the presence of malaria parasites, additional or alternative causes of severe anemia should be considered.	[Calis, Job C. J.; Brabin, Bernard J.; van Hensbroek, Michael Boele] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Global Child Hlth Grp, NL-1105 AZ Amsterdam, Netherlands; [Calis, Job C. J.; Phiri, Kamija S.; Phiri, Ajib I.; Malange, Pelani; Khoka, Mirriam; Molyneux, Malcolm E.; van Hensbroek, Michael Boele] Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [de Haan, Rob J.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; [Beld, Marcel G. H. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol, NL-1105 AZ Amsterdam, Netherlands; [Faragher, E. Brian; Brabin, Bernard J.; Bates, Imelda; Cuevas, Luis E.; Molyneux, Malcolm E.; van Hensbroek, Michael Boele] Univ Liverpool, Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool L3 5QA, Merseyside, England; [Hulshof, Paul J. M.] Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands; [van Lieshout, Lisette] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Teo, Yik Y.; Rockett, Kirk A.; Richardson, Anna; Kwiatkowski, Dominic P.] Wellcome Trust Ctr Human Genet, Oxford, England	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Malawi; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Liverpool School of Tropical Medicine; University of Liverpool; Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford; Wellcome Centre for Human Genetics	Calis, JCJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Global Child Hlth Grp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	job.calis@gmail.com	Swinkels, Dorine W./H-8098-2014; van der Ven, A.J.A.M./H-8102-2014; Cuevas, Luis E/I-3697-2015; Brabin, Bernard/AAJ-7389-2020; de Mast, Quirijn/H-3427-2015	Swinkels, Dorine W./0000-0002-1040-9446; van der Ven, A.J.A.M./0000-0003-1833-3391; Cuevas, Luis E/0000-0002-6581-0587; Phiri, Kamija/0000-0003-1753-2727; bates, imelda/0000-0002-0862-8199; Boele van Hensbroek, Michael/0000-0003-1907-5427; Kwiatkowski, Dominic/0000-0002-5023-0176; Hulshof, Paul/0000-0003-3260-2658; Brabin, Bernard/0000-0001-6860-2508	MRC [G19/9, G0600230] Funding Source: UKRI; Medical Research Council [G0600230, G19/9] Funding Source: Medline; Wellcome Trust [064722] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ABDALLA SH, 1990, ANN TROP PAEDIATR, V10, P265, DOI 10.1080/02724936.1990.11747441; Albonico M, 1998, INT J EPIDEMIOL, V27, P530, DOI 10.1093/ije/27.3.530; Arbuckle J. L., 2007, AMOS 6 0 USERS GUIDE; Biemba G, 2000, TROP MED INT HEALTH, V5, P9, DOI 10.1046/j.1365-3156.2000.00506.x; BIERI JG, 1979, AM J CLIN NUTR, V32, P2143, DOI 10.1093/ajcn/32.10.2143; Boom R, 1999, J CLIN MICROBIOL, V37, P1489, DOI 10.1128/JCM.37.5.1489-1497.1999; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; de Gruijter JM, 2005, TROP MED INT HEALTH, V10, P574, DOI 10.1111/j.1365-3156.2005.01440.x; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; Dicko A, 2004, BLOOD, V104, P1198, DOI 10.1182/blood-2003-11-3884; Dierkes J, 1999, METABOLISM, V48, P631, DOI 10.1016/S0026-0495(99)90062-8; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; GALE E, 1963, J CLIN INVEST, V42, P1076, DOI 10.1172/JCI104793; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; KATZ N, 1970, J PARASITOL, V56, P1032, DOI 10.2307/3277532; Koppelman MHGM, 2004, TRANSFUSION, V44, P97, DOI 10.1046/j.0041-1132.2004.00610.x; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; Kurtzhals J, 1999, LANCET, V353, P848; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; Kurtzhals JAL, 1998, LANCET, V352, P242; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; May J, 2000, J INFECT DIS, V182, P1570, DOI 10.1086/315857; Molyneux E, 2004, ARCH DIS CHILD, V89, P395, DOI 10.1136/adc.2003.025890corr1; Molyneux EM, 2003, ARCH DIS CHILD, V88, P1112, DOI 10.1136/adc.88.12.1112; MURRAY MJ, 1978, BRIT MED J, V2, P1113, DOI 10.1136/bmj.2.6145.1113; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Savage DG, 1999, AM J MED SCI, V317, P22, DOI 10.1097/00000441-199901000-00004; Sazawal S, 2006, LANCET, V367, P302; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Shaker Z A, 1994, J Egypt Soc Parasitol, V24, P656; Shankar AH, 1999, LANCET, V354, P203, DOI 10.1016/S0140-6736(98)08293-2; SOMMER A, 1983, LANCET, V2, P585; Sullivan AD, 1996, PARASITOLOGY, V112, P285, DOI 10.1017/S003118200006580X; van den Broek NR, 2000, AM J CLIN NUTR, V72, p247S, DOI 10.1093/ajcn/72.1.247S; van den Broek NR, 1998, BRIT J HAEMATOL, V103, P817, DOI 10.1046/j.1365-2141.1998.01035.x; vandenHombergh J, 1996, J TROP PEDIATRICS, V42, P220, DOI 10.1093/tropej/42.4.220; vanHensbroek MB, 1995, T ROY SOC TROP MED H, V89, P672, DOI 10.1016/0035-9203(95)90438-7; Villamor E, 2000, AM J TROP MED HYG, V62, P590, DOI 10.4269/ajtmh.2000.62.590; WHO, 2001, IRON DEFICIENCY ANAE; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; World Health Organization, 1998, GUID US IR SUPPL PRE	46	249	254	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					888	899		10.1056/NEJMoa072727	http://dx.doi.org/10.1056/NEJMoa072727			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18305266	Green Published			2022-12-24	WOS:000253430200004
J	Mechali, M; Lutzmann, M				Mechali, Marcel; Lutzmann, Malik			The cell cycle: Now live and in color	CELL			English	Editorial Material							DNA-REPLICATION; LICENSING FACTOR; CDT1; GEMININ	When observing living cells, only mitosis is easily distinguishable from other phases of the cell cycle. In this issue, Sakaue-Sawano et al. (2008) present a method to visually distinguish cells at different phases of the cell cycle by the expression of colored fusion proteins that are under the control of the ubiquitin ligases SCF and APC.	[Mechali, Marcel; Lutzmann, Malik] CNRS, Inst Human Genet, F-34396 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Mechali, M (corresponding author), CNRS, Inst Human Genet, 41 Rue Cardonille, F-34396 Montpellier, France.	mechali@igh.cnrs.fr						Berger C, 2005, NAT CELL BIOL, V7, P56, DOI 10.1038/ncb1203; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Maiorano D, 2004, EXP CELL RES, V295, P138, DOI 10.1016/j.yexcr.2003.11.018; Mechali M, 2001, NAT REV GENET, V2, P640, DOI 10.1038/35084598; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x	9	14	16	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					341	343		10.1016/j.cell.2008.01.031	http://dx.doi.org/10.1016/j.cell.2008.01.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267067	Bronze			2022-12-24	WOS:000253180700010
J	LEBERMAN, R; SOPER, AK				LEBERMAN, R; SOPER, AK			EFFECT OF HIGH-SALT CONCENTRATIONS ON WATER-STRUCTURE	NATURE			English	Article							NEUTRON-SCATTERING	THE characteristic tetrahedral structure of water is known to be disrupted by changes in pressure and temperature(1-3). It has been suggested that ions in solution may have a similar perturbing effect(4,5). Here we use neutron diffraction to compare the effects of applied pressure and high salt concentrations on the hydrogen-bonded network of water. We find that the ions induce a change in structure equivalent to the application of high pressures, and that the size of the effect is ion-specific. Ionic concentrations of a few moles per litre have equivalent pressures that can exceed a thousand atmospheres. We propose that these changes may be understood in terms of the partial molar volume of the ions, relative to those of water molecules. The equivalent induced pressure of a particular ion species is correlated,vith its efficacy in precipitating, or salting-out, proteins from solution(6).	RUTHERFORD APPLETON LAB,ISIS FACIL,DIDCOT OX11 0QX,OXON,ENGLAND	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	LEBERMAN, R (corresponding author), EUROPEAN MOLEC BIOL LAB,GRENOBLE OUTSTN,BP 156,F-38042 GRENOBLE,FRANCE.			Soper, Alan/0000-0002-7903-8356				ENDERBY JE, 1973, CHEM PHYS LETT, V21, P109, DOI 10.1016/0009-2614(73)80025-9; HERDMAN GJ, 1990, J MOL LIQ, V46, P165, DOI 10.1016/0167-7322(90)80052-L; Hofmeister F., 1888, N-S ARCH EXP PATH PH, V24, P247; MILLERO FJ, 1971, CHEM REV, V72, P147; POSTORINO P, 1994, J CHEM PHYS, V101, P4123, DOI 10.1063/1.467462; POSTORINO P, 1993, NATURE, V366, P668, DOI 10.1038/366668a0; Soper A., 1989, ATLAS ANAL TIME FLIG; SOPER AK, 1993, INT J MOD PHYS B, V7, P3049, DOI 10.1142/S0217979293003152; SOPER AK, 1993, CHEM PHYS, V107, P47; SOPER AK, 1993, J CHEM PHYS, V97, P1320; TROMP RH, 1994, J CHEM PHYS, V101, P6210, DOI 10.1063/1.468403; TROMP RH, 1992, J CHEM PHYS, V96, P8460, DOI 10.1063/1.462298; Zubay G., 1993, BIOCHEMISTRY; 1974, HDB CHEM PHYSICS, pD194	14	364	372	4	107	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					364	366		10.1038/378364a0	http://dx.doi.org/10.1038/378364a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	18286746				2022-12-24	WOS:A1995TF89300050
J	Minobe, S; Kuwano-Yoshida, A; Komori, N; Xie, SP; Small, RJ				Minobe, Shoshiro; Kuwano-Yoshida, Akira; Komori, Nobumasa; Xie, Shang-Ping; Small, Richard Justin			Influence of the Gulf Stream on the troposphere	NATURE			English	Article							SEA-SURFACE TEMPERATURE; SATELLITE-OBSERVATIONS; NUMERICAL-SIMULATION; OCEAN; CLIMATE; CONVERGENCE; CIRCULATION; WINDS	The Gulf Stream transports large amounts of heat from the tropics to middle and high latitudes, and thereby affects weather phenomena such as cyclogenesis(1,2) and low cloud formation(3). But its climatic influence, on monthly and longer timescales, remains poorly understood. In particular, it is unclear how the warm current affects the free atmosphere above the marine atmospheric boundary layer. Here we consider the Gulf Stream's influence on the troposphere, using a combination of operational weather analyses, satellite observations and an atmospheric general circulation model(4). Our results reveal that the Gulf Stream affects the entire troposphere. In the marine boundary layer, atmospheric pressure adjustments to sharp sea surface temperature gradients lead to surface wind convergence, which anchors a narrow band of precipitation along the Gulf Stream. In this rain band, upward motion and cloud formation extend into the upper troposphere, as corroborated by the frequent occurrence of very low cloud- top temperatures. These mechanisms provide a pathway by which the Gulf Stream can affect the atmosphere locally, and possibly also in remote regions by forcing planetary waves(5,6). The identification of this pathway may have implications for our understanding of the processes involved in climate change, because the Gulf Stream is the upper limb of the Atlantic meridional overturning circulation, which has varied in strength in the past(7) and is predicted to weaken in response to human- induced global warming in the future(8).	[Minobe, Shoshiro] Hokkaido Univ, Dept Nat Hist Sci, Grad Sch Sci, Sapporo, Hokkaido 0600810, Japan; [Kuwano-Yoshida, Akira; Komori, Nobumasa] Japan Agcy Marine Earth Sci & Technol, Earth Simulator Ctr, Yokohama, Kanagawa 2360001, Japan; [Xie, Shang-Ping; Small, Richard Justin] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Xie, Shang-Ping] Univ Hawaii Manoa, Dept Meteorol, Honolulu, HI 96822 USA	Hokkaido University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Minobe, S (corresponding author), Hokkaido Univ, Dept Nat Hist Sci, Grad Sch Sci, Sapporo, Hokkaido 0600810, Japan.	minobe@sci.hokudai.ac.jp	Kuwano-Yoshida, Akira/Q-5616-2019; Xie, Shang-Ping/C-1254-2009; Kuwano-Yoshida, Akira/AGR-6960-2022; Komori, Nobumasa/D-1989-2013; Kuwano-Yoshida, Akira/I-8652-2014; Minobe, Shoshiro/E-2997-2010	Kuwano-Yoshida, Akira/0000-0003-3151-8550; Xie, Shang-Ping/0000-0002-3676-1325; Kuwano-Yoshida, Akira/0000-0003-3151-8550; Komori, Nobumasa/0000-0001-6067-8356; Kuwano-Yoshida, Akira/0000-0003-3151-8550; Minobe, Shoshiro/0000-0002-9487-9006; Small, Richard/0000-0002-3452-2179				Broecker WS, 2003, SCIENCE, V300, P1519, DOI 10.1126/science.1083797; Chelton DB, 2005, B AM METEOROL SOC, V86, P1097, DOI 10.1175/BAMS-86-8-1097; Chelton DB, 2004, SCIENCE, V303, P978, DOI 10.1126/science.1091901; Christian HJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002347; Ciasto LM, 2004, J CLIMATE, V17, P1617, DOI 10.1175/1520-0442(2004)017<1617:NAAIOI>2.0.CO;2; Czaja A, 2002, J CLIMATE, V15, P606, DOI 10.1175/1520-0442(2002)015<0606:OIOASA>2.0.CO;2; Dai A, 2005, J CLIMATE, V18, P3270, DOI 10.1175/JCLI3481.1; Ducet N, 2001, J GEOPHYS RES-OCEANS, V106, P16603, DOI 10.1029/2000JC000205; Enomoto T, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P77, DOI 10.1007/978-0-387-49791-4_5; Held IM, 2002, J CLIMATE, V15, P2125, DOI 10.1175/1520-0442(2002)015<2125:NWSWTA>2.0.CO;2; HOSKINS BJ, 1990, J ATMOS SCI, V47, P1854, DOI 10.1175/1520-0469(1990)047<1854:OTEOST>2.0.CO;2; KUO YH, 1991, MON WEATHER REV, V119, P368, DOI 10.1175/1520-0493(1991)119<0368:TIBBAD>2.0.CO;2; LINDZEN RS, 1987, J ATMOS SCI, V44, P2418, DOI 10.1175/1520-0469(1987)044<2418:OTROSS>2.0.CO;2; Liu WT, 2002, J OCEANOGR, V58, P121, DOI 10.1023/A:1015832919110; Lund DC, 2006, NATURE, V444, P601, DOI 10.1038/nature05277; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; NEIMAN PJ, 1993, MON WEATHER REV, V121, P2153, DOI 10.1175/1520-0493(1993)121<2153:TLCOAE>2.0.CO;2; O'Neill LW, 2005, J CLIMATE, V18, P2706, DOI 10.1175/JCLI3415.1; Pan JY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015015; Peng SL, 2001, J CLIMATE, V14, P2943, DOI 10.1175/1520-0442(2001)014<2943:RBAIVA>2.0.CO;2; Rio MH, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002226; SANDERS F, 1986, MON WEATHER REV, V114, P1781, DOI 10.1175/1520-0493(1986)114<1781:ECITWC>2.0.CO;2; Skyllingstad ED, 2007, BOUND-LAY METEOROL, V123, P219, DOI 10.1007/s10546-006-9127-8; Small RJ, 2003, J CLIMATE, V16, P3723, DOI 10.1175/1520-0442(2003)016<3723:NSOART>2.0.CO;2; Song QT, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003680; Thiebaux J, 2003, B AM METEOROL SOC, V84, P645, DOI 10.1175/BAMS-84-5-645; Timmermann A, 2007, J CLIMATE, V20, P4899, DOI 10.1175/JCLI4283.1; Tokinaga H, 2005, J CLIMATE, V18, P3470, DOI 10.1175/JCLI3485.1; TRUNK TJ, 1990, MON WEATHER REV, V118, P459, DOI 10.1175/1520-0493(1990)118<0459:MRECDP>2.0.CO;2; Watanabe M, 2006, J ATMOS SCI, V63, P3366, DOI 10.1175/JAS3807.1; Xie SP, 2004, B AM METEOROL SOC, V85, P195, DOI 10.1175/BAMS-85-2-195; Xie SP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015884; Young GS, 2003, MON WEATHER REV, V131, P2177, DOI 10.1175/1520-0493(2003)131<2177:MSBCBG>2.0.CO;2	33	524	550	4	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2008	452	7184					206	U51		10.1038/nature06690	http://dx.doi.org/10.1038/nature06690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337820	Green Submitted			2022-12-24	WOS:000253925600038
J	Paralkar, V				Paralkar, Vikram			Worlds apart - Tuberculosis in India and the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS		[Paralkar, Vikram] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Paralkar, V (corresponding author), Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA.							Bhanu NV, 2004, AM J TROP MED HYG, V70, P527, DOI 10.4269/ajtmh.2004.70.527; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P1072; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Rao KG, 2004, INT J TUBERC LUNG D, V8, P1392; 2007, MMWR MORB MORTAL WKL, V56, P245	5	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1092	1095		10.1056/NEJMp0707933	http://dx.doi.org/10.1056/NEJMp0707933			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	272RK	18337599				2022-12-24	WOS:000253877200002
J	Lenzer, J; Brownlee, S				Lenzer, Jeanne; Brownlee, Shannon			An untold story?	BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS		[Brownlee, Shannon] New Amer Fdn, Washington, DC USA			jeanne.lenzer@gmail.com						Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Groves T, 2008, BRIT MED J, V336, P170, DOI 10.1136/bmj.39469.465139.80; Juni P, 2005, BMJ-BRIT MED J, V330, P1342, DOI 10.1136/bmj.330.7504.1342; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; LENZER J, 2006, NEW REPUBLIC    1030; LENZER J, 2005, SLATE           0927; Pitkin RM, 1999, JAMA-J AM MED ASSOC, V281, P1110, DOI 10.1001/jama.281.12.1110; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; WAKNINE Y, 2005, MEDSCAPE TODAY  0407	10	11	11	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 8	2008	336	7643					532	534		10.1136/bmj.39504.662685.0F	http://dx.doi.org/10.1136/bmj.39504.662685.0F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JV	18304990	Green Published			2022-12-24	WOS:000253998500025
J	Ringel, SP				Ringel, Steven P.			Lessons from the Santa Fe Trail	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												steven.ringel@uchsc.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2008	299	9					998	999		10.1001/jama.299.9.998	http://dx.doi.org/10.1001/jama.299.9.998			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JH	18319403				2022-12-24	WOS:000253644800001
J	Philips, M; Zachariah, R; Venis, S				Philips, Mit; Zachariah, Rony; Venis, Sarah			Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea	LANCET			English	Editorial Material							HEALTH-WORKERS; DISTRICT		[Philips, Mit] Med Sans Frontieres, Brussels Operat Ctr, Anal & Advocacy Unit, B-1090 Brussels, Belgium; [Zachariah, Rony] Med Sans Frontieres, Brussels Operat Ctr, Med Dept Operat Res, B-1090 Brussels, Belgium; [Venis, Sarah] Med Sans Frontieres, London, England	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders	Philips, M (corresponding author), Med Sans Frontieres, Brussels Operat Ctr, Anal & Advocacy Unit, 94 Dupre St, B-1090 Brussels, Belgium.	mit.philips@brussels.msf.org		zachariah, rony/0000-0002-2915-9328				Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; BERMAN PA, 1987, SOC SCI MED, V25, P443, DOI 10.1016/0277-9536(87)90168-7; BLUESTONE J, 2005, TASK SHIFTING STRATE, P72; Buchan J, 2002, B WORLD HEALTH ORGAN, V80, P575; BUCHAN J, 2000, HUM RES HLTH DEV J, V4, P111; Dambisya YM, 2007, REV NONFINANCIAL INC; Dovlo Delanyo, 2004, Hum Resour Health, V2, P7, DOI 10.1186/1478-4491-2-7; Gimbel-Sherr Sarah O, 2007, Hum Resour Health, V5, P7, DOI 10.1186/1478-4491-5-7; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; *HRH WORK GROUP HI, 2005, WORK TOG TACKL CRIS, P72; KOBER K, 2005, EXPERT PATIENTS AIDS, P72; Lewin SA, 2005, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD004015.PUB2; Medecins sans Frontieres, 2007, HELP WANT CONFR HLTH; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Ooms G, 2007, PLOS MED, V4, P605, DOI 10.1371/journal.pmed.0040128; Rowe SY, 2007, T ROY SOC TROP MED H, V101, P188, DOI 10.1016/j.trstmh.2006.02.023; Serneels P, 2007, HEALTH POLICY PLANN, V22, P128, DOI 10.1093/heapol/czm005; Sibbald Bonnie, 2004, J Health Serv Res Policy, V9 Suppl 1, P28, DOI 10.1258/135581904322724112; Van Damme W, 2006, AIDS, V20, P653, DOI 10.1097/01.aids.0000216364.44409.b1; WALT G, 1992, COMMUNITY HLTH WORKE; *WEM FDN, 2005, BUDG CEIL HLTH KEN C, P72; WHO, 2006, WORK TOG HLTH WORLD; World Health Organization, TASK SHIFT RAT RED T; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	25	105	105	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2008	371	9613					682	684		10.1016/S0140-6736(08)60307-4	http://dx.doi.org/10.1016/S0140-6736(08)60307-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266LL	18295026				2022-12-24	WOS:000253436700033
J	Bukovinszky, T; van Veen, FJF; Jongema, Y; Dicke, M				Bukovinszky, Tibor; van Veen, F. J. Frank; Jongema, Yde; Dicke, Marcel			Direct and indirect effects of resource quality on food web structure	SCIENCE			English	Article							APPARENT COMPETITION; COMMUNITIES; HERBIVORE; ECOSYSTEMS; DIVERSITY; STABILITY	The diversity and complexity of food webs ( the networks of feeding relationships within an ecological community) are considered to be important factors determining ecosystem function and stability. However, the biological processes driving these factors are poorly understood. Resource quality affects species interactions by limiting energy transfer to consumers and their predators, affecting life history and morphological traits. We show that differences in plant traits affect the structure of an entire food web through a series of direct and indirect effects. Three trophic levels of consumers were influenced by plant quality, as shown by quantitative herbivore - parasitoid - secondary parasitoid food webs. We conclude, on the basis of our data, that changes in the food web are dependent on both trait- and density- mediated interactions among species.	[Bukovinszky, Tibor; Jongema, Yde; Dicke, Marcel] Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 EH Wageningen, Netherlands; [van Veen, F. J. Frank] Univ London Imperial Coll Sci Technol & Med, Nat Environm Res Council Ctr Populat Biol, Div Biol, Ascot SL5 7PY, Berks, England	Wageningen University & Research; Imperial College London	Bukovinszky, T (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, POB 8031, NL-6700 EH Wageningen, Netherlands.	tibor.bukovinszky@wur.nl	van Veen, Franciscus JF/H-2101-2013; Bukovinszky, Tibor/B-1262-2011; Dicke, Marcel/B-2300-2010	Dicke, Marcel/0000-0001-8565-8896; van Veen, Frank/0000-0003-0708-5492	Natural Environment Research Council [cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Beckerman AP, 2006, P NATL ACAD SCI USA, V103, P13745, DOI 10.1073/pnas.0603039103; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.1890/0012-9658(2002)083[2394:QDOFWM]2.0.CO;2; Godfray H. C. J, 1994, PARASITOIDS BEHAV EV, P9; GOMEZCAMPO C, 1999, DEV PLANT GENETICS B, pCH4; Harvey JA, 2003, J ANIM ECOL, V72, P520, DOI 10.1046/j.1365-2656.2003.00722.x; HUNTER MD, 1992, ECOLOGY, V73, P724; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Ives AR, 2004, NATURE, V429, P174, DOI 10.1038/nature02515; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Morris RJ, 2004, NATURE, V428, P310, DOI 10.1038/nature02394; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Sullivan DJ, 1999, ANNU REV ENTOMOL, V44, P291, DOI 10.1146/annurev.ento.44.1.291; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Underwood N, 2000, ECOLOGY, V81, P1565, DOI 10.1890/0012-9658(2000)081[1565:TEOHPG]2.0.CO;2; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	22	186	189	6	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					804	807		10.1126/science.1148310	http://dx.doi.org/10.1126/science.1148310			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258913				2022-12-24	WOS:000252963000059
J	Hawkes, N				Hawkes, Nigel			How do we get the measure of patient care?	BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY					nigel.hawkes@thetimes.co.uk						Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; Lilford RJ, 2007, BMJ-BRIT MED J, V335, P648, DOI 10.1136/bmj.39317.641296.AD	2	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 2	2008	336	7638					249	249		10.1136/bmj.39470.702627.59	http://dx.doi.org/10.1136/bmj.39470.702627.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	261TM	18244995	Green Published			2022-12-24	WOS:000253102900034
J	Nariya, H; Inouye, M				Nariya, Hirofumi; Inouye, Masayori			MazF, an mRNA interferase, mediates programmed cell death during multicellular Myxococcus development	CELL			English	Article							SER/THR KINASE CASCADE; ESCHERICHIA-COLI; XANTHUS DEVELOPMENT; PROTEIN-SYNTHESIS; GENES; SPORULATION; BACTERIA; 6-PHOSPHOFRUCTOKINASE; IDENTIFICATION; MUTANTS	In prokaryotes, the toxin-antitoxin systems are thought to play important roles in growth regulation under stress conditions. In the E. coli MazE-MazF system, MazF toxin functions as an mRNA interferase cleaving mRNAs at ACA sequences to inhibit protein synthesis leading to cell growth arrest. Myxococcus xanthus is a bacterium displaying multicellular fruiting body development during which approximately 80% of cells undergo obligatory cell lysis. Here, we demonstrate that M. xanthus has a solitary mazF gene that lacks a cotranscribed antitoxin gene. The mazF deletion results in elimination of the obligatory cell death during development causing dramatic reduction in spore formation. Surprisingly, MrpC, a key developmental regulator, functions as a MazF antitoxin and a mazF transcription activator. Transcription of mrpC and mazF is negatively regulated via MrpC phosphorylation by a Ser/Thr kinase cascade. These findings reveal the regulated deployment of a toxin gene for developmental programmed cell death in bacteria.	[Nariya, Hirofumi; Inouye, Masayori] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, M (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	inouye@umdnj.edu						Berleman JE, 2007, J BACTERIOL, V189, P5675, DOI 10.1128/JB.00544-07; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; Dworkin M, 1996, MICROBIOL REV, V60, P70, DOI 10.1128/MMBR.60.1.70-102.1996; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2003, SCIENCE, V301, P467, DOI 10.1126/science.1088051; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; INOUYE M, 1979, P NATL ACAD SCI USA, V76, P209, DOI 10.1073/pnas.76.1.209; James P, 1996, GENETICS, V144, P1425; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kimura Y, 2002, J BACTERIOL, V184, P3578, DOI 10.1128/JB.184.13.3578-3585.2002; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Komano T, 2000, MOL MICROBIOL, V35, P1348, DOI 10.1046/j.1365-2958.2000.01769.x; KROOS L, 1986, DEV BIOL, V117, P252, DOI 10.1016/0012-1606(86)90368-4; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; LIU YC, 1990, BIOTECHNIQUES, V9, P558; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; Miller J.H., 1972, EXPT MOL GENETICS CO; MORRISON CE, 1979, J BACTERIOL, V140, P1036, DOI 10.1128/JB.140.3.1036-1042.1979; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; Nariya H, 2005, MOL MICROBIOL, V56, P1314, DOI 10.1111/j.1365-2958.2005.04619.x; Nariya H, 2003, MOL MICROBIOL, V49, P517, DOI 10.1046/j.1365-2958.2003.03572.x; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; NORIOKA N, 1995, J BACTERIOL, V177, P4179, DOI 10.1128/jb.177.14.4179-4182.1995; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pellegrini O, 2005, MOL MICROBIOL, V56, P1139, DOI 10.1111/j.1365-2958.2005.04606.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sun H, 2001, J BACTERIOL, V183, P4786, DOI 10.1128/JB.183.16.4786-4795.2001; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Tojo N, 1996, J BACTERIOL, V178, P4004, DOI 10.1128/jb.178.14.4004-4011.1996; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Ueki T, 2003, P NATL ACAD SCI USA, V100, P8782, DOI 10.1073/pnas.1533026100; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200; ZUKER M, 1989, METHOD ENZYMOL, V180, P262	44	187	195	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2008	132	1					55	66		10.1016/j.cell.2007.11.044	http://dx.doi.org/10.1016/j.cell.2007.11.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191220	Bronze			2022-12-24	WOS:000253427600015
J	Westphal, V; Rizzoli, SO; Lauterbach, MA; Kamin, D; Jahn, R; Hell, SW				Westphal, Volker; Rizzoli, Silvio O.; Lauterbach, Marcel A.; Kamin, Dirk; Jahn, Reinhard; Hell, Stefan W.			Video-rate far-field optical nanoscopy dissects synaptic vesicle movement	SCIENCE			English	Article							FLUORESCENCE MICROSCOPY; NERVE-TERMINALS; STED MICROSCOPY; RESOLUTION; BOUTONS; SYNAPSES; DYNAMICS; RECOVERY; MOBILITY; POOLS	We present video-rate (28 frames per second) far-field optical imaging with a focal spot size of 62 nanometers in living cells. Fluorescently labeled synaptic vesicles inside the axons of cultured neurons were recorded with stimulated emission depletion (STED) microscopy in a 2.5-micrometer by 1.8-micrometer field of view. By reducing the cross-sectional area of the focal spot by about a factor of 18 below the diffraction limit (260 nanometers), STED allowed us to map and describe the vesicle mobility within the highly confined space of synaptic boutons. Although restricted within boutons, the vesicle movement was substantially faster in nonbouton areas, consistent with the observation that a sizable vesicle pool continuously transits through the axons. Our study demonstrates the emerging ability of optical microscopy to investigate intracellular physiological processes on the nanoscale in real time.	[Westphal, Volker; Lauterbach, Marcel A.; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany; [Rizzoli, Silvio O.; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Rizzoli, Silvio O.; Kamin, Dirk] European Neurosci Inst, STED Microscopy Synapt Funct, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Hell, SW (corresponding author), Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany.	shell@gwdg.de	Rizzoli, Silvio/ABG-2227-2020	Jahn, Reinhard/0000-0003-1542-3498; Rizzoli, Silvio/0000-0002-1667-7839				Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Donnert G, 2007, BIOPHYS J, V92, pL67, DOI 10.1529/biophysj.107.104497; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Gaffield MA, 2006, NEURON, V51, P317, DOI 10.1016/j.neuron.2006.06.031; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; HELL S, 1992, J OPT SOC AM A, V9, P2159, DOI 10.1364/JOSAA.9.002159; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Henkel AW, 1996, J NEUROSCI, V16, P3960; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; Kraszewski K, 1996, J NEUROSCI, V16, P5905; Lemke EA, 2005, J NEUROSCI, V25, P11034, DOI 10.1523/JNEUROSCI.2971-05.2005; Rizzoli SO, 2007, TRAFFIC, V8, P1137, DOI 10.1111/j.1600-0854.2007.00614.x; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shtrahman M, 2005, BIOPHYS J, V89, P3615, DOI 10.1529/biophysj.105.059295; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tinnefeld P, 2003, J PHYS CHEM A, V107, P323, DOI 10.1021/jp026565u; Westphal V, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/435; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Yeung C, 2007, BIOPHYS J, V92, P2271, DOI 10.1529/biophysj.106.081794	27	581	607	2	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 11	2008	320	5873					246	249		10.1126/science.1154228	http://dx.doi.org/10.1126/science.1154228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286HJ	18292304				2022-12-24	WOS:000254836700048
J	Ball, P				Ball, Philip			Water: Water - an enduring mystery	NATURE			English	Editorial Material																		Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Franks F., 1975, WATER COMPREHENSIVE, V1; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205	5	267	272	0	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					291	292		10.1038/452291a	http://dx.doi.org/10.1038/452291a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354466	Bronze			2022-12-24	WOS:000254117400028
J	Reuben, DB				Reuben, David B.			The geriatrician's lab (Yellow)	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Geriatr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Reuben, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Geriatr, Le Conte Ave,Suite 2339, Los Angeles, CA 90095 USA.	dreuben@mednet.ucia.edu							0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2008	148	6					480	481		10.7326/0003-4819-148-6-200803180-00011	http://dx.doi.org/10.7326/0003-4819-148-6-200803180-00011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	279KT	18347354				2022-12-24	WOS:000254354800009
J	Bodenheimer, T				Bodenheimer, Thomas			Coordinating care - A perilous journey through the health care system	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PARTICIPATORY DECISION-MAKING; CONTROLLED-TRIAL; TRANSITIONS INTERVENTION; PHYSICIAN COMMUNICATION; UNITED-STATES; PATIENT-CARE; INFORMATION; TIME; QUALITY; SATISFACTION		[Bodenheimer, Thomas] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Family & Community Med, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Family & Community Med, San Francisco, CA 94143 USA.							*AG HEALTHC RES QU, 2005, AHRQ PARTN IMPL PAT; *AM COLL PHYS, 2006, SYST NEED CHANG REST; American Academy of Family Physicians; American Academy of Pediatrics; American College of Physicians; American Osteopathic Association, 2007, JOINT PRINC PAT CTR; Anderson G, 2001, HEALTH AFFAIR, V20, P146, DOI 10.1377/hlthaff.20.6.146; Anthony D., 2005, ADV PATIENT SAFETY R; Bodenheimer T, 2007, BUILDING TEAMS PRIMA; Bodenheimer T, 2007, ANN FAM MED, V5, P457, DOI 10.1370/afm.731; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Casalino LP, 2003, ARCH INTERN MED, V163, P1958, DOI 10.1001/archinte.163.16.1958; Coleman EA, 2004, J AM GERIATR SOC, V52, P1817, DOI 10.1111/j.1532-5415.2004.52504.x; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Crosson FJ, 2005, HEALTH AFFAIR, V24, P1543, DOI 10.1377/hlthaff.24.6.1543; *CTR STUD HLTH SYS, CTS PHYS SURV; Davis K, 2005, J GEN INTERN MED, V20, P953, DOI 10.1111/j.1525-1497.2005.0178.x; Davis K, 2007, NEW ENGL J MED, V356, P1166, DOI 10.1056/NEJMe078007; Deveugele M, 2004, PATIENT EDUC COUNS, V54, P227, DOI 10.1016/S0738-3991(03)00239-8; Farber J, 2007, ANN INTERN MED, V147, P693, DOI 10.7326/0003-4819-147-10-200711200-00005; Forrest CB, 2000, ARCH PEDIAT ADOL MED, V154, P499, DOI 10.1001/archpedi.154.5.499; Gandhi TK, 2000, J GEN INTERN MED, V15, P626, DOI 10.1046/j.1525-1497.2000.91119.x; Gandhi TK, 2005, ANN INTERN MED, V142, P352, DOI 10.7326/0003-4819-142-5-200503010-00010; Gillies RR, 2006, HEALTH SERV RES, V41, P1181, DOI 10.1111/j.1475-6773.2006.00529.x; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; Gottschalk A, 2005, ANN FAM MED, V3, P488, DOI 10.1370/afm.404; Grumbach K, 2002, JAMA-J AM MED ASSOC, V288, P889, DOI 10.1001/jama.288.7.889; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Halamka J, 2005, HEALTH AFFAIR, V24, P1170, DOI 10.1377/hlthaff.24.5.1170; Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Kaplan SH, 1996, ANN INTERN MED, V124, P497, DOI 10.7326/0003-4819-124-5-199603010-00007; Kilo CM, 2005, HEALTH AFFAIR, V24, P1296, DOI 10.1377/hlthaff.24.5.1296; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Levine C., 1998, ROUGH CROSSINGS FAMI; LIEBHABER A, 2007, 18 CTR STUD HLTH SYS; McDonald CJ, 2005, HEALTH AFFAIR, V24, P1214, DOI 10.1377/hlthaff.24.5.1214; McDonald K, 2007, CLOSING QUALITY GAP, V7; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; *MED PAYM ADV COMM, 2006, INCR VAL MED REP C; Mehrotra A, 2006, ANN INTERN MED, V145, P826, DOI 10.7326/0003-4819-145-11-200612050-00007; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Murray Mark, 2002, Fam Pract Manag, V9, P39; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Naylor MD, 2004, J AM GERIATR SOC, V52, P1228; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Overhage JM, 2002, ANN EMERG MED, V39, P14, DOI 10.1067/mem.2002.120794; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; ROTER DL, 1989, ANNU REV PUBL HEALTH, V10, P163, DOI 10.1146/annurev.pu.10.050189.001115; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; SCHOEN C, 2004, HLTH AFFAIRS W, V4, P487, DOI DOI 10.1377/HLTHAFF.W4.487; Schoen C, 2005, HLTH AFF MILLWOOD S; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	52	642	648	1	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					1064	1071		10.1056/NEJMhpr0706165	http://dx.doi.org/10.1056/NEJMhpr0706165			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269JG	18322289				2022-12-24	WOS:000253644700012
J	Ladet, S; David, L; Domard, A				Ladet, Sebastien; David, Laurent; Domard, Alain			Multi-membrane hydrogels	NATURE			English	Article							PHYSICAL HYDROGELS; HYDROALCOHOLIC MEDIUM; ACETYLATED CHITOSANS; AQUEOUS-SOLUTION; TRANSITION; GELS	Polysaccharide- based hydrogels are useful for numerous applications, from food(1) and cosmetic processing to drug delivery and tissue engineering(2,3). The formation of hydrogels from polyelectrolyte solutions is complex, involving a variety of molecular interactions. The physical gelation of polysaccharides can be achieved by balancing solvophobic and solvophilic interactions(4). Polymer chain reorganization can be obtained by solvent exchange, one of the processing routes forming a simple hydrogel assembly. Nevertheless, many studies on hydrogel formation are empirical with a limited understanding of the mechanisms involved, delaying the processing of more complex structures. Here we use a multi- step interrupted gelation process in controlled physico- chemical conditions to generate complex hydrogels with multi- membrane 'onion-like' architectures. Our approach greatly simplifies the processing of gels with complex shapes and a multi- membrane organization. In contrast with existing assemblies described in the literature, our method allows the formation of free 'inter-membrane' spaces well suited for cell or drug introduction. These architectures, potentially useful in biomedical applications, open interesting perspectives by taking advantage of tailor- made three- dimensional multimembrane tubular or spherical structures.	[Ladet, Sebastien; David, Laurent; Domard, Alain] Univ Lyon 1, CNRS, Polymer Mat Polymeres & Biomat, UMR 5223, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	David, L (corresponding author), Univ Lyon 1, CNRS, Polymer Mat Polymeres & Biomat, UMR 5223, 15 Blvd A Latarjet,Batiment ISTIL, F-69622 Villeurbanne, France.	laurent.david@univ-lyon1.fr; alain.domard@univ-lyon1.fr		DAVID, Laurent/0000-0003-3632-8537				Boucard N, 2005, BIOMACROMOLECULES, V6, P3227, DOI 10.1021/bm050653d; Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021; Domard A., 2001, POLYM BIOMATER, V9, P187, DOI DOI 10.1201/9780203904671.CH9; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; HIRANO S, 1985, J BIOMED MATER RES, V19, P413, DOI 10.1002/jbm.820190406; ILMAIN F, 1991, NATURE, V349, P400, DOI 10.1038/349400a0; Lamarque G, 2005, BIOMACROMOLECULES, V6, P131, DOI 10.1021/bm0496357; MALETTE WG, 1983, ANN THORAC SURG, V36, P55, DOI 10.1016/S0003-4975(10)60649-2; Montembault A, 2006, BIOCHIMIE, V88, P551, DOI 10.1016/j.biochi.2006.03.002; Montembault A, 2005, BIOMATERIALS, V26, P933, DOI 10.1016/j.biomaterials.2004.03.033; Ostroha J, 2004, BIOMATERIALS, V25, P4345, DOI 10.1016/j.biomaterials.2003.11.019; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; PILNIK W, 1985, CARBOHYD RES, V142, P93, DOI 10.1016/S0008-6215(00)90736-5; PORATH J, 1973, NATURE, V245, P465, DOI 10.1038/245465a0; Pu Q, 2004, J PHYS CHEM B, V108, P14124, DOI 10.1021/jp0486200; Schatz C, 2003, BIOMACROMOLECULES, V4, P641, DOI 10.1021/bm025724c; SIEGEL RA, 1988, MACROMOLECULES, V21, P3254, DOI 10.1021/ma00189a021; Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+; Strand SP, 2001, BIOMACROMOLECULES, V2, P126, DOI 10.1021/bm005601x; Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1; VASQUEZ B, 1997, BIOMETERIALS, V18, P521; VONHIPPE.PH, 1969, ACCOUNTS CHEM RES, V2, P257, DOI 10.1021/ar50021a001	22	416	430	15	538	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					76	U6		10.1038/nature06619	http://dx.doi.org/10.1038/nature06619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322531				2022-12-24	WOS:000253671900049
J	Gray, JAM; Patnick, J; Blanks, RG				Gray, J. A. Muir; Patnick, J.; Blanks, R. G.			Maximising benefit and minimising harm of screening	BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER; PROGRAM; MAMMOGRAPHY; UK; CONSISTENCY; MORTALITY; SCHEME		[Gray, J. A. Muir] Natl Knowledge Serv, Oxford OX3 7LG, England; [Patnick, J.] NHS Canc Screening Programmes, Sheffield, S Yorkshire, England; [Blanks, R. G.] Inst Canc Res, Surrey, England	University of London; Institute of Cancer Research - UK	Gray, JAM (corresponding author), Natl Knowledge Serv, Oxford OX3 7LG, England.	muir.gray@medknox.net						Ayer A. J., 1936, LANGUAGE TRUTH LOGIC; Blanks R G, 1996, J Med Screen, V3, P79; Blanks RG, 2000, BRIT MED J, V321, P665, DOI 10.1136/bmj.321.7262.665; Blanks RG, 1998, J MED SCREEN, V5, P195, DOI 10.1136/jms.5.4.195; Blanks RG, 2002, J MED SCREEN, V9, P11, DOI 10.1136/jms.9.1.11; Donabedian A, 1980, EXPLORATIONS QUALITY, V1; Ellis IO, 2006, J CLIN PATHOL, V59, P138, DOI 10.1136/jcp.2004.025551; Forrest APM, 1986, REPORT HLTH MINISTER; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; GRAY JAM, 1990, GEN PRINCIPLES QUALI; Prior P, 1996, J Med Screen, V3, P119; PRITCHARD J, 1989, QUALITY ASSURANCE GU; Sauven P, 2003, BRIT J SURG, V90, P82, DOI 10.1002/bjs.4013; Sloane JP, 1999, VIRCHOWS ARCH, V434, P3; SLOANE JP, 1994, EUR J CANCER, V30A, P1414, DOI 10.1016/0959-8049(94)00261-3; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4	16	61	61	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 1	2008	336	7642					480	483		10.1136/bmj.39470.643218.94	http://dx.doi.org/10.1136/bmj.39470.643218.94			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274JL	18310003	Green Published			2022-12-24	WOS:000253997500039
J	Shaw, AD; Stafford-Smith, M; White, WD; Phillips-Bute, B; Swaminathan, M; Milano, C; Welsby, IJ; Aronson, S; Mathew, JP; Peterson, ED; Newman, MF				Shaw, Andrew D.; Stafford-Smith, Mark; White, William D.; Phillips-Bute, Barbara; Swaminathan, Madhav; Milano, Carmelo; Welsby, Ian J.; Aronson, Solomon; Mathew, Joseph P.; Peterson, Eric D.; Newman, Mark F.			The effect of aprotinin on outcome after coronary-artery bypass grafting.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC-SURGERY; TRANSFUSION; RISK	Background Aprotinin has recently been associated with adverse outcomes in patients undergoing cardiac surgery. We reviewed our experience with this agent in patients undergoing cardiac surgery at Duke University Medical Center. Methods We retrieved data on 10,275 consecutive patients undergoing surgical coronary revascularization at Duke between January 1, 1996, and December 31, 2005. We fit data to a logistic-regression model predicting each patient's likelihood of receiving aprotinin on the basis of preoperative characteristics and to models predicting long-term survival (up to 10 years) and decline in renal function, as measured by increases in serum creatinine levels. Results A total of 1343 patients (13.2%) received aprotinin, 6776 patients (66.8%) received aminocaproic acid, and 2029 patients (20.0%) received no antifibrinolytic therapy. All patients underwent coronary-artery bypass grafting, and 1181 patients (11.5%) underwent combined coronary-artery bypass grafting and valve surgery. In the risk-adjusted model, survival was worse among patients treated with aprotinin, with a main-effects hazard ratio for death of 1.32 (95% confidence interval [CI], 1.12 to 1.55) for the comparison with patients receiving no antifibrinolytic therapy (P=0.003) and 1.27 (95% CI, 1.10 to 1.46) for the comparison with patients receiving aminocaproic acid (P=0.004). As compared with the use of aminocaproic acid or no antifibrinolytic agent, aprotinin use was also associated with a larger risk-adjusted increase in the serum creatinine level (P<0.001) but not with a greater risk-adjusted incidence of dialysis (P=0.56). Conclusions Patients who received aprotinin had a higher mortality rate and larger increases in serum creatinine levels than those who received aminocaproic acid or no antifibrinolytic agent.	[Shaw, Andrew D.; Stafford-Smith, Mark; White, William D.; Phillips-Bute, Barbara; Swaminathan, Madhav; Welsby, Ian J.; Aronson, Solomon; Mathew, Joseph P.; Newman, Mark F.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27516 USA; [Milano, Carmelo] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27516 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27516 USA	Duke University; Duke University; Duke University	Shaw, AD (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27516 USA.	andrew.shaw@duke.edu	Peterson, Eric David/ABF-5033-2021	Swaminathan, Madhav/0000-0001-9136-8609; Mathew, Joseph/0000-0002-3815-4131; Shaw, Andrew/0000-0002-0566-8005; Welsby, Ian/0000-0002-2789-5612				Brown JR, 2007, CIRCULATION, V115, P2801, DOI 10.1161/CIRCULATIONAHA.106.671222; Chelemer SB, 2002, ANN THORAC SURG, V73, P138, DOI 10.1016/S0003-4975(01)03308-2; D'Agostino RB, 2007, CIRCULATION, V115, P2340, DOI 10.1161/CIRCULATIONAHA.105.594952; Dietrich W, 2007, ANN THORAC SURG, V84, P1144, DOI 10.1016/j.athoracsur.2007.05.015; Dietrich W, 2006, ANESTH ANALG, V103, P1074, DOI 10.1213/01.ane.0000238446.30034.c8; *FOOD DRUG ADM, 2007, FDA REQ MARK SUSP TR; Furnary AP, 2007, CIRCULATION, V116, pI127, DOI 10.1161/CIRCULATIONAHA.106.681395; Henry DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub2; Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.x; Kertai MD, 2007, J CARDIOVASC SURG, V48, P761; Mangano DT, 2007, JAMA-J AM MED ASSOC, V297, P471, DOI 10.1001/jama.297.5.471; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; MAZER CD, 2007, HEART SURG FORUM, V5, P10; PARSONNET V, 1989, CIRCULATION, V79, P3; PARSONNET V, 1990, CIRCULATION, V82, P1078; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROYSTON D, 1987, LANCET, V2, P1289; Sodha NR, 2007, DRUG SAFETY, V30, P731, DOI 10.2165/00002018-200730090-00001; Stover EP, 1998, ANESTHESIOLOGY, V88, P327, DOI 10.1097/00000542-199802000-00009; Van der Linden PJ, 2007, BRIT J ANAESTH, V99, P646, DOI 10.1093/bja/aem252	20	149	153	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2008	358	8					784	793		10.1056/NEJMoa0707768	http://dx.doi.org/10.1056/NEJMoa0707768			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	264AN	18287601	Bronze			2022-12-24	WOS:000253257700004
J	Zhang, CL; Zou, YH; He, WM; Gage, FH; Evans, RM				Zhang, Chun-Li; Zou, Yuhua; He, Weimin; Gage, Fred H.; Evans, Ronald M.			A role for adult TLX-positive neural stem cells in learning and behaviour	NATURE			English	Article							NUCLEAR RECEPTOR TLX; ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; TAILLESS GENE; MICE; MEMORY; MOUSE; PROLIFERATION	Neurogenesis persists in the adult brain and can be regulated by a plethora of external stimuli, such as learning, memory, exercise, environment and stress(1). Although newly generated neurons are able to migrate and preferentially incorporate into the neural network(2-5), how these cells are molecularly regulated and whether they are required for any normal brain function are unresolved questions(6). The adult neural stem cell pool is composed of orphan nuclear receptor TLX- positive cells(7). Here, using genetic approaches in mice, we demonstrate that TLX ( also called NR2E1) regulates adult neural stem cell proliferation in a cell- autonomous manner by controlling a defined genetic network implicated in cell proliferation and growth. Consequently, specific removal of TLX from the adult mouse brain through inducible recombination results in a significant reduction of stem cell proliferation and a marked decrement in spatial learning. In contrast, the resulting suppression of adult neurogenesis does not affect contextual fear conditioning, locomotion or diurnal rhythmic activities, indicating a more selective contribution of newly generated neurons to specific cognitive functions.	[Zhang, Chun-Li; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Zhang, Chun-Li; Zou, Yuhua; He, Weimin; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu; evans@salk.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965				Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Cho YH, 1999, BEHAV BRAIN RES, V98, P77; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; MONAGHAN AP, 1995, DEVELOPMENT, V121, P839; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Prickaerts J, 2004, NEUROBIOL LEARN MEM, V81, P1, DOI 10.1016/j.nlm.2003.09.001; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Roy K, 2002, PHYSIOL BEHAV, V77, P595, DOI 10.1016/S0031-9384(02)00902-2; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Whishaw IQ, 1996, PHYSIOL BEHAV, V60, P1191, DOI 10.1016/S0031-9384(96)00176-X; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Zhang CL, 2006, GENE DEV, V20, P1308, DOI 10.1101/gad.1413606	31	412	433	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2008	451	7181					1004	U7		10.1038/nature06562	http://dx.doi.org/10.1038/nature06562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18235445				2022-12-24	WOS:000253313100051
J	Chan, F; Barth, JA; Lubchenco, J; Kirincich, A; Weeks, H; Peterson, WT; Menge, BA				Chan, F.; Barth, J. A.; Lubchenco, J.; Kirincich, A.; Weeks, H.; Peterson, W. T.; Menge, B. A.			Emergence of anoxia in the California current large marine ecosystem	SCIENCE			English	Article							HYPOXIA		[Chan, F.; Lubchenco, J.; Menge, B. A.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Barth, J. A.; Kirincich, A.] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Weeks, H.] Oregon Dept Fish & Wildlife, Newport, OR 97365 USA; [Peterson, W. T.] Natl Ocean & Atmospher Adm, NW Fisheries Sci Ctr, Newport, OR 97365 USA	Oregon State University; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA	Chan, F (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	chanft@science.oregonstate.edu	Menge, Bruce/I-6571-2012	Kirincich, Anthony/0000-0001-7954-8543				Bakun A, 2004, ECOL LETT, V7, P1015, DOI 10.1111/j.1461-0248.2004.00665.x; Barth JA, 2007, P NATL ACAD SCI USA, V104, P3719, DOI 10.1073/pnas.0700462104; Childress JJ, 1998, J EXP BIOL, V201, P1223; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; McGregor HV, 2007, SCIENCE, V315, P637, DOI 10.1126/science.1134839; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0	8	393	404	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					920	920		10.1126/science.1149016	http://dx.doi.org/10.1126/science.1149016			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276882	Green Submitted			2022-12-24	WOS:000253165700036
J	Boldajipour, B; Mahabaleshwar, H; Kardash, E; Reichman-Fried, M; Blaser, H; Minina, S; Wilson, D; Xu, QL; Raz, E				Boldajipour, Bijan; Mahabaleshwar, Harsha; Kardash, Elena; Reichman-Fried, Michal; Blaser, Heiko; Minina, Sofia; Wilson, Duncan; Xu, Qiling; Raz, Erez			Control of chemokine-guided cell migration by ligand sequestration	CELL			English	Article							PRIMORDIAL GERM-CELLS; DROSOPHILA EMBRYO; RECEPTOR CXCR4; T-LYMPHOCYTES; ZEBRAFISH; CHEMOTAXIS; EXPRESSION; SDF-1; GENE; INFLAMMATION	Primordial germ cell (PGC) migration in zebrafish is directed by the chemokine SDF-1a that activates its receptor CXCR4b. Little is known about the molecular mechanisms controlling the distribution of this chemoattractant in vivo. We demonstrate that the activity of a second SDF-1/CXCL12 receptor, CXCR7, is crucial for proper migration of PGCs toward their targets. We show that CXCR7 functions primarily in the somatic environment rather than within the migrating cells. In CXCR7 knocked-down embryos, the PGCs exhibit a phenotype that signifies defects in SDF-1a gradient formation as the cells fail to polarize effectively and to migrate toward their targets. Indeed, somatic cells expressing CXCR7 show enhanced internalization of the chemokine suggesting that CXCR7 acts as a sink for SDF-1a, thus allowing the dynamic changes in the transcription of sdf-1a to be mirrored by similar dynamics at the protein level.	[Boldajipour, Bijan; Mahabaleshwar, Harsha; Kardash, Elena; Reichman-Fried, Michal; Raz, Erez] Ctt Mol Biol Inflammat, D-48149 Munster, Germany; [Minina, Sofia] Max Planck Inst Biophys Chem, Germ Cell Dev, D-37077 Gottingen, Germany; [Wilson, Duncan; Xu, Qiling] Natl Inst Med Res, Div Dev Biol, London NW7 1AA, England	Max Planck Society; MRC National Institute for Medical Research	Raz, E (corresponding author), Ctt Mol Biol Inflammat, Von Esmarch Str 56, D-48149 Munster, Germany.	erez.raz@uni-muenster.de		Boldajipour, Bijan/0000-0003-2065-555X; Kardash, Elena/0000-0002-7425-9862	MRC [MC_U117560481] Funding Source: UKRI; Medical Research Council [MC_U117560481] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; ANDREWS S, 2007, SCI STKE, pCM2; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; BERG HC, 1975, ANNU REV BIOPHYS BIO, V4, P119, DOI 10.1146/annurev.bb.04.060175.001003; Blaser H, 2005, J CELL SCI, V118, P4027, DOI 10.1242/jcs.02522; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Charest PG, 2006, CURR OPIN GENET DEV, V16, P339, DOI 10.1016/j.gde.2006.06.016; D Renault A, 2006, CURR OPIN GENET DEV, V16, P348, DOI 10.1016/j.gde.2006.06.015; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; De Klerck B, 2005, ARTHRITIS RES THER, V7, pR1208, DOI 10.1186/ar1806; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Franca-Koh J, 2006, CURR OPIN GENET DEV, V16, P333, DOI 10.1016/j.gde.2006.06.001; HANSELL C, 2007, SCI STKE, pPE18; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Koprunner M, 2001, GENE DEV, V15, P2877; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; Minina S, 2007, CURR BIOL, V17, P1164, DOI 10.1016/j.cub.2007.05.073; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Muller K, 2002, MECH DEVELOP, V117, P253, DOI 10.1016/S0925-4773(02)00174-0; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petty JM, 2007, J IMMUNOL, V178, P8148, DOI 10.4049/jimmunol.178.12.8148; Proost P, 2007, BLOOD, V110, P37, DOI 10.1182/blood-2006-10-049072; Raz E, 2006, CURR OPIN GENET DEV, V16, P355, DOI 10.1016/j.gde.2006.06.007; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; Renault AD, 2004, SCIENCE, V305, P1963, DOI 10.1126/science.1102421; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Vicente-Manzanares M, 1999, J IMMUNOL, V163, P4001; Weidinger G, 2002, DEVELOPMENT, V129, P25; Weidinger G, 1999, DEVELOPMENT, V126, P5295; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	46	484	500	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					463	473		10.1016/j.cell.2007.12.034	http://dx.doi.org/10.1016/j.cell.2007.12.034			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267076	Green Submitted, Bronze			2022-12-24	WOS:000253180700020
J	Yingling, J; Youn, YH; Darling, D; Toyo-Oka, K; Pramparo, T; Hirotsune, S; Wynshaw-Boris, A				Yingling, Jessica; Youn, Yong Ha; Darling, Dawn; Toyo-Oka, Kazuhito; Pramparo, Tiziano; Hirotsune, Shinji; Wynshaw-Boris, Anthony			Neuroepithelial stem cell proliferation requires LIS1 for precise spindle orientation and symmetric division	CELL			English	Article							LISSENCEPHALY GENE LIS1; ASYMMETRIC INHERITANCE; CYTOPLASMIC DYNEIN; PROTEIN; CRE; MICROTUBULES; CENTROSOME; EXPRESSION; MIGRATION; DYNACTIN	Mitotic spindle orientation and plane of cleavage in mammals is a determinant of whether division yields progenitor expansion and/or birth of new neurons during radial glial progenitor cell (RGPC) neurogenesis, but its role earlier in neuroepithelial stem cells is poorly understood. Here we report that Lis1 is essential for precise control of mitotic spindle orientation in both neuroepithelial stem cells and radial glial progenitor cells. Controlled gene deletion of Lis1 in vivo in neuroepithelial stem cells, where cleavage is uniformly vertical and symmetrical, provokes rapid apoptosis of those cells, while radial glial progenitors are less affected. Impaired cortical microtubule capture via loss of cortical dynein causes astral and cortical microtubules to be greatly reduced in Lis1-deficient cells. Increased expression of the LIS/dynein binding partner NDEL1 restores cortical microtubule and dynein localization in Lis1-deficient cells. Thus, control of symmetric division, essential for neuroepithelial stem cell proliferation, is mediated through spindle orientation determined via LIS1/NDEL1/dynein-mediated cortical microtubule capture.	[Yingling, Jessica; Youn, Yong Ha; Darling, Dawn; Pramparo, Tiziano; Wynshaw-Boris, Anthony] UCSD Sch Med, Dept Med, Ctr Human Genet & Genom, La Jolla, CA 92098 USA; [Yingling, Jessica] UCSD Sch Med, Biomed Sci Grad Program, La Jolla, CA 92098 USA; [Toyo-Oka, Kazuhito; Hirotsune, Shinji] Osaka City Univ, Grad Sch Med, Dept Genet Dis Res, Osaka 5458585, Japan; [Yingling, Jessica; Youn, Yong Ha; Darling, Dawn; Toyo-Oka, Kazuhito; Pramparo, Tiziano; Wynshaw-Boris, Anthony] UCSD Sch Med, Dept Pediat, Ctr Human Genet & Genom, La Jolla, CA 92098 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Osaka Metropolitan University; University of California System; University of California San Diego	Wynshaw-Boris, A (corresponding author), Univ Calif San Francisco, Sch Med, Dept Pediat, Inst Human Genet, 513 Parnassus Ave,HSE901F, San Francisco, CA 94143 USA.	wynshawborist@peds.ucsf.edu	Toyooka, Kazuhito/AAQ-6928-2020; Toyooka, Kazuhito/AAH-7175-2019	Toyooka, Kazuhito/0000-0002-0173-0430; Toyooka, Kazuhito/0000-0002-0173-0430	NICHD NIH HHS [R01 HD047380-03, R01 HD047380-01A1, R01 HD047380, HD047380, R01 HD047380-02] Funding Source: Medline; NINDS NIH HHS [R01 NS041030-01A2, R01 NS041030-05, R01 NS041030, R01 NS041030-06, NS041310, R01 NS041310, P30 NS047101, R01 NS041030-03, R01 NS041030-02, R01 NS041030-04] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041030, P30NS047101, R01NS041310] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chai Y, 2000, DEVELOPMENT, V127, P1671; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; Rehberg M, 2005, MOL BIOL CELL, V16, P2759, DOI 10.1091/mbc.E05-01-0069; Reilein A, 2005, NAT CELL BIOL, V7, P463, DOI 10.1038/ncb1248; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	43	212	215	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					474	486		10.1016/j.cell.2008.01.026	http://dx.doi.org/10.1016/j.cell.2008.01.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267077	Bronze, Green Accepted			2022-12-24	WOS:000253180700021
J	Karpova, TS; Kim, MJ; Spriet, C; Nalley, K; Stasevich, TJ; Kherrouche, Z; Heliot, L; McNally, JG				Karpova, Tatiana S.; Kim, Min J.; Spriet, Corentin; Nalley, Kip; Stasevich, Timothy J.; Kherrouche, Zoulika; Heliot, Laurent; McNally, James G.			Concurrent fast and slow cycling of a transcriptional activator at an endogenous promoter	SCIENCE			English	Article							IN-VIVO; RECEPTOR; DYNAMICS; RECRUITMENT; EXCHANGE; RSC; DNA	For gene regulation, some transcriptional activators bind periodically to promoters with either a fast (similar to 1 minute) or a slow (similar to 15 to 90 minutes) cycle. It is uncertain whether the fast cycle occurs on natural promoters, and the function of either cycle in transcription remains unclear. We report that fast and slow cycling can occur simultaneously on an endogenous yeast promoter and that slow cycling in this system reflects an oscillation in the fraction of accessible promoters rather than the recruitment and release of stably bound transcriptional activators. This observation, combined with single- cell measurements of messenger RNA ( mRNA) production, argues that fast cycling initiates transcription and that slow cycling regulates the quantity of mRNA produced. These findings counter the prevailing view that slow cycling initiates transcription.	[Karpova, Tatiana S.; Kim, Min J.; Nalley, Kip; Stasevich, Timothy J.; McNally, James G.] NCI, Ctr Canc Res, Core Imaging Facil, Lab Receptor Biol & Gene Express,NIH, Bethesda, MD 20892 USA; [Spriet, Corentin; Heliot, Laurent] Lille Univ Sci & Technol, Interdisciplinary Res Inst, CNRS, USR 3078, F-59021 Lille, France; [Kherrouche, Zoulika] Inst Pasteur, UMR 8161, Inst Biol Lille, F-59021 Lille, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	McNally, JG (corresponding author), NCI, Ctr Canc Res, Core Imaging Facil, Lab Receptor Biol & Gene Express,NIH, 41 Lib Dr, Bethesda, MD 20892 USA.	mcnallyj@exchange.nih.gov	KHERROUCHE, Zoulika/L-6549-2019; Spriet, Corentin/ABE-4215-2021; KHERROUCHE, Zoulika/HHN-0213-2022	Spriet, Corentin/0000-0002-5805-3426; Karpova, Tatiana/0000-0001-6025-2128	NATIONAL CANCER INSTITUTE [Z01BC010561, ZIABC010561] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Barrow J, 2006, FEBS LETT, V580, P711, DOI 10.1016/j.febslet.2005.12.061; Belmont AS, 1998, TRENDS CELL BIOL, V8, P121, DOI 10.1016/S0962-8924(97)01211-7; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Bullitt E, 1997, CELL, V89, P1077, DOI 10.1016/S0092-8674(00)80295-0; Burakov D, 2002, J BIOL CHEM, V277, P14359, DOI 10.1074/jbc.C200099200; Fowler Amy M, 2004, Sci STKE, V2004, ppe51, DOI 10.1126/stke.2562004pe51; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Karpova TS, 2004, EMBO REP, V5, P1064, DOI 10.1038/sj.embor.7400281; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; WELCH JW, 1983, MOL CELL BIOL, V3, P1353, DOI 10.1128/MCB.3.8.1353; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	22	113	115	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					466	469		10.1126/science.1150559	http://dx.doi.org/10.1126/science.1150559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218898				2022-12-24	WOS:000252576600039
J	Hart, JT				Hart, Julian Tudor			A few lessons in screening for Gordon Brown	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												julian@tudorhart.freeserve.co.uk						HART JT, 1991, BMJ-BRIT MED J, V302, P1509, DOI 10.1136/bmj.302.6791.1509; 2008, BMJ, V336, P62	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2008	336	7636					123	123		10.1136/bmj.39461.502581.59	http://dx.doi.org/10.1136/bmj.39461.502581.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257SS	18202064	Green Published			2022-12-24	WOS:000252819400027
J	Takacs, CM; Baird, JR; Hughes, EG; Kent, SS; Benchabane, H; Paik, R; Ahmed, Y				Takacs, Carter M.; Baird, Jason R.; Hughes, Edward G.; Kent, Sierra S.; Benchabane, Hassina; Paik, Raehum; Ahmed, Yashi			Dual positive and negative regulation of Wingless signaling by adenomatous polyposis coli	SCIENCE			English	Article							TUMOR-SUPPRESSOR PROTEIN; CATENIN-TCF COMPLEX; BETA-CATENIN; DROSOPHILA APC2; AXIN; ARMADILLO; PATHWAY; HOMOLOG; ACTIVATION; MUTATION	Understanding cancer pathogenesis requires knowledge of not only the specific contributory genetic mutations but also the cellular framework in which they arise and function. Here we explore the clonal evolution of a form of childhood precursor- B cell acute lymphoblastic leukemia that is characterized by a chromosomal translocation generating a TEL- AML1 fusion gene. We identify a cell compartment in leukemic children that can propagate leukemia when transplanted in mice. By studying a monochorionic twin pair, one preleukemic and one with frank leukemia, we establish the lineal relationship between these "cancer- propagating" cells and the preleukemic cell in which the TEL- AML1 fusion first arises or has functional impact. Analysis of TEL- AML1- transduced cord blood cells suggests that TEL- AML1 functions as a first- hit mutation by endowing this preleukemic cell with altered self- renewal and survival properties.	[Takacs, Carter M.; Baird, Jason R.; Hughes, Edward G.; Kent, Sierra S.; Benchabane, Hassina; Paik, Raehum; Ahmed, Yashi] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Takacs, Carter M.; Baird, Jason R.; Hughes, Edward G.; Kent, Sierra S.; Benchabane, Hassina; Paik, Raehum; Ahmed, Yashi] Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Ahmed, Y (corresponding author), Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA.	yfa@dartmouth.edu			NATIONAL CANCER INSTITUTE [R01CA105038, K08CA078532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122222] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA105038, KO8CA078532, R01 CA105038] Funding Source: Medline; NIGMS NIH HHS [R01 GM122222] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ahmed Y, 1998, CELL, V93, P1171, DOI 10.1016/S0092-8674(00)81461-0; Ahmed Y, 2002, DEVELOPMENT, V129, P1751; Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; BAKER NE, 1988, DEVELOPMENT, V102, P489; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hayashi S, 1997, P NATL ACAD SCI USA, V94, P242, DOI 10.1073/pnas.94.1.242; Hoier EF, 2000, GENE DEV, V14, P874; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; McCartney BM, 2006, DEVELOPMENT, V133, P2407, DOI 10.1242/dev.02398; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; PEIFER M, 1991, DEVELOPMENT, V111, P1029; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; SHARMA RP, 1976, DEV BIOL, V48, P461, DOI 10.1016/0012-1606(76)90108-1; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; Vleminckx K, 1997, J CELL BIOL, V136, P411, DOI 10.1083/jcb.136.2.411; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Yu X, 1999, NAT CELL BIOL, V1, P144, DOI 10.1038/11064	36	47	50	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					333	336		10.1126/science.1151232	http://dx.doi.org/10.1126/science.1151232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202290				2022-12-24	WOS:000252436200039
J	Allen, KJ; Gurrin, LC; Constantine, CC; Osborne, NJ; Delatycki, MB; Nicoll, AJ; McLaren, CE; Bahlo, M; Nisselle, AE; Vulpe, CD; Anderson, GJ; Southey, MC; Giles, GG; English, DR; Hopper, JL; Olynyk, JK; Powell, LW; Gertig, DM				Allen, Katrina J.; Gurrin, Lyle C.; Constantine, Clare C.; Osborne, Nicholas J.; Delatycki, Martin B.; Nicoll, Amanda J.; McLaren, Christine E.; Bahlo, Melanie; Nisselle, Amy E.; Vulpe, Chris D.; Anderson, Gregory J.; Southey, Melissa C.; Giles, Graham G.; English, Dallas R.; Hopper, John L.; Olynyk, John K.; Powell, Lawrie W.; Gertig, Dorota M.			Iron-overload-related disease in HFE hereditary hemochromatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL EXPRESSION; AFRICAN-AMERICANS; POPULATION; ASSOCIATION; MANAGEMENT; DIAGNOSIS; MUTATION; FIBROSIS	Background: Most persons who are homozygous for C282Y, the HFE allele most commonly asssociated with hereditary hemochromatosis, have elevated levels of serum ferritin and transferrin saturation. Diseases related to iron overload develop in some C282Y homozygotes, but the extent of the risk is controversial. Methods: We assessed HFE mutations in 31,192 persons of northern European descent between the ages of 40 and 69 years who participated in the Melbourne Collaborative Cohort Study and were followed for an average of 12 years. In a random sample of 1438 subjects stratified according to HFE genotype, including all 203 C282Y homozygotes (of whom 108 were women and 95 were men), we obtained clinical and biochemical data, including two sets of iron measurements performed 12 years apart. Disease related to iron overload was defined as documented iron overload and one or more of the following conditions: cirrhosis, liver fibrosis, hepatocellular carcinoma, elevated aminotransferase levels, physician-diagnosed symptomatic hemochromatosis, and arthropathy of the second and third metacarpophalangeal joints. Results: The proportion of C282Y homozygotes with documented iron-overload-related disease was 28.4% (95% confidence interval [CI], 18.8 to 40.2) for men and 1.2% (95% CI, 0.03 to 6.5) for women. Only one non-C282Y homozygote (a compound heterozygote) had documented iron-overload-related disease. Male C282Y homozygotes with a serum ferritin level of 1000 microg per liter or more were more likely to report fatigue, use of arthritis medicine, and a history of liver disease than were men who had the wild-type gene. Conclusions: In persons who are homozygous for the C282Y mutation, iron-overload-related disease developed in a substantial proportion of men but in a small proportion of women.	[Allen, Katrina J.; Osborne, Nicholas J.; Delatycki, Martin B.; Nisselle, Amy E.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Gurrin, Lyle C.; Constantine, Clare C.; Osborne, Nicholas J.; Giles, Graham G.; English, Dallas R.; Hopper, John L.; Gertig, Dorota M.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Allen, Katrina J.; Delatycki, Martin B.; Nisselle, Amy E.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Nicoll, Amanda J.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Anderson, Gregory J.; Powell, Lawrie W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Anderson, Gregory J.; Powell, Lawrie W.] Univ Queensland, Brisbane, Qld, Australia; [Giles, Graham G.; English, Dallas R.] Canc Council Victoria, Melbourne, Vic, Australia; [Olynyk, John K.] Univ Western Australia, Perth, WA 6009, Australia; [Olynyk, John K.] Western Australian Inst Med Res, Perth, WA, Australia; [McLaren, Christine E.] Univ Calif Irvine, Irvine, CA USA; [Vulpe, Chris D.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; QIMR Berghofer Medical Research Institute; University of Queensland; Cancer Council Victoria; University of Western Australia; University of Western Australia; University of California System; University of California Irvine; University of California System; University of California Berkeley	Allen, KJ (corresponding author), Royal Childrens Hosp, Dept Gastroenterol, Flemington Rd, Parkville, Vic 3052, Australia.	katie.allen@rch.org.au	Vulpe, Chris/AAF-9170-2020; Anderson, Gregory J/G-4148-2013; Osborne, Nicholas/D-2086-2011; Allen, Katrina/I-4361-2018; Gertig, Dorota/Z-1087-2019; , Amy/M-3622-2019; Delatycki, Martin B/A-5409-2013; English, Dallas/AAH-5005-2019	Vulpe, Chris/0000-0001-5134-8929; Anderson, Gregory J/0000-0002-8814-5866; Osborne, Nicholas/0000-0002-6700-2284; Allen, Katrina/0000-0002-1921-4493; , Amy/0000-0002-8908-5906; English, Dallas/0000-0001-7828-8188; Nicoll, Amanda/0000-0002-1855-2757; Southey, Melissa/0000-0002-6313-9005; Giles, Graham/0000-0003-4946-9099; Bahlo, Melanie/0000-0001-5132-0774; Olynyk, John/0000-0003-0417-3411; Gurrin, Lyle/0000-0001-7052-1969	NIDDK NIH HHS [1-RO1-DK061885-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061885] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams P, 2000, J HEPATOL, V33, P487, DOI 10.1016/S0168-8278(01)80874-6; Adams PC, 2007, LANCET, V370, P1855, DOI 10.1016/S0140-6736(07)61782-6; Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Ajioka RS, 2003, BLOOD, V101, P3351, DOI 10.1182/blood-2002-11-3453; Allen KJ, 2002, LANCET, V360, P412, DOI 10.1016/S0140-6736(02)09583-1; Andersen RV, 2004, BLOOD, V103, P2914, DOI 10.1182/blood-2003-10-3564; Barton JC, 2005, BLOOD CELL MOL DIS, V34, P38, DOI 10.1016/j.bcmd.2004.08.022; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Beutler E, 2003, BLOOD CELL MOL DIS, V31, P305, DOI 10.1016/S1079-9796(03)00165-7; Bulaj ZJ, 2000, NEW ENGL J MED, V343, P1529, DOI 10.1056/NEJM200011233432104; Delatycki MB, 2005, LANCET, V366, P314, DOI 10.1016/S0140-6736(05)63012-7; EDWARDS CQ, 1993, NEW ENGL J MED, V328, P1616; Falize L, 2006, HEPATOLOGY, V44, P472, DOI 10.1002/hep.21260; Giles G G, 2002, IARC Sci Publ, V156, P69; Gochee PA, 2002, GASTROENTEROLOGY, V122, P646, DOI 10.1016/S0016-5085(02)80116-0; Gochee PA, 2002, GASTROENTEROLOGY, V122, P1191; Guyader D, 1998, GASTROENTEROLOGY, V115, P929, DOI 10.1016/S0016-5085(98)70265-3; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Olynyk JK, 2004, MAYO CLIN PROC, V79, P309, DOI 10.4065/79.3.309; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietrangelo A, 2006, ANNU REV NUTR, V26, P251, DOI 10.1146/annurev.nutr.26.061505.111226; Powell LW, 2006, ARCH INTERN MED, V166, P294, DOI 10.1001/archinte.166.3.294; River CA, 2007, BLOOD CELL MOL DIS, V38, P247, DOI 10.1016/j.bcmd.2006.12.002; Tavill AS, 2001, HEPATOLOGY, V33, P1321, DOI 10.1053/jhep.2001.24783; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009; Worwood M, 2005, BLOOD REV, V19, P69, DOI 10.1016/j.blre.2004.03.003	27	485	502	2	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2008	358	3					221	230		10.1056/NEJMoa073286	http://dx.doi.org/10.1056/NEJMoa073286			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251LS	18199861				2022-12-24	WOS:000252375600003
J	Deana, A; Celesnik, H; Belasco, JG				Deana, Atilio; Celesnik, Helena; Belasco, Joel G.			The bacterial enzyme RppH triggers messenger RNA degradation by 5' pyrophosphate removal	NATURE			English	Article							ESCHERICHIA-COLI K1; NUDIX HYDROLASE; RIBOSOMAL PROTEIN-S20; RIBONUCLEASE-E; STEM-LOOP; IN-VIVO; GENE; CLEAVAGE; STABILIZATION; ABILITY	The long- standing assumption that messenger RNA ( mRNA) degradation in Escherichia coli begins with endonucleolytic cleavage has been challenged by the recent discovery that RNA decay can be triggered by a prior non- nucleolytic event that marks transcripts for rapid turnover: the rate- determining conversion of the 5' terminus from a triphosphate to a monophosphate(1). This modification creates better substrates for the endonuclease RNase E, whose cleavage activity at internal sites is greatly enhanced when the RNA 5' end is monophosphorylated(2,3). Moreover, it suggests an explanation for the influence of 5' termini on the endonucleolytic cleavage of primary transcripts, which are triphosphorylated(4-) (8). However, no enzyme capable of removing pyrophosphate from RNA 5' ends has been identified in any bacterial species. Here we show that the E. coli protein RppH ( formerly NudH/Y gdP) is the RNA pyrophosphohydrolase that initiates mRNA decay by this 5'- end- dependent pathway. In vitro, RppH efficiently removes pyrophosphate from the 5' end of triphosphorylated RNA, irrespective of the identity of the 5'- terminal nucleotide. In vivo, it accelerates the degradation of hundreds of E. coli transcripts by converting their triphosphorylated 5' ends to a more labile mono-phosphorylated state that can stimulate subsequent ribonuclease cleavage. That the action of the pyrophosphohydrolase is impeded when the 5' end is structurally sequestered by a stem- loop helps to explain the stabilizing influence of 5'- terminal base pairing on mRNA lifetimes. Together, these findings suggest a possible basis for the effect of RppH and its orthologues on the invasiveness of bacterial pathogens. Interestingly, this master regulator of 5'- end-dependent mRNA degradation in E. coli not only catalyses a process functionally reminiscent of eukaryotic mRNA decapping but also bears an evolutionary relationship to the eukaryotic decapping enzyme Dcp2.	[Deana, Atilio; Celesnik, Helena; Belasco, Joel G.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Deana, Atilio; Celesnik, Helena; Belasco, Joel G.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University	Belasco, JG (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA.	belasco@saturn.med.nyu.edu		Deana, Atilio/0000-0003-1804-1823	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035769] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM035769] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold TE, 1998, RNA, V4, P319; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Badger JL, 2000, MOL MICROBIOL, V36, P174, DOI 10.1046/j.1365-2958.2000.01840.x; Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Bessman MJ, 2001, J BIOL CHEM, V276, P37834; BOUVET P, 1992, NATURE, V360, P488, DOI 10.1038/360488a0; Bricker AL, 1999, J BACTERIOL, V181, P3587, DOI 10.1128/JB.181.11.3587-3590.1999; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Coleman TM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh007; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Edelstein PH, 2005, INFECT IMMUN, V73, P6567, DOI 10.1128/IAI.73.10.6567-6576.2005; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; Feng YN, 2000, P NATL ACAD SCI USA, V97, P6415, DOI 10.1073/pnas.120173797; Ismail TM, 2003, J BIOL CHEM, V278, P32602, DOI 10.1074/jbc.M305994200; Jiang XQ, 2004, P NATL ACAD SCI USA, V101, P9211, DOI 10.1073/pnas.0401382101; Jiang XQ, 2000, J BACTERIOL, V182, P2468, DOI 10.1128/JB.182.9.2468-2475.2000; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; MACKIE GA, 1992, J BIOL CHEM, V267, P1054; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; MACKIE GA, 1991, J BACTERIOL, V173, P2488, DOI 10.1128/jb.173.8.2488-2497.1991; MACKIE GA, 1983, J BIOL CHEM, V258, P7840; Mackie GA, 2000, J BIOL CHEM, V275, P25069, DOI 10.1074/jbc.C000363200; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Ow MC, 2003, MOL MICROBIOL, V49, P607, DOI 10.1046/j.1365-2958.2003.03587.x; Tock MR, 2000, J BIOL CHEM, V275, P8726, DOI 10.1074/jbc.275.12.8726; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599	31	302	309	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					355	U14		10.1038/nature06475	http://dx.doi.org/10.1038/nature06475			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202662				2022-12-24	WOS:000252432100054
J	Mendez-Ferrer, S; Lucas, D; Battista, M; Frenette, PS				Mendez-Ferrer, Simon; Lucas, Daniel; Battista, Michela; Frenette, Paul S.			Haematopoietic stem cell release is regulated by circadian oscillations	NATURE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; MYELOID PROGENITOR CELLS; BONE-MARROW; TARGETED DISRUPTION; PROTEIN-KINASE; STROMAL CELLS; RECEPTOR GENE; E-SELECTIN; MOBILIZATION; NICHE	Haematopoietic stem cells ( HSCs) circulate in the bloodstream under steady- state conditions, but the mechanisms controlling their physiological trafficking are unknown. Here we show that circulating HSCs and their progenitors exhibit robust circadian fluctuations, peaking 5 h after the initiation of light and reaching a nadir 5 h after darkness. Circadian oscillations are markedly altered when mice are subjected to continuous light or to a 'jet lag' ( defined as a shift of 12 h). Circulating HSCs and their progenitors fluctuate in antiphase with the expression of the chemokine CXCL12 in the bone marrow microenvironment. The cyclical release of HSCs and expression of Cxcl12 are regulated by core genes of the molecular clock through circadian noradrenaline secretion by the sympathetic nervous system. These adrenergic signals are locally delivered by nerves in the bone marrow, transmitted to stromal cells by the beta(3)- adrenergic receptor, leading to a decreased nuclear content of Sp1 transcription factor and the rapid downregulation of Cxcl12. These data indicate that a circadian, neurally driven release of HSC during the animal's resting period may promote the regeneration of the stem cell niche and possibly other tissues.	[Mendez-Ferrer, Simon; Lucas, Daniel; Battista, Michela; Frenette, Paul S.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Mendez-Ferrer, Simon; Lucas, Daniel; Battista, Michela; Frenette, Paul S.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Frenette, Paul S.] Black Family Stem Cell Inst, New York, NY 10029 USA; [Frenette, Paul S.] Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Frenette, PS (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	paul.frenette@mssm.edu	Lucas, Daniel/ABB-6893-2021; Frenette, Paul S/J-8272-2012; Méndez-Ferrer, Simón/L-8088-2014; Méndez-Ferrer, Simón/ABG-8547-2020	Lucas, Daniel/0000-0002-0147-5425; Frenette, Paul S/0000-0003-0862-9922; Méndez-Ferrer, Simón/0000-0002-9805-9988; Méndez-Ferrer, Simón/0000-0002-9805-9988				Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arraj M, 2006, CHRONOBIOL INT, V23, P795, DOI 10.1080/07420520600827111; Benestad HB, 1998, BLOOD, V91, P1280, DOI 10.1182/blood.V91.4.1280; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Garcia-Moruja C, 2005, J MOL BIOL, V348, P43, DOI 10.1016/j.jmb.2005.02.016; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Katayama Y, 2004, BLOOD, V104, P2020, DOI 10.1182/blood-2003-12-4157; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Katayama Y, 2003, IMMUNITY, V18, P789, DOI 10.1016/S1074-7613(03)00150-X; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Maestroni GJM, 1998, EXP HEMATOL, V26, P1172; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Rohlff C, 1997, J BIOL CHEM, V272, P21137, DOI 10.1074/jbc.272.34.21137; ROSS DD, 1980, EXP HEMATOL, V8, P954; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Soeder KJ, 1999, J BIOL CHEM, V274, P12017, DOI 10.1074/jbc.274.17.12017; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; Thomas J, 2002, CURR OPIN HEMATOL, V9, P183, DOI 10.1097/00062752-200205000-00002; VERMA DS, 1980, AM J HEMATOL, V9, P185, DOI 10.1002/ajh.2830090206; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; YAMAZAKI K, 1990, AM J ANAT, V187, P261, DOI 10.1002/aja.1001870306; Ye XB, 2002, J BIOL CHEM, V277, P31863, DOI 10.1074/jbc.M205544200; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	48	892	916	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2008	452	7186					442	U4		10.1038/nature06685	http://dx.doi.org/10.1038/nature06685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18256599				2022-12-24	WOS:000254341300025
J	Ruggenenti, P; Remuzzi, A; Remuzzi, G				Ruggenenti, Piero; Remuzzi, Andrea; Remuzzi, Giuseppe			Decision time for pancreatic islet-cell transplantation	LANCET			English	Editorial Material							MICE		[Ruggenenti, Piero; Remuzzi, Andrea; Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy; [Ruggenenti, Piero; Remuzzi, Giuseppe] Azienda Osped Osped Riuniti, Dept Transplant Med, Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy.	gremuzzi@marionegri.it	Remuzzi, Giuseppe/V-9766-2017; Remuzzi, Andrea/F-2409-2015	Remuzzi, Giuseppe/0000-0002-6194-3446; Remuzzi, Andrea/0000-0002-4301-8927				Amer Diabet Assoc, 2006, DIABETES CARE, V29, P935; Bromberg JS, 2007, AM J TRANSPLANT, V7, P2217, DOI 10.1111/j.1600-6143.2007.01957.x; Campbell PM, 2007, AM J TRANSPLANT, V7, P2311, DOI 10.1111/j.1600-6143.2007.01923.x; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Martina Y, 2006, J VIROL, V80, P3135, DOI 10.1128/JVI.80.7.3135-3146.2006; Matas AJ, 2005, AM J TRANSPLANT, V5, P2473, DOI 10.1111/j.1600-6143.2005.01051.x; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Rajotte RV, 2007, XENOTRANSPLANTATION, V14, P446; Senior PA, 2007, AM J TRANSPLANT, V7, P91, DOI 10.1111/j.1600-6143.2006.01573.x; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; *SYS CON MED, 2007, LIV CELL TECHN ANN 1	11	14	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2008	371	9616					883	884		10.1016/S0140-6736(08)60395-5	http://dx.doi.org/10.1016/S0140-6736(08)60395-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342671				2022-12-24	WOS:000254056800010
J	Poxleitner, MK; Carpenter, ML; Mancuso, JJ; Wang, CJR; Dawson, SC; Cande, WZ				Poxleitner, Marianne K.; Carpenter, Meredith L.; Mancuso, Joel J.; Wang, Chung-Ju R.; Dawson, Scott C.; Cande, W. Zacheus			Evidence for karyogamy and exchange of genetic material in the binucleate intestinal parasite Giardia intestinalis	SCIENCE			English	Article							2 NUCLEI; LAMBLIA; CYTOKINESIS; CHROMOSOMES; MEIOSIS; GENOME	The diplomonad parasite Giardia intestinalis contains two functionally equivalent nuclei that are inherited independently during mitosis. Although presumed to be asexual, Giardia has low levels of allelic heterozygosity, indicating that the two nuclear genomes may exchange genetic material. Fluorescence in situ hybridization performed with probes to an episomal plasmid suggests that plasmids are transferred between nuclei in the cyst, and transmission electron micrographs demonstrate fusion between cyst nuclei. Green fluorescent protein fusions of giardial homologs of meiosis- specific genes localized to the nuclei of cysts, but not the vegetative trophozoite. These data suggest that the fusion of nuclei, or karyogamy, and subsequently somatic homologous recombination facilitated by the meiosis gene homologs, occur in the giardial cyst.	[Poxleitner, Marianne K.; Carpenter, Meredith L.; Mancuso, Joel J.; Wang, Chung-Ju R.; Cande, W. Zacheus] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Dawson, Scott C.] Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA	University of California System; University of California Berkeley; University of California System; University of California Davis	Cande, WZ (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	zcande@berkeley.edu	Carpenter, Meredith/B-4290-2011; Wang, Chung-Ju Rachel/ABH-1022-2020	Wang, Chung-Ju Rachel/0000-0002-1046-3012; Carpenter, Meredith/0000-0002-9798-9374; Dawson, Scott/0000-0002-0843-1759	NIGMS NIH HHS [1F32GM078971] Funding Source: Medline; PHS HHS [A1054693] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078971] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM RD, 1988, NUCLEIC ACIDS RES, V16, P4555, DOI 10.1093/nar/16.10.4555; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Bernander R, 2001, CELL MICROBIOL, V3, P55, DOI 10.1046/j.1462-5822.2001.00094.x; Birky CW, 1996, GENETICS, V144, P427; Cooper MA, 2007, CURR BIOL, V17, P1984, DOI 10.1016/j.cub.2007.10.020; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; KABNICK KS, 1990, J CELL SCI, V95, P353; Kondrashov AS, 1997, ANNU REV ECOL SYST, V28, P391, DOI 10.1146/annurev.ecolsys.28.1.391; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; REINER DS, 1989, INFECT IMMUN, V57, P963, DOI 10.1128/IAI.57.3.963-968.1989; Sagolla MS, 2006, J CELL SCI, V119, P4889, DOI 10.1242/jcs.03276; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Teodorovic S, 2007, EUKARYOT CELL, V6, P1421, DOI 10.1128/EC.00138-07; Villeneuve AM, 2001, CELL, V106, P647, DOI 10.1016/S0092-8674(01)00500-1; Yu LZ, 2002, EUKARYOT CELL, V1, P191, DOI 10.1128/EC.1.2.191-199.2002	16	124	124	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1530	1533		10.1126/science.1153752	http://dx.doi.org/10.1126/science.1153752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339940				2022-12-24	WOS:000253943800040
J	Vaughn, D; Strathmann, RR				Vaughn, Dawn; Strathmann, Richard R.			Predators induce cloning in echinoderm larvae	SCIENCE			English	Article							SIZE; REPRODUCTION		[Vaughn, Dawn; Strathmann, Richard R.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA	University of Washington	Vaughn, D (corresponding author), Univ Washington, Friday Harbor Labs, 620 Univ Rd, Friday Harbor, WA 98250 USA.	dvaughn@u.washington.edu						Allen JD, 2008, BIOL BULL-US, V214, P42, DOI 10.2307/25066658; Eaves AA, 2003, NATURE, V425, P146, DOI 10.1038/425146a; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; JAECKLE WB, 1994, BIOL BULL, V186, P62, DOI 10.2307/1542036; LITVAK MK, 1992, MAR ECOL PROG SER, V81, P13, DOI 10.3354/meps081013; Suchman CL, 2000, J PLANKTON RES, V22, P2289, DOI 10.1093/plankt/22.12.2289; Vickery MS, 2000, BIOL BULL, V199, P298, DOI 10.2307/1543186	7	39	39	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1503	1503		10.1126/science.1151995	http://dx.doi.org/10.1126/science.1151995			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339931				2022-12-24	WOS:000253943800030
J	Yi, R; Poy, MN; Stoffel, M; Fuchs, E				Yi, Rui; Poy, Matthew N.; Stoffel, Markus; Fuchs, Elaine			A skin microRNA promotes differentiation by repressing 'stemness'	NATURE			English	Article							GENE-EXPRESSION; P53 HOMOLOG; IN-VIVO; P63; KERATINOCYTE; CELLS; PROLIFERATION; MORPHOGENESIS; COMMITMENT; ZEBRAFISH	In stratified epithelial tissues, homeostasis relies on the self-renewing capacity of stem cells located within the innermost basal layer(1). As basal cells become suprabasal, they lose proliferative potential and embark on a terminal differentiation programme(2,3). Here, we show that microRNA- 203 is induced in the skin concomitantly with stratification and differentiation. By alteringmiR- 203' s spatiotemporal expression in vivo, we show that miR- 203 promotes epidermal differentiation by restricting proliferative potential and inducing cell- cycle exit. We identify p63 as one of the conserved targets of miR- 203 across vertebrates. Notably, p63 is an essential regulator of stem- cell maintenance in stratified epithelial tissues(4-9). We show that miR- 203 directly represses the expression of p63: it fails to switch off suprabasally when either Dicer1 or miR- 203 is absent and it becomes repressed basally when miR- 203 is prematurely expressed. Our findings suggest that miR- 203 defines a molecular boundary between proliferative basal progenitors and terminally differentiating suprabasal cells, ensuring proper identity of neighbouring layers.	[Yi, Rui; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Yi, Rui; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Poy, Matthew N.; Stoffel, Markus] ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Poy, Matthew/F-6914-2017; Fuchs, Elaine/G-1565-2016	Poy, Matthew/0000-0002-4904-2426; YI, RUI/0000-0002-6934-7091; Stoffel, Markus/0000-0003-1304-5817	Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [R01 AR050452] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Davis S, 2006, NUCLEIC ACIDS RES, V34, P2294, DOI 10.1093/nar/gkl183; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	30	601	642	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					225	U69		10.1038/nature06642	http://dx.doi.org/10.1038/nature06642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18311128	Green Accepted			2022-12-24	WOS:000253925600042
J	Unger, RH				Unger, Roger H.			Reinventing type 2 diabetes - Pathogenesis, treatment, and prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSULIN-RESISTANCE; METABOLIC SYNDROME; UNITED-STATES; OBESITY; MELLITUS; SENSITIVITY; DISEASE		Univ Texas SW Med Ctr Dallas, Touchstone Ctr Diabet Res, Dallas, TX 75390 USA; Vet Affairs Med Ctr, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Unger, RH (corresponding author), Univ Texas SW Med Ctr Dallas, Touchstone Ctr Diabet Res, 5323 Harry Hines Blvd,L5-202, Dallas, TX 75390 USA.	roger.unger@utsouthwestern.edu						Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P80; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Eaton Danice K., 2006, Morbidity and Mortality Weekly Report, V55, P1; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; MERIMEE TJ, 1971, NEW ENGL J MED, V285, P856, DOI 10.1056/NEJM197110072851511; Nauck MA, 2007, DIABETOLOGIA, V50, P259, DOI 10.1007/s00125-006-0510-2; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; RANDLE PJ, 1963, LANCET, V1, P785; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REAVEN GM, 1984, DIABETES CARE, V7, P17; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; SHERWIN RS, 1974, J CLIN INVEST, V53, P1481, DOI 10.1172/JCI107697; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; YALOW RS, 1960, J CLIN INVEST, V39, P1157, DOI 10.1172/JCI104130	20	77	84	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2008	299	10					1185	1187		10.1001/jama.299.10.1185	http://dx.doi.org/10.1001/jama.299.10.1185			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272CE	18334695				2022-12-24	WOS:000253835000023
J	Capadona, JR; Shanmuganathan, K; Tyler, DJ; Rowan, SJ; Weder, C				Capadona, Jeffrey R.; Shanmuganathan, Kadhiravan; Tyler, Dustin J.; Rowan, Stuart J.; Weder, Christoph			Stimuli-responsive polymer nanocomposites inspired by the sea cucumber dermis	SCIENCE			English	Article							TUNICATE CELLULOSE WHISKERS; MUTABLE COLLAGENOUS TISSUE; COMPOSITE; VISCOSITY; NETWORK; DEVICES	Generation, investigation, and manipulation of nanostructured materials are of fundamental and practical importance for several disciplines, including materials science and medicine. Recently, atmospheric new particle formation in the nanometer- size range has been found to be a global phenomenon. Still, its detailed mechanisms are mostly unknown, largely depending on the incapability to generate and measure nanoparticles in a controlled way. In our experiments, an organic vapor ( n- propanol) condenses on molecular ions, as well as on charged and uncharged inorganic nanoparticles, via initial activation by heterogeneous nucleation. We found a smooth transition in activation behavior as a function of size and activation to occur well before the onset of homogeneous nucleation. Furthermore, nucleation enhancement for charged particles and a substantial negative sign preference were quantitatively detected.	[Capadona, Jeffrey R.; Shanmuganathan, Kadhiravan; Rowan, Stuart J.; Weder, Christoph] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA; [Capadona, Jeffrey R.; Tyler, Dustin J.; Rowan, Stuart J.; Weder, Christoph] Louis Stokes Cleveland DVA Med Ctr, Cleveland, OH 44106 USA; [Capadona, Jeffrey R.; Tyler, Dustin J.; Rowan, Stuart J.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Rowan, Stuart J.; Weder, Christoph] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University	Rowan, SJ (corresponding author), Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA.	stuart.rowan@case.edu; christoph.weder@case.edu	Shanmuganathan, Kadhiravan/AFV-0951-2022; Tyler, Dustin J/C-7995-2015; Weder, Christoph/K-7453-2012; Tyler, Dustin/AAB-4164-2019; Capadona, Jeffrey R/G-4772-2010	Shanmuganathan, Kadhiravan/0000-0001-8062-6684; Tyler, Dustin J/0000-0002-2298-8510; Tyler, Dustin/0000-0002-2298-8510; Weder, Christoph/0000-0001-7183-1790; Rowan, Stuart/0000-0001-8176-0594	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053798] Funding Source: NIH RePORTER; NINDS NIH HHS [R21 NS053798-02, R21 NS053798] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELTON PS, 1989, MACROMOLECULES, V22, P1615, DOI 10.1021/ma00194a019; Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138; Capadona JR, 2007, NAT NANOTECHNOL, V2, P765, DOI 10.1038/nnano.2007.379; Grunlan JC, 2006, NANO LETT, V6, P911, DOI 10.1021/nl052486t; Hajji P, 1996, POLYM COMPOSITE, V17, P612, DOI 10.1002/pc.10651; HALPIN JC, 1972, J APPL PHYS, V43, P2235, DOI 10.1063/1.1661482; Heinzeller T, 2004, ECHINODERMS; Jaber JA, 2006, J AM CHEM SOC, V128, P2940, DOI 10.1021/ja055892n; Kunzelman J, 2007, J MATER CHEM, V17, P2989, DOI 10.1039/b705880b; Lima MMD, 2004, MACROMOL RAPID COMM, V25, P771, DOI 10.1002/marc.200300268; Loveless DM, 2007, J MATER CHEM, V17, P56, DOI 10.1039/b614026b; MOTOKAWA T, 1994, COMP BIOCHEM PHYS B, V109, P613, DOI 10.1016/0305-0491(94)90124-4; NAJAFI K, 1990, IEEE T BIO-MED ENG, V37, P474, DOI 10.1109/10.55638; OUALI N, 1991, J PLAST RUBBER COMP, V16, P55; Rutten WLC, 2002, ANNU REV BIOMED ENG, V4, P407, DOI 10.1146/annurev.bioeng.4.020702.153427; Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Sturcova A, 2005, BIOMACROMOLECULES, V6, P1055, DOI 10.1021/bm049291k; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Szulgit GK, 2000, J EXP BIOL, V203, P1539; Takayanagi M., 1964, J POLYM SCI C, V5, P113, DOI DOI 10.1002/POLC.5070050111; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Thurmond FA, 1996, J EXP BIOL, V199, P1817; Trotter JA, 2000, BIOCHEM SOC T, V28, P357, DOI 10.1042/0300-5127:0280357; Trotter JA, 1999, MATRIX BIOL, V18, P569, DOI 10.1016/S0945-053X(99)00050-5; van den Berg O, 2007, BIOMACROMOLECULES, V8, P1353, DOI 10.1021/bm061104q; Wilkie IC, 2002, J EXP BIOL, V205, P159	27	740	760	31	691	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1370	1374		10.1126/science.1153307	http://dx.doi.org/10.1126/science.1153307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323449				2022-12-24	WOS:000253712900038
J	Keel, SB; Doty, RT; Yang, Z; Quigley, JG; Chen, J; Knoblaugh, S; Kingsley, PD; De Domenico, I; Vaughn, MB; Kaplan, J; Palis, J; Abkowitz, JL				Keel, Sioban B.; Doty, Raymond T.; Yang, Zhantao; Quigley, John G.; Chen, Jing; Knoblaugh, Sue; Kingsley, Paul D.; De Domenico, Ivana; Vaughn, Michael B.; Kaplan, Jerry; Palis, James; Abkowitz, Janis L.			A heme export protein is required for red blood cell differentiation and iron homeostasis	SCIENCE			English	Article							FELINE LEUKEMIA-VIRUS; ERYTHROPOIETIN RECEPTOR; SUBGROUP-C; BFU-E; HEPCIDIN; EXPRESSION; RETROVIRUS; IDENTIFICATION; FERROPORTIN; PROGENITORS	Hemoproteins are critical for the function and integrity of aerobic cells. However, free heme is toxic. Therefore, cells must balance heme synthesis with its use. We previously demonstrated that the feline leukemia virus, subgroup C, receptor ( FLVCR) exports cytoplasmic heme. Here, we show that FLVCR- null mice lack definitive erythropoiesis, have craniofacial and limb deformities resembling those of patients with Diamond- Blackfan anemia, and die in midgestation. Mice with FLVCR that is deleted neonatally develop a severe macrocytic anemia with proerythroblast maturation arrest, which suggests that erythroid precursors export excess heme to ensure survival. We further demonstrate that FLVCR mediates heme export from macrophages that ingest senescent red cells and regulates hepatic iron. Thus, the trafficking of heme, and not just elemental iron, facilitates erythropoiesis and systemic iron balance.	[Keel, Sioban B.; Doty, Raymond T.; Yang, Zhantao; Quigley, John G.; Chen, Jing; Abkowitz, Janis L.] Univ Washington, Div Hematol, Seattle, WA 98195 USA; [Knoblaugh, Sue] Fred Hutchinson Canc Res Ctr, Anim Hlth Shared Resources, Seattle, WA 98109 USA; [Kingsley, Paul D.; Palis, James] Univ Rochester, Dept Pediat, Rochester, NY 14642 USA; [De Domenico, Ivana; Vaughn, Michael B.; Kaplan, Jerry] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Rochester; Utah System of Higher Education; University of Utah	Abkowitz, JL (corresponding author), Univ Washington, Div Hematol, Seattle, WA 98195 USA.	janabk@u.washington.edu	Quigley, John/X-4366-2019	Doty, Raymond/0000-0002-9312-8622; Palis, James/0000-0001-7324-1049; quigley, john/0000-0003-3116-4545				ABKOWITZ JL, 1991, BLOOD, V77, P1442; ABKOWITZ JL, 1987, J CLIN INVEST, V80, P1056, DOI 10.1172/JCI113160; CATHIE IAB, 1950, ARCH DIS CHILD, V25, P313, DOI 10.1136/adc.25.124.313; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rafie-Kolpin M, 2000, J BIOL CHEM, V275, P5171, DOI 10.1074/jbc.275.7.5171; RIEDEL N, 1988, P NATL ACAD SCI USA, V85, P2758, DOI 10.1073/pnas.85.8.2758; RIGBY MA, 1992, J GEN VIROL, V73, P2839, DOI 10.1099/0022-1317-73-11-2839; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Tailor CS, 1999, J VIROL, V73, P6500, DOI 10.1128/JVI.73.8.6500-6505.1999; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; TESTA NG, 1983, LEUKEMIA RES, V7, P103, DOI 10.1016/0145-2126(83)90001-2; Vokurka M, 2006, PHYSIOL RES, V55, P667, DOI 10.33549/physiolres.930841; Wang VEH, 2004, MOL CELL BIOL, V24, P1022, DOI 10.1128/MCB.24.3.1022-1032.2004; Watanabe S, 2004, PLACENTA, V25, P387, DOI 10.1016/j.placenta.2003.10.012; WICKREMA A, 1992, BLOOD, V80, P1940, DOI 10.1182/blood.V80.8.1940.1940; Willig TN, 1999, PEDIATR RES, V46, P553, DOI 10.1203/00006450-199911000-00011; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	23	279	292	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					825	828		10.1126/science.1151133	http://dx.doi.org/10.1126/science.1151133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258918				2022-12-24	WOS:000252963000066
J	Kang, JS; Tian, JH; Pan, PY; Zald, P; Li, C; Deng, C; Sheng, ZH				Kang, Jian-Sheng; Tian, Jin-Hua; Pan, Ping-Yue; Zald, Philip; Li, Cuiling; Deng, Chuxia; Sheng, Zu-Hang			Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation	CELL			English	Article							TRANSPORT; PROTEIN; MICROTUBULES; ORGANELLES; SYNAPSES; NEURONS; MILTON; TRANSMISSION; POTENTIATION; CYTOSKELETON	Proper distribution of mitochondria within axons and at synapses is critical for neuronal function. While one-third of axonal mitochondria are mobile, a large proportion remains in a stationary phase. However, the mechanisms controlling mitochondrial docking within axons remain elusive. Here, we report a role for axon-targeted syntaphilin (SNPH) in mitochondrial docking through its interaction with microtubules. Axonal mitochondria that contain exogenously or endogenously expressed SNPH lose mobility. Deletion of the mouse snph gene results in a substantially higher proportion of axonal mitochondria in the mobile state and reduces the density of mitochondria in axons. The snph mutant neurons exhibit enhanced short-term facilitation during prolonged stimulation, probably by affecting calcium signaling at presynaptic boutons. This phenotype is fully rescued by reintroducing the snph gene into the mutant neurons. These findings demonstrate a molecular mechanism for controlling mitochondrial docking in axons that has a physiological impact on synaptic function.	[Kang, Jian-Sheng; Tian, Jin-Hua; Pan, Ping-Yue; Zald, Philip; Sheng, Zu-Hang] NINDS, NIH, Porter Neurosci Res Ctr, Synapt Funct Sect, Bethesda, MD 20892 USA; [Pan, Ping-Yue] Shanghai Jiao Tong Univ, Sch Med, Dept Neurobiol, Shanghai 200030, Peoples R China; [Li, Cuiling; Deng, Chuxia] NIDDK, NIH, Genet Dev & Dis Branch, Mammalian Genet Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Sheng, ZH (corresponding author), NINDS, NIH, Porter Neurosci Res Ctr, Synapt Funct Sect, Bldg 35,Rm 4B203, Bethesda, MD 20892 USA.	shengz@ninds.nih.gov	deng, chuxia/N-6713-2016	Kang, Jian-Sheng/0000-0002-2603-9718; Pan, Pingyue/0000-0002-2805-6810	Intramural NIH HHS [Z01 NS002946-11] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003029, Z01NS002946] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aiello GL, 2000, J NEUROSCI METH, V103, P145, DOI 10.1016/S0165-0270(00)00308-3; BELLES B, 1987, PFLUG ARCH EUR J PHY, V409, P582, DOI 10.1007/BF00584657; BENSHALOM G, 1985, J NEUROCYTOL, V14, P943, DOI 10.1007/BF01224806; BERTHOLD CH, 1993, J NEUROCYTOL, V22, P925, DOI 10.1007/BF01218351; Billups B, 2002, J NEUROSCI, V22, P5840; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Das S, 2003, MOL BRAIN RES, V116, P38, DOI 10.1016/S0169-328X(03)00212-2; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gorska-Andrzejak J, 2003, J COMP NEUROL, V463, P372, DOI 10.1002/cne.10750; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Hollenbeck, 1996, FRONT BIOSCI, V1, pD91; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hubley MJ, 1996, BBA-GEN SUBJECTS, V1291, P115, DOI 10.1016/0304-4165(96)00053-0; JONAS E, 1993, CYTOSKELETON, V24, P245; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; LETERRIER JF, 1994, MICROSC RES TECHNIQ, V27, P233, DOI 10.1002/jemt.1070270305; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; LINDEN M, 1989, J BIOENERG BIOMEMBR, V21, P507, DOI 10.1007/BF00762522; Mattson MP, 2007, NEUROCHEM RES, V32, P707, DOI 10.1007/s11064-006-9170-3; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Moore D.S., 1993, INTRO PRACTICE STAT; MORRIS RL, 1993, J CELL SCI, V104, P917; PANNESE E, 1986, CELL TISSUE RES, V245, P1; PRICE RL, 1991, BRAIN RES, V540, P209, DOI 10.1016/0006-8993(91)90509-T; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; REYNOLDS IJ, 2004, SCI STKE, V251, pPE46; Rowland KC, 2000, J NEUROSCI, V20, P9135; Safieddine S, 2002, MOL CELL NEUROSCI, V20, P343, DOI 10.1006/mcne.2002.1120; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; SMITH DS, 1977, J CELL SCI, V27, P255; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; WERTH JL, 1994, J NEUROSCI, V14, P348; Yang F, 2003, J CELL BIOL, V163, P511, DOI 10.1083/jcb.200307027	43	390	399	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					137	148		10.1016/j.cell.2007.11.024	http://dx.doi.org/10.1016/j.cell.2007.11.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191227	Green Accepted, Bronze			2022-12-24	WOS:000253427600022
J	Lorenz, RD; Stiles, BW; Kirk, RL; Allison, MD; del Marmo, PP; Iess, L; Lunine, JI; Ostro, SJ; Hensley, S				Lorenz, Ralph D.; Stiles, Bryan W.; Kirk, Randolph L.; Allison, Michael D.; del Marmo, Paolo Persi; Iess, Luciano; Lunine, Jonathan I.; Ostro, Steven J.; Hensley, Scott			Titan's rotation reveals an internal ocean and changing zonal winds	SCIENCE			English	Article							GALILEAN SATELLITES; SURFACE	Cassini radar observations of Saturn's moon Titan over several years show that its rotational period is changing and is different from its orbital period. The present- day rotation period difference from synchronous spin leads to a shift of similar to 0.36 per year in apparent longitude and is consistent with seasonal exchange of angular momentum between the surface and Titan's dense superrotating atmosphere, but only if Titan's crust is decoupled from the core by an internal water ocean like that on Europa.	[Lorenz, Ralph D.] Johns Hopkins Univ, Appl Phys Lab, Dept Space, Laurel, MD 20723 USA; [Stiles, Bryan W.; Ostro, Steven J.; Hensley, Scott] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Kirk, Randolph L.] US Geol Survey, Flagstaff, AZ 86001 USA; [Allison, Michael D.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [del Marmo, Paolo Persi; Iess, Luciano] Univ Roma La Sapienza, I-00184 Rome, Italy; [Lunine, Jonathan I.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Sapienza University Rome; University of Arizona	Lorenz, RD (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Dept Space, Johns Hopkins Rd, Laurel, MD 20723 USA.	ralph.lorenz@jhuapl.edu	Lorenz, Ralph D/B-8759-2016; IESS, Luciano/F-4902-2011	Lorenz, Ralph D/0000-0001-8528-4644; IESS, Luciano/0000-0002-6230-5825; Lunine, Jonathan/0000-0003-2279-4131				Bills BG, 2005, ICARUS, V175, P233, DOI 10.1016/j.icarus.2004.10.028; Bird MK, 2005, NATURE, V438, P800, DOI 10.1038/nature04060; DEMALMO PP, 2007, B AM ASTRON SOC, V39, P543; Elachi C, 2006, NATURE, V441, P709, DOI 10.1038/nature04786; Folkner WM, 1997, SCIENCE, V278, P1749, DOI 10.1126/science.278.5344.1749; Fortes AD, 2000, ICARUS, V146, P444, DOI 10.1006/icar.2000.6400; GOLDREICH P, 1961, ASTRON J, V71, P1; Grasset O, 2000, PLANET SPACE SCI, V48, P617, DOI 10.1016/S0032-0633(00)00039-8; GREENBERG R, 1984, ICARUS, V58, P186, DOI 10.1016/0019-1035(84)90038-1; HIDE R, 1980, NATURE, V286, P114, DOI 10.1038/286114a0; Margot JL, 2007, SCIENCE, V316, P710, DOI 10.1126/science.1140514; Peixoto J.P., 1992, PHYS CLIMATE, P520; RADEBAUGH J, 2006, LUNAR PLANET SCI, V37, P1007; Rappaport N, 1997, ICARUS, V126, P313, DOI 10.1006/icar.1996.5661; Richardson J, 2004, ICARUS, V170, P113, DOI 10.1016/j.icarus.2004.03.010; SEARS WD, 1993, ICARUS, V105, P259, DOI 10.1006/icar.1993.1123; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023; Sohl F, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002044; STEVENSON DJ, 1992, ESA SP, V338, P29; STILES B, 2007, B AM ASTRON SOC, V39, P543; Tokano T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024456; WHITE RM, 1949, J METEOROL, V6, P353, DOI 10.1175/1520-0469(1949)006<0353:TROMIT>2.0.CO;2; Zimmer C, 2000, ICARUS, V147, P329, DOI 10.1006/icar.2000.6456	23	140	142	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2008	319	5870					1649	1651		10.1126/science.1151639	http://dx.doi.org/10.1126/science.1151639			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356521				2022-12-24	WOS:000254172300035
J	Kim, J; Darley, DJ; Buckel, W; Pierik, AJ				Kim, Jihoe; Darley, Daniel J.; Buckel, Wolfgang; Pierik, Antonio J.			An allylic ketyl radical intermediate in clostridial amino-acid fermentation	NATURE			English	Article							IRON-SULFUR CLUSTERS; LYSINE 2,3-AMINOMUTASE; MECHANISTIC PROPOSAL; ANAEROBIC-BACTERIA; DIFFICILE; DEHYDRATASE; LEUCINE; GENOME; ANALOG	The human pathogenic bacterium Clostridium difficile thrives by the fermentation of L- leucine toammonia, CO2, 3-methylbutanoate and 4-methylpentanoate under anaerobic conditions(1). The reductive branch to 4- methylpentanoate proceeds by means of the dehydration of ( R)- 2- hydroxy- 4- methylpentanoyl- CoA to 4- methylpent-2- enoyl- CoA, which is chemically the most demanding step. Ketyl radicals have been proposed(2) to mediate this reaction catalysed by an iron - sulphur- cluster- containing dehydratase, which requires activation by ATP- dependent electron transfer from a second iron - sulphur protein functionally similar to the iron protein of nitrogenase. Here we identify a kinetically competent product-related allylic ketyl radical bound to the enzyme by electron paramagnetic resonance spectroscopy employing isotope- labelled ( R)- 2- hydroxy- 4- methylpentanoyl- CoA species. We also found that the enzyme generated the stabilized pentadienoyl ketyl radical from the substrate analogue 2- hydroxypent- 4- enoyl- CoA, supporting the proposed mechanism. Our results imply that also other 2- hydroxyacyl- CoA dehydratases(3) and the related benzoyl- CoA reductases(4) - present in anaerobically living bacteria - employ ketyl radical intermediates. The absence of radical generators such as coenzyme B-12, S- adenosylmethionine or oxygen makes these enzymes unprecedented in biochemistry.	[Kim, Jihoe; Darley, Daniel J.; Buckel, Wolfgang; Pierik, Antonio J.] Univ Marburg, Fachbereich Biol, Mikrobiol Lab, D-35032 Marburg, Germany	Philipps University Marburg	Pierik, AJ (corresponding author), Univ Marburg, Fachbereich Biol, Mikrobiol Lab, D-35032 Marburg, Germany.	pierik@staff.uni-marburg.de	Pierik, Antonio J/G-1108-2010	Pierik, Antonio J/0000-0002-1509-6370				BALLINGER MD, 1992, BIOCHEMISTRY-US, V31, P949, DOI 10.1021/bi00119a001; BARKER HA, 1981, ANNU REV BIOCHEM, V50, P23, DOI 10.1146/annurev.bi.50.070181.000323; BEINERT H, 1982, BIOCHIM BIOPHYS ACTA, V683, P245, DOI 10.1016/0304-4173(82)90003-9; Boll M, 2005, BIOL CHEM, V386, P989, DOI 10.1515/BC.2005.115; Bruckner R, 2003, REAKTIONSMECHANISMEN; Buckel W, 2004, CURR OPIN CHEM BIOL, V8, P462, DOI 10.1016/j.cbpa.2004.07.001; BUCKEL W, 1995, ANGEW CHEM INT EDIT, V34, P1502, DOI 10.1002/anie.199515021; BUCKEL W, 1980, EUR J BIOCHEM, V106, P439, DOI 10.1111/j.1432-1033.1980.tb04590.x; Buckel W., 1999, BIOL PROKARYOTES, P278; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; ELSDEN SR, 1978, ARCH MICROBIOL, V117, P165, DOI 10.1007/BF00402304; Hans M, 2000, EUR J BIOCHEM, V267, P7082, DOI 10.1046/j.1432-1327.2000.01809.x; Kim J, 2005, FEBS J, V272, P550, DOI 10.1111/j.1742-4658.2004.04498.x; Kim J, 2006, APPL ENVIRON MICROB, V72, P6062, DOI 10.1128/AEM.00772-06; Layer G, 2006, J BIOL CHEM, V281, P15727, DOI 10.1074/jbc.M512628200; Magnusson OT, 2001, BIOCHEMISTRY-US, V40, P7773, DOI 10.1021/bi0104569; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Sebaihia M, 2006, NAT REV MICROBIOL, V4, P882, DOI 10.1038/nrmicro1571; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; SEEBACH D, 1979, ANGEW CHEM INT EDIT, V18, P239, DOI 10.1002/anie.197902393; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; Smith DM, 2003, ANGEW CHEM INT EDIT, V42, P1867, DOI 10.1002/anie.200250502; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Tsai AL, 1998, ANAL BIOCHEM, V264, P165, DOI 10.1006/abio.1998.2774; Weil J. A., 2007, ELECT PARAMAGNETIC R; Wu WM, 2000, BIOCHEMISTRY-US, V39, P9561, DOI 10.1021/bi000658p	26	53	58	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					239	U85		10.1038/nature06637	http://dx.doi.org/10.1038/nature06637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337824				2022-12-24	WOS:000253925600045
J	Colman, A				Colman, Alan			Stem cell research in Singapore	CELL			English	Editorial Material							HUMAN BLASTOCYSTS; LINES	Singapore is investing heavily in stem cell research. This investment is part of an ambitious biomedical science initiative designed to enhance its thriving economy.	Singapore Stem Cell Consortium, ASTAR Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Colman, A (corresponding author), Singapore Stem Cell Consortium, ASTAR Inst Med Biol, Singapore 138648, Singapore.	alan.colman@imb.a-star.edu.sg						BONGSO A, 1994, HUM REPROD, V9, P2110, DOI 10.1093/oxfordjournals.humrep.a138401; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; HOON HT, 2006, BUSINESS TIMES  0614; Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tan DTH, 2004, TRANSPLANTATION, V77, P1729, DOI 10.1097/01.TP.0000127593.65888.A6; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	10	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					519	521		10.1016/j.cell.2008.01.037	http://dx.doi.org/10.1016/j.cell.2008.01.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295566	Bronze			2022-12-24	WOS:000253817900008
J	Setoguchi, R; Tachibana, M; Naoe, Y; Muroi, S; Akiyama, K; Tezuka, C; Okuda, T; Taniuchi, I				Setoguchi, Ruka; Tachibana, Masashi; Naoe, Yoshinori; Muroi, Sawako; Akiyama, Kaori; Tezuka, Chieko; Okuda, Tsukasa; Taniuchi, Ichiro			Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development	SCIENCE			English	Article							LINEAGE DIFFERENTIATION; POSITIVE SELECTION; GENE-EXPRESSION; CD4; COMMITMENT; PROTEINS; DURATION; SILENCER; FATE	Mouse CD4(+) CD8(+) double- positive ( DP) thymocytes differentiate into CD4(+) helper- lineage cells upon expression of the transcription factor Th- POK but commit to the CD8(+) cytotoxic lineage in its absence. We report the redirected differentiation of class I - restricted thymocytes into CD4(+) CD8(-) helper- like T cells upon loss of Runx transcription factor complexes. A Runx- binding sequence within the Th- POK locus acts as a transcriptional silencer that is essential for Th- POK repression and for development of CD8(+) T cells. Thus, Th- POK expression and genetic programming for T helper cell development are actively inhibited by Runx- dependent silencer activity, allowing for cytotoxic T cell differentiation. Identification of the transcription factors network in CD4 and CD8 lineage choice provides insight into how distinct T cell subsets are developed for regulating the adaptive immune system.	[Setoguchi, Ruka; Tachibana, Masashi; Naoe, Yoshinori; Muroi, Sawako; Akiyama, Kaori; Tezuka, Chieko; Taniuchi, Ichiro] RIKEN, Res Ctr Allergy & Immunol, Lab Transcript Regulat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Muroi, Sawako; Akiyama, Kaori; Taniuchi, Ichiro] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Okuda, Tsukasa] Kyoto Prefectural Univ Med, Kamigyo Ku, Kyoto 6028566, Japan	RIKEN; Japan Science & Technology Agency (JST); Kyoto Prefectural University of Medicine	Taniuchi, I (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Transcript Regulat, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	taniuchi@rcai.riken.jp	Taniuchi, Ichiro/N-6399-2015	Taniuchi, Ichiro/0000-0002-9853-9068; Tachibana, Masashi/0000-0002-0376-508X				Aronson BD, 1997, MOL CELL BIOL, V17, P5581, DOI 10.1128/MCB.17.9.5581; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Ito Y, 1999, GENES CELLS, V4, P685, DOI 10.1046/j.1365-2443.1999.00298.x; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Nishimura M, 2004, BLOOD, V103, P562, DOI 10.1182/blood-2003-06-2109; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; ROY M, 1993, J IMMUNOL, V151, P2497; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; Singer A, 2004, ADV IMMUNOL, V83, P91; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Wildt KF, 2007, J IMMUNOL, V179, P4405, DOI 10.4049/jimmunol.179.7.4405; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	21	189	198	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					822	825		10.1126/science.1151844	http://dx.doi.org/10.1126/science.1151844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258917				2022-12-24	WOS:000252963000065
J	Haubek, D; Ennibi, OK; Poulsen, K; Vaeth, M; Poulsen, S; Kilian, M				Haubek, Dorte; Ennibi, Oum-Keltoum; Poulsen, Knud; Vaeth, Michael; Poulsen, Sven; Kilian, Mogens			Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study	LANCET			English	Article							EARLY-ONSET PERIODONTITIS; HIGHLY TOXIC CLONE; JUVENILE PERIODONTITIS; LOCALIZED JUVENILE; POPULATION-STRUCTURE; DISEASE; CHILDREN; STRAINS; PLAQUE; MICROBIOLOGY	Background Periodontitis is a loss of supporting connective tissue and alveolar bone around teeth, and if it occurs in an aggressive form it can lead to tooth loss before the age of 20 years. Although the cause of periodontitis in general remains elusive, a particular clone (JP2) of the gram-negative rod Aggregatibacter (Actinobacillus) actinomycetemcomitans is considered a possible aetiological agent of the aggressive form in adolescents living in or originating from north and west Africa, where the disease is highly prevalent. We did a population-based longitudinal study of adolescents to assess the role of the JP2 clone in the initiation of aggressive periodontitis. Methods A total of 700 adolescents from public schools in Rabat, Morocco, were enrolled in the study. We used PCR to detect A actinomycetemcomitans in plaque samples (taken from molar and incisor sites) and to differentiate between the JP2 clone and other non-JP2 genotypes of the bacterium. 18 individuals were found to already have periodontitis and were excluded. The 682 periodontally healthy adolescents (mean age 12.5 years; SD 1 . 0) were classified according to their A actinomycetemcomitans carrier status at baseline. After 2 years, 428 (62. 8%) individuals returned for re-examination, which included recording of periodontal attachment loss measured from the cemento-enamel junction to the bottom of the periodontal pockets of all teeth present. Findings Individuals who carried the JP2 clone of A actinomycetemcomitans alone (relative risk 18 . 0; 95% CI 7.8-41.2, p<0 . 0001) or together with non-JP2 clones of A actinomycetemcomitans (12.4; 5.2-29.9, p<0 . 0001) had a significantly increased risk of periodontal attachment loss. A much less pronounced disease risk was found in those carrying non-JP2 clones only (3 . 0; 1. 3-7. 1, p=0 . 012). Interpretation The JP2 clone of A actinomycetemcomitans is likely to be an important aetiological agent in initiation of periodontal attachment loss in children and adolescents. Co-occurrence of non-JP2 clones of A actinomycetemcomitans reduces the risk of development of periodontitis, suggesting competition for the ecological niche between the JP2 and non-JP2 clones of this species.	[Haubek, Dorte; Poulsen, Sven] Aarhus Univ, Fac Hlth Sci, Dept Community Oral Hlth & Pediat Dent, DK-8000 Aarhus C, Denmark; [Poulsen, Knud; Kilian, Mogens] Aarhus Univ, Inst Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark; [Vaeth, Michael] Aarhus Univ, Dept Biostat, DK-8000 Aarhus C, Denmark; [Ennibi, Oum-Keltoum] Univ Rabat, Fac Dent, Dept Periodontol, Rabat, Morocco	Aarhus University; Aarhus University; Aarhus University; Mohammed V University in Rabat	Haubek, D (corresponding author), Aarhus Univ, Fac Hlth Sci, Dept Community Oral Hlth & Pediat Dent, Vennelyst Blvd, DK-8000 Aarhus C, Denmark.	dhaubek@odont.au.dk	Ennibi, Oumkeltoum/AAT-4626-2020; Vaeth, Michael/T-6882-2017	Kilian, Mogens/0000-0002-5861-0472; Vaeth, Michael/0000-0002-0134-5006; ENNIBI, OUMKELTOUM/0000-0002-1224-9124				Albandar JM, 2002, PERIODONTOL 2000, V29, P153, DOI 10.1034/j.1600-0757.2002.290108.x; BROGAN JM, 1994, INFECT IMMUN, V62, P501, DOI 10.1128/IAI.62.2.501-508.1994; Bueno LC, 1998, J PERIODONTOL, V69, P998, DOI 10.1902/jop.1998.69.9.998; Cortelli JR, 2005, J CLIN PERIODONTOL, V32, P860, DOI 10.1111/j.1600-051X.2005.00777.x; Guthmiller JM, 2001, CRIT REV ORAL BIOL M, V12, P116, DOI 10.1177/10454411010120020201; Haraszthy VI, 2000, J PERIODONTOL, V71, P912, DOI 10.1902/jop.2000.71.6.912; Haubek D, 1997, J CLIN MICROBIOL, V35, P3037, DOI 10.1128/JCM.35.12.3037-3042.1997; Haubek D, 2004, J DENT RES, V83, P767, DOI 10.1177/154405910408301006; Haubek D, 2002, J CLIN PERIODONTOL, V29, P657, DOI 10.1034/j.1600-051X.2002.290711.x; Haubek D, 1996, J CLIN MICROBIOL, V34, P1576, DOI 10.1128/JCM.34.6.1576-1578.1996; Haubek D, 2001, J DENT RES, V80, P1580, DOI 10.1177/00220345010800062001; Haubek D, 2007, INFECT IMMUN, V75, P3080, DOI 10.1128/IAI.01734-06; HORMAND J, 1979, J CLIN PERIODONTOL, V6, P407; Jenkins WMM, 2001, PERIODONTOL 2000, V26, P16, DOI 10.1034/j.1600-0757.2001.2260102.x; Kaplan JB, 2002, J CLIN MICROBIOL, V40, P1181, DOI 10.1128/JCm.40.4.1181-1187.2002; Kilian M, 2006, PERIODONTOL 2000, V42, P158, DOI 10.1111/j.1600-0757.2006.00159.x; Kimura S, 2002, J PERIODONTOL, V73, P20, DOI 10.1902/jop.2002.73.1.20; Listgarten Max A, 2003, Ann Periodontol, V8, P182, DOI 10.1902/annals.2003.8.1.182; Lopez R, 2003, COMMUNITY DENT ORAL, V31, P136, DOI 10.1034/j.1600-0528.2003.00022.x; Marsh PD, 2005, J CLIN PERIODONTOL, V32, P7, DOI 10.1111/j.1600-051X.2005.00790.x; Norskov-Lauritsen N, 2006, INT J SYST EVOL MICR, V56, P2135, DOI 10.1099/ijs.0.64207-0; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Poulsen K, 2003, J CLIN MICROBIOL, V41, P4829, DOI 10.1128/JCM.41.10.4829-4832.2003; POULSEN K, 1994, MICROBIOL-UK, V140, P2049, DOI 10.1099/13500872-140-8-2049; Sanz M, 2004, J CLIN PERIODONTOL, V31, P1034, DOI 10.1111/j.1600-051X.2004.00609.x; SAXEN L, 1980, J CLIN PERIODONTOL, V7, P1, DOI 10.1111/j.1600-051X.1980.tb01944.x; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Van der Velden U, 2006, J CLIN PERIODONTOL, V33, P540, DOI 10.1111/j.1600-051X.2006.00953.x; Zambon JJ, 1996, J PERIODONTOL, V67, P282, DOI 10.1902/jop.1996.67.3s.282	30	236	241	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2008	371	9608					237	242		10.1016/S0140-6736(08)60135-X	http://dx.doi.org/10.1016/S0140-6736(08)60135-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	252UK	18207019				2022-12-24	WOS:000252471900027
J	Grueninger, D; Treiber, N; Ziegler, MOP; Koetter, JWA; Schulze, MS; Schulz, GE				Grueninger, Dirk; Treiber, Nora; Ziegler, Mathias O. P.; Koetter, Jochen W. A.; Schulze, Monika-Sarah; Schulz, Georg E.			Designed protein-protein association	SCIENCE			English	Article							CONFORMATIONAL ENTROPY; SPECIFICITY; RECOGNITION; CRYSTALLIZATION; PRINCIPLES; INTERFACES; MECHANISM; CRYSTALS; DOCKING	The analysis of natural contact interfaces between protein subunits and between proteins has disclosed some general rules governing their association. We have applied these rules to produce a number of novel assemblies, demonstrating that a given protein can be engineered to form contacts at various points of its surface. Symmetry plays an important role because it defines the multiplicity of a designed contact and therefore the number of required mutations. Some of the proteins needed only a single side- chain alteration in order to associate to a higher- order complex. The mobility of the buried side chains has to be taken into account. Four assemblies have been structurally elucidated. Comparisons between the designed contacts and the results will provide useful guidelines for the development of future architectures.	[Grueninger, Dirk; Treiber, Nora; Ziegler, Mathias O. P.; Koetter, Jochen W. A.; Schulze, Monika-Sarah; Schulz, Georg E.] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Freiburg	Schulz, GE (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Albertstr 21, D-79104 Freiburg, Germany.	georg.schulz@ocbc.uni-freiburg.de						Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Cerutti DS, 2006, PROTEIN SCI, V15, P1579, DOI 10.1110/ps.051985106; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Claus MT, 2005, BIOCHEMISTRY-US, V44, P8620, DOI 10.1021/bi050485+; Cole C, 2002, PROTEIN SCI, V11, P2860, DOI 10.1110/ps.0222702; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Kessler D, 2004, J MOL BIOL, V342, P183, DOI 10.1016/j.jmb.2004.07.028; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kroemer M, 2003, BIOCHEMISTRY-US, V42, P10560, DOI 10.1021/bi0349266; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Pautsch A, 1999, PROTEINS, V34, P167, DOI 10.1002/(SICI)1097-0134(19990201)34:2<167::AID-PROT2>3.3.CO;2-8; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; Schweizer A, 2007, STRUCTURE, V15, P625, DOI 10.1016/j.str.2007.03.014; Shifman JM, 2002, J MOL BIOL, V323, P417, DOI 10.1016/S0022-2836(02)00881-1; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Wiesmann C, 1997, ACTA CRYSTALLOGR D, V53, P274, DOI 10.1107/S0907444996014977	26	114	118	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2008	319	5860					206	209		10.1126/science.1150421	http://dx.doi.org/10.1126/science.1150421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187656				2022-12-24	WOS:000252246400042
J	Muruve, DA; Petrilli, V; Zaiss, AK; White, LR; Clark, SA; Ross, PJ; Parks, RJ; Tschopp, J				Muruve, Daniel A.; Petrilli, Virginie; Zaiss, Anne K.; White, Lindsay R.; Clark, Sharon A.; Ross, P. Joel; Parks, Robin J.; Tschopp, Jurg			The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response	NATURE			English	Article							ADENOVIRUS VECTORS; CASPASE-1 ACTIVATION; NALP3 INFLAMMASOME; GENE-THERAPY; IN-VIVO; INFECTION; EXPRESSION; RECEPTOR; DISEASE; ASC	The innate immune system recognizes nucleic acids during infection and tissue damage. Whereas viral RNA is detected by endosomal toll- like receptors ( TLR3, TLR7, TLR8) and cytoplasmic RIG-I and MDA5, endosomal TLR9 and cytoplasmic DAI bind DNA(1), resulting in the activation of nuclear factor-kappa B and interferon regulatory factor transcription factors. However, viruses also trigger pro- inflammatory responses(2), which remain poorly defined. Here we show that internalized adenoviral DNA induces maturation of pro- interleukin-1 beta in macrophages, which is dependent on NALP3 and ASC, components of the innate cytosolic molecular complex termed the inflammasome. Correspondingly, NALP3- and ASC- deficient mice display reduced innate inflammatory responses to adenovirus particles. Inflammasome activation also occurs as a result of transfected cytosolic bacterial, viral and mammalian ( host) DNA, but in this case sensing is dependent on ASC but not NALP3. The DNA- sensing pro- inflammatory pathway functions independently of TLRs and interferon regulatory factors. Thus, in addition to viral and bacterial components or danger signals in general, inflammasomes sense potentially dangerous cytoplasmic DNA, strengthening their central role in innate immunity.	[Petrilli, Virginie; Tschopp, Jurg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Muruve, Daniel A.; White, Lindsay R.; Clark, Sharon A.] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada; [Zaiss, Anne K.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Ross, P. Joel; Parks, Robin J.] Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON K1Y 4E9, Canada	University of Lausanne; University of Calgary; University of Calgary; University of Ottawa; Ottawa Hospital Research Institute	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	Jurg.Tschopp@unil.ch	Ross, Joel/K-3361-2019; Petrilli, Virginie/ABI-8199-2020	Ross, Joel/0000-0001-7105-7117; Petrilli, Virginie/0000-0001-8502-6979				Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; COTTEN M, 1994, VIROLOGY, V205, P254, DOI 10.1006/viro.1994.1641; Cotter MJ, 2005, J VIROL, V79, P14622, DOI 10.1128/JVI.79.23.14622-14631.2005; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Fujioka N, 1999, J VIROL, V73, P2401, DOI 10.1128/JVI.73.3.2401-2409.1999; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Sergerie Y, 2007, J INFECT DIS, V196, P853, DOI 10.1086/520094; Shayakhmetov DM, 2005, J IMMUNOL, V174, P7310, DOI 10.4049/jimmunol.174.11.7310; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stilwell JL, 2003, J VIROL, V77, P12881, DOI 10.1128/JVI.77.23.12881-12885.2003; Sun KH, 2000, IMMUNOLOGY, V99, P352, DOI 10.1046/j.1365-2567.2000.00970.x; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tibbles LA, 2002, J VIROL, V76, P1559, DOI 10.1128/JVI.76.4.1559-1568.2002; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	30	729	769	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					103	U11		10.1038/nature06664	http://dx.doi.org/10.1038/nature06664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18288107				2022-12-24	WOS:000253671900055
J	Christakis, NA				Christakis, Nicholas A.			What networks can teach us about drug use	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Christakis, Nicholas A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Christakis, Nicholas A.] Mt Auburn Hosp, Cambridge, England	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/B-6690-2008; Christakis, Nicholas A/C-3205-2009						0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 23	2008	336	7641					420	420		10.1136/bmj.39496.537396.59	http://dx.doi.org/10.1136/bmj.39496.537396.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18292167	Green Published			2022-12-24	WOS:000253664000035
J	Schmitz, OJ				Schmitz, Oswald J.			Effects of predator hunting mode on grassland ecosystem function	SCIENCE			English	Article							TROPHIC CASCADES; ISLE-ROYALE; BIODIVERSITY; PLANT; DIVERSITY; DYNAMICS; FOREST	The way predators control their prey populations is determined by the interplay between predator hunting mode and prey antipredator behavior. It is uncertain, however, how the effects of such interplay control ecosystem function. A 3- year experiment in grassland mesocosms revealed that actively hunting spiders reduced plant species diversity and enhanced aboveground net primary production and nitrogen mineralization rate, whereas sit- and- wait ambush spiders had opposite effects. These effects arise from the different responses to the two different predators by their grasshopper prey- the dominant herbivore species that controls plant species composition and accordingly ecosystem functioning. Predator hunting mode is thus a key functional trait that can help to explain variation in the nature of top- down control of ecosystems.	Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; Yale Univ, Dept Ecol & Evolut Biol, New Haven, CT 06511 USA	Yale University; Yale University	Schmitz, OJ (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	oswald.schmitz@yale.edu						Belovsky GE, 2000, P NATL ACAD SCI USA, V97, P14412, DOI 10.1073/pnas.250483797; Chalcraft DR, 2003, AM NAT, V162, P390, DOI 10.1086/378210; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Downing AL, 2002, NATURE, V416, P837, DOI 10.1038/416837a; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Dyer LA, 2003, ECOL LETT, V6, P60, DOI 10.1046/j.1461-0248.2003.00398.x; Frank DA, 1998, ECOLOGY, V79, P2229, DOI 10.1890/0012-9658(1998)079[2229:UVLCOS]2.0.CO;2; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Maron JL, 2006, ECOL MONOGR, V76, P3, DOI 10.1890/05-0496; MCINNES PF, 1992, ECOLOGY, V73, P2059, DOI 10.2307/1941455; PASTOR J, 1993, ECOLOGY, V74, P467, DOI 10.2307/1939308; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.1890/0012-9658(1998)079[0165:HEOPAN]2.0.CO;2; Schmidt Oswald J., 2005, P256; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2003, ECOL LETT, V6, P156, DOI 10.1046/j.1461-0248.2003.00412.x; Schmitz OJ, 2004, ECOL STU AN, V173, P277; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Sinclair ARE, 2006, J ANIM ECOL, V75, P64, DOI 10.1111/j.1365-2656.2006.01036.x; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thebault E, 2003, P NATL ACAD SCI USA, V100, P14949, DOI 10.1073/pnas.2434847100; Wardle DA, 2002, COMMUNITIES ECOSYSTE; Wright JP, 2006, ECOL LETT, V9, P111, DOI 10.1111/j.1461-0248.2005.00850.x	30	372	382	2	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					952	954		10.1126/science.1152355	http://dx.doi.org/10.1126/science.1152355			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276890				2022-12-24	WOS:000253165700046
J	Wajapeyee, N; Serra, RW; Zhu, X; Mahalingam, M; Green, MR				Wajapeyee, Narendra; Serra, Ryan W.; Zhu, Xiaochun; Mahalingam, Meera; Green, Michael R.			Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7	CELL			English	Article							CELL-CYCLE ARREST; MALIGNANT-MELANOMA; CANCER-CELLS; C-JUN; GROWTH; MUTATIONS; KINASE; INHIBITION; EXPRESSION; INDUCTION	Expression of an oncogene in a primary cell can, paradoxically, block proliferation by inducing senescence or apoptosis through pathways that remain to be elucidated. Here we perform genome-wide RNA-interference screening to identify 17 genes required for an activated BRAF oncogene (BRAFV600E) to block proliferation of human primary fibroblasts and melanocytes. Surprisingly, we find a secreted protein, IGFBP7, has a central role in BRAFV600E-mediated senescence and apoptosis. Expression of BRAFV600E in primary cells leads to synthesis and secretion of IGFBP7, which acts through autocrine/paracrine pathways to inhibit BRAF-MEK-ERK signaling and induce senescence and apoptosis. Apoptosis results from IGFBP7-mediated upregulation of BNIP3L, a proapoptotic BCL2 family protein. Recombinant IGFBP7 (rIGFBP7) induces apoptosis in BRAFV600E-positive human melanoma cell lines, and systemically administered rlGFBP7 markedly suppresses growth of BRAFV600E-positive tumors in xenografted mice. Immunohistochemical analysis of human skin, nevi, and melanoma samples implicates loss of IGFBP7 expression as a critical step in melanoma genesis.	[Wajapeyee, Narendra; Serra, Ryan W.; Zhu, Xiaochun; Green, Michael R.] Univ Massachusetts, Howard Hughes Med Inst, Programs Gene Funct & Express & Mol Med, Worcester, MA 01605 USA; [Mahalingam, Meera] Boston Univ, Sch Med, Dept Dermatol, Boston, MA 02118 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Boston University	Green, MR (corresponding author), Univ Massachusetts, Howard Hughes Med Inst, Programs Gene Funct & Express & Mol Med, Worcester, MA 01605 USA.	michael.green@umassmed.edu	Wajapeyee, Narendra/F-3011-2012	Mahalingam, Meera/0000-0002-2800-9985	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Bennett DC, 2003, ONCOGENE, V22, P3063, DOI 10.1038/sj.onc.1206446; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Chin L, 1998, GENE DEV, V12, P3467, DOI 10.1101/gad.12.22.3467; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Emrick MA, 2006, P NATL ACAD SCI USA, V103, P18101, DOI 10.1073/pnas.0608849103; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Hingorani SR, 2003, CANCER RES, V63, P5198; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Mutaguchi K, 2003, CANCER RES, V63, P7717; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322; Park S, 2005, ONCOGENE, V24, P3535, DOI 10.1038/sj.onc.1208435; PEEPER DS, 2002, NUCLEIC ACIDS RES, V29, pE45; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Ruan Wen-jing, 2006, J Zhejiang Univ Sci B, V7, P929, DOI 10.1631/jzus.2006.B0929; Satyamoorthy K, 2003, CANCER RES, V63, P756; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sparrow LE, 1998, AM J DERMATOPATH, V20, P255, DOI 10.1097/00000372-199806000-00006; SWISSHELM K, 1995, P NATL ACAD SCI USA, V92, P4472, DOI 10.1073/pnas.92.10.4472; Tournier C, 1999, MOL CELL BIOL, V19, P1569; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wang YL, 1996, BRIT J DERMATOL, V134, P269; Wilson EM, 1997, J CLIN ENDOCR METAB, V82, P1301, DOI 10.1210/jc.82.4.1301; Wilson HMP, 2002, CELL GROWTH DIFFER, V13, P205; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	38	668	701	0	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					363	374		10.1016/j.cell.2007.12.032	http://dx.doi.org/10.1016/j.cell.2007.12.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267069	Bronze, Green Accepted			2022-12-24	WOS:000253180700012
J	Asagiri, M; Hirai, T; Kunigami, T; Kamano, S; Gober, HJ; Okamoto, K; Nishikawa, K; Latz, E; Golenbock, DT; Aoki, K; Ohya, K; Imai, Y; Morishita, Y; Miyazono, K; Kato, S; Saftig, P; Takayanagi, H				Asagiri, Masataka; Hirai, Toshitake; Kunigami, Toshihiro; Kamano, Shunya; Gober, Hans-Juergen; Okamoto, Kazuo; Nishikawa, Keizo; Latz, Eicke; Golenbock, Douglas T.; Aoki, Kazuhiro; Ohya, Keiichi; Imai, Yuuki; Morishita, Yasuyuki; Miyazono, Kohei; Kato, Shigeaki; Saftig, Paul; Takayanagi, Hiroshi			Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis	SCIENCE			English	Article							LYSOSOMAL CYSTEINE PROTEASES; ANTIGEN PRESENTATION; DENDRITIC CELLS; INNATE IMMUNITY; BONE LOSS; T-CELLS; PYCNODYSOSTOSIS; AUTOIMMUNITY; ACTIVATION; ADJUVANTS	Cathepsin K was originally identified as an osteoclast- specific lysosomal protease, the inhibitor of which has been considered might have therapeutic potential. We show that inhibition of cathepsin K could potently suppress autoimmune inflammation of the joints as well as osteoclastic bone resorption in autoimmune arthritis. Furthermore, cathepsin K-/- mice were resistant to experimental autoimmune encephalomyelitis. Pharmacological inhibition or targeted disruption of cathepsin K resulted in defective Toll- like receptor 9 signaling in dendritic cells in response to unmethylated CpG DNA, which in turn led to attenuated induction of T helper 17 cells, without affecting the antigen- presenting ability of dendritic cells. These results suggest that cathepsin K plays an important role in the immune system and may serve as a valid therapeutic target in autoimmune diseases.	[Asagiri, Masataka; Hirai, Toshitake; Kunigami, Toshihiro; Kamano, Shunya; Gober, Hans-Juergen; Okamoto, Kazuo; Nishikawa, Keizo; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch, Dept Cell Signaling, Tokyo 1138549, Japan; [Asagiri, Masataka; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Ctr Excellence Program Frontier Res Mol Destruct, Tokyo 1138549, Japan; [Aoki, Kazuhiro; Ohya, Keiichi] Tokyo Med & Dent Univ, Grad Sch, Pharmacol Sect, Dept Hard Tissue Engn, Tokyo 1138549, Japan; [Hirai, Toshitake; Kunigami, Toshihiro] Nippon Chemiphar Co Ltd, Saitama 3410005, Japan; [Kamano, Shunya] Juntendo Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1138421, Japan; [Latz, Eicke; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Imai, Yuuki; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Morishita, Yasuyuki; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; [Imai, Yuuki; Kato, Shigeaki] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Kawaguchi, Saitama 3320012, Japan; [Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Juntendo University; University of Massachusetts System; University of Massachusetts Worcester; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Kiel	Takayanagi, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Cell Signaling, Tokyo 1138549, Japan.	taka.csi@tmd.ac.jp	Saftig, Paul/A-7966-2010; Latz, Eicke/H-3951-2014; Imai, Yuuki/ABC-4687-2020; AOKI, Kazuhiro/GRO-6475-2022	Latz, Eicke/0000-0003-1488-5666; AOKI, Kazuhiro/0000-0001-6643-6315				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Holmdahl R, 2001, IMMUNOL REV, V184, P184, DOI 10.1034/j.1600-065x.2001.1840117.x; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Ochi S, 2007, P NATL ACAD SCI USA, V104, P11394, DOI 10.1073/pnas.0701971104; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Ronaghy A, 2002, J IMMUNOL, V168, P51, DOI 10.4049/jimmunol.168.1.51; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Segal BM, 2000, J IMMUNOL, V164, P5683, DOI 10.4049/jimmunol.164.11.5683; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Yasuda Y, 2005, ADV DRUG DELIVER REV, V57, P973, DOI 10.1016/j.addr.2004.12.013	25	252	264	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					624	627		10.1126/science.1150110	http://dx.doi.org/10.1126/science.1150110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239127				2022-12-24	WOS:000252772000042
J	Sliwa, K; Wilkinson, D; Hansen, C; Ntyintyane, L; Tibazarwa, K; Becker, A; Stewart, S				Sliwa, Karen; Wilkinson, David; Hansen, Craig; Ntyintyane, Lucas; Tibazarwa, Kemi; Becker, Anthony; Stewart, Simon			Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study	LANCET			English	Article							CARDIOVASCULAR-DISEASE; MANAGEMENT; BURDEN; HEALTH; PREVENTION; TRANSITION; FAILURE	Background The Heart of Soweto Study aims to increase our understanding of the characteristics and burden imposed by heart disease in an urban African community in probable epidemiological transition. We aimed to investigate the clinical range of disorders related to cardiovascular disease in patients presenting for the first time to a tertiary-care centre. Methods From Jan 1 to Dec 31, 2006, we recorded data for 4162 patients with confirmed cases of cardiovascular disease (1593 newly diagnosed and 2569 previously diagnosed and under treatment) who attended the cardiology unit at the Chris Hani Baragwanath Hospital in Soweto, South Africa. We developed a prospectively designed registry and gathered detailed clinical data relating to the presentation, investigations, and treatment of all 1593 patients with newly diagnosed cardiovascular disease. Findings Most patients were black Africans (n=1359 [85%]), and the study population contained more women (n=939 [59%]) than men. Women were slightly younger than were men (mean 53 [SD 16] years vs 55 [15] years; p=0 . 031), with 399 (25%) patients younger than 40 years. Heart failure was the most common primary diagnosis (704 cases, 44% of total). Moderate to severe systolic dysfunction was evident in 415 (53%) of 844 identified cases of heart failure, 577 (68%) of which were attributable to dilated cardiomyopathy or hypertensive heart disease, or both. Black Africans were more likely to be diagnosed with heart failure than were the rest of the cohort (739 [54%] vs 105 [45%]; odds ratio [OR] 1. 46, 95% Cl 1. 11-1 . 94; p=0.009) but were less likely to be diagnosed with coronary artery disease (77 [6%] vs 88 [38%]; OR 0.10, 0.07-0.14; p<0.0001). Prevalence of cardiovascular risk factors was very high, with 897 (56%) patients diagnosed with hypertension (190 [44%] of whom were also obese). Only 209 (13%) patients had no identifiable risk factors, whereas 933 (59%) had several risk factors. Interpretation We noted many threats to the present and future cardiac health of Soweto, including a high prevalence of modifiable risk factors for atherosclerotic disease and a combination of infectious and non-communicable forms of heart disease, with late clinical presentations. Overall, our findings provide strong evidence that epidemiological transition in Soweto, South Africa has broadened the complexity and spectrum of heart disease in this community. This registry will enable continued monitoring of the range of heart disease.	[Sliwa, Karen; Wilkinson, David; Ntyintyane, Lucas; Tibazarwa, Kemi; Becker, Anthony; Stewart, Simon] Univ Witwatersrand, Soweto Cardiovasc Res Unit, Chris Hani Baragwanath Hosp, ZA-2013 Johannesburg, South Africa; [Wilkinson, David; Hansen, Craig] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Stewart, Simon] Baker Heart Res Inst, Melbourne, Vic, Australia	University of Witwatersrand; University of Queensland; Baker Heart and Diabetes Institute	Stewart, S (corresponding author), Univ Witwatersrand, Soweto Cardiovasc Res Unit, Chris Hani Baragwanath Hosp, POBertsham, ZA-2013 Johannesburg, South Africa.	simon.stewart@baker.edu.au	Stewart, Simon/M-3316-2016; Hansen, Craig/C-7543-2014; Wilkinson, David/A-6207-2008	Stewart, Simon/0000-0001-9032-8998; Hansen, Craig/0000-0002-5227-0155; Wilkinson, David/0000-0002-7265-9846; Sliwa, Karen/0000-0002-8272-0911				AMIRA C, 2006, S AFR HEART J, V3, P7; BARLOW JB, 1990, S AFR MED J, V78, P181; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Commerford P, 2006, LANCET, V367, P1884, DOI 10.1016/S0140-6736(06)68822-3; ESSOP MR, 1993, J AM COLL CARDIOL, V22, P826, DOI 10.1016/0735-1097(93)90197-9; *EUR SOC CARD, ESC GUID; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Gaziano TA, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P645; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Kengne Andre Pascal, 2007, Afr Health Sci, V7, P38; Kruger R, 2006, PUBLIC HEALTH NUTR, V9, P351, DOI 10.1079/PHN2006849; Lawoyin T O, 2002, West Afr J Med, V21, P208; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Mark DB, 2007, EUR HEART J, V28, P2678, DOI 10.1093/eurheartj/ehm411; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; Mayosi BM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-2; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; PEARSON TA, 1993, DIS CONTROL PRIORITI, P577; Prineas R., 1982, MINNESOTA CODE MANUA; Robertson KA, 2006, SAMJ S AFR MED J, V96, P241; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Shisana O, 2006, SAMJ S AFR MED J, V96, P814; Sliwa K, 2005, CIRCULATION, V112, P3577, DOI 10.1161/CIRCULATIONAHA.105.542894; Stewart S, 2006, INT J CARDIOL, V108, P101, DOI 10.1016/j.ijcard.2006.01.001; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; STEYN K, 2006, CHRONIC DIS LIFESTYL, P1; Tibazarwa K, 2009, INT J CARDIOL, V132, P233, DOI 10.1016/j.ijcard.2007.11.067; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; *WHO, 2005, GLOB BURD COR HEART, pCH13; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	33	274	276	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2008	371	9616					915	922		10.1016/S0140-6736(08)60417-1	http://dx.doi.org/10.1016/S0140-6736(08)60417-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275FH	18342686				2022-12-24	WOS:000254056800028
J	Wickens, M; Kwak, JE				Wickens, Marvin; Kwak, Jae Eun			Molecular biology - A tail tale for U	SCIENCE			English	Editorial Material							MESSENGER-RNA; POLYMERASES		[Wickens, Marvin; Kwak, Jae Eun] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Wickens, M (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	wickens@biochem.wisc.edu						Aphasizhev R, 2005, CELL MOL LIFE SCI, V62, P2194, DOI 10.1007/s00018-005-5198-9; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; LUND E, 1992, SCIENCE, V255, P327, DOI 10.1126/science.1549778; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Song MG, 2007, RNA, V13, P2356, DOI 10.1261/rna.765807; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Trippe R, 2006, RNA, V12, P1494, DOI 10.1261/rna.87706	13	20	21	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1344	1345		10.1126/science.1154946	http://dx.doi.org/10.1126/science.1154946			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323438				2022-12-24	WOS:000253712900027
J	Langer, A; Villar, J; Tell, K; Kim, T; Kennedy, S				Langer, Ana; Villar, Jose; Tell, Katie; Kim, Theresa; Kennedy, Stephen			Reducing eclampsia-related deaths - a call to action	LANCET			English	Editorial Material							HYPERTENSIVE DISORDERS; MAGNESIUM-SULFATE; PREECLAMPSIA; PREGNANCY; TRIAL; WOMEN		[Langer, Ana; Tell, Katie; Kim, Theresa] EngenderHlth, New York, NY 10001 USA; [Villar, Jose; Kennedy, Stephen] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	University of Oxford	Langer, A (corresponding author), EngenderHlth, New York, NY 10001 USA.	alanger@engenderhealth.org	Kennedy, Stephen/B-8950-2009					DULEY L, 1995, LANCET, V345, P1455; Duley L, 2003, BRIT MED BULL, V67, P161, DOI 10.1093/bmb/ldg005; DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; MAHLER H, 1987, LANCET, V1, P668; Sevene E, 2005, BMJ-BRIT MED J, V331, P765, DOI 10.1136/bmj.331.7519.765; WHO, 1994, MOTH BAB PACK IMPL S; 2007, LANCET, V370, P1283	9	30	32	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 1	2008	371	9614					705	706		10.1016/S0140-6736(08)60321-9	http://dx.doi.org/10.1016/S0140-6736(08)60321-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313488				2022-12-24	WOS:000253596700008
J	Jiang, W; Baker, ML; Jakana, J; Weigele, PR; King, J; Chiu, W				Jiang, Wen; Baker, Matthew L.; Jakana, Joanita; Weigele, Peter R.; King, Jonathan; Chiu, Wah			Backbone structure of the infectious epsilon 15 virus capsid revealed by electron cryomicroscopy	NATURE			English	Article							DENSITY MAPS; PROTEIN; VIRUSES; BACTERIOPHAGES; MICROSCOPY; PARTICLES; ALGORITHM; EVOLUTION; TOPOLOGY; BINDING	A half- century after the determination of the first three-dimensional crystal structure of a protein(1), more than 40,000 structures ranging from single polypeptides to large assemblies have been reported(2). The challenge for crystallographers, however, remains the growing of a diffracting crystal. Here we report the 4.5- angstrom resolution structure of a 22-MDa macromolecular assembly, the capsid of the infectious epsilon15 ( epsilon 15) particle, by single-particle electron cryomicroscopy. From this density map we constructed a complete backbone trace of its major capsid protein, gene product 7 ( gp7). The structure reveals a similar protein architecture to that of other tailed double- stranded DNA viruses, even in the absence of detectable sequence similarity(3,4). However, the connectivity of the secondary structure elements ( topology) in gp7 is unique. Protruding densities are observed around the two- fold axes that cannot be accounted for by gp7. A subsequent proteomic analysis of the whole virus identifies these densities as gp10, a 12- kDa protein. Its structure, location and high binding affinity to the capsid indicate that the gp10 dimer functions as a molecular staple between neighbouring capsomeres to ensure the particle's stability. Beyond epsilon 15, this method potentially offers a new approach for modelling the backbone conformations of the protein subunits in other macromolecular assemblies at near- native solution states.	[Baker, Matthew L.; Jakana, Joanita; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA; [Jiang, Wen] Purdue Univ, Markey Ctr Struct Biol, Dept Biol Sci, W Lafayette, IN 47907 USA; [Weigele, Peter R.; King, Jonathan] MIT, Dept Biol, Cambridge, MA 02139 USA	Baylor College of Medicine; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Massachusetts Institute of Technology (MIT)	Chiu, W (corresponding author), Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA.	jiang12@purdue.edu; wah@bcm.edu	Weigele, Peter/AIE-8230-2022; jiang, wen/GYI-9662-2022	Weigele, Peter/0000-0003-3696-4541; Jiang, Wen/0000-0002-1292-2411				Agrawal V, 2001, BMC Struct Biol, V1, P5, DOI 10.1186/1472-6807-1-5; Baker ML, 2007, STRUCTURE, V15, P7, DOI 10.1016/j.str.2006.11.008; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Bamford DH, 2005, CURR OPIN STRUC BIOL, V15, P655, DOI 10.1016/j.sbi.2005.10.012; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chen Dong-hua, 2007, Journal of Chinese Electron Microscopy Society, V26, P473; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUJIYOSHI Y, 1991, ULTRAMICROSCOPY, V38, P241, DOI 10.1016/0304-3991(91)90159-4; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; HARAUZ G, 1986, OPTIK, V73, P146; Hendrix RW, 1998, ADV VIRUS RES, V50, P235, DOI 10.1016/S0065-3527(08)60810-6; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Iwasaki K, 2000, VIROLOGY, V271, P321, DOI 10.1006/viro.2000.0321; Jewett AI, 2003, BIOINFORMATICS, V19, P625, DOI 10.1093/bioinformatics/btg035; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; King J, 1996, FASEB J, V10, P57, DOI 10.1096/fasebj.10.1.8566549; Kivioja T, 2000, J STRUCT BIOL, V131, P126, DOI 10.1006/jsbi.2000.4279; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Pan JH, 2007, P NATL ACAD SCI USA, V104, P7385, DOI 10.1073/pnas.0611599104; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; PREVELIGE PE, 1993, PROG MED VIROL, V40, P206; Saad A, 2001, J STRUCT BIOL, V133, P32, DOI 10.1006/jsbi.2001.4330; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Tang L, 2006, STRUCTURE, V14, P837, DOI 10.1016/j.str.2006.03.010; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yang F, 2000, NAT STRUCT BIOL, V7, P230; Yuan X, 2005, BIOINFORMATICS, V21, P1010, DOI 10.1093/bioinformatics/bti128	35	172	180	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1130	U12		10.1038/nature06665	http://dx.doi.org/10.1038/nature06665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305544				2022-12-24	WOS:000253453600047
J	Sivertsen, A; Wilcox, AJ; Skjaerven, R; Vindenes, HA; Abyholm, F; Harville, E; Lie, RT				Sivertsen, Ase; Wilcox, Allen J.; Skjaerven, Rov; Vindenes, Hallvard Andreas; Abyholm, Frank; Harville, Emily; Lie, Rolv Terje			Familial risk of oral clefts by morphological type and severity: population based cohort study of first degree relatives	BRITISH MEDICAL JOURNAL			English	Article							BIRTH-DEFECTS; RECURRENCE; PALATE; LIP; SURVIVAL; GENETICS; CHILDREN	Objective To estimate the relative risk of recurrence of oral cleft in first degree relatives in relation to cleft morphology. Design Population based cohort study. Setting Data from the medical birth registry of Norway linked with clinical data on virtually all cleft patients treated in Norway over a 35 year period. Participants 2.1 million children born in Norway between 1967 and 2001, 4138 of whom were treated for an oral cleft. Main outcome measure Relative risk of recurrence of isolated clefts from parent to child and between full siblings, for anatomic subgroups of clefts. Results Among first degree relatives, the relative risk of recurrence of cleft was 32 (95% confidence interval 24.6 to 40.3) for any cleft lip and 56 (37.2 to 84.8) for cleft palate only (P difference=0.02). The risk of clefts among children of affected mothers and affected fathers was similar. Risks of recurrence were also similar for parent-offspring and sibling-sibling pairs. The "crossover" risk between any cleft lip and cleft palate only was 3.0 (1.3 to 6.7). The severity of the primary case was unrelated to the risk of recurrence. Conclusions The stronger family recurrence of cleft palate only suggests a larger genetic component for cleft palate only than for any cleft lip. The weaker risk of crossover between the two types of cleft indicates relatively distinct causes. The similarity of mother-offspring, father-offspring, and sibling-sibling risks is consistent with genetic risk that works chiefly through fetal genes. Anatomical severity does not affect the recurrence risk in first degree relatives, which argues against a multifactorial threshold model of causation.	[Sivertsen, Ase; Vindenes, Hallvard Andreas] Haukeland Hosp, Dept Plast Surg, NO-5021 Bergen, Norway; [Sivertsen, Ase; Skjaerven, Rov; Lie, Rolv Terje] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5018 Bergen, Norway; [Wilcox, Allen J.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Abyholm, Frank] Univ Oslo, Rikshosp, Dept Plast Surg, N-0027 Oslo, Norway; [Harville, Emily] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA	University of Bergen; Haukeland University Hospital; University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Oslo; National Hospital Norway; Tulane University	Sivertsen, A (corresponding author), Haukeland Hosp, Dept Plast Surg, NO-5021 Bergen, Norway.	ase.sivertsen@isf.uib.no	Wilcox, Allen J/C-7723-2019	Wilcox, Allen J/0000-0002-3376-1311	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049027] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDCR NIH HHS [2R01 DE-11948-04] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CARTER CO, 1970, MULTIFACTORIAL INHER; Christensen K, 1996, AM J HUM GENET, V58, P182; Firth HV, 2005, OXFORD DESK REFERENC; Fogh-Andersen, 1942, INHERITANCE HARELIP; FOGHANDERSEN P, 1942, THESIS U COPENHAGEN; FRASER FC, 1976, TERATOLOGY, V14, P267, DOI 10.1002/tera.1420140302; Gorlin RJ, 2001, OROFACIAL CLEFTING S; HARPER PS, 1998, PRACTICAL GENETIC CO; Lidral AC, 2004, BIRTH DEFECTS RES A, V70, P893, DOI 10.1002/bdra.20096; Lie RT, 2007, PAEDIATR PERINAT EP, V21, P13, DOI 10.1111/j.1365-3016.2007.00832.x; LIE RT, 1994, NEW ENGL J MED, V331, P1, DOI 10.1056/NEJM199407073310101; Lie RT, 2001, JAMA-J AM MED ASSOC, V285, P755, DOI 10.1001/jama.285.6.755; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; MELNICK M, 1992, AM J MED GENET, V42, P10, DOI 10.1002/ajmg.1320420104; Mitchell LE, 1996, AM J MED GENET, V61, P371, DOI 10.1002/(SICI)1096-8628(19960202)61:4<371::AID-AJMG12>3.0.CO;2-P; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; Mossey P., 2002, CLEFT LIP PALATE, P127; Mueller Robert F., 2001, EMERYS ELEMENTS MED; NUSSBAUM RL, 2001, THOMPSON THOMPSON GE; Robert E, 1996, J CRAN GENET DEV BIO, V16, P234; SIVERTSEN A, IN PRESS PLAST RECON; Skjaerven R, 1999, NEW ENGL J MED, V340, P1057, DOI 10.1056/NEJM199904083401401; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Wyszynski DF, 1996, CLEFT PALATE-CRAN J, V33, P406, DOI 10.1597/1545-1569(1996)033<0406:GONOCR>2.3.CO;2	25	118	124	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 23	2008	336	7641					432	434A		10.1136/bmj.39458.563611.AE	http://dx.doi.org/10.1136/bmj.39458.563611.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269QM	18250102	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000253664000039
J	Chen, Y; Yang, YT; van Overbeek, M; Donigian, JR; Baciu, P; de Lange, T; Lei, M				Chen, Yong; Yang, Yuting; van Overbeek, Megan; Donigian, Jill R.; Baciu, Paul; de Lange, Titia; Lei, Ming			A shared docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins	SCIENCE			English	Article							DNA; COMPLEX; TIN2; POLYMERASE; INTERACTS; APOLLO	Mammalian telomeres are protected by a six- protein complex: shelterin. Shelterin contains two closely related proteins ( TRF1 and TRF2), which recruit various proteins to telomeres. We dissect the interactions of TRF1 and TRF2 with their shared binding partner ( TIN2) and other shelterin accessory factors. TRF1 recognizes TIN2 using a conserved molecular surface in its TRF homology ( TRFH) domain. However, this same surface does not act as a TIN2 binding site in TRF2, and TIN2 binding to TRF2 is mediated by a region outside the TRFH domain. Instead, the TRFH docking site of TRF2 binds a shelterin accessory factor ( Apollo), which does not interact with the TRFH domain of TRF1. Conversely, the TRFH domain of TRF1, but not of TRF2, interacts with another shelterin- associated factor: PinX1.	[Chen, Yong; Yang, Yuting; Baciu, Paul; Lei, Ming] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [van Overbeek, Megan; Donigian, Jill R.; de Lange, Titia] Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10065 USA	University of Michigan System; University of Michigan; Rockefeller University	Lei, M (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	leim@umich.edu	Chen, Yong/AAF-9915-2020; de Lange, Titia/B-8263-2011; chen, Yong/F-3938-2010	Chen, Yong/0000-0001-5857-6086; de Lange, Titia/0000-0002-9267-367X; 				Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Fotiadou P, 2004, CANCER RES, V64, P3830, DOI 10.1158/0008-5472.CAN-04-0136; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Nishikawa T, 2001, STRUCTURE, V9, P1237, DOI 10.1016/S0969-2126(01)00688-8; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	17	186	195	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1092	1096		10.1126/science.1151804	http://dx.doi.org/10.1126/science.1151804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18202258				2022-12-24	WOS:000253311700044
J	Fudge, N; Wolfe, CDA; McKevitt, C				Fudge, Nina; Wolfe, Charles D. A.; McKevitt, Christopher			Assessing the promise of user involvement in health service development: ethnographic study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOCIAL-MOVEMENTS; PARTICIPATION; DELIVERY; PEOPLE; IMPACT; POWER	Objectives To understand how the policy of user involvement is interpreted in health service organisations and to identify factors that influence how user involvement is put into practice. Design Ethnographic study using participant observation, interviews, and collection of documentary evidence. Setting A multiagency modernisation programme to improve stroke services in two London boroughs. Participants Service users, National Health Service managers, and clinicians. Results User involvement in the programme was initiated and led by professionals. Professionals determined the areas of service improvement service users could participate in. A wide range of activities were considered "user involvement," from patient satisfaction surveys to service users delivering peer support. Involvement tended to be most active in the least technical areas and areas with least input from clinicians. Factors that might explain this included organisational structure, the vagueness of the concept of user involvement, the value attributed to service users' experiential knowledge, and variations in professional and service user understandings of and commitment to involvement. The gains of involvement were harder to identify in terms of impact on services. More evident were the personal gains for those involved: satisfaction of feeling listened to by professionals, social opportunities of meeting others in a similar situation, and increased knowledge about stroke and services available. Conclusions User involvement may not automatically lead to improved service quality. Healthcare professionals and service users understand and practise user involvement in different ways according to individual ideologies, circumstances, and needs. Given the resource implications of undertaking user involvement in service development there is a need for critical debate on the purpose of such involvement as well as better evidence of the benefits claimed for it.	[Fudge, Nina; Wolfe, Charles D. A.; McKevitt, Christopher] Kings Coll London, Div Hlth & Social Care Res, London SE1 3QD, England; [Wolfe, Charles D. A.] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res Comprehens Biomed Res Ctr, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Fudge, N (corresponding author), Kings Coll London, Div Hlth & Social Care Res, London SE1 3QD, England.	nina.fudge@kcl.ac.uk	mckevitt, christopher/AAN-7271-2021	Wolfe, Charles/0000-0001-8264-0981; Fudge, Nina/0000-0002-7161-4355; MCKEVITT, CHRISTOPHER/0000-0002-5290-4613	National Institute for Health Research [RP-PG-0407-10184] Funding Source: researchfish; Department of Health [RP-PG-0407-10184] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		[Anonymous], 1988, BRIT MED J, V297, P126; *ASS PUBL HLTH OBS, 2006, COMM HLTH PROF LAMB; *ASS PUBL HLTH OBS, 2006, COMM HLTH PROF SOUTH; Beresford P, 2007, HEALTH SOC CARE COMM, V15, P306, DOI 10.1111/j.1365-2524.2007.00688.x; Brown P, 2004, SOCIOL HEALTH ILL, V26, P679, DOI 10.1111/j.0141-9889.2004.00413.x; Contandriopoulos D, 2004, SOC SCI MED, V58, P321, DOI 10.1016/S0277-9536(03)00164-3; Crawford MJ, 2003, ACTA PSYCHIAT SCAND, V107, P410, DOI 10.1034/j.1600-0447.2003.00049.x; Crawford MJ, 2002, BRIT MED J, V325, P1263, DOI 10.1136/bmj.325.7375.1263; DAVIES CA, 1999, RELFEXIVE ETHNOGRAPH; DAYKIN N, 2004, CRITICAL PUBLIC HLTH, V14, P277; *DEP HLTH, 2001, SHIFT BAL POW NEXT S; Department of Health, 2005, CREAT PAT LED NHS; Farrell C., 2004, PATIENT PUBLIC INVOL; FLETCHER G, 2003, OBSTET GYNAECOLOGIST, V5, P218; Florin D, 2004, BRIT MED J, V328, P159, DOI 10.1136/bmj.328.7432.159; Hammersley M., 1995, ETHNOGRAPHY PRINCIPL; Harrison S, 2002, HEALTH SOC CARE COMM, V10, P63, DOI 10.1046/j.1365-2524.2002.00342.x; Hodge S, 2005, CRIT SOC POLICY, V25, P164, DOI 10.1177/0261018305051324; Kolker ES, 2004, SOCIOL HEALTH ILL, V26, P820, DOI 10.1111/j.0141-9889.2004.00420.x; Lambert H, 2002, BRIT MED J, V325, P210, DOI 10.1136/bmj.325.7357.210; Low JTS, 1999, SOC SCI MED, V49, P711, DOI 10.1016/S0277-9536(99)00194-X; Milewa T, 1999, SOCIOL HEALTH ILL, V21, P445, DOI 10.1111/1467-9566.00166; Murphy E., 2003, QUALITATIVE METHODS; National Audit Office, 2005, RED BRAIN DAM FAST A; Nilsen ES, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004563.pub2; Roy CM, 2001, AIDS CARE, V13, P421, DOI 10.1080/09540120120057950; Rutter D, 2004, SOC SCI MED, V58, P1973, DOI 10.1016/S0277-9536(03)00401-5; Savage J, 2000, BMJ-BRIT MED J, V321, P1400, DOI 10.1136/bmj.321.7273.1400; Simpson EL, 2002, BRIT MED J, V325, P1265, DOI 10.1136/bmj.325.7375.1265; St John of God Health Care, 2019, OUR VIS; Wellard Sally, 2003, Int J Nurs Pract, V9, P255, DOI 10.1046/j.1440-172X.2003.00429.x; Wilson T, 2005, BMJ-BRIT MED J, V330, P657, DOI 10.1136/bmj.330.7492.657; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	33	107	107	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2008	336	7639					313	+		10.1136/bmj.39456.552257.BE	http://dx.doi.org/10.1136/bmj.39456.552257.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	266LR	18230646	Green Submitted, Green Published			2022-12-24	WOS:000253437400032
J	Carr, JS; Najita, JR				Carr, John S.; Najita, Joan R.			Organic molecules and water in the planet formation region of young circumstellar disks	SCIENCE			English	Article							T-TAURI STARS; EMISSION; GAS; SPECTROGRAPH; SPECTRA; H2O; IRS	The chemical composition of protoplanetary disks is expected to hold clues to the physical and chemical processes that influence the formation of planetary systems. However, characterizing the gas composition in the planet formation region of disks has been a challenge to date. We report here that the protoplanetary disk within 3 astronomical units of AA Tauri possesses a rich molecular emission spectrum in the mid- infrared, indicating a high abundance of simple organic molecules ( HCN, C2H2, and CO2), water vapor, and OH. These results suggest that water is abundant throughout the inner disk and that the disk supports an active organic chemistry.	[Carr, John S.] USN, Res Lab, Remote Sensing Div, Washington, DC 20375 USA; [Najita, Joan R.] Natl Opt Astron Observ, Tucson, AZ 85719 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; National Optical Astronomy Observatory	Carr, JS (corresponding author), USN, Res Lab, Remote Sensing Div, Code 7210, Washington, DC 20375 USA.							BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; Bockelee-Morvan D, 2004, SPACE SCI S, P391; Boonman AMS, 2003, ASTRON ASTROPHYS, V399, P1063, DOI 10.1051/0004-6361:20021868; Boonman AMS, 2003, ASTRON ASTROPHYS, V403, P1003, DOI 10.1051/0004-6361:20030364; Carr JS, 2004, ASTROPHYS J, V603, P213, DOI 10.1086/381356; CECCARELLI C, 2007, PROTOSTARS PLANETS, V5, P47; Ciesla F.J., 2006, METEORITES EARLY SOL, VII, P209; Ciesla FJ, 2006, ICARUS, V181, P178, DOI 10.1016/j.icarus.2005.11.009; Ciesla FJ, 2007, SCIENCE, V318, P613, DOI 10.1126/science.1147273; DUTREY A, 2007, PROTOSTARS PLANETS, V5, P495; Furlan E, 2006, ASTROPHYS J SUPPL S, V165, P568, DOI 10.1086/505468; Glassgold AE, 2004, ASTROPHYS J, V615, P972, DOI 10.1086/424509; Houck JR, 2004, ASTROPHYS J SUPPL S, V154, P18, DOI 10.1086/423134; Kessler-Silacci J, 2006, ASTROPHYS J, V639, P275, DOI 10.1086/499330; Lahuis F, 2000, ASTRON ASTROPHYS, V355, P699; Lahuis F, 2006, ASTROPHYS J, V636, pL145, DOI 10.1086/500084; Markwick AJ, 2002, ASTRON ASTROPHYS, V385, P632, DOI 10.1051/0004-6361:20020050; McLean IS, 2000, P SOC PHOTO-OPT INS, V4008, P1048, DOI 10.1117/12.395422; Najita J, 1996, ASTROPHYS J, V462, P919, DOI 10.1086/177205; Najita J, 2003, ASTROPHYS J, V589, P931, DOI 10.1086/374809; Nomura H, 2007, ASTROPHYS J, V661, P334, DOI 10.1086/513419; Reipurth B., 2007, PROTOSTARS PLANETS, VV, P507; STEVENSON DJ, 1988, ICARUS, V75, P146, DOI 10.1016/0019-1035(88)90133-9; Turner NJ, 2006, ASTROPHYS J, V639, P1218, DOI 10.1086/499486; Werner MW, 2004, ASTROPHYS J SUPPL S, V154, P1, DOI 10.1086/422992; Willacy K, 1998, ASTRON ASTROPHYS, V338, P995	26	239	239	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1504	1506		10.1126/science.1153807	http://dx.doi.org/10.1126/science.1153807			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339932				2022-12-24	WOS:000253943800031
J	Chung, CH; Mirakhur, B; Chan, E; Le, Q; Berlin, J; Morse, M; Murphy, BA; Satinover, SM; Hosen, J; Mauro, D; Slebos, RJ; Zhou, QW; Gold, D; Hatley, T; Hicklin, DJ; Platts-Mills, TAE				Chung, Christine H.; Mirakhur, Beloo; Chan, Emily; Le, Quynh-Thu; Berlin, Jordan; Morse, Michael; Murphy, Barbara A.; Satinover, Shama M.; Hosen, Jacob; Mauro, David; Slebos, Robbert J.; Zhou, Qinwei; Gold, Diane; Hatley, Tina; Hicklin, Daniel J.; Platts-Mills, Thomas A. E.			Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; INFUSION REACTIONS; COLORECTAL-CANCER; MONOCLONAL-ANTIBODIES; PREVALENCE; ALLERGENS; SWEDEN; IMMUNOTHERAPY; DEFINITION; EXPERIENCE	Background: Cetuximab, a chimeric mouse-human IgG1 monoclonal antibody against the epidermal growth factor receptor, is approved for use in colorectal cancer and squamous-cell carcinoma of the head and neck. A high prevalence of hypersensitivity reactions to cetuximab has been reported in some areas of the United States. Methods: We analyzed serum samples from four groups of subjects for IgE antibodies against cetuximab: pretreatment samples from 76 case subjects who had been treated with cetuximab at multiple centers, predominantly in Tennessee, Arkansas, and North Carolina; samples from 72 control subjects in Tennessee; samples from 49 control subjects with cancer in northern California; and samples from 341 female control subjects in Boston. Results: Among 76 cetuximab-treated subjects, 25 had a hypersensitivity reaction to the drug. IgE antibodies against cetuximab were found in pretreatment samples from 17 of these subjects; only 1 of 51 subjects who did not have a hypersensitivity reaction had such antibodies (P<0.001). IgE antibodies against cetuximab were found in 15 of 72 samples (20.8%) from control subjects in Tennessee, in 3 of 49 samples (6.1%) from northern California, and in 2 of 341 samples (0.6%) from Boston. The IgE antibodies were shown to be specific for an oligosaccharide, galactose-alpha-1,3-galactose, which is present on the Fab portion of the cetuximab heavy chain. Conclusions: In most subjects who had a hypersensitivity reaction to cetuximab, IgE antibodies against cetuximab were present in serum before therapy. The antibodies were specific for galactose-alpha-1,3-galactose.	[Satinover, Shama M.; Hosen, Jacob; Platts-Mills, Thomas A. E.] Univ Virginia, Sch Med, Asthma & Allerg Dis Ctr, Charlottesville, VA 22908 USA; [Zhou, Qinwei; Hicklin, Daniel J.] ImClone Syst, Branchburg, NJ USA; [Gold, Diane] Harvard Univ, Channing Lab, Boston, MA 02115 USA; [Hatley, Tina] Allergy & Asthma Clin NW Arkansas, Bentonville, AK USA; [Chung, Christine H.; Chan, Emily; Berlin, Jordan; Murphy, Barbara A.] Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med, Nashville, TN 37212 USA; [Chung, Christine H.; Slebos, Robbert J.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Slebos, Robbert J.] Vanderbilt Univ, Sch Med, Dept Otolaryngol, Nashville, TN 37212 USA; [Mirakhur, Beloo; Mauro, David] Bristol Myers Squibb Co, Plainsboro, NJ USA; [Le, Quynh-Thu] Stanford Univ, Sch Med, Menlo Pk, CA USA; [Morse, Michael] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	University of Virginia; Eli Lilly; Harvard University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Bristol-Myers Squibb; Stanford University; Duke University	Platts-Mills, TAE (corresponding author), Univ Virginia, Sch Med, Asthma & Allerg Dis Ctr, Box 801355, Charlottesville, VA 22908 USA.	tap2z@virginia.edu	Hosen, Jacob/F-9224-2013	Hosen, Jacob/0000-0003-2559-0687; Le, Quynh Thu/0000-0002-3682-1439; Platts-Mills, Thomas/0000-0002-1263-329X	NATIONAL CANCER INSTITUTE [R01CA118582, P50CA095103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI035796, R01AI020565, R37AI020565, R01AI035796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017982] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adedoyin J, 2007, J ALLERGY CLIN IMMUN, V119, P640, DOI 10.1016/j.jaci.2006.11.637; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cavalier E, 2006, ANN BIOL CLIN-PARIS, V64, P91; CHAPMAN MD, 1988, J IMMUNOL, V140, P812; Cheifetz A, 2005, MT SINAI J MED, V72, P250; Cheifetz A, 2003, AM J GASTROENTEROL, V98, P1315, DOI 10.1016/S0002-9270(03)00231-4; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cook-Bruns N, 2001, ONCOLOGY-BASEL, V61, P58, DOI 10.1159/000055403; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P1029, DOI 10.1016/j.jaci.2004.12.1131; Florvaag E, 2005, ACTA ANAESTH SCAND, V49, P437, DOI 10.1111/j.1399-6576.2004.00591.x; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; Johansson SGO, 2005, ALLERGY, V60, P1312, DOI 10.1111/j.1398-9995.2005.00896.x; *JOINT TASK FORC P, 2005, J ALLERGY CLIN IM S2, V0115, pS 483; Koike C, 2007, P NATL ACAD SCI USA, V104, P559, DOI 10.1073/pnas.0610012104; Lewis SA, 2002, AM J RESP CRIT CARE, V165, P961, DOI 10.1164/ajrccm.165.7.2103044; Milland J, 2006, TISSUE ANTIGENS, V68, P459, DOI 10.1111/j.1399-0039.2006.00721.x; Needle MN, 2002, SEMIN ONCOL, V29, P55, DOI 10.1053/sonc.2002.35648; O'Neil BH, 2007, J CLIN ONCOL, V25, P3644, DOI 10.1200/JCO.2007.11.7812; Paschinger K, 2005, ACTA BIOCHIM POL, V52, P629; Platts-Mills TAE, 2007, J ALLERGY CLIN IMMUN, V120, P1058, DOI 10.1016/j.jaci.2007.06.032; Qian J, 2007, ANAL BIOCHEM, V364, P8, DOI 10.1016/j.ab.2007.01.023; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Sampson HA, 2005, J ALLERGY CLIN IMMUN, V115, P584, DOI 10.1016/j.jaci.2005.01.009; vanderVeen MJ, 1997, J ALLERGY CLIN IMMUN, V100, P327, DOI 10.1016/S0091-6749(97)70245-8; [No title captured]	28	1005	1075	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1109	1117		10.1056/NEJMoa074943	http://dx.doi.org/10.1056/NEJMoa074943			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337601	Bronze, Green Accepted			2022-12-24	WOS:000253877200004
J	He, Y; Ye, T; Su, M; Zhang, C; Ribbe, AE; Jiang, W; Mao, CD				He, Yu; Ye, Tao; Su, Min; Zhang, Chuan; Ribbe, Alexander E.; Jiang, Wen; Mao, Chengde			Hierarchical self-assembly of DNA into symmetric supramolecular polyhedra	NATURE			English	Article							DESIGN; OCTAHEDRON; ARRAYS	DNA is renowned for its double helix structure and the base pairing that enables the recognition and highly selective binding of complementary DNA strands. These features, and the ability to create DNA strands with any desired sequence of bases, have led to the use of DNA rationally to design various nanostructures and even execute molecular computations(1-4). Of the wide range of self- assembled DNA nanostructures reported, most are one- or two- dimensional(5-9). Examples of three- dimensional DNA structures include cubes(10), truncated octahedra(11), octohedra(12) and tetrahedra(13,14), which are all comprised of many different DNA strands with unique sequences. When aiming for large structures, the need to synthesize large numbers ( hundreds) of unique DNA strands poses a challenging design problem(9,15). Here, we demonstrate a simple solution to this problem: the design of basic DNA building units in such a way that many copies of identical units assemble into larger three- dimensional structures. We test this hierarchical self- assembly concept with DNA molecules that form three- point- star motifs, or tiles. By controlling the flexibility and concentration of the tiles, the one- pot assembly yields tetrahedra, dodecahedra or buckyballs that are tens of nanometres in size and comprised of four, twenty or sixty individual tiles, respectively. We expect that our assembly strategy can be adapted to allow the fabrication of a range of relatively complex three- dimensional structures.	[He, Yu; Ye, Tao; Zhang, Chuan; Ribbe, Alexander E.; Mao, Chengde] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Su, Min; Jiang, Wen] Purdue Univ, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA; [Su, Min; Jiang, Wen] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Mao, CD (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	mao@purdue.edu	jiang, wen/GYI-9662-2022; Zhang, Chuan/B-4349-2014; Mao, Chengde/GPP-1546-2022; Ribbe, Alexander/D-4988-2009; He, Yu/A-6189-2011	Zhang, Chuan/0000-0003-2981-0923; Ribbe, Alexander/0000-0002-9924-3429; Jiang, Wen/0000-0002-1292-2411				ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Feldkamp U, 2006, ANGEW CHEM INT EDIT, V45, P1856, DOI 10.1002/anie.200502358; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; Goodman RP, 2004, CHEM COMMUN, P1372, DOI 10.1039/b402293a; He Y, 2006, CHEM COMMUN, P968, DOI 10.1039/b513962g; He Y, 2005, J AM CHEM SOC, V127, P12202, DOI 10.1021/ja0541938; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Scheffler M, 1999, ANGEW CHEM INT EDIT, V38, P3312; Seeman NC, 2005, Q REV BIOPHYS, V38, P363, DOI 10.1017/S0033583505004087; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006	20	963	1002	20	627	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					198	U41		10.1038/nature06597	http://dx.doi.org/10.1038/nature06597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337818				2022-12-24	WOS:000253925600036
J	Kim, YM; Brinkmann, MM; Paquet, ME; Ploegh, HL				Kim, You-Me; Brinkmann, Melanie M.; Paquet, Marie-Eve; Ploegh, Hidde L.			UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes	NATURE			English	Article							PLASMA-MEMBRANE; CPG-DNA; SUBCELLULAR-LOCALIZATION; EXOGENOUS ANTIGEN; MESSENGER-RNA; PROTEIN; PATHWAY; ER; RECOGNITION; DISTINCT	Signalling by means of toll- like receptors ( TLRs) is essential for the development of innate and adaptive immune responses(1-3). UNC93B1, essential for signalling of TLR3, TLR7 and TLR9 in both humans and mice, physically interacts with these TLRs in the endoplasmic reticulum ( ER)(4-6). Here we show that the function of the polytopic membrane protein UNC93B1 is to deliver the nucleotide- sensing receptors TLR7 and TLR9 from the ER to endolysosomes. In dendritic cells of 3d mice, which express an UNC93B1 missense mutant ( H412R) incapable of TLR binding, neither TLR7 nor TLR9 exits the ER. Furthermore, the trafficking and signalling defects of the nucleotide- sensing TLRs in 3d dendritic cells are corrected by expression of wild- type UNC93B1. However, UNC93B1 is dispensable for ligand recognition and signal initiation by TLRs. To our knowledge, UNC93B1 is the first protein to be identified as a molecule specifically involved in trafficking of nucleotide- sensing TLRs. By inhibiting the interaction between UNC93B1 and TLRs it should be possible to achieve specific regulation of the nucleotide- sensing TLRs without compromising signalling via the cell- surface- disposed TLRs.	[Kim, You-Me; Brinkmann, Melanie M.; Paquet, Marie-Eve; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Kim, YM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ykim@wi.mit.edu; ploegh@wi.mit.edu	Kim, You-Me/I-5553-2013	Kim, You-Me/0000-0001-8780-704X				Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Conley ME, 2007, TRENDS IMMUNOL, V28, P99, DOI 10.1016/j.it.2007.01.001; Franz A, 2007, FEBS LETT, V581, P401, DOI 10.1016/j.febslet.2006.12.048; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Juschke C, 2004, CURR BIOL, V14, P406, DOI 10.1016/j.cub.2004.02.034; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	24	501	516	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					234	U80		10.1038/nature06726	http://dx.doi.org/10.1038/nature06726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18305481				2022-12-24	WOS:000253925600044
J	Jiang, L; Althoff, EA; Clemente, FR; Doyle, L; Rothlisberger, D; Zanghellini, A; Gallaher, JL; Betker, JL; Tanaka, F; Barbas, CF; Hilvert, D; Houk, KN; Stoddard, BL; Baker, D				Jiang, Lin; Althoff, Eric A.; Clemente, Fernando R.; Doyle, Lindsey; Rothlisberger, Daniela; Zanghellini, Alexandre; Gallaher, Jasmine L.; Betker, Jamie L.; Tanaka, Fujie; Barbas, Carlos F., III; Hilvert, Donald; Houk, Kendall N.; Stoddard, Barry L.; Baker, David			De novo computational design of retro-aldol enzymes	SCIENCE			English	Article							EVOLUTION; PROTEINS; ANTIBODIES; MECHANISM; RESOLUTION; SELECTION	The creation of enzymes capable of catalyzing any desired chemical reaction is a grand challenge for computational protein design. Using new algorithms that rely on hashing techniques to construct active sites for multistep reactions, we designed retro- aldolases that use four different catalytic motifs to catalyze the breaking of a carbon- carbon bond in a nonnatural substrate. Of the 72 designs that were experimentally characterized, 32, spanning a range of protein folds, had detectable retro-aldolase activity. Designs that used an explicit water molecule to mediate proton shuffling were significantly more successful, with rate accelerations of up to four orders of magnitude and multiple turnovers, than those involving charged side- chain networks. The atomic accuracy of the design process was confirmed by the x- ray crystal structure of active designs embedded in two protein scaffolds, both of which were nearly superimposable on the design model.	[Jiang, Lin; Althoff, Eric A.; Rothlisberger, Daniela; Zanghellini, Alexandre; Gallaher, Jasmine L.; Betker, Jamie L.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Jiang, Lin; Zanghellini, Alexandre; Baker, David] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Clemente, Fernando R.; Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Doyle, Lindsey; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Tanaka, Fujie; Barbas, Carlos F., III] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Tanaka, Fujie; Barbas, Carlos F., III] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Tanaka, Fujie; Barbas, Carlos F., III] Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; [Hilvert, Donald] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; Fred Hutchinson Cancer Center; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012; Tanaka, Fujie/K-2069-2014; Jiang, Lin/G-1575-2010	Baker, David/0000-0001-7896-6217; Tanaka, Fujie/0000-0001-6388-9343; Doyle, Lindsey/0000-0002-0008-473X	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA097328] Funding Source: Medline; NIGMS NIH HHS [R01 GM049857] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA097328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049857] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Clemente FR, 2005, J AM CHEM SOC, V127, P11294, DOI 10.1021/ja0507620; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Fullerton SWB, 2006, BIOORGAN MED CHEM, V14, P3002, DOI 10.1016/j.bmc.2005.12.022; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Janssen DB, 2005, ENVIRON MICROBIOL, V7, P1868, DOI 10.1111/j.1462-2920.2005.00966.x; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Press W., 1992, NUMERICAL RECIPES FO; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Tanaka F, 2002, J AM CHEM SOC, V124, P3510, DOI 10.1021/ja0171815; Tanaka F, 2004, J MOL BIOL, V335, P1007, DOI 10.1016/j.jmb.2003.11.014; WAGNER J, 1995, SCIENCE, V270, P1797, DOI 10.1126/science.270.5243.1797; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhong GF, 1998, ANGEW CHEM INT EDIT, V37, P2481, DOI 10.1002/(SICI)1521-3773(19981002)37:18<2481::AID-ANIE2481>3.0.CO;2-T	22	828	887	6	367	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2008	319	5868					1387	1391		10.1126/science.1152692	http://dx.doi.org/10.1126/science.1152692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323453	Green Accepted			2022-12-24	WOS:000253712900043
J	Thabut, G; Christie, JD; Ravaud, P; Castier, Y; Brugiere, O; Fournier, M; Mal, H; Leseche, G; Porcher, R				Thabut, Gabriel; Christie, Jason D.; Ravaud, Philippe; Castier, Yves; Brugiere, Olivier; Fournier, Michel; Mal, Herve; Leseche, Guy; Porcher, Raphael			Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data	LANCET			English	Article							PROPENSITY SCORE; NATIVE LUNG; EMPHYSEMA; BIAS	Background Both single and bilateral lung transplantation are recognised options for patients who have end-stage chronic obstructive pulmonary disease (COPD); however, which procedure leads to longer survival remains unclear. We aimed to compare survival after each procedure by analysing data from the registry of the International Society for Heart and Lung Transplantation. Methods We analysed data for 9883 patients with COPD, 3525 (35.7%) of whom underwent bilateral lung transplantation, and 6358 (64.3%) single lung transplantation, between 1987 and 2006. We accounted for possible selection bias with analysis of covariance, propensity-score risk adjustment, and propensity-based matching. Findings Median survival after either type of lung transplantation for patients with COPD was 5.0 years (95% Cl 4. 8-5. 2). Survival for patients who had lung transplantation before 1998 was 4.5 years (4.3-4.8), compared with 5.3 years (5.0-5.5) for those who had it after 1998 (p<0.0001). The proportion of patients who had bilateral lung transplantation increased from 101/467 (21.6%) in 1993 to 345/614 (56.2%) in 2006. Median survival time after bilateral lung transplantation was longer than that after single lung transplantation: 6.41 years (6.02-6.88) versus 4.59 years (4.41-4.76) (p<0.0001). Pretransplant characteristics of patients who had single and bilateral lung transplantation differed, but whichever method was used to adjust for baseline differences, bilateral lung transplantation was associated with longer survival than was single lung transplantation; the hazard ratio ranged from 0.83 (0.78-0.92) for analysis of covariance to 0.89 (0.80-0.97) for propensity-based matching. However, bilateral lung transplantation had little benefit compared with single lung transplantation for patients who were 60 years and older (HR 0 . 95; 0 . 81-1.13). Interpretation Bilateral lung transplantation leads to longer survival than single lung transplantation in patients with COPD, especially those who are younger than 60 years.	[Thabut, Gabriel; Brugiere, Olivier; Fournier, Michel; Mal, Herve] Hop Bichat Claude Bernard, Serv Pneumol B & Transplantat Pulm, APHP, F-75018 Paris, France; [Castier, Yves; Leseche, Guy] Hop Bichat Claude Bernard, Serv Chirurg Thorac & Vasc, APHP, F-75018 Paris, France; [Ravaud, Philippe] Hop Bichat Claude Bernard, Dept Epidemiol & Biostat, APHP, F-75018 Paris, France; [Ravaud, Philippe] Hop Bichat Claude Bernard, Rech Clin, APHP, F-75018 Paris, France; [Thabut, Gabriel; Ravaud, Philippe; Porcher, Raphael] Univ Paris 07, Paris, France; [Thabut, Gabriel; Ravaud, Philippe] French Inst Hlth & Med Res, INSERM, U738, Paris, France; [Porcher, Raphael] French Inst Hlth & Med Res, INSERM, U717, Paris, France; [Porcher, Raphael] Hop St Louis, Dept Biostat & Informat Med, APHP, Paris, France; [Christie, Jason D.] Univ Penn, Div Pulm & Crit Care Med, Dept Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; Pennsylvania Medicine	Thabut, G (corresponding author), Hop Bichat Claude Bernard, Serv Pneumol B & Transplantat Pulm, APHP, 46 Rue Henri Huchard, F-75018 Paris, France.	gabriel.thabut@bch.aphp.fr	ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206; Porcher, Raphael/0000-0002-5277-4679				Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Cassivi SD, 2002, ANN THORAC SURG, V74, P1663, DOI 10.1016/S0003-4975(02)04064-X; COOPER JD, 1989, AM REV RESPIR DIS, V139, P303, DOI 10.1164/ajrccm/139.2.303; CORRIS PA, 1999, THORAX S2, V54, P24; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; FROST AE, 1995, CHEST, V107, P981, DOI 10.1378/chest.107.4.981; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gunes A, 2006, INTERN MED J, V36, P5, DOI 10.1111/j.1445-5994.2006.01003.x; Hertz MI, 2006, J HEART LUNG TRANSPL, V25, P1179, DOI 10.1016/j.healun.2006.07.004; Hosmer D. W., 1999, APPL SURVIVAL ANAL; KALBFLEISH J, 2002, STAT ANAL FAILURE DA; LEVINE SM, 1994, AM J RESP CRIT CARE, V150, P398, DOI 10.1164/ajrccm.150.2.8049821; MAL H, 1989, AM REV RESPIR DIS, V140, P797, DOI 10.1164/ajrccm/140.3.797; Mal H, 2000, J HEART LUNG TRANSPL, V19, P220, DOI 10.1016/S1053-2498(99)00130-8; MAL H, 1994, AM J RESP CRIT CARE, V149, P1476, DOI 10.1164/ajrccm.149.6.8004301; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mant J, 2006, J CLIN EPIDEMIOL, V59, P862, DOI 10.1016/j.jclinepi.2005.11.021; Meyer DM, 2001, J HEART LUNG TRANSPL, V20, P935, DOI 10.1016/S1053-2498(01)00295-9; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; MIYOSHI S, 1990, CHEST, V97, P1130, DOI 10.1378/chest.97.5.1130; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Snell GI, 2006, INTERN MED J, V36, P3, DOI 10.1111/j.1445-5994.2006.00999.x; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Trulock EP, 2006, J HEART LUNG TRANSPL, V25, P880, DOI 10.1016/j.healun.2006.06.001; Trulock EP, 1998, CHEST, V113, p269S, DOI 10.1378/chest.113.4_Supplement.269S; Trulock EP, 1997, AM J RESP CRIT CARE, V155, P789, DOI 10.1164/ajrccm.155.3.9117010; TRULOCK EP, 1989, CHEST, V96, P738, DOI 10.1378/chest.96.4.738; Weill D, 2001, J HEART LUNG TRANSPL, V20, P739, DOI 10.1016/S1053-2498(00)00322-3; WILLIAMS TJ, 1992, AM REV RESPIR DIS, V145, P101, DOI 10.1164/ajrccm/145.1.101	32	129	136	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2008	371	9614					744	751		10.1016/S0140-6736(08)60344-X	http://dx.doi.org/10.1016/S0140-6736(08)60344-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268RI	18313503	Green Submitted			2022-12-24	WOS:000253596700028
J	Gibson, DG; Benders, GA; Andrews-Pfannkoch, C; Denisova, EA; Baden-Tillson, H; Zaveri, J; Stockwell, TB; Brownley, A; Thomas, DW; Algire, MA; Merryman, C; Young, L; Noskov, VN; Glass, JI; Venter, JC; Hutchison, CA; Smith, HO				Gibson, Daniel G.; Benders, Gwynedd A.; Andrews-Pfannkoch, Cynthia; Denisova, Evgeniya A.; Baden-Tillson, Holly; Zaveri, Jayshree; Stockwell, Timothy B.; Brownley, Anushka; Thomas, David W.; Algire, Mikkel A.; Merryman, Chuck; Young, Lei; Noskov, Vladimir N.; Glass, John I.; Venter, J. Craig; Hutchison, Clyde A., III; Smith, Hamilton O.			Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome	SCIENCE			English	Article							TRANSFORMATION-ASSOCIATED RECOMBINATION; SELECTIVE ISOLATION; HOMOLOGOUS RECOMBINATION; YEAST; DNA; GENE; SEGMENTS; REGIONS; VIRUS; CELLS	We have synthesized a 582,970 - base pair Mycoplasma genitalium genome. This synthetic genome, named M. genitalium JCVI- 1.0, contains all the genes of wild- type M. genitalium G37 except MG408, which was disrupted by an antibiotic marker to block pathogenicity and to allow for selection. To identify the genome as synthetic, we inserted "watermarks" at intergenic sites known to tolerate transposon insertions. Overlapping "cassettes" of 5 to 7 kilobases ( kb), assembled from chemically synthesized oligonucleotides, were joined by in vitro recombination to produce intermediate assemblies of approximately 24 kb, 72 kb ("1/ 8 genome"), and 144 kb ("1/ 4 genome"), which were all cloned as bacterial artificial chromosomes in Escherichia coli. Most of these intermediate clones were sequenced, and clones of all four 1/ 4 genomes with the correct sequence were identified. The complete synthetic genome was assembled by transformation-associated recombination cloning in the yeast Saccharomyces cerevisiae, then isolated and sequenced. A clone with the correct sequence was identified. The methods described here will be generally useful for constructing large DNA molecules from chemically synthesized pieces and also from combinations of natural and synthetic DNA segments.	[Gibson, Daniel G.; Benders, Gwynedd A.; Andrews-Pfannkoch, Cynthia; Denisova, Evgeniya A.; Baden-Tillson, Holly; Zaveri, Jayshree; Stockwell, Timothy B.; Brownley, Anushka; Thomas, David W.; Algire, Mikkel A.; Merryman, Chuck; Young, Lei; Noskov, Vladimir N.; Glass, John I.; Venter, J. Craig; Hutchison, Clyde A., III; Smith, Hamilton O.] J Craig Venter Inst, Rockville, MD 20850 USA	J. Craig Venter Institute	Smith, HO (corresponding author), J Craig Venter Inst, Rockville, MD 20850 USA.	hsmith@jcvi.org	Glass, John/A-6572-2015	Glass, John/0000-0002-3784-5301; Stockwell, Timothy/0000-0002-3595-4539				Arita M, 2004, BIOTECHNOL PROGR, V20, P1605, DOI 10.1021/bp049917i; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; COLMAN SD, 1990, MOL MICROBIOL, V4, P683, DOI 10.1111/j.1365-2958.1990.tb00638.x; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Heider D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-176; Holt RA, 2007, BIOESSAYS, V29, P580, DOI 10.1002/bies.20585; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Itaya M, 2005, P NATL ACAD SCI USA, V102, P15971, DOI 10.1073/pnas.0503868102; Itaya M, 2008, NAT METHODS, V5, P41, DOI 10.1038/NMETH1143; KNIGHT T, 2003, IDEMPOTENT VECTOR DE; Kodumal SJ, 2004, P NATL ACAD SCI USA, V101, P15573, DOI 10.1073/pnas.0406911101; Kouprina N, 2003, EMBO REP, V4, P257, DOI 10.1038/sj.embor.embor766; Kouprina Natalay, 2006, V349, P85; Larionov V, 1996, P NATL ACAD SCI USA, V93, P13925, DOI 10.1073/pnas.93.24.13925; Larionov V, 1997, P NATL ACAD SCI USA, V94, P7384, DOI 10.1073/pnas.94.14.7384; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Leem SH, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng029; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Marschall P, 1999, GENE THER, V6, P1634, DOI 10.1038/sj.gt.3300975; NEWLON CS, 1993, CURR OPIN GENET DEV, V3, P752, DOI 10.1016/S0959-437X(05)80094-2; Noskov VN, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e32; SHENG Y, 1995, NUCLEIC ACIDS RES, V23, P1990, DOI 10.1093/nar/23.11.1990; Shimanovsky B., 2003, 5 INT WORKSH INF HID; Silverman G A, 1996, Methods Mol Biol, V54, P65; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Yount B, 2002, J VIROL, V76, P11065, DOI 10.1128/JVI.76.21.11065-11078.2002; Zeng CJ, 2001, GENOMICS, V77, P27, DOI 10.1006/geno.2001.6616	31	758	902	7	348	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1215	1220		10.1126/science.1151721	http://dx.doi.org/10.1126/science.1151721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18218864				2022-12-24	WOS:000253530600035
J	Ferrari, MJ; Grais, RF; Bharti, N; Conlan, AJK; Bjornstad, ON; Wolfson, LJ; Guerin, PJ; Djibo, A; Grenfell, BT				Ferrari, Matthew J.; Grais, Rebecca F.; Bharti, Nita; Conlan, Andrew J. K.; Bjornstad, Ottar N.; Wolfson, Lara J.; Guerin, Philippe J.; Djibo, Ali; Grenfell, Bryan T.			The dynamics of measles in sub-Saharan Africa	NATURE			English	Article							TIME-SERIES; DEVELOPING-COUNTRIES; CHILDHOOD DISEASES; VACCINATION; EPIDEMICS; COMMUNITY; IMMUNIZATION; PERSISTENCE; OUTBREAK; ENGLAND	Although vaccination has almost eliminated measles in parts of the world, the disease remains a major killer in some high birth rate countries of the Sahel. On the basis of measles dynamics for industrialized countries, high birth rate regions should experience regular annual epidemics. Here, however, we show that measles epidemics in Niger are highly episodic, particularly in the capital Niamey. Models demonstrate that this variability arises from powerful seasonality in transmission - generating high amplitude epidemics - within the chaotic domain of deterministic dynamics. In practice, this leads to frequent stochastic fadeouts, interspersed with irregular, large epidemics. A metapopulation model illustrates how increased vaccine coverage, but still below the local elimination threshold, could lead to increasingly variable major outbreaks in highly seasonally forced contexts. Such erratic dynamics emphasize the importance both of control strategies that address build- up of susceptible individuals and efforts to mitigate the impact of large outbreaks when they occur.	[Ferrari, Matthew J.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Bharti, Nita; Bjornstad, Ottar N.; Grenfell, Bryan T.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Bjornstad, Ottar N.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Grais, Rebecca F.; Guerin, Philippe J.] Epictr, F-75011 Paris, France; [Conlan, Andrew J. K.] Ctr Math Sci, DAMTP, Cambridge CB3 0WA, England; [Bjornstad, Ottar N.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Wolfson, Lara J.] WHO, CH-1211 Geneva 27, Switzerland; [Djibo, Ali] Minist Sante, Direct Gen Sante Publ, Niamey, Niger	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Cambridge; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); World Health Organization	Ferrari, MJ (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	mferrari@psu.edu	Conlan, Andrew/Q-3861-2019; Bjornstad, Ottar N/I-4518-2012; Wolfson, Lara/AAC-1400-2019; Guerin, Philippe/AAH-8873-2021	Conlan, Andrew/0000-0002-2593-6353; Wolfson, Lara/0000-0002-6454-3368; Freeman Grais, Rebecca/0000-0002-5037-8218; Bharti, Nita/0000-0003-1940-7794; Guerin, Philippe/0000-0002-6008-2963				ANDERSON R M, 1991; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; BOLKER B, 1995, PHILOS T R SOC B, V348, P309, DOI 10.1098/rstb.1995.0070; *CDC, 2004, MMWR-MORBID MORTAL W, V53, P897; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P657; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P757; Central Intelligence Agency (CIA), WORLD FACTB NIG; Cliff A, 1993, MEASLES HIST GEOGRAP, P1840; Conlan AJK, 2007, P ROY SOC B-BIOL SCI, V274, P1133, DOI 10.1098/rspb.2006.0030; Cummings DAT, 2006, INT J INFECT DIS, V10, P148, DOI 10.1016/j.ijid.2004.10.010; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; FINE PEM, 1983, INT J EPIDEMIOL, V12, P332, DOI 10.1093/ije/12.3.332; FINE PEM, 1982, INT J EPIDEMIOL, V11, P15, DOI 10.1093/ije/11.1.15; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Grais RF, 2007, PLOS MED, V4, P122, DOI 10.1371/journal.pmed.0040016; Grais RF, 2008, J R SOC INTERFACE, V5, P67, DOI 10.1098/rsif.2007.1038; Grais RF, 2006, T ROY SOC TROP MED H, V100, P867, DOI 10.1016/j.trstmh.2005.10.014; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; GRENFELL BT, 1994, PHILOS T R SOC A, V348, P515, DOI 10.1098/rsta.1994.0108; GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859; Griffin DE, 2007, MICROBE, V1, P409; Guris D, 1998, PEDIATR INFECT DIS J, V17, P33, DOI 10.1097/00006454-199801000-00008; Hyde TB, 2006, INT J EPIDEMIOL, V35, P299, DOI 10.1093/ije/dyi222; Kambire C, 2003, J INFECT DIS, V187, pS80, DOI 10.1086/368043; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; MALFAIT P, 1994, PEDIATR INFECT DIS J, V13, P38, DOI 10.1097/00006454-199401000-00009; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P111, DOI 10.1017/S0950268800065614; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P419, DOI 10.1017/S0950268800067170; Morton A, 2005, J R STAT SOC C-APPL, V54, P575, DOI 10.1111/j.1467-9876.2005.05366.x; OLSEN LF, 1988, THEOR POPUL BIOL, V33, P344, DOI 10.1016/0040-5809(88)90019-6; Rain D., 2018, EATERS DRY SEASON CI, DOI 10.4324/9780429500886; SCHAFFER WM, 1985, J THEOR BIOL, V112, P403, DOI 10.1016/S0022-5193(85)80294-0; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Shulgin B, 1998, B MATH BIOL, V60, P1123, DOI 10.1016/S0092-8240(98)90005-2; Sniadack DH, 1999, B WORLD HEALTH ORGAN, V77, P545; Stone L, 2000, MATH COMPUT MODEL, V31, P207, DOI 10.1016/S0895-7177(00)00040-6; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Strebel P, 2003, J INFECT DIS, V187, pS1, DOI 10.1086/368226; TIDD CW, 1993, P ROY SOC B-BIOL SCI, V254, P257, DOI 10.1098/rspb.1993.0155; Venczel L, 2003, J INFECT DIS, V187, pS127, DOI 10.1086/368029; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	46	236	243	0	70	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					679	684		10.1038/nature06509	http://dx.doi.org/10.1038/nature06509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256664	Bronze			2022-12-24	WOS:000252929500033
J	Saze, H; Shiraishi, A; Miura, A; Kakutani, T				Saze, Hidetoshi; Shiraishi, Akiko; Miura, Asuka; Kakutani, Tetsuji			Control of genic DNA methylation by a jmjC domain - Containing protein in Arabidopsis thaliana	SCIENCE			English	Article							NON-CG METHYLATION; MAINTENANCE; HETEROCHROMATIN; TRANSPOSONS; MUTATION; GENOME	Differential cytosine methylation of repeats and genes is important for coordination of genome stability and proper gene expression. Through genetic screen of mutants showing ectopic cytosine methylation in a genic region, we identified a jmjC- domain gene, IBM1 ( increase in bonsai methylation 1), in Arabidopsis thaliana. In addition to the ectopic cytosine methylation, the ibm1 mutations induced a variety of developmental phenotypes, which depend on methylation of histone H3 at lysine 9. Paradoxically, the developmental phenotypes of the ibm1 were enhanced by the mutation in the chromatin- remodeling gene DDM1 ( decrease in DNA methylation 1), which is necessary for keeping methylation and silencing of repeated heterochromatin loci. Our results demonstrate the importance of chromatin remodeling and histone modifications in the differential epigenetic control of repeats and genes.	[Saze, Hidetoshi; Shiraishi, Akiko; Miura, Asuka; Kakutani, Tetsuji] Natl Inst Genet, Dept Integrated Genet, Shizuoka 4118540, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Saze, H (corresponding author), Natl Inst Genet, Dept Integrated Genet, Yata 1111, Shizuoka 4118540, Japan.	hsaze@lab.nig.ac.jp	Saze, Hidetoshi/B-5922-2015; Hu, Ruogu/B-2203-2008	Saze, Hidetoshi/0000-0002-8647-1430; 				Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; Brzeski J, 2003, J BIOL CHEM, V278, P823, DOI 10.1074/jbc.M209260200; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Kakutani T, 2004, COLD SPRING HARB SYM, V69, P139, DOI 10.1101/sqb.2004.69.139; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kankel MW, 2003, GENETICS, V163, P1109; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	28	208	226	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					462	465		10.1126/science.1150987	http://dx.doi.org/10.1126/science.1150987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218897				2022-12-24	WOS:000252576600038
J	Shimada, M; Niida, H; Zineldeen, DH; Tagami, H; Tanaka, M; Saito, H; Nakanishi, M				Shimada, Midori; Niida, Hiroyuki; Zineldeen, Doaa H.; Tagami, Hideaki; Tanaka, Masafumi; Saito, Hiroyuki; Nakanishi, Makoto			Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression	CELL			English	Article							TATA-BINDING PROTEIN; CELL-CYCLE ARREST; SAGA COMPLEX; GCN5; ACTIVATION; CHECKPOINT; H3; PHOSPHORYLATION; ACETYLATION; ACETYLTRANSFERASE	DNA damage results in activation or suppression of transcription of a large number of genes. Transcriptional activation has been well characterized in the context of sequence-specific DNA-bound activators, whereas mechanisms of transcriptional suppression are largely unexplored. We show here that DNA damage rapidly reduces histone H3 Threonine 11 (T11) phosphorylation. This correlates with repression of genes, including cyclin B1 and cdk1. H3-T11 phosphorylation occurs throughout the cell cycle and is Chk1 dependent in vivo. Following DNA damage, Chk1 undergoes rapid chromatin dissociation, concomitant with reduced H3-T11 phosphorylation. Furthermore, we find that loss of H3-T11 phosphorylation correlates with reduced binding of the histone acetyltransferase GCN5 at cyclin B1 and cdk1 promoters and reduced H3-K9 acetylation. We propose a mechanism for Chk1 as a histone kinase, responsible for DNA-damage-induced transcriptional repression by loss of histone acetylation.	[Shimada, Midori; Niida, Hiroyuki; Zineldeen, Doaa H.; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem & Cell Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Tagami, Hideaki] Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Tanaka, Masafumi; Saito, Hiroyuki] Kobe Pharmaceut Univ, Biophys Chem Lab, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Nagoya City University; Nagoya City University; Kobe Pharmaceutical University	Nakanishi, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Biochem & Cell Biol, Mizuho Ku, 1 Kawasumi Mizuho Cho, Nagoya, Aichi 4678601, Japan.	mkt-naka@med.nagoya-cu.ac.jp	Zineldeen, Doaa/AAK-4525-2020; zineldeen, Doaa/GZG-4789-2022	Zineldeen, Doaa/0000-0002-7877-8571; 				BARLEV NA, 1995, J BIOL CHEM, V270, P19337, DOI 10.1074/jbc.270.33.19337; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Bu P, 2007, MOL CELL BIOL, V27, P3405, DOI 10.1128/MCB.00066-07; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Flatt PM, 2000, MOL CELL BIOL, V20, P4210, DOI 10.1128/MCB.20.12.4210-4223.2000; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1998, MOL CELL, V2, P863, DOI 10.1016/S1097-2765(00)80300-7; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Kikuchi H, 2005, GENE, V347, P83, DOI 10.1016/j.gene.2004.12.007; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Liu QH, 2000, GENE DEV, V14, P1448; Luger K, 1999, METHOD ENZYMOL, V304, P3; Niida H, 2005, J BIOL CHEM, V280, P39246, DOI 10.1074/jbc.M505009200; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Takai H, 2000, GENE DEV, V14, P1439; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109	32	198	204	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					221	232		10.1016/j.cell.2007.12.013	http://dx.doi.org/10.1016/j.cell.2007.12.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243098	Bronze			2022-12-24	WOS:000253427700009
J	Parikh, NI; Pencina, MJ; Wang, TJ; Benjamin, EJ; Lanier, KJ; Levy, D; D'Agostino, RB; Kannel, WB; Vasan, RS				Parikh, Nisha I.; Pencina, Michael J.; Wang, Thomas J.; Benjamin, Emelia J.; Lanier, Katherine J.; Levy, Daniel; D'Agostino, Ralph B., Sr.; Kannel, William B.; Vasan, Ramachandran S.			A risk score for predicting near-term incidence of hypertension: The Framingham Heart Study	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BLOOD-PRESSURE; CIGARETTE-SMOKING; BODY-WEIGHT; PARENTAL HISTORY; ANALGESIC USE; NONHYPERTENSIVE PARTICIPANTS; CARDIOVASCULAR-DISEASE; ARTERIAL STIFFNESS; FAMILY-HISTORY	Background: Studies suggest that targeting high-risk, nonhypertensive individuals for treatment may delay hypertension onset, thereby possibly mitigating vascular complications. Risk stratification may facilitate cost-effective approaches to management. Objective: To develop a simple risk score for predicting hypertension incidence by using measures readily obtained in the physician's office. Design: Longitudinal cohort study. Setting: Framingham Heart Study, Framingham, Massachusetts. Patients: 1717 nonhypertensive white individuals 20 to 69 years of age (mean age, 42 years; 54% women), without diabetes and with both parents in the original cohort of the Framingham Heart Study, contributed 5814 person-examinations. Measurements: Scores were developed for predicting the 1-, 2- and 4-year risk for new-onset hypertension, and performance characteristics of the prediction algorithm were assessed by using calibration and discrimination measures. Parental hypertension was ascertained from examinations of the original cohort of the Framingham Heart Study. Results: During follow-up (median time over all person-examinations, 3.8 years), 796 persons (52% women) developed new-onset hypertension. In multivariable analyses, age, sex, systolic and diastolic blood pressure, body mass index, parental hypertension, and cigarette smoking were significant predictors of hypertension. According to the risk score based on these factors, the 4-year risk for incident hypertension was classified as low (<5%) in 34% of participants, medium (5% to 10%) in 19%, and high (>10%) in 47%. The c-statistic for the prediction model was 0.788, and calibration was very good. Limitations: The risk score findings may not be generalizable to persons of nonwhite race or ethnicity or to persons with diabetes. The risk score algorithm has not been validated in an independent cohort and is based on single measurements of risk factors and blood pressure. Conclusion: The hypertension risk prediction score can be used to estimate an individual's absolute risk for hypertension on short-term follow-up, and it represents a simple, office-based tool that may facilitate management of high-risk individuals with prehypertension.	[Vasan, Ramachandran S.] Framing Heart Study, Newark, NJ 07102 USA		Vasan, RS (corresponding author), Framing Heart Study, 73 Mt Ave, Suit 2, Newark, NJ 07102 USA.	vasan@bu.edu	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Pencina, Michael/0000-0001-5798-8855; Wang, Thomas/0000-0003-4063-6508; Benjamin, Emelia/0000-0003-4076-2336	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334, ZIAHL006001, K23HL074077] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Bakx JC, 1999, J CLIN EPIDEMIOL, V52, P531, DOI 10.1016/S0895-4356(99)00023-2; Benetos A, 2002, AM J HYPERTENS, V15, P1101, DOI 10.1016/S0895-7061(02)03029-7; BERGLUND G, 1975, ACTA MED SCAND, V198, P291; BORKAN GA, 1986, AM J EPIDEMIOL, V124, P410, DOI 10.1093/oxfordjournals.aje.a114411; BURKE GL, 1991, CIRCULATION, V84, P1176, DOI 10.1161/01.CIR.84.3.1176; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chu N F, 1996, J Cardiovasc Risk, V3, P205, DOI 10.1097/00043798-199604000-00012; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COMONIHUNTLEY J, 1989, ARCH INTERN MED, V149, P780; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cox D. R., 1984, ANAL SURVIVAL DATA; CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; CUPPLES LA, 1987, FRAMINGHAM HEART STU, P87; Curhan GC, 2002, ARCH INTERN MED, V162, P2204, DOI 10.1001/archinte.162.19.2204; Czernichow S, 2002, INT J OBESITY, V26, P1138, DOI 10.1038/sj.ijo.0802059; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Dyer AR, 1999, J HUM HYPERTENS, V13, P13, DOI 10.1038/sj.jhh.1000740; Forman JP, 2007, ARCH INTERN MED, V167, P394, DOI 10.1001/archinte.167.4.394; France CR, 1998, PSYCHOPHYSIOLOGY, V35, P341, DOI 10.1017/S0048577298000833; Franco OH, 2005, HYPERTENSION, V46, P280, DOI 10.1161/01.HYP.0000173433.67426.9b; Franklin SS, 1997, CIRCULATION, V96, P308; Gambini G, 1997, G Ital Cardiol, V27, P1153; GRASSI G, 1994, CIRCULATION, V90, P248, DOI 10.1161/01.CIR.90.1.248; GRIMM RH, 1985, ARCH INTERN MED, V145, P1191, DOI 10.1001/archinte.145.7.1191; Halimi JM, 2002, J HYPERTENS, V20, P187, DOI 10.1097/00004872-200202000-00007; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; He JA, 2000, HYPERTENSION, V35, P544, DOI 10.1161/01.HYP.35.2.544; HOSMER DW, 1989, APPL LOGISTIC REGRES; HUBERT HB, 1987, AM J EPIDEMIOL, V125, P812, DOI 10.1093/oxfordjournals.aje.a114598; Imamura H, 1996, CLIN EXP PHARMACOL P, V23, P397, DOI 10.1111/j.1440-1681.1996.tb02748.x; Janzon E, 2004, J INTERN MED, V255, P266, DOI 10.1046/j.1365-2796.2003.01293.x; JOHN U, 2006, QJM, V99, P47; JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011; Jones DW, 1996, AM J HYPERTENS, V9, pS50, DOI 10.1016/0895-7061(96)00183-5; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kim JW, 2005, BLOOD PRESSURE, V14, P80, DOI 10.1080/08037050510008896; Kurth T, 2005, ARCH INTERN MED, V165, P1903, DOI 10.1001/archinte.165.16.1903; Lascaux-Lefebvre V, 1999, J HUM HYPERTENS, V13, P631, DOI 10.1038/sj.jhh.1000884; Lee DH, 2001, HYPERTENSION, V37, P194, DOI 10.1161/01.HYP.37.2.194; Lee JS, 2004, INT J OBESITY, V28, P391, DOI 10.1038/sj.ijo.0802568; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mahmud A, 2003, HYPERTENSION, V41, P183, DOI 10.1161/01.HYP.0000047464.66901.60; MANN SJ, 1991, JAMA-J AM MED ASSOC, V265, P2226, DOI 10.1001/jama.265.17.2226; Niskanen L, 2004, HYPERTENSION, V44, P859, DOI 10.1161/01.HYP.0000146691.51307.84; Okubo Y, 2004, DRUG ALCOHOL DEPEN, V73, P167, DOI 10.1016/j.drugalcdep.2003.10.005; Okubo Y, 2002, J HUM HYPERTENS, V16, P91, DOI 10.1038/sj.jhh.1001303; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; POPE JE, 1993, ARCH INTERN MED, V153, P477, DOI 10.1001/archinte.153.4.477; Radi S, 2004, J HUM HYPERTENS, V18, P487, DOI 10.1038/sj.jhh.1001682; Rebbeck TR, 1996, J CLIN EPIDEMIOL, V49, P727, DOI 10.1016/0895-4356(96)00015-7; Retnakaran R, 2005, CAN MED ASSOC J, V173, P885, DOI 10.1503/cmaj.045159; ROSNER B, 1983, AM J EPIDEMIOL, V117, P429, DOI 10.1093/oxfordjournals.aje.a113561; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Shirakawa T, 2006, HYPERTENS RES, V29, P81, DOI 10.1291/hypres.29.81; STAMLER R, 1979, JAMA-J AM MED ASSOC, V241, P43, DOI 10.1001/jama.241.1.43; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Tozawa M, 2001, HYPERTENS RES, V24, P93, DOI 10.1291/hypres.24.93; van der Sande MAB, 2001, B WORLD HEALTH ORGAN, V79, P321; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; VERDECCHIA P, 1995, J HYPERTENS, V13, P1209, DOI 10.1097/00004872-199510000-00016; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Wilsgaard T, 2000, ARCH INTERN MED, V160, P2847, DOI 10.1001/archinte.160.18.2847; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yeh CJ, 2001, J FORMOS MED ASSOC, V100, P668; Zhang HF, 2006, J HYPERTENS, V24, P1719, DOI 10.1097/01.hjh.0000242395.07473.92; ZINNER SH, 1971, NEW ENGL J MED, V284, P401, DOI 10.1056/NEJM197102252840801	72	197	211	4	50	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2008	148	2					102	110		10.7326/0003-4819-148-2-200801150-00005	http://dx.doi.org/10.7326/0003-4819-148-2-200801150-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254NZ	18195335				2022-12-24	WOS:000252594600003
J	Yu, WQ; Gius, D; Onyango, P; Muldoon-Jacobs, K; Karp, J; Feinberg, AP; Cui, HM				Yu, Wenqiang; Gius, David; Onyango, Patrick; Muldoon-Jacobs, Kristi; Karp, Judith; Feinberg, Andrew P.; Cui, Hengmi			Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA	NATURE			English	Article							HUMAN CANCER; METHYLATION; CELLS; DNA; TRANSCRIPTION; INHIBITOR; PROTEINS; IGF2	Tumour suppressor genes ( TSGs) inhibiting normal cellular growth are frequently silenced epigenetically in cancer(1). DNA methylation is commonly associated with TSG silencing(1), yet mutations in the DNA methylation initiation and recognition machinery in carcinogenesis are unknown(2). An intriguing possible mechanism for gene regulation involves widespread non- coding RNAs such as microRNA, Piwi- interacting RNA and antisense RNAs3-5. Widespread sense - antisense transcripts have been systematically identified in mammalian cells(6), and global transcriptome analysis shows that up to 70% of transcripts have antisense partners and that perturbation of antisense RNA can alter the expression of the sense gene(7). For example, it has been shown that an antisense transcript not naturally occurring but induced by genetic mutation leads to gene silencing and DNA methylation, causing thalassaemia in a patient(8). Here we show that many TSGs have nearby antisense RNAs, and we focus on the role of one RNA in silencing p15, a cyclin- dependent kinase inhibitor implicated in leukaemia. We found an inverse relation between p15 antisense ( p15AS) and p15 sense expression in leukaemia. A p15AS expression construct induced p15 silencing in cis and in trans through heterochromatin formation but not DNA methylation; the silencing persisted after p15AS was turned off, although methylation and heterochromatin inhibitors reversed this process. The p15AS-induced silencing was Dicer- independent. Expression of exogenous p15AS in mouse embryonic stem cells caused p15 silencing and increased growth, through heterochromatin formation, as well as DNA methylation after differentiation of the embryonic stem cells. Thus, natural antisense RNA may be a trigger for heterochromatin formation and DNA methylation in TSG silencing in tumorigenesis.	[Yu, Wenqiang; Onyango, Patrick; Feinberg, Andrew P.; Cui, Hengmi] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA; [Yu, Wenqiang; Onyango, Patrick; Feinberg, Andrew P.; Cui, Hengmi] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Gius, David; Muldoon-Jacobs, Kristi] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Karp, Judith] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine	Cui, HM (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Epigenet, 720 Rutland Ave, Baltimore, MD 21205 USA.	afeinberg@jhu.edu; hcui@jhmi.edu	Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [ZIABC010544, R37CA054358, R01CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA054358, R01 CA054358, R37 CA054358-18] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cui HM, 2002, CANCER RES, V62, P6442; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lubbert M, 2003, LEUKEMIA, V17, P1762, DOI 10.1038/sj.leu.2403045; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rosok O, 2004, NAT BIOTECHNOL, V22, P104, DOI 10.1038/nbt925; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; Sandhu C, 1997, MOL CELL BIOL, V17, P2458, DOI 10.1128/MCB.17.5.2458; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Weinberg MS, 2006, RNA, V12, P256, DOI 10.1261/rna.2235106; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763	22	672	740	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2008	451	7175					202	U10		10.1038/nature06468	http://dx.doi.org/10.1038/nature06468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185590	Green Accepted			2022-12-24	WOS:000252214400045
J	Vahisalu, T; Kollist, H; Wang, YF; Nishimura, N; Chan, WY; Valerio, G; Lamminmaki, A; Brosche, M; Moldau, H; Desikan, R; Schroeder, JI; Kangasjarvi, J				Vahisalu, Triin; Kollist, Hannes; Wang, Yong-Fei; Nishimura, Noriyuki; Chan, Wai-Yin; Valerio, Gabriel; Lamminmaki, Airi; Brosche, Mikael; Moldau, Heino; Desikan, Radhika; Schroeder, Julian I.; Kangasjarvi, Jaakko			SLAC1 is required for plant guard cell S-type anion channel function in stomatal signalling	NATURE			English	Article							ABSCISIC-ACID; PLASMA-MEMBRANE; ION CHANNELS; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; VICIA-FABA; CLOSURE; OZONE; MUTANT; TRANSDUCTION	Stomatal pores, formed by two surrounding guard cells in the epidermis of plant leaves, allow influx of atmospheric carbon dioxide in exchange for transpirational water loss. Stomata also restrict the entry of ozone - an important air pollutant that has an increasingly negative impact on crop yields, and thus global carbon fixation(1) and climate change(2). The aperture of stomatal pores is regulated by the transport of osmotically active ions and metabolites across guard cell membranes(3,4). Despite the vital role of guard cells in controlling plant water loss(3,4), ozone sensitivity(1,2) and CO2 supply(2,5-7), the genes encoding some of the main regulators of stomatal movements remain unknown. It has been proposed that guard cell anion channels function as important regulators of stomatal closure and are essential in mediating stomatal responses to physiological and stress stimuli(3,4,8). However, the genes encoding membrane proteins that mediate guard cell anion efflux have not yet been identified. Here we report the mapping and characterization of an ozone- sensitive Arabidopsis thaliana mutant, slac1. We show that SLAC1 ( SLOW ANION CHANNEL- ASSOCIATED 1) is preferentially expressed in guard cells and encodes a distant homologue of fungal and bacterial dicarboxylate/ malic acid transport proteins. The plasma membrane protein SLAC1 is essential for stomatal closure in response to CO2, abscisic acid, ozone, light/ dark transitions, humidity change, calcium ions, hydrogen peroxide and nitric oxide. Mutations in SLAC1 impair slow ( S- type) anion channel currents that are activated by cytosolic Ca2(+) and abscisic acid, but do not affect rapid ( R- type) anion channel currents or Ca2+ channel function. A low homology of SLAC1 to bacterial and fungal organic acid transport proteins, and the permeability of S- type anion channels to malate(9) suggest a vital role for SLAC1 in the function of S- type anion channels.	[Vahisalu, Triin; Kollist, Hannes; Lamminmaki, Airi; Brosche, Mikael; Kangasjarvi, Jaakko] Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland; [Vahisalu, Triin] Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, EE-51005 Tartu, Estonia; [Kollist, Hannes; Moldau, Heino] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia; [Wang, Yong-Fei; Nishimura, Noriyuki; Chan, Wai-Yin; Valerio, Gabriel; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Desikan, Radhika] Univ W England, Ctr Res Plant Sci, Bristol BS16 1QY, Avon, England	University of Helsinki; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Tartu; University of California System; University of California San Diego; University of West England	Kangasjarvi, J (corresponding author), Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland.	jaakko.kangasjarvi@helsinki.fi	Kangasjärvi, Jaakko/AAP-8639-2021; Kollist, Hannes/X-1446-2019; Kollist, Hannes/P-1548-2016; Brosché, Mikael/H-2260-2015; Kangasjärvi, Jaakko/A-3024-2015; Vahisalu, Triin/AAS-5223-2020; Nishimura, Noriyuki/E-3580-2010; Vahisalu, Triin/AAK-2337-2020	Kangasjärvi, Jaakko/0000-0002-8959-1809; Kollist, Hannes/0000-0002-6895-3583; Kollist, Hannes/0000-0002-6895-3583; Brosché, Mikael/0000-0002-1135-2496; Kangasjärvi, Jaakko/0000-0002-8959-1809; Vahisalu, Triin/0000-0001-6050-0320; Nishimura, Noriyuki/0000-0003-2946-3124; Schroeder, Julian/0000-0002-3283-5972; Lamminmaki, Airi/0000-0002-6133-8553	NIEHS NIH HHS [P42 ES010337-070008, P42 ES010337] Funding Source: Medline; NIGMS NIH HHS [R01 GM060396-07, R01 GM060396] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen GJ, 2002, PLANT CELL, V14, P1649, DOI 10.1105/tpc.010448; Allen GJ, 2001, NATURE, V411, P1053, DOI 10.1038/35082575; Camarasa C, 2001, APPL ENVIRON MICROB, V67, P4144, DOI 10.1128/AEM.67.9.4144-4151.2001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Desikan R, 2002, P NATL ACAD SCI USA, V99, P16314, DOI 10.1073/pnas.252461999; Frachisse JM, 1999, PLANT PHYSIOL, V121, P253, DOI 10.1104/pp.121.1.253; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hopkin M, 2007, NATURE, V448, P396, DOI 10.1038/448396b; Janausch IG, 2001, ARCH MICROBIOL, V176, P224, DOI 10.1007/s002030100317; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; KELLER BU, 1989, NATURE, V341, P450, DOI 10.1038/341450a0; Kollist T, 2007, PHYSIOL PLANTARUM, V129, P796, DOI 10.1111/j.1399-3054.2006.00851.x; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Li Y, 2004, PLANT SCI, V166, P415, DOI 10.1016/j.plantsci.2003.10.008; LINDER B, 1992, FEBS LETT, V313, P27, DOI 10.1016/0014-5793(92)81176-M; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; MACROBBIE EAC, 1981, J EXP BOT, V32, P545, DOI 10.1093/jxb/32.3.545; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; Pandey S, 2007, FEBS LETT, V581, P2325, DOI 10.1016/j.febslet.2007.04.008; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; SCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9535, DOI 10.1073/pnas.92.21.9535; SCHMIDT C, 1994, PLANT PHYSIOL, V106, P383, DOI 10.1104/pp.106.1.383; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Suh SJ, 2007, J BIOL CHEM, V282, P1916, DOI 10.1074/jbc.M607926200; Suntio T. M., 1994, Plant Molecular Biology Reporter, V12, P43, DOI 10.1007/BF02668663; TAYLOR DE, 1994, J BACTERIOL, V176, P2740, DOI 10.1128/JB.176.9.2740-2742.1994; Torsethaugen G, 1999, P NATL ACAD SCI USA, V96, P13577, DOI 10.1073/pnas.96.23.13577; VANKIRK CA, 1978, PLANT PHYSIOL, V61, P474, DOI 10.1104/pp.61.3.474; Webb AAR, 1997, PLANT PHYSIOL, V114, P1557, DOI 10.1104/pp.114.4.1557; Weigel D., 2002, ARABIDOPSIS LAB MANU; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; YANG Y, IN PRESS BMC PL METH; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	43	567	593	11	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2008	452	7186					487	U15		10.1038/nature06608	http://dx.doi.org/10.1038/nature06608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18305484	Green Accepted			2022-12-24	WOS:000254341300035
J	Trajkovic, K; Hsu, C; Chiantia, S; Rajendran, L; Wenzel, D; Wieland, F; Schwille, P; Brugger, B; Simons, M				Trajkovic, Katarina; Hsu, Chieh; Chiantia, Salvatore; Rajendran, Lawrence; Wenzel, Dirk; Wieland, Felix; Schwille, Petra; Bruegger, Britta; Simons, Mikael			Ceramide triggers budding of exosome vesicles into multivesicular Endosomes	SCIENCE			English	Article							BIOGENESIS; RAFT; MICRODOMAINS; ENDOCYTOSIS; PATHWAY; TSG101; HRS	Intraluminal vesicles of multivesicular endosomes are either sorted for cargo degradation into lysosomes or secreted as exosomes into the extracellular milieu. The mechanisms underlying the sorting of membrane into the different populations of intraluminal vesicles are unknown. Here, we find that cargo is segregated into distinct subdomains on the endosomal membrane and that the transfer of exosome- associated domains into the lumen of the endosome did not depend on the function of the ESCRT ( endosomal sorting complex required for transport) machinery, but required the sphingolipid ceramide. Purified exosomes were enriched in ceramide, and the release of exosomes was reduced after the inhibition of neutral sphingomyelinases. These results establish a pathway in intraendosomal membrane transport and exosome formation.	[Trajkovic, Katarina; Hsu, Chieh; Simons, Mikael] Univ Gottingen, Ctr Biochem & Mol Cell Biol, D-37073 Gottingen, Germany; [Trajkovic, Katarina; Hsu, Chieh; Simons, Mikael] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Wenzel, Dirk] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Wieland, Felix; Bruegger, Britta] Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany; [Chiantia, Salvatore; Schwille, Petra] Tech Univ Dresden, BioTec, D-01307 Dresden, Germany; [Rajendran, Lawrence] Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; [Simons, Mikael] Univ Gottingen, Dept Neurol, D-37073 Gottingen, Germany	University of Gottingen; Max Planck Society; Max Planck Society; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Max Planck Society; University of Gottingen	Simons, M (corresponding author), Univ Gottingen, Ctr Biochem & Mol Cell Biol, D-37073 Gottingen, Germany.	msimons@gwdg.de	Chiantia, Salvatore/A-4546-2010; Schwille, Petra/A-4983-2010; Trajkovic, Katarina/AAJ-4219-2021; Chiantia, Salvatore/U-6363-2019	Trajkovic, Katarina/0000-0002-2716-1491; Rajendran, Lawrence/0000-0002-6390-1821; Hsu, Chieh/0000-0002-4780-1222; Chiantia, Salvatore/0000-0003-0791-967X; Simons, Mikael/0000-0001-5329-192X				Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Li RX, 1999, J BIOL CHEM, V274, P21121, DOI 10.1074/jbc.274.30.21121; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	24	2166	2246	22	551	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1244	1247		10.1126/science.1153124	http://dx.doi.org/10.1126/science.1153124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309083				2022-12-24	WOS:000253530600044
J	Yang, J; Brown, MS; Liang, G; Grishin, NV; Goldstein, JL				Yang, Jing; Brown, Michael S.; Liang, Guosheng; Grishin, Nick V.; Goldstein, Joseph L.			Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone	CELL			English	Article							FOOD-INTAKE; ACYLATED PEPTIDE; FATTY-ACIDS; BODY-WEIGHT; PROTEIN; SECRETION; OBESTATIN; OBESITY; HUMANS; ESTABLISHMENT	Ghrelin is a 28 amino acid, appetite-stimulating peptide hormone secreted by the food-deprived stomach. Serine-3 of ghrelin is acylated with an eight-carbon fatty acid, octanoate, which is required for its endocrine actions. Here, we identify GOAT ((G) under bar hrelin (O) under bar-(A) under bar cyl (t) under bar ransferase), a polytopic membrane-bound enzyme that attaches octanoate to serine-3 of ghrelin. Analysis of the mouse genome revealed that GOAT belongs to a family of 16 hydrophobic membrane-bound acyltransferases that includes Porcupine, which attaches long-chain fatty acids to Wnt proteins. GOAT is the only member of this family that octanoylates ghrelin when coexpressed in cultured endocrine cell lines with prepro-ghrelin. GOAT activity requires catalytic asparagine and histidine residues that are conserved in this family. Consistent with its function, GOAT mRNA is largely restricted to stomach and intestine, the major ghrelin-secreting tissues. Identification of GOAT will facilitate the search for inhibitors that reduce appetite and diminish obesity in humans.	[Yang, Jing; Brown, Michael S.; Liang, Guosheng; Goldstein, Joseph L.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu	Yang, Jing/D-4039-2009; Yang, Jing/M-2831-2017	Yang, Jing/0000-0002-2048-735X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL20948] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BIZZOZERO OA, 1995, METHOD ENZYMOL, V250, P361; Chartrel N, 2007, SCIENCE, V315, DOI 10.1126/science.1135047; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Gourcerol G, 2007, OBESITY, V15, P2643, DOI 10.1038/oby.2007.316; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kaiya H, 2004, GEN COMP ENDOCR, V138, P50, DOI 10.1016/j.ygcen.2004.05.005; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Karreman C, 1998, BIOTECHNIQUES, V24, P736, DOI 10.2144/98245bm08; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2255, DOI 10.1210/en.2004-0695; Nogueiras R, 2007, ENDOCRINOLOGY, V148, P21, DOI 10.1210/en.2006-0915; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Sambrook J, 2001, MOL CLONING LAB MANU; Small CJ, 2004, TRENDS ENDOCRIN MET, V15, P259, DOI 10.1016/j.tem.2004.06.002; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; WALKER DR, 1997, INTELL SYST MOL BIOL, V5, P333; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhu XR, 2006, J BIOL CHEM, V281, P38867, DOI 10.1074/jbc.M607955200; Zigman JM, 2006, P NATL ACAD SCI USA, V103, P12961, DOI 10.1073/pnas.0605959103; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002; Zorrilla EP, 2006, P NATL ACAD SCI USA, V103, P13226, DOI 10.1073/pnas.0605376103	33	868	901	5	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					387	396		10.1016/j.cell.2008.01.017	http://dx.doi.org/10.1016/j.cell.2008.01.017			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267071	Bronze			2022-12-24	WOS:000253180700014
J	McNamara, C; Zinkernagel, AS; Macheboeuf, P; Cunningham, MW; Nizet, V; Ghosh, P				McNamara, Case; Zinkernagel, Annelies S.; Macheboeuf, Pauline; Cunningham, Madeleine W.; Nizet, Victor; Ghosh, Partho			Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence	SCIENCE			English	Article							M-PROTEIN; CRYSTAL-STRUCTURES; TROPOMYOSIN; BINDING; FIBRINOGEN; STABILITY; PYOGENES; FRAGMENT; DESIGN; REGION	Antigenically variable M proteins are major virulence factors and immunogens of the human pathogen group A Streptococcus ( GAS). Here, we report the similar to 3 angstrom resolution structure of a GAS M1 fragment containing the regions responsible for eliciting type- specific, protective immunity and for binding fibrinogen, which promotes M1 proinflammatory and antiphagocytic functions. The structure revealed substantial irregularities and instabilities throughout the coiled coil of the M1 fragment. Similar structural irregularities occur in myosin and tropomyosin, explaining the patterns of cross- reactivity seen in autoimmune sequelae of GAS infection. Sequence idealization of a large segment of the M1 coiled coil enhanced stability but diminished fibrinogen binding, proinflammatory effects, and antibody cross- reactivity, whereas it left protective immunogenicity undiminished. Idealized M proteins appear to have promise as vaccine immunogens.	[McNamara, Case; Macheboeuf, Pauline; Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Zinkernagel, Annelies S.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Cunningham, Madeleine W.] Univ Oklahoma, Hlth Sci Ctr, Biomed Res Ctr, Oklahoma City, OK 73104 USA; [Nizet, Victor] Univ Calif San Diego, Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Ghosh, Partho] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Diego; University of California System; University of California San Diego	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pghosh@ucsd.edu	Nizet, Victor/AAF-3190-2019; Zinkernagel, Annelies S/F-1780-2017	Zinkernagel, Annelies S/0000-0003-4700-1118; Nizet, Victor/0000-0003-3847-0422; Macheboeuf, Pauline/0000-0003-4523-9923	NHLBI NIH HHS [R56 HL056267] Funding Source: Medline; NIAID NIH HHS [R37 AI052453, R01 AI052453-08, R01 AI048694, R01 AI052453, R21 AI071167-01A1, R21 AI071167] Funding Source: Medline; NIGMS NIH HHS [T32 GM008326] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL056267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052453, R01AI048694, R21AI071167, R37AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andre I, 2006, BIOCHEMISTRY-US, V45, P4559, DOI 10.1021/bi052455c; Blankenfeldt W, 2006, P NATL ACAD SCI USA, V103, P17713, DOI 10.1073/pnas.0606741103; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; CUNNINGHAM MW, 1992, P NATL ACAD SCI USA, V89, P1320, DOI 10.1073/pnas.89.4.1320; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hicks MR, 2002, J STRUCT BIOL, V137, P73, DOI 10.1006/jsbi.2002.4462; Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; MASSELL BF, 1969, J AMER MED ASSOC, V207, P1115, DOI 10.1001/jama.207.6.1115; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; Mertens NMJ, 2000, MOL IMMUNOL, V37, P901, DOI 10.1016/S0161-5890(01)00007-4; NILSON BHK, 1995, BIOCHEMISTRY-US, V34, P13688, DOI 10.1021/bi00041a051; PHILLIPS GN, 1981, P NATL ACAD SCI-BIOL, V78, P4689, DOI 10.1073/pnas.78.8.4689; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866	25	109	113	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1405	1408		10.1126/science.1154470	http://dx.doi.org/10.1126/science.1154470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18323455	Green Accepted			2022-12-24	WOS:000253712900048
J	Kangaspeska, S; Stride, B; Metivier, R; Polycarpou-Schwarz, M; Ibberson, D; Carmouche, RP; Benes, V; Gannon, F; Reid, G				Kangaspeska, Sara; Stride, Brenda; Metivier, Raphael; Polycarpou-Schwarz, Maria; Ibberson, David; Carmouche, Richard Paul; Benes, Vladimir; Gannon, Frank; Reid, George			Transient cyclical methylation of promoter DNA	NATURE			English	Article							ESTROGEN-RECEPTOR-ALPHA; CHROMATIN MODIFICATION; NUCLEAR RECEPTOR; GENE-REGULATION; TRANSCRIPTION; ORGANIZATION; MECHANISMS; DYNAMICS	Methylation of CpG dinucleotides is generally associated with epigenetic silencing of transcription and is maintained through cellular division(1-3). Multiple CpG sequences are rare in mammalian genomes, but frequently occur at the transcriptional start site of active genes, with most clusters of CpGs being hypomethylated(4). We reported previously that the proximal region of the trefoil factor 1 ( TFF1, also known as pS2) and oestrogen receptor alpha ( ER alpha) promoters could be partially methylated by treatment with deacetylase inhibitors(5), suggesting the possibility of dynamic changes in DNA methylation. Here we show that cyclical methylation and demethylation of CpG dinucleotides, with a periodicity of around 100 min, is characteristic for five selected promoters, including the oestrogen ( E2)- responsive pS2 gene, in human cells. When the pS2 gene is actively transcribed, DNA methylation occurs after the cyclical occupancy of ER alpha and RNA polymerase II ( polII). Moreover, we report conditions that provoke methylation cycling of the pS2 promoter in cell lines in which pS2 expression is quiescent and the proximal promoter is methylated. This coincides with a low- level re- expression of ER alpha and of pS2 transcripts.	[Kangaspeska, Sara; Stride, Brenda; Polycarpou-Schwarz, Maria; Ibberson, David; Carmouche, Richard Paul; Benes, Vladimir; Gannon, Frank; Reid, George] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Metivier, Raphael] Univ Rennes 1, SPARTE, CNRS, UMR 6026, F-35042 Rennes, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Reid, G (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	george.reid@embl.de	Hu, Ruogu/B-2203-2008; Gannon, Frank/G-1194-2015	Benes, Vladimir/0000-0002-0352-2547; Reid, George/0000-0002-0298-693X; Polycarpou-Schwarz, Maria/0000-0002-9125-6460				Costello JF, 2001, J MED GENET, V38, P285, DOI 10.1136/jmg.38.5.285; Dillon N, 2006, CHROMOSOME RES, V14, P117, DOI 10.1007/s10577-006-1027-8; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kress C, 2006, P NATL ACAD SCI USA, V103, P11112, DOI 10.1073/pnas.0601793103; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; METIVIER R, NATURE; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; NELSON JE, 1992, ANAL BIOCHEM, V207, P197, DOI 10.1016/0003-2697(92)90523-A; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Yokochi T, 2004, MOL PHARMACOL, V66, P1415, DOI 10.1124/mol.104.002634	23	512	536	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					112	U14		10.1038/nature06640	http://dx.doi.org/10.1038/nature06640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322535				2022-12-24	WOS:000253671900057
J	Martin, F; Aerts, A; Ahren, D; Brun, A; Danchin, EGJ; Duchaussoy, F; Gibon, J; Kohler, A; Lindquist, E; Pereda, V; Salamov, A; Shapiro, HJ; Wuyts, J; Blaudez, D; Buee, M; Brokstein, P; Canback, B; Cohen, D; Courty, PE; Coutinho, PM; Delaruelle, C; Detter, JC; Deveau, A; DiFazio, S; Duplessis, S; Fraissinet-Tachet, L; Lucic, E; Frey-Klett, P; Fourrey, C; Feussner, I; Gay, G; Grimwood, J; Hoegger, PJ; Jain, P; Kilaru, S; Labbe, J; Lin, YC; Legue, V; Le Tacon, F; Marmeisse, R; Melayah, D; Montanini, B; Muratet, M; Nehls, U; Niculita-Hirzel, H; Oudot-Le Secq, MP; Peter, M; Quesneville, H; Rajashekar, B; Reich, M; Rouhier, N; Schmutz, J; Yin, T; Chalot, M; Henrissat, B; Kues, U; Lucas, S; Van de Peer, Y; Podila, GK; Polle, A; Pukkila, PJ; Richardson, PM; Rouze, P; Sanders, IR; Stajich, JE; Tunlid, A; Tuskan, G; Grigoriev, IV				Martin, F.; Aerts, A.; Ahren, D.; Brun, A.; Danchin, E. G. J.; Duchaussoy, F.; Gibon, J.; Kohler, A.; Lindquist, E.; Pereda, V.; Salamov, A.; Shapiro, H. J.; Wuyts, J.; Blaudez, D.; Buee, M.; Brokstein, P.; Canback, B.; Cohen, D.; Courty, P. E.; Coutinho, P. M.; Delaruelle, C.; Detter, J. C.; Deveau, A.; DiFazio, S.; Duplessis, S.; Fraissinet-Tachet, L.; Lucic, E.; Frey-Klett, P.; Fourrey, C.; Feussner, I.; Gay, G.; Grimwood, J.; Hoegger, P. J.; Jain, P.; Kilaru, S.; Labbe, J.; Lin, Y. C.; Legue, V.; Le Tacon, F.; Marmeisse, R.; Melayah, D.; Montanini, B.; Muratet, M.; Nehls, U.; Niculita-Hirzel, H.; Oudot-Le Secq, M. P.; Peter, M.; Quesneville, H.; Rajashekar, B.; Reich, M.; Rouhier, N.; Schmutz, J.; Yin, T.; Chalot, M.; Henrissat, B.; Kuees, U.; Lucas, S.; Van de Peer, Y.; Podila, G. K.; Polle, A.; Pukkila, P. J.; Richardson, P. M.; Rouze, P.; Sanders, I. R.; Stajich, J. E.; Tunlid, A.; Tuskan, G.; Grigoriev, I. V.			The genome of Laccaria bicolor provides insights into mycorrhizal symbiosis	NATURE			English	Article							MEDICAGO-TRUNCATULA; PROTEINS; BIOLOGY	Mycorrhizal symbioses - the union of roots and soil fungi - are universal in terrestrial ecosystems and may have been fundamental to land colonization by plants(1,2). Boreal, temperate and montane forests all depend on ectomycorrhizae(1). Identification of the primary factors that regulate symbiotic development and metabolic activity will therefore open the door to understanding the role of ectomycorrhizae in plant development and physiology, allowing the full ecological significance of this symbiosis to be explored. Here we report the genome sequence of the ectomycorrhizal basidiomycete Laccaria bicolor ( Fig. 1) and highlight gene sets involved in rhizosphere colonization and symbiosis. This 65- megabase genome assembly contains 20,000 predicted protein- encoding genes and a very large number of transposons and repeated sequences. We detected unexpected genomic features, most notably a battery of effector- type small secreted proteins ( SSPs) with unknown function, several of which are only expressed in symbiotic tissues. The most highly expressed SSP accumulates in the proliferating hyphae colonizing the host root. The ectomycorrhizae- specific SSPs probably have a decisive role in the establishment of the symbiosis. The unexpected observation that the genome of L. bicolor lacks carbohydrate- active enzymes involved in degradation of plant cell walls, but maintains the ability to degrade non- plant cell wall polysaccharides, reveals the dual saprotrophic and biotrophic lifestyle of the mycorrhizal fungus that enables it to grow within both soil and living plant roots. The predicted gene inventory of the L. bicolor genome, therefore, points to previously unknown mechanisms of symbiosis operating in biotrophic mycorrhizal fungi. The availability of this genome provides an unparalleled opportunity to develop a deeper understanding of the processes by which symbionts interact with plants within their ecosystem to perform vital functions in the carbon and nitrogen cycles that are fundamental to sustainable plant productivity.	[Martin, F.; Brun, A.; Duchaussoy, F.; Gibon, J.; Kohler, A.; Pereda, V.; Wuyts, J.; Blaudez, D.; Buee, M.; Cohen, D.; Courty, P. E.; Delaruelle, C.; Deveau, A.; Duplessis, S.; Lucic, E.; Frey-Klett, P.; Fourrey, C.; Labbe, J.; Legue, V.; Le Tacon, F.; Montanini, B.; Oudot-Le Secq, M. P.; Peter, M.; Reich, M.; Rouhier, N.; Chalot, M.] Univ Nancy 1, INRA, UMR 1136, F-54280 Champenoux, France; [Aerts, A.; Lindquist, E.; Salamov, A.; Shapiro, H. J.; Brokstein, P.; Detter, J. C.; Lucas, S.; Richardson, P. M.; Grigoriev, I. V.] US DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Ahren, D.; Canback, B.; Rajashekar, B.; Tunlid, A.] Lund Univ, SE-22362 Lund, Sweden; [Danchin, E. G. J.; Coutinho, P. M.; Henrissat, B.] Univ Aix Marseille 1, CNRS, UMR 6098, F-13288 Marseille 9, France; [Danchin, E. G. J.; Coutinho, P. M.; Henrissat, B.] Univ Aix Marseille 2, CNRS, UMR 6098, F-13288 Marseille 9, France; [Wuyts, J.; Lin, Y. C.; Van de Peer, Y.; Rouze, P.] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [DiFazio, S.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; [Feussner, I.] Univ Gottingen, Dept Plant Biochem, D-37077 Gottingen, Germany; [Fraissinet-Tachet, L.; Gay, G.; Marmeisse, R.; Melayah, D.] Univ Lyon 1, CNRS, UMR USC INRA Ecol Microbienne, F-69622 Villeurbanne, France; [Grimwood, J.; Schmutz, J.] Stanford Univ, Sch Med, Stanford Human Genome Ctr, Dept Genet, Palo Alto, CA 94304 USA; [Hoegger, P. J.; Kilaru, S.; Reich, M.; Kuees, U.; Polle, A.] Univ Gottingen, Inst Forest Bot, D-37077 Gottingen, Germany; [Jain, P.; Muratet, M.; Podila, G. K.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; [Nehls, U.] Univ Tubingen, D-72076 Tubingen, Germany; [Niculita-Hirzel, H.; Sanders, I. R.] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Peter, M.] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Quesneville, H.] INRA, Unite Rech Genom Info, F-91034 Evry, France; [Yin, T.; Tuskan, G.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Pukkila, P. J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Rouze, P.] Univ Ghent, Lab Assoc INRA, B-9052 Ghent, Belgium; [Stajich, J. E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	INRAE; Universite de Lorraine; United States Department of Energy (DOE); Lund University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Flanders Institute for Biotechnology (VIB); Ghent University; West Virginia University; University of Gottingen; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Stanford University; University of Gottingen; University of Alabama System; University of Alabama Huntsville; Eberhard Karls University of Tubingen; University of Lausanne; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; INRAE; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of North Carolina; University of North Carolina Chapel Hill; Ghent University; University of California System; University of California Berkeley	Martin, F (corresponding author), Univ Nancy 1, INRA, UMR 1136, F-54280 Champenoux, France.	fmartin@nancy.inra.fr	Danchin, Etienne GJ/X-6969-2019; Henrissat, Bernard/J-2475-2012; Sanders, Ian R/T-9988-2017; Van de Peer, Yves/AAE-7666-2019; Peter, Martina/G-2284-2018; Grimwood, Jane/ABD-5737-2021; Kües, Ursula/B-8280-2008; Schmutz, Jeremy/N-3173-2013; Danchin, Etienne G.J./A-6648-2008; Labbe, Jessy/G-9532-2011; Pereda-Loth, Veronica/A-1296-2011; Quesneville, Hadi/AAG-1048-2020; Tuskan, Gerald/A-6225-2011; DEVEAU, Aurélie/AFH-1153-2022; LIN, Yao-Cheng/B-4394-2008; Kohler, Annegret/AAD-1876-2019; Stajich, Jason Eric/C-7297-2008; Reich, Marlis/AAC-4604-2021; , DUPLESSIS/G-4150-2011; , Deveau/AAD-4442-2020; Feussner, Ivo/H-9320-2013; Coutinho, Pedro M/C-4473-2008; Rajashekar, Balaji/W-8012-2018; CHALOT, Michel/A-1113-2012; Blaudez, Damien/AAF-6517-2020; Niculita-Hirzel, Helene/I-8741-2012; Van de Peer, Yves/D-4388-2009; Niculita-Hirzel, Helene/AAS-5375-2021	Danchin, Etienne GJ/0000-0003-4146-5608; Henrissat, Bernard/0000-0002-3434-8588; Sanders, Ian R/0000-0002-9591-8214; Van de Peer, Yves/0000-0003-4327-3730; Peter, Martina/0000-0002-6365-6889; Kües, Ursula/0000-0001-9180-4079; Schmutz, Jeremy/0000-0001-8062-9172; Danchin, Etienne G.J./0000-0003-4146-5608; Labbe, Jessy/0000-0003-0368-2054; Quesneville, Hadi/0000-0003-3001-4908; Tuskan, Gerald/0000-0003-0106-1289; LIN, Yao-Cheng/0000-0002-9390-795X; Stajich, Jason Eric/0000-0002-7591-0020; Reich, Marlis/0000-0001-7537-5809; , DUPLESSIS/0000-0002-2072-2989; , Deveau/0000-0001-6266-5241; Feussner, Ivo/0000-0002-9888-7003; Rajashekar, Balaji/0000-0002-1665-5584; CHALOT, Michel/0000-0001-8614-0917; Van de Peer, Yves/0000-0003-4327-3730; Niculita-Hirzel, Helene/0000-0003-1467-8819; Rouhier, Nicolas/0000-0002-2036-7884; Montanini, Barbara/0000-0002-5419-7975; DiFazio, Stephen/0000-0003-4077-1590; Kilaru, Sreedhar/0000-0002-8580-6358; Cohen, David/0000-0002-0320-8865; Legue, Valerie/0000-0003-2090-9580; COURTY, Pierre-Emmanuel/0000-0003-2789-7818; Polle, Andrea/0000-0001-8697-6394; Buee, Marc/0000-0001-8614-3886; Veneault-Fourrey, Claire/0000-0001-9778-2659; valerie, legue/0000-0001-6626-5149; Blaudez, Damien/0000-0003-3287-3482; Nehls, Uwe/0000-0003-4421-6455; Marmeisse, Roland/0000-0003-1653-3517; Grigoriev, Igor/0000-0002-3136-8903				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blancaflor EB, 2001, PROTOPLASMA, V217, P154, DOI 10.1007/BF01283396; Catanzariti AM, 2006, PLANT CELL, V18, P243, DOI 10.1105/tpc.105.035980; Chalot M, 2006, TRENDS PLANT SCI, V11, P263, DOI 10.1016/j.tplants.2006.04.005; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Klironomos JN, 2001, NATURE, V410, P651, DOI 10.1038/35070643; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Martin F, 2007, CURR OPIN PLANT BIOL, V10, P204, DOI 10.1016/j.pbi.2007.01.006; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Nehls U, 2007, PHYTOCHEMISTRY, V68, P82, DOI 10.1016/j.phytochem.2006.09.024; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SCHIEX T, LECT NOTES COMPUTER, V2066, P111; Tenney AE, 2004, GENOME RES, V14, P2330, DOI 10.1101/gr.2816704; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wirsel SGR, 2001, MOL PLANT MICROBE IN, V14, P1319, DOI 10.1094/MPMI.2001.14.11.1319; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	27	702	799	7	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					88	U7		10.1038/nature06556	http://dx.doi.org/10.1038/nature06556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322534	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000253671900052
J	Emilsson, V; Thorleifsson, G; Zhang, B; Leonardson, AS; Zink, F; Zhu, J; Carlson, S; Helgason, A; Walters, GB; Gunnarsdottir, S; Mouy, M; Steinthorsdottir, V; Eiriksdottir, GH; Bjornsdottir, G; Reynisdottir, I; Gudbjartsson, D; Helgadottir, A; Jonasdottir, A; Jonasdottir, A; Styrkarsdottir, U; Gretarsdottir, S; Magnusson, KP; Stefansson, H; Fossdal, R; Kristjansson, K; Gislason, HG; Stefansson, T; Leifsson, BG; Thorsteinsdottir, U; Lamb, JR; Gulcher, JR; Reitman, ML; Kong, A; Schadt, EE; Stefansson, K				Emilsson, Valur; Thorleifsson, Gudmar; Zhang, Bin; Leonardson, Amy S.; Zink, Florian; Zhu, Jun; Carlson, Sonia; Helgason, Agnar; Walters, G. Bragi; Gunnarsdottir, Steinunn; Mouy, Magali; Steinthorsdottir, Valgerdur; Eiriksdottir, Gudrun H.; Bjornsdottir, Gyda; Reynisdottir, Inga; Gudbjartsson, Daniel; Helgadottir, Anna; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Styrkarsdottir, Unnur; Gretarsdottir, Solveig; Magnusson, Kristinn P.; Stefansson, Hreinn; Fossdal, Ragnheidur; Kristjansson, Kristleifur; Gislason, Hjortur G.; Stefansson, Tryggvi; Leifsson, Bjorn G.; Thorsteinsdottir, Unnur; Lamb, John R.; Gulcher, Jeffrey R.; Reitman, Marc L.; Kong, Augustine; Schadt, Eric E.; Stefansson, Kari			Genetics of gene expression and its effect on disease	NATURE			English	Article							INTEGRATIVE GENOMICS APPROACH; SEGREGATING MOUSE-POPULATION; LINKAGE ANALYSIS; ADIPOSE-TISSUE; OBESITY; NETWORKS; YEAST; ASSOCIATION; PEDIGREES; DISCOVERY	Common human diseases result from the interplay of many genes and environmental factors. Therefore, a more integrative biology approach is needed to unravel the complexity and causes of such diseases. To elucidate the complexity of common human diseases such as obesity, we have analysed the expression of 23,720 transcripts in large population- based blood and adipose tissue cohorts comprehensively assessed for various phenotypes, including traits related to clinical obesity. In contrast to the blood expression profiles, we observed a marked correlation between gene expression in adipose tissue and obesity- related traits. Genome- wide linkage and association mapping revealed a highly significant genetic component to gene expression traits, including a strong genetic effect of proximal ( cis) signals, with 50% of the cis signals overlapping between the two tissues profiled. Here we demonstrate an extensive transcriptional network constructed from the human adipose data that exhibits significant overlap with similar network modules constructed from mouse adipose data. A core network module in humans and mice was identified that is enriched for genes involved in the inflammatory and immune response and has been found to be causally associated to obesity- related traits.	[Emilsson, Valur; Thorleifsson, Gudmar; Zink, Florian; Helgason, Agnar; Walters, G. Bragi; Gunnarsdottir, Steinunn; Mouy, Magali; Steinthorsdottir, Valgerdur; Eiriksdottir, Gudrun H.; Bjornsdottir, Gyda; Reynisdottir, Inga; Gudbjartsson, Daniel; Helgadottir, Anna; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Styrkarsdottir, Unnur; Gretarsdottir, Solveig; Magnusson, Kristinn P.; Stefansson, Hreinn; Fossdal, Ragnheidur; Kristjansson, Kristleifur; Thorsteinsdottir, Unnur; Gulcher, Jeffrey R.; Kong, Augustine; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Emilsson, Valur; Zhang, Bin; Leonardson, Amy S.; Zhu, Jun; Carlson, Sonia; Lamb, John R.; Schadt, Eric E.] Rosetta Inpharmat LLC, Seattle, WA 98109 USA; [Gislason, Hjortur G.; Stefansson, Tryggvi; Leifsson, Bjorn G.] Natl Univ Hosp Reykjavik, Dept Surg, IS-101 Reykjavik, Iceland; [Reitman, Marc L.] Merck Res Labs, Rahway, NJ 07065 USA	Merck & Company; Landspitali National University Hospital; Merck & Company	Stefansson, K (corresponding author), deCODE Genet, IS-101 Reykjavik, Iceland.	eric_schadt@merck.com; kari.stefansson@decode.is	Helgason, Agnar/K-1522-2015; Magnusson, Kristinn/A-6479-2011; Magnusson, Kristinn P Pétur/X-4907-2019; Stefansson, Kari/AAE-7187-2019; Walters, G. Bragi/L-4215-2013; Reitman, Marc/B-4448-2013	Magnusson, Kristinn/0000-0003-4528-6826; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Walters, G. Bragi/0000-0002-5415-6487; Reitman, Marc/0000-0002-0426-9475; Reynisdottir, Inga/0000-0002-9730-7476; Helgason, Agnar/0000-0002-8545-3767; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Emilsson, Valur/0000-0001-9982-0524; Styrkarsdottir, Unnur/0000-0001-8146-8278; Stefansson, Hreinn/0000-0002-9331-6666; Carlson, Sonia/0000-0002-1413-4056				Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Badner JA, 1998, AM J HUM GENET, V63, P880, DOI 10.1086/302007; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; CHURCHILL GA, 1994, GENETICS, V138, P963; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; He YDD, 2003, BIOINFORMATICS, V19, P956, DOI 10.1093/bioinformatics/btg126; Hubbard T, 2005, NUCLEIC ACIDS RES, V33, pD447, DOI 10.1093/nar/gki138; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SCHADT EE, 2005, SCI STKE, pPE40; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Steemers FJ, 2005, PHARMACOGENOMICS, V6, P777, DOI 10.2217/14622416.6.7.777; Storey John D, 2003, Methods Mol Biol, V224, P149; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209	40	943	973	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2008	452	7186					423	U2		10.1038/nature06758	http://dx.doi.org/10.1038/nature06758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18344981				2022-12-24	WOS:000254341300022
J	Desnues, C; Rodriguez-Brito, B; Rayhawk, S; Kelley, S; Tran, T; Haynes, M; Liu, H; Furlan, M; Wegley, L; Chau, B; Ruan, YJ; Hall, D; Angly, FE; Edwards, RA; Li, LL; Thurber, RV; Reid, RP; Siefert, J; Souza, V; Valentine, DL; Swan, BK; Breitbart, M; Rohwer, F				Desnues, Christelle; Rodriguez-Brito, Beltran; Rayhawk, Steve; Kelley, Scott; Tran, Tuong; Haynes, Matthew; Liu, Hong; Furlan, Mike; Wegley, Linda; Chau, Betty; Ruan, Yijun; Hall, Dana; Angly, Florent E.; Edwards, Robert A.; Li, Linlin; Thurber, Rebecca Vega; Reid, R. Pamela; Siefert, Janet; Souza, Valeria; Valentine, David L.; Swan, Brandon K.; Breitbart, Mya; Rohwer, Forest			Biodiversity and biogeography of phages in modern stromatolites and thrombolites	NATURE			English	Article							ONLINE TOOL; VIRUSES; MARINE; DIVERSITY; ALIGNMENT	Viruses, and more particularly phages ( viruses that infect bacteria), represent one of the most abundant living entities in aquatic and terrestrial environments. The biogeography of phages has only recently been investigated and so far reveals a cosmopolitan distribution of phage genetic material ( or genotypes)(1-4). Here we address this cosmopolitan distribution through the analysis of phage communities in modern microbialites, the living representatives of one of the most ancient life forms on Earth. On the basis of a comparative metagenomic analysis of viral communities associated with marine ( Highborne Cay, Bahamas) and freshwater ( Pozas Azules II and Rio Mesquites, Mexico) microbialites, we show that some phage genotypes are geographically restricted. The high percentage of unknown sequences recovered from the three metagenomes (>97%), the low percentage similarities with sequences from other environmental viral ( n = 42) and microbial ( n = 36) metagenomes, and the absence of viral genotypes shared among microbialites indicate that viruses are genetically unique in these environments. Identifiable sequences in the Highborne Cay metagenome were dominated by single- stranded DNA microphages that were not detected in any other samples examined, including sea water, fresh water, sediment, terrestrial, extreme, metazoan- associated and marine microbial mats. Finally, a marine signature was present in the phage community of the Pozas Azules II microbialites, even though this environment has not been in contact with the ocean for tens of millions of years. Taken together, these results prove that viruses in modern microbialites display biogeographical variability and suggest that they may be derived from an ancient community.	[Desnues, Christelle; Rodriguez-Brito, Beltran; Rayhawk, Steve; Kelley, Scott; Tran, Tuong; Haynes, Matthew; Liu, Hong; Furlan, Mike; Wegley, Linda; Chau, Betty; Hall, Dana; Angly, Florent E.; Edwards, Robert A.; Li, Linlin; Thurber, Rebecca Vega; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Rodriguez-Brito, Beltran; Rayhawk, Steve; Edwards, Robert A.] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Kelley, Scott; Edwards, Robert A.; Rohwer, Forest] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Ruan, Yijun] Genome Inst Singapore, Singapore 138672, Singapore; [Edwards, Robert A.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Reid, R. Pamela] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Siefert, Janet] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Souza, Valeria] Univ Nacl Autonoma Mexico, Dept Ecol Evolut, Inst Ecol, Mexico City 04510, DF, Mexico; [Valentine, David L.; Swan, Brandon K.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Breitbart, Mya] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); United States Department of Energy (DOE); Argonne National Laboratory; University of Miami; Rice University; Universidad Nacional Autonoma de Mexico; University of California System; University of California Santa Barbara; State University System of Florida; University of South Florida	Desnues, C (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	cdesnues@yahoo.fr	Desnues, Christelle/B-1383-2010; Edwards, Robert/Q-1691-2019; Rohwer, Forest/AAC-5315-2019; Breitbart, Mya/B-1366-2009; Li, Linlin/E-3335-2010; Valentine, David/E-5594-2012; Swan, Brandon K/O-9824-2018; Angly, Florent E/A-7717-2011; Desnues, Christelle/ABG-2910-2021	Desnues, Christelle/0000-0002-2178-0355; Edwards, Robert/0000-0001-8383-8949; Breitbart, Mya/0000-0003-3210-2899; Swan, Brandon K/0000-0003-0465-1444; Angly, Florent E/0000-0002-8999-0738; Desnues, Christelle/0000-0002-2178-0355; Rohwer, Forest/0000-0003-1548-5429; souza, valeria/0000-0002-2992-4229; Valentine, David/0000-0001-5914-9107				Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Casas V, 2006, FEMS MICROBIOL LETT, V261, P141, DOI 10.1111/j.1574-6968.2006.00345.x; Chen F, 2001, APPL ENVIRON MICROB, V67, P539, DOI 10.1128/AEM.67.2.539-545.2001; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; FANE B, 2005, VIRUS TAXONOMY, P289; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; REID RP, 1999, ATOLL RES B, V466, P1; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; SAITO N, 1987, MOL BIOL EVOL, V79, P426; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sano E, 2004, APPL ENVIRON MICROB, V70, P5842, DOI 10.1128/AEM.70.10.5842-5846.2004; Schopf JW, 2006, PHILOS T R SOC B, V361, P869, DOI 10.1098/rstb.2006.1834; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; Souza V, 2006, P NATL ACAD SCI USA, V103, P6565, DOI 10.1073/pnas.0601434103; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walter M. R., 1976, STROMATOLITES; Whitaker RJ, 2006, PHILOS T R SOC B, V361, P1975, DOI 10.1098/rstb.2006.1927; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909	30	186	193	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					340	U5		10.1038/nature06735	http://dx.doi.org/10.1038/nature06735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18311127				2022-12-24	WOS:000254117400044
J	Babic, A; Lindner, AB; Vulic, M; Stewart, EJ; Radman, M				Babic, Ana; Lindner, Ariel B.; Vulic, Marin; Stewart, Eric J.; Radman, Miroslav			Direct visualization of horizontal gene transfer	SCIENCE			English	Article							ESCHERICHIA-COLI; DNA TRANSFER; CONJUGATIONAL RECOMBINATION; REPLICATION INITIATION; F-PILIN; SEQA; PROTEIN; MIGRATION; SEQUENCE; CONTACT	Conjugation allows bacteria to acquire genes for antibiotic resistance, novel virulence attributes, and alternative metabolic pathways. Using a fluorescent protein fusion, SeqA- YFP, we have visualized this process in real time and in single cells of Escherichia coli. We found that the F pilus mediates DNA transfer at considerable cell- to- cell distances. Integration of transferred DNA by recombination occurred in up to 96% of recipients; in the remaining cells, the transferred DNA was fully degraded by the RecBCD helicase/ nuclease. The acquired integrated DNA was tracked through successive replication rounds and was found to occasionally split and segregate with different chromosomes, leading to the inheritance of different gene clusters within the cell lineage. The incidence of DNA splitting corresponds to about one crossover per cell generation.	[Babic, Ana; Lindner, Ariel B.; Vulic, Marin; Stewart, Eric J.; Radman, Miroslav] INSERM, U571, F-75015 Paris, France; [Babic, Ana; Lindner, Ariel B.; Vulic, Marin; Stewart, Eric J.; Radman, Miroslav] Univ Paris Descartes Fac Med, F-75015 Paris, France; [Radman, Miroslav] Mediterranean Inst Life Sci, Split 21000, Croatia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Radman, M (corresponding author), INSERM, U571, F-75015 Paris, France.	radman@necker.fr	Lindner, Ariel B/I-8503-2016; Lindner, Ariel/K-9247-2019; Radman, Miroslav/HDM-5955-2022	Lindner, Ariel B/0000-0001-5015-6511; Lindner, Ariel/0000-0001-5015-6511; Radman, Miroslav/0000-0003-0216-3148; Radman, Miroslav/0000-0002-7034-4365				ACHTMAN M, 1978, J BACTERIOL, V135, P1053, DOI 10.1128/JB.135.3.1053-1061.1978; BARON LS, 1968, BACTERIOL REV, V32, P362, DOI 10.1128/MMBR.32.4_Pt_1.362-369.1968; BRENDLER T, 1995, EMBO J, V14, P4083, DOI 10.1002/j.1460-2075.1995.tb00080.x; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Delmas S, 2006, P NATL ACAD SCI USA, V103, P4564, DOI 10.1073/pnas.0509012103; Eggleston AK, 1997, CURR BIOL, V7, pR745, DOI 10.1016/S0960-9822(06)00394-0; FROST LS, 1984, J BACTERIOL, V160, P395, DOI 10.1128/JB.160.1.395-401.1984; HARRINGTON LC, 1990, J BACTERIOL, V172, P7263, DOI 10.1128/jb.172.12.7263-7264.1990; HAYES W, 1953, COLD SPRING HARB SYM, V18, P75, DOI 10.1101/SQB.1953.018.01.016; HELMSTETTER C, 1968, COLD SPRING HARB SYM, V33, P809, DOI 10.1101/SQB.1968.033.01.093; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; JACOB F, 1956, ANN I PASTEUR PARIS, V91, P486; Kohiyama M, 2003, SCIENCE, V301, P802, DOI 10.1126/science.1085154; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lawley TD, 2002, MOL MICROBIOL, V44, P947, DOI 10.1046/j.1365-2958.2002.02938.x; LEDERBERG J, 1946, COLD SPRING HARB SYM, V11, P113; LLOYD RG, 1995, GENETICS, V139, P1123; LOW B, 1968, P NATL ACAD SCI USA, V60, P160, DOI 10.1073/pnas.60.1.160; LOW KB, 1991, METHODS ENZYMOL, V204, P43; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Manchak J, 2002, MOL MICROBIOL, V43, P195, DOI 10.1046/j.1365-2958.2002.02731.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Onogi T, 1999, MOL MICROBIOL, V31, P1775, DOI 10.1046/j.1365-2958.1999.01313.x; PANICKER MM, 1985, J BACTERIOL, V162, P584, DOI 10.1128/JB.162.2.584-590.1985; RAYSSIGUIER C, 1991, BIOCHIMIE, V73, P371, DOI 10.1016/0300-9084(91)90103-8; SLATER S, 1995, CELL, V82, P927, DOI 10.1016/0092-8674(95)90272-4; SMITH GR, 1991, CELL, V64, P19, DOI 10.1016/0092-8674(91)90205-D; WILLETTS N, 1987, CELLULAR MOL BIOL, P1110	29	146	152	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1533	1536		10.1126/science.1153498	http://dx.doi.org/10.1126/science.1153498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339941				2022-12-24	WOS:000253943800041
J	Metivier, R; Gallais, R; Tiffoche, C; Le Peron, C; Jurkowska, RZ; Carmouche, RP; Ibberson, D; Barath, P; Demay, F; Reid, G; Benes, V; Jeltsch, A; Gannon, F; Salbert, G				Metivier, Raphael; Gallais, Rozenn; Tiffoche, Christophe; Le Peron, Christine; Jurkowska, Renata Z.; Carmouche, Richard P.; Ibberson, David; Barath, Peter; Demay, Florence; Reid, George; Benes, Vladimir; Jeltsch, Albert; Gannon, Frank; Salbert, Gilles			Cyclical DNA methylation of a transcriptionally active promoter	NATURE			English	Article							ESTROGEN-RECEPTOR-ALPHA; REGULATED TRANSCRIPTION; NUCLEAR RECEPTOR; GENE ACTIVATION; GENOMIC DNA; DEMETHYLATION; GLYCOSYLASE; DNMT3A; ORGANIZATION; COMPLEX	Processes that regulate gene transcription are directly under the influence of the genome organization. The epigenome contains additional information that is not brought by DNA sequence, and generates spatial and functional constraints that complement genetic instructions. DNA methylation on CpGs constitutes an epigenetic mark generally correlated with transcriptionally silent condensed chromatin. Replication of methylation patterns by DNA methyltransferases maintains genome stability through cell division. Here we present evidence of an unanticipated dynamic role for DNA methylation in gene regulation in human cells. Periodic, strand- specific methylation/ demethylation occurs during transcriptional cycling of the pS2/TFF1 gene promoter on activation by oestrogens. DNA methyltransferases exhibit dual actions during these cycles, being involved in CpG methylation and active demethylation of (5m)CpGs through deamination. Inhibition of this process precludes demethylation of the pS2 gene promoter and its subsequent transcriptional activation. Cyclical changes in the methylation status of promoter CpGs may thus represent a critical event in transcriptional achievement.	[Metivier, Raphael; Gallais, Rozenn; Tiffoche, Christophe; Le Peron, Christine; Barath, Peter; Demay, Florence; Salbert, Gilles] Univ Rennes 1, CNRS, Equipe SPARTE,GFAS IFR 140, UMR 6026, F-35042 Rennes, France; [Jurkowska, Renata Z.; Jeltsch, Albert] Jacobs Univ Bremen, D-28759 Bremen, Germany; [Carmouche, Richard P.; Ibberson, David; Reid, George; Benes, Vladimir; Gannon, Frank] European Mol Biol Lab, D-69117 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Jacobs University; European Molecular Biology Laboratory (EMBL)	Metivier, R (corresponding author), Univ Rennes 1, CNRS, Equipe SPARTE,GFAS IFR 140, UMR 6026, Campus Beaulieu, F-35042 Rennes, France.	Raphael.Metivier@univ-rennes1.fr	Barath, Peter/T-7563-2019; Hu, Ruogu/B-2203-2008; li, ran/K-1896-2012; Gannon, Frank/G-1194-2015; Jeltsch, Albert/O-7404-2014; Salbert, Gilles/W-9196-2019; demay, florence/K-1881-2015; Jurkowska, Renata/AAE-2504-2020	Barath, Peter/0000-0001-7330-955X; Jeltsch, Albert/0000-0001-6113-9290; Salbert, Gilles/0000-0001-6115-4140; Jurkowska, Renata/0000-0002-4507-2222; florence, DEMAY/0000-0002-4855-7241; Benes, Vladimir/0000-0002-0352-2547; Reid, George/0000-0002-0298-693X				Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Dillon N, 2006, CHROMOSOME RES, V14, P117, DOI 10.1007/s10577-006-1027-8; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Fatemi M, 2002, EUR J BIOCHEM, V269, P4981, DOI 10.1046/j.1432-1033.2002.03198.x; Fritah A, 2006, J ENDOCRINOL, V191, P613, DOI 10.1677/joe.1.07009; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Gallais R, 2007, MOL ENDOCRINOL, V21, P2085, DOI 10.1210/me.2006-0490; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Jost JP, 2002, FEBS LETT, V527, P63, DOI 10.1016/S0014-5793(02)03166-6; Jost JP, 1999, NUCLEIC ACIDS RES, V27, P3245, DOI 10.1093/nar/27.16.3245; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kress C, 2006, P NATL ACAD SCI USA, V103, P11112, DOI 10.1073/pnas.0601793103; Lamm GM, 1996, NUCLEIC ACIDS RES, V24, P3739, DOI 10.1093/nar/24.19.3739; LETEURTRE F, 1994, J BIOL CHEM, V269, P7893; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Lucarelli M, 2001, J BIOL CHEM, V276, P7500, DOI 10.1074/jbc.M008234200; Matsuo K, 1998, EMBO J, V17, P1446, DOI 10.1093/emboj/17.5.1446; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; NELSON JE, 1992, ANAL BIOCHEM, V207, P197, DOI 10.1016/0003-2697(92)90523-A; Oka M, 2006, J BIOL CHEM, V281, P9901, DOI 10.1074/jbc.M511100200; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharath AN, 2000, BIOCHEMISTRY-US, V39, P14611, DOI 10.1021/bi001610e; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597; Zingg JM, 1996, NUCLEIC ACIDS RES, V24, P3267, DOI 10.1093/nar/24.16.3267	47	697	736	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					45	U2		10.1038/nature06544	http://dx.doi.org/10.1038/nature06544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322525				2022-12-24	WOS:000253671900043
J	Searchinger, T; Heimlich, R; Houghton, RA; Dong, FX; Elobeid, A; Fabiosa, J; Tokgoz, S; Hayes, D; Yu, TH				Searchinger, Timothy; Heimlich, Ralph; Houghton, R. A.; Dong, Fengxia; Elobeid, Amani; Fabiosa, Jacinto; Tokgoz, Simla; Hayes, Dermot; Yu, Tun-Hsiang			Use of US croplands for biofuels increases greenhouse gases through emissions from land-use change	SCIENCE			English	Article							SOIL CARBON	Most prior studies have found that substituting biofuels for gasoline will reduce greenhouse gases because biofuels sequester carbon through the growth of the feedstock. These analyses have failed to count the carbon emissions that occur as farmers worldwide respond to higher prices and convert forest and grassland to new cropland to replace the grain ( or cropland) diverted to biofuels. By using a worldwide agricultural model to estimate emissions from land- use change, we found that corn- based ethanol, instead of producing a 20% savings, nearly doubles greenhouse emissions over 30 years and increases greenhouse gases for 167 years. Biofuels from switchgrass, if grown on U. S. corn lands, increase emissions by 50%. This result raises concerns about large biofuel mandates and highlights the value of using waste products.	[Searchinger, Timothy] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Searchinger, Timothy] German Marshall Fund US, Washington, DC 20009 USA; [Searchinger, Timothy] Georgetown Environm Law & Policy Inst, Washington, DC 20001 USA; [Heimlich, Ralph] Agr Conservat Econ, Laurel, MD 20723 USA; [Houghton, R. A.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Dong, Fengxia; Elobeid, Amani; Fabiosa, Jacinto; Tokgoz, Simla; Hayes, Dermot; Yu, Tun-Hsiang] Iowa State Univ, Ctr Agr & Rural Dev, Ames, IA 50011 USA	Princeton University; Woods Hole Research Center; Iowa State University	Searchinger, T (corresponding author), Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA.	tsearchi@princeton.edu	Molina, Carolina/E-3898-2015	Molina, Carolina/0000-0001-6659-994X; Tokgoz, Simla/0000-0002-9358-0491; Hayes, Dermot/0000-0002-6278-7238				[Anonymous], 4 IPCC; [Anonymous], WORLD AGR 2015 30 FA; Argonne National Laboratory, 2007, GREENH GAS REG EM EN; Commission of the European Communities, 2006, COM2006845 COMM EUR; DELUCHI M, 2005, UCDITSRR0510; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; *IA CORN GROW ASS, US CORN FACT SHEET; IPCC, 2001, ADV CLIM CHANG RES; JOHANNS M, 2007, ADV REN EN C US DEP; MACEDO IDC, 2004, ASSESSMENT GREENHOUS; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; PERLACK RD, 2005, 20666 ORNLTM; Righelato R, 2007, SCIENCE, V317, P902, DOI 10.1126/science.1141361; SCHNEPF RD, 2001, WRS0103 USDA EC RES; SHEAN MJ, 2003, BRAZIL FUTURE AGR EX; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; TOKGOZ S, 2007, DATA FILES REVISED 2; Tokgoz S., 2007, 07SR101 IOW STAT U C; Wang M., 2005, 15 INT S ALC FUELS S; WANG M, 1999, EFFECTS FUEL ETHANTO	25	3028	3090	21	1342	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1238	1240		10.1126/science.1151861	http://dx.doi.org/10.1126/science.1151861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18258860				2022-12-24	WOS:000253530600042
J	Moore, RB; Obornik, M; Janouskovec, J; Chrudimsky, T; Vancova, M; Green, DH; Wright, SW; Davies, NW; Bolch, CJS; Heimann, K; Slapeta, J; Hoegh-Guldberg, O; Logsdon, JM; Carter, DA				Moore, Robert B.; Obornik, Miroslav; Janouskovec, Jan; Chrudimsky, Tomas; Vancova, Marie; Green, David H.; Wright, Simon W.; Davies, Noel W.; Bolch, Christopher J. S.; Heimann, Kirsten; Slapeta, Jan; Hoegh-Guldberg, Ove; Logsdon, John M., Jr.; Carter, Dee A.			A photosynthetic alveolate closely related to apicomplexan parasites	NATURE			English	Article							CRYPTOSPORIDIUM-PARVUM; TOXOPLASMA-GONDII; COMMON ORIGIN; DINOFLAGELLATE; PHYLOGENY; DIVERSITY; SPOROZOAN; PLASTIDS; TAXONOMY; PROTEIN	Many parasitic Apicomplexa, such as Plasmodium falciparum, contain an unpigmented chloroplast remnant termed the apicoplast, which is a target for malaria treatment. However, no close relative of apicomplexans with a functional photosynthetic plastid has yet been described. Here we describe a newly cultured organism that has ultrastructural features typical for alveolates, is phylogenetically related to apicomplexans, and contains a photosynthetic plastid. The plastid is surrounded by four membranes, is pigmented by chlorophyll a, and uses the codon UGA to encode tryptophan in the psbA gene. This genetic feature has been found only in coccidian apicoplasts and various mitochondria. The UGA-Trp codon and phylogenies of plastid and nuclear ribosomal RNA genes indicate that the organism is the closest known photosynthetic relative to apicomplexan parasites and that its plastid shares an origin with the apicoplasts. The discovery of this organism provides a powerful model with which to study the evolution of parasitism in Apicomplexa.	[Moore, Robert B.; Carter, Dee A.] Univ Sydney, Sch Mol & Microbial Biosci, Darlington, NSW 2006, Australia; [Moore, Robert B.; Logsdon, John M., Jr.] Univ Iowa, Roy J Carver Ctr Comparat Genom, Dept Biol Sci, Iowa City, IA 52242 USA; [Obornik, Miroslav; Janouskovec, Jan; Chrudimsky, Tomas; Vancova, Marie] Acad Sci Czech Republ, Ctr Biol, Inst Parasitol, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav; Janouskovec, Jan; Chrudimsky, Tomas; Vancova, Marie] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Green, David H.] Dunstaffnage Marine Lab Oban, Scottish Assoc Marine Sci, Argyll PA37 1QA, Scotland; [Wright, Simon W.] Australian Antarctic Div, Kingston, Tas 7050, Australia; [Davies, Noel W.] Univ Tasmania, Cent Sci Lab, Hobart, Tas 7001, Australia; [Bolch, Christopher J. S.] Univ Tasmania, Sch Aquaculture, Launceston, Tas 7250, Australia; [Heimann, Kirsten] James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Slapeta, Jan] Univ Sydney, Fac Vet Sci, Camperdown, NSW 2006, Australia; [Hoegh-Guldberg, Ove] Univ Queensland, Ctr Marine Studies, St Lucia, Qld 4072, Australia	University of Sydney; University of Iowa; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Australian Antarctic Division; University of Tasmania; University of Tasmania; James Cook University; University of Sydney; University of Queensland	Carter, DA (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Darlington, NSW 2006, Australia.	d.carter@mmb.usyd.edu.au	Green, David/E-2533-2012; Janouškovec, Jan/ABA-2568-2021; Carter, Dee/C-1331-2010; Hoegh-Guldberg, Ove/ABA-5420-2020; Chrudimský, Tomáš/L-5628-2014; Heimann, Kirsten/M-4814-2019; Hoegh-Guldberg, Ove/H-6169-2011; Vancova, Marie/G-8347-2014; Logsdon, John M/B-7812-2009; Obornik, Miroslav/G-9350-2014; Heimann, Kirsten/C-4539-2012; Heimann, Kirsten/N-1512-2013; Bolch, Christopher J/J-7619-2014; Davies, Noel W/J-7714-2014	Green, David/0000-0001-7499-6021; Janouškovec, Jan/0000-0001-6547-749X; Carter, Dee/0000-0002-4638-0059; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Heimann, Kirsten/0000-0003-2691-9659; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Vancova, Marie/0000-0003-0678-8268; Heimann, Kirsten/0000-0003-2691-9659; Bolch, Christopher J/0000-0001-9047-2391; Davies, Noel W/0000-0002-9624-0935; Slapeta, Jan/0000-0003-1459-9117	Natural Environment Research Council [dml010007] Funding Source: researchfish; NERC [dml010007] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adl SM, 2007, SYST BIOL, V56, P684, DOI 10.1080/10635150701494127; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Barta JR, 2006, TRENDS PARASITOL, V22, P463, DOI 10.1016/j.pt.2006.08.001; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; CAVALIERSMITH T, 1991, SYST ASSOC SPEC VOL, V45, P113; DODGE J D, 1971, Protistologica, V7, P295; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Huang JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r88; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Kohler S, 2005, PARASITOL RES, V96, P258, DOI 10.1007/s00436-005-1338-2; Kremp A, 2005, J PHYCOL, V41, P629, DOI 10.1111/j.1529-8817.2005.00070.x; Kuvardina ON, 2002, J EUKARYOT MICROBIOL, V49, P498, DOI 10.1111/j.1550-7408.2002.tb00235.x; Lang-Unnasch N, 1998, INT J PARASITOL, V28, P1743, DOI 10.1016/S0020-7519(98)00136-2; Lang-Unnasch N, 1999, INT J PARASITOL, V29, P1557, DOI 10.1016/S0020-7519(99)00119-8; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; Leander BS, 2003, INT J SYST EVOL MICR, V53, P345, DOI 10.1099/ijs.0.02284-0; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Ralph SA, 2001, DRUG RESIST UPDATE, V4, P145, DOI 10.1054/drup.2001.0205; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Scheer Hugo, 2003, Advances in Photosynthesis and Respiration, V13, P29; Teles-Grilo ML, 2007, EUR J PROTISTOL, V43, P163, DOI 10.1016/j.ejop.2007.02.002; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Toso MA, 2007, J EUKARYOT MICROBIOL, V54, P66, DOI 10.1111/j.1550-7408.2006.00229.x; Wakefield TS, 2000, BIOL BULL-US, V199, P76, DOI 10.2307/1542709; York R. H., 1986, CORAL REEF POPULATIO, P486; Zhang ZD, 2000, J MOL EVOL, V51, P26, DOI 10.1007/s002390010064; Zhu G, 2000, MICROBIOL-SGM, V146, P315, DOI 10.1099/00221287-146-2-315	30	325	334	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					959	963		10.1038/nature06635	http://dx.doi.org/10.1038/nature06635			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288187				2022-12-24	WOS:000253313100041
J	Martin, BI; Deyo, RA; Mirza, SK; Turner, JA; Comstock, BA; Hollingworth, W; Sullivan, SD				Martin, Brook I.; Deyo, Richard A.; Mirza, Sohail K.; Turner, Judith A.; Comstock, Bryan A.; Hollingworth, William; Sullivan, Sean D.			Expenditures and health status among adults with back and neck problems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; MEDICARE POPULATION; CARE EXPENDITURES; SPINE SURGERY; PANEL SURVEY; TRENDS; PAIN; INDIVIDUALS; PREVALENCE; PATTERNS	Context Back and neck problems are among the symptoms most commonly encountered in clinical practice. However, few studies have examined national trends in expenditures for back and neck problems or related these trends to health status measures. Objectives To estimate inpatient, outpatient, emergency department, and pharmacy expenditures related to back and neck problems in the United States from 1997 through 2005 and to examine associated trends in health status. Design and Setting Age- and sex- adjusted analysis of the nationally representative Medical Expenditure Panel Survey ( MEPS) from 1997 to 2005 using complex survey regression methods. The MEPS is a household survey of medical expenditures weighted to represent national estimates. Respondents were US adults ( > 17 years) who self-reported back and neck problems ( referred to as "spine problems" based on MEPS descriptions and International Classification of Diseases, Ninth Revision, Clinical Modification definitions). Main Outcome Measures Spine- related expenditures for health services ( inflation-adjusted); annual surveys of self- reported health status. Results National estimates were based on annual samples of survey respondents with and without self- reported spine problems from 1997 through 2005. A total of 23 045 respondents were sampled in 1997, including 3139 who reported spine problems. In 2005, the sample included 22 258 respondents, including 3187 who reported spine problems. In 1997, the mean age- and sex- adjusted medical costs for respondents with spine problems was $4695 ( 95% confidence interval [ CI], $4181-$ 5209), compared with $2731 ( 95% CI, $2557-$ 2904) among those without spine problems ( inflation- adjusted to 2005 dollars). In 2005, the mean age- and sex- adjusted medical expenditure among respondents with spine problems was $6096 ( 95% CI, $5670-$6522), compared with $ 3516 ( 95% CI, $ 3266-$ 3765) among those without spine problems. Total estimated expenditures among respondents with spine problems increased 65% ( adjusted for inflation) from 1997 to 2005, more rapidly than overall health expenditures. The estimated proportion of persons with back or neck problems who self- reported physical functioning limitations increased from 20.7% ( 95% CI, 19.9%- 21.4%) to 24.7% ( 95% CI, 23.7%-25.6%) from 1997 to 2005. Age- and sex- adjusted self- reported measures of mental health, physical functioning, work or school limitations, and social limitations among adults with spine problems were worse in 2005 than in 1997. Conclusions In this survey population, self- reported back and neck problems accounted for a large proportion of health care expenditures. These spine- related expenditures have increased substantially from 1997 to 2005, without evidence of corresponding improvement in self- assessed health status.	[Martin, Brook I.; Deyo, Richard A.; Mirza, Sohail K.; Turner, Judith A.; Comstock, Bryan A.; Hollingworth, William; Sullivan, Sean D.] Univ Washington, Ctr Cost & Outcomes Res, Seattle, WA 98104 USA; [Martin, Brook I.; Mirza, Sohail K.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Martin, Brook I.; Sullivan, Sean D.] Univ Washington, Dept Hlth Sci, Seattle, WA 98195 USA; [Turner, Judith A.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Comstock, Bryan A.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Sullivan, Sean D.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University	Martin, BI (corresponding author), Univ Washington, Ctr Cost & Outcomes Res, Box 359736-PSB5073,325 9th Ave, Seattle, WA 98104 USA.	bim@u.washington.edu	Martin, Brook/L-4698-2019; Fahimifar, Sepideh/M-5303-2019	Hollingworth, William/0000-0002-0840-6254	NIAMS NIH HHS [K23AR48979, P60AR48093] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR048093, K23AR048979] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AM PAIN SOC, PROM PAIN REL PREV A; *AM PAIN SOC, US OP TREATM CHRON P; American Heart Association, 2005, HEART DIS STROKE STA; [Anonymous], MED EXP PAN SURV; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Carrino JA, 2002, RADIOLOGY, V225, P723, DOI 10.1148/radiol.2253011401; CHANTALA K, 2001, USING STATA ANAL DAT; CHERKIN DC, 1992, SPINE, V17, P817, DOI 10.1097/00007632-199207000-00015; Cohen JW, 1996, INQUIRY-J HEALTH CAR, V33, P373; Cohen SB, 2003, MED CARE, V41, P5; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Feuerstein Michael, 2004, Spine J, V4, P56, DOI 10.1016/j.spinee.2003.08.003; Friedly J, 2007, SPINE, V32, P1754, DOI 10.1097/BRS.0b013e3180b9f96e; FRYMOYER JW, 1997, ADULT SPINE PRINCIPL, V2; Gray DT, 2006, SPINE, V31, P1957, DOI 10.1097/01.brs.0000229148.63418.c1; GRAZIER KL, 1984, FREQUENCY OCCURRENCE, P72; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; KATZ S, 1976, MED CARE, V14, P116, DOI 10.1097/00005650-197605001-00018; Kessler RC, 2001, ANN INTERN MED, V135, P262, DOI 10.7326/0003-4819-135-4-200108210-00011; Luo XM, 2004, SPINE, V29, P884, DOI 10.1097/00007632-200404150-00012; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; *NAT HEART LUNG BL, 2006, NHLBI FACTB DIR IND; Petersen M, 2003, DIABETES CARE, V26, P917; Savage SR, 2003, J PAIN SYMPTOM MANAG, V26, P655, DOI 10.1016/S0885-3924(03)00219-7; StataCorp, 2005, STAT BAS REF MAN REL; Strine TW, 2007, ARTHRIT RHEUM-ARTHR, V57, P656, DOI 10.1002/art.22684; *US BUR CENS, POP EST TABL; *US BUR LAB STAT, CONS PRIC IND CALC; Von Korff M, 2004, PAIN, V109, P207, DOI 10.1016/j.pain.2004.02.019; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weiner DK, 2006, PAIN MED, V7, P143, DOI 10.1111/j.1526-4637.2006.00112.x; Yelin E, 2007, ARTHRITIS RHEUM-US, V56, P1397, DOI 10.1002/art.22565; Zerzan JT, 2006, MED CARE, V44, P1005, DOI 10.1097/01.mlr.0000228025.04535.25	37	1041	1065	2	64	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2008	299	6					656	664		10.1001/jama.299.6.656	http://dx.doi.org/10.1001/jama.299.6.656			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261QN	18270354	Bronze			2022-12-24	WOS:000253095200023
J	Donelan, JM; Li, Q; Naing, V; Hoffer, JA; Weber, DJ; Kuo, AD				Donelan, J. M.; Li, Q.; Naing, V.; Hoffer, J. A.; Weber, D. J.; Kuo, A. D.			Biomechanical energy harvesting: Generating electricity during walking with minimal user effort	SCIENCE			English	Article							PROSTHETIC KNEE; ENERGETICS; LOADS; COST; LEG	We have developed a biomechanical energy harvester that generates electricity during human walking with little extra effort. Unlike conventional human- powered generators that use positive muscle work, our technology assists muscles in performing negative work, analogous to regenerative braking in hybrid cars, where energy normally dissipated during braking drives a generator instead. The energy harvester mounts at the knee and selectively engages power generation at the end of the swing phase, thus assisting deceleration of the joint. Test subjects walking with one device on each leg produced an average of 5 watts of electricity, which is about 10 times that of shoe- mounted devices. The cost of harvesting - the additional metabolic power required to produce 1 watt of electricity - is less than one- eighth of that for conventional human power generation. Producing substantial electricity with little extra effort makes this method well- suited for charging powered prosthetic limbs and other portable medical devices.	[Donelan, J. M.; Li, Q.; Naing, V.; Hoffer, J. A.] Simon Fraser Univ, Sch Kinesiol, Burnaby, BC V5A 1S6, Canada; [Weber, D. J.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Kuo, A. D.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Kuo, A. D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	Simon Fraser University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Donelan, JM (corresponding author), Simon Fraser Univ, Sch Kinesiol, Burnaby, BC V5A 1S6, Canada.	mdonelan@sfu.ca	Weber, Douglas/E-7554-2011; Kuo, Arthur/L-3359-2013; Donelan, James/G-1443-2011	Kuo, Arthur/0000-0001-5233-9709; 				Berry Dale, 2006, Phys Med Rehabil Clin N Am, V17, P91, DOI 10.1016/j.pmr.2005.10.006; Brooks GA, 2005, EXERCISE PHYSL HUMAN, V4th; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; Demirdoven N, 2004, SCIENCE, V305, P974, DOI 10.1126/science.1093965; Doke J, 2005, J EXP BIOL, V208, P439, DOI 10.1242/jeb.01408; Elftman H, 1939, AM J PHYSIOL, V125, P339, DOI 10.1152/ajplegacy.1939.125.2.339; International Energy Agency, 2006, WORLD EN OUTL; Johansson JL, 2005, AM J PHYS MED REHAB, V84, P563, DOI 10.1097/01.phm.0000174665.74933.0b; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Kuo AD, 2005, SCIENCE, V309, P1686, DOI 10.1126/science.1118058; Margaria R, 1968, Int Z Angew Physiol, V25, P339; Margaria R., 1976, BIOMECHANICS ENERGET; Marsh RL, 2004, SCIENCE, V303, P80, DOI 10.1126/science.1090704; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Rome LC, 2006, NATURE, V444, P1023, DOI 10.1038/4441023a; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Seymour R, 2007, PROSTHET ORTHOT INT, V31, P51, DOI 10.1080/03093640600982255; SOULE RG, 1969, J APPL PHYSIOL, V27, P687, DOI 10.1152/jappl.1969.27.5.687; SOYKAN O, 2002, BUSINESS BRIEFING ME, P76; Starner T, 1996, IBM SYST J, V35, P618, DOI 10.1147/sj.353.0618; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd	21	525	538	21	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					807	810		10.1126/science.1149860	http://dx.doi.org/10.1126/science.1149860			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258914				2022-12-24	WOS:000252963000060
J	Hilf, RJC; Dutzler, R				Hilf, Ricarda J. C.; Dutzler, Raimund			X-ray structure of a prokaryotic pentameric ligand-gated ion channel	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SELECTIVITY FILTER; GATING MECHANISM; AMINO-ACIDS; K+ CHANNEL; BINDING; LOOP; MUTATIONS; REVEALS; PROGRAM	Pentameric ligand- gated ion channels ( pLGICs) are key players in the early events of electrical signal transduction at chemical synapses. The family codes for a structurally conserved scaffold of channel proteins that open in response to the binding of neurotransmitter molecules. All proteins share a pentameric organization of identical or related subunits that consist of an extracellular ligand- binding domain followed by a transmembrane channel domain. The nicotinic acetylcholine receptor ( nAChR) is the most thoroughly studied member of the pLGIC family ( for recent reviews see refs 1 - 3). Two sources of structural information provided an architectural framework for the family. The structure of the soluble acetylcholine- binding protein ( AChBP) defined the organization of the extracellular domain and revealed the chemical basis of ligand interaction(4-6). Electron microscopy studies of the nAChR from Torpedo electric ray have yielded a picture of the full- length protein and have recently led to the interpretation of an electron density map at 4.0 angstrom resolution(7-9). Despite the wealth of experimental information, high- resolution structures of any family member have so far not been available. Until recently, the pLGICs were believed to be only expressed in multicellular eukaryotic organisms. The abundance of prokaryotic genome sequences, however, allowed the identification of several homologous proteins in bacterial sources(10,11). Here we present the X- ray structure of a prokaryotic pLGIC from the bacterium Erwinia chrysanthemi ( ELIC) at 3.3 angstrom resolution. Our study reveals the first structure of a pLGIC at high resolution and provides an important model system for the investigation of the general mechanisms of ion permeation and gating within the family.	[Hilf, Ricarda J. C.; Dutzler, Raimund] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Dutzler, R (corresponding author), Univ Zurich, Dept Biochem, Winterthurer Str 190, CH-8057 Zurich, Switzerland.	dutzler@bioc.uzh.ch						ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; COHEN BN, 1992, J GEN PHYSIOL, V100, P373, DOI 10.1085/jgp.100.3.373; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; de La Fortelle E., 1997, METHOD ENZYMOL, P492; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; Le Novere N, 2001, NUCLEIC ACIDS RES, V29, P294, DOI 10.1093/nar/29.1.294; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nimigean CM, 2002, J GEN PHYSIOL, V120, P323, DOI 10.1085/jgp.20028614; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2003, FEBS LETT, V555, P91, DOI 10.1016/S0014-5793(03)01084-6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	43	568	577	3	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					375	U12		10.1038/nature06717	http://dx.doi.org/10.1038/nature06717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18322461				2022-12-24	WOS:000254117400052
J	Chaisson, RE; Martinson, NA				Chaisson, Richard E.; Martinson, Neil A.			Tuberculosis in Africa - Combating an HIV-driven crisis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMPACT		[Chaisson, Richard E.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21204 USA; [Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, ZA-2050 Johannesburg, South Africa	Johns Hopkins University; University of Witwatersrand	Chaisson, RE (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21204 USA.							Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; WHO, 2007, WHOHTMTB2007376	5	144	156	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1089	1092		10.1056/NEJMp0800809	http://dx.doi.org/10.1056/NEJMp0800809			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	272RK	18337598				2022-12-24	WOS:000253877200001
J	Reddy, KL; Zullo, JM; Bertolino, E; Singh, H				Reddy, K. L.; Zullo, J. M.; Bertolino, E.; Singh, H.			Transcriptional repression mediated by repositioning of genes to the nuclear lamina	NATURE			English	Article							CELL DIFFERENTIATION; MEMBRANE PROTEIN; GENOME; LOCUS; EMERIN; COMPARTMENTALIZATION; ORGANIZATION; ARCHITECTURE; ASSOCIATION; EXPRESSION	Nuclear compartmentalization seems to have an important role in regulating metazoan genes(1,2). Although studies on immunoglobulin and other loci have shown a correlation between positioning at the nuclear lamina and gene repression, the functional consequences of this compartmentalization remain untested(2,3). We devised an approach for inducible tethering of genes to the inner nuclear membrane ( INM), and tested the consequences of such repositioning on gene activity in mouse fibroblasts. Here, using three- dimensional DNA- immunoFISH, we demonstrate repositioning of chromosomal regions to the nuclear lamina that is dependent on breakdown and reformation of the nuclear envelope during mitosis. Moreover, tethering leads to the accumulation of lamin and INM proteins, but not to association with pericentro-meric heterochromatin or nuclear pore complexes. Recruitment of genes to the INM can result in their transcriptional repression. Finally, we use targeted adenine methylation ( DamID) to show that, as is the case for our model system, inactive immunoglobulin loci at the nuclear periphery are contacted by INM and lamina proteins. We propose that these molecular interactions may be used to compartmentalize and to limit the accessibility of immunoglobulin loci to transcription and recombination factors.	[Reddy, K. L.; Zullo, J. M.; Singh, H.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Reddy, K. L.; Zullo, J. M.; Bertolino, E.; Singh, H.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, GCIS W522,929 E 57th St, Chicago, IL 60637 USA.	hsingh@uchicago.edu		Reddy, Karen/0000-0003-4548-5999	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Belmont AS, 1999, METHOD CELL BIOL, V58, P203; Bengtsson L, 2004, CURR OPIN CELL BIOL, V16, P73, DOI 10.1016/j.ceb.2003.11.012; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Hewitt SL, 2004, EUR J IMMUNOL, V34, P3604, DOI 10.1002/eji.200425469; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Jolly C, 1997, J HISTOCHEM CYTOCHEM, V45, P1585, DOI 10.1177/002215549704501201; Kim SH, 2004, CYTOGENET GENOME RES, V105, P292, DOI 10.1159/000078201; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Pawlitzky I, 2006, J IMMUNOL, V176, P6839, DOI 10.4049/jimmunol.176.11.6839; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Polioudaki H, 2001, EMBO REP, V2, P920, DOI 10.1093/embo-reports/kve199; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; SCHMID M, 2006, MOL CELL, V31, P279; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Tsuchiya Y, 1999, EUR J BIOCHEM, V259, P859, DOI 10.1046/j.1432-1327.1999.00112.x; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Yang QX, 2005, MOL CELL BIOL, V25, P6021, DOI 10.1128/MCB.25.14.6021-6030.2005; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107	28	554	571	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					243	247		10.1038/nature06727	http://dx.doi.org/10.1038/nature06727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18272965				2022-12-24	WOS:000253925600046
J	Johnnidis, JB; Harris, MH; Wheeler, RT; Stehling-Sun, S; Lam, MH; Kirak, O; Brummelkamp, TR; Fleming, MD; Camargo, FD				Johnnidis, Jonathan B.; Harris, Marian H.; Wheeler, Robert T.; Stehling-Sun, Sandra; Lam, Michael H.; Kirak, Oktay; Brummelkamp, Thijn R.; Fleming, Mark D.; Camargo, Fernando D.			Regulation of progenitor cell proliferation and granulocyte function by microRNA-223	NATURE			English	Article							GROWTH-FACTOR-I; RESPIRATORY BURST; NEUTROPHILS; INFLAMMATION; EXPRESSION; MECHANISM; CAPACITY; HORMONE	MicroRNAs are abundant in animal genomes and have been predicted to have important roles in a broad range of gene expression programmes(1,2). Despite this prominence, there is a dearth of functional knowledge regarding individual mammalian microRNAs. Using a loss- of- function allele in mice, we report here that the myeloid- specific microRNA- 223 ( miR- 223) negatively regulates progenitor proliferation and granulocyte differentiation and activation. miR- 223 ( also called Mirn223) mutant mice have an expanded granulocytic compartment resulting from a cell-autonomous increase in the number of granulocyte progenitors. We show that Mef2c, a transcription factor that promotes myeloid progenitor proliferation, is a target of miR- 223, and that genetic ablation of Mef2c suppresses progenitor expansion and corrects the neutrophilic phenotype in miR- 223 null mice. In addition, granulocytes lacking miR- 223 are hypermature, hypersensitive to activating stimuli and display increased fungicidal activity. As a consequence of this neutrophil hyperactivity, miR- 223 mutant mice spontaneously develop inflammatory lung pathology and exhibit exaggerated tissue destruction after endotoxin challenge. Our data support a model in which miR- 223 acts as a fine- tuner of granulocyte production and the inflammatory response.	[Johnnidis, Jonathan B.; Wheeler, Robert T.; Stehling-Sun, Sandra; Lam, Michael H.; Kirak, Oktay; Brummelkamp, Thijn R.; Camargo, Fernando D.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Harris, Marian H.; Fleming, Mark D.] Harvard Univ, Sch Med, Dept Pathol, Childrens Hosp, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Camargo, FD (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	camargo@wi.mit.edu	; Kirak, Oktay/H-6347-2013	Fleming, Mark/0000-0003-0948-4024; Kirak, Oktay/0000-0002-6524-4685				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BJERKNES R, 1995, J CLIN ENDOCR METAB, V80, P1948, DOI 10.1210/jc.80.6.1948; BOHINJEC J, 1981, BLUT, V42, P191, DOI 10.1007/BF01026389; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Ernst M, 2002, J EXP MED, V196, P589, DOI 10.1084/jem.20020873; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; FU YK, 1991, J IMMUNOL, V146, P1602; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Inoue T, 1998, SHOCK, V10, P278, DOI 10.1097/00024382-199810000-00008; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; ROTHE G, 1991, J IMMUNOL METHODS, V138, P133, DOI 10.1016/0022-1759(91)90074-P; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; VONCKEN JW, 1995, CELL, V80, P719, DOI 10.1016/0092-8674(95)90350-X; Vong LH, 2005, GENESIS, V43, P43, DOI 10.1002/gene.20152; Yu CCK, 1996, J EXP MED, V183, P371, DOI 10.1084/jem.183.2.371	26	926	1002	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1125	U11		10.1038/nature06607	http://dx.doi.org/10.1038/nature06607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18278031				2022-12-24	WOS:000253453600046
J	de Lucas, M; Daviere, JM; Rodriguez-Falcon, M; Pontin, M; Iglesias-Pedraz, JM; Lorrain, S; Fankhauser, C; Blazquez, MA; Titarenko, E; Prat, S				de Lucas, Miguel; Daviere, Jean-Michel; Rodriguez-Falcon, Mariana; Pontin, Mariela; Iglesias-Pedraz, Juan Manuel; Lorrain, Severine; Fankhauser, Christian; Blazquez, Miguel Angel; Titarenko, Elena; Prat, Salome			A molecular framework for light and gibberellin control of cell elongation	NATURE			English	Article							SIGNAL-TRANSDUCTION; PHYTOCHROME-B; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; INDUCED DEGRADATION; PROTEIN; GENE; PLANTS; PHOTOMORPHOGENESIS; RGA	Cell elongation during seedling development is antagonistically regulated by light and gibberellins (GAs)(1,2). Light induces photomorphogenesis, leading to inhibition of hypocotyl growth, whereas GAs promote etiolated growth, characterized by increased hypocotyl elongation. The mechanism underlying this antagonistic interaction remains unclear. Here we report on the central role of the Arabidopsis thaliana nuclear transcription factor PIF4 ( encoded by PHYTOCHROME INTERACTING FACTOR 4)(3) in the positive control of genes mediating cell elongation and show that this factor is negatively regulated by the light photoreceptor phyB ( ref. 4) and by DELLA proteins that have a key repressor function in GA signalling(5). Our results demonstrate that PIF4 is destabilized by phyB in the light and that DELLAs block PIF4 transcriptional activity by binding the DNA- recognition domain of this factor. We show that GAs abrogate such repression by promoting DELLA destabilization, and therefore cause a concomitant accumulation of free PIF4 in the nucleus. Consistent with this model, intermediate hypocotyl lengths were observed in transgenic plants over- accumulating both DELLAs and PIF4. Destabilization of this factor by phyB, together with its inactivation by DELLAs, constitutes a protein interaction framework that explains how plants integrate both light and GA signals to optimize growth and development in response to changing environments.	[de Lucas, Miguel; Daviere, Jean-Michel; Rodriguez-Falcon, Mariana; Pontin, Mariela; Iglesias-Pedraz, Juan Manuel; Titarenko, Elena; Prat, Salome] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Madrid 28049, Spain; [Lorrain, Severine; Fankhauser, Christian] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Blazquez, Miguel Angel] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Prat, S (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Campus Univ Autonoma Madrid,C Darwin 3, Madrid 28049, Spain.	sprat@cnb.uam.es	Iglesias Pedraz, Juan Manuel/AAH-6075-2019; Fankhauser, Christian/C-4291-2018; Iglesias-Pedraz, Juan Manuel/U-7205-2017; Prat, Salome/L-9240-2014; Pedraz, Juan Manuel Iglesias/AAH-6067-2019; Fankhauser, Christian/ABE-8757-2021; Blazquez, Miguel A/B-1495-2008	Iglesias Pedraz, Juan Manuel/0000-0003-0070-8116; Fankhauser, Christian/0000-0003-4719-5901; Iglesias-Pedraz, Juan Manuel/0000-0003-0070-8116; Prat, Salome/0000-0003-2684-5485; Fankhauser, Christian/0000-0003-4719-5901; Blazquez, Miguel A/0000-0001-5743-0448; De Lucas, Miguel/0000-0002-6544-6404				Achard P, 2007, PLANT PHYSIOL, V143, P1163, DOI 10.1104/pp.106.092254; Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Alabadi D, 2004, PLANT PHYSIOL, V134, P1050, DOI 10.1104/pp.103.035451; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Fujimori T, 2004, PLANT CELL PHYSIOL, V45, P1078, DOI 10.1093/pcp/pch124; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; Huq E, 2003, PLANT J, V35, P660, DOI 10.1046/j.1365-313X.2003.01836.x; Huq E, 2002, EMBO J, V21, P2441, DOI 10.1093/emboj/21.10.2441; Huq E, 2000, PLANT J, V23, P461, DOI 10.1046/j.1365-313x.2000.00810.x; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Kim JY, 2003, PLANT CELL, V15, P2399, DOI 10.1105/tpc.014498; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Nagy F, 2000, CURR OPIN PLANT BIOL, V3, P450, DOI 10.1016/S1369-5266(00)00112-6; Neff MM, 2000, GENE DEV, V14, P257; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; Oh E, 2006, PLANT J, V47, P124, DOI 10.1111/j.1365-313X.2006.02773.x; Peng J, 1997, PLANT PHYSIOL, V113, P1051, DOI 10.1104/pp.113.4.1051; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x	36	830	850	18	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					480	U11		10.1038/nature06520	http://dx.doi.org/10.1038/nature06520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216857	Bronze			2022-12-24	WOS:000252554100048
J	Ogawa, M; Shinohara, H; Sakagami, Y; Matsubayashi, Y				Ogawa, Mari; Shinohara, Hidefumi; Sakagami, Youji; Matsubayashi, Yoshikatsu			Arabidopsis CLV3 peptide directly binds CLV1 ectodomain	SCIENCE			English	Article							MERISTEM; KINASE; SHOOT		[Ogawa, Mari; Shinohara, Hidefumi; Sakagami, Youji; Matsubayashi, Yoshikatsu] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Matsubayashi, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	matsu@agr.nagoya-u.ac.jp	MATSUBAYASHI, Yoshikatsu/AAA-9705-2019	Matsubayashi, Yoshikatsu/0000-0002-2669-2119; Ogawa-Ohnishi, Mari/0000-0002-7581-2607				Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Fletcher JC, 2000, CURR OPIN PLANT BIOL, V3, P23, DOI 10.1016/S1369-5266(99)00033-3; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Shinohara H, 2007, PLANT J, V52, P175, DOI 10.1111/j.1365-313X.2007.03204.x; Strabala TJ, 2006, PLANT PHYSIOL, V140, P1331, DOI 10.1104/pp.105.075515	7	356	381	4	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					294	294		10.1126/science.1150083	http://dx.doi.org/10.1126/science.1150083			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202283				2022-12-24	WOS:000252436200027
J	Field, B; Osbourn, AE				Field, Ben; Osbourn, Anne E.			Metabolic diversification - Independent assembly of operon-like gene clusters in different plants	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; TRITERPENOIDS; BIOSYNTHESIS; SUPERFAMILY; DIVERSITY; EVOLUTION; PATTERNS; MUTANTS; STEROLS; RICE	Operons are clusters of unrelated genes with related functions that are a feature of prokaryotic genomes. Here, we report on an operon- like gene cluster in the plant Arabidopsis thaliana that is required for triterpene synthesis ( the thalianol pathway). The clustered genes are coexpressed, as in bacterial operons. However, despite the resemblance to a bacterial operon, this gene cluster has been assembled from plant genes by gene duplication, neofunctionalization, and genome reorganization, rather than by horizontal gene transfer from bacteria. Furthermore, recent assembly of operon- like gene clusters for triterpene synthesis has occurred independently in divergent plant lineages ( Arabidopsis and oat). Thus, selection pressure may act during the formation of certain plant metabolic pathways to drive gene clustering.	[Field, Ben; Osbourn, Anne E.] John Innes Ctr Plant Sci Res, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Osbourn, AE (corresponding author), John Innes Ctr Plant Sci Res, Dept Metab Biol, Colney Lane, Norwich NR4 7UH, Norfolk, England.	anne.osbourn@bbsrc.ac.uk	Field, Benjamin/AAR-8077-2020; Field, Ben/E-9762-2010; Martinez, Octavio/B-7375-2009	Field, Benjamin/0000-0003-2142-4606; Field, Ben/0000-0003-2142-4606; 	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abe I, 2007, NAT PROD REP, V24, P1311, DOI 10.1039/b616857b; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Clouse SD, 2002, PLANT CELL, V14, P1995, DOI 10.1105/tpc.140930; Ehlting J, 2006, BIOCHEM SOC T, V34, P1192, DOI 10.1042/BST0341192; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fazio GC, 2004, J AM CHEM SOC, V126, P5678, DOI 10.1021/ja0318784; Gierl A, 2001, PLANTA, V213, P493, DOI 10.1007/s004250100594; Hamberger B, 2006, BIOCHEM SOC T, V34, P1209, DOI 10.1042/BST0341209; Haralampidis K, 2001, P NATL ACAD SCI USA, V98, P13431, DOI 10.1073/pnas.231324698; Hostettmann K, 1995, SAPONINS, DOI 10.1017/CBO9780511565113; Jonczyk R, 2008, PLANT PHYSIOL, V146, P1053, DOI 10.1104/pp.107.111237; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Mylona P, 2008, PLANT CELL, V20, P201, DOI 10.1105/tpc.107.056531; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Papadopoulou K, 1999, P NATL ACAD SCI USA, V96, P12923, DOI 10.1073/pnas.96.22.12923; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; RETTIE AE, 1987, SCIENCE, V235, P890, DOI 10.1126/science.3101178; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; Yokota T, 1997, TRENDS PLANT SCI, V2, P137, DOI 10.1016/S1360-1385(97)01017-0; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	26	295	320	9	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					543	547		10.1126/science.1154990	http://dx.doi.org/10.1126/science.1154990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18356490				2022-12-24	WOS:000255249300054
J	Chen, YQ; Zhu, J; Lum, PY; Yang, X; Pinto, S; MacNeil, DJ; Zhang, CS; Lamb, J; Edwards, S; Sieberts, SK; Leonardson, A; Castellini, LW; Wang, S; Champy, MF; Zhang, B; Emilsson, V; Doss, S; Ghazalpour, A; Horvath, S; Drake, TA; Lusis, AJ; Schadt, EE				Chen, Yanqing; Zhu, Jun; Lum, Pek Yee; Yang, Xia; Pinto, Shirly; MacNeil, Douglas J.; Zhang, Chunsheng; Lamb, John; Edwards, Stephen; Sieberts, Solveig K.; Leonardson, Amy; Castellini, Lawrence W.; Wang, Susanna; Champy, Marie-France; Zhang, Bin; Emilsson, Valur; Doss, Sudheer; Ghazalpour, Anatole; Horvath, Steve; Drake, Thomas A.; Lusis, Aldons J.; Schadt, Eric E.			Variations in DNA elucidate molecular networks that cause disease	NATURE			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; UPSTREAM TRANSCRIPTION FACTOR-1; SEGREGATING MOUSE-POPULATION; TISSUE-SPECIFIC EXPRESSION; FACTOR-H POLYMORPHISM; GENE-EXPRESSION; LIPOPROTEIN-LIPASE; TRAIT ANALYSIS; ATHEROSCLEROSIS; IDENTIFY	Identifying variations in DNA that increase susceptibility to disease is one of the primary aims of genetic studies using a forward genetics approach. However, identification of disease- susceptibility genes by means of such studies provides limited functional information on how genes lead to disease. In fact, in most cases there is an absence of functional information altogether, preventing a definitive identification of the susceptibility gene or genes. Here we develop an alternative to the classic forward genetics approach for dissecting complex disease traits where, instead of identifying susceptibility genes directly affected by variations in DNA, we identify gene networks that are perturbed by susceptibility loci and that in turn lead to disease. Application of this method to liver and adipose gene expression data generated from a segregating mouse population results in the identification of a macrophage- enriched network supported as having a causal relationship with disease traits associated with metabolic syndrome. Three genes in this network, lipoprotein lipase ( Lpl), lactamase beta ( Lactb) and protein phosphatase 1- like ( Ppm1l), are validated as previously unknown obesity genes, strengthening the association between this network and metabolic disease traits. Our analysis provides direct experimental support that complex traits such as obesity are emergent properties of molecular networks that are modulated by complex genetic loci and environmental factors.	[Chen, Yanqing; Zhu, Jun; Lum, Pek Yee; Yang, Xia; Zhang, Chunsheng; Lamb, John; Edwards, Stephen; Sieberts, Solveig K.; Leonardson, Amy; Zhang, Bin; Emilsson, Valur; Schadt, Eric E.] Merck & Co Inc, Rosetta Inpharmat LLC, Seattle, WA 98109 USA; [Pinto, Shirly; MacNeil, Douglas J.] Merck & Co Inc, Dept Metab Disorders, Rahway, NJ 07065 USA; [Castellini, Lawrence W.; Wang, Susanna; Doss, Sudheer; Ghazalpour, Anatole; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Horvath, Steve; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Drake, Thomas A.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Champy, Marie-France] ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Merck & Company; Merck & Company; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schadt, EE (corresponding author), Merck & Co Inc, Rosetta Inpharmat LLC, 401 Terry Ave N, Seattle, WA 98109 USA.	eric_schadt@merck.com	Chen, Yanqing/B-5614-2009; Edwards, Stephen W/G-4482-2011	Edwards, Stephen/0000-0002-7985-111X; Chen, Yanqing/0000-0002-9534-6199; Emilsson, Valur/0000-0001-9982-0524; MacNeil, Doug/0000-0001-7089-0668	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, P01HL030568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071673] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL028481-240010, P01 HL028481-24, P01 HL030568-250011, P01 HL030568, P01 HL028481] Funding Source: Medline; NIDDK NIH HHS [R01 DK071673-03, R01 DK071673] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams LD, 2006, ARTERIOSCL THROM VAS, V26, P319, DOI 10.1161/01.ATV.0000196647.45718.d6; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Babinska A, 2002, THROMB HAEMOSTASIS, V88, P843, DOI 10.1055/s-0037-1613312; Bains RK, 2004, ENDOCRINOLOGY, V145, P2666, DOI 10.1210/en.2003-1608; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Castellani LW, 2001, DIABETES, V50, P643, DOI 10.2337/diabetes.50.3.643; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P16380; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ezzahiri R, 2006, APMIS, V114, P117, DOI 10.1111/j.1600-0463.2006.apm_205.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gaucher SP, 2004, J PROTEOME RES, V3, P495, DOI 10.1021/pr034102a; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hu YM, 2006, J LIPID RES, V47, P1908, DOI 10.1194/jlr.M600108-JLR200; Huertas-Vazquez A, 2005, ARTERIOSCL THROM VAS, V25, P1985, DOI 10.1161/01.ATV.0000175297.37214.a0; Jacobs C, 1997, SCIENCE, V278, P1731, DOI 10.1126/science.278.5344.1731b; JIANG CJ, 1995, GENETICS, V140, P1111; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Liobikas J, 2006, PROTEIN EXPRES PURIF, V45, P335, DOI 10.1016/j.pep.2005.08.006; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; PAIGEN B, 1987, BIOCHEM GENET, V25, P501, DOI 10.1007/BF00554352; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; Preiss-Landl K, 2002, CURR OPIN LIPIDOL, V13, P471, DOI 10.1097/00041433-200210000-00002; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SCHADT EE, 2005, SCI STKE, pPE40; Schadt EE, 2006, J LIPID RES, V47, P2601, DOI 10.1194/jlr.R600026-JLR200; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith TS, 2001, GENOMICS, V78, P12, DOI 10.1006/geno.2001.6643; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; WARDEN CH, 1993, SCIENCE, V261, P469, DOI 10.1126/science.8332912; Welch CL, 2004, PHYSIOL GENOMICS, V17, P48, DOI 10.1152/physiolgenomics.00124.2003; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yost T J, 1993, Obes Res, V1, P1	50	667	693	0	66	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 27	2008	452	7186					429	435		10.1038/nature06757	http://dx.doi.org/10.1038/nature06757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18344982	Green Accepted			2022-12-24	WOS:000254341300023
J	Yang, JW; Chandler, C; Stadler, M; Kampen, D; List, B				Yang, Jung Woon; Chandler, Carley; Stadler, Michael; Kampen, Daniela; List, Benjamin			Proline-catalysed Mannich reactions of acetaldehyde	NATURE			English	Article							BETA-AMINO ACIDS; ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC-SYNTHESIS; ALDOL REACTIONS; ALDEHYDES; UK-427,857; INHIBITOR; MARAVIROC; IMINES; POTENT	Small organic molecules recently emerged as a third class of broadly useful asymmetric catalysts that direct reactions to yield predominantly one chiral product, complementing enzymes and metal complexes(1). For instance, the amino acid proline and its derivatives are useful for the catalytic activation of carbonyl compounds via nucleophilic enamine intermediates. Several important carbon carbon bond- forming reactions, including the Mannich reaction, have been developed using this approach(2), all of which are useful for making chiral, biologically relevant compounds. Remarkably, despite attempts(3,4), the simplest of all nucleophiles, acetaldehyde, could not be used in this way. Here we show that acetaldehyde is a powerful nucleophile in asymmetric, proline- catalysed Mannich reactions with N- tert- butoxycarbonyl ( N- Boc)- imines, yielding beta- amino aldehydes with extremely high enantioselectivities- desirable products as drug intermediates and in the synthesis of other biologically active molecules. Although acetaldehyde has been used as a nucleophile in reactions with biological catalysts such as aldolases(5) and thiamine- dependent enzymes(6), and has also been employed indirectly(7-9), its use as an inexpensive and versatile two- carbon nucleophile in asymmetric, small- molecule catalysis will find many practical applications.	[Yang, Jung Woon; Chandler, Carley; Stadler, Michael; Kampen, Daniela; List, Benjamin] Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany	Max Planck Society	List, B (corresponding author), Max Planck Inst Kohlenforsch, Kaiser Wilhelm Pl 1, D-45470 Mulheim, Germany.	list@mpi-muelheim.mpg.de	Yang, Jung Woon/N-6725-2019; List, Benjamin/A-2121-2014; Yang, Jung Woon/A-5072-2013	Yang, Jung Woon/0000-0001-8636-0901; Yang, Jung Woon/0000-0001-8636-0901				Bogevig A, 2002, CHEM COMMUN, P620, DOI 10.1039/b200681b; Boxer MB, 2006, J AM CHEM SOC, V128, P48, DOI 10.1021/ja054725k; Chi YG, 2007, J AM CHEM SOC, V129, P6050, DOI 10.1021/ja070063i; Cordova A, 2002, J ORG CHEM, V67, P301, DOI 10.1021/jo015881m; Davies SG, 2006, ORG BIOMOL CHEM, V4, P2753, DOI 10.1039/b604073j; Davis FA, 1998, TETRAHEDRON LETT, V39, P5951, DOI 10.1016/S0040-4039(98)01223-4; Denmark SE, 2005, J ORG CHEM, V70, P10190, DOI 10.1021/jo0517500; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; ENDERS D, 1987, CHEM BER-RECL, V120, P1223, DOI 10.1002/cber.19871200718; Enders D, 2006, SYNTHESIS-STUTTGART, P2155, DOI 10.1055/s-2006-942413; Fodor G. B., 1985, ALKALOIDS CHEM BIOL, P1; Goetz G, 2001, BIOTECHNOL BIOENG, V74, P317, DOI 10.1002/bit.1122; List B, 2000, J AM CHEM SOC, V122, P9336, DOI 10.1021/ja001923x; List B, 2006, SCIENCE, V313, P1584, DOI 10.1126/science.1131945; Machajewski TD, 2000, ANGEW CHEM INT EDIT, V39, P1352, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; Price DA, 2005, TETRAHEDRON LETT, V46, P5005, DOI 10.1016/j.tetlet.2005.05.082; Ramachandran PV, 2005, CHEM-EUR J, V11, P4387, DOI 10.1002/chem.200401295; Seebach D, 2000, HELV CHIM ACTA, V83, P2115, DOI 10.1002/1522-2675(20000906)83:9<2115::AID-HLCA2115>3.0.CO;2-E; Siddiqui SA, 2007, TETRAHEDRON-ASYMMETR, V18, P2099, DOI 10.1016/j.tetasy.2007.07.028; Song J, 2006, J AM CHEM SOC, V128, P6048, DOI 10.1021/ja060716f; Sorbera LA, 2004, DRUG FUTURE, V29, P1201, DOI 10.1358/dof.2004.029.12.865936; Yang JW, 2007, ANGEW CHEM INT EDIT, V46, P609, DOI 10.1002/anie.200603188	24	241	244	10	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2008	452	7186					453	455		10.1038/nature06740	http://dx.doi.org/10.1038/nature06740			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	279FU	18288105				2022-12-24	WOS:000254341300027
J	Gutnisky, DA; Dragoi, V				Gutnisky, Diego A.; Dragoi, Valentin			Adaptive coding of visual information in neural populations	NATURE			English	Article							ORIENTATION DISCRIMINATION; RAPID ADAPTATION; FIRING RATE; CORTEX; TRANSMISSION; VARIABILITY; STATISTICS; SYNCHRONY; DYNAMICS; MACAQUE	Our perception of the environment relies on the capacity of neural networks to adapt rapidly to changes in incoming stimuli(1-4). It is increasingly being realized that the neural code is adaptive(5), that is, sensory neurons change their responses and selectivity in a dynamic manner to match the changes in input stimuli(1,2,5). Understanding how rapid exposure, or adaptation, to a stimulus of fixed structure changes information processing by cortical networks is essential for understanding the relationship between sensory coding and behaviour(5-8). Physiological investigations of adaptation have contributed greatly to our understanding of how individual sensory neurons change their responses to influence stimulus coding(2,9-12), yet whether and how adaptation affects information coding in neural populations is unknown. Here we examine how brief adaptation ( on the timescale of visual fixation)(2,9,10) influences the structure of interneuronal correlations and the accuracy of population coding in the macaque ( Macaca mulatta) primary visual cortex ( V1). We find that brief adaptation to a stimulus of fixed structure reorganizes the distribution of correlations across the entire network by selectively reducing their mean and variability. The post- adaptation changes in neuronal correlations are associated with specific, stimulus- dependent changes in the efficiency of the population code, and are consistent with changes in perceptual performance after adaptation(2,13,14). Our results have implications beyond the predictions of current theories of sensory coding, suggesting that brief adaptation improves the accuracy of population coding to optimize neuronal performance during natural viewing.	[Gutnisky, Diego A.; Dragoi, Valentin] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Dragoi, V (corresponding author), Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA.	v.dragoi@uth.tmc.edu	Gutnisky, Diego/E-3846-2012	Gutnisky, Diego/0000-0002-8578-0039				Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Clifford CWG, 2001, VISION RES, V41, P151, DOI 10.1016/S0042-6989(00)00248-0; DAYAN P, 2001, THEORETICAL NEUROSCI, P108; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NEURON, V32, P1181, DOI 10.1016/S0896-6273(01)00540-2; Dragoi V, 2006, J COGNITIVE NEUROSCI, V18, P737, DOI 10.1162/jocn.2006.18.5.737; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; Kay S. M., 1993, FUNDAMENTALS STAT SI; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schneidman E, 2003, J NEUROSCI, V23, P11539; Schwabe L, 2002, BIOSYSTEMS, V67, P239, DOI 10.1016/S0303-2647(02)00082-5; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; TSO DY, 1986, J NEUROSCI, V6, P1160; van der Togt C, 2006, CEREB CORTEX, V16, P136, DOI 10.1093/cercor/bhi093; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wilke SD, 2002, NEUROCOMPUTING, V44, P1023, DOI 10.1016/S0925-2312(02)00506-4; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	32	213	213	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					220	U63		10.1038/nature06563	http://dx.doi.org/10.1038/nature06563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337822				2022-12-24	WOS:000253925600041
J	Mulholland, PJ; Helton, AM; Poole, GC; Hall, RO; Hamilton, SK; Peterson, BJ; Tank, JL; Ashkenas, LR; Cooper, LW; Dahm, CN; Dodds, WK; Findlay, SEG; Gregory, SV; Grimm, NB; Johnson, SL; McDowell, WH; Meyer, JL; Valett, HM; Webster, JR; Arango, CP; Beaulieu, JJ; Bernot, MJ; Burgin, AJ; Crenshaw, CL; Johnson, LT; Niederlehner, BR; O'Brien, JM; Potter, JD; Sheibley, RW; Sobota, DJ; Thomas, SM				Mulholland, Patrick J.; Helton, Ashley M.; Poole, Geoffrey C.; Hall, Robert O., Jr.; Hamilton, Stephen K.; Peterson, Bruce J.; Tank, Jennifer L.; Ashkenas, Linda R.; Cooper, Lee W.; Dahm, Clifford N.; Dodds, Walter K.; Findlay, Stuart E. G.; Gregory, Stanley V.; Grimm, Nancy B.; Johnson, Sherri L.; McDowell, William H.; Meyer, Judy L.; Valett, H. Maurice; Webster, Jackson R.; Arango, Clay P.; Beaulieu, Jake J.; Bernot, Melody J.; Burgin, Amy J.; Crenshaw, Chelsea L.; Johnson, Laura T.; Niederlehner, B. R.; O'Brien, Jonathan M.; Potter, Jody D.; Sheibley, Richard W.; Sobota, Daniel J.; Thomas, Suzanne M.			Stream denitrification across biomes and its response to anthropogenic nitrate loading	NATURE			English	Article							NITROGEN; WATERSHEDS; LAND; SIZE	Anthropogenic addition of bioavailable nitrogen to the biosphere is increasing(1,2) and terrestrial ecosystems are becoming increasingly nitrogen- saturated(3), causing more bioavailable nitrogen to enter groundwater and surface waters(4-6). Large- scale nitrogen budgets show that an average of about 20 - 25 per cent of the nitrogen added to the biosphere is exported from rivers to the ocean or inland basins(7,8), indicating that substantial sinks for nitrogen must exist in the landscape(9). Streams and rivers may themselves be important sinks for bioavailable nitrogen owing to their hydrological connections with terrestrial systems, high rates of biological activity, and streambed sediment environments that favour microbial denitrification(6,10,11). Here we present data from nitrogen stable isotope tracer experiments across 72 streams and 8 regions representing several biomes. We show that total biotic uptake and denitrification of nitrate increase with stream nitrate concentration, but that the efficiency of biotic uptake and denitrification declines as concentration increases, reducing the proportion of in- stream nitrate that is removed from transport. Our data suggest that the total uptake of nitrate is related to ecosystem photosynthesis and that denitrification is related to ecosystem respiration. In addition, we use a stream network model to demonstrate that excess nitrate in streams elicits a disproportionate increase in the fraction of nitrate that is exported to receiving waters and reduces the relative role of small versus large streams as nitrate sinks.	[Mulholland, Patrick J.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Mulholland, Patrick J.; Cooper, Lee W.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Helton, Ashley M.; Poole, Geoffrey C.; Meyer, Judy L.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Poole, Geoffrey C.] Ecometr Inc, Tucker, GA 30084 USA; [Hall, Robert O., Jr.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Hamilton, Stephen K.; Burgin, Amy J.; O'Brien, Jonathan M.] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Peterson, Bruce J.; Thomas, Suzanne M.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Tank, Jennifer L.; Arango, Clay P.; Beaulieu, Jake J.; Johnson, Laura T.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Ashkenas, Linda R.; Gregory, Stanley V.; Sobota, Daniel J.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Dahm, Clifford N.; Crenshaw, Chelsea L.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Dodds, Walter K.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Findlay, Stuart E. G.] Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Grimm, Nancy B.; Sheibley, Richard W.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Johnson, Sherri L.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [McDowell, William H.; Potter, Jody D.] Univ New Hampshire, Dept Nat Resources, Durham, NH 03824 USA; [Valett, H. Maurice; Webster, Jackson R.; Niederlehner, B. R.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Bernot, Melody J.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University System of Georgia; University of Georgia; University of Wyoming; Michigan State University; Marine Biological Laboratory - Woods Hole; University of Notre Dame; Oregon State University; University of New Mexico; Kansas State University; Cary Institute of Ecosystem Studies; Arizona State University; Arizona State University-Tempe; United States Department of Agriculture (USDA); United States Forest Service; University System Of New Hampshire; University of New Hampshire; Virginia Polytechnic Institute & State University; Ball State University	Mulholland, PJ (corresponding author), Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA.	mulhollandpj@ornl.gov	McDowell, William H/E-9767-2010; Burgin, Amy/G-7444-2014; O'Brien, Jonathan/G-6786-2012; Hamilton, Stephen K/N-2979-2014; Cooper, Lee W./E-5251-2012; Grimm, Nancy B/D-2840-2009; Mulholland, Patrick/C-3142-2012; Burgin, Amy/ABI-2572-2020; Burgin, Amy J/C-1528-2010	McDowell, William H/0000-0002-8739-9047; Burgin, Amy/0000-0001-8489-4002; Hamilton, Stephen K/0000-0002-4702-9017; Cooper, Lee W./0000-0001-7734-8388; Grimm, Nancy B/0000-0001-9374-660X; Burgin, Amy/0000-0001-8489-4002; Burgin, Amy J/0000-0001-8489-4002; Poole, Geoffrey/0000-0002-8458-0203; Dodds, Walter/0000-0002-6666-8930; Sheibley, Richard/0000-0003-1627-8536; Webster, Jackson/0000-0002-2649-0867; Niederlehner, Barbara/0000-0002-6933-336X; Potter, Jody/0000-0002-3757-138X				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; AUMEN NG, 1990, J N AM BENTHOL SOC, V9, P95; Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Bouwman AF, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002314; Boyer EW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002537; CHRISTENSEN PB, 1990, LIMNOL OCEANOGR, V35, P640, DOI 10.4319/lo.1990.35.3.0640; Dodds WK, 2002, J N AM BENTHOL SOC, V21, P206, DOI 10.2307/1468410; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hall RO, 2003, LIMNOL OCEANOGR, V48, P1120, DOI 10.4319/lo.2003.48.3.1120; Hamilton SK, 2007, LIMNOL OCEANOGR-METH, V5, P233, DOI 10.4319/lom.2007.5.233; Hedin LO, 1998, ECOLOGY, V79, P684, DOI 10.2307/176963; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Johnes PJ, 2002, BIOGEOCHEMISTRY, V57, P429, DOI 10.1023/A:1015721416839; McIsaac GF, 2001, NATURE, V414, P166, DOI 10.1038/35102672; Mulholland PJ, 2006, J N AM BENTHOL SOC, V25, P583, DOI 10.1899/0887-3593(2006)25[583:EOLONU]2.0.CO;2; Mulholland PJ, 2004, LIMNOL OCEANOGR, V49, P809, DOI 10.4319/lo.2004.49.3.0809; NEWBOLD JD, 1981, CAN J FISH AQUAT SCI, V38, P860, DOI 10.1139/f81-114; O'Brien JM, 2007, BIOGEOCHEMISTRY, V84, P31, DOI 10.1007/s10533-007-9073-7; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; Pina-Ochoa E, 2006, BIOGEOCHEMISTRY, V81, P111, DOI 10.1007/s10533-006-9033-7; Schlesinger WH, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004300; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Seitzinger SP, 2002, BIOGEOCHEMISTRY, V57, P199, DOI 10.1023/A:1015745629794; Sigman DM, 1997, MAR CHEM, V57, P227, DOI 10.1016/S0304-4203(97)00009-1; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Van Breemen N, 2002, BIOGEOCHEMISTRY, V57, P267, DOI 10.1023/A:1015775225913; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Webster Jackson R., 2007, P169, DOI 10.1016/B978-012332908-0.50010-3; Wollheim WM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025845	32	931	983	29	756	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2008	452	7184					202	U46		10.1038/nature06686	http://dx.doi.org/10.1038/nature06686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337819	Green Submitted			2022-12-24	WOS:000253925600037
J	Sakai, W; Swisher, EM; Karlan, BY; Agarwal, MK; Higgins, J; Friedman, C; Villegas, E; Jacquemont, C; Farrugia, DJ; Couch, FJ; Urban, N; Taniguchi, T				Sakai, Wataru; Swisher, Elizabeth M.; Karlan, Beth Y.; Agarwal, Mukesh K.; Higgins, Jake; Friedman, Cynthia; Villegas, Emily; Jacquemont, Celine; Farrugia, Daniel J.; Couch, Fergus J.; Urban, Nicole; Taniguchi, Toshiyasu			Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers	NATURE			English	Article							HOMOLOGY-DIRECTED REPAIR; BRCA MUTANT-CELLS; FANCONI-ANEMIA; OVARIAN-CANCER; BREAST-CANCER; IN-VIVO; PATHWAY; GENE; INHIBITORS; DEFECT	Ovarian carcinomas with mutations in the tumour suppressor BRCA2 are particularly sensitive to platinum compounds(1). However, such carcinomas ultimately develop cisplatin resistance. The mechanism of that resistance is largely unknown(2). Here we show that acquired resistance to cisplatin can be mediated by secondary intragenic mutations in BRCA2 that restore the wildtype BRCA2 reading frame. First, in a cisplatin- resistant BRCA2-mutated breast- cancer cell line, HCC1428, a secondary genetic change in BRCA2 rescued BRCA2 function. Second, cisplatin selection of a BRCA2- mutated pancreatic cancer cell line, Capan- 1 ( refs 3, 4), led to five different secondary mutations that restored the wild- type BRCA2 reading frame. All clones with secondary mutations were resistant both to cisplatin and to a poly( ADP- ribose) polymerase ( PARP) inhibitor ( AG14361). Finally, we evaluated recurrent cancers from patients whose primary BRCA2- mutated ovarian carcinomas were treated with cisplatin. The recurrent tumour that acquired cisplatin resistance had undergone reversion of its BRCA2 mutation. Our results suggest that secondary mutations that restore the wild- type BRCA2 reading frame may be a major clinical mediator of acquired resistance to platinum- based chemotherapy.	[Sakai, Wataru; Friedman, Cynthia; Villegas, Emily; Jacquemont, Celine; Taniguchi, Toshiyasu] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Sakai, Wataru; Villegas, Emily; Jacquemont, Celine; Urban, Nicole; Taniguchi, Toshiyasu] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Swisher, Elizabeth M.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Swisher, Elizabeth M.; Higgins, Jake] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Karlan, Beth Y.] Cedars Sinai Med Ctr, Womens Canc Res Inst, Los Angeles, CA 90048 USA; [Agarwal, Mukesh K.; Farrugia, Daniel J.; Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Higgins, Jake] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; Mayo Clinic; University of Washington; University of Washington Seattle	Taniguchi, T (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.	ttaniguc@fhcrc.org	Taniguchi, Toshiyasu/ADD-8489-2022; Sakai, Wataru/J-6917-2012; Farrugia, Daniel/E-4752-2015	Sakai, Wataru/0000-0002-6561-5773; Taniguchi, Toshiyasu/0000-0002-7746-3658	NCI NIH HHS [R01 CA125636-02, R01 CA125636, P50 CA083636, P50 CA083636-10, K08 CA096610-01, K08 CA096610] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA083636, R01CA125636, K08CA096610] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbott DW, 1998, J NATL CANCER I, V90, P978, DOI 10.1093/jnci/90.13.978; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; COLLINS N, 1995, ONCOGENE, V10, P1673; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Foulkes WD, 2006, FAM CANCER, V5, P135, DOI 10.1007/s10689-005-2832-5; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Goggins M, 1996, CANCER RES, V56, P5360; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; GUDMUNDSSON J, 1995, CANCER RES, V55, P4830; Hamanoue S, 2006, BRIT J HAEMATOL, V132, P630, DOI 10.1111/j.1365-2141.2005.05916.x; Hilton JL, 2002, JNCI-J NATL CANCER I, V94, P1396; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Ikeda H, 2003, CANCER RES, V63, P2688; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Li A J, 2001, Curr Oncol Rep, V3, P27, DOI 10.1007/s11912-001-0039-y; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Naf D, 1998, MOL CELL BIOL, V18, P5952; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; NEUHAUSEN SL, 1994, CANCER RES, V54, P6069; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; Skalitzky DJ, 2003, J MED CHEM, V46, P210, DOI 10.1021/jm0255769; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Trask B, 1999, GENOME ANAL, V4, P303; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; van Asperen CJ, 2005, J MED GENET, V42, P711, DOI 10.1136/jmg.2004.028829; Wiegant WW, 2006, MUTAT RES-FUND MOL M, V600, P79, DOI 10.1016/j.mrfmmm.2006.03.001; Wu KJ, 2005, CANCER RES, V65, P417; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P6712, DOI 10.1073/pnas.91.14.6712; Yuan SSF, 1999, CANCER RES, V59, P3547	39	762	789	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1116	U9		10.1038/nature06633	http://dx.doi.org/10.1038/nature06633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18264087	Green Accepted			2022-12-24	WOS:000253453600044
J	Feng, HC; Shuda, M; Chang, Y; Moore, PS				Feng, Huichen; Shuda, Masahiro; Chang, Yuan; Moore, Patrick S.			Clonal integration of a polyomavirus in human Merkel cell carcinoma	SCIENCE			English	Article							PROTEIN PHOSPHATASE-2A; TUMOR-ANTIGEN; DNA-SEQUENCE; T-ANTIGENS; CANCER; SV40; GENE; IDENTIFICATION; SUBTRACTION; PRODUCT	Merkel cell carcinoma ( MCC) is a rare but aggressive human skin cancer that typically affects elderly and immunosuppressed individuals, a feature suggestive of an infectious origin. We studied MCC samples by digital transcriptome subtraction and detected a fusion transcript between a previously undescribed virus T antigen and a human receptor tyrosine phosphatase. Further investigation led to identification and sequence analysis of the 5387- base- pair genome of a previously unknown polyomavirus that we call Merkel cell polyomavirus ( MCV or MCPyV). MCV sequences were detected in 8 of 10 ( 80%) MCC tumors but only 5 of 59 ( 8%) control tissues from various body sites and 4 of 25 ( 16%) control skin tissues. In six of eight MCV- positive MCCs, viral DNA was integrated within the tumor genome in a clonal pattern, suggesting that MCV infection and integration preceded clonal expansion of the tumor cells. Thus, MCV may be a contributing factor in the pathogenesis of MCC.	[Feng, Huichen; Shuda, Masahiro; Chang, Yuan; Moore, Patrick S.] Univ Pittsburgh, Inst Canc, Mol Virol Program, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chang, Y (corresponding author), Univ Pittsburgh, Inst Canc, Mol Virol Program, 5117 Ctr Ave,Suite 1-8, Pittsburgh, PA 15213 USA.	yc70@pitt.edu; psm9@pitt.edu	Feng, Huichen/F-5502-2011; Chang, Yuan/F-4146-2011; Moore, Patrick/GVR-8294-2022; SHUDA, MASAHIRO/N-8239-2019; SHUDA, MASAHIRO/F-5505-2011; Moore, Patrick S./F-3960-2011	Feng, Huichen/0000-0003-3069-8174; Chang, Yuan/0000-0003-1125-4041; SHUDA, MASAHIRO/0000-0003-0595-2572; SHUDA, MASAHIRO/0000-0003-0595-2572; Moore, Patrick S./0000-0002-8132-858X	NCI NIH HHS [R33 CA120726, R33CA120726, R33 CA120726-02, R01 CA136806] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA197463, R01CA136806, R33CA120726] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Crandall KA, 2006, ADV EXP MED BIOL, V577, P46; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; Dilworth SM, 2002, NAT REV CANCER, V2, P951, DOI 10.1038/nrc946; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; Engels EA, 2002, LANCET, V359, P497, DOI 10.1016/S0140-6736(02)07668-7; Feng HC, 2007, J VIROL, V81, P11332, DOI 10.1128/JVI.00875-07; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; GROSS L, 1953, P SOC EXP BIOL MED, V83, P414; Hollanderova D, 2003, INT J ONCOL, V23, P333; Lemos B, 2007, J INVEST DERMATOL, V127, P2100, DOI 10.1038/sj.jid.5700925; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Parsonnet J, 1999, MICROBES AND MALIGNANCY, P3; PAWLITA M, 1985, VIROLOGY, V143, P196, DOI 10.1016/0042-6822(85)90108-4; PIPAS JM, 1992, J VIROL, V66, P3979, DOI 10.1128/JVI.66.7.3979-3985.1992; Pitterle DM, 1998, IN VIVO, V12, P643; Poulin DL, 2006, J CLIN ONCOL, V24, P4356, DOI 10.1200/JCO.2005.03.7101; Van Gele M, 2004, ONCOGENE, V23, P2732, DOI 10.1038/sj.onc.1207421; WALTER G, 1990, P NATL ACAD SCI USA, V87, P2521, DOI 10.1073/pnas.87.7.2521; Xu YH, 2003, GENOMICS, V81, P329, DOI 10.1016/S0888-7543(02)00043-5	22	2092	2139	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1096	1100		10.1126/science.1152586	http://dx.doi.org/10.1126/science.1152586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18202256	Green Accepted			2022-12-24	WOS:000253311700045
J	King, N; Westbrook, MJ; Young, SL; Kuo, A; Abedin, M; Chapman, J; Fairclough, S; Hellsten, U; Isogai, Y; Letunic, I; Marr, M; Pincus, D; Putnam, N; Rokas, A; Wright, KJ; Zuzow, R; Dirks, W; Good, M; Goodstein, D; Lemons, D; Li, WQ; Lyons, JB; Morris, A; Nichols, S; Richter, DJ; Salamov, A; Bork, P; Lim, WA; Manning, G; Miller, WT; McGinnis, W; Shapiro, H; Tjian, R; Grigoriev, IV; Rokhsar, D				King, Nicole; Westbrook, M. Jody; Young, Susan L.; Kuo, Alan; Abedin, Monika; Chapman, Jarrod; Fairclough, Stephen; Hellsten, Uffe; Isogai, Yoh; Letunic, Ivica; Marr, Michael; Pincus, David; Putnam, Nicholas; Rokas, Antonis; Wright, Kevin J.; Zuzow, Richard; Dirks, William; Good, Matthew; Goodstein, David; Lemons, Derek; Li, Wanqing; Lyons, Jessica B.; Morris, Andrea; Nichols, Scott; Richter, Daniel J.; Salamov, Asaf; Bork, Peer; Lim, Wendell A.; Manning, Gerard; Miller, W. Todd; McGinnis, William; Shapiro, Harris; Tjian, Robert; Grigoriev, Igor V.; Rokhsar, Daniel		JGI Sequencing	The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans	NATURE			English	Article							UNICELLULAR RELATIVES; EVOLUTIONARY ORIGIN; CELL-ADHESION; INSIGHTS; CONSERVATION; ARCHITECTURE; PROTEINS; FAMILY	Choanoflagellates are the closest known relatives of metazoans. To discover potential molecular mechanisms underlying the evolution of metazoan multicellularity, we sequenced and analysed the genome of the unicellular choanoflagellate Monosiga brevicollis. The genome contains approximately 9,200 intron- rich genes, including a number that encode cell adhesion and signalling protein domains that are otherwise restricted to metazoans. Here we show that the physical linkages among protein domains often differ between M. brevicollis and metazoans, suggesting that abundant domain shuffling followed the separation of the choanoflagellate and metazoan lineages. The completion of the M. brevicollis genome allows us to reconstruct with increasing resolution the genomic changes that accompanied the origin of metazoans.	[King, Nicole; Westbrook, M. Jody; Young, Susan L.; Abedin, Monika; Chapman, Jarrod; Fairclough, Stephen; Isogai, Yoh; Putnam, Nicholas; Wright, Kevin J.; Zuzow, Richard; Dirks, William; Goodstein, David; Lyons, Jessica B.; Nichols, Scott; Richter, Daniel J.; Tjian, Robert; Rokhsar, Daniel] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [King, Nicole; Westbrook, M. Jody; Young, Susan L.; Abedin, Monika; Chapman, Jarrod; Fairclough, Stephen; Isogai, Yoh; Putnam, Nicholas; Wright, Kevin J.; Zuzow, Richard; Dirks, William; Goodstein, David; Lyons, Jessica B.; Nichols, Scott; Richter, Daniel J.; Tjian, Robert; Rokhsar, Daniel] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [King, Nicole] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Kuo, Alan; Hellsten, Uffe; Salamov, Asaf; Shapiro, Harris; Grigoriev, Igor V.; Rokhsar, Daniel; JGI Sequencing] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Letunic, Ivica; Bork, Peer] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Marr, Michael] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Pincus, David; Good, Matthew; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Lemons, Derek; McGinnis, William] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Li, Wanqing; Miller, W. Todd] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Morris, Andrea] Univ Michigan, Dept Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Bioinformat Ctr, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; European Molecular Biology Laboratory (EMBL); Brandeis University; University of California System; University of California San Francisco; Vanderbilt University; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Michigan System; University of Michigan; Salk Institute	King, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	nking@berkeley.edu; dsrokhsar@lbl.gov	Good, Matthew C/GLS-0964-2022; Letunic, Ivica/A-6032-2009; Putnam, Nicholas/B-9968-2008; Puigbò, Pere/A-2214-2008; Bork, Peer/F-1813-2013; Manning, Gerard/C-8308-2009; Rokas, Antonis/A-9775-2008; Lyons, Jessica/ABB-5014-2020; Letunic, Ivica/K-1102-2019	Putnam, Nicholas/0000-0002-1315-782X; Bork, Peer/0000-0002-2627-833X; Rokas, Antonis/0000-0002-7248-6551; Lyons, Jessica/0000-0002-3886-2146; Letunic, Ivica/0000-0003-3560-4288; Richter, Daniel/0000-0002-9238-5571; Rokhsar, Daniel/0000-0002-8704-2224; Zhi, Iris/0000-0003-4263-7272; Manning, Gerard/0000-0002-5087-9151; Goodstein, David/0000-0001-6287-2697; Rojahn, Susan/0000-0001-5888-7693; Good, Matthew/0000-0002-6367-1034; Sigg, Monika/0000-0001-8522-9127; Grigoriev, Igor/0000-0002-3136-8903	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028315] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA058530] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077197] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA058530, R01 CA058530-14] Funding Source: Medline; NHGRI NIH HHS [R01 HG004164, R01 HG004164-01] Funding Source: Medline; NICHD NIH HHS [R37 HD028315] Funding Source: Medline; NIGMS NIH HHS [R01 GM077197] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamska M, 2007, CURR BIOL, V17, pR836, DOI 10.1016/j.cub.2007.08.010; Akiyama S K, 1996, Hum Cell, V9, P181; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arndt H., 2000, FLAGELLATES, P240; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Boenigk J, 2002, ANTON LEEUW INT J G, V81, P465, DOI 10.1023/A:1020509305868; BUCK KR, 1988, MAR BIOL, V98, P263, DOI 10.1007/BF00391204; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; CSUROS M, 2005, P 3 RECOMB SAT WORKS, P47; Derelle R, 2007, EVOL DEV, V9, P212, DOI 10.1111/j.1525-142X.2007.00153.x; Ekman D, 2007, J MOL BIOL, V372, P1337, DOI 10.1016/j.jmb.2007.06.022; ERWIN DH, 1993, BIOL J LINN SOC, V50, P255, DOI 10.1006/bijl.1993.1058; Gupta G, 2007, BIOESSAYS, V29, P452, DOI 10.1002/bies.20573; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hutter H, 2000, SCIENCE, V287, P989, DOI 10.1126/science.287.5455.989; James-Clark H., 1868, BOWERBANK ANN MAG NA, V1, P133; James-Clark H, 1868, ANN MAG NAT HIST, V1, P250; James-Clark H, 1868, ANN MAG NAT HIST, V1, P188; King N, 2001, P NATL ACAD SCI USA, V98, P15032, DOI 10.1073/pnas.261477698; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; Knoll AH., 2003, LIFE YOUNG PLANET; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; LEADBEATER BSC, 1983, J MAR BIOL ASSOC UK, V63, P135, DOI 10.1017/S0025315400049857; LEADBEATER BSC, 1979, PROC R SOC SER B-BIO, V204, P57, DOI 10.1098/rspb.1979.0012; LEADBEATER BSC, 1994, EUR J PROTISTOL, V30, P111, DOI 10.1016/S0932-4739(11)80204-X; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Medina M, 2003, INT J ASTROBIOL, V2, P203, DOI [DOI 10.1017/S1473550403001551), 10.1017/S1473550403001551, DOI 10.1017/S1473550403001551]; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Roy SW, 2005, P NATL ACAD SCI USA, V102, P1986, DOI 10.1073/pnas.0408355101; Ruiz-Trillo I, 2006, J EUKARYOT MICROBIOL, V53, P379, DOI 10.1111/j.1550-7408.2006.00118.x; Saville Kent W., 1880, MANUAL INFUSORIA; Segawa Y, 2006, P NATL ACAD SCI USA, V103, P12021, DOI 10.1073/pnas.0600021103; Seo HC, 2001, SCIENCE, V294, P2506, DOI 10.1126/science.294.5551.2506; Snell EA, 2006, P ROY SOC B-BIOL SCI, V273, P401, DOI 10.1098/rspb.2005.3263; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Suarez-Castillo EC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-23; Sullivan James C, 2006, Genome Inform, V17, P219; THOMSEN HA, 1992, POLAR BIOL, V12, P53; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tordai H, 2005, FEBS J, V272, P5064, DOI 10.1111/j.1742-4658.2005.04917.x; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	50	776	832	1	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					783	788		10.1038/nature06617	http://dx.doi.org/10.1038/nature06617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273011	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-24	WOS:000253191400033
J	Pique, M; Lopez, JM; Foissac, S; Guigo, R; Mendez, R				Pique, Maria; Lopez, Jose Manuel; Foissac, Sylvain; Guigo, Roderic; Mendez, Raul			A combinatorial code for CPE-mediated translational control	CELL			English	Article							B1 MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION ELEMENTS; C-MOS; OOCYTE MATURATION; MEIOTIC MATURATION; SPECIFICITY FACTOR; XENOPUS PUMILIO; BINDING PROTEIN; CYCLIN; PHOSPHORYLATION	Cytoplasmic polyadenylation plays a key role in the translational control of mRNAs driving biological processes such as gametogenesis, cell-cycle progression, and synaptic plasticity. What determines the distinct time of polyadenylation and extent of translational control of a given mRNA, however, is poorly understood. The polyadenylation-regulated translation is controlled by the cytoplasmic polyadenylation element (CPE) and its binding protein, CPEB, which can assemble both translational repression or activation complexes. Using a combination of mutagenesis and experimental validation of genome-wide computational predictions, we show that the number and relative position of two elements, the CPE and the Pumilio-binding element, with respect to the polyadenylation signal define a combinatorial code that determines whether an mRNA will be translationally repressed by CPEB, as well as the extent and time of cytoplasmic polyadenylation-dependent translational activation.	[Pique, Maria; Lopez, Jose Manuel; Foissac, Sylvain; Guigo, Roderic; Mendez, Raul] UPF, Ctr Genom Regulat CRG, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Mendez, R (corresponding author), UPF, Ctr Genom Regulat CRG, C-Dr Aiguader 88, Barcelona, Spain.	rau1.mendez@crg.es	Lopez, Jose M/D-1654-2011; Lopez, Jose/AAF-3798-2020; Guigo, Roderic/D-1303-2010	Lopez, Jose M/0000-0002-4104-6262; Lopez, Jose/0000-0002-4104-6262; Guigo, Roderic/0000-0002-5738-4477; Mendez, Raul/0000-0002-1952-6905; Foissac, Sylvain/0000-0002-2631-5356				Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; BILGER A, 1994, GENE DEV, V8, P1106, DOI 10.1101/gad.8.9.1106; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2000, DEV BIOL, V227, P706, DOI 10.1006/dbio.2000.9922; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Dickson KS, 1999, MOL CELL BIOL, V19, P5707; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hochegger H, 2001, DEVELOPMENT, V128, P3795; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11; Nakahata S, 2003, MECH DEVELOP, V120, P865, DOI 10.1016/S0925-4773(03)00160-6; Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200; Okano H, 2002, J CELL SCI, V115, P1355; Pique Maria, 2006, V322, P183; Reverte CG, 2001, DEV BIOL, V231, P447, DOI 10.1006/dbio.2001.0153; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Rouhana L, 2007, RNA, V13, P188, DOI 10.1261/rna.333507; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x	32	261	267	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					434	448		10.1016/j.cell.2007.12.038	http://dx.doi.org/10.1016/j.cell.2007.12.038			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267074	Bronze			2022-12-24	WOS:000253180700018
J	Chen, ES; Zhang, K; Nicolas, E; Cam, HP; Zofall, M; Grewal, SIS				Chen, Ee Sin; Zhang, Ke; Nicolas, Estelle; Cam, Hugh P.; Zofall, Martin; Grewal, Shiv I. S.			Cell cycle control of centromeric repeat transcription and heterochromatin assembly	NATURE			English	Article							RNA-POLYMERASE-II; FISSION YEAST; CHROMOSOME CONDENSATION; LYSINE-9 METHYLATION; EPIGENETIC CONTROL; UBIQUITIN LIGASE; CHROMATIN; PHOSPHORYLATION; RITS; MAINTENANCE	Heterochromatin in eukaryotic genomes regulates diverse chromosomal processes including transcriptional silencing(1). However, in Schizosaccharomyces pombe RNA polymerase II ( RNAPII) transcription of centromeric repeats is essential for RNA- interference- mediated heterochromatin assembly(2-5). Here we study heterochromatin dynamics during the cell cycle and its effect on RNAPII transcription. We describe a brief period during the S phase of the cell cycle in which RNAPII preferentially transcribes centromeric repeats. This period is enforced by heterochromatin, which restricts RNAPII accessibility at centromeric repeats for most of the cell cycle. RNAPII transcription during S phase is linked to loading of RNA interference and heterochromatin factors such as the Ago1 subunit of the RITS complex(6) and the Clr4 methyltransferase complex subunit Rik1 ( ref. 7). Moreover, Set2, an RNAPII- associated methyltransferase(8) that methylates histone H3 lysine 36 at repeat loci during S phase, acts in a pathway parallel to Clr4 to promote heterochromatin assembly. We also show that phosphorylation of histone H3 serine 10 alters heterochromatin during mitosis, correlating with recruitment of condensin that affects silencing of centromeric repeats. Our analyses suggest at least two distinct modes of heterochromatin targeting to centromeric repeats, whereby RNAPII transcription of repeats and chromodomain proteins bound to methylated histone H3 lysine 9 mediate recruitment of silencing factors. Together, these processes probably facilitate heterochromatin maintenance through successive cell divisions.	[Chen, Ee Sin; Zhang, Ke; Nicolas, Estelle; Cam, Hugh P.; Zofall, Martin; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Nicolas, Estelle/C-4425-2008	Nicolas, Estelle/0000-0003-0412-8477; Grewal, Shiv/0000-0002-4552-9261	NATIONAL CANCER INSTITUTE [Z01BC010523, ZIABC011208, ZIABC010523] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alfa C, 1993, EXPT FISSION YEAST L; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Meyer BJ, 2000, TRENDS GENET, V16, P247, DOI 10.1016/S0168-9525(00)02004-7; Morris SA, 2005, EUKARYOT CELL, V4, P1446, DOI 10.1128/EC.4.8.1446-1454.2005; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Oliveira RA, 2005, MOL CELL BIOL, V25, P8971, DOI 10.1128/MCB.25.20.8971-8984.2005; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Schramke V, 2005, NATURE, V435, P1275, DOI 10.1038/nature03652; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Zofall M, 2007, J BIOL CHEM, V282, P14065, DOI 10.1074/jbc.M700292200	30	284	289	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					734	737		10.1038/nature06561	http://dx.doi.org/10.1038/nature06561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18216783				2022-12-24	WOS:000252929500045
J	Meyer-Luehmann, M; Spires-Jones, TL; Prada, C; Garcia-Alloza, M; de Calignon, A; Rozkalne, A; Koenigsknecht-Talboo, J; Holtzman, DM; Bacskai, BJ; Hyman, BT				Meyer-Luehmann, Melanie; Spires-Jones, Tara L.; Prada, Claudia; Garcia-Alloza, Monica; de Calignon, Alix; Rozkalne, Anete; Koenigsknecht-Talboo, Jessica; Holtzman, David M.; Bacskai, Brian J.; Hyman, Bradley T.			Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease	NATURE			English	Article							TRANSGENIC MICE; MULTIPHOTON MICROSCOPY; PRECURSOR PROTEIN; IN-VIVO; MICROGLIA; ABNORMALITIES; NEUROTOXICITY; DISRUPTION; DEFICITS; MEMORY	Senile plaques accumulate over the course of decades in the brains of patients with Alzheimer's disease. A fundamental tenet of the amyloid hypothesis of Alzheimer's disease is that the deposition of amyloid-beta precedes and induces the neuronal abnormalities that underlie dementia(1). This idea has been challenged, however, by the suggestion that alterations in axonal trafficking and morphological abnormalities precede and lead to senile plaques(2). The role of microglia in accelerating or retarding these processes has been uncertain. To investigate the temporal relation between plaque formation and the changes in local neuritic architecture, we used longitudinal in vivo multiphoton microscopy to sequentially image young APPswe/ PS1d9xYFP ( B6C3-YFP) transgenic mice(3). Here we show that plaques form extraordinarily quickly, over 24 h. Within 1-2 days of a new plaque's appearance, microglia are activated and recruited to the site. Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks. These data establish plaques as a critical mediator of neuritic pathology.	[Meyer-Luehmann, Melanie; Spires-Jones, Tara L.; Prada, Claudia; Garcia-Alloza, Monica; de Calignon, Alix; Rozkalne, Anete; Bacskai, Brian J.; Hyman, Bradley T.] Harvard Univ, Massgen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Alzheimers Dis Res Lab,Dept Neurol,Sch Med, Charlestown, MA 02129 USA; [Koenigsknecht-Talboo, Jessica; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Harvard University; Massachusetts General Hospital; Washington University (WUSTL)	Hyman, BT (corresponding author), Harvard Univ, Massgen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Alzheimers Dis Res Lab,Dept Neurol,Sch Med, Charlestown, MA 02129 USA.	bhyman@partners.org	Spires-Jones, Tara/AAR-7697-2020; Garcia-Alloza, Monica/F-3313-2016; Garcia-Alloza, Monica/AAN-9799-2021; Bacskai, Brian/AAE-9583-2021	Spires-Jones, Tara/0000-0003-2530-0598; Garcia-Alloza, Monica/0000-0003-1610-4114; Garcia-Alloza, Monica/0000-0003-1610-4114; Meyer-Luehmann, Melanie/0000-0003-3661-2220	NIA NIH HHS [R01 AG008487-20, P30 AG062421, P50 AG005134, R01 AG008487] Funding Source: Medline; NIDDK NIH HHS [P30 DK056341-08, P30 DK056341-07, P30 DK056341] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008487, P50AG005134] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Combs CK, 2001, J NEUROSCI, V21, P1179; Frautschy SA, 1998, AM J PATHOL, V152, P307; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HYMAN BT, 1995, P NATL ACAD SCI USA, V92, P3586, DOI 10.1073/pnas.92.8.3586; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KAWAI M, 1990, AM J PATHOL, V137, P1435; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Le R, 2001, J NEUROPATH EXP NEUR, V60, P753, DOI 10.1093/jnen/60.8.753; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Qin S, 2006, J NEUROSCI, V26, P3345, DOI 10.1523/JNEUROSCI.5186-05.2006; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	27	770	789	3	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					720	U5		10.1038/nature06616	http://dx.doi.org/10.1038/nature06616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256671	Green Accepted			2022-12-24	WOS:000252929500042
J	DalCorso, G; Pesaresi, P; Masiero, S; Aseeva, E; Nemann, DS; Finazzi, G; Joliot, P; Barbato, R; Leister, D				DalCorso, Giovanni; Pesaresi, Paolo; Masiero, Simona; Aseeva, Elena; Schuenemann, Danja; Finazzi, Giovanni; Joliot, Pierre; Barbato, Roberto; Leister, Dario			A complex containing PGRL1 and PGR5 is involved in the switch between linear and cyclic electron flow in Arabidopsis	CELL			English	Article							CYTOCHROME B(6)F COMPLEX; PHOTOSYSTEM-I; PHOTOACOUSTIC MEASUREMENTS; CHLAMYDOMONAS-REINHARDTII; DEHYDROGENASE COMPLEX; STATE TRANSITIONS; ENERGY-STORAGE; NUCLEAR GENES; HIGHER-PLANTS; REDOX STATE	During photosynthesis, two photoreaction centers located in the thylakoid membranes of the chloroplast, photosystems I and II (PSI and PSII), use light energy to mobilize electrons to generate ATP and NADPH. Different modes of electron flow exist, of which the linear electron flow is driven by PSI and PSII, generating ATP and NADPH, whereas the cyclic electron flow (CEF) only generates ATP and is driven by the PSI alone. Different environmental and metabolic conditions require the adjustment of ATP/NADPH ratios and a switch of electron distribution between the two photosystems. With the exception of PGR5, other components facilitating CEF are unknown. Here, we report the identification of PGRL1, a transmembrane protein present in thylakoids of Arabidopsis thaliana. Plants lacking PGRL1 show perturbation of CEF, similar to PGR5-deficient plants. We find that PGRL1 and PGR5 interact physically and associate with PSI. We therefore propose that the PGRL1-PGR5 complex facilitates CEF in eukaryotes.	[DalCorso, Giovanni; Aseeva, Elena; Leister, Dario] Univ Munich, Dept Biol, Lehrstuhl Bot, D-80638 Munich, Germany; [Pesaresi, Paolo] Univ Statale Milano, Dipartimento Prod Veget, I-26900 Lodi, Italy; [Masiero, Simona] Univ Milan, Dipartimento Biol, I-20133 Milan, Italy; [Schuenemann, Danja] Ruhr Univ Bochum, Lehrstuhl Allgemeine & Mol Bot, D-44780 Bochum, Germany; [Finazzi, Giovanni; Joliot, Pierre] Inst Biol Physicochim, CNRS, UMR 7141, F-75005 Paris, France; [Barbato, Roberto] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci & Tecnol Avanzate, I-15100 Alessandria, Italy	University of Munich; University of Milan; University of Milan; Ruhr University Bochum; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Eastern Piedmont Amedeo Avogadro	Leister, D (corresponding author), Univ Munich, Dept Biol, Lehrstuhl Bot, Menzinger Str 67, D-80638 Munich, Germany.	leister@lrz.uni-muenchen.de	Leister, Dario/D-5587-2009; Masiero, Simona/J-2898-2013; Pesaresi, Paolo/F-9476-2014	Leister, Dario/0000-0003-1897-8421; Pesaresi, Paolo/0000-0002-3236-7005; masiero, simona/0000-0002-7563-7634; DalCorso, GIOVANNI/0000-0002-0594-5930; Schuenemann, Danja/0000-0001-8894-7685				Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ASADA K, 1993, PLANT CELL PHYSIOL, V34, P39; Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; Biehl A, 2005, GENE, V344, P33, DOI 10.1016/j.gene.2004.09.009; Breyton C, 2006, BIOCHEMISTRY-US, V45, P13465, DOI 10.1021/bi061439s; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Clarke JE, 2001, PLANTA, V212, P808, DOI 10.1007/s004250000432; CLELAND RE, 1992, PHOTOSYNTH RES, V34, P409, DOI 10.1007/BF00029815; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Golding AJ, 2004, PLANTA, V220, P356, DOI 10.1007/s00425-004-1345-z; Golding AJ, 2003, PLANTA, V218, P107, DOI 10.1007/s00425-003-1077-5; Haldrup A, 2003, J BIOL CHEM, V278, P33276, DOI 10.1074/jbc.M305106200; HARBINSON J, 1991, PLANT PHYSIOL, V97, P41, DOI 10.1104/pp.97.1.41; Havaux M, 2005, BBA-BIOENERGETICS, V1709, P203, DOI 10.1016/j.bbabio.2005.07.010; HAVAUX M, 1991, PLANTA, V186, P88, DOI 10.1007/BF00201502; HERBERT SK, 1990, PLANT PHYSIOL, V94, P926, DOI 10.1104/pp.94.3.926; Ihnatowicz A, 2004, PLANT J, V37, P839, DOI 10.1111/j.1365-313X.2004.02011.x; Ihnatowicz A, 2007, PLANTA, V226, P889, DOI 10.1007/s00425-007-0534-y; Joet T, 2002, PLANT PHYSIOL, V128, P760, DOI 10.1104/pp.010775; Joliot P, 2005, P NATL ACAD SCI USA, V102, P4913, DOI 10.1073/pnas.0501268102; Joliot P, 2004, BBA-BIOENERGETICS, V1656, P166, DOI 10.1016/j.bbabio.2004.03.010; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; Kramer DM, 2004, TRENDS PLANT SCI, V9, P349, DOI 10.1016/j.tplants.2004.05.001; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; MI H, 1994, PLANT CELL PHYSIOL, V35, P163; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; MOSS DA, 1984, BIOCHIM BIOPHYS ACTA, V767, P389, DOI 10.1016/0005-2728(84)90036-7; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Nandha B, 2007, BBA-BIOENERGETICS, V1767, P1252, DOI 10.1016/j.bbabio.2007.07.007; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Okegawa Y, 2005, J BIOL CHEM, V280, P28332, DOI 10.1074/jbc.M505703200; RAVENEL J, 1994, PLANTA, V193, P251; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Takabayashi A, 2005, P NATL ACAD SCI USA, V102, P16898, DOI 10.1073/pnas.0507095102; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; YU L, 1993, PLANT PHYSIOL, V103, P171, DOI 10.1104/pp.103.1.171; Zhang HM, 2001, J BIOL CHEM, V276, P38159	44	397	419	7	123	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 25	2008	132	2					273	285		10.1016/j.cell.2007.12.028	http://dx.doi.org/10.1016/j.cell.2007.12.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243102	Bronze, Green Submitted			2022-12-24	WOS:000253427700013
J	Lynch, AI; Boerwinkle, E; Davis, BR; Ford, CE; Eckfeldt, JH; Leiendecker-Foster, C; Arnett, DK				Lynch, Amy I.; Boerwinkle, Eric; Davis, Barry R.; Ford, Charles E.; Eckfeldt, John H.; Leiendecker-Foster, Catherine; Arnett, Donna K.			Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; POLYMORPHISMS; MARKERS; DESIGN; STROKE	Context The NPPA gene codes for the precursor of atrial natriuretic polypeptide, suggesting that NPPA may modulate the efficacy of some antihypertensive drugs. Objective To test whether participants with minor NPPA alleles in the T2238C or G664A variants had different rates of cardiovascular disease or blood pressure ( BP) changes than common allele homozygotes when treated with a diuretic vs other antihypertensive medications. Design, Setting, and Patients Post hoc analysis of 38 462 participants with hypertension from ALLHAT, a multicenter randomized clinical trial conducted in the United States and Canada. Genotyping was performed from February 2004 to January 2005. Intervention Participants were randomly assigned to receive a diuretic ( chlorthalidone; n= 13 860), a calcium antagonist ( amlodipine; n= 8174), an angiotensin-converting enzyme inhibitor ( lisinopril; n= 8233), or an alpha-blocker ( doxazosin; n= 8195). Main Outcome Measure The primary outcome measure was coronary heart disease ( CHD), defined as fatal CHD or nonfatal myocardial infarction ( mean follow- up, 4.9 years). Secondary outcomes were stroke, all- cause mortality, combined cardiovascular disease outcomes, and 6- month systolic and diastolic BP changes. Genotype x treatment interactions were tested where genotypes were modeled additively and dominantly. Results Depending on genotype, the event rates per 1000 person- years were 15.3 to 19.7 for CHO, 9.6 to 15.4 for stroke, and 27.4 to 30.7 for all- cause mortality. For the NPPA T2238C variant, lower event rates were found for the C allele carriers than for the TT homozygous individuals when comparing chlorthalidone and amlodipine ( CHD: CC= 0.86; TC= 0.90; TT= 1.09; P=. 03[ dominant model]; stroke: CC= 1.18; TC= 0.82; TT= 1.26; P=. 01 [ additive and dominant models]; all- cause mortality: CC= 0.87; TC= 0.98; TT= 1.12; P=. 05 [ dominant model]). Combined end points yielded similar results. Consistent with these clinical findings, 6- month changes in systolic BP for those with the CC genotype showed larger reductions with chlorthalidone (- 6.5 mm Hg) than with amlodipine (- 3.8 mm Hg), lisinopril (- 2.4 mm Hg), or doxazosin (- 3.8 mm Hg). Among those with the TT genotype, systolic BP differences between drugs were less ( range, - 5.4 to - 7.5 mm Hg; P value, <. 001 to .003 for interaction); diastolic BP showed similar results. We found no pharmacogenetic associations with the NPPA G664A variant. Conclusions The NPPA T2238C variant was associated with modification of antihypertensive medication effects on cardiovascular disease and BP. Minor C allele carriers experienced more favorable cardiovascular disease outcomes when randomized to receive a diuretic, whereas TT allele carriers had more favorable outcomes when randomized to receive a calcium channel blocker.	[Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Lynch, Amy I.; Eckfeldt, John H.; Leiendecker-Foster, Catherine] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Davis, Barry R.; Ford, Charles E.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA	University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Arnett, DK (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, RPHB 220E,1530 3rd Ave S, Birmingham, AL USA.	arnett@ms.soph.uab.edu			NHLBI NIH HHS [R01 HL083498, HL63082, N01-HC-35130] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083498, R01HL063082] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACKERMANN U, 1986, CLIN CHEM, V32, P241; Alderman MH, 2003, HYPERTENSION, V42, P239, DOI 10.1161/01.HYP.0000086521.95630.5A; Arnett D. K., 2002, Pharmacogenomics Journal, V2, P309; Cadman PE, 2003, CURR OPIN NEPHROL HY, V12, P61, DOI 10.1097/00041552-200301000-00011; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P7; Cheng S, 1999, GENOME RES, V9, P936, DOI 10.1101/gr.9.10.936; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Dedoussis GVZ, 2006, J CLIN LAB ANAL, V20, P98, DOI 10.1002/jcla.20108; Deschepper CF, 2002, HYPERTENSION, V39, P332, DOI 10.1161/hy0202.102787; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Guo XQ, 2005, HYPERTENSION, V45, P799, DOI 10.1161/01.HYP.0000154786.17416.ea; Hardy G H, 2003, Yale J Biol Med, V76, P79; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; KANFER A, 1989, CLIN NEPHROL, V32, P51; Kato N, 2000, CLIN SCI, V98, P251, DOI 10.1042/CS19990220; Kurland L, 2005, TRENDS PHARMACOL SCI, V26, P443, DOI 10.1016/j.tips.2005.07.008; Liguori A, 1994, Riv Eur Sci Med Farmacol, V16, P61; PETERSON B, 1994, CONTROL CLIN TRIALS, V15, P326; PETERSON B, 1993, CONTROL CLIN TRIALS, V14, P511, DOI 10.1016/0197-2456(93)90031-8; Rubattu S, 2004, STROKE, V35, P814, DOI 10.1161/01.STR.0000119381.52589.AB; Rubattu S, 2007, J HUM HYPERTENS, V21, P822, DOI 10.1038/sj.jhh.1002228; Rubattu S, 2006, J AM COLL CARDIOL, V48, P499, DOI 10.1016/j.jacc.2005.12.081; STEINHELPER ME, 1990, HYPERTENSION, V16, P301, DOI 10.1161/01.HYP.16.3.301; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600	26	75	86	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2008	299	3					296	307		10.1001/jama.299.3.296	http://dx.doi.org/10.1001/jama.299.3.296			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253DB	18212314	Bronze			2022-12-24	WOS:000252497800021
J	Gao, DC; Nolan, DJ; Mellick, AS; Bambino, K; McDonnell, K; Mittal, V				Gao, Dingcheng; Nolan, Daniel J.; Mellick, Albert S.; Bambino, Kathryn; McDonnell, Kevin; Mittal, Vivek			Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELLS; MARROW; RECRUITMENT; DORMANCY; GROWTH	Angiogenesis- mediated progression of micrometastasis to lethal macrometastasis is the major cause of death in cancer patients. Here, using mouse models of pulmonary metastasis, we identify bone marrow ( BM)- derived endothelial progenitor cells ( EPCs) as critical regulators of this angiogenic switch. We show that tumors induce expression of the transcription factor Id1 in the EPCs and that suppression of Id1 after metastatic colonization blocked EPC mobilization, caused angiogenesis inhibition, impaired pulmonary macrometastases, and increased survival of tumor- bearing animals. These findings establish the role of EPCs in metastatic progression in preclinical models and suggest that selective targeting of EPCs may merit investigation as a therapy for cancer patients with lung metastases.	[Gao, Dingcheng; Nolan, Daniel J.; Mellick, Albert S.; Bambino, Kathryn; McDonnell, Kevin; Mittal, Vivek] Cold Spring Harbor Lab, Canc Genome Res Ctr, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Mittal, V (corresponding author), Cold Spring Harbor Lab, Canc Genome Res Ctr, POB 100, Cold Spring Harbor, NY 11724 USA.	mittal@cshl.edu	Gao, Dingcheng/P-5889-2019	Mellick, Albert/0000-0002-0668-2706				Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Beaudry P, 2005, CLIN CANCER RES, V11, P3514, DOI 10.1158/1078-0432.CCR-04-2271; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Garmy-Susini B, 2005, J CLIN INVEST, V115, P1542, DOI 10.1172/JCI23445; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; Jin H, 2006, J CLIN INVEST, V116, P652, DOI 10.1172/JCI24751; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da; Laitinen L, 1987, J HISTOCHEM CYTOCHEM, V35, P55, DOI 10.1177/35.1.3794309; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Prindull GA, 2007, EXP HEMATOL, V35, P691, DOI 10.1016/j.exphem.2007.01.047; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Townson JL, 2006, CELL CYCLE, V5, P1744, DOI 10.4161/cc.5.16.2864	20	514	550	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2008	319	5860					195	198		10.1126/science.1150224	http://dx.doi.org/10.1126/science.1150224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187653				2022-12-24	WOS:000252246400039
J	Christofk, HR; Vander Heiden, MG; Harris, MH; Ramanathan, A; Gerszten, RE; Wei, R; Fleming, MD; Schreiber, SL; Cantley, LC				Christofk, Heather R.; Vander Heiden, Matthew G.; Harris, Marian H.; Ramanathan, Arvind; Gerszten, Robert E.; Wei, Ru; Fleming, Mark D.; Schreiber, Stuart L.; Cantley, Lewis C.			The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth	NATURE			English	Article							ALLOSTERIC REGULATION; AEROBIC GLYCOLYSIS; INHIBITION; CELLS	Many tumour cells have elevated rates of glucose uptake but reduced rates of oxidative phosphorylation. This persistence of high lactate production by tumours in the presence of oxygen, known as aerobic glycolysis, was first noted by Otto Warburg more than 75 yr ago(1). How tumour cells establish this altered metabolic phenotype and whether it is essential for tumorigenesis is as yet unknown. Here we show that a single switch in a splice isoform of the glycolytic enzyme pyruvate kinase is necessary for the shift in cellular metabolism to aerobic glycolysis and that this promotes tumorigenesis. Tumour cells have been shown to express exclusively the embryonic M2 isoform of pyruvate kinase(2). Here we use short hairpin RNA to knockdown pyruvate kinase M2 expression in human cancer cell lines and replace it with pyruvate kinase M1. Switching pyruvate kinase expression to the M1 ( adult) isoform leads to reversal of the Warburg effect, as judged by reduced lactate production and increased oxygen consumption, and this correlates with a reduced ability to form tumours in nude mouse xenografts. These results demonstrate that M2 expression is necessary for aerobic glycolysis and that this metabolic phenotype provides a selective growth advantage for tumour cells in vivo.	[Christofk, Heather R.; Vander Heiden, Matthew G.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Harris, Marian H.; Fleming, Mark D.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ramanathan, Arvind; Gerszten, Robert E.; Wei, Ru; Schreiber, Stuart L.] Harvard Univ, Broad Inst, Chem Biol Program, Cambridge, MA 02142 USA; [Ramanathan, Arvind; Gerszten, Robert E.; Wei, Ru; Schreiber, Stuart L.] MIT, Cambridge, MA 02142 USA; [Gerszten, Robert E.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02129 USA; [Gerszten, Robert E.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA; [Gerszten, Robert E.] Harvard Univ, Sch Med, Donald W Reynolds Cardiovasc Clin Res Ctr Atheros, Boston, MA 02115 USA; [Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Beth Israel Deaconess Medical Center	Cantley, LC (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	lcantley@hms.harvard.edu	Cantley, Lewis C/D-1800-2014; Harris, Marian/R-7049-2019	Cantley, Lewis C/0000-0002-1298-7653; Christofk, Heather/0000-0002-8662-4425; Fleming, Mark/0000-0003-0948-4024	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32 CA009172] Funding Source: Medline; NIGMS NIH HHS [R01 GM056203] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Budinger GRS, 1996, AM J PHYSIOL-LUNG C, V270, pL44, DOI 10.1152/ajplung.1996.270.1.L44; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Manes NP, 2005, ARCH BIOCHEM BIOPHYS, V438, P125, DOI 10.1016/j.abb.2005.04.011; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	19	1989	2107	10	341	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					230	U74		10.1038/nature06734	http://dx.doi.org/10.1038/nature06734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337823				2022-12-24	WOS:000253925600043
J	Hom, G; Graham, RR; Modrek, B; Taylor, KE; Ortmann, W; Garnier, S; Lee, AT; Chung, SA; Ferreira, RC; Pant, PVK; Ballinger, DG; Kosoy, R; Demirci, FY; Kamboh, MI; Kao, AH; Tian, C; Gunnarsson, I; Bengtsson, AA; Rantapaa-Dahlqvist, S; Petri, M; Manzi, S; Seldin, MF; Ronnblom, L; Syvanen, AC; Criswell, LA; Gregersen, PK; Behrens, TW				Hom, Geoffrey; Graham, Robert R.; Modrek, Barmak; Taylor, Kimberly E.; Ortmann, Ward; Garnier, Sophie; Lee, Annette T.; Chung, Sharon A.; Ferreira, Ricardo C.; Pant, P. V. Krishna; Ballinger, Dennis G.; Kosoy, Roman; Demirci, F. Yesim; Kamboh, M. Ilyas; Kao, Amy H.; Tian, Chao; Gunnarsson, Iva; Bengtsson, Anders A.; Rantapaa-Dahlqvist, Solbritt; Petri, Michelle; Manzi, Susan; Seldin, Michael F.; Ronnblom, Lars; Syvanen, Ann-Christine; Criswell, Lindsey A.; Gregersen, Peter K.; Behrens, Timothy W.			Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; B-CELL DEVELOPMENT; TYROSINE KINASE; INCREASED RISK; INTERFERON; EXPRESSION; TOLERANCE; HAPLOTYPES; SUSCEPTIBILITY; POLYMORPHISMS	Background Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease in which the risk of disease is influenced by complex genetic and environmental contributions. Alleles of HLA-DRB1, IRF5, and STAT4 are established susceptibility genes; there is strong evidence for the existence of additional risk loci. Methods We genotyped more than 500,000 single-nucleotide polymorphisms (SNPs) in DNA samples from 1311 case subjects with SLE and 1783 control subjects; all subjects were North Americans of European descent. Genotypes from 1557 additional control subjects were obtained from public data repositories. We measured the association between the SNPs and SLE after applying strict quality-control filters to reduce technical artifacts and to correct for the presence of population stratification. Replication of the top loci was performed in 793 case subjects and 857 control subjects from Sweden. Results Genetic variation in the region upstream from the transcription initiation site of the gene encoding B lymphoid tyrosine kinase (BLK) and C8orf13 (chromosome 8p23.1) was associated with disease risk in both the U.S. and Swedish case-control series (rs13277113; odds ratio, 1.39; P=1 x 10(-10)) and also with altered levels of messenger RNA in B-cell lines. In addition, variants on chromosome 16p11.22, near the genes encoding integrin alpha M (ITGAM, or CD11b) and integrin alpha X (ITGAX), were associated with SLE in the combined sample (rs11574637; odds ratio, 1.33; P=3 x 1 (-11)). Conclusions We identified and then confirmed through replication two new genetic loci for SLE: a promoter-region allele associated with reduced expression of BLK and increased expression of C8orf13 and variants in the ITGAM-ITGAX region.	[Hom, Geoffrey; Graham, Robert R.; Modrek, Barmak; Ortmann, Ward; Ferreira, Ricardo C.; Behrens, Timothy W.] Genentech Inc, San Francisco, CA 94080 USA; [Taylor, Kimberly E.; Chung, Sharon A.; Criswell, Lindsey A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Garnier, Sophie; Ronnblom, Lars; Syvanen, Ann-Christine] Uppsala Univ, Uppsala, Sweden; [Lee, Annette T.; Gregersen, Peter K.] Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Pant, P. V. Krishna; Ballinger, Dennis G.] Perlegen Sci, Mountain View, CA USA; [Kosoy, Roman; Tian, Chao; Seldin, Michael F.] Univ Calif Davis, Davis, CA 95616 USA; [Demirci, F. Yesim; Kamboh, M. Ilyas; Kao, Amy H.; Manzi, Susan] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Gunnarsson, Iva] Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden; [Bengtsson, Anders A.] Univ Lund Hosp, S-22185 Lund, Sweden; [Rantapaa-Dahlqvist, Solbritt] Univ Umea Hosp, S-90185 Umea, Sweden; [Petri, Michelle] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Roche Holding; Genentech; University of California System; University of California San Francisco; Uppsala University; Northwell Health; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; Umea University; Johns Hopkins University	Behrens, TW (corresponding author), Genentech Inc, 1 DNA Way,45-3B, San Francisco, CA 94080 USA.	behrens.timothy@gene.com		Ferreira, Ricardo C./0000-0001-5733-3285; Kamboh, M. Ilyas/0000-0002-3453-1438; Garnier, Sophie/0000-0002-7492-1617; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863; Demirci, F. Yesim/0000-0001-6907-9843	NCRR NIH HHS [M01-RR00052, 5-M01-RR00079] Funding Source: Medline; NHLBI NIH HHS [HL74165, HL54900] Funding Source: Medline; NIAID NIH HHS [N01-AI95386] Funding Source: Medline; NIAMS NIH HHS [K23-AR051044, P60 AR053308, AR43737, R01-AR046588, N01-AR1-2256, R01-AR44804, AR050267, K24-AR02175] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054900, R01HL074165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR053308, K24AR002175, R01AR050267, R01AR044804, R01AR046588, N01AR012256, K23AR051044] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Baechler EC, 2004, CURR OPIN IMMUNOL, V16, P801, DOI 10.1016/j.coi.2004.09.014; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; BUYON JP, 1988, CLIN IMMUNOL IMMUNOP, V46, P141, DOI 10.1016/0090-1229(88)90014-1; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cornall RJ, 1998, CIBA F SYMP, V215, P21; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Demirci FYK, 2007, ANN HUM GENET, V71, P308, DOI 10.1111/j.1469-1809.2006.00336.x; Devlin B, 2000, Biostatistics, V1, P369, DOI 10.1093/biostatistics/1.4.369; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dunn MJ, 2001, PROTEOMICS, V1, P1; DYMECKI SM, 1992, J BIOL CHEM, V267, P4815; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; GOLDBERG MA, 1976, ARTHRITIS RHEUM, V19, P129, DOI 10.1002/art.1780190201; Graham RR, 2007, EUR J HUM GENET, V15, P823, DOI 10.1038/sj.ejhg.5201827; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2002, AM J HUM GENET, V71, P543, DOI 10.1086/342290; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Hammerberg C, 1998, J EXP MED, V187, P1133, DOI 10.1084/jem.187.7.1133; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOCHBERG MC, 1997, DUBOIS LUPUS ERYTHEM, P49; Hsu TM, 2001, BIOTECHNIQUES, V31, P560, DOI 10.2144/01313rr01; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Lu HF, 1997, J CLIN INVEST, V99, P1340, DOI 10.1172/JCI119293; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Nath SK, 2004, CURR OPIN IMMUNOL, V16, P794, DOI 10.1016/j.coi.2004.09.007; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Ronnblom L, 2001, J EXP MED, V194, pF59, DOI 10.1084/jem.194.12.f59; Seligman VA, 2001, ARTHRITIS RHEUM, V44, P618, DOI 10.1002/1529-0131(200103)44:3<618::AID-ANR110>3.0.CO;2-R; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sugawara H, 2003, GENOMICS, V82, P238, DOI 10.1016/S0888-7543(03)00108-3; Texido G, 2000, MOL CELL BIOL, V20, P1227, DOI 10.1128/MCB.20.4.1227-1233.2000; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; WASSERMAN R, 1995, J IMMUNOL, V155, P644; Watts GM, 2005, J IMMUNOL, V174, P3668, DOI 10.4049/jimmunol.174.6.3668	49	694	712	1	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					900	909		10.1056/NEJMoa0707865	http://dx.doi.org/10.1056/NEJMoa0707865			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18204098				2022-12-24	WOS:000253430200005
J	Dinneny, JR; Benfey, PN				Dinneny, Jose R.; Benfey, Philip N.			Plant stem cell niches: Standing the test of time	CELL			English	Article							ARABIDOPSIS ROOT-MERISTEM; SHOOT APEX; WUSCHEL; GROWTH; MODEL; FATE; PHYLLOTAXIS; REGULATORS; TRANSPORT; PROTEINS	Similar to animal stem cells, plant stem cells require special niche microenvironments to continuously generate the tissues that constitute the plant body. Recent work using computer modeling and live imaging is helping to elucidate some of the mechanisms responsible for the specification and maintenance of stem cells in the root and shoot.	[Dinneny, Jose R.; Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Dinneny, Jose/J-8312-2012	Dinneny, Jose/0000-0002-3998-724X				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Fiers M, 2005, PLANT CELL, V17, P2542, DOI 10.1105/tpc.105.034009; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Giulini A, 2004, NATURE, V430, P1031, DOI 10.1038/nature02778; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Likhoshvai V. A., 2007, Russian Journal of Developmental Biology, V38, P374, DOI 10.1134/S1062360407060057; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042	26	103	111	4	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					553	557		10.1016/j.cell.2008.02.001	http://dx.doi.org/10.1016/j.cell.2008.02.001			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295573	Bronze			2022-12-24	WOS:000253817900015
J	Beninca, E; Huisman, J; Heerkloss, R; Johnk, KD; Branco, P; Van Nes, EH; Scheffer, M; Ellner, SP				Beninca, Elisa; Huisman, Jef; Heerkloss, Reinhard; Johnk, Klaus D.; Branco, Pedro; Van Nes, Egbert H.; Scheffer, Marten; Ellner, Stephen P.			Chaos in a long-term experiment with a plankton community	NATURE			English	Article							CYCLES; SERIES; OSCILLATIONS; MODELS	Mathematical models predict that species interactions such as competition and predation can generate chaos(1-8). However, experimental demonstrations of chaos in ecology are scarce, and have been limited to simple laboratory systems with a short duration and artificial species combinations(9-12). Here, we present the first experimental demonstration of chaos in a long- term experiment with a complex food web. Our food web was isolated from the Baltic Sea, and consisted of bacteria, several phytoplankton species, herbivorous and predatory zooplankton species, and detritivores. The food web was cultured in a laboratory mesocosm, and sampled twice a week for more than 2,300 days. Despite constant external conditions, the species abundances showed striking fluctuations over several orders of magnitude. These fluctuations displayed a variety of different periodicities, which could be attributed to different species interactions in the food web. The population dynamics were characterized by positive Lyapunov exponents of similar magnitude for each species. Predictability was limited to a time horizon of 15 - 30 days, only slightly longer than the local weather forecast. Hence, our results demonstrate that species interactions in food webs can generate chaos. This implies that stability is not required for the persistence of complex food webs, and that the long- term prediction of species abundances can be fundamentally impossible.	[Beninca, Elisa; Huisman, Jef; Johnk, Klaus D.; Branco, Pedro] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1018 WS Amsterdam, Netherlands; [Beninca, Elisa; Van Nes, Egbert H.; Scheffer, Marten] Univ Wageningen & Res Ctr, Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [Heerkloss, Reinhard] Univ Rostock, Inst Biosci, Rostock, Germany; [Ellner, Stephen P.] Cornell Univ, Ithaca, NY 14853 USA	University of Amsterdam; Wageningen University & Research; University of Rostock; Cornell University	Huisman, J (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Nieuwe Achtergracht 127, NL-1018 WS Amsterdam, Netherlands.	jef.huisman@science.uva.nl	Huisman, Jef/A-1089-2013; Scheffer, Marten/C-1852-2012; Jöhnk, Klaus/B-3382-2008; van Nes, Egbert H/F-2681-2011	Huisman, Jef/0000-0001-9598-3211; Jöhnk, Klaus/0000-0002-5972-4201; van Nes, Egbert/0000-0002-6345-104X; Branco, Pedro/0000-0002-5010-0419				Becks L, 2005, NATURE, V435, P1226, DOI 10.1038/nature03627; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; GAEDEKE A, 1986, OECOLOGIA, V71, P25, DOI 10.1007/BF00377315; GILPIN ME, 1979, AM NAT, V113, P306, DOI 10.1086/283389; Graham DW, 2007, ISME J, V1, P385, DOI 10.1038/ismej.2007.45; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; Heerkloss R, 1998, INT VER THEOR ANGEW, V26, P1952; Huisman J, 2006, NATURE, V439, P322, DOI 10.1038/nature04245; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Kantz H., 1997, NONLINEAR TIME SERIE; Kendall BE, 2001, CHAOS SOLITON FRACT, V12, P321, DOI 10.1016/S0960-0779(00)00180-6; LORENZ EN, 1982, TELLUS, V34, P505, DOI 10.1111/j.2153-3490.1982.tb01839.x; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; NYCHKA D, 1992, J ROY STAT SOC B MET, V54, P399; REDFIELD AC, 1958, AM SCI, V46, P205; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Scheffer M, 2000, FRESHWATER BIOL, V45, P265, DOI 10.1046/j.1365-2427.2000.00674.x; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Takens F, 1981, LECT NOTES MATH, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; THEILER J, 1986, PHYS REV A, V34, P2427, DOI 10.1103/PhysRevA.34.2427; van Nes EH, 2004, AM NAT, V164, P255, DOI 10.1086/422204; VANDERMEER J, 1993, AM NAT, V141, P687, DOI 10.1086/285500; Zimmer C, 1999, SCIENCE, V284, P83, DOI 10.1126/science.284.5411.83	30	246	255	6	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					822	U7		10.1038/nature06512	http://dx.doi.org/10.1038/nature06512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273017				2022-12-24	WOS:000253191400041
J	Smith, WR; Penberthy, LT; Bovbjerg, VE; McClish, DK; Roberts, JD; Dahman, B; Aisiku, IP; Levenson, JL; Roseff, SD				Smith, Wally R.; Penberthy, Lynne T.; Bovbjerg, Viktor E.; McClish, Donna K.; Roberts, John D.; Dahman, Bassarn; Aisiku, Imoigele P.; Levenson, James L.; Roseff, Susan D.			Daily assessment of pain in adults with sickle cell disease	ANNALS OF INTERNAL MEDICINE			English	Article							NITRIC-OXIDE BIOAVAILABILITY; HEALTH-CARE UTILIZATION; BELIEF MODEL; RISK-FACTORS; MANAGEMENT; ANEMIA; CHILDREN; ADOLESCENTS; HYDROXYUREA; ADHESION	Background: Researchers of sickle cell disease have traditionally used health care utilization as a proxy for pain and underlying vaso-occlusion. However, utilization may not completely reflect the amount of self-reported pain or acute, painful episodes (crises). Objective: To examine the prevalence of self-reported pain and the relationship among pain, crises, and utilization in adults with sickle cell disease. Design: Prospective cohort study. Setting: Academic and community practices in Virginia. Patients: 232 patients age 16 years or older with sickle cell disease. Measurements: Patients completed a daily diary for up to 6 months, recording their maximum pain (on a scale of 0 to 9); whether they were in a crisis (crisis day); and whether they used hospital, emergency, or unscheduled ambulatory care for pain on the, previous day (utilization day). Summary measures included both simple proportions and adjusted probabilities (for repeated measures within patients) of pain days, crisis days, and utilization days, as well as mean pain intensity. Results: Pain (with or without crisis or utilization of care) was reported on 54.5% of 31 017 analyzed patient-days (adjusted probability, 56%). Crises without utilization were reported on 12.7% of days and utilization on only 3.5% (unadjusted). In total, 29.3% of patients reported pain in greater than 95% of diary days, whereas only 14.2% reported pain in 5% or fewer diary days (adjusted). The frequency of home opiate use varied and independently predicted pain, crises, and utilization. Mean pain intensity on crisis days, noncrisis pain days, and total pain days increased as the percentage of pain days increased (P < 0.001). Intensity was significantly higher on utilization days (P < 0.001). However, utilization was not an independent predictor of crisis, after controlling for pain intensity. Limitations: The study was done in a single state. Patients did not always send in their diaries. Conclusion: Pain in adults with sickle cell disease is the rule rather than the exception and is far more prevalent and severe than previous large-scale studies have portrayed. It is mostly managed at home; therefore, its prevalence is probably underestimated by health care providers, resulting in misclassification, distorted communication, and undertreatment.	[Smith, Wally R.] Virginia Commonwealth Univ, Dept Internal Med, Div Quality Hlth Care, Richmond, VA 23298 USA	Virginia Commonwealth University	Smith, WR (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, Div Quality Hlth Care, Box 980306, Richmond, VA 23298 USA.	wrsmith@vcu.edu			NHLBI NIH HHS [1R01HL64122-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064122] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen KD, 2006, JCR-J CLIN RHEUMATOL, V12, P118, DOI 10.1097/01.rhu.0000221801.63880.3f; Anie Kofi A, 2003, Hematol J, V4, P71, DOI 10.1038/sj.thj.6200227; Ballas SK, 2005, HEMATOL ONCOL CLIN N, V19, P785, DOI 10.1016/j.hoc.2005.07.008; Baron Michael J, 2006, J Opioid Manag, V2, P277; BECKER MH, 1974, HEALTH EDUC QUART, V2, P409, DOI 10.1177/109019817400200407; Blum A, 2005, J THROMB THROMBOLYS, V19, P83, DOI 10.1007/s11239-005-1377-7; BOBO L, 1989, SOUTHERN MED J, V82, P9, DOI 10.1097/00007611-198901000-00004; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Charache S, 1995, CONTROL CLIN TRIALS, V16, P432, DOI 10.1016/S0197-2456(95)00098-4; CHEN MS, 1986, SOC PSYCHOL QUART, V49, P45, DOI 10.2307/2786856; Dampier C, 2004, J PEDIAT HEMATOL ONC, V26, P785; Dimcevski G, 2006, EUR J GASTROEN HEPAT, V18, P755, DOI 10.1097/01.meg.0000223903.70492.c5; El Nemer W, 2007, BLOOD, V109, P3544, DOI 10.1182/blood-2006-07-035139; Elander J, 2004, J PAIN SYMPTOM MANAG, V27, P156, DOI 10.1016/j.jpainsymman.2003.12.001; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Fuggle P, 1996, ARCH DIS CHILD, V75, P199, DOI 10.1136/adc.75.3.199; Gil KM, 2004, HEALTH PSYCHOL, V23, P267, DOI 10.1037/0278-6133.23.3.267; Gil KM, 2003, J PEDIATR PSYCHOL, V28, P363, DOI 10.1093/jpepsy/jsg026; Gil KM, 2000, CHILD HEALTH CARE, V29, P225, DOI 10.1207/S15326888CHC2904_1; Gladwin MT, 2003, CIRCULATION, V107, P271, DOI 10.1161/01.CIR.0000044943.12533.A8; Graido-Gonzalez E, 1998, BLOOD, V92, P2551, DOI 10.1182/blood.V92.7.2551.2551_2551_2555; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; Hermann C, 2006, PAIN, V125, P278, DOI 10.1016/j.pain.2006.08.026; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; KAUL DK, 1989, P NATL ACAD SCI USA, V86, P3356, DOI 10.1073/pnas.86.9.3356; Kaul DK, 2000, AM J PHYSIOL-HEART C, V278, pH1799, DOI 10.1152/ajpheart.2000.278.6.H1799; Lefebvre JC, 2002, CLIN J PAIN, V18, P56, DOI 10.1097/00002508-200201000-00009; McClish DK, 2006, J WOMENS HEALTH, V15, P146, DOI 10.1089/jwh.2006.15.146; Michaels LA, 1998, BLOOD, V92, P3148, DOI 10.1182/blood.V92.9.3148.421k12_3148_3151; MURRAY N, 1988, BRIT MED J, V297, P452, DOI 10.1136/bmj.297.6646.452; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Porter LS, 1998, INT J BEHAV MED, V5, P185, DOI 10.1207/s15327558ijbm0503_1; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Reese FL, 1997, ANN BEHAV MED, V19, P171, DOI 10.1007/BF02883334; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Sakhalkar VS, 2004, AM J HEMATOL, V76, P57, DOI 10.1002/ajh.20016; Serjeant GR, 1997, LANCET, V350, P725, DOI 10.1016/S0140-6736(97)07330-3; SERJEANT GR, 1993, BLOOD REV, V7, P137, DOI 10.1016/0268-960X(93)90001-K; Setty BNY, 2003, LANCET, V362, P1450, DOI 10.1016/S0140-6736(03)14689-2; SHAPIRO BS, 1995, PAIN, V61, P139, DOI 10.1016/0304-3959(94)00164-A; Shapiro BS, 1997, J PAIN SYMPTOM MANAG, V14, P168, DOI 10.1016/S0885-3924(97)00019-5; Smith WR, 2005, J NATL MED ASSOC, V97, P183; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; Wagner MC, 2004, J LAB CLIN MED, V144, P260, DOI 10.1016/j.lab.2004.08.004; Westerman MP, 1997, AM J HEMATOL, V54, P183, DOI 10.1002/(SICI)1096-8652(199703)54:3<183::AID-AJH2>3.0.CO;2-S; [No title captured]	50	372	376	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2008	148	2					94	101		10.7326/0003-4819-148-2-200801150-00004	http://dx.doi.org/10.7326/0003-4819-148-2-200801150-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254NZ	18195334				2022-12-24	WOS:000252594600002
J	Richardson, AR; Libby, SJ; Fang, FC				Richardson, Anthony R.; Libby, Stephen J.; Fang, Ferric C.			A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity	SCIENCE			English	Article							PYRUVATE FORMATE-LYASE; ENZYME; OXYGEN	Staphylococcus aureus is one of the most successful human pathogens, colonizing 2 billion individuals worldwide and causing invasive infections even in immunocompetent hosts. S. aureus can evade multiple components of host innate immunity, including the antimicrobial radical nitric oxide ( NO.) produced by activated phagocytes. We show that S. aureus is capable of metabolically adapting to nitrosative stress by expressing an NO.- inducible L- lactate dehydrogenase ( ldh1, SACOL0222) divergently transcribed from the NO.- detoxifying flavohemoglobin ( hmp). L- Lactate production allows S. aureus to maintain redox homeostasis during nitrosative stress and is essential for virulence. NO.- inducible lactate dehydrogenase activity and NO. resistance distinguish S. aureus from the closely related commensal species S. epidermidis and S. saprophyticus.	[Richardson, Anthony R.; Libby, Stephen J.; Fang, Ferric C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Fang, Ferric C.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fang, FC (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	fcfang@u.washington.edu		Fang, Ferric/0000-0002-3243-110X	NIAID NIH HHS [AI055396, AI039557] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039557, T32AI055396, R01AI039557] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersson JA, 2002, ACTA OTO-LARYNGOL, V122, P861, DOI 10.1080/003655402/000028053; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Broderick JB, 2000, BIOCHEM BIOPH RES CO, V269, P451, DOI 10.1006/bbrc.2000.2313; Brown GC, 1997, BIOCHEM SOC T, V25, P901, DOI 10.1042/bst0250901; Butler AR, 2002, CHEM REV, V102, P1155, DOI 10.1021/cr000076d; Choi KC, 1998, ADV PERIT D, V14, P173; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Perham R N, 1987, Biochem Soc Symp, V54, P67; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Shay AH, 2003, J INFECT DIS, V187, P700, DOI 10.1086/368370; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068	16	199	213	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1672	1676		10.1126/science.1155207	http://dx.doi.org/10.1126/science.1155207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356528				2022-12-24	WOS:000254172300043
J	Sreedharan, J; Blair, IP; Tripathi, VB; Hu, X; Vance, C; Rogelj, B; Ackerley, S; Durnall, JC; Williams, KL; Buratti, E; Baralle, F; de Belleroche, J; Mitchell, JD; Leigh, PN; Al-Chalabi, A; Miller, CC; Nicholson, G; Shaw, CE				Sreedharan, Jemeen; Blair, Ian P.; Tripathi, Vineeta B.; Hu, Xun; Vance, Caroline; Rogelj, Boris; Ackerley, Steven; Durnall, Jennifer C.; Williams, Kelly L.; Buratti, Emanuele; Baralle, Francisco; de Belleroche, Jacqueline; Mitchell, J. Douglas; Leigh, P. Nigel; Al-Chalabi, Ammar; Miller, Christopher C.; Nicholson, Garth; Shaw, Christopher E.			TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis	SCIENCE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; NEURON DISEASE-TYPE; INCLUSIONS; DEMENTIA; GENE; LOCUS; REGULATOR	Amyotrophic lateral sclerosis ( ALS) is a fatal motor neuron disorder characterized pathologically by ubiquitinated TAR DNA binding protein ( TDP- 43) inclusions. The function of TDP- 43 in the nervous system is uncertain, and a mechanistic role in neurodegeneration remains speculative. We identified neighboring mutations in a highly conserved region of TARDBP in sporadic and familial ALS cases. TARDBP(M337V) segregated with disease within one kindred and a genome- wide scan confirmed that linkage was restricted to chromosome 1p36, which contains the TARDBP locus. Mutant forms of TDP- 43 fragmented in vitro more readily than wild type and, in vivo, caused neural apoptosis and developmental delay in the chick embryo. Our evidence suggests a pathophysiological link between TDP- 43 and ALS.	[Sreedharan, Jemeen; Tripathi, Vineeta B.; Hu, Xun; Vance, Caroline; Rogelj, Boris; Ackerley, Steven; Leigh, P. Nigel; Al-Chalabi, Ammar; Miller, Christopher C.; Shaw, Christopher E.] Kings Coll London, MRC Ctr Neurodegenerat Res, Dept Clin Neurosci, London SE5 8AF, England; [Sreedharan, Jemeen; Tripathi, Vineeta B.; Hu, Xun; Vance, Caroline; Rogelj, Boris; Ackerley, Steven; Leigh, P. Nigel; Al-Chalabi, Ammar; Miller, Christopher C.; Shaw, Christopher E.] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London SE5 8AF, England; [Ackerley, Steven; Miller, Christopher C.] Kings Coll London, Dept Neurosci, MRC Ctr Neurodegenerat Res, London SE5 8AF, England; [Blair, Ian P.; Durnall, Jennifer C.; Williams, Kelly L.; Nicholson, Garth] ANZAC Res Inst, Northcott Neurosci Lab, Concord, NSW 2137, Australia; [Blair, Ian P.; Nicholson, Garth] Univ Sydney, Fac Med, Sydney, NSW 2139, Australia; [Buratti, Emanuele; Baralle, Francisco] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [de Belleroche, Jacqueline] Univ London Imperial Coll Sci Technol & Med, Div Neurosci & Mental Hlth, Fac Med, London W6 8RF, England; [de Belleroche, Jacqueline] Charing Cross Hosp, London W6 8RF, England; [Mitchell, J. Douglas] Royal Preston Hosp, Dept Neurol, Preston PR2 9HT, Lancs, England; [Nicholson, Garth] Concord Repatriat Gen Hosp, Mol Med Lab, Concord, NSW 2139, Australia	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Sydney; ANZAC Research Institute; University of Sydney; International Center for Genetic Engineering & Biotechnology (ICGEB); Imperial College London; Imperial College London; Royal Preston Hospital; Concord Repatriation General Hospital	Shaw, CE (corresponding author), Kings Coll London, MRC Ctr Neurodegenerat Res, Dept Clin Neurosci, London SE5 8AF, England.	chris.shaw@iop.kcl.ac.uk	Miller, Christopher/H-5733-2012; Rogelj, Boris/G-9252-2011; Vance, Caroline/Q-2633-2019; Buratti, Emanuele/K-4691-2016; Leigh, Peter/AAD-5638-2019; Williams, Kelly L/A-5545-2010; Research Institute, ANZAC/CAE-9030-2022; Al-Chalabi, Ammar/E-5361-2010; Vance, Caroline/C-3047-2012; sreedharan, jemeen/E-7327-2016	Rogelj, Boris/0000-0003-3898-1943; Vance, Caroline/0000-0001-5780-6951; Buratti, Emanuele/0000-0002-1356-9074; Williams, Kelly L/0000-0001-6319-9473; Al-Chalabi, Ammar/0000-0002-4924-7712; Vance, Caroline/0000-0001-5780-6951; Shaw, Christopher/0000-0003-0251-0146; Nicholson, Garth/0000-0001-9694-066X; sreedharan, jemeen/0000-0002-8682-6844; Miller, Christopher/0000-0002-5130-1845; Blair, Ian/0000-0003-3083-0075	Medical Research Council [G0000749, G0500289, G0600974, G0501573] Funding Source: Medline; Wellcome Trust [076671] Funding Source: Medline; Medical Research Council [G0500289B] Funding Source: researchfish; MRC [G0000749, G0600974, G0501573, G0500289] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P62, DOI 10.1097/nen.0b013e3181609361; GIJSELINCK I, 2007, IN PRESS NEUROBIOL A; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hasegawa M, 2007, BRAIN, V130, P1386, DOI 10.1093/brain/awm065; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; LEIGH PN, 1991, BRAIN, V114, P775, DOI 10.1093/brain/114.2.775; Lipton AM, 2004, ACTA NEUROPATHOL, V108, P379, DOI 10.1007/s00401-004-0900-9; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Rollinson S, 2007, NEUROSCI LETT, V419, P1, DOI 10.1016/j.neulet.2007.03.044; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Rothstein JD, 2007, ANN NEUROL, V61, P382, DOI 10.1002/ana.21155; Ruddy DM, 2003, AM J HUM GENET, V73, P390, DOI 10.1086/377157; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; SCHUMACHER A, IN PRESS NEUROBIOL A; Shaw C E, 2001, Curr Neurol Neurosci Rep, V1, P69, DOI 10.1007/s11910-001-0078-7; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030	26	1849	1917	8	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1668	1672		10.1126/science.1154584	http://dx.doi.org/10.1126/science.1154584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18309045	Green Accepted			2022-12-24	WOS:000254172300042
J	Gonzalez-Maeso, J; Ang, RL; Yuen, T; Chan, P; Weisstaub, NV; Lopez-Gimenez, JF; Zhou, MM; Okawa, Y; Callado, LF; Milligan, G; Gingrich, JA; Filizola, M; Meana, JJ; Sealfon, SC				Gonzalez-Maeso, Javier; Ang, Rosalind L.; Yuen, Tony; Chan, Pokman; Weisstaub, Noelia V.; Lopez-Gimenez, Juan F.; Zhou, Mingming; Okawa, Yuuya; Callado, Luis F.; Milligan, Graeme; Gingrich, Jay A.; Filizola, Marta; Meana, J. Javier; Sealfon, Stuart C.			Identification of a serotonin/glutamate receptor complex implicated in psychosis	NATURE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; SCHIZOPHRENIA; MODEL; RHODOPSIN; AGONIST; POSTMORTEM; PSILOCYBIN; PSYCHOPATHOLOGY	The psychosis associated with schizophrenia is characterized by alterations in sensory processing and perception(1,2). Some antipsychotic drugs were identified by their high affinity for serotonin 5-HT2A receptors (2AR)(3,4). Drugs that interact with metabotropic glutamate receptors (mGluR) also have potential for the treatment of schizophrenia(5-7). The effects of hallucinogenic drugs, such as psilocybin and lysergic acid diethylamide, require the 2AR(8-10) and resemble some of the core symptoms of schizophrenia(10-12). Here we show that the mGluR2 interacts through specific transmembrane helix domains with the 2AR, a member of an unrelated G- protein- coupled receptor family, to form functional complexes in brain cortex. The 2AR - mGluR2 complex triggers unique cellular responses when targeted by hallucinogenic drugs, and activation of mGluR2 abolishes hallucinogen- specific signalling and behavioural responses. In post- mortem human brain from untreated schizophrenic subjects, the 2AR is upregulated and the mGluR2 is downregulated, a pattern that could predispose to psychosis. These regulatory changes indicate that the 2AR mGluR2 complex may be involved in the altered cortical processes of schizophrenia, and this complex is therefore a promising new target for the treatment of psychosis.	[Gonzalez-Maeso, Javier; Ang, Rosalind L.; Yuen, Tony; Chan, Pokman; Okawa, Yuuya; Sealfon, Stuart C.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Gonzalez-Maeso, Javier] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Filizola, Marta] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Sealfon, Stuart C.] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; [Weisstaub, Noelia V.; Zhou, Mingming; Gingrich, Jay A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Weisstaub, Noelia V.; Gingrich, Jay A.] Columbia Univ, Sackler Inst Labs, New York, NY 10032 USA; [Gingrich, Jay A.] Columbia Univ, Lieber Ctr Schizophrenia Res, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Lopez-Gimenez, Juan F.; Milligan, Graeme] Univ Glasgow, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Callado, Luis F.; Meana, J. Javier] Univ Basque Country, CIBER Mental Hlth, E-48940 Leioa, Spain; [Callado, Luis F.; Meana, J. Javier] Univ Basque Country, Dept Pharmacol, E-48940 Leioa, Spain	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; University of Glasgow; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Basque Country; University of Basque Country	Gonzalez-Maeso, J (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	javier.maeso@mssm.edu; stuart.sealfon@mssm.edu	Callado, Luis F./A-7024-2008; Lopez-Gimenez, Juan/K-5823-2014; Milligan, Graeme/F-9426-2011; Weisstaub, Noelia/ABA-1706-2021	Callado, Luis F./0000-0001-9941-012X; Lopez-Gimenez, Juan/0000-0003-3021-6200; Milligan, Graeme/0000-0002-6946-3519; CALLADO HERNANDO, LUIS FELIPE/0000-0002-5564-3447; SEALFON, Stuart/0000-0001-5791-1217; Filizola, Marta/0000-0002-4382-8276; MEANA, JOSE JAVIER/0000-0002-7913-6714	Medical Research Council [G9811527] Funding Source: Medline; NIDA NIH HHS [T32 DA007135, T32 DA007135-25S1, P01 DA012923-06A10004, P01 DA012923] Funding Source: Medline; NIGMS NIH HHS [T32 GM062754] Funding Source: Medline; NIMH NIH HHS [U01 MH083545] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012923, T32DA007135] Funding Source: NIH RePORTER; MRC [G9811527] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aghajanian GK, 2000, BRAIN RES REV, V31, P302, DOI 10.1016/S0165-0173(99)00046-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Benneyworth MA, 2007, MOL PHARMACOL, V72, P477, DOI 10.1124/mol.107.035170; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Blahos J, 1998, J BIOL CHEM, V273, P25765, DOI 10.1074/jbc.273.40.25765; Carlsson A, 2006, PHARMACOPSYCHIATRY, V39, pS10, DOI 10.1055/s-2006-931483; Chan PM, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni162; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Colpaert FC, 2003, NAT REV DRUG DISCOV, V2, P315, DOI 10.1038/nrd1062; DAVIDSON M, 1995, AM J PSYCHIAT, V152, P197; Dean B, 2003, J NEUROCHEM, V85, P1, DOI 10.1046/j.1471-4159.2003.01693.x; Ebersole BJ, 2003, MOL PHARMACOL, V63, P36, DOI 10.1124/mol.63.1.36; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2002, EUR J PHARMACOL, V452, P21, DOI 10.1016/S0014-2999(02)02242-2; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Gouzoulis-Mayfrank E, 2006, NEUROPSYCHOPHARMACOL, V31, P431, DOI 10.1038/sj.npp.1300882; Gouzoulis-Mayfrank E, 2005, PHARMACOPSYCHIATRY, V38, P301, DOI 10.1055/s-2005-916185; Gurevich EV, 1997, BIOL PSYCHIAT, V42, P529, DOI 10.1016/S0006-3223(97)00321-1; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lieberman JA, 1998, BIOL PSYCHIAT, V44, P1099, DOI 10.1016/S0006-3223(98)00187-5; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Marek GJ, 2000, J PHARMACOL EXP THER, V292, P76; Marek GJ, 2004, CURR OPIN PHARMACOL, V4, P18, DOI 10.1016/j.coph.2003.10.003; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Umbricht D, 2003, NEUROPSYCHOPHARMACOL, V28, P170, DOI 10.1038/sj.npp.1300005; Vollenweider FX, 2001, BRAIN RES BULL, V56, P495, DOI 10.1016/S0361-9230(01)00646-3; Vollenweider FX, 1997, NEUROPSYCHOPHARMACOL, V16, P357, DOI 10.1016/S0893-133X(96)00246-1; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Wright RA, 2001, J PHARMACOL EXP THER, V298, P453	44	619	652	1	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					93	U9		10.1038/nature06612	http://dx.doi.org/10.1038/nature06612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18297054	Green Accepted			2022-12-24	WOS:000253671900053
J	Marchiori, D; Warglien, M				Marchiori, Davide; Warglien, Massimo			Predicting human interactive learning by regret-driven neural networks	SCIENCE			English	Article							GAMES; EXPERIENCE; DECISIONS; UNIQUE	Much of human learning in a social context has an interactive nature: What an individual learns is affected by what other individuals are learning at the same time. Games represent a widely accepted paradigm for representing interactive decision- making. We explored the potential value of neural networks for modeling and predicting human interactive learning in repeated games. We found that even very simple learning networks, driven by regret- based feedback, accurately predict observed human behavior in different experiments on 21 games with unique equilibria in mixed strategies. Introducing regret in the feedback dramatically improved the performance of the neural network. We show that regret- based models provide better predictions of learning than established economic models.	[Warglien, Massimo] Ca Foscari Univ, Adv Sch Econ, Venice, Italy; [Warglien, Massimo] Ca Foscari Univ, Dept Business Econ & Management, Venice, Italy; [Marchiori, Davide] Univ Trent, Interdept Ctr Res Training Econ & Management CIFR, I-38100 Trento, Italy	Universita Ca Foscari Venezia; Universita Ca Foscari Venezia; University of Trento	Warglien, M (corresponding author), Ca Foscari Univ, Adv Sch Econ, Venice, Italy.	warglien@unive.it		Marchiori, Davide/0000-0001-7914-5568; warglien, massimo/0000-0002-0615-4938				Avrahami J, 2005, THEOR DECIS, V59, P255, DOI 10.1007/s11238-005-2883-y; Busemeyer JR, 2000, J MATH PSYCHOL, V44, P171, DOI 10.1006/jmps.1999.1282; Camerer C, 1999, ECONOMETRICA, V67, P827, DOI 10.1111/1468-0262.00054; Camerer C, 2003, BEHAV GAME THEORY; Camerer CF, 2003, SCIENCE, V300, P1673, DOI 10.1126/science.1086215; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Erev I, 1998, AM ECON REV, V88, P848; Erev I, 2007, ECON THEOR, V33, P29, DOI 10.1007/s00199-007-0214-y; Ert E, 2007, J BEHAV DECIS MAKING, V20, P305, DOI 10.1002/bdm.556; Hart S, 2000, ECONOMETRICA, V68, P1127, DOI 10.1111/1468-0262.00153; Hertz JA, 2018, INTRO THEORY NEURAL; Ho TH, 2007, J ECON THEORY, V133, P177, DOI 10.1016/j.jet.2005.12.008; HOPFIELD JJ, 1987, P NATL ACAD SCI USA, V84, P8429, DOI 10.1073/pnas.84.23.8429; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lee D, 2006, NATURE, V441, P822, DOI 10.1038/441822a; MALCOLM D, 1965, PSYCHON SCI, V2, P373; OCHS J, 1995, GAME ECON BEHAV, V10, P202, DOI 10.1006/game.1995.1030; ONEILL B, 1987, P NATL ACAD SCI USA, V84, P2106, DOI 10.1073/pnas.84.7.2106; RAPOPORT A, 1992, GAME ECON BEHAV, V4, P261, DOI 10.1016/0899-8256(92)90019-O; ROTH AE, 1995, GAME ECON BEHAV, V8, P164, DOI 10.1016/S0899-8256(05)80020-X; SELTEN R, 1986, J ECON BEHAV ORGAN, V7, P47, DOI 10.1016/0167-2681(86)90021-1; Selten R, 2005, EXP ECON, V8, P5, DOI 10.1007/s10683-005-1407-5; Selten R., 1998, EXP ECON, V1, P43, DOI [10.1023/A:1009957816843, DOI 10.1007/BF01426214]; Sgroi D, 2007, PHYSICA A, V375, P717, DOI 10.1016/j.physa.2006.10.026; Suppes P., 1960, MARKOV LEARNING MODE	27	63	68	3	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1111	1113		10.1126/science.1151185	http://dx.doi.org/10.1126/science.1151185			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	264SW	18292345				2022-12-24	WOS:000253311700049
J	Wendt, KS; Yoshida, K; Itoh, T; Bando, M; Koch, B; Schirghuber, E; Tsutsumi, S; Nagae, G; Ishihara, K; Mishiro, T; Yahata, K; Imamoto, F; Aburatani, H; Nakao, M; Imamoto, N; Maeshima, K; Shirahige, K; Peters, JM				Wendt, Kerstin S.; Yoshida, Keisuke; Itoh, Takehiko; Bando, Masashige; Koch, Birgit; Schirghuber, Erika; Tsutsumi, Shuichi; Nagae, Genta; Ishihara, Ko; Mishiro, Tsuyoshi; Yahata, Kazuhide; Imamoto, Fumio; Aburatani, Hiroyuki; Nakao, Mitsuyoshi; Imamoto, Naoko; Maeshima, Kazuhiro; Shirahige, Katsuhiko; Peters, Jan-Michael			Cohesin mediates transcriptional insulation by CCCTC-binding factor	NATURE			English	Article							SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; ENHANCER-BLOCKING ACTIVITY; HUMAN GENOME; NIPPED-B; CTCF-BINDING; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; ROBERTS-SYNDROME; GENE-EXPRESSION	Cohesin complexes mediate sister- chromatid cohesion in dividing cells but may also contribute to gene regulation in postmitotic cells. How cohesin regulates gene expression is not known. Here we describe cohesin- binding sites in the human genome and show that most of these are associated with the CCCTC- binding factor ( CTCF), a zinc- finger protein required for transcriptional insulation. CTCF is dispensable for cohesin loading onto DNA, but is needed to enrich cohesin at specific binding sites. Cohesin enables CTCF to insulate promoters from distant enhancers and controls transcription at the H19/IGF2 ( insulin- like growth factor 2) locus. This role of cohesin seems to be independent of its role in cohesion. We propose that cohesin functions as a transcriptional insulator, and speculate that subtle deficiencies in this function contribute to 'cohesinopathies' such as Cornelia de Lange syndrome.	[Yoshida, Keisuke; Bando, Masashige; Shirahige, Katsuhiko] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Kanagawa 2268501, Japan; [Wendt, Kerstin S.; Koch, Birgit; Schirghuber, Erika; Peters, Jan-Michael] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Itoh, Takehiko] Mitsubishi Res Inst Inc, Adv Sci & Technol Res Ctr, Chiyoda Ku, Tokyo 1008141, Japan; [Tsutsumi, Shuichi; Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; [Yahata, Kazuhide; Imamoto, Fumio] Osaka Univ, Dept Mol Biol, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Ishihara, Ko; Mishiro, Tsuyoshi; Nakao, Mitsuyoshi] Kumamoto Univ, Dept Regenerat Med, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Imamoto, Naoko; Maeshima, Kazuhiro] RIKEN, Cellular Dynam Lab, Wako, Saitama 3510198, Japan	Tokyo Institute of Technology; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Mitsubishi Research Institute; University of Tokyo; Osaka University; Kumamoto University; RIKEN	Shirahige, K (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, B2C4259, Kanagawa 2268501, Japan.	kshirahi@bio.titech.ac.jp; peters@imp.univie.ac.at	Nagae, Genta/H-6579-2019; Imamoto, Naoko/A-7458-2015; Nagae, Genta/AAN-1167-2021; Itoh, Takehiko/E-8873-2014	Nagae, Genta/0000-0002-2929-7990; Imamoto, Naoko/0000-0002-2886-3022; Itoh, Takehiko/0000-0002-6113-557X; Yoshida, Keisuke/0000-0002-5579-9716; Maeshima, Kazuhiro/0000-0003-3909-0341; Koch, Birgit/0000-0003-4683-3115; Shirahige, Katsuhiko/0000-0002-7862-1144	Austrian Science Fund FWF [F 3407] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Benard CY, 2004, DEVELOPMENT, V131, P5947, DOI 10.1242/dev.01433; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Dorsett D, 2007, CHROMOSOMA, V116, P1, DOI 10.1007/s00412-006-0072-6; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kugoh H, 1999, DNA Res, V6, P165, DOI 10.1093/dnares/6.3.165; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee MP, 1997, NAT GENET, V15, P181, DOI 10.1038/ng0297-181; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Maeshima K, 2006, J CELL SCI, V119, P4442, DOI 10.1242/jcs.03207; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Rollins RA, 1999, GENETICS, V152, P577; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Verni F, 2000, GENETICS, V154, P1693; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yahata K, 2007, J MOL BIOL, V374, P580, DOI 10.1016/j.jmb.2007.09.054; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884	55	836	860	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					796	U3		10.1038/nature06634	http://dx.doi.org/10.1038/nature06634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18235444				2022-12-24	WOS:000253191400035
J	Waddington, SN; Mcvey, JH; Bhella, D; Parker, AL; Barker, K; Atoda, H; Pink, R; Buckley, SMK; Greig, JA; Denby, L; Custers, J; Morita, T; Francischetti, IMB; Monteiro, RQ; Barouch, DH; van Rooijen, N; Napoli, C; Hlavenga, MJE; Nicklin, SA; Baker, AH				Waddington, Simon N.; McVey, John H.; Bhella, David; Parker, Alan L.; Barker, Kristeen; Atoda, Hideko; Pink, Rebecca; Buckley, Suzanne M. K.; Greig, Jenny A.; Denby, Laura; Custers, Jerome; Morita, Takashi; Francischetti, Ivo M. B.; Monteiro, Robson Q.; Barouch, Dan H.; van Rooijen, Nico; Napoli, Claudio; Hlavenga, Menzo J. E.; Nicklin, Stuart A.; Baker, Andrew H.			Adenovirus serotype 5 hexon mediates liver gene transfer	CELL			English	Article							HEPARIN-BINDING EXOSITE; IN-VIVO; ALPHA(V) INTEGRIN; VACCINE VECTORS; CELL INFECTION; CAR-BINDING; FIBER SHAFT; SUBGROUP-B; RECEPTOR; DELIVERY	Adenoviruses are used extensively as gene transfer agents, both experimentally and clinically. However, targeting of liver cells by adenoviruses compromises their potential efficacy. In cell culture, the adenovirus serotype 5 fiber protein engages the coxsackievirus and adenovirus receptor (CAR) to bind cells. Paradoxically, following intravascular delivery, CAR is not used for liver transduction, implicating alternate pathways. Recently, we demonstrated that coagulation factor (F)X directly binds adenovirus leading to liver infection. Here, we show that FX binds to the Ad5 hexon, not fiber, via an interaction between the FX Gla domain and hypervariable regions of the hexon surface. Binding occurs in multiple human adenovirus serotypes. Liver infection by the FX-Ad5 complex is mediated through a heparin-binding exosite in the FX serine protease domain. This study reveals an unanticipated function for hexon in mediating liver gene transfer in vivo.	[Parker, Alan L.; Barker, Kristeen; Greig, Jenny A.; Denby, Laura; Nicklin, Stuart A.; Baker, Andrew H.] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland; [Waddington, Simon N.] UCL Royal Free & Univ Coll Med Sch, Dept Haematol, Haemophilia Ctr, London NW3 2PF, England; [McVey, John H.] UCL Royal Free & Univ Coll Med Sch, Haemostasis Unit, London NW3 2PF, England; [Bhella, David; Pink, Rebecca] Univ Glasgow, MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Atoda, Hideko; Morita, Takashi] Meiji Pharmaceut Univ, Dept Biochem, Tokyo, Japan; [Custers, Jerome; Hlavenga, Menzo J. E.] Crucell, NL-2301 CA Leiden, Netherlands; [Francischetti, Ivo M. B.] NIAID NIH, Lab Malaria & Vector Res, Bethesda, MD 20892 USA; [Monteiro, Robson Q.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941 Rio De Janeiro, Brazil; [Barouch, Dan H.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands; [Napoli, Claudio] Univ Naples 2, Dept Gen Pathol, I-80138 Naples, Italy; [Napoli, Claudio] Temple Univ, Coll Sci & Technol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA	University of Glasgow; University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; University of Glasgow; Meiji Pharmaceutical University; Johnson & Johnson; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal do Rio de Janeiro; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Vrije Universiteit Amsterdam; Universita della Campania Vanvitelli; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Baker, AH (corresponding author), Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	ab11f@clinmed.gla.ac.uk	Waddington, Simon/G-3778-2011; Baker, Andy/AAO-5250-2021; Barouch, Dan/Y-3918-2019; Denby, Laura/AAO-9765-2020; de Queiroz Monteiro, Robson/M-7097-2019; Monteiro, Robson/GRX-0672-2022; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Van Rooijen, Nico/Z-1578-2019; Bhella, David/J-8514-2012; Parker, Alan L/B-8187-2009	Waddington, Simon/0000-0003-4970-4730; Baker, Andy/0000-0003-1441-5576; Denby, Laura/0000-0003-1277-708X; Monteiro, Robson/0000-0002-5260-2332; Bhella, David/0000-0003-2096-8310; Parker, Alan L/0000-0002-9302-1761; Napoli, Claudio/0000-0002-5455-555X; Buckley, Suzanne/0000-0003-1286-1003; Nicklin, Stuart/0000-0002-9691-6210; McVey, John/0000-0002-7416-533X	BBSRC [BB/E02145X/1, BB/E021301/1] Funding Source: UKRI; MRC [MC_U130115834, MC_U120074259] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, Z01AI000810] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E02145X/1, BB/E021301/1] Funding Source: Medline; Medical Research Council [MC_U120074259, MC_U130115834] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; ATHAPPILLY FK, 1994, J MOL BIOL, V242, P430, DOI 10.1006/jmbi.1994.1593; Atoda H, 1998, BIOCHEMISTRY-US, V37, P17361, DOI 10.1021/bi981177x; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; CROWTHER RA, 1970, NATURE, V226, P421, DOI 10.1038/226421a0; Fuller SD, 1996, J STRUCT BIOL, V116, P48, DOI 10.1006/jsbi.1996.0009; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Hiltunen MO, 2000, FASEB J, V14, P2230, DOI 10.1096/fj.00-0145com; HUARD J, 1995, GENE THER, V2, P107; Kawabata K, 2006, MOL PHARMACEUT, V3, P95, DOI 10.1021/mp0500925; Koizumi N, 2006, HUM GENE THER, V17, P264, DOI 10.1089/hum.2006.17.264; Kritz AB, 2007, MOL THER, V15, P741, DOI 10.1038/sj.mt.6300094; Lecollinet S, 2006, J VIROL, V80, P2747, DOI 10.1128/JVI.80.6.2747-2759.2006; Li JL, 2006, J VIROL, V80, P12324, DOI 10.1128/JVI.01331-06; Madisch I, 2005, J VIROL, V79, P15265, DOI 10.1128/JVI.79.24.15265-15276.2005; Martin K, 2003, MOL THER, V8, P485, DOI 10.1016/S1525-0016(03)00182-5; Monteiro RQ, 2005, BIOCHEM J, V387, P871, DOI 10.1042/BJ20041738; Murakami MT, 2007, J MOL BIOL, V366, P602, DOI 10.1016/j.jmb.2006.11.040; Nicklin SA, 2005, MOL THER, V12, P384, DOI 10.1016/j.ymthe.2005.05.008; Nicol CG, 2004, MOL THER, V10, P344, DOI 10.1016/j.ymthe.2004.05.020; Oldstone MBA, 1999, CELL, V98, P629, DOI 10.1016/S0092-8674(00)80050-1; Parker AL, 2007, J VIROL, V81, P3627, DOI 10.1128/JVI.02786-06; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pichla-Gollon SL, 2007, J VIROL, V81, P1680, DOI 10.1128/JVI.02023-06; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; ROBERTS MM, 1986, SCIENCE, V232, P1148, DOI 10.1126/science.3704642; Rux JJ, 2000, MOL THER, V1, P18, DOI 10.1006/mthe.1999.0001; RUX JJ, 1999, METH MOLEC MED, V21, P259; Sakurai F, 2006, GENE THER, V13, P1118, DOI 10.1038/sj.gt.3302749; San Martin C, 2003, CURR TOP MICROBIOL, V272, P57; Schenk-Braat EAM, 2007, J GENE MED, V9, P910, DOI 10.1002/jgm.1096; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Shayakhmetov DM, 2000, J VIROL, V74, P2567, DOI 10.1128/JVI.74.6.2567-2583.2000; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Shayakhmetov DM, 2002, CANCER RES, V62, P1063; Smith TAG, 2003, HUM GENE THER, V14, P1595, DOI 10.1089/104303403322542248; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Tuve S, 2006, J VIROL, V80, P12109, DOI 10.1128/JVI.01370-06; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Venkateswarlu D, 2002, BIOPHYS J, V82, P1190, DOI 10.1016/S0006-3495(02)75476-3; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; von Seggern DJ, 1999, J VIROL, V73, P1601, DOI 10.1128/JVI.73.2.1601-1608.1999; Waddington SN, 2007, J VIROL, V81, P9568, DOI 10.1128/JVI.00663-07; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E	55	480	495	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					397	409		10.1016/j.cell.2008.01.016	http://dx.doi.org/10.1016/j.cell.2008.01.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267072	Bronze			2022-12-24	WOS:000253180700015
J	Beg, AA; Ernstrom, GG; Nix, P; Davis, MW; Jorgensen, EM				Beg, Asim A.; Ernstrom, Glen G.; Nix, Paola; Davis, M. Wayne; Jorgensen, Erik M.			Protons act as a transmitter for muscle contraction in C-elegans	CELL			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CALCINEURIN HOMOLOGOUS PROTEIN; NA+/H+ EXCHANGER NHE1; GATED ION-CHANNEL; CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; SYNAPTIC-TRANSMISSION; FAMILY; BINDING; PH	Muscle contraction is normally mediated by the release of neurotransmitters from motor neurons. Here we demonstrate that protons can act as a direct transmitter from intestinal cells to stimulate muscle contraction. During the C. elegans defecation motor program the posterior body muscles contract even in the absence of neuronal inputs or vesicular neurotransmission. In this study, we demonstrate that the space between the intestine and the muscle is acidified just prior to muscle contraction and that the release of caged protons is sufficient to induce muscle contraction. PBO-4 is a putative Na+/H+ ion exchanger expressed on the basolateral membrane of the intestine, juxtaposed to the posterior body muscles. In pbo-4 mutants the extracellular space is not acidified and the muscles fail to contract. The pbo-5 and pbo-6 genes encode subunits of a "cysloop'' proton-gated cation channel required for muscles to respond to acidification. In heterologous expression assays the PBO receptor is half-maximally activated at a pH of 6.8. The identification of the mechanisms for release and reception of proton signals establishes a highly unusual mechanism for intercellular communication.	[Beg, Asim A.; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Neurosci Program, Salt Lake City, UT 84112 USA; [Beg, Asim A.; Ernstrom, Glen G.; Nix, Paola; Davis, M. Wayne; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Howard Hughes Med Inst, Neurosci Program, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu		Davis, Mikel/0000-0003-1867-1593	Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R37 NS034307-13, R37 NS034307] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034307] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Brachmann CB, 1998, YEAST, V14, P115; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BRENNER S, 1974, GENETICS, V77, P71; CLARK SG, 1994, GENETICS, V137, P987; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; COWAN WM, 2001, HOWARD HUGHES MED I; CROLL N A, 1975, P71, DOI 10.1016/S0065-308X(08)60319-X; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; DELCASTILLO J, 1962, J CELL COMPAR PHYSL, V59, P35, DOI 10.1002/jcp.1030590105; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; Hyman SE, 2005, CURR BIOL, V15, pR154, DOI 10.1016/j.cub.2005.02.037; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; Kaila K., 1998, PH BRAIN FUNCTION; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; MARUYAMA IN, 1995, NUCLEIC ACIDS RES, V23, P3796, DOI 10.1093/nar/23.18.3796; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nehrke K, 2002, J BIOL CHEM, V277, P29036, DOI 10.1074/jbc.M203200200; Norman KR, 2005, CELL, V123, P119, DOI 10.1016/j.cell.2005.08.001; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; PALMA A, 1991, J MEMBRANE BIOL, V120, P67, DOI 10.1007/BF01868592; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; PATON WDM, 1958, ANNU REV PHYSIOL, V20, P431, DOI 10.1146/annurev.ph.20.030158.002243; Peters MA, 2007, CURR BIOL, V17, P1601, DOI 10.1016/j.cub.2007.08.031; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SMART TG, 1982, PROC R SOC SER B-BIO, V215, P327, DOI 10.1098/rspb.1982.0045; TAKEUCHI A, 1967, J PHYSIOL-LONDON, V191, P575, DOI 10.1113/jphysiol.1967.sp008269; THOMAS JH, 1990, GENETICS, V124, P855; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Villmann C, 1997, J NEUROSCI, V17, P7634, DOI 10.1523/jneurosci.17-20-07634.1997; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	49	95	108	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					149	160		10.1016/j.cell.2007.10.058	http://dx.doi.org/10.1016/j.cell.2007.10.058			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191228	Green Accepted, Bronze			2022-12-24	WOS:000253427600023
J	Olsen, SR; Wilson, RI				Olsen, Shawn R.; Wilson, Rachel I.			Lateral presynaptic inhibition mediates gain control in an olfactory circuit	NATURE			English	Article							DROSOPHILA ANTENNAL LOBE; CENTER-SURROUND INHIBITION; BULB GLOMERULI; ODOR QUALITY; MITRAL CELLS; NEURONS; REPRESENTATIONS; MECHANISMS; RECEPTORS; INPUT	Olfactory signals are transduced by a large family of odorant receptor proteins, each of which corresponds to a unique glomerulus in the first olfactory relay of the brain. Crosstalk between glomeruli has been proposed to be important in olfactory processing, but it is not clear how these interactions shape the odour responses of second- order neurons. In the Drosophila antennal lobe ( a region analogous to the vertebrate olfactory bulb), we selectively removed most interglomerular input to genetically identified second- order olfactory neurons. Here we show that this broadens the odour tuning of these neurons, implying that interglomerular inhibition dominates over interglomerular excitation. The strength of this inhibitory signal scales with total feedforward input to the entire antennal lobe, and has similar tuning in different glomeruli. A substantial portion of this interglomerular inhibition acts at a presynaptic locus, and our results imply that this is mediated by both ionotropic and metabotropic receptors on the same nerve terminal.	[Olsen, Shawn R.; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012	Olsen, Shawn/0000-0002-9568-7057; Wilson, Rachel/0000-0001-8573-9266	NIDCD NIH HHS [R01 DC008174, R01 DC008174-03] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; CHAPUT M, 1980, J PHYSIOL-PARIS, V76, P551; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Distler PG, 1997, J COMP NEUROL, V383, P529, DOI 10.1002/(SICI)1096-9861(19970714)383:4&lt;529::AID-CNE9&gt;3.0.CO;2-4; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Fischer Y, 1996, J NEUROPHYSIOL, V76, P3807, DOI 10.1152/jn.1996.76.6.3807; Fischer Y, 1996, J NEUROPHYSIOL, V75, P1377, DOI 10.1152/jn.1996.75.4.1377; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Laissue PP, 1999, J COMP NEUROL, V405, P543; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MATHEWS DF, 1972, BRAIN RES, V47, P389, DOI 10.1016/0006-8993(72)90647-6; MATTHEWS G, 1994, J NEUROSCI, V14, P1079, DOI 10.1523/JNEUROSCI.14-03-01079.1994; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; MEREDITH M, 1978, J GEN PHYSIOL, V71, P615, DOI 10.1085/jgp.71.6.615; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; NICKELL WT, 1994, BRAIN RES BULL, V35, P119, DOI 10.1016/0361-9230(94)90091-4; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; SHIBUYA T, 1962, P JPN ACAD, V38, P231, DOI 10.2183/pjab1945.38.231; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; STUART GJ, 1992, J PHYSIOL-LONDON, V447, P675, DOI 10.1113/jphysiol.1992.sp019023; TANABE T, 1975, J NEUROPHYSIOL, V38, P1284, DOI 10.1152/jn.1975.38.5.1284; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Vucinic D, 2006, J NEUROPHYSIOL, V95, P1881, DOI 10.1152/jn.00918.2005; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	42	324	328	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					956	U3		10.1038/nature06864	http://dx.doi.org/10.1038/nature06864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18344978	Green Accepted			2022-12-24	WOS:000255208600031
J	Dreber, A; Rand, DG; Fudenberg, D; Nowak, MA				Dreber, Anna; Rand, David G.; Fudenberg, Drew; Nowak, Martin A.			Winners don't punish	NATURE			English	Article							ALTRUISTIC PUNISHMENT; REPEATED GAMES; COOPERATION; EVOLUTION; RECIPROCITY	A key aspect of human behaviour is cooperation(1-7). We tend to help others even if costs are involved. We are more likely to help when the costs are small and the benefits for the other person significant. Cooperation leads to a tension between what is best for the individual and what is best for the group. A group does better if everyone cooperates, but each individual is tempted to defect. Recently there has been much interest in exploring the effect of costly punishment on human cooperation(8-23). Costly punishment means paying a cost for another individual to incur a cost. It has been suggested that costly punishment promotes cooperation even in non- repeated games and without any possibility of reputation effects(10). But most of our interactions are repeated and reputation is always at stake. Thus, if costly punishment is important in promoting cooperation, it must do so in a repeated setting. We have performed experiments in which, in each round of a repeated game, people choose between cooperation, defection and costly punishment. In control experiments, people could only cooperate or defect. Here we show that the option of costly punishment increases the amount of cooperation but not the average payoff of the group. Furthermore, there is a strong negative correlation between total payoff and use of costly punishment. Those people who gain the highest total payoff tend not to use costly punishment: winners don't punish. This suggests that costly punishment behaviour is maladaptive in cooperation games and might have evolved for other reasons.	[Dreber, Anna; Rand, David G.; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Rand, David G.] Harvard Univ, Dept Syst Biol, Cambridge, MA 02138 USA; [Fudenberg, Drew] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolut Biol, Cambridge, MA 02138 USA; [Dreber, Anna] Stockholm Sch Econ, Dept Econ, S-11358 Stockholm, Sweden	Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Stockholm School of Economics	Nowak, MA (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Rand, David G./B-3716-2009; Nowak, Martin A/A-6977-2008; Dreber, Anna/D-8709-2010	Rand, David G./0000-0002-2821-468X; Rand, David/0000-0001-8975-2783	NIGMS NIH HHS [R01 GM078986-02, R01 GM078986] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BINMORE KG, 1992, J ECON THEORY, V57, P278, DOI 10.1016/0022-0531(92)90037-I; Bochet O, 2006, J ECON BEHAV ORGAN, V60, P11, DOI 10.1016/j.jebo.2003.06.006; BOTELHO A, 2005, 0523 U CENTR FLOR CO; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Carpenter J., 2006, 0602 MIDDL COLL; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Colman AM., 1995, GAME THEORY ITS APPL; Dal Bo P, 2005, AM ECON REV, V95, P1591; Denant-Boemont L, 2007, ECON THEOR, V33, P145, DOI 10.1007/s00199-007-0212-0; EGAS M, 2005, 1646 IZA I STUD LAB; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; FUDENBERG D, 1990, AM ECON REV, V80, P274; FUDENBERG D, 1993, ADV EC THEOR 6 WORLD, P89; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; HARDIN G, 1968, SCIENCE, V162, P1248; NIKIFORAKIS N, 2005, 0507 ROYAL HOLL U LO; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Page T, 2005, ECON J, V115, P1032, DOI 10.1111/j.1468-0297.2005.01031.x; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Samuelson L, 2005, J ECON LIT, V43, P65, DOI 10.1257/0022051053737816; SEFTON M, 2006, 2006005 CAEPR IND U; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	30	457	465	2	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					348	351		10.1038/nature06723	http://dx.doi.org/10.1038/nature06723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276BX	18354481	Green Submitted, Green Accepted			2022-12-24	WOS:000254117400046
J	Bashor, CJ; Helman, NC; Yan, SD; Lim, WA				Bashor, Caleb J.; Helman, Noah C.; Yan, Shude; Lim, Wendell A.			Using engineered scaffold interactions to reshape MAP kinase pathway signaling dynamics	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; ERK ACTIVATION; STE5 SCAFFOLD; SPECIFICITY; YEAST; CASCADE; TRANSIENT; PROTEINS; SYSTEM; DROSOPHILA	Scaffold proteins link signaling molecules into linear pathways by physically assembling them into complexes. Scaffolds may also have a higher- order role as signal- processing hubs, serving as the target of feedback loops that optimize signaling amplitude and timing. We demonstrate that the Ste5 scaffold protein can be used as a platform to systematically reshape output of the yeast mating MAP kinase pathway. We constructed synthetic positive- and negative- feedback loops by dynamically regulating recruitment of pathway modulators to an artificial binding site on Ste5. These engineered circuits yielded diverse behaviors: ultrasensitive dose response, accelerated or delayed response times, and tunable adaptation. Protein scaffolds provide a flexible platform for reprogramming cellular responses and could be exploited to engineer cells with novel therapeutic and biotechnological functions.	[Bashor, Caleb J.; Helman, Noah C.; Yan, Shude; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Bashor, Caleb J.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu						Acharya A, 2002, BIOCHEMISTRY-US, V41, P14122, DOI 10.1021/bi020486r; ALBERTS B, 2003, ESSENTIAL CELL BIOL; Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Choi BK, 2004, NEUROTOXICOLOGY, V25, P915, DOI 10.1016/j.neuro.2004.06.002; CHOI KY, 1994, CELL, V78, P499; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; FERRELL JE, 2000, SCI STKE, pPE1; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; PRINTEN JA, 1994, GENETICS, V138, P609; Ptashne M, 2001, GENES SIGNALS; Ramezani-Rad M, 2003, CURR GENET, V43, P161, DOI 10.1007/s00294-003-0383-6; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Villedieu M, 2006, GYNECOL ONCOL, V101, P507, DOI 10.1016/j.ygyno.2005.11.017; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690	36	260	271	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1539	1543		10.1126/science.1151153	http://dx.doi.org/10.1126/science.1151153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339942				2022-12-24	WOS:000253943800043
J	Bingel-Erlenmeyer, R; Kohler, R; Kramer, G; Sandikci, A; Antolic, S; Maier, T; Schaffitzel, C; Wiedmann, B; Bukau, B; Ban, N				Bingel-Erlenmeyer, Rouven; Kohler, Rebecca; Kramer, Guenter; Sandikci, Arzu; Antolic, Snjezana; Maier, Timm; Schaffitzel, Christiane; Wiedmann, Brigitte; Bukau, Bernd; Ban, Nenad			A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing	NATURE			English	Article							ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; TRIGGER FACTOR; IN-VITRO; INITIATION; TRANSLATION; EXCISION; RESIDUE; DOMAIN; AGENTS	Messenger- RNA- directed protein synthesis is accomplished by the ribosome(1-3). In eubacteria, this complex process is initiated by a specialized transfer RNA charged with formylmethionine ( tRNA(fMet))(4-6). The amino- terminal formylated methionine of all bacterial nascent polypeptides blocks the reactive amino group to prevent unfavourable side- reactions and to enhance the efficiency of translation initiation(7,8). The first enzymatic factor that processes nascent chains is peptide deformylase ( PDF)(5,9-11); it removes this formyl group as polypeptides emerge from the ribosomal tunnel(12,13) and before the newly synthesized proteins can adopt their native fold, which may bury the N terminus. Next, the N-terminal methionine is excised by methionine aminopeptidase(14). Bacterial PDFs are metalloproteases sharing a conserved N- terminal catalytic domain. All Gram- negative bacteria, including Escherichia coli, possess class- 1 PDFs characterized by a carboxy- terminal alpha- helical extension(15). Studies focusing on PDF as a target for antibacterial drugs(14,16) have not revealed the mechanism of its co- translational mode of action despite indications in early work that it co- purifies with ribosomes(17). Here we provide biochemical evidence that E. coli PDF interacts directly with the ribosome via its C- terminal extension. Crystallographic analysis of the complex between the ribosome- interacting helix of PDF and the ribosome at 3.7 angstrom resolution reveals that the enzyme orients its active site towards the ribosomal tunnel exit for efficient co- translational processing of emerging nascent chains. Furthermore, we have found that the interaction of PDF with the ribosome enhances cell viability. These results provide the structural basis for understanding the coupling between protein synthesis and enzymatic processing of nascent chains, and offer insights into the interplay of PDF with the ribosome- associated chaperone trigger factor.	[Bingel-Erlenmeyer, Rouven; Kohler, Rebecca; Antolic, Snjezana; Maier, Timm; Schaffitzel, Christiane; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Kramer, Guenter; Sandikci, Arzu; Bukau, Bernd] Univ Heidelberg, Zentrum Mol Biol ZMBH, D-69120 Heidelberg, Germany; [Wiedmann, Brigitte] Novartis Inst Biomed Res Inc, Cambridge, MA 02139 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg; Novartis	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch	Maier, Timm/A-8835-2016; Bingel-Erlenmeyer, Rouven/AAH-3962-2019	Maier, Timm/0000-0002-7459-1363; Bukau, Bernd/0000-0003-0521-7199; Kramer, Gunter/0000-0001-7552-8393; Berger-Schaffitzel, Christiane Helene/0000-0002-1516-9760				ADAMS JM, 1966, P NATL ACAD SCI USA, V55, P147, DOI 10.1073/pnas.55.1.147; ADAMS JM, 1968, J MOL BIOL, V33, P571, DOI 10.1016/0022-2836(68)90307-0; Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Addlagatta A, 2005, BIOCHEMISTRY-US, V44, P7166, DOI 10.1021/bi0501176; Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; BALL LA, 1973, J MOL BIOL, V79, P531, DOI 10.1016/0022-2836(73)90404-X; Becker A, 1998, NAT STRUCT BIOL, V5, P1053, DOI 10.1038/4162; Cull MG, 2000, METHOD ENZYMOL, V326, P430; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; EISENSTADT J, 1966, SCIENCE, V154, P524; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; FRY KT, 1967, J MOL BIOL, V28, P423, DOI 10.1016/S0022-2836(67)80091-3; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Giglione C, 2000, MOL MICROBIOL, V36, P1197, DOI 10.1046/j.1365-2958.2000.01908.x; Guilloteau JP, 2002, J MOL BIOL, V320, P951, DOI 10.1016/S0022-2836(02)00549-1; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hardesty B, 2001, PROG NUCLEIC ACID RE, V66, P41; HARLOW E, 1988, ANTIBODIES LABORATOR, P313; HARVEY RJ, 1973, J BACTERIOL, V114, P309, DOI 10.1128/JB.114.1.309-322.1973; HOUSMAN D, 1972, J MOL BIOL, V65, P163, DOI 10.1016/0022-2836(72)90498-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Liljas A, 2006, ACS CHEM BIOL, V1, P567, DOI 10.1021/cb600407u; MARCKER K, 1964, J MOL BIOL, V8, P835, DOI 10.1016/S0022-2836(64)80164-9; Meinnel T, 1996, FEBS LETT, V385, P91, DOI 10.1016/0014-5793(96)00357-2; Moore PB, 2005, TRENDS BIOCHEM SCI, V30, P281, DOI 10.1016/j.tibs.2005.04.006; PINE MJ, 1969, BIOCHIM BIOPHYS ACTA, V174, P359, DOI 10.1016/0005-2787(69)90261-5; Ragusa S, 1998, J MOL BIOL, V280, P515, DOI 10.1006/jmbi.1998.1883; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; TAKEDA M, 1968, P NATL ACAD SCI USA, V60, P1487, DOI 10.1073/pnas.60.4.1487; Vetro JA, 2002, J CELL BIOCHEM, V85, P678, DOI 10.1002/jcb.10161; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z	37	78	81	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2008	452	7183					108	U13		10.1038/nature06683	http://dx.doi.org/10.1038/nature06683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18288106				2022-12-24	WOS:000253671900056
J	Edwards, SL; Brough, R; Lord, CJ; Natrajan, R; Vatcheva, R; Levine, DA; Boyd, J; Reis, JS; Ashworth, A				Edwards, Stacey L.; Brough, Rachel; Lord, Christopher J.; Natrajan, Rachael; Vatcheva, Radost; Levine, Douglas A.; Boyd, Jeff; Reis-Filho, Jorge S.; Ashworth, Alan			Resistance to therapy caused by intragenic deletion in BRCA2	NATURE			English	Article							HOMOLOGY-DIRECTED REPAIR; ADP-RIBOSE POLYMERASE; GENOMIC STABILITY; IMPROVED SURVIVAL; MUTANT-CELLS; CANCER; MUTATIONS; PROTEIN; BREAKS; DEFECT	Cells with loss of BRCA2 function are defective in homologous recombination ( HR) and are highly sensitive to inhibitors of poly( ADP- ribose) polymerase ( PARP)(1,2), which provides the basis for a new therapeutic approach. Here we show that resistance to PARP inhibition can be acquired by deletion of a mutation in BRCA2. We derived PARP- inhibitor- resistant ( PIR) clones from the human CAPAN1 pancreatic cancer cell line, which carries the protein- truncating c.6174delT frameshift mutation. PIR clones could form DNA- damage- induced RAD51 nuclear foci and were able to limit genotoxin- induced genomic instability, both hallmarks of a competent HR pathway. New BRCA2 isoforms were expressed in the resistant lines as a result of intragenic deletion of the c.6174delT mutation and restoration of the open reading frame ( ORF). Reconstitution of BRCA2- deficient cells with these revertant BRCA2 alleles rescued PARP inhibitor sensitivity and HR deficiency. Most of the deletions in BRCA2 were associated with small tracts of homology, and possibly arose from error-prone repair caused by BRCA2 deficiency(3,4). Similar ORF-restoring mutations were present in carboplatin- resistant ovarian tumours from c.6174delT mutation carriers. These observations have implications for understanding drug resistance in BRCA mutation carriers as well as in defining functionally important domains within BRCA2.	[Edwards, Stacey L.; Brough, Rachel; Lord, Christopher J.; Natrajan, Rachael; Vatcheva, Radost; Reis-Filho, Jorge S.; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Boyd, Jeff] Mem Hlth Univ Med Ctr, Anderson Canc Inst, Savannah, GA 31404 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Memorial Sloan Kettering Cancer Center	Ashworth, A (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, Fulham Rd, London SW3 6JB, England.	alan.ashworth@icr.ac.uk	Edwards, Stacey/A-4980-2011; Lord, Christopher/AAX-7130-2021; Lord, Christopher J/B-3295-2012	Lord, Christopher J/0000-0002-3226-0515; Natrajan, Rachael/0000-0002-9987-2946; Boyd, Jeff/0000-0002-3517-7637; Edwards, Stacey/0000-0001-7428-4139; Levine, Douglas/0000-0003-1038-8232	Cancer Research UK [A8363] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Breast Cancer Now		Abaji C, 2005, CANCER RES, V65, P4117, DOI 10.1158/0008-5472.CAN-04-3071; Bertwistle D, 1997, CANCER RES, V57, P5485; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Domchek SM, 2006, ONCOGENE, V25, P5825, DOI 10.1038/sj.onc.1209881; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Goggins M, 1996, CANCER RES, V56, P5360; Gudmundsdottir K, 2004, EMBO REP, V5, P989, DOI 10.1038/sj.embor.7400255; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Lambros MBK, 2006, LAB INVEST, V86, P398, DOI 10.1038/labinvest.3700390; McCabe N, 2005, CANCER BIOL THER, V4, P934, DOI 10.4161/cbt.4.9.2141; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Pal T, 2007, FAM CANCER, V6, P113, DOI 10.1007/s10689-006-9112-x; POCH G, 1995, J PHARMACOL TOXICOL, V33, P137, DOI 10.1016/1056-8719(94)00068-F; Ratnam K, 2007, CLIN CANCER RES, V13, P1383, DOI 10.1158/1078-0432.CCR-06-2260; Reis JS, 2005, J PATHOL, V207, P1, DOI 10.1002/path.1806; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; Spain BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/pnas.96.24.13920; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Weinstock DM, 2006, BLOOD, V107, P777, DOI 10.1182/blood-2005-06-2437; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	30	744	767	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					1111	U8		10.1038/nature06548	http://dx.doi.org/10.1038/nature06548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18264088				2022-12-24	WOS:000253453600043
J	Li, JZ; Absher, DM; Tang, H; Southwick, AM; Casto, AM; Ramachandran, S; Cann, HM; Barsh, GS; Feldman, M; Cavalli-Sforza, LL; Myers, RM				Li, Jun Z.; Absher, Devin M.; Tang, Hua; Southwick, Audrey M.; Casto, Amanda M.; Ramachandran, Sohini; Cann, Howard M.; Barsh, Gregory S.; Feldman, Marcus; Cavalli-Sforza, Luigi L.; Myers, Richard M.			Worldwide human relationships inferred from genome-wide patterns of variation	SCIENCE			English	Article							ALLELE FREQUENCY-SPECTRUM; HUMAN-POPULATIONS; EVOLUTIONARY TREES; GENETIC DIVERSITY; DISTANCE; AFRICA	Human genetic diversity is shaped by both demographic and biological factors and has fundamental implications for understanding the genetic basis of diseases. We studied 938 unrelated individuals from 51 populations of the Human Genome Diversity Panel at 650,000 common single- nucleotide polymorphism loci. Individual ancestry and population substructure were detectable with very high resolution. The relationship between haplotype heterozygosity and geography was consistent with the hypothesis of a serial founder effect with a single origin in sub- Saharan Africa. In addition, we observed a pattern of ancestral allele frequency distributions that reflects variation in population dynamics among geographic regions. This data set allows the most comprehensive characterization to date of human genetic variation.	[Ramachandran, Sohini; Feldman, Marcus] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Li, Jun Z.; Absher, Devin M.; Tang, Hua; Southwick, Audrey M.; Casto, Amanda M.; Barsh, Gregory S.; Cavalli-Sforza, Luigi L.; Myers, Richard M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Li, Jun Z.; Absher, Devin M.; Southwick, Audrey M.; Myers, Richard M.] Stanford Univ, Sch Med, Stanford Human Genome Ctr, Stanford, CA 94305 USA; [Barsh, Gregory S.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Cann, Howard M.] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France	Stanford University; Stanford University; Stanford University; Stanford University; Foundation Jean Dausset-CEPH	Feldman, M (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	marc@charles.stanford.edu; cavalli@stanford.edu; myers@shgc.stanford.edu		Casto, Amanda/0000-0001-8332-8578; Li, Jun/0000-0001-6727-0812	NIGMS NIH HHS [GM28016, GM073059] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028016, R01GM073059] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Cavalli-Sforza LL, 2007, ANNU REV GENOM HUM G, V8, P1, DOI 10.1146/annurev.genom.8.080706.092403; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Edwards AWF, 2003, BIOESSAYS, V25, P798, DOI 10.1002/bies.10315; EXCOFFIER L, 1992, GENETICS, V131, P479; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; KIMURA M, 1973, GENETICS, V75, P199; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ramachandran Sohini, 2004, Human Genomics, V1, P87; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS., 1996, GENETIC DATA ANAL; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120	29	1353	1393	2	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1100	1104		10.1126/science.1153717	http://dx.doi.org/10.1126/science.1153717			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292342				2022-12-24	WOS:000253311700046
J	Arany, Z; Foo, SY; Ma, YH; Ruas, JL; Bommi-Reddy, A; Girnun, G; Cooper, M; Laznik, D; Chinsomboon, J; Rangwala, SM; Baek, KH; Rosenzweig, A; Spiegelman, BM				Arany, Zoltan; Foo, Shi-Yin; Ma, Yanhong; Ruas, Jorge L.; Bommi-Reddy, Archana; Girnun, Geoffrey; Cooper, Marcus; Laznik, Dina; Chinsomboon, Jessica; Rangwala, Shamina M.; Baek, Kwan Hyuck; Rosenzweig, Anthony; Spiegelman, Bruce M.			HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1 alpha	NATURE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; CONTROLLING MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; GENE-EXPRESSION; ERR-ALPHA; PGC-1; METABOLISM; FIBERS; DRIVES; CELLS	Ischaemia of the heart, brain and limbs is a leading cause of morbidity and mortality worldwide. Hypoxia stimulates the secretion of vascular endothelial growth factor ( VEGF) and other angiogenic factors, leading to neovascularization and protection against ischaemic injury(1). Here we show that the transcriptional coactivator PGC-1 alpha ( peroxisome- proliferator- activated receptor-gamma coactivator-1 alpha), a potent metabolic sensor and regulator(2), is induced by a lack of nutrients and oxygen, and PGC-1 alpha powerfully regulates VEGF expression and angiogenesis in cultured muscle cells and skeletal muscle in vivo. PGC-1 alpha(-/-) mice show a striking failure to reconstitute blood flow in a normal manner to the limb after an ischaemic insult, whereas transgenic expression of PGC-1 alpha in skeletal muscle is protective. Surprisingly, the induction of VEGF by PGC-1 alpha does not involve the canonical hypoxia response pathway and hypoxia inducible factor ( HIF). Instead, PGC-1 alpha coactivates the orphan nuclear receptor ERR-alpha ( oestrogen- related receptor- alpha) on conserved binding sites found in the promoter and in a cluster within the first intron of the VEGF gene. Thus, PGC-1 alpha and ERR-alpha, major regulators of mitochondrial function in response to exercise and other stimuli, also control a novel angiogenic pathway that delivers needed oxygen and substrates. PGC-1 alpha may provide a novel therapeutic target for treating ischaemic diseases.	[Arany, Zoltan; Ma, Yanhong; Ruas, Jorge L.; Bommi-Reddy, Archana; Girnun, Geoffrey; Cooper, Marcus; Laznik, Dina; Chinsomboon, Jessica; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Arany, Zoltan; Ma, Yanhong; Ruas, Jorge L.; Bommi-Reddy, Archana; Girnun, Geoffrey; Cooper, Marcus; Laznik, Dina; Chinsomboon, Jessica; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Arany, Zoltan; Foo, Shi-Yin; Rosenzweig, Anthony] Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02215 USA; [Arany, Zoltan; Foo, Shi-Yin; Rosenzweig, Anthony] Harvard Stem Cell Inst, Boston, MA 02215 USA; [Rangwala, Shamina M.] Novartis Inst Biomed Res Diabet & Metab, Cambridge, MA 02139 USA; [Baek, Kwan Hyuck] Harvard Univ, Sch Med, Vasc Biol Program, Dept Surg,Childrens Hosp, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Novartis; Harvard University; Boston Children's Hospital; Harvard Medical School	Arany, Z (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	zarany1@partners.org; bruce_spiegelman@dfci.harvard.edu	Ruas, Jorge/AAE-6094-2019; Rosenzweig, Anthony/AAD-7893-2019; MA, YAN/HHN-2912-2022	Ruas, Jorge/0000-0002-1110-2606; 	NIDDK NIH HHS [P30 DK040561, P30 DK040561-12, R01 DK054477] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, R01DK054477] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Pajusola K, 2005, FASEB J, V19, P1365, DOI 10.1096/fj.05-3720fje; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	23	786	833	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2008	451	7181					1008	U8		10.1038/nature06613	http://dx.doi.org/10.1038/nature06613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288196	Bronze			2022-12-24	WOS:000253313100052
J	Corbin, BD; Seeley, EH; Raab, A; Feldmann, J; Miller, MR; Torres, VJ; Anderson, KL; Dattilo, BM; Dunman, PM; Gerads, R; Caprioli, RM; Nacken, W; Chazin, WJ; Skaar, EP				Corbin, Brian D.; Seeley, Erin H.; Raab, Andrea; Feldmann, Joerg; Miller, Michael R.; Torres, Victor J.; Anderson, Kelsi L.; Dattilo, Brian M.; Dunman, Paul M.; Gerads, Russell; Caprioli, Richard M.; Nacken, Wolfgang; Chazin, Walter J.; Skaar, Eric P.			Metal chelation and inhibition of bacterial growth in tissue abscesses	SCIENCE			English	Article							STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL ACTIVITY; PROTEINS 8; CALPROTECTIN; EXPRESSION	Bacterial infection often results in the formation of tissue abscesses, which represent the primary site of interaction between invading bacteria and the innate immune system. We identify the host protein calprotectin as a neutrophil- dependent factor expressed inside Staphylococcus aureus abscesses. Neutrophil- derived calprotectin inhibited S. aureus growth through chelation of nutrient Mn2+ and Zn2+: an activity that results in reprogramming of the bacterial transcriptome. The abscesses of mice lacking calprotectin were enriched in metal, and staphylococcal proliferation was enhanced in these metal- rich abscesses. These results demonstrate that calprotectin is a critical factor in the innate immune response to infection and define metal chelation as a strategy for inhibiting microbial growth inside abscessed tissue.	[Corbin, Brian D.; Torres, Victor J.; Skaar, Eric P.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Seeley, Erin H.; Miller, Michael R.; Dattilo, Brian M.; Caprioli, Richard M.; Chazin, Walter J.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Seeley, Erin H.; Miller, Michael R.; Dattilo, Brian M.; Caprioli, Richard M.; Chazin, Walter J.] Vanderbilt Univ, Med Ctr, Dept Chem, Nashville, TN 37232 USA; [Miller, Michael R.; Dattilo, Brian M.; Chazin, Walter J.] Vanderbilt Univ, Med Ctr, Ctr Struct Biol, Nashville, TN 37232 USA; [Anderson, Kelsi L.; Dunman, Paul M.] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Nacken, Wolfgang] Univ Munster, Inst Expt Dermatol, D-48149 Munster, Germany; [Raab, Andrea; Feldmann, Joerg] Univ Aberdeen, Coll Phys Sci, Aberdeen AB24 3UE, Scotland; [Gerads, Russell] Appl Speciat & Consulting, Tukwila, WA 98188 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Nebraska System; University of Nebraska Medical Center; University of Munster; University of Aberdeen	Skaar, EP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA.	eric.skaar@vanderbilt.edu	Johnson, Michael D. L./B-4352-2012; Feldmann, Jorg/B-8079-2011; Feldmann, Jörg/AAT-3703-2020	Seeley, Erin/0000-0002-8000-5754; Torres, Victor/0000-0002-7126-0489; Feldmann, Joerg/0000-0002-0524-8254; Miller, Michael/0000-0002-7726-0519	NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI071487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062112, R01GM058008, T32GM008320] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [GR/S98696/01, GR/S98689/01] Funding Source: researchfish; NCI NIH HHS [P50 CA068485] Funding Source: Medline; NHLBI NIH HHS [T32 HL069765] Funding Source: Medline; NIAID NIH HHS [F32 AI071487] Funding Source: Medline; NIGMS NIH HHS [5R01 GM58008-09, T32 GM008320, R01 GM62112, T32 GM08320] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Benedyk M, 2007, J INVEST DERMATOL, V127, P2001, DOI 10.1038/sj.jid.5700820; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Loomans HJ, 1998, J INFECT DIS, V177, P812, DOI 10.1086/517816; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lusitani D, 2003, INFECT IMMUN, V71, P4711, DOI 10.1128/IAI.71.8.4711-4716.2003; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; Yui S, 2003, BIOL PHARM BULL, V26, P753	11	627	654	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					962	965		10.1126/science.1152449	http://dx.doi.org/10.1126/science.1152449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276893				2022-12-24	WOS:000253165700049
J	Caplan, JL; Mamillapalli, P; Burch-Smith, TM; Czymmek, K; Dinesh-Kumar, SP				Caplan, Jeffrey L.; Mamillapalli, Padmavathi; Burch-Smith, Tessa M.; Czymmek, Kirk; Dinesh-Kumar, S. P.			Chloroplastic protein NRIP1 mediates innate immune receptor recognition of a viral effector	CELL			English	Article							DISEASE-RESISTANCE; HYPERSENSITIVE RESPONSE; VIRULENCE EFFECTOR; PLANT-RESISTANCE; SALICYLIC-ACID; ARABIDOPSIS; GENE; STROMULES; COMPLEX; LOCALIZATION	Plant innate immunity relies on the recognition of pathogen effector molecules by nucleotide-binding-leucine-rich repeat (NB-LRR) immune receptor families. Previously we have shown the N immune receptor, a member of TIR-NB-LRR family, indirectly recognizes the 50 kDa helicase (p50) domain of Tobacco mosaic virus (TMV) through its TIR domain. We have identified an N receptor-interacting protein, NRIP1, that directly interacts with both N's TIR domain and p50. NRIP1 is a functional rhodanese sulfur-transferase and is required for N to provide complete resistance to TMV. Interestingly, NRIP1 that normally localizes to the chloroplasts is recruited to the cytoplasm and nucleus by the p50 effector. As a consequence, NRIP1 interacts with N only in the presence of the p50 effector. Our findings show that a chloroplastic protein is intimately involved in pathogen recognition. We propose that N's activation requires a prerecognition complex containing the p50 effector and NRIP1.	[Caplan, Jeffrey L.; Mamillapalli, Padmavathi; Burch-Smith, Tessa M.; Dinesh-Kumar, S. P.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Czymmek, Kirk] Univ Delaware, Dept Biol Sci, Delaware Biotechnol Inst, Newark, DE 19711 USA	Yale University; University of Delaware	Dinesh-Kumar, SP (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	savithramma.dinesh-kumar@yale.edu	Dinesh-Kumar, Savithramma/E-1153-2011; Rechsteiner, Cindy/I-4137-2013	Caplan, Jeffrey/0000-0002-3991-0912; Burch-Smith, Tessa/0000-0002-5994-4343; Czymmek, Kirk/0000-0002-5471-7395	NIGMS NIH HHS [R01 GM062625, GM62625, R01 GM062625-06A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062625] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbink TEM, 2002, VIROLOGY, V295, P307, DOI 10.1006/viro.2002.1332; Abbink TEM, 2001, MOL PLANT MICROBE IN, V14, P1086, DOI 10.1094/MPMI.2001.14.9.1086; Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bauer M, 2004, PLANT PHYSIOL, V135, P916, DOI 10.1104/pp.104.040121; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Holt BF, 2002, DEV CELL, V2, P807, DOI 10.1016/S1534-5807(02)00174-0; Holzinger A, 2007, PROTOPLASMA, V230, P23, DOI 10.1007/s00709-006-0222-y; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Ishibashi K, 2007, P NATL ACAD SCI USA, V104, P13833, DOI 10.1073/pnas.0703203104; Jelenska J, 2007, CURR BIOL, V17, P499, DOI 10.1016/j.cub.2007.02.028; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kwok EY, 2004, PLANT CELL REP, V23, P188, DOI 10.1007/s00299-004-0824-9; Lehto K, 2003, MOL PLANT MICROBE IN, V16, P1135, DOI 10.1094/MPMI.2003.16.12.1135; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; MILLERMARTINI DM, 1994, J BIOL CHEM, V269, P12414; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Natesan SKA, 2005, J EXP BOT, V56, P787, DOI 10.1093/jxb/eri088; Papenbrock J, 2000, EUR J BIOCHEM, V267, P145, DOI 10.1046/j.1432-1327.2000.00980.x; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Schenk PM, 2005, PLANT PHYSIOL BIOCH, V43, P997, DOI 10.1016/j.plaphy.2005.09.002; Seo S, 2000, PLANT CELL, V12, P917, DOI 10.1105/tpc.12.6.917; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Shapiro AD, 2005, VITAM HORM, V72, P339, DOI 10.1016/S0083-6729(05)72010-0; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Soosaar JLM, 2005, NAT REV MICROBIOL, V3, P789, DOI 10.1038/nrmicro1239; Ueda H, 2006, PLANT MOL BIOL, V61, P31, DOI 10.1007/s11103-005-5817-8; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yang SH, 2003, PLANT CELL PHYSIOL, V44, P1037, DOI 10.1093/pcp/pcg122; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	43	269	285	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					449	462		10.1016/j.cell.2007.12.031	http://dx.doi.org/10.1016/j.cell.2007.12.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267075	Bronze, Green Accepted			2022-12-24	WOS:000253180700019
J	Peer, D; Park, EJ; Morishita, Y; Carman, CV; Shimaoka, M				Peer, Dan; Park, Eun Jeong; Morishita, Yoshiyuki; Carman, Christopher V.; Shimaoka, Motomu			Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target	SCIENCE			English	Article							SMALL INTERFERING RNAS; GENE	Cyclin D1 ( CyD1) is a pivotal cell cycle - regulatory molecule and a well- studied therapeutic target for cancer. Although CyD1 is also strongly up- regulated at sites of inflammation, its exact roles in this context remain uncharacterized. To address this question, we developed a strategy for selectively silencing CyD1 in leukocytes in vivo. Targeted stabilized nanoparticles ( tsNPs) were loaded with CyD1 - small interfering RNA ( siRNA). Antibodies to beta(7) integrin ( beta(7) I) were then used to target specific leukocyte subsets involved in gut inflammation. Systemic application of beta(7) I-tsNPs silenced CyD1 in leukocytes and reversed experimentally induced colitis in mice by suppressing leukocyte proliferation and T helper cell 1 cytokine expression. This study reveals CyD1 to be a potential anti- inflammatory target, and suggests that the application of similar modes of targeting by siRNA may be feasible in other therapeutic settings.	[Peer, Dan; Park, Eun Jeong; Morishita, Yoshiyuki; Shimaoka, Motomu] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Peer, Dan; Park, Eun Jeong; Morishita, Yoshiyuki; Shimaoka, Motomu] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Carman, Christopher V.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Carman, Christopher V.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Shimaoka, M (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 200 Longwood Ave, Boston, MA 02115 USA.	shimaoka@cbrinstitute.org	Park, Eun Jeong/AAV-2056-2020; Carman, Christopher V./AAX-8995-2020; Peer, Dan/A-1785-2011; Carman, Christopher/L-8108-2016	Park, Eun Jeong/0000-0002-4288-5893; Carman, Christopher V./0000-0001-7358-2548; Peer, Dan/0000-0001-8238-0673; Carman, Christopher/0000-0001-7358-2548	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063421] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL048675, P01 HL048675-150013, HL048675] Funding Source: Medline; NIAID NIH HHS [R01 AI063421, R01 AI063421-04, AI63421] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDREW DP, 1994, J IMMUNOL, V153, P3847; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Dass CR, 2004, J MOL MED, V82, P579, DOI 10.1007/s00109-004-0558-8; Dykxhoorn DM, 2006, ANNU REV BIOMED ENG, V8, P377, DOI 10.1146/annurev.bioeng.8.061505.095848; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Heidel JD, 2007, P NATL ACAD SCI USA, V104, P5715, DOI 10.1073/pnas.0701458104; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Li SD, 2006, MOL PHARMACEUT, V3, P579, DOI 10.1021/mp060039w; Lindsay JO, 2004, DIGEST DIS SCI, V49, P1327, DOI 10.1023/B:DDAS.0000037830.22065.71; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Peer D, 2003, BBA-BIOMEMBRANES, V1612, P76, DOI 10.1016/S0005-2736(03)00106-8; Peer D, 2007, P NATL ACAD SCI USA, V104, P4095, DOI 10.1073/pnas.0608491104; Schiffelers RM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh140; Shaw S K, 1995, Semin Immunol, V7, P335, DOI 10.1016/1044-5323(95)90014-4; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Sorgi FL, 1997, GENE THER, V4, P961, DOI 10.1038/sj.gt.3300484; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; van Dekken H, 2007, ACTA HISTOCHEM, V109, P266, DOI 10.1016/j.acthis.2007.02.007; Yang RY, 2006, CELL CYCLE, V5, P180, DOI 10.4161/cc.5.2.2306	21	415	466	7	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					627	630		10.1126/science.1149859	http://dx.doi.org/10.1126/science.1149859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239128	Green Accepted			2022-12-24	WOS:000252772000043
J	Reddy, P; Liu, L; Adhikari, D; Jagarlamudi, K; Rajareddy, S; Shen, Y; Du, C; Tang, WL; Hamalainen, T; Peng, SL; Lan, ZJ; Cooney, AJ; Huhtaniemi, I; Liu, K				Reddy, Pradeep; Liu, Lian; Adhikari, Deepak; Jagarlamudi, Krishna; Rajareddy, Singareddy; Shen, Yan; Du, Chun; Tang, Wenli; Hamalainen, Tuula; Peng, Stanford L.; Lan, Zi-Jian; Cooney, Austin J.; Huhtaniemi, Ilpo; Liu, Kui			Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool	SCIENCE			English	Article							PATHWAY; GROWTH	In the mammalian ovary, progressive activation of primordial follicles from the dormant pool serves as the source of fertilizable ova. Menopause, or the end of female reproductive life, occurs when the primordial follicle pool is exhausted. However, the molecular mechanisms underlying follicle activation are poorly understood. We provide genetic evidence that in mice lacking PTEN ( phosphatase and tensin homolog deleted on chromosome 10) in oocytes, a major negative regulator of phosphatidylinositol 3- kinase ( PI3K), the entire primordial follicle pool becomes activated. Subsequently, all primordial follicles become depleted in early adulthood, causing premature ovarian failure ( POF). Our results show that the mammalian oocyte serves as the headquarters of programming of follicle activation and that the oocyte PTEN- PI3K pathway governs follicle activation through control of initiation of oocyte growth.	[Reddy, Pradeep; Liu, Lian; Adhikari, Deepak; Jagarlamudi, Krishna; Rajareddy, Singareddy; Shen, Yan; Du, Chun; Tang, Wenli; Liu, Kui] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Liu, Lian] Shandong Univ, Qilu Hosp, Ctr Canc, Dept Chemotherapy, Jinan 250012, Peoples R China; [Hamalainen, Tuula; Huhtaniemi, Ilpo] Univ Turku, Inst Biomed, Dept Physiol, FIN-20520 Turku, Finland; [Peng, Stanford L.] Roche Palo Alto, Clin Res & Exploratory Dev, Palo Alto, CA 94304 USA; [Lan, Zi-Jian] Univ Louisville, Hlth Sci Ctr, Dept Mol Cellular & Craniofacial Biol, Birth Defects Ctr, Louisville, KY 40202 USA; [Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Huhtaniemi, Ilpo] Univ London Imperial Coll Sci Technol & Med, Dept Reprod Biol, London W12 0NN, England	Umea University; Shandong University; University of Turku; Roche Holding; University of Louisville; Baylor College of Medicine; Imperial College London	Liu, K (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	kui.liu@medchem.umu.se	Lan, Zi-Jian/F-2747-2012; Adhikari, Deepak/H-6176-2013; Reddy, Pradeep/G-1770-2014; Peng, Stanford/S-6723-2019; SINGAREDDY, RAJAREDDY/C-8771-2011	Adhikari, Deepak/0000-0003-0656-9858; Reddy, Pradeep/0000-0002-9173-3845; Lan, Zi-Jian/0000-0002-5904-6834; Liu, Lian/0000-0001-5868-4482; Liu, Kui/0000-0002-7519-3332; Peng, Stanford/0000-0001-7445-2542; Adhikari, Deepak/0000-0002-3404-8753				Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Erickson GF, 2001, J SOC GYNECOL INVEST, V8, pS13, DOI 10.1016/S1071-5576(00)00098-8; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Reddy P, 2005, DEV BIOL, V281, P160, DOI 10.1016/j.ydbio.2005.02.013; Wassarman Paul M., 1994, P79	10	533	583	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					611	613		10.1126/science.1152257	http://dx.doi.org/10.1126/science.1152257			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239123				2022-12-24	WOS:000252772000038
J	Miller, EJ; Li, J; Leng, L; McDonald, C; Atsumi, T; Bucala, R; Young, LH				Miller, Edward J.; Li, Ji; Leng, Lin; McDonald, Courtney; Atsumi, Toshiya; Bucala, Richard; Young, Lawrence H.			Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart	NATURE			English	Article							FACTOR MIF GENE; GLUCOSE-UPTAKE; CARDIAC DYSFUNCTION; DISEASE SEVERITY; REGULATORY ROLE; CYTOKINE; INJURY; TRANSLOCATION; POLYMORPHISM; BINDING	Understanding cellular response to environmental stress has broad implications for human disease. AMP- activated protein kinase ( AMPK) orchestrates the regulation of energy- generating and - consuming pathways, and protects the heart against ischaemic injury and apoptosis(1). A role for circulating hormones such as adiponectin(2) and leptin(3) in the activation of AMPK has received recent attention. Whether local autocrine and paracrine factors within target organs such as the heart modulate AMPK is unknown. Here we show that macrophage migration inhibitory factor ( MIF), an upstream regulator of inflammation(4), is released in the ischaemic heart, where it stimulates AMPK activation through CD74, promotes glucose uptake and protects the heart during ischaemia- reperfusion injury. Germline deletion of the Mif gene impairs ischaemic AMPK signalling in the mouse heart. Human fibroblasts with a low- activity MIF promoter polymorphism(5) have diminished MIF release and AMPK activation during hypoxia. Thus, MIF modulates the activation of the cardioprotective AMPK pathway during ischaemia, functionally linking inflammation and metabolism in the heart. We anticipate that genetic variation in MIF expression may impact on the response of the human heart to ischaemia by the AMPK pathway, and that diagnostic MIF genotyping might predict risk in patients with coronary artery disease.	[Miller, Edward J.; Li, Ji; Young, Lawrence H.] Yale Univ, Sch Med, Dept Internal Med, Cardiovasc Med Sect, New Haven, CT 06520 USA; [Leng, Lin; McDonald, Courtney; Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA; [Bucala, Richard] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Young, Lawrence H.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Atsumi, Toshiya] Hokkaido Univ, Dept Med 2, Sapporo, Hokkaido 0608638, Japan	Yale University; Yale University; Yale University; Yale University; Hokkaido University	Young, LH (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Cardiovasc Med Sect, 333 Cedar St, New Haven, CT 06520 USA.	lawrence.young@yale.edu		Leng, Lin/0000-0002-0605-358X; Miller, Edward/0000-0002-2156-5962				Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Benigni F, 2000, J CLIN INVEST, V106, P1291, DOI 10.1172/JCI9900; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Coven DL, 2003, AM J PHYSIOL-ENDOC M, V285, pE629, DOI 10.1152/ajpendo.00171.2003; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li J, 2004, AM J PHYSIOL-ENDOC M, V287, pE834, DOI 10.1152/ajpendo.00234.2004; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Plant BJ, 2005, AM J RESP CRIT CARE, V172, P1412, DOI 10.1164/rccm.200412-1714OC; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Sukhodub A, 2007, J CELL PHYSIOL, V210, P224, DOI 10.1002/jcp.20862; Takahashi M, 2001, CARDIOVASC RES, V52, P438, DOI 10.1016/S0008-6363(01)00408-4; Willis MS, 2005, AM J PHYSIOL-HEART C, V288, pH795, DOI 10.1152/ajpheart.00189.2004; Xing YQ, 2003, J BIOL CHEM, V278, P28372, DOI 10.1074/jbc.M303521200; Zhong XB, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni123	32	342	354	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2008	451	7178					578	U9		10.1038/nature06504	http://dx.doi.org/10.1038/nature06504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235500				2022-12-24	WOS:000252739900043
J	Warner, DA; Shine, R				Warner, D. A.; Shine, R.			The adaptive significance of temperature-dependent sex determination in a reptile	NATURE			English	Article							GECKO EUBLEPHARIS-MACULARIUS; LIZARD; ESTRADIOL; EVOLUTION; ECOLOGY; GROWTH	Understanding the mechanisms that determine an individual's sex remains a primary challenge for evolutionary biology. Chromosome- based systems ( genotypic sex determination) that generate roughly equal numbers of sons and daughters accord with theory(1), but the adaptive significance of environmental sex determination ( that is, when embryonic environmental conditions determine offspring sex, ESD) is a major unsolved problem(2,3). Theoretical models predict that selection should favour ESD over genotypic sex determination when the developmental environment differentially influences male versus female fitness ( that is, the Charnov - Bull model)(4), but empirical evidence for this hypothesis remains elusive in amniote vertebrates - the clade in which ESD is most prevalent(5). Here we provide the first substantial empirical support for this model by showing that incubation temperatures influence reproductive success of males differently than that of females in a short- lived lizard ( Amphibolurus muricatus, Agamidae) with temperature- dependent sex determination. We incubated eggs at a variety of temperatures, and de- confounded sex and incubation temperature by using hormonal manipulations to embryos. We then raised lizards in field enclosures and quantified their lifetime reproductive success. Incubation temperature affected reproductive success differently in males versus females in exactly the way predicted by theory: the fitness of each sex was maximized by the incubation temperature that produces that sex. Our results	[Warner, D. A.; Shine, R.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Warner, DA (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	dwarner@iastate.edu	Shine, Richard/B-8711-2008	Warner, Daniel/0000-0001-7231-7785				Austin JJ, 2006, MOL ECOL NOTES, V6, P194, DOI 10.1111/j.1471-8286.2005.01190.x; BULL JJ, 1989, EVOLUTION, V43, P1561, DOI 10.1111/j.1558-5646.1989.tb02605.x; CHARNOV EL, 1989, J THEOR BIOL, V139, P431, DOI 10.1016/S0022-5193(89)80063-3; CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; Conover David O., 2004, P11; Fisher R.A., 1930, GENETICAL THEORY NAT; Freedberg S, 2006, BIOL LETTERS, V2, P378, DOI 10.1098/rsbl.2006.0454; GUTZKE WHN, 1988, NATURE, V332, P832, DOI 10.1038/332832a0; Harlow PS, 2000, AUSTRAL ECOL, V25, P640, DOI 10.1046/j.1442-9993.2000.01064.x; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; JANZEN FJ, 1995, EVOLUTION, V49, P864, DOI 10.1111/j.1558-5646.1995.tb02322.x; JANZEN FJ, 1991, EVOLUTION, V45, P435, DOI 10.1111/j.1558-5646.1991.tb04417.x; JANZEN FJ, 1991, Q REV BIOL, V66, P149, DOI 10.1086/417143; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Schwartz TS, 2007, MOL ECOL NOTES, V7, P528, DOI 10.1111/j.1471-8286.2006.01644.x; Shine R, 1999, TRENDS ECOL EVOL, V14, P186, DOI 10.1016/S0169-5347(98)01575-4; SHINE R, 1995, NATURE, V378, P451, DOI 10.1038/378451a0; Shine R, 2007, ECOLOGY, V88, P1781, DOI 10.1890/06-2024.1; TOUSIGNANT A, 1994, J EXP ZOOL, V268, P17, DOI 10.1002/jez.1402680104; TOUSIGNANT A, 1995, J MORPHOL, V224, P159, DOI 10.1002/jmor.1052240205; Warner DA, 2005, EVOLUTION, V59, P2209; WARNER DA, IN PRESS ANIM BEHAV; Warner DA, 2007, OECOLOGIA, V154, P65, DOI 10.1007/s00442-007-0809-9; WENNSTROM KL, 1995, GEN COMP ENDOCR, V99, P316, DOI 10.1006/gcen.1995.1115; WIBBELS T, 1994, J ENDOCRINOL, V141, P295, DOI 10.1677/joe.0.1410295	25	242	250	2	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2008	451	7178					566	U5		10.1038/nature06519	http://dx.doi.org/10.1038/nature06519			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18204437				2022-12-24	WOS:000252739900040
J	Huang, GN; Huso, DL; Bouyain, S; Tu, JC; McCorkell, KA; May, MJ; Zhu, YW; Lutz, M; Collins, S; Dehoff, M; Kang, S; Whartenby, K; Powell, J; Leahy, D; Worley, PF				Huang, Guo N.; Huso, David L.; Bouyain, Samuel; Tu, Jianchen; McCorkell, Kelly A.; May, Michael J.; Zhu, Yuwen; Lutz, Michael; Collins, Samuel; Dehoff, Marlin; Kang, Shin; Whartenby, Katharine; Powell, Jonathan; Leahy, Daniel; Worley, Paul F.			NFAT binding and regulation of T cell activation by the cytoplasmic scaffolding Homer proteins	SCIENCE			English	Article							CD28 COSTIMULATORY SIGNAL; CALCIUM; KINASE; AKT	T cell receptor ( TCR) and costimulatory receptor ( CD28) signals cooperate in activating T cells, although understanding of how these pathways are themselves regulated is incomplete. We found that Homer2 and Homer3, members of the Homer family of cytoplasmic scaffolding proteins, are negative regulators of T cell activation. This is achieved through binding of nuclear factor of activated T cells ( NFAT) and by competing with calcineurin. Homer-NFAT binding was also antagonized by active serine- threonine kinase AKT, thereby enhancing TCR signaling via calcineurin- dependent dephosphorylation of NFAT. This corresponded with changes in cytokine expression and an increase in effector- memory T cell populations in Homer- deficient mice, which also developed autoimmune- like pathology. These results demonstrate a further means by which costimulatory signals are regulated to control self- reactivity.	[Huang, Guo N.; Tu, Jianchen; Dehoff, Marlin; Kang, Shin; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Huang, Guo N.] Johns Hopkins Univ, Sch Med, Program Biochem Cellular & Mol Biol, Baltimore, MD 21205 USA; [Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Bouyain, Samuel; Leahy, Daniel] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [McCorkell, Kelly A.; May, Michael J.] Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; [Zhu, Yuwen] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Lutz, Michael; Collins, Samuel; Whartenby, Katharine; Powell, Jonathan] Johns Hopkins Univ, Sch Med, Dept Oncol Immunol Hematopoiesis, Baltimore, MD 21205 USA; [Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	pworley@jhmi.edu	zhu, yuwen/C-9010-2011	Huang, Guo/0000-0002-4335-9123; May, Michael/0000-0002-2485-3716	NATIONAL CANCER INSTITUTE [R01CA098109, P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010309, R37DA010309, P50DA000266] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098109, P30 CA006973] Funding Source: Medline; NIDA NIH HHS [P50 DA000266, DA10309, R01 DA010309, DA00266, R37 DA010309] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Duncan RS, 2005, EXP BIOL MED, V230, P527, DOI 10.1177/153537020523000803; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Huang CT, 2003, J IMMUNOL, V170, P3945, DOI 10.4049/jimmunol.170.8.3945; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042	16	66	72	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2008	319	5862					476	481		10.1126/science.1151227	http://dx.doi.org/10.1126/science.1151227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218901	Green Accepted			2022-12-24	WOS:000252576600042
J	Bartali, B; Frongillo, EA; Guralnik, JM; Stipanuk, MH; Allore, HG; Cherubini, A; Bandinelli, S; Ferrucci, L; Gill, TM				Bartali, Benedetta; Frongillo, Edward A.; Guralnik, Jack M.; Stipanuk, Martha H.; Allore, Heather G.; Cherubini, Antonio; Bandinelli, Stefania; Ferrucci, Luigi; Gill, Thomas M.			Serum micronutrient concentrations and decline in physical function among older persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINI-MENTAL-STATE; OXIDATIVE STRESS; VITAMIN-E; DISABILITY; HEALTH; PERFORMANCE; INCHIANTI; DAMAGE; AGE; ANTIOXIDANTS	Context Maintaining independence of older persons is a public health priority, and identifying the factors that contribute to decline in physical function is needed to prevent or postpone the disablement process. The potential deleterious effect of poor nutrition on decline in physical function in older persons is unclear. Objective To determine whether a low serum concentration of micronutrients is associated with subsequent decline in physical function among older men and women living in the community. Design, Setting, and Participants Longitudinal study of 698 community- living persons 65 years or older who were randomly selected from a population registry in Tuscany, Italy. Participants completed the baseline examination from November 1, 1998, through May 28, 2000, and the 3- year follow- up assessments from November 1, 2001, through March 30, 2003. Main Outcome Measure Decline in physical function was defined as a loss of at least 1 point in the Short Physical Performance Battery during the 3- year follow- up. Odds ratios ( ORs) were calculated for the lowest quartile of each nutrient using the other 3 quartiles combined as the reference group. Two additional and complementary analytical approaches were used to confirm the validity of the results. Results The mean decline in the Short Physical Performance Battery score was 1.1 point. In a logistic regression analysis that was adjusted for potential confounders, only a low concentration of vitamin E ( < 1.1 mu g/ mL [ < 24.9 mu mol/L]) was significantly associated with subsequent decline in physical function ( OR, 1.62; 95% confidence interval, 1.11- 2.36; P=. 01 for association of lowest alpha-tocopherol quartile with at least a 1- point decline in physical function). In a general linear model, the concentration of vitamin E at baseline, when analyzed as a continuous measure, was significantly associated with the Short Physical Performance Battery score at follow- up after adjustment for potential confounders and Short Physical Performance Battery score at baseline ( beta=.023; P=. 01). In a classification and regression tree analysis, age older than 81 years and vitamin E ( in participants aged 70- 80 years) were identified as the strongest determinants of decline in physical function ( physical decline in 84% and 60%, respectively; misclassification error rate, 0.33). Conclusions These results provide empirical evidence that a low serum concentration of vitamin E is associated with subsequent decline in physical function among community-living older adults. Clinical trials may be warranted to determine whether an optimal concentration of vitamin E reduces functional decline and the onset of disability in older persons.	[Bartali, Benedetta; Allore, Heather G.; Gill, Thomas M.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06504 USA; [Bartali, Benedetta; Frongillo, Edward A.; Stipanuk, Martha H.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Frongillo, Edward A.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Guralnik, Jack M.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, Bethesda, MD 20892 USA; [Cherubini, Antonio] Univ Perugia, Sch Med, Monteluce Policlin, Inst Gerontol & Geriatr, I-06100 Perugia, Italy; [Bandinelli, Stefania] Azienda Sanit Firenze, Florence, Italy	Yale University; Cornell University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Perugia; Azienda Sanitaria di Firenze	Bartali, B (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 20 York St,TMP 17B, New Haven, CT 06504 USA.	benedetta.bartali@yale.edu	Cherubini, Antonio/AAL-4632-2020; bandinelli, stefania/AAL-4570-2020; Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368; Cherubini, Antonio/0000-0003-0261-9897; Allore, Heather/0000-0001-7685-8175	NATIONAL INSTITUTE ON AGING [P30AG021342, ZIAAG001050, Z01AG000971, Z01AG000631, K24AG021507] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AG999999] Funding Source: Medline; NIA NIH HHS [K24 AG021507, K24AG021507, P30 AG021342, P30AG21342] Funding Source: Medline; NIMHD NIH HHS [R01 MD009164] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Allore H, 2005, J CLIN EPIDEMIOL, V58, P154, DOI 10.1016/j.jclinepi.2004.09.001; APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1207; Bartali B, 2006, ARCH INTERN MED, V166, P2335, DOI 10.1001/archinte.166.21.2335; Bartali B, 2006, J GERONTOL A-BIOL, V61, P589, DOI 10.1093/gerona/61.6.589; Ble A, 2006, J GERONTOL A-BIOL, V61, P278, DOI 10.1093/gerona/61.3.278; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cesari M, 2005, ARCH INTERN MED, V165, P2148, DOI 10.1001/archinte.165.18.2148; Cesari M, 2004, AM J CLIN NUTR, V79, P289; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Deeg DJH, 2002, J CLIN EPIDEMIOL, V55, P319, DOI 10.1016/S0895-4356(01)00475-9; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; Ebrahim S, 1999, LANCET, V353, P1990, DOI 10.1016/S0140-6736(99)00195-6; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Evans WJ, 2000, AM J CLIN NUTR, V72, p647S, DOI 10.1093/ajcn/72.2.647S; Fano G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Finaud J, 2006, SPORTS MED, V36, P327, DOI 10.2165/00007256-200636040-00004; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Food and Nutrition Board, 2006, DIET REF INT ESS GUI; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Guralnik JM, 2002, AM J PUBLIC HEALTH, V92, P1244, DOI 10.2105/AJPH.92.8.1244; Guralnik JM, 1995, NIH PUBLICATION, V95-4009; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; LIU IY, 1989, AM J EPIDEMIOL, V130, P416, DOI 10.1093/oxfordjournals.aje.a115350; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; MathSoft, 1999, S PLUS 2000 GUID STA, V1; Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1; Ostir GV, 2002, J CLIN EPIDEMIOL, V55, P916, DOI 10.1016/S0895-4356(02)00436-5; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; PETTE D, 1986, FED PROC, V45, P2910; Pisani P, 1997, INT J EPIDEMIOL, V26, pS152, DOI 10.1093/ije/26.suppl_1.S152; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; *SAS I INC, 2000, SAS PROC GUID COMP P; Snowdon DA, 1996, J GERONTOL A-BIOL, V51, pM10, DOI 10.1093/gerona/51A.1.M10; Traber MG, 1996, ANNU REV NUTR, V16, P321, DOI 10.1146/annurev.nu.16.070196.001541; Traber MG, 2000, LANCET, V355, P2013, DOI 10.1016/S0140-6736(00)02345-X; *US BUR CENS, 2000, ANN PROJ RES POP AG	39	81	85	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2008	299	3					308	315		10.1001/jama.299.3.308	http://dx.doi.org/10.1001/jama.299.3.308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253DB	18212315	Green Accepted, Bronze			2022-12-24	WOS:000252497800022
J	Viswanathan, SR; Daley, GQ; Gregory, RI				Viswanathan, Srinivas R.; Daley, George Q.; Gregory, Richard I.			Selective blockade of MicroRNA processing by Lin28	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; POSTTRANSCRIPTIONAL REGULATION; LET-7 MICRORNA; BIOGENESIS; PROFILE; COMPLEX; RNA	MicroRNAs ( miRNAs) play critical roles in development, and dysregulation of miRNA expression has been observed in human malignancies. Recent evidence suggests that the processing of several primary miRNA transcripts (pri- miRNAs) is blocked posttranscriptionally in embryonic stem cells, embryonal carcinoma cells, and primary tumors. Here we show that Lin28, a developmentally regulated RNA binding protein, selectively blocks the processing of pri- let- 7 miRNAs in embryonic cells. Using in vitro and in vivo studies, we found that Lin28 is necessary and sufficient for blocking Microprocessor- mediated cleavage of pri- let- 7 miRNAs. Our results identify Lin28 as a negative regulator of miRNA biogenesis and suggest that Lin28 may play a central role in blocking miRNA-mediated differentiation in stem cells and in certain cancers.	[Viswanathan, Srinivas R.; Daley, George Q.; Gregory, Richard I.] Harvard Univ, Childrens Hosp Boston, Dept Biol Chem & Mol Pharmacol, Stem Cell Program,Sch Med,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Pediat Hematol Oncol, Childrens Hosp Boston, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Howard Hughes Med Inst, Div Hematol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Harvard Univ, Childrens Hosp Boston, Dept Biol Chem & Mol Pharmacol, Stem Cell Program,Sch Med,Harvard Stem Cell Inst, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; rgregory@enders.tch.harvard.edu	Viswanathan, Srinivas/ABA-6316-2021	Viswanathan, Srinivas/0000-0003-1856-3023	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070055] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [DK70055] Funding Source: Medline; NIH HHS [DP1 OD000256] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	22	1126	1189	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2008	320	5872					97	100		10.1126/science.1154040	http://dx.doi.org/10.1126/science.1154040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283JR	18292307	Green Accepted			2022-12-24	WOS:000254633000039
J	Guardavaccaro, D; Frescas, D; Dorrello, NV; Peschiaroli, A; Multani, AS; Cardozo, T; Lasorella, A; Iavarone, A; Chang, S; Hernando, E; Pagano, M				Guardavaccaro, Daniele; Frescas, David; Dorrello, N. Valerio; Peschiaroli, Angelo; Multani, Asha S.; Cardozo, Timothy; Lasorella, Anna; Iavarone, Antonio; Chang, Sandy; Hernando, Eva; Pagano, Michele			Control of chromosome stability by the beta-TrCP-REST-Mad2 axis	NATURE			English	Article							RESTRICTIVE SILENCER FACTOR; CELL LUNG-CANCER; TRCP-MEDIATED DEGRADATION; BOX PROTEIN BETA-TRCP1; BETA-TRCP; GLYCINE RECEPTOR; REST; TRANSCRIPTION; REPRESSOR; DIFFERENTIATION	REST/NRSF ( repressor-element-1-silencing transcription factor/ neuron- restrictive silencing factor) negatively regulates the transcription of genes containing RE1 sites(1,2). REST is expressed in non- neuronal cells and stem/ progenitor neuronal cells, in which it inhibits the expression of neuron- specific genes. Overexpression of REST is frequently found in human medulloblastomas and neuroblastomas(3-7), in which it is thought to maintain the stem character of tumour cells. Neural stem cells forced to express REST and c- Myc fail to differentiate and give rise to tumours in the mouse cerebellum(3). Expression of a splice variant of REST that lacks the carboxy terminus has been associated with neuronal tumours and small- cell lung carcinomas(8-10), and a frameshift mutant ( REST- FS), which is also truncated at the C terminus, has oncogenic properties(11). Here we show, by using an unbiased screen, that REST is an interactor of the F- box protein beta-TrCP. REST is degraded by means of the ubiquitin ligase SCF beta-TrCP during the G2 phase of the cell cycle to allow transcriptional derepression of Mad2, an essential component of the spindle assembly checkpoint. The expression in cultured cells of a stable REST mutant, which is unable to bind beta-TrCP, inhibited Mad2 expression and resulted in a phenotype analogous to that observed in Mad2(+/-) cells. In particular, we observed defects that were consistent with faulty activation of the spindle checkpoint, such as shortened mitosis, premature sister- chromatid separation, chromosome bridges and mis- segregation in anaphase, tetraploidy, and faster mitotic slippage in the presence of a spindle inhibitor. An indistinguishable phenotype was observed by expressing the oncogenic REST- FS mutant(11), which does not bind beta-TrCP. Thus, SCF beta-TrCP-dependent degradation of REST during G2 permits the optimal activation of the spindle checkpoint, and consequently it is required for the fidelity of mitosis. The high levels of REST or its truncated variants found in certain human tumours may contribute to cellular transformation by promoting genomic instability.	[Guardavaccaro, Daniele; Frescas, David; Dorrello, N. Valerio; Peschiaroli, Angelo; Hernando, Eva; Pagano, Michele] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Cardozo, Timothy] NYU, Sch Med, Dept Pharmacol, NYU Canc Inst, New York, NY 10016 USA; [Multani, Asha S.; Chang, Sandy] Univ Texas Houston, MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA; [Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA	New York University; New York University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Columbia University	Pagano, M (corresponding author), NYU, Sch Med, Dept Pathol, 550 1st Ave, MSB 599, New York, NY 10016 USA.	michele.pagano@nyumc.org		Guardavaccaro, Daniele/0000-0002-4517-1765; Hernando, Eva/0000-0003-1023-0312; PESCHIAROLI, ANGELO/0000-0001-6311-2382; pagano, michele/0000-0003-3210-2442; Iavarone, Antonio/0000-0002-0683-4634	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM057587, R01 GM057587-10] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Coulson JM, 2000, CANCER RES, V60, P1840; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fuller GN, 2005, MOL CANCER THER, V4, P343; Guardavaccaro D, 2006, MOL CELL, V22, P1, DOI 10.1016/j.molcel.2006.03.017; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Gurrola-Diaz C, 2003, ONCOGENE, V22, P5636, DOI 10.1038/sj.onc.1206790; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Higashino K, 2003, CANCER SCI, V94, P37, DOI 10.1111/j.1349-7006.2003.tb01349.x; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kudo Y, 2004, MOL CELL BIOL, V24, P8184, DOI 10.1128/MCB.24.18.8184-8194.2004; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Majumder S, 2006, CELL CYCLE, V5, P1929, DOI 10.4161/cc.5.17.2982; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Neumann SB, 2004, MOL BRAIN RES, V120, P173, DOI 10.1016/j.molbrainres.2003.10.021; Nishimura E, 1996, NEUROSCI LETT, V211, P101, DOI 10.1016/0304-3940(96)12722-1; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Su XH, 2006, MOL CELL BIOL, V26, P1666, DOI 10.1128/MCB.26.5.1666-1678.2006; Totrov M, 2001, BIOPOLYMERS, V60, P124, DOI 10.1002/1097-0282(2001)60:2<124::AID-BIP1008>3.0.CO;2-S; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X	32	157	162	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2008	452	7185					365	U10		10.1038/nature06641	http://dx.doi.org/10.1038/nature06641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354482	Green Accepted			2022-12-24	WOS:000254117400050
J	Xu, YP; Ramu, Y; Lu, Z				Xu, Yanping; Ramu, Yajamana; Lu, Zhe			Removal of phospho-head groups of membrane lipids immobilizes voltage sensors of K+ channels	NATURE			English	Article							POTASSIUM CHANNELS; GATING CHARGE; SODIUM-CHANNELS; LYMPHOCYTE-T; ACTIVATION; SEQUENCE; CURRENTS; TOXIN; SPHINGOMYELIN; TARANTULA	A fundamental question about the gating mechanism of voltage-activated K+ ( Kv) channels is how five positively charged voltage-sensing residues(1,2) in the fourth transmembrane segment are energetically stabilized, because they operate in a low- dielectric cell membrane. The simplest solution would be to pair them with negative charges(3). However, too few negatively charged channel residues are positioned for such a role(4,5). Recent studies suggest that some of the channel's positively charged residues are exposed to cell membrane phospholipids and interact with their head groups(5-9). A key question nevertheless remains: is the phosphohead of membrane lipids necessary for the proper function of the voltage sensor itself? Here we show that a given type of Kv channel may interact with several species of phospholipid and that enzymatic removal of their phospho-head creates an insuperable energy barrier for the positively charged voltage sensor to move through the initial gating step( s), thus immobilizing it, and also raises the energy barrier for the downstream step( s).	[Xu, Yanping; Ramu, Yajamana; Lu, Zhe] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Lu, Z (corresponding author), Univ Penn, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.	zhelu@mail.med.upenn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055560] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055560] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; DOERY HM, 1963, NATURE, V198, P1091, DOI 10.1038/1981091a0; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; Glenny AT, 1935, J PATHOL BACTERIOL, V40, P201, DOI 10.1002/path.1700400202; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kitaguchi T, 2004, J GEN PHYSIOL, V124, P319, DOI 10.1085/jgp.200409098; KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8; Loboda A, 2001, BIOPHYS J, V81, P905, DOI 10.1016/S0006-3495(01)75750-5; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; MATTESON DR, 1984, NATURE, V307, P468, DOI 10.1038/307468a0; MCNAMARA PJ, 1995, GENE, V156, P113, DOI 10.1016/0378-1119(95)00002-N; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; PROJAN SJ, 1989, NUCLEIC ACIDS RES, V17, P3305, DOI 10.1093/nar/17.8.3305; Ramu Y, 2007, P NATL ACAD SCI USA, V104, P6448, DOI 10.1073/pnas.0701354104; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2	31	147	150	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					826	U8		10.1038/nature06618	http://dx.doi.org/10.1038/nature06618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273018	Green Accepted			2022-12-24	WOS:000253191400042
J	Mou, XZ; Sun, SL; Edwards, RA; Hodson, RE; Moran, MA				Mou, Xiaozhen; Sun, Shulei; Edwards, Robert A.; Hodson, Robert E.; Moran, Mary Ann			Bacterial carbon processing by generalist species in the coastal ocean	NATURE			English	Article							MARINE; GENES; BACTERIOPLANKTON; ASSEMBLAGES; SEQUENCE; IDENTIFICATION; BIOGEOGRAPHY; COMMUNITIES; MORTALITY; EVOLUTION	The assimilation and mineralization of dissolved organic carbon ( DOC) by marine bacterioplankton is a major process in the ocean carbon cycle(1). However, little information exists on the specific metabolic functions of participating bacteria and on whether individual taxa specialize on particular components of the marine DOC pool(2). Here we use experimental metagenomics to show that coastal communities are populated by taxa capable of metabolizing a wide variety of organic carbon compounds. Genomic DNA captured from bacterial community subsets metabolizing a single model component of the DOC pool ( either dimethylsulphoniopropionate or vanillate) showed substantial overlap in gene composition as well as a diversity of carbon- processing capabilities beyond the selected phenotypes. Our direct measure of niche breadth for bacterial functional assemblages indicates that, in accordance with ecological theory, heterogeneity in the composition and supply of organic carbon to coastal oceans may favour generalist bacteria. In the important interplay between microbial community structure and biogeochemical cycling, coastal heterotrophic communities may be controlled less by transient changes in the carbon reservoir that they process and more by factors such as trophic interactions and physical conditions.	[Mou, Xiaozhen; Sun, Shulei; Hodson, Robert E.; Moran, Mary Ann] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA	University System of Georgia; University of Georgia; California State University System; San Diego State University	Moran, MA (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.	mmoran@uga.edu	Mou, Xiaozhen/AAG-2806-2020; Moran, Mary Ann/B-6939-2012; Edwards, Robert/Q-1691-2019	Edwards, Robert/0000-0001-8383-8949; Moran, Mary Ann/0000-0002-0702-8167				Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Beardsley C, 2003, APPL ENVIRON MICROB, V69, P2624, DOI 10.1128/AEM.69.5.2624-2630.2003; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Buchan A, 2000, APPL ENVIRON MICROB, V66, P4662, DOI 10.1128/AEM.66.11.4662-4672.2000; Button DK, 2004, APPL ENVIRON MICROB, V70, P5511, DOI 10.1128/AEM.70.9.5511-5521.2004; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Doney SC, 2004, FRONT ECOL ENVIRON, V2, P457, DOI 10.1890/1540-9295(2004)002[0457:FGTETO]2.0.CO;2; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Hamasaki K, 2007, APPL ENVIRON MICROB, V73, P2787, DOI 10.1128/AEM.02111-06; Hewson I, 2006, MAR ECOL PROG SER, V311, P67, DOI 10.3354/meps311067; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Moran MA, 1999, ESTUARIES, V22, P55, DOI 10.2307/1352927; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; MORAN MA, 1994, LIMNOL OCEANOGR, V39, P762, DOI 10.4319/lo.1994.39.4.0762; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Su ZC, 2006, NUCLEIC ACIDS RES, V34, P1050, DOI 10.1093/nar/gkj496; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Urbach E, 1999, APPL ENVIRON MICROB, V65, P1207; Vila M, 2004, APPL ENVIRON MICROB, V70, P4648, DOI 10.1128/AEM.70.8.4648-4657.2004; Yokokawa T, 2005, APPL ENVIRON MICROB, V71, P6799, DOI 10.1128/AEM.71.11.6799-6807.2005; Yutin N, 2007, ENVIRON MICROBIOL, V9, P1464, DOI 10.1111/j.1462-2920.2007.01265.x	37	224	241	6	117	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 7	2008	451	7179					708	U4		10.1038/nature06513	http://dx.doi.org/10.1038/nature06513			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18223640				2022-12-24	WOS:000252929500039
J	Ogushi, S; Palmieri, C; Fulka, H; Saitou, M; Miyano, T; Fulka, J				Ogushi, Sugako; Palmieri, Chiara; Fulka, Helena; Saitou, Mitinori; Miyano, Takashi; Fulka, Josef, Jr.			The maternal nucleolus is essential for early embryonic development in mammals	SCIENCE			English	Article							RNA GENE-EXPRESSION; PORCINE OOCYTES; PREIMPLANTATION EMBRYOS; MOUSE ZYGOTES; NUCLEOLOGENESIS; SPERMIOGENESIS; FERTILIZATION; INHERITANCE; DNA	With fertilization, the paternal and maternal contributions to the zygote are not equal. The oocyte and spermatozoon are equipped with complementary arsenals of cellular structures and molecules necessary for the creation of a developmentally competent embryo. We show that the nucleolus is exclusively of maternal origin. The maternal nucleolus is not necessary for oocyte maturation; however, it is necessary for the formation of pronuclear nucleoli after fertilization or parthenogenetic activation and is essential for further embryonic development. In addition, the nucleolus in the embryo produced by somatic cell nuclear transfer originates from the oocyte, demonstrating that the maternal nucleolus supports successful embryonic development.	[Ogushi, Sugako; Miyano, Takashi] Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan; [Ogushi, Sugako; Saitou, Mitinori] RIKEN, Kobe Inst, Lab Mammalian Germ Cell Biol, Kobe, Hyogo 6500047, Japan; [Ogushi, Sugako; Fulka, Helena; Fulka, Josef, Jr.] Inst Anim Sci, Prague 10401, Czech Republic; [Fulka, Helena] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic; [Palmieri, Chiara] Univ Teramo, Fac Vet Med, I-64100 Teramo, Italy	Kobe University; RIKEN; Czech Research Institute of Animal Science; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Teramo	Ogushi, S (corresponding author), Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6578501, Japan.	ogushi@cdb.riken.jp	Palmieri, Chiara/J-4003-2013; Palmieri, Chiara/AAV-8908-2020	Palmieri, Chiara/0000-0002-5791-6066; Palmieri, Chiara/0000-0002-5791-6066; Ogushi, Sugako/0000-0001-8497-6972; Fulka, Helena/0000-0001-7414-5024				Bjerregaard B, 2004, ANIM REPROD SCI, V82-3, P605, DOI 10.1016/j.anireprosci.2004.04.023; CROZET N, 1981, BIOL CELL, V41, P35; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Fulka J, 2003, THERIOGENOLOGY, V59, P1879, DOI 10.1016/S0093-691X(02)01226-8; Gao SR, 2002, BIOL REPROD, V67, P928, DOI 10.1095/biolreprod.102.004606; Greda P, 2006, REPRODUCTION, V132, P741, DOI 10.1530/rep.1.01204; HUTCHISO.CA, 1974, NATURE, V251, P536, DOI 10.1038/251536a0; Hyttel P, 2001, REPRODUCTION, V122, P21, DOI 10.1530/rep.0.1220021; KOPECNY V, 1989, REPROD NUTR DEV, V29, P589, DOI 10.1051/rnd:19890508; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; MONESI V, 1965, EXP CELL RES, V39, P197, DOI 10.1016/0014-4827(65)90023-6; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; SCHULTZ MC, 1990, AM J ANAT, V189, P1, DOI 10.1002/aja.1001890102; Sutovsky P, 1998, REPROD NUTR DEV, V38, P629, DOI 10.1051/rnd:19980605; TAKEUCHI IK, 1990, J STRUCT BIOL, V103, P104, DOI 10.1016/1047-8477(90)90014-4; TESARIK J, 1987, DEVELOPMENT, V101, P777; Viuff D, 2002, BIOL REPROD, V66, P629, DOI 10.1095/biolreprod66.3.629	17	110	117	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					613	616		10.1126/science.1151276	http://dx.doi.org/10.1126/science.1151276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239124				2022-12-24	WOS:000252772000039
J	Barbier, EB; Koch, EW; Silliman, BR; Hacker, SD; Wolanski, E; Primavera, J; Granek, EF; Polasky, S; Aswani, S; Cramer, LA; Stoms, DM; Kennedy, CJ; Bael, D; Kappel, CV; Perillo, GME; Reed, DJ				Barbier, Edward B.; Koch, Evamaria W.; Silliman, Brian R.; Hacker, Sally D.; Wolanski, Eric; Primavera, Jurgenne; Granek, Elise F.; Polasky, Stephen; Aswani, Shankar; Cramer, Lori A.; Stoms, David M.; Kennedy, Chris J.; Bael, David; Kappel, Carrie V.; Perillo, Gerardo M. E.; Reed, Denise J.			Coastal ecosystem-based management with nonlinear ecological functions and values	SCIENCE			English	Article							MANGROVE FORESTS; THAILAND	A common assumption is that ecosystem services respond linearly to changes in habitat size. This assumption leads frequently to an "all or none" choice of either preserving coastal habitats or converting them to human use. However, our survey of wave attenuation data from field studies of mangroves, salt marshes, seagrass beds, nearshore coral reefs, and sand dunes reveals that these relationships are rarely linear. By incorporating nonlinear wave attenuation in estimating coastal protection values of mangroves in Thailand, we show that the optimal land use option may instead be the integration of development and conservation consistent with ecosystem- based management goals. This result suggests that reconciling competing demands on coastal habitats should not always result in stark preservation- versus- conversion choices.	[Barbier, Edward B.; Kennedy, Chris J.] Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA; [Koch, Evamaria W.] Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA; [Silliman, Brian R.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Hacker, Sally D.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Wolanski, Eric] James Cook Univ N Queensland, Australian Ctr Trop Freshwater Res, Townsville, Qld 4810, Australia; [Wolanski, Eric] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Primavera, Jurgenne] SE Asian Fisheries Dev Ctr, Dept Aquaculture, Iloilo 5021, Philippines; [Granek, Elise F.] Portland State Univ, Portland, OR 97207 USA; [Polasky, Stephen; Bael, David] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Aswani, Shankar] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Cramer, Lori A.] Oregon State Univ, Dept Sociol, Corvallis, OR 97331 USA; [Stoms, David M.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Kappel, Carrie V.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Perillo, Gerardo M. E.] Inst Argentino Oceanog, Bahia Blanca, Buenos Aires, Argentina; [Reed, Denise J.] Univ New Orleans, Dept Earth & Environm Sci, New Orleans, LA 70148 USA	University of Wyoming; University System of Maryland; University of Maryland Center for Environmental Science; State University System of Florida; University of Florida; Oregon State University; James Cook University; Australian Institute of Marine Science; Southeast Asian Fisheries Development Center; Portland State University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Santa Barbara; Oregon State University; University of California System; University of California Santa Barbara; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of Louisiana System; University of New Orleans	Barbier, EB (corresponding author), Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA.	ebarbier@uwyo.edu	Kennedy, Chris/B-3496-2008; Perillo, GME/AAV-3784-2021; Kappel, Carrie Vanessa/B-9534-2009; Polasky, Stephen/AAC-5341-2019	Perillo, GME/0000-0002-1200-5138; Kappel, Carrie Vanessa/0000-0003-2507-8042; Kennedy, Chris/0000-0002-0360-9116; Silliman, Brian/0000-0001-6360-650X				Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Barbier EB, 2003, CONTEMP ECON POLICY, V21, P59, DOI 10.1093/cep/21.1.59; Barbier EB, 2007, ECON POLICY, P178, DOI 10.1111/j.1468-0327.2007.00174.x; Brander LM, 2006, ENVIRON RESOUR ECON, V33, P223, DOI 10.1007/s10640-005-3104-4; Chua TE, 2006, COAST MANAGE, V34, P303, DOI 10.1080/08920750600686695; Farnsworth EJ, 1998, GLOBAL ECOL BIOGEOGR, V7, P15, DOI 10.2307/2997694; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Massel SR, 1999, FLUID DYN RES, V24, P219, DOI 10.1016/S0169-5983(98)00024-0; Mazda Y., 1997, MANGROVE SALT MARCHE, V1, P127, DOI DOI 10.1023/A:1009928003700; Mazda Yoshihiro, 2006, Wetlands Ecology and Management, V14, P365, DOI 10.1007/s11273-005-5388-0; McLeod K.L., 2005, SCI CONSENSUS STATEM; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING CU; Petersen JE, 2003, BIOSCIENCE, V53, P1181, DOI 10.1641/0006-3568(2003)053[1181:MEICEI]2.0.CO;2; Primavera JH, 2007, B MAR SCI, V80, P795; Saenger P., 1983, GLOBAL STATUS MANGRO; Sathirathai S, 2001, CONTEMP ECON POLICY, V19, P109, DOI 10.1093/cep/19.2.109; *UN ENV PROGR GPA, 2006, EC BAS MAN MARK ASS; United Nations Environment Programme, 2006, MAR COAST EC HUM WEL; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; WOLANSKI E, 2007, COASTAL PROTECTION A, P157	21	666	734	24	618	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2008	319	5861					321	323		10.1126/science.1150349	http://dx.doi.org/10.1126/science.1150349			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202288				2022-12-24	WOS:000252436200035
J	Vidula, H; Tian, L; Liu, K; Criqui, MH; Ferrucci, L; Pearce, WH; Greenland, P; Green, D; Tan, J; Garside, DB; Guralnik, J; Ridker, PM; Rifai, N; McDermott, MM				Vidula, Himabindu; Tian, Lu; Liu, Kiang; Criqui, Michael H.; Ferrucci, Luigi; Pearce, William H.; Greenland, Philip; Green, David; Tan, Jin; Garside, Daniel B.; Guralnik, Jack; Ridker, Paul M.; Rifai, Nader; McDermott, Mary M.			Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: A cohort study	ANNALS OF INTERNAL MEDICINE			English	Article							C-REACTIVE PROTEIN; AORTIC ENDOTHELIAL-CELLS; ANKLE BRACHIAL INDEX; ATHEROSCLEROTIC LESIONS; ASSOCIATION; SERUM; CHOLESTEROL; PREVALENCE; EXPRESSION; MARKER	Background: Traditional atherosclerotic risk factors predict long-term cardiovascular disease events but are poor predictors of near-term events. Objective: To determine whether elevated levels Of D-dimer and biomarkers of inflammation were more closely associated with near-term than long-term mortality in patients with lower-extremity peripheral arterial disease (PAD) and whether greater increases in biomarker levels were associated with higher mortality rates during the first year after the increase than during later years. Design: Prospective cohort study with a mean follow-up of 3.4 years. Setting: Academic medical center. Patients: 377 men and women with PAD. Measurements: Mortality within 1 year after biomarker measurement, 1 to 2 years after biomarker measurement, and 2 to 3 years after biomarker measurement. Cox regression analyses were used to evaluate associations of biomarkers levels and changes in biomarkers with cardiovascular and all-cause mortality. Hazard ratios were calculated for each 1-unit increase in log(1.5)(biomarker level). Analyses were adjusted for age, sex, race, comorbid conditions, ankle-brachial index, and other confounders. Results: Seventy-six patients (20%) died during follow-up. Higher levels Of D-dimer, C-reactive protein, and serum amyloid A were associated with higher all-cause mortality among patients who died within 1 year after biomarker measurement (hazard ratio, 1.20 [95% CI, 1.08 to 1.33], 1.13 [CI, 1.05 to 1.21], and 1.12 [CI, 1.04 to 1.20], respectively; P < 0.001, P < 0.001, and P = 0.003) and among patients who died 1 to 2 years after biomarker measurement (hazard ratio, 1.14 [Cl, 1.02 to 1.27], 1.15 [C], 1.06 to 1.24], and 1.13 [C], 1.04 to 1.24]; P = 0.022, P = 0.001, and P = 0.005]). However, higher levels of each biomarker were not associated with all-cause mortality for deaths occurring 2 to 3 years after biomarker measurement. Similar results were observed for cardiovascular mortality. Greater increases in each biomarker were associated with higher all-cause and cardiovascular mortality during the following year. Limitation: The small number of deaths limited the statistical power of the analyses. Conclusion: Among persons with PAD, circulating levels Of D-dimer and inflammatory markers are higher in the 1 to 2 years before death than in periods more remote from death. increasing levels of D-dimer and inflammatory biomarkers are independently associated with higher mortality in persons with PAD.			McDermott, MM (corresponding author), 750 N Lake Shore Dr,10th Floor, Chicago, IL 60611 USA.		Greenland, Philip/ABD-5528-2021		Intramural NIH HHS [Z99 AG999999] Funding Source: Medline; NCRR NIH HHS [RR-00048, M01 RR000048] Funding Source: Medline; NHLBI NIH HHS [R01 HL076298, R01-HL64739, R01 HL064739, R01-HL076298, R01-HL58099] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076298, R01HL064739, R01HL058099] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; DAVIES MJ, 1990, CIRCULATION, V82, P38; Devaraj S, 2004, J MOL CELL CARDIOL, V36, P405, DOI 10.1016/j.yjmcc.2003.12.005; FUSTER V, 1994, CIRCULATION, V90, P2126, DOI 10.1161/01.CIR.90.4.2126; Guralnik JM, 1995, NIH PUBLICATION, V95-4009; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607; Li L, 2004, CIRC RES, V95, P877, DOI 10.1161/01.RES.0000147309.54227.42; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Lu KF, 2001, BIOMETRICS, V57, P1191, DOI 10.1111/j.0006-341X.2001.01191.x; McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640; McDermott MM, 2005, AM HEART J, V150, P276, DOI 10.1016/j.ahj.2004.09.032; McDermott MM, 2003, AM J CARDIOL, V92, P194, DOI 10.1016/S0002-9149(03)00537-X; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Shadman R, 2004, J AM COLL CARDIOL, V44, P618, DOI 10.1016/j.jacc.2004.04.044; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; Torzewski J, 1998, ARTERIOSCL THROM VAS, V18, P1386, DOI 10.1161/01.ATV.18.9.1386; Wilson AM, 2006, INT J CARDIOL, V106, P291, DOI 10.1016/j.ijcard.2005.01.068	25	106	111	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2008	148	2					85	93		10.7326/0003-4819-148-2-200801150-00003	http://dx.doi.org/10.7326/0003-4819-148-2-200801150-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254NZ	18195333	Green Accepted			2022-12-24	WOS:000252594600001
J	Amin, R; Widmer, B; Prevost, AT; Schwarze, P; Cooper, J; Edge, J; Marcovecchio, L; Neil, A; Dalton, RN; Dunger, DB				Amin, Rakesh; Widmer, Barry; Prevost, A. Toby; Schwarze, Phillip; Cooper, Jason; Edge, Julie; Marcovecchio, Loredana; Neil, Andrew; Dalton, R. Neil; Dunger, David B.			Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLOMERULAR-FILTRATION-RATE; METABOLIC-CONTROL; GLYCEMIC CONTROL; NATURAL-HISTORY; NEPHROPATHY; YOUNG; MELLITUS; RETINOPATHY; PREDICTOR; CHILDREN	Objectives To describe independent predictors for the development of microalbuminuria and progression to macroalbuminuria in those with childhood onset type 1 diabetes. Design Prospective observational study with follow-up for 9.8 (SD 3.8) years. Setting Oxford regional prospective study. Participants 527 participants with a diagnosis of type 1 diabetes at mean age 8.8 (SD 4.0) years. Main outcome measures Annual measurement of glycated haemoglobin (HbA(1c)) and assessment of urinary albumin: creatinine ratio. Results Cumulative prevalence of microalbuminuria was 25.7% (95% confidence interval 21.3% to 30.1%) after 10 years of diabetes and 50.7% (40.5% to 60.9%) after 19 years of diabetes and 5182 patient years of follow-up. The only modifiable adjusted predictor for microalbuminuria was high HbA(1c) concentrations (hazard ratio per 1% rise in HbA(1c) 1.39, 1.27 to 1.52). Blood pressure and history of smoking were not predictors. Microalbuminuria was persistent in 48% of patients. Cumulative prevalence of progression from microalbuminuria to macroalbuminuria was 13.9% (12.9% to 14.9%); progression occurred at a mean age of 18.5 (5.8) years. Although the sample size was small, modifiable predictors of macroalbuminuria were higher HbA(1c) levels and both persistent and intermittent microalbuminuria hazard ratios 1.42 (1.22 to 1.78), 27.72 (7.99 to 96.12), and 8.76 (2.44 to 31.44), respectively). Conclusion In childhood onset type 1 diabetes, the only modifiable predictors were poor glycaemic control for the development of microalbuminuria and poor control and microalburninuria (both persistent and intermittent) for progression to macroalbuminuria. Risk for macroalbuminuria is similar to that observed in cohorts with adult onset disease but as it occurs in young adult life early intervention in normotensive adolescents might be needed to improve prognosis.	[Amin, Rakesh; Widmer, Barry; Schwarze, Phillip; Marcovecchio, Loredana; Dunger, David B.] Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 0QQ, England; [Prevost, A. Toby] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; [Cooper, Jason] Cambridge Inst Med Res, IDRF Wellcome Trust Diabet Inflammat Lab, Cambridge CB2 0XY, England; [Edge, Julie] John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; [Neil, Andrew] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Dalton, R. Neil] Kings Coll London, Guys Hosp, Wellchild Lab, London WC2R 2LS, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; University of Oxford; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Dunger, DB (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 0QQ, England.	dbd25@cam.ac.uk	Schwarze, Per/I-2080-2016	Dunger, Professor David/0000-0002-2566-9304; Prevost, A. Toby/0000-0003-1723-0796	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amin R, 2005, KIDNEY INT, V68, P1740, DOI 10.1111/j.1523-1755.2005.00590.x; Amin R, 2003, DIABETES CARE, V26, P1456, DOI 10.2337/diacare.26.5.1456; BANGSTAD HJ, 1993, DIABETOLOGIA, V36, P523, DOI 10.1007/BF02743268; Bojestig M, 1996, DIABETES CARE, V19, P313, DOI 10.2337/diacare.19.4.313; BORCHJOHNSEN K, 1987, BMJ-BRIT MED J, V294, P1651, DOI 10.1136/bmj.294.6588.1651; Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536; Diabetes UK, 2004, NAT PAED DIAB AUD RE; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; Gorman D, 1999, J PEDIATR-US, V134, P333, DOI 10.1016/S0022-3476(99)70459-2; Holl RW, 2003, EUR J PEDIATR, V162, P22, DOI 10.1007/s00431-002-1037-2; Hovind P, 2004, BRIT MED J, V328, P1105, DOI 10.1136/bmj.38070.450891.FE; JONER G, 1992, DIABETOLOGIA, V35, P1049, DOI 10.1007/BF02221680; Jones CA, 1998, ARCH DIS CHILD, V78, P518, DOI 10.1136/adc.78.6.518; KROLEWSKI AS, 1985, AM J MED, V78, P785, DOI 10.1016/0002-9343(85)90284-0; Nordwall M, 2004, DIABETOLOGIA, V47, P1266, DOI 10.1007/s00125-004-1431-6; Olsen BS, 2000, J DIABETES COMPLICAT, V14, P295, DOI 10.1016/S1056-8727(00)00078-7; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Reckelhoff JF, 1999, CLIN EXP PHARMACOL P, V26, P127, DOI 10.1046/j.1440-1681.1999.02996.x; RUDBERG S, 1993, DIABETOLOGIA, V36, P1309, DOI 10.1007/BF00400811; RUDBERG S, 1992, KIDNEY INT, V41, P822, DOI 10.1038/ki.1992.126; Schultz CJ, 2000, DIABETES CARE, V23, P1811, DOI 10.2337/diacare.23.12.1811; Schultz CJ, 1999, DIABETES CARE, V22, P495, DOI 10.2337/diacare.22.3.495; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; VIBERTI GC, 1982, LANCET, V2, P611; Warram JH, 2000, DIABETES, V49, P94, DOI 10.2337/diabetes.49.1.94	25	121	126	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2008	336	7646					697	701		10.1136/bmj.39478.378241.BE	http://dx.doi.org/10.1136/bmj.39478.378241.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZS	18349042	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000254675600027
J	Bakker, A; Kirwan, CB; Miller, M; Stark, CEL				Bakker, Arnold; Kirwan, C. Brock; Miller, Michael; Stark, Craig E. L.			Pattern separation in the human hippocampal CA3 and dentate gyrus	SCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; RECOGNITION MEMORY; PLACE CELLS; FMRI; COMPLEMENTARY; REPRESENTATIONS; DISTINCT	Pattern separation, the process of transforming similar representations or memories into highly dissimilar, nonoverlapping representations, is a key component of many functions ascribed to the hippocampus. Computational models have stressed the role of the hippocampus and, in particular, the dentate gyrus and its projections into the CA3 subregion in pattern separation. We used high- resolution ( 1.5- millimeter isotropic voxels) functional magnetic resonance imaging to measure brain activity during incidental memory encoding. Although activity consistent with a bias toward pattern completion was observed in CA1, the subiculum, and the entorhinal and parahippocampal cortices, activity consistent with a strong bias toward pattern separation was observed in, and limited to, the CA3/ dentate gyrus. These results provide compelling evidence of a key role of the human CA3/ dentate gyrus in pattern separation.	[Bakker, Arnold; Stark, Craig E. L.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21204 USA; [Kirwan, C. Brock] Univ Calif San Diego, Inst Neural Computat, San Diego, CA 92103 USA; [Miller, Michael] Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD USA; [Stark, Craig E. L.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA; [Stark, Craig E. L.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA	Johns Hopkins University; University of California System; University of California San Diego; Johns Hopkins University; University of California System; University of California Irvine; University of California System; University of California Irvine	Stark, CEL (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21204 USA.	cestark@uci.edu	Kirwan, Brock/B-1520-2014; Kirwan, Brock/A-8051-2009; Bakker, Arnold B./F-8494-2010	Kirwan, Brock/0000-0003-0768-1446; Bakker, Arnold B./0000-0003-1489-1847	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008171, R01EB000975] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR15241-01A1] Funding Source: Medline; NIBIB NIH HHS [R01 EB000975-04, R01 EB008171-01A1, R01 EB008171, R01 EB000975, R01 EB00975-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Hyde JS, 2001, MAGN RESON MED, V46, P114, DOI 10.1002/mrm.1166; Kirwan CB, 2007, HUM BRAIN MAPP, V28, P959, DOI 10.1002/hbm.20331; Kirwan CB, 2007, LEARN MEMORY, V14, P625, DOI 10.1101/lm.663507; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	22	647	656	3	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1640	1642		10.1126/science.1152882	http://dx.doi.org/10.1126/science.1152882			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356518	Green Accepted			2022-12-24	WOS:000254172300032
J	Carballo, JA; Johnson, AL; Sedgwick, SG; Cha, RS				Carballo, Jesus A.; Johnson, Anthony L.; Sedgwick, Steven G.; Cha, Rita S.			Phosphorylation of the axial element protein Hop1 by Mec1/Tel1 ensures meiotic interhomolog recombination	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND-BREAK; DNA-DAMAGE; CHROMOSOME SYNAPSIS; SISTER CHROMATIDS; YEAST HOMOLOG; MEIOSIS; KINASE; MEC1; MUTANTS	An essential feature of meiosis is interhomolog recombination whereby a significant fraction of the programmed meiotic double-strand breaks (DSBs) is repaired using an intact homologous non-sister chromatid rather than a sister. Involvement of Mec1 and Tel1, the budding yeast homologs of the mammalian ATR and ATM kinases, in meiotic interhomlog bias has been implicated, but the mechanism remains elusive. Here, we demonstrate that Mec1 and Tel1 promote meiotic interhomolog recombination by targeting the axial element protein Hop1. Without Mec1/Tel1 phosphorylation of Hop1, meiotic DSBs are rapidly repaired via a Dmc1-independent inter-sister repair pathway, resulting in diminished interhomolog crossing-over leading to spore lethality. We find that Mec1/Tel1-mediated phosphorylation of Hop1 is required for activation of Mek1, a meiotic paralogue of the DNA-damage effector kinase, Rad53p/CHK2. Thus, Hop1 is a meiosis-specific adaptor protein of the Mec1/Tel1 signaling pathway that ensures interhomolog recombination by preventing Dmc1-independent repair of meiotic DSBs.	[Carballo, Jesus A.; Johnson, Anthony L.; Sedgwick, Steven G.; Cha, Rita S.] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England	MRC National Institute for Medical Research	Cha, RS (corresponding author), Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England.	rcha@nimr.mrc.ac.uk	Carballo, Jesus/K-9899-2014	Carballo, Jesus/0000-0003-2259-3743; Cha, Rita/0000-0001-8223-1520	MRC [MC_U117531949, MC_U117573806] Funding Source: UKRI; Medical Research Council [MC_U117531949, MC_U117573806] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Anuradha S, 2004, J BIOL CHEM, V279, P28961, DOI 10.1074/jbc.M403727200; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; Bailis JM, 2000, CELL, V101, P211, DOI 10.1016/S0092-8674(00)80831-4; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Burgoyne PS, 2007, BIOESSAYS, V29, P974, DOI 10.1002/bies.20639; Carballo JA, 2007, CHROMOSOME RES, V15, P539, DOI 10.1007/s10577-007-1145-y; Cartagena-Lirola H, 2006, CELL CYCLE, V5, P1549, DOI 10.4161/cc.5.14.2916; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chen Yao-Tseng, 2005, Cancer Immun, V5, P9; de los Santos T, 1999, J BIOL CHEM, V274, P1783, DOI 10.1074/jbc.274.3.1783; DRESSER ME, 1988, J CELL BIOL, V106, P567, DOI 10.1083/jcb.106.3.567; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Grushcow JM, 1999, GENETICS, V153, P607; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; HOLLINGSWORTH NM, 1989, GENETICS, V121, P445; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; KADYK LC, 1992, GENETICS, V132, P387; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; LEEM SH, 1992, NUCLEIC ACIDS RES, V20, P449, DOI 10.1093/nar/20.3.449; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; LOIDL J, 1994, J CELL BIOL, V125, P1191, DOI 10.1083/jcb.125.6.1191; Lorenz A, 2004, J CELL SCI, V117, P3343, DOI 10.1242/jcs.01203; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Mallory JC, 2000, P NATL ACAD SCI USA, V97, P13749, DOI 10.1073/pnas.250475697; MaoDraayer Y, 1996, GENETICS, V144, P71; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; NAG DK, 1995, GENETICS, V141, P75; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; ROCKMILL B, 1991, GENE DEV, V5, P2392, DOI 10.1101/gad.5.12b.2392; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Thompson DA, 1999, GENETICS, V153, P621; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Wan LH, 2004, MOL BIOL CELL, V15, P11, DOI 10.1091/mbc.E03-07-0499; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Woltering D, 2000, MOL CELL BIOL, V20, P6646, DOI 10.1128/MCB.20.18.6646-6658.2000; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	54	194	195	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					758	770		10.1016/j.cell.2008.01.035	http://dx.doi.org/10.1016/j.cell.2008.01.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329363	Bronze			2022-12-24	WOS:000253818000014
J	Jeong, S; Rebeiz, M; Andolfatto, P; Werner, T; True, J; Carroll, SB				Jeong, Sangyun; Rebeiz, Mark; Andolfatto, Peter; Werner, Thomas; True, John; Carroll, Sean B.			The evolution of gene regulation underlies a morphological difference between two Drosophila sister species	CELL			English	Article							PARALLEL EVOLUTION; POSITIVE SELECTION; PIGMENT PATTERNS; MELANOGASTER; STICKLEBACKS; SANTOMEA; HISTORY; YAKUBA; LOCUS; DNA	Understanding the mechanisms underlying the morphological divergence of species is one of the central goals of evolutionary biology. Here, we analyze the genetic and molecular bases of the divergence of body pigmentation patterns between Drosophila yakuba and its sister species Drosophila santomea. We found that loss of pigmentation in D. santomea involved the selective loss of expression of the tan and yellow pigmentation genes. We demonstrate that tan gene expression was eliminated through the mutational inactivation of one specific tan cis-regulatory element (CRE) whereas the Tan protein sequence remained unchanged. Surprisingly, we identify three independent loss-of-function alleles of the tan CRE in the young D. santomea lineage. We submit that there is sufficient empirical evidence to support the general prediction that functional evolutionary changes at pleiotropic loci will most often involve mutations in their discrete, modular cis-regulatory elements.	[Jeong, Sangyun; Rebeiz, Mark; Werner, Thomas; Carroll, Sean B.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Jeong, Sangyun; Rebeiz, Mark; Werner, Thomas; Carroll, Sean B.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Andolfatto, Peter] Univ Calif San Diego, Sect Ecol Behav & Evolut, Div Biol Sci, La Jolla, CA 92093 USA; [True, John] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu		True, John/0000-0001-5124-5495; Rebeiz, Mark/0000-0001-5731-5570; Andolfatto, Peter/0000-0003-3393-4574	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078972] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM-078972] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Bachtrog D, 2006, GENETICS, V174, P2045, DOI 10.1534/genetics.106.062760; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Belting HG, 1998, P NATL ACAD SCI USA, V95, P2355, DOI 10.1073/pnas.95.5.2355; Carbone MA, 2005, GENETICS, V171, P211, DOI 10.1534/genetics.105.044412; Cariou ML, 2001, MOL ECOL, V10, P649, DOI 10.1046/j.1365-294x.2001.01225.x; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Davidson E. H., 2001, DEV EVOLUTION; Drapeau MD, 2006, GENETICS, V172, P1009, DOI 10.1534/genetics.105.045666; DYKHUIZEN D, 1980, GENETICS, V96, P801; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; HUDSON RR, 1985, GENETICS, V111, P147; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; Kim Y, 2003, GENETICS, V164, P389; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Llopart A, 2002, EVOLUTION, V56, P2262; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; NELSON HB, 1993, ROUX ARCH DEV BIOL, V202, P341, DOI 10.1007/BF00188733; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Orr HA, 2001, GENETICS, V157, P875; Pennings PS, 2006, PLOS GENET, V2, P1998, DOI 10.1371/journal.pgen.0020186; Pool JE, 2007, MOL ECOL, V16, P2844, DOI 10.1111/j.1365-294X.2007.03324.x; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Takahashi A, 2007, GENETICS, V177, P1233, DOI 10.1534/genetics.107.075283; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5	52	208	215	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					783	793		10.1016/j.cell.2008.01.014	http://dx.doi.org/10.1016/j.cell.2008.01.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329365	Bronze			2022-12-24	WOS:000253818000016
J	Liu, CI; Liu, GY; Song, YC; Yin, FL; Hensler, ME; Jeng, WY; Nizet, V; Wang, AHJ; Oldfield, E				Liu, Chia-I; Liu, George Y.; Song, Yongcheng; Yin, Fenglin; Hensler, Mary E.; Jeng, Wen-Yih; Nizet, Victor; Wang, Andrew H. -J.; Oldfield, Eric			A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence	SCIENCE			English	Article							SQUALENE SYNTHASE INHIBITOR; TARGET	Staphylococcus aureus produces hospital- and community- acquired infections, with methicillin- resistant S. aureus posing a serious public health threat. The golden carotenoid pigment of S. aureus, staphyloxanthin, promotes resistance to reactive oxygen species and host neutrophil- based killing, and early enzymatic steps in staphyloxanthin production resemble those for cholesterol biosynthesis. We determined the crystal structures of S. aureus dehydrosqualene synthase ( CrtM) at 1.58 angstrom resolution, finding structural similarity to human squalene synthase ( SQS). We screened nine SQS inhibitors and determined the structures of three, bound to CrtM. One, previously tested for cholesterol- lowering activity in humans, blocked staphyloxanthin biosynthesis in vitro ( median inhibitory concentration similar to 100 nM), resulting in colorless bacteria with increased susceptibility to killing by human blood and to innate immune clearance in a mouse infection model. This finding represents proof of principle for a virulence factor - based therapy against S. aureus.	[Hensler, Mary E.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Liu, Chia-I; Jeng, Wen-Yih; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Liu, Chia-I; Jeng, Wen-Yih; Wang, Andrew H. -J.] Acad Sinica, Natl Core Facil High Throughput Prot Crystallog, Taipei 11529, Taiwan; [Liu, Chia-I; Wang, Andrew H. -J.] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei 10098, Taiwan; [Liu, George Y.] Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA; [Liu, George Y.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Song, Yongcheng; Oldfield, Eric] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Yin, Fenglin; Oldfield, Eric] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nizet, V (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	vnizet@ucsd.edu; ahjwang@gate.sinica.edu.tw; eo@chad.scs.uiuc.edu	Nizet, Victor/AAF-3190-2019; Liu, Guang Yu/A-8802-2008	Nizet, Victor/0000-0003-3847-0422	NIAID NIH HHS [AI07482] Funding Source: Medline; NICHD NIH HHS [HD051796] Funding Source: Medline; NIGMS NIH HHS [R01 GM065307, GM65307, R01 GM073216, R01 GM065307-07, R01 GM073216-29, GM073216] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065307, R01GM073216] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alksne LE, 2000, CURR OPIN BIOTECH, V11, P625, DOI 10.1016/S0958-1669(00)00155-5; [Anonymous], 2006, TREAT INF DIS MICR W, P21; Bancroft EA, 2007, JAMA-J AM MED ASSOC, V298, P1803, DOI 10.1001/jama.298.15.1803; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; Guo RT, 2007, P NATL ACAD SCI USA, V104, P10022, DOI 10.1073/pnas.0702254104; Hiyoshi H, 2000, J LIPID RES, V41, P1136; Ishihara T, 2003, BIOORGAN MED CHEM, V11, P2403, DOI 10.1016/S0968-0896(03)00143-3; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lyon GJ, 2000, P NATL ACAD SCI USA, V97, P13330, DOI 10.1073/pnas.97.24.13330; Magnin DR, 1996, J MED CHEM, V39, P657, DOI 10.1021/jm9507340; Nishimoto T, 2003, BRIT J PHARMACOL, V139, P911, DOI 10.1038/sj.bjp.0705332; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Sharma A, 1998, PHARMACEUT RES, V15, P1782, DOI 10.1023/A:1011977116543; Sharma A, 1998, J CLIN PHARMACOL, V38, P1116; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ton-That H, 1999, J BIOL CHEM, V274, P24316, DOI 10.1074/jbc.274.34.24316	17	321	336	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1391	1394		10.1126/science.1153018	http://dx.doi.org/10.1126/science.1153018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	270HW	18276850	Green Accepted, Green Published			2022-12-24	WOS:000253712900044
J	Daley, GQ; Scadden, DT				Daley, George Q.; Scadden, David T.			Prospects for stem cell-based therapy	CELL			English	Article							HEMATOPOIETIC STEM; PROGENITOR CELLS; FIBROBLASTS; POPULATION; RECEPTORS; REJECTION; MIGRATION; LINES	Resident pools of somatic stem cells in many organs are responsible for tissue maintenance and repair. The goal of regenerative medicine is to exploit these cells either by transplanting them from an exogenous source or by activating endogenous stem cells pharmacologically. For diseases caused by mutations in a single gene, the therapeutic goal is tissue replacement using stem cells engineered to correct the genetic defect. However, a number of technical hurdles must be overcome before therapies based on pluripotent human stem cells can enter the clinic.	[Daley, George Q.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.; Scadden, David T.] Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; [Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02115 USA; [Scadden, David T.] Harvard Univ, Dept Stem Cell & regenerat Biol, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp, Div Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; scadden.david@mgh.harvard.edu						Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Eckardt S, 2007, GENE DEV, V21, P409, DOI 10.1101/gad.1524207; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; FRENCH AJ, 2008, STEM CELLS; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mandelboim O, 1997, P NATL ACAD SCI USA, V94, P14666, DOI 10.1073/pnas.94.26.14666; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nakajima F, 2007, STEM CELLS, V25, P983, DOI 10.1634/stemcells.2006-0566; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; REVAZOVA ES, 2007, CLONING STEM CELLS; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; SACKSTEIN R, 2008, NAT MED; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; STRAIN L, 1995, NAT GENET, V11, P164, DOI 10.1038/ng1095-164; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu GD, 2003, TRANSPLANTATION, V75, P679, DOI 10.1097/01.TP.0000048488.35010.95; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	42	232	248	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					544	548		10.1016/j.cell.2008.02.009	http://dx.doi.org/10.1016/j.cell.2008.02.009			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295571	Bronze			2022-12-24	WOS:000253817900013
J	Chibalin, AV; Leng, Y; Vieira, E; Krook, A; Bjoernholm, M; Long, YC; Kotova, O; Zhong, ZH; Sakane, F; Steiler, T; Nylen, C; Wang, JJ; Laakso, M; Topham, MK; Gilbert, M; Wallberg-Henriksson, H; Zierath, JR				Chibalin, Alexander V.; Leng, Ying; Vieira, Elaine; Krook, Anna; Bjoernholm, Marie; Long, Yun Chau; Kotova, Olga; Zhong, Zhihui; Sakane, Fumio; Steiler, Tatiana; Nylen, Carolina; Wang, Jianjun; Laakso, Markku; Topham, Matthew K.; Gilbert, Marc; Wallberg-Henriksson, Harriet; Zierath, Juleen R.			Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance	CELL			English	Article							TYPE-2 DIABETIC-PATIENTS; GLUCOSE-TRANSPORT; SKELETAL-MUSCLE; METABOLIC SYNDROME; SIGNAL-TRANSDUCTION; TRANSGENIC MICE; RECEPTOR; EXPRESSION; TOLERANCE; MECHANISM	Type 2 (non-insulin-dependent) diabetes mellitus is a progressive metabolic disorder arising from genetic and environmental factors that impair beta cell function and insulin action in peripheral tissues. We identified reduced diacylglycerol kinase delta (DGK delta) expression and DGK activity in skeletal muscle from type 2 diabetic patients. In diabetic animals, reduced DGK delta protein and DGK kinase activity were restored upon correction of glycemia. DGK delta haploinsufficiency increased diacylglycerol content, reduced peripheral insulin sensitivity, insulin signaling, and glucose transport, and led to age-dependent obesity. Metabolic flexibility, evident by the transition between lipid and carbohydrate utilization during fasted and fed conditions, was impaired in DGK delta haploinsufficient mice. We reveal a previously unrecognized role for DGK delta in contributing to hyperglycemia-induced peripheral insulin resistance and thereby exacerbating the severity of type 2 diabetes. DGK delta deficiency causes peripheral insulin resistance and metabolic inflexibility. These defects in glucose and energy homeostasis contribute to mild obesity later in life.	[Chibalin, Alexander V.; Leng, Ying; Vieira, Elaine; Bjoernholm, Marie; Long, Yun Chau; Kotova, Olga; Zhong, Zhihui; Nylen, Carolina; Gilbert, Marc; Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Krook, Anna; Steiler, Tatiana; Wallberg-Henriksson, Harriet] Karolinska Inst, Dept Physiol & Pharmacol, Sect Integrat Physiol, S-17177 Stockholm, Sweden; [Sakane, Fumio; Topham, Matthew K.] Univ Kuopio, Huntsman Canc Inst, Kuopio 70210, Finland; [Wang, Jianjun; Laakso, Markku] Univ Kuopio, Dept Med, Kuopio 70210, Finland; [Topham, Matthew K.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA	Karolinska Institutet; Karolinska Institutet; University of Eastern Finland; University of Eastern Finland; Utah System of Higher Education; University of Utah	Zierath, JR (corresponding author), Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden.	juleen.zierath@ki.se	Sakane, Fumio/H-2693-2017; Vieira, Elaine/AAG-1127-2020; Vieira, Elaine/F-7273-2019; Krook, Anna/K-1192-2015; NylÃ©n, Carolina/AAD-5207-2021	Sakane, Fumio/0000-0003-0857-0377; Vieira, Elaine/0000-0002-0621-9367; Vieira, Elaine/0000-0002-0621-9367; Krook, Anna/0000-0002-0891-0258; Zierath, Juleen/0000-0001-6891-7497; Chibalin, Alexander/0000-0002-6339-6271				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; CARTEE GD, 1991, J APPL PHYSIOL, V70, P1593, DOI 10.1152/jappl.1991.70.4.1593; CHANG PY, 1994, J BIOL CHEM, V269, P16034; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; ERIKSSON J, 1989, NEW ENGL J MED, V321, P337, DOI 10.1056/NEJM198908103210601; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Fritz T, 2006, DIABETES-METAB RES, V22, P492, DOI 10.1002/dmrr.656; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0; Kanoh H, 2002, J BIOCHEM, V131, P629, DOI 10.1093/oxfordjournals.jbchem.a003144; KIKKAWA U, 1983, METHOD ENZYMOL, V99, P288; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; Krook A, 1997, DIABETES, V46, P2110, DOI 10.2337/diabetes.46.12.2110; Laakso M, 2005, CURR MOL MED, V5, P365, DOI 10.2174/1566524053766040; Leach NT, 2007, AM J HUM GENET, V80, P792, DOI 10.1086/513019; Lee IK, 1999, DIABETES RES CLIN PR, V45, P183, DOI 10.1016/S0168-8227(99)00048-0; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Moller DE, 1996, ENDOCRINOLOGY, V137, P2397, DOI 10.1210/en.137.6.2397; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Montell E, 2001, AM J PHYSIOL-ENDOC M, V280, pE229, DOI 10.1152/ajpendo.2001.280.2.E229; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nagaya H, 2002, MOL BIOL CELL, V13, P302, DOI 10.1091/mbc.01-05-0255; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Portha B, 2005, DIABETES-METAB RES, V21, P495, DOI 10.1002/dmrr.566; PREISS J, 1986, J BIOL CHEM, V261, P8597; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Salmenniemi U, 2004, CIRCULATION, V110, P3842, DOI 10.1161/01.CIR.0000150391.38660.9B; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song XM, 1999, DIABETES, V48, P664, DOI 10.2337/diabetes.48.3.664; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Teran-Garcia M, 2005, AM J PHYSIOL-ENDOC M, V288, pE1168, DOI 10.1152/ajpendo.00467.2004; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; WALLBERGHENRIKSSON H, 1987, ACTA PHYSIOL SCAND, V131, P1; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; ZIERATH JR, 1994, DIABETOLOGIA, V37, P270, DOI 10.1007/BF00398054; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	51	167	174	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					375	386		10.1016/j.cell.2007.12.035	http://dx.doi.org/10.1016/j.cell.2007.12.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267070	Bronze			2022-12-24	WOS:000253180700013
J	LaPorte, SL; Juo, ZS; Vaclavikova, J; Colf, LA; Qi, XL; Heller, NM; Keegan, AD; Garcia, KC				LaPorte, Sherry L.; Juo, Z. Sean; Vaclavikova, Jana; Colf, Leremy A.; Qi, Xiulan; Heller, Nicola M.; Keegan, Achsah D.; Garcia, K. Christopher			Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system	CELL			English	Article							COMMON GAMMA-CHAIN; SEVERE COMBINED IMMUNODEFICIENCY; CRYSTAL-STRUCTURE; FUNCTIONAL COMPONENT; JUXTAMEMBRANE DOMAIN; IL-4 RECEPTOR; ALPHA-CHAIN; BINDING; COMPLEX; CLONING	Interleukin-4 and Interleukin-13 are cytokines critical to the development of T cell-mediated humoral immune responses, which are associated with allergy and asthma, and exert their actions through three different combinations of shared receptors. Here we present the crystal structures of the complete set of type I (IL-4R alpha/gamma(c)/IL-4) and type II (IL-4R alpha/IL-13R alpha 1/ IL-4, IL-4R alpha/IL-13R alpha 1/IL-13) ternary signaling complexes. The type I complex reveals a structural basis for gamma(c)'s ability to recognize six different gamma(c)-cytokines. The two type II complexes utilize an unusual top-mounted Ig-like domain on IL-13R alpha 1 for a novel mode of cytokine engagement that contributes to a reversal in the IL-4 versus IL-13 ternary complex assembly sequences, which are mediated through substantially different recognition chemistries. We also show that the type II receptor heterodimer signals with different potencies in response to IL-4 versus IL-13 and suggest that the extracellular cytokine-receptor interactions are modulating intracellular membrane-proximal signaling events.	[LaPorte, Sherry L.; Juo, Z. Sean; Vaclavikova, Jana; Colf, Leremy A.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Qi, Xiulan; Heller, Nicola M.; Keegan, Achsah D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Qi, Xiulan; Heller, Nicola M.; Keegan, Achsah D.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Qi, Xiulan; Heller, Nicola M.; Keegan, Achsah D.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038985, R01AI051321, R37AI051321, R01AI038985] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [T32 HL007698] Funding Source: Medline; NIAID NIH HHS [R01 AI051321-05, R37 AI051321, AI51321, R29 AI038985, R01 AI038985, AI38985, R01 AI051321] Funding Source: Medline; PHS HHS [HHMI_GARCIA_K] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Andrews AL, 2002, J BIOL CHEM, V277, P46073, DOI 10.1074/jbc.M209560200; Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Arima K, 2005, J BIOL CHEM, V280, P24915, DOI 10.1074/jbc.M502571200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnes PJ, 2002, ANNU REV PHARMACOL, V42, P81, DOI 10.1146/annurev.pharmtox.42.111901.111143; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chirifu M, 2007, NAT IMMUNOL, V8, P1001, DOI 10.1038/ni1492; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster PS, 2002, PHARMACOL THERAPEUT, V94, P253, DOI 10.1016/S0163-7258(02)00220-6; Greiser JS, 2002, J BIOL CHEM, V277, P26959, DOI 10.1074/jbc.M204113200; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Keller Y, 2003, IEEE T CIRC SYST VID, V13, P300, DOI 10.1109/TCSVT.2003.811360; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kraich M, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-13; Lai SY, 1996, P NATL ACAD SCI USA, V93, P231, DOI 10.1073/pnas.93.1.231; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard W.J., 1999, FUNDAMENTAL IMMUNOLO, Vfourth, P741; LEONARD WJ, 1994, ADV EXP MED BIOL, V365, P225; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miloux B, 1997, FEBS LETT, V401, P163, DOI 10.1016/S0014-5793(96)01462-7; Moy FJ, 2001, J MOL BIOL, V310, P219, DOI 10.1006/jmbi.2001.4764; Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X; Murata T, 1998, BLOOD, V91, P3884; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; OBIRI NI, 1995, J BIOL CHEM, V270, P8797, DOI 10.1074/jbc.270.15.8797; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; PARK LS, 1987, J EXP MED, V166, P476, DOI 10.1084/jem.166.2.476; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Socolovsky M, 1998, BLOOD, V92, P1491, DOI 10.1182/blood.V92.5.1491.417k40_1491_1496; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; WALTER MR, 1992, J BIOL CHEM, V267, P20371; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Williams J, 2004, HEALTH ECON, V13, P123, DOI 10.1002/hec.796; WLODAVER A, 1992, FEBS LETT, V309, P59, DOI 10.1016/0014-5793(92)80739-4; Zamorano J, 1996, J IMMUNOL, V157, P4926; Zhang JL, 2002, EUR J BIOCHEM, V269, P1490, DOI 10.1046/j.1432-1033.2002.02796.x; Zhang JL, 2002, J MOL BIOL, V315, P399, DOI 10.1006/jmbi.2001.5243	55	371	403	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					259	272		10.1016/j.cell.2007.12.030	http://dx.doi.org/10.1016/j.cell.2007.12.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243101	Green Accepted, Bronze			2022-12-24	WOS:000253427700012
J	Paul, K; Erhardt, M; Hirano, T; Blair, DF; Hughes, KT				Paul, Koushik; Erhardt, Marc; Hirano, Takanori; Blair, David F.; Hughes, Kelly T.			Energy source of flagellar type III secretion	NATURE			English	Article							PROTON MOTIVE FORCE; SALMONELLA-TYPHIMURIUM; NEGATIVE REGULATOR; ESCHERICHIA-COLI; EXPORT APPARATUS; ATPASE; FLII; FLGM; COMPONENTS; PROTEINS	Bacterial flagella contain a specialized secretion apparatus that functions to deliver the protein subunits that form the filament and other structures to outside the membrane(1). This apparatus is related to the injectisome used by many gram- negative pathogens and symbionts to transfer effector proteins into host cells; in both systems this export mechanism is termed 'type III' secretion(2,3). The flagellar secretion apparatus comprises a membrane- embedded complex of about five proteins, and soluble factors, which include export- dedicated chaperones and an ATPase, FliI, that was thought to provide the energy for export(1,4). Here we show that flagellar secretion in Salmonella enterica requires the proton motive force ( PMF) and does not require ATP hydrolysis by FliI. The export of several flagellar export substrates was prevented by treatment with the protonophore CCCP, with no accompanying decrease in cellular ATP levels. Weak swarming motility and rare flagella were observed in a mutant deleted for FliI and for the non-flagellar type- III secretion ATPases InvJ and SsaN. These findings show that the flagellar secretion apparatus functions as a proton-driven protein exporter and that ATP hydrolysis is not essential for type III secretion.	[Paul, Koushik; Erhardt, Marc; Hirano, Takanori; Blair, David F.; Hughes, Kelly T.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Blair, DF (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	blair@bioscience.utah.edu; hughes@biology.utah.edu		Erhardt, Marc/0000-0001-6292-619X				Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Aldridge P, 2006, MOL MICROBIOL, V60, P630, DOI 10.1111/j.1365-2958.2006.05135.x; BAKKER EP, 1983, BIOCHIM BIOPHYS ACTA, V730, P379, DOI 10.1016/0005-2736(83)90355-3; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Davis R., 1980, ADV BACTERIAL GENETI; DREYFUS G, 1993, J BACTERIOL, V175, P3131, DOI 10.1128/JB.175.10.3131-3138.1993; Evans LDB, 2006, P NATL ACAD SCI USA, V103, P17474, DOI 10.1073/pnas.0605197103; Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981; Fraser GM, 2003, J BACTERIOL, V185, P5546, DOI 10.1128/JB.185.18.5546-5554.2003; GALPERIN MY, 1982, FEBS LETT, V143, P319, DOI 10.1016/0014-5793(82)80125-7; GILLEN KL, 1991, J BACTERIOL, V173, P2301, DOI 10.1128/JB.173.7.2301-2310.1991; GILLEN KL, 1991, J BACTERIOL, V173, P6453, DOI 10.1128/jb.173.20.6453-6459.1991; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Karlinsey JE, 1998, J BACTERIOL, V180, P5384, DOI 10.1128/JB.180.20.5384-5397.1998; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lee HJ, 2006, J BACTERIOL, V188, P3308, DOI 10.1128/JB.188.9.3308-3316.2006; LINO T, 1974, Journal of Supramolecular Structure, V2, P372, DOI 10.1002/jss.400020226; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 2003, J BACTERIOL, V185, P1190, DOI 10.1128/JB.185.4.1190-1194.2003; Rosu V, 2006, J BACTERIOL, V188, P5196, DOI 10.1128/JB.00299-06; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; VOGLER AP, 1991, J BACTERIOL, V173, P3564, DOI 10.1128/jb.173.11.3564-3572.1991; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004	27	237	240	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					489	U13		10.1038/nature06497	http://dx.doi.org/10.1038/nature06497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216859	Bronze			2022-12-24	WOS:000252554100050
J	Mi, SJ; Cai, T; Hu, YG; Chen, Y; Hodges, E; Ni, FR; Wu, L; Li, S; Zhou, H; Long, CZ; Chen, S; Hannon, GJ; Qi, YJ				Mi, Shijun; Cai, Tao; Hu, Yugang; Chen, Yemiao; Hodges, Emily; Ni, Fangrui; Wu, Liang; Li, Shan; Zhou, Huanyu; Long, Chengzu; Chen, She; Hannon, Gregory J.; Qi, Yijun			Sorting of small RNAs into Arabidopsis argonaute complexes is directed by the 5 ' terminal nucleotide	CELL			English	Article							TRANS-ACTING SIRNAS; C-ELEGANS; ANTISENSE TRANSCRIPTS; ENDOGENOUS SIRNAS; PROCESSING CENTER; DNA METHYLATION; MESSENGER-RNAS; MICRORNAS; BIOGENESIS; DROSOPHILA	Argonaute (AGO) proteins recruit small RNAs to form the core of RNAi effector complexes. Arabidopsis encodes ten AGO proteins and a large network of small RNAs. How these small RNAs are sorted into specific AGO complexes remains largely unknown. We have cataloged small RNAs resident in four AGO complexes. We found that AGO2 and AGO4 preferentially recruit small RNAs with a 5 ' terminal adenosine, whereas AGO1 harbors microRNAs (miRNAs) that favor a 5 ' terminal uridine. AGO5 predominantly binds small RNAs that initiate with cytosine. Changing the 5 ' terminal nucleotide of an miRNA predictably redirected it into a different AGO complex and alters its biological activity. These results reveal a role for small RNA sequences in assorting among AGO complexes. This suggests that specialization of AGO complexes might involve remodeling the 5 ' end-binding pocket to accept certain small RNA sequences, perhaps explaining the evolutionary drive for miRNAs to initiate with uridine.	[Mi, Shijun; Cai, Tao; Hu, Yugang; Chen, Yemiao; Ni, Fangrui; Wu, Liang; Li, Shan; Zhou, Huanyu; Long, Chengzu; Chen, She; Qi, Yijun] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Hodges, Emily; Hannon, Gregory J.] Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hodges, Emily; Hannon, Gregory J.] Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	National Institute of Biological Sciences, Beijing; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Qi, YJ (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	qiyijun@nibs.ac.cn	Mi, Shijun/C-9777-2012; Qi, Yijun/AAE-8797-2019; Hannon, Gregory/AAB-3568-2019	Li, Shan/0000-0001-8646-3193; Hodges, Emily/0000-0001-6513-610X	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM062534-08, R01 GM062534] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lynn K, 1999, DEVELOPMENT, V126, P469; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Song JJ, 2006, CURR OPIN STRUC BIOL, V16, P5, DOI 10.1016/j.sbi.2006.01.010; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wang H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r92; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	56	931	997	6	154	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 4	2008	133	1					116	127		10.1016/j.cell.2008.02.034	http://dx.doi.org/10.1016/j.cell.2008.02.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	283MW	18342361	Green Accepted, Bronze			2022-12-24	WOS:000254641300013
J	Yeh, JH; Sidhu, SS; Chan, AC				Yeh, Jung-Hua; Sidhu, Sachdev S.; Chan, Andrew C.			Regulation of a late phase of T cell polarity and effector functions by Crtam	CELL			English	Article							IMMUNOLOGICAL SYNAPSE; NK-CELL; RECEPTOR; COMPLEXES; SCRIBBLE; CD4(+); NECTIN; TH1; PROLIFERATION; TRANSCRIPTION	Spatial organization of cellular proteins plays an important role in establishment of cellular polarity to regulate cell division, differentiation, migration, and organogenesis. Activation of T cells by antigen-presenting cells (APCs) results in the formation of an immunological synapse (IS), assembly of a signaling scaffold at the T cell receptor (TCR) contact, cytoskeletal reorganization, and generation of second messengers within the first hours following intercellular contact. We demonstrate here that Crtam (class-I MHC-restricted T-cell associated molecule), an immunoglobulin-superfamily transmembrane protein, coordinates a signaling complex anchored by the Scrib polarity protein to establish a later phase of T cell polarity on a subset of CD4(+) T cells > 6 hours following activation. Maintenance of this late cellular polarity results in the ability of CD4(+) Crtam(+) T cells to selectively produce more IFN gamma and IL22. Crtam engagement thus modulates signals many hours beyond the initial activation event and dynamically influences the adaptive immune response.	[Yeh, Jung-Hua; Chan, Andrew C.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Sidhu, Sachdev S.] Genentech Inc, Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Chan, AC (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	acc@gene.com	YEH, JUNG-HUA/I-6084-2017					Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Du Pasquier L, 2004, CR BIOL, V327, P591, DOI 10.1016/j.crvi.2004.04.004; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Fuchs A, 2006, SEMIN CANCER BIOL, V16, P359, DOI 10.1016/j.semcancer.2006.07.002; GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; Holzer U, 2003, J IMMUNOL, V170, P1218, DOI 10.4049/jimmunol.170.3.1218; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Kennedy J, 2000, J LEUKOCYTE BIOL, V67, P725, DOI 10.1002/jlb.67.5.725; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; KUPFER A, 1984, J IMMUNOL, V133, P2762; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; LEZZI G, 1999, EUR J IMMUNOL, V29, P4092; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Nagasaka K, 2006, CANCER SCI, V97, P1217, DOI 10.1111/j.1349-7006.2006.00315.x; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Zeitler J, 2004, J CELL BIOL, V167, P1137, DOI 10.1083/jcb.200407158; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	38	87	92	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					846	859		10.1016/j.cell.2008.01.013	http://dx.doi.org/10.1016/j.cell.2008.01.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329370	Bronze			2022-12-24	WOS:000253818000021
J	Orkin, SH; Zon, LI				Orkin, Stuart H.; Zon, Leonard I.			Hematopoiesis: An evolving paradigm for stem cell biology	CELL			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; MOUSE EMBRYO; TRANSCRIPTION FACTORS; DEFINITIVE HEMATOPOIESIS; LINEAGE COMMITMENT; ZEBRAFISH EMBRYOS; YOLK-SAC; ADULT HEMATOPOIESIS; ENDOTHELIAL-CELLS	Establishment and maintenance of the blood system relies on self-renewing hematopoietic stem cells (HSCs) that normally reside in small numbers in the bone marrow niche of adult mammals. This Review describes the developmental origins of HSCs and the molecular mechanisms that regulate lineage-specific differentiation. Studies of hematopoiesis provide critical insights of general relevance to other areas of stem cell biology including the role of cellular interactions in development and tissue homeostasis, lineage programming and reprogramming by transcription factors, and stage- and age-specific differences in cellular phenotypes.	[Orkin, Stuart H.; Zon, Leonard I.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.; Zon, Leonard I.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Stem Cell Inst, Boston, MA 02115 USA; [Orkin, Stuart H.; Zon, Leonard I.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [P01 HL032262-27, R01 HL075735, R01 HL032259, R01 HL032259-27, P01 HL032262, R01 HL075735-06] Funding Source: Medline; NIDDK NIH HHS [P30 DK049216-15, P30 DK049216] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259, P01HL032262, R01HL075735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alden G.S., 2007, NAT REPORTS STEM CEL, DOI [DOI 10.1038/STEMCELLS.2007.42, 10.1038/stemcells.2007.22, DOI 10.1038/STEMCELLS.2007.22]; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Brown RC, 2002, MOL CELL BIOL, V22, P161, DOI 10.1128/MCB.22.1.161-170.2002; Bultman SJ, 2005, GENE DEV, V19, P2849, DOI 10.1101/gad.1364105; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Choi K, 1998, DEVELOPMENT, V125, P725; Ciau-Uitz A, 2000, CELL, V102, P787, DOI 10.1016/S0092-8674(00)00067-2; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Dahl R, 2007, J BIOL CHEM, V282, P6473, DOI 10.1074/jbc.M607613200; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Delassus S, 1996, IMMUNITY, V4, P97, DOI 10.1016/S1074-7613(00)80302-7; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Ema M, 2003, TRENDS CARDIOVAS MED, V13, P254, DOI 10.1016/S1050-1738(03)00105-1; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Galloway JL, 2003, CURR TOP DEV BIOL, V53, P139, DOI 10.1016/S0070-2153(03)53004-6; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Hart DO, 2007, NATURE, V450, P1082, DOI 10.1038/nature06349; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Inman KE, 2007, GENESIS, V45, P237, DOI 10.1002/dvg.20281; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jin H, 2007, BLOOD, V109, P5208, DOI 10.1182/blood-2007-01-069005; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Lane MC, 2002, DEV BIOL, V248, P52, DOI 10.1006/dbio.2002.0717; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martinez J, 2007, GENE DEV, V21, P1983, DOI 10.1101/gad.1591407; Maslova M. N., 1993, Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, V29, P211; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Orkin SH, 2003, IMMUNITY, V19, P633, DOI 10.1016/S1074-7613(03)00302-9; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Palis J, 2001, P NATL ACAD SCI USA, V98, P4528, DOI 10.1073/pnas.071002398; Pardanaud L, 1999, DEVELOPMENT, V126, P617; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Perry JM, 2007, CELL, V129, P1045, DOI 10.1016/j.cell.2007.05.053; Porcher C, 1999, DEVELOPMENT, V126, P4603; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Rossant J, 2007, NATURE, V448, P260, DOI 10.1038/448260a; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; SALEQUE S, 2007, COREST MOL CELL, V27, P562; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Turpen JB, 1997, IMMUNITY, V7, P325, DOI 10.1016/S1074-7613(00)80354-4; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Villablanca EJ, 2007, J IMMUNOL, V179, P357, DOI 10.4049/jimmunol.179.1.357; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Weissman I, 1978, DIFFERENTIATION NORM, V5, P33; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yan JZ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000047; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	113	1575	1640	10	291	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 22	2008	132	4					631	644		10.1016/j.cell.2008.01.025	http://dx.doi.org/10.1016/j.cell.2008.01.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295580	Green Accepted, Bronze			2022-12-24	WOS:000253817900022
J	Wu, SM; Chien, KR; Mummery, C				Wu, Sean M.; Chien, Kenneth R.; Mummery, Christine			Origins and fates of cardiovascular progenitor cells	CELL			English	Article							EMBRYONIC STEM-CELLS; BONE-MARROW; SMOOTH-MUSCLE; MYOCARDIAL-INFARCTION; DIFFERENTIATION; CARDIOMYOCYTES; HEART; MULTIPOTENT; EXPRESSION; TRANSPLANTATION	Multipotent cardiac progenitor cells are found in the fetal and adult heart of many mammalian species including humans and form as intermediates during the differentiation of embryonic stem cells. Despite similar biological properties, the molecular identities of these different cardiac progenitor cell populations appear to be distinct. Elucidating the origins and lineage relationships of these cell populations will accelerate clinical applications such as drug screening and cell therapy as well as shedding light on the pathogenic mechanisms underlying cardiac diseases.	[Mummery, Christine] Utrecht & Interuniv Cardiol Inst, Hubrecht Inst, Univ Med Ctr, NL-3584 CT Utrecht, Netherlands; [Wu, Sean M.; Chien, Kenneth R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Chien, Kenneth R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Wu, Sean M.; Chien, Kenneth R.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University	Mummery, C (corresponding author), Utrecht & Interuniv Cardiol Inst, Hubrecht Inst, Univ Med Ctr, NL-3584 CT Utrecht, Netherlands.	c.mummery@niob.knaw.nl		Wu, Sean/0000-0002-0000-3821; Mummery, Christine/0000-0002-4549-6535	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081086] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL081086, K08 HL081086-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Evans SM, 2007, SEMIN CELL DEV BIOL, V18, P153, DOI 10.1016/j.semcdb.2006.12.009; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Hudon-David F, 2007, J MOL CELL CARDIOL, V42, P991, DOI 10.1016/j.yjmcc.2007.02.009; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; KOH GY, 1995, J CLIN INVEST, V96, P2034, DOI 10.1172/JCI118251; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2007, NATURE, V446, P934, DOI 10.1038/nature05790; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Meyer N, 2000, FEBS LETT, V478, P151, DOI 10.1016/S0014-5793(00)01839-1; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Parmacek MS, 2005, CELL, V120, P295, DOI 10.1016/j.cell.2005.01.025; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; POULY J, 2008, THORAC CARDIOVASC SU, DOI DOI 10.1016/J.JTCVS.2007.10.024; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rawles Mary E., 1943, PHYSIOL ZOOL, V16, P22; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Solloway MJ, 2003, CARDIOVASC RES, V58, P264, DOI 10.1016/S0008-6363(03)00286-4; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	63	145	156	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					537	543		10.1016/j.cell.2008.02.002	http://dx.doi.org/10.1016/j.cell.2008.02.002			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295570	Bronze, Green Accepted			2022-12-24	WOS:000253817900012
J	Kwon, C; Neu, C; Pajonk, S; Yun, HS; Lipka, U; Humphry, M; Bau, S; Straus, M; Kwaaitaal, M; Rampelt, H; El Kasmi, F; Jurgens, G; Parker, J; Panstruga, R; Lipka, V; Schulze-Lefert, P				Kwon, Chian; Neu, Christina; Pajonk, Simone; Yun, Hye Sup; Lipka, Ulrike; Humphry, Matt; Bau, Stefan; Straus, Marco; Kwaaitaal, Mark; Rampelt, Heike; El Kasmi, Farid; Juergens, Gerd; Parker, Jane; Panstruga, Ralph; Lipka, Volker; Schulze-Lefert, Paul			Co-option of a default secretory pathway for plant immune responses	NATURE			English	Article							DISEASE-RESISTANCE; NONHOST RESISTANCE; SNARE-PROTEIN; PENETRATION RESISTANCE; ARABIDOPSIS-THALIANA; CALLOSE SYNTHASE; MEMBRANE-FUSION; COMPLEX; CELLS; REORGANIZATION	Cell- autonomous immunity is widespread in plant - fungus interactions and terminates fungal pathogenesis either at the cell surface or after pathogen entry. Although post- invasive resistance responses typically coincide with a self- contained cell death of plant cells undergoing attack by parasites, these cells survive pre- invasive defence. Mutational analysis in Arabidopsis identified PEN1 syntaxin as one component of two pre- invasive resistance pathways against ascomycete powdery mildew fungi(1-3). Here we show that plasma- membrane- resident PEN1 promiscuously forms SDS- resistant soluble N- ethylmaleimide sensitive factor attachment protein receptor ( SNARE) complexes together with the SNAP33 adaptor and a subset of vesicle- associated membrane proteins ( VAMPs). PEN1- dependent disease resistance acts in vivo mainly through two functionally redundant VAMP72 subfamily members, VAMP721 and VAMP722. Unexpectedly, the same two VAMP proteins also operate redundantly in a default secretory pathway, suggesting dual functions in separate biological processes owing to evolutionary co- option of the default pathway for plant immunity. The disease resistance function of the secretory PEN1 - SNAP33 - VAMP721/ 722 complex and the pathogen- induced subcellular dynamics of its components are mechanistically reminiscent of immunological synapse formation in vertebrates, enabling execution of immune responses through focal secretion.	[Kwon, Chian; Neu, Christina; Pajonk, Simone; Yun, Hye Sup; Lipka, Ulrike; Humphry, Matt; Bau, Stefan; Straus, Marco; Kwaaitaal, Mark; Parker, Jane; Panstruga, Ralph; Lipka, Volker; Schulze-Lefert, Paul] Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Lipka, Ulrike; Rampelt, Heike; Lipka, Volker] Univ Tubingen, ZMBP, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen	Lipka, V (corresponding author), John Innes Inst, John Innes Ctr Plant Sci Res, Sainsbury Lab, Colney Lane, Norwich NR4 7UH, Norfolk, England.	panstrug@mpiz-koeln.mpg.de; Volker.Lipka@sainsbury-laboratory.ac.uk; schlef@mpiz-koeln.mpg.de	El Kasmi, Farid/AHC-5099-2022; Schulze-Lefert, Paul/A-7746-2008; Panstruga, Ralph/F-3340-2011; Humphry, Matthew/A-8136-2008	Panstruga, Ralph/0000-0002-3756-8957; El Kasmi, Farid/0000-0002-4634-7689; Rampelt, Heike/0000-0002-5458-5652; Straus, Marco R/0000-0003-1087-2091				Assaad FF, 2004, MOL BIOL CELL, V15, P5118, DOI 10.1091/mbc.E04-02-0140; Baluska F, 2005, TRENDS PLANT SCI, V10, P106, DOI 10.1016/j.tplants.2005.01.002; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Heese M, 2001, J CELL BIOL, V155, P239, DOI 10.1083/jcb.200107126; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; Kalde M, 2007, P NATL ACAD SCI USA, V104, P11850, DOI 10.1073/pnas.0701083104; Kobayashi Y, 1997, PLANT J, V11, P525, DOI 10.1046/j.1365-313X.1997.11030525.x; Koh S, 2005, PLANT J, V44, P516, DOI 10.1111/j.1365-313X.2005.02545.x; KWON C, IN PRESS TRENDS IMMU; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Roslan HA, 2001, PLANT J, V28, P225, DOI 10.1046/j.1365-313X.2001.01146.x; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takemoto D, 2003, PLANT J, V33, P775, DOI 10.1046/j.1365-313X.2003.01673.x; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Zhang ZG, 2007, PLANT J, V49, P302, DOI 10.1111/j.1365-313X.2006.02961.x	28	332	344	5	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					835	U10		10.1038/nature06545	http://dx.doi.org/10.1038/nature06545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273019	Green Published			2022-12-24	WOS:000253191400044
J	Ryu, JH; Kim, SH; Lee, HY; Bai, JY; Nam, YD; Bae, JW; Lee, DG; Shin, SC; Ha, EM; Lee, WJ				Ryu, Ji-Hwan; Kim, Sung-Hee; Lee, Hyo-Young; Bai, Jin Young; Nam, Young-Do; Bae, Jin-Woo; Lee, Dong Gun; Shin, Seung Chul; Ha, Eun-Mi; Lee, Won-Jae			Innate immune homeostasis by the homeobox gene Caudal and commensal-gut mutualism in Drosophila	SCIENCE			English	Article							ANTIMICROBIAL PEPTIDE GENES; HOST-DEFENSE; INFLAMMATION; EXPRESSION; INFECTION; EPITHELIA; PATHWAY; DISEASE	Although commensalism with gut microbiota exists in all metazoans, the host factors that maintain this homeostatic relationship remain largely unknown. We show that the intestinal homeobox gene Caudal regulates the commensal-gut mutualism by repressing nuclear factor kappa B-dependent antimicrobial peptide genes. Inhibition of Caudal expression in flies via RNA interference led to overexpression of antimicrobial peptides, which in turn altered the commensal population within the intestine. In particular, the dominance of one gut microbe, Gluconobacter sp. strain EW707, eventually led to gut cell apoptosis and host mortality. However, restoration of a healthy microbiota community and normal host survival in the Caudal-RNAi flies was achieved by reintroduction of the Caudal gene. These results reveal that a specific genetic deficiency within a host can profoundly influence the gut commensal microbial community and host physiology.	[Ryu, Ji-Hwan; Kim, Sung-Hee; Lee, Hyo-Young; Bai, Jin Young; Shin, Seung Chul; Ha, Eun-Mi; Lee, Won-Jae] Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; [Ryu, Ji-Hwan; Kim, Sung-Hee; Lee, Hyo-Young; Bai, Jin Young; Shin, Seung Chul; Ha, Eun-Mi; Lee, Won-Jae] Natl Creat Res Initiat Ctr Symbiosyst, Seoul 120750, South Korea; [Lee, Hyo-Young] Inst Pasteur, Lab BBMI, F-75724 Paris, France; [Nam, Young-Do; Bae, Jin-Woo] Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Taejon 305806, South Korea; [Lee, Dong Gun] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Shin, Seung Chul] Yonsei Univ, Coll Med, Brain Korea Program 21, Seoul 120752, South Korea	Ewha Womans University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyungpook National University; Yonsei University; Yonsei University Health System	Lee, WJ (corresponding author), Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea.	lwj@ewha.ac.kr	; Bae, Jin-Woo/S-1955-2017	Nam, Young-Do/0000-0002-2660-3569; Bae, Jin-Woo/0000-0001-6433-5270				Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; MLODZIK M, 1987, CELL, V48, P465, DOI 10.1016/0092-8674(87)90197-8; Moreno E, 1999, NATURE, V400, P873, DOI 10.1038/23709; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ryu JH, 2004, MOL CELL BIOL, V24, P172, DOI 10.1128/MCB.24.1.172-185.2004; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Tingvall TO, 2001, EMBO REP, V2, P239; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	28	570	596	9	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					777	782		10.1126/science.1149357	http://dx.doi.org/10.1126/science.1149357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18218863				2022-12-24	WOS:000252963000052
J	Stouffer, AL; Acharya, R; Salom, D; Levine, AS; Di Costanzo, L; Soto, CS; Tereshko, V; Nanda, V; Stayrook, S; DeGrado, WF				Stouffer, Amanda L.; Acharya, Rudresh; Salom, David; Levine, Anna S.; Di Costanzo, Luigi; Soto, Cinque S.; Tereshko, Valentina; Nanda, Vikas; Stayrook, Steven; DeGrado, William F.			Structural basis for the function and inhibition of an influenza virus proton channel	NATURE			English	Article							M-2 ION-CHANNEL; A VIRUS; ADAMANTANE RESISTANCE; TRANSMEMBRANE DOMAIN; MEMBRANE-PROTEINS; M2; MECHANISM; MODEL; HELIX; STATE	The M2 protein from influenza A virus is a pH- activated proton channel that mediates acidification of the interior of viral particles entrapped in endosomes. M2 is the target of the anti- influenza drugs amantadine and rimantadine; recently, resistance to these drugs in humans, birds and pigs has reached more than 90% ( ref. 1). Here we describe the crystal structure of the transmembrane- spanning region of the homotetrameric protein in the presence and absence of the channel- blocking drug amantadine. pH- dependent structural changes occur near a set of conserved His and Trp residues that are involved in proton gating(2). The drug- binding site is lined by residues that are mutated in amantadine- resistant viruses(3,4). Binding of amantadine physically occludes the pore, and might also perturb the pK(a) of the critical His residue. The structure provides a starting point for solving the problem of resistance to M2- channel blockers.	[Stouffer, Amanda L.; Acharya, Rudresh; Salom, David; Levine, Anna S.; Soto, Cinque S.; Nanda, Vikas; Stayrook, Steven; DeGrado, William F.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Stouffer, Amanda L.; Di Costanzo, Luigi; DeGrado, William F.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Tereshko, Valentina] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Pennsylvania; University of Pennsylvania; University of Chicago	DeGrado, WF (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	wdegrado@mail.med.upenn.edu	Acharya, Rudresh/AAD-1247-2021; Di Costanzo, Luigi Franklin/AAL-6761-2020	Acharya, Rudresh/0000-0002-9012-9849; Di Costanzo, Luigi Franklin/0000-0002-4795-2573; Nanda, Vikas/0000-0003-2786-8347; Stayrook, Steven/0000-0002-1677-8293; Salom, David/0000-0002-3208-1509	NIAID NIH HHS [U01 AI074571] Funding Source: Medline; NIGMS NIH HHS [T32 GM008275, R01 GM054616, R01 GM056423, R37 GM054616, R01 GM088204] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088204, R37GM054616, T32GM008275, R01GM056423, R01GM054616] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayton GS, 2007, J STRUCT BIOL, V157, P570, DOI 10.1016/j.jsb.2006.10.020; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer CM, 1999, VIROLOGY, V254, P196, DOI 10.1006/viro.1998.9552; Betakova T, 2005, J GEN VIROL, V86, P181, DOI 10.1099/vir.0.80358-0; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; *BRUK AXS INC, 2000, SMART SAINT SADABS X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cady SD, 2007, J AM CHEM SOC, V129, P5719, DOI 10.1021/ja070305e; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Christopher NA, 1996, COMPUT CHEM, V20, P339, DOI 10.1016/0097-8485(95)00075-5; Czabotar PE, 2004, VIRUS RES, V99, P57, DOI 10.1016/j.virusres.2003.10.004; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; DUFF KC, 1992, VIROLOGY, V190, P485, DOI 10.1016/0042-6822(92)91239-Q; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gandhi CS, 1999, J BIOL CHEM, V274, P5474, DOI 10.1074/jbc.274.9.5474; GRAMBAS S, 1992, VIROLOGY, V191, P541, DOI 10.1016/0042-6822(92)90229-I; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hu J, 2007, BIOPHYS J, V92, P4335, DOI 10.1529/biophysj.106.090183; Hu J, 2007, BIOPHYS J, V93, P276, DOI 10.1529/biophysj.106.102103; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; MacKinnon R, 2003, FEBS LETT, V555, P62, DOI 10.1016/S0014-5793(03)01104-9; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mould JA, 2000, J BIOL CHEM, V275, P8592, DOI 10.1074/jbc.275.12.8592; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Salom D, 2000, BIOCHEMISTRY-US, V39, P14160, DOI 10.1021/bi001799u; Sansom MSP, 1997, VIROLOGY, V233, P163, DOI 10.1006/viro.1997.8578; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Stouffer AL, 2005, J MOL BIOL, V347, P169, DOI 10.1016/j.jmb.2005.01.023; Takeuchi H, 2003, FEBS LETT, V552, P35, DOI 10.1016/S0014-5793(03)00781-6; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Wang JF, 2001, PROTEIN SCI, V10, P2241, DOI 10.1110/ps.17901; Zhong QF, 2000, FEBS LETT, V473, P195, DOI 10.1016/S0014-5793(00)01522-2	42	480	500	4	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					596	U13		10.1038/nature06528	http://dx.doi.org/10.1038/nature06528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235504	Green Accepted			2022-12-24	WOS:000252739900047
J	Bessonov, S; Anokhina, M; Will, CL; Urlaub, H; Luhrmann, R				Bessonov, Sergey; Anokhina, Maria; Will, Cindy L.; Urlaub, Henning; Luehrmann, Reinhard			Isolation of an active step I spliceosome and composition of its RNP core	NATURE			English	Article							BIMOLECULAR EXON LIGATION; PROTEIN-COMPOSITION; COMPLEX; U2; PRP19; SITE	Formation of catalytically active RNA structures within the spliceosome requires the assistance of proteins. However, little is known about the number and nature of proteins needed to establish and maintain the spliceosome's active site. Here we affinity- purified human spliceosomal C complexes and show that they catalyse exon ligation in the absence of added factors. Comparisons of the composition of the precatalytic versus the catalytic spliceosome revealed a marked exchange of proteins during the transition from the B to the C complex, with apparent stabilization of Prp19 - CDC5 complex proteins and destabilization of SF3a/ b proteins. Disruption of purified C complexes led to the isolation of a salt- stable ribonucleoprotein ( RNP) core that contained both splicing intermediates and U2, U5 and U6 small nuclear RNA plus predominantly U5 and human Prp19 - CDC5 proteins and Prp19- related factors. Our data provide insights into the spliceosome's catalytic RNP domain and indicate a central role for the aforementioned proteins in sustaining its catalytically active structure.	[Bessonov, Sergey; Anokhina, Maria; Will, Cindy L.; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Luhrmann, R (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany.	reinhard.luehrmann@mpi-bpc.mpg.de						Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Anderson K, 2000, RNA, V6, P16, DOI 10.1017/S1355838200001862; Anderson K, 1997, SCIENCE, V276, P1712, DOI 10.1126/science.276.5319.1712; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dybkov O, 2006, MOL CELL BIOL, V26, P2803, DOI 10.1128/MCB.26.7.2803-2816.2006; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Konarska MM, 2006, MOL CELL, V21, P543, DOI 10.1016/j.molcel.2006.01.017; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Nilsen TW, 1998, COLD SPRING HARBOR M, P279; Smith DJ, 2007, MOL CELL, V26, P883, DOI 10.1016/j.molcel.2007.05.020; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Umen JG, 1995, RNA, V1, P869; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Will CL, 2006, COLD SPRING HARB MON, V43, P369; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1	27	286	296	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2008	452	7189					846	U3		10.1038/nature06842	http://dx.doi.org/10.1038/nature06842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18322460	Green Published			2022-12-24	WOS:000255026000042
J	Negi, J; Matsuda, O; Nagasawa, T; Oba, Y; Takahashi, H; Kawai-Yamada, M; Uchimiya, H; Hashimoto, M; Iba, K				Negi, Juntaro; Matsuda, Osamu; Nagasawa, Takashi; Oba, Yasuhiro; Takahashi, Hideyuki; Kawai-Yamada, Maki; Uchimiya, Hirofumi; Hashimoto, Mimi; Iba, Koh			CO2 regulator SLAC1 and its homologues are essential for anion homeostasis in plant cells	NATURE			English	Article							ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; PROTEIN-KINASE; ABSCISIC-ACID; ION CHANNELS; CONDUCTANCE; PROTOPLASTS; ACTIVATION; MALATE; GENE	The continuing rise in atmospheric [ CO2] is predicted to have diverse and dramatic effects on the productivity of agriculture, plant ecosystems and gas exchange(1-3). Stomatal pores in the epidermis provide gates for the exchange of CO2 and water between plants and the atmosphere, processes vital to plant life(4-6). Increased [ CO2] has been shown to enhance anion channel activity(7) proposed to mediate efflux of osmoregulatory anions ( Cl- and malate(2-)) from guard cells during stomatal closure(8,9). However, the genes encoding anion efflux channels in plant plasma membranes remain unknown. Here we report the isolation of an Arabidopsis gene, SLAC1 ( SLOW ANION CHANNEL-ASSOCIATED 1, At1g12480), which mediates CO2 sensitivity in regulation of plant gas exchange. The SLAC1 protein is a distant homologue of bacterial and fungal C4- dicarboxylate transporters, and is localized specifically to the plasma membrane of guard cells. It belongs to a protein family that in Arabidopsis consists of four structurally related members that are common in their plasma membrane localization, but show distinct tissue- specific expression patterns. The loss- of- function mutation in SLAC1 was accompanied by an over- accumulation of the osmoregulatory anions in guard cell protoplasts. Guard- cell- specific expression of SLAC1 or its family members resulted in restoration of the wild- type stomatal responses, including CO2 sensitivity, and also in the dissipation of the over- accumulated anions. These results suggest that SLAC1-family proteins have an evolutionarily conserved function that is required for the maintenance of organic/ inorganic anion homeostasis on the cellular level.	[Negi, Juntaro; Matsuda, Osamu; Nagasawa, Takashi; Oba, Yasuhiro; Hashimoto, Mimi; Iba, Koh] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan; [Takahashi, Hideyuki; Uchimiya, Hirofumi] Iwate Biotechnol Ctr, Kitakami, Iwate 0240003, Japan; [Kawai-Yamada, Maki; Uchimiya, Hirofumi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Kyushu University; University of Tokyo	Iba, K (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan.	koibascb@mbox.nc.kyushu-u.ac.jp	Uchimiya, Hirofumi/B-3813-2012; Takahashi, Hideyuki/V-6943-2018; Kawai-Yamada, Maki/B-2739-2012; Hashimoto-Sugimoto, Mimi/AAJ-6411-2021	Takahashi, Hideyuki/0000-0002-2265-5353; Kawai-Yamada, Maki/0000-0002-8732-052X; Negi, Juntaro/0000-0001-7457-1269				Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; GOTOW K, 1985, PLANT PHYSIOL, V79, P829, DOI 10.1104/pp.79.3.829; Grobler J, 1995, YEAST, V11, P1485, DOI 10.1002/yea.320111503; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Hirata N, 2004, PLANT CELL PHYSIOL, V45, P176, DOI 10.1093/pcp/pch021; Inada H, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P2999; Kohler B, 2000, PLANT PHYSIOL, V122, P243, DOI 10.1104/pp.122.1.243; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Negi J, 2005, PLANT CELL PHYSIOL, V46, pS176; Outlaw WH, 2002, ARCH BIOCHEM BIOPHYS, V407, P63, DOI 10.1016/S0003-9861(02)00460-5; Pandey S, 2002, NEW PHYTOL, V153, P517, DOI 10.1046/j.0028-646X.2001.00329.x; Raschke K, 2003, PLANTA, V217, P639, DOI 10.1007/s00425-003-1033-4; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Uemura T, 2002, GENES CELLS, V7, P743, DOI 10.1046/j.1365-2443.2002.00550.x; Ueno K, 2005, PLANT CELL PHYSIOL, V46, P955, DOI 10.1093/pcp/pci104; Vavasseur A, 2005, NEW PHYTOL, V165, P665, DOI 10.1111/j.1469-8137.2004.01276.x; Willmer C., 1996, STOMATA, DOI DOI 10.1007/978-94-011-0579-8; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; 2007, PFAM DATABASE; 2007, TMHMM SERVER V 2 0	33	424	450	6	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2008	452	7186					483	U13		10.1038/nature06720	http://dx.doi.org/10.1038/nature06720			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18305482				2022-12-24	WOS:000254341300034
J	Venail, PA; MacLean, RC; Bouvier, T; Brockhurst, MA; Hochberg, ME; Mouquet, N				Venail, P. A.; MacLean, R. C.; Bouvier, T.; Brockhurst, M. A.; Hochberg, M. E.; Mouquet, N.			Diversity and productivity peak at intermediate dispersal rate in evolving metacommunities	NATURE			English	Article							SPECIES-DIVERSITY; EVOLUTIONARY DIVERSIFICATION; ECOLOGICAL THEORY; CURRENT KNOWLEDGE; ESCHERICHIA-COLI; PLANT DIVERSITY; BIODIVERSITY; POPULATIONS; COEXISTENCE; HETEROGENEITY	Positive relationships between species diversity and productivity have been reported for a number of ecosystems(1,2). Theoretical and experimental studies have attempted to determine the mechanisms that generate this pattern over short timescales(1,2), but little attention has been given to the problem of understanding how diversity and productivity are linked over evolutionary timescales. Here, we investigate the role of dispersal in determining both diversity and productivity over evolutionary timescales, using experimental metacommunities of the bacterium Pseudomonas fluorescens assembled by divergent natural selection. We show that both regional diversity and productivity peak at an intermediate dispersal rate. Moreover, we demonstrate that these two patterns are linked: selection at intermediate rates of dispersal leads to high niche differentiation between genotypes, allowing greater coverage of the heterogeneous environment and a higher regional productivity. We argue that processes that operate over both ecological and evolutionary timescales should be jointly considered when attempting to understand the emergence of ecosystem- level properties such as diversity - function relationships.	[Venail, P. A.; Hochberg, M. E.; Mouquet, N.] Univ Montpellier 2, CNRS, Inst Sci Evolut, UMR 5554, F-34095 Montpellier 05, France; [Bouvier, T.] Univ Montpellier 2, CNRS, IFREMER, Ecosyst Lagunaires UMR 5119, F-34095 Montpellier, France; [MacLean, R. C.] Univ London Imperial Coll Sci Technol & Med, NERC Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Brockhurst, M. A.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Ifremer; Universite de Montpellier; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Liverpool	Venail, PA (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut, UMR 5554, CC065 Pl Eugene Bataillon, F-34095 Montpellier 05, France.	pvenail@univ-montp2.fr; nmouquet@univ-montp2.fr	Mouquet, Nicolas/G-1285-2010; Bouvier, Thierry/A-1895-2013; MOUQUET, Nicolas/AAL-1440-2021; Venail, Patrick/D-2968-2018; Brockhurst, Michael A/A-6247-2009	Venail, Patrick/0000-0003-1126-280X; Mouquet, Nicolas/0000-0003-1840-6984; Brockhurst, Michael/0000-0003-0362-820X; bouvier, thierry/0000-0002-7151-5680; MacLean, Craig/0000-0002-7941-813X	Natural Environment Research Council [cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; Barrett RDH, 2005, AM NAT, V166, P470, DOI 10.1086/444440; BELL G, 1990, PROC R SOC SER B-BIO, V240, P295, DOI 10.1098/rspb.1990.0039; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Cadotte MW, 2005, ECOL LETT, V8, P548, DOI 10.1111/j.1461-0248.2005.00750.x; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Day T, 2000, AM NAT, V155, P790, DOI 10.1086/303356; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Habets MGJL, 2006, ECOL LETT, V9, P1041, DOI 10.1111/j.1461-0248.2006.00955.x; Hall AR, 2007, P ROY SOC B-BIOL SCI, V274, P73, DOI 10.1098/rspb.2006.3703; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; Mouquet N, 2002, ECOL LETT, V5, P56, DOI 10.1046/j.1461-0248.2002.00281.x; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984	29	126	127	0	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2008	452	7184					210	U57		10.1038/nature06554	http://dx.doi.org/10.1038/nature06554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18337821	Green Published			2022-12-24	WOS:000253925600039
J	Cordier, P; Tournilhac, F; Soulie-Ziakovic, C; Leibler, L				Cordier, Philippe; Tournilhac, Francois; Soulie-Ziakovic, Corinne; Leibler, Ludwik			Self-healing and thermoreversible rubber from supramolecular assembly	NATURE			English	Article							HYDROGEN-BONDING NETWORKS; THERMOPLASTIC ELASTOMERS; POLYMERS; DYNAMICS; POLYBUTADIENE; COPOLYMERS	Rubbers exhibit enormous extensibility up to several hundred per cent, compared with a few per cent for ordinary solids, and have the ability to recover their original shape and dimensions on release of stress(1,2). Rubber elasticity is a property of macromolecules that are either covalently cross- linked(1,2) or connected in a network by physical associations such as small glassy or crystalline domains(3-5), ionic aggregates(6) or multiple hydrogen bonds(7-16). Covalent cross-links or strong physical associations prevent flow and creep. Here we design and synthesize molecules that associate together to form both chains and cross-links via hydrogen bonds. The system shows recoverable extensibility up to several hundred per cent and little creep under load. In striking contrast to conventional cross-linked or thermoreversible rubbers made of macromolecules, these systems, when broken or cut, can be simply repaired by bringing together fractured surfaces to self- heal at room temperature. Repaired samples recuperate their enormous extensibility. The process of breaking and healing can be repeated many times. These materials can be easily processed, re- used and recycled. Their unique self-repairing properties, the simplicity of their synthesis, their availability from renewable resources and the low cost of raw ingredients (fatty acids and urea) bode well for future applications.	[Cordier, Philippe; Tournilhac, Francois; Soulie-Ziakovic, Corinne; Leibler, Ludwik] Ecole Super Phys & Chim Ind Ville Paris, CNRS ESPCI, UMR 7167, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Leibler, L (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS ESPCI, UMR 7167, 10 Rue Vauquelin, F-75005 Paris, France.	ludwik.leibler@espci.fr	Cordier, Philippe/AAS-3134-2020	Cordier, Philippe/0000-0002-6439-9263				AULT WC, 1964, KIRKOTHMER ENCY CHEM, V8, P845; Bosman AW, 2003, MACROMOL SYMP, V201, P143, DOI 10.1002/masy.200351117; Bouteiller L, 2007, ADV POLYM SCI, V207, P79, DOI 10.1007/12_2006_110; CATES ME, 1987, MACROMOLECULES, V20, P2289, DOI 10.1021/ma00175a038; Chino K, 2001, MACROMOLECULES, V34, P9201, DOI 10.1021/ma011253v; Cipelletti L, 2000, PHYS REV LETT, V84, P2275, DOI 10.1103/PhysRevLett.84.2275; Cloitre M, 2000, PHYS REV LETT, V85, P4819, DOI 10.1103/PhysRevLett.85.4819; Colombani O, 2005, MACROMOLECULES, V38, P1752, DOI 10.1021/ma048006m; DRYE TJ, 1992, J CHEM PHYS, V96, P1367, DOI 10.1063/1.462172; Elkins CL, 2005, J POLYM SCI POL CHEM, V43, P4618, DOI 10.1002/pola.20961; Fakirov S, 2005, HANDBOOK OF CONDENSATION THERMOPLASTIC ELASTOMERS, P1, DOI 10.1002/3527606610; Fouquey C., 1990, ADV MATER, V2, P254; HANDLIN DL, 2007, MACROMOLECULAR ENG, V4, P2001; Holden G., 2004, THERMOPLASTIC ELASTO, V3; Kautz H, 2006, MACROMOLECULES, V39, P4265, DOI 10.1021/ma060706z; Kolomiets E, 2006, MACROMOLECULES, V39, P1173, DOI 10.1021/ma0523522; Lange RFM, 1999, J POLYM SCI POL CHEM, V37, P3657, DOI 10.1002/(SICI)1099-0518(19991001)37:19<3657::AID-POLA1>3.0.CO;2-6; Lehn J. M., 1995, SUPRAMOLECULAR CHEM; Ligthart G.B.W.L, 2007, MACROMOL ENG, V1, P351; MACKNIGHT WJ, 2004, THERMOPLASTIC ELASTO, P261; Muller M, 1996, MACROMOLECULES, V29, P2577, DOI 10.1021/ma950984q; Peng CC, 2005, MACROMOLECULES, V38, P5575, DOI 10.1021/ma050419f; Rubinstein M, 2001, MACROMOLECULES, V34, P1058, DOI 10.1021/ma0013049; Rubinstein M, 2003, POLYM PHYS; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; STADLER R, 1986, COLLOID POLYM SCI, V264, P773, DOI 10.1007/BF01500752; STADLER R, 1993, KAUT GUMMI KUNSTST, V46, P619; STPOURCAIN CB, 1995, MACROMOLECULES, V28, P4116, DOI 10.1021/ma00116a010; Tabor D., 1991, LIQUIDS SOLIDS OTHER; Warner M, 1996, PROG POLYM SCI, V21, P853, DOI 10.1016/S0079-6700(96)00013-5	30	2167	2262	78	2924	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					977	980		10.1038/nature06669	http://dx.doi.org/10.1038/nature06669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288191				2022-12-24	WOS:000253313100045
J	Lobell, DB; Burke, MB; Tebaldi, C; Mastrandrea, MD; Falcon, WP; Naylor, RL				Lobell, David B.; Burke, Marshall B.; Tebaldi, Claudia; Mastrandrea, Michael D.; Falcon, Walter P.; Naylor, Rosamond L.			Prioritizing climate change adaptation needs for food security in 2030	SCIENCE			English	Article								Investments aimed at improving agricultural adaptation to climate change inevitably favor some crops and regions over others. An analysis of climate risks for crops in 12 food- insecure regions was conducted to identify adaptation priorities, based on statistical crop models and climate projections for 2030 from 20 general circulation models. Results indicate South Asia and Southern Africa as two regions that, without sufficient adaptation measures, will likely suffer negative impacts on several crops that are important to large food- insecure human populations. We also find that uncertainties vary widely by crop, and therefore priorities will depend on the risk attitudes of investment institutions.	[Lobell, David B.; Burke, Marshall B.; Mastrandrea, Michael D.; Falcon, Walter P.; Naylor, Rosamond L.] Stanford Univ, Woods Inst Environm, Food Secur & Environm Program, Stanford, CA 94305 USA; [Lobell, David B.; Burke, Marshall B.; Falcon, Walter P.; Naylor, Rosamond L.] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA; [Lobell, David B.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Tebaldi, Claudia] Natl Ctr Atmospher Res, Boulder, CO 80305 USA	Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; National Center Atmospheric Research (NCAR) - USA	Lobell, DB (corresponding author), Stanford Univ, Woods Inst Environm, Food Secur & Environm Program, Stanford, CA 94305 USA.	dlobell@stanford.edu	Zhong, Hong Lin/C-2633-2012; tebaldi, claudia/E-3089-2013	tebaldi, claudia/0000-0001-9233-8903; Burke, Marshall/0000-0003-4288-5858; Lobell, David/0000-0002-5969-3476				Alston J. M., 2000, META ANAL RATES RETU; Burton I, 2004, LOOK YOU LEAP RISK M; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Reilly J, 2000, CLIMATIC CHANGE, V45, P253, DOI 10.1023/A:1005669807945; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Smit B, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P877	7	1704	1766	27	949	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					607	610		10.1126/science.1152339	http://dx.doi.org/10.1126/science.1152339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18239122				2022-12-24	WOS:000252772000037
J	Boyle, AP; Davis, S; Shulha, HP; Meltzer, P; Margulies, EH; Weng, Z; Furey, TS; Crawford, GE				Boyle, Alan P.; Davis, Sean; Shulha, Hennady P.; Meltzer, Paul; Margulies, Elliott H.; Weng, Zhiping; Furey, Terrence S.; Crawford, Gregory E.			High-resolution mapping and characterization of open chromatin across the genome	CELL			English	Article							I HYPERSENSITIVE SITES; DNASE-I; REGULATORY ELEMENTS; PROTEIN CTCF; 5 ENDS; GENE; TRANSCRIPTION; SENSITIVITY; ENHANCER; REGION	Mapping DNase I hypersensitive (HS) sites is an accurate method of identifying the location of genetic regulatory elements, including promoters, enhancers, silencers, insulators, and locus control regions. We employed high-throughput sequencing and whole-genome tiled array strategies to identify DNase I HS sites within human primary CD4(+) T cells. Combining these two technologies, we have created a comprehensive and accurate genome-wide open chromatin map. Surprisingly, only 16%-21% of the identified 94,925 DNase I HS sites are found in promoters or first exons of known genes, but nearly half of the most open sites are in these regions. In conjunction with expression, motif, and chromatin immunoprecipitation data, we find evidence of cell-type-specific characteristics, including the ability to identify transcription start sites and locations of different chromatin marks utilized in these cells. In addition, and unexpectedly, our analyses have uncovered detailed features of nucleosome structure.	[Boyle, Alan P.; Furey, Terrence S.; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Shulha, Hennady P.; Weng, Zhiping] Boston Univ, Dept Biomed Engn, Boston, MA 02115 USA; [Davis, Sean; Meltzer, Paul] NCI, Natl Inst Hlth, Ctr Canc Res, Bethesda, MD 20892 USA; [Margulies, Elliott H.] NHGRI, Natl Inst Hlth, Bethesda, MD 20892 USA	Duke University; Boston University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Crawford, GE (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA.	terry.furey@duke.edu; greg.crawford@duke.edu	Davis, Sean/AAD-1801-2021; Boyle, Alan/I-1848-2014	Davis, Sean/0000-0002-8991-6458; Boyle, Alan/0000-0002-2081-1105; Furey, Terry/0000-0001-5546-9672	NATIONAL CANCER INSTITUTE [ZIABC011091] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG003169, Z01HG200341] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHGRI NIH HHS [K22 HG003169-03, HG003169, K22 HG003169] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; Cousins DJ, 2004, J MOL BIOL, V335, P1199, DOI 10.1016/j.jmb.2003.11.052; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034; KEENE MA, 1981, P NATL ACAD SCI-BIOL, V78, P143, DOI 10.1073/pnas.78.1.143; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; MCGHEE JD, 1981, CELL, V27, P45, DOI 10.1016/0092-8674(81)90359-7; Meraro D, 1999, J IMMUNOL, V163, P6468; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; NOLL M, 1974, NUCLEIC ACIDS RES, V1, P1573, DOI 10.1093/nar/1.11.1573; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Scacheri PC, 2006, METHOD ENZYMOL, V411, P270, DOI 10.1016/S0076-6879(06)11014-9; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; SIEBENLIST U, 1986, MOL CELL BIOL, V6, P3042, DOI 10.1128/MCB.6.9.3042; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; SOLLNERWEBB B, 1978, CELL, V14, P611, DOI 10.1016/0092-8674(78)90246-5; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103	42	890	933	4	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					311	322		10.1016/j.cell.2007.12.014	http://dx.doi.org/10.1016/j.cell.2007.12.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243105	Bronze, Green Accepted			2022-12-24	WOS:000253427700016
J	Yang, CH; Belawat, P; Hafen, E; Jan, LY; Jan, YN				Yang, Chung-hui; Belawat, Priyanka; Hafen, Ernst; Jan, Lily Y.; Jan, Yuh-Nung			Drosophila egg-laying site selection as a system to study simple decision-making processes	SCIENCE			English	Article							MELANOGASTER; OCTOPAMINE; BEHAVIOR; PREFERENCE; RESPONSES; DOPAMINE; RECEPTOR; FLIES; ODOR	The ability to select a better option from multiple acceptable ones is important for animals to optimize their resources. The mechanisms that underlie such decision- making processes are not well understood. We found that selection of egg- laying site in Drosophila melanogaster is a suitable system to probe the neural circuit that governs simple decision- making processes. First, Drosophila females pursue active probing of the environment before depositing each egg, apparently to evaluate site quality for every egg. Second, Drosophila females can either accept or reject a sucrose- containing medium, depending on the context. Last, communication of the "acceptability" of the sucrose- containing medium as an egg- laying option to the reproductive system depends on the function of a group of insulin- like peptide 7 ( ILP7)- producing neurons. These findings suggest that selection of egg- laying site involves a simple decision- making process and provide an entry point toward a systematic dissection of this process.	[Yang, Chung-hui; Jan, Lily Y.; Jan, Yuh-Nung] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol Biochem & Biophys, San Francisco, CA 94143 USA; [Belawat, Priyanka; Hafen, Ernst] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol Biochem & Biophys, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01 MH084234] Funding Source: Medline; NINDS NIH HHS [R01 NS40929, R01 NS047200-04, R01 NS040929, R01 NS040929-08, R37 NS040929] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047200, R37NS040929, R01NS040929] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEMAND R, 1989, EXPERIENTIA, V45, P1147, DOI 10.1007/BF01950184; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Eisses KT, 1997, BEHAV GENET, V27, P171, DOI 10.1023/A:1025697627556; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hammer M, 1998, LEARN MEMORY, V5, P146; HUDSON P, 1981, NATURE, V291, P127, DOI 10.1038/291127a0; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Mery F, 2002, P NATL ACAD SCI USA, V99, P14274, DOI 10.1073/pnas.222371199; Monastirioti M, 1996, J NEUROSCI, V16, P3900; RICHMOND RC, 1979, BEHAV GENET, V9, P233, DOI 10.1007/BF01071304; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Spradling Allan C., 1993, P1; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; TAKAMURA T, 1980, BEHAV GENET, V10, P105, DOI 10.1007/BF01067322; THOMPSON KJ, 1986, J EXP BIOL, V122, P387; VANDELDEN W, 1990, BEHAV GENET, V20, P661, DOI 10.1007/BF01065877; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357	21	250	258	9	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1679	1683		10.1126/science.1151842	http://dx.doi.org/10.1126/science.1151842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356529	Green Accepted			2022-12-24	WOS:000254172300045
J	Nykypanchuk, D; Maye, MM; van der Lelie, D; Gang, O				Nykypanchuk, Dmytro; Maye, Mathew M.; van der Lelie, Daniel; Gang, Oleg			DNA-guided crystallization of colloidal nanoparticles	NATURE			English	Article							SUPERLATTICES; ASSEMBLIES; HYBRIDIZATION; NANOCRYSTALS; PROTEIN; ARRAYS	Many nanometre-sized building blocks will readily assemble into macroscopic structures. If the process is accompanied by effective control over the interactions between the blocks and all entropic effects(1,2), then the resultant structures will be ordered with a precision hard to achieve with other fabrication methods. But it remains challenging to use self- assembly to design systems comprised of different types of building blocks - to realize novel magnetic, plasmonic and photonic metamaterials(3-5), for example. A conceptually simple idea for overcoming this problem is the use of 'encodable' interactions between building blocks; this can in principle be straightforwardly implemented using biomolecules(6-10). Strategies that use DNA programmability to control the placement of nanoparticles in one and two dimensions have indeed been demonstrated(11-13). However, our theoretical understanding of how to extend this approach to three dimensions is limited(14,15), and most experiments have yielded amorphous aggregates(16-19) and only occasionally crystallites of close- packed micrometre- sized particles(9,10). Here, we report the formation of three- dimensional crystalline assemblies of gold nanoparticles mediated by interactions between complementary DNA molecules attached to the nanoparticles' surface. We find that the nanoparticle crystals form reversibly during heating and cooling cycles. Moreover, the body- centred- cubic lattice structure is temperature-tuneable and structurally open, with particles occupying only similar to 4% of the unit cell volume. We expect that our DNA-mediated crystallization approach, and the insight into DNA design requirements it has provided, will facilitate both the creation of new classes of ordered multicomponent metamaterials and the exploration of the phase behaviour of hybrid systems with addressable interactions.	[Nykypanchuk, Dmytro; Maye, Mathew M.; Gang, Oleg] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [van der Lelie, Daniel] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory	Gang, O (corresponding author), Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA.	ogang@bnl.gov	Han, Kyuhee/B-6201-2009					[Anonymous], 1992, INTERMOLECULAR SURFA; Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; DAN N, 1992, MACROMOLECULES, V25, P2890, DOI 10.1021/ma00037a016; Hurst SJ, 2006, ANAL CHEM, V78, P8313, DOI 10.1021/ac0613582; KATZ E, 1996, NATURE, V382, P609; Kim AJ, 2006, LANGMUIR, V22, P1991, DOI 10.1021/la0528955; Lee J, 2007, NAT MATER, V6, P291, DOI 10.1038/nmat1869; Lukatsky DB, 2006, J PHYS-CONDENS MAT, V18, pS567, DOI 10.1088/0953-8984/18/18/S05; Lytton-Jean AKR, 2005, J AM CHEM SOC, V127, P12754, DOI 10.1021/ja052255o; Maye MM, 2007, SMALL, V3, P1678, DOI 10.1002/smll.200700357; Maye MM, 2006, J AM CHEM SOC, V128, P14020, DOI 10.1021/ja0654229; MILNER ST, 1988, EUROPHYS LETT, V7, P695, DOI 10.1209/0295-5075/7/8/005; MIRKIN CA, 1996, NATURE, V382, P609; Nykypanchuk D, 2007, LANGMUIR, V23, P6305, DOI 10.1021/la0637566; Park SJ, 2001, ANGEW CHEM INT EDIT, V40, P2909, DOI 10.1002/1521-3773(20010803)40:15<2909::AID-ANIE2909>3.0.CO;2-O; Park SJ, 2004, J PHYS CHEM B, V108, P12375, DOI 10.1021/jp040242b; Pinto YY, 2005, NANO LETT, V5, P2399, DOI 10.1021/nl0515495; Redl FX, 2003, NATURE, V423, P968, DOI 10.1038/nature01702; Rogers PH, 2005, LANGMUIR, V21, P5562, DOI 10.1021/la046790y; Rubinstein M., 2003, POLYM PHYS; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Tang ZY, 2005, ADV MATER, V17, P951, DOI 10.1002/adma.200401593; Tkachenko AV, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.148303; Urban JJ, 2007, NAT MATER, V6, P115, DOI 10.1038/nmat1826; Valignat MP, 2005, P NATL ACAD SCI USA, V102, P4225, DOI 10.1073/pnas.0500507102; WARREN BE, 1969, XRAY DIFFRACTION, pCH13; Zhang H, 2006, PHYS CHEM CHEM PHYS, V8, P3288, DOI 10.1039/b604745a; Zhang JP, 2006, NANO LETT, V6, P248, DOI 10.1021/nl052210l	28	1232	1257	13	779	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2008	451	7178					549	552		10.1038/nature06560	http://dx.doi.org/10.1038/nature06560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235496				2022-12-24	WOS:000252739900036
J	Xu, XB; D'Hoker, J; Stange, G; Bonne, S; De Leu, N; Xiao, XW; De Casteele, MV; Mellitzer, G; Ling, ZD; Pipeleers, D; Bouwens, L; Scharfmann, R; Gradwohl, G; Heimberg, H				Xu, Xiaobo; D'Hoker, Joke; Stange, Geert; Bonne, Stefan; De Leu, Nico; Xiao, Xiangwei; De Casteele, Mark Van; Mellitzer, Georg; Ling, Zhidong; Pipeleers, Danny; Bouwens, Luc; Scharfmann, Raphael; Gradwohl, Gerard; Heimberg, Harry			beta cells can be generated from endogenous progenitors in injured adult mouse pancreas	CELL			English	Article							IN-VITRO; HUMAN ISLETS; DUCT-CELL; ENDOCRINE; DIFFERENTIATION; NEUROGENIN3; NEOGENESIS; IDENTIFICATION; REGENERATION; EXPRESSION	Novel strategies in diabetes therapy would obviously benefit from the use of beta (beta) cell stem/progenitor cells. However, whether or not adult b cell progenitors exist is one of the most controversial issues in today's diabetes research. Guided by the expression of Neurogenin 3 (Ngn3), the earliest islet cell-specific transcription factor in embryonic development, we show that b cell progenitors can be activated in injured adult mouse pancreas and are located in the ductal lining. Differentiation of the adult progenitors is Ngn3 dependent and gives rise to all islet cell types, including glucose responsive b cells that subsequently proliferate, both in situ and when cultured in embryonic pancreas explants. Multipotent progenitor cells thus exist in the pancreas of adult mice and can be activated cell autonomously to increase the functional b cell mass by differentiation and proliferation rather than by self-duplication of pre-existing beta cells only.	[Xu, Xiaobo; D'Hoker, Joke; Stange, Geert; Bonne, Stefan; De Leu, Nico; Xiao, Xiangwei; De Casteele, Mark Van; Ling, Zhidong; Pipeleers, Danny; Bouwens, Luc; Heimberg, Harry] Vrije Univ Brussel, Diabet Res Ctr, B-1090 Brussels, Belgium; [Mellitzer, Georg; Gradwohl, Gerard] INSERM, U682, F-67200 Strasbourg, France; [Scharfmann, Raphael] INSERM, U845, F-75730 Paris, France; [Scharfmann, Raphael; Gradwohl, Gerard; Heimberg, Harry] Beta Cell Biol Consortium, Nashville, TN 37323 USA; [Xu, Xiaobo; D'Hoker, Joke; Stange, Geert; Bonne, Stefan; De Leu, Nico; De Casteele, Mark Van; Mellitzer, Georg; Ling, Zhidong; Pipeleers, Danny; Bouwens, Luc; Scharfmann, Raphael; Gradwohl, Gerard; Heimberg, Harry] JRDF, Ctr Beta Cell Therapy Diabet, B-1090 Brussels, Belgium	Vrije Universiteit Brussel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm)	Heimberg, H (corresponding author), Vrije Univ Brussel, Diabet Res Ctr, Laarbeeklan 103, B-1090 Brussels, Belgium.	harry.heimberg@vub.ac.be	stange, geert m/C-1092-2009; xiao, xiangwei/K-1218-2012; Gradwohl, Gérard/H-8543-2014; Georg, Mellitzer/R-4180-2016; Gradwohl, Gérard/AFM-9024-2022; scharfmann, raphael/L-3296-2017	stange, geert m/0000-0003-3148-1372; Gradwohl, Gérard/0000-0002-6730-2615; Georg, Mellitzer/0000-0003-4467-0789; Gradwohl, Gérard/0000-0002-6730-2615; Heimberg, Harry/0000-0003-1954-7375; Pipeleers, Daniel/0000-0002-6440-2485; Van De Casteele, mark/0000-0002-8594-9260; Xiao, Xiangwei/0000-0003-0890-9203; Scharfmann, Raphael/0000-0001-7619-337X; De Leu, Nico/0000-0002-0542-5708; Bouwens, Luc/0000-0001-5767-7002				Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; BLUME N, 1990, BIOMED BIOCHIM ACTA, V49, P1247; Bogdani M, 2003, DIABETOLOGIA, V46, P830, DOI 10.1007/s00125-003-1118-4; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; Gao R, 2005, DIABETOLOGIA, V48, P2296, DOI 10.1007/s00125-005-1935-8; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Lee CS, 2006, DIABETES, V55, P269; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Mellitzer G, 2004, MOL ENDOCRINOL, V18, P2765, DOI 10.1210/me.2004-0243; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Miralles F, 1998, DEVELOPMENT, V125, P1017; ORCI L, 1985, CELL, V42, P671, DOI 10.1016/0092-8674(85)90124-2; Ramiya VK, 2000, NAT MED, V6, P278; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Schonhoff SE, 2004, DEV BIOL, V270, P443, DOI 10.1016/j.ydbio.2004.03.013; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Scoggins CR, 2000, AM J PHYSIOL-GASTR L, V279, pG827, DOI 10.1152/ajpgi.2000.279.4.G827; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Suzuki S, 2004, DIABETES, V53, pA214, DOI 10.2337/diabetes.53.8.2143; Taniguchi H, 2003, GENE THER, V10, P15, DOI 10.1038/sj.gt.3301846; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Zahn S, 2004, HYBRIDOMA HYBRIDOM, V23, P385, DOI 10.1089/hyb.2004.23.385	35	760	800	0	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					197	207		10.1016/j.cell.2007.12.015	http://dx.doi.org/10.1016/j.cell.2007.12.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243096	Bronze			2022-12-24	WOS:000253427700007
J	Harrington, LE; Janowski, KM; Oliver, JR; Zajac, AJ; Weaver, CT				Harrington, Laurie E.; Janowski, Karen M.; Oliver, James R.; Zajac, Allan J.; Weaver, Casey T.			Memory CD4 T cells emerge from effector T-cell progenitors	NATURE			English	Article							CLASS-II; LINEAGE RELATIONSHIP; VACCINE DEVELOPMENT; ESCHERICHIA-COLI; VIRUS-INFECTION; CUTTING EDGE; IN-VIVO; EXPRESSION; GENERATION; DISTINCT	A hallmark of adaptive immunity is the generation of memory T cells that confer long- lived, antigen- specific protection against repeat challenges by pathogens(1-5). Understanding the mechanisms by which memory T cells arise is important for rational vaccination strategies and improved therapeutic interventions for chronic infections and autoimmune disorders. The large clonal expansion of CD8 T cells in response to some infections has made the development of CD8 T- cell memory more amenable to study, giving rise to a model of memory cell differentiation in which a fraction of fully competent effector T cells transition into long-lived memory T cells(4,6,7). Delineation of CD4 T- cell memory development has proved more difficult as a result of limitations on tracking the smaller populations of CD4 effector T cells generated during a pathogenic challenge(8-10), complicating efforts to determine whether CD4 memory T cells are direct descendants of effector T cells or whether they develop by alternative pathways(3,4). Here, using two complementary cytokine reporter mouse models to identify interferon ( IFN)- gamma-positive effector T cells and track their fate, we show that the lineage relationship between effector and memory CD4 T cells resembles that for CD8 T cells responding to the same pathogen. We find that, in parallel with effector CD8 T cells, IFN-gamma-positive effector CD4 T cells give rise to long- lived memory T cells capable of anamnestic responses to antigenic rechallenge.	[Harrington, Laurie E.; Janowski, Karen M.; Oliver, James R.; Weaver, Casey T.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Zajac, Allan J.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Weaver, CT (corresponding author), Univ Alabama, Dept Pathol, 845 19th St S, Birmingham, AL 35294 USA.	cweaver@uab.edu		Weaver, Casey/0000-0002-2180-1793				Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Bevan MJ, 2002, NATURE, V420, P748, DOI 10.1038/420748a; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Fuller MJ, 2005, J IMMUNOL, V174, P5926, DOI 10.4049/jimmunol.174.10.5926; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Varga SM, 1998, J IMMUNOL, V161, P367; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Whitmire JK, 1998, J VIROL, V72, P8281, DOI 10.1128/JVI.72.10.8281-8288.1998; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	35	183	192	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					356	U8		10.1038/nature06672	http://dx.doi.org/10.1038/nature06672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18322463				2022-12-24	WOS:000254117400048
J	Wasmer, C; Lange, A; Van Melckebeke, H; Siemer, AB; Riek, R; Meier, BH				Wasmer, Christian; Lange, Adam; Van Melckebeke, Helene; Siemer, Ansgar B.; Riek, Roland; Meier, Beat H.			Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core	SCIENCE			English	Article							HET-S PRION; SOLID-STATE NMR; ANGLE-SPINNING NMR; CRYSTAL-STRUCTURE; PROTEIN; DOMAIN; SPECTROSCOPY; C-13; POLYMORPHISM; CONSTRAINTS	Prion and nonprion forms of proteins are believed to differ solely in their three- dimensional structure, which is therefore of paramount importance for the prion function. However, no atomic-resolution structure of the fibrillar state that is likely infectious has been reported to date. We present a structural model based on solid- state nuclear magnetic resonance restraints for amyloid fibrils from the prion- forming domain ( residues 218 to 289) of the HET- s protein from the filamentous fungus Podospora anserina. On the basis of 134 intra- and intermolecular experimental distance restraints, we find that HET- s( 218 - 289) forms a left- handed beta solenoid, with each molecule forming two helical windings, a compact hydrophobic core, at least 23 hydrogen bonds, three salt bridges, and two asparagine ladders. The structure is likely to have broad implications for understanding the infectious amyloid state.	[Wasmer, Christian; Lange, Adam; Van Melckebeke, Helene; Siemer, Ansgar B.; Riek, Roland; Meier, Beat H.] ETH, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Meier, BH (corresponding author), ETH, CH-8093 Zurich, Switzerland.	beme@ethz.ch	Wasmer, Christian/A-7922-2008; Meier, Beat H/K-4066-2016	Wasmer, Christian/0000-0001-6842-350X; Meier, Beat H/0000-0002-9107-4464; Riek, Roland/0000-0002-6333-066X; Lange, Adam/0000-0002-7534-5973				Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Baxa U, 2006, ADV PROTEIN CHEM, V73, P125, DOI 10.1016/S0065-3233(06)73005-4; Benkemoun L, 2006, FUNGAL GENET BIOL, V43, P789, DOI 10.1016/j.fgb.2006.06.006; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Etzkorn M, 2004, J AM CHEM SOC, V126, P14746, DOI 10.1021/ja0479181; Ferguson N, 2006, P NATL ACAD SCI USA, V103, P16248, DOI 10.1073/pnas.0607815103; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P1, DOI 10.1016/S0065-3233(06)73001-7; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lange A, 2005, ANGEW CHEM INT EDIT, V44, P2089, DOI 10.1002/anie.200462516; Lange A, 2002, J AM CHEM SOC, V124, P9704, DOI 10.1021/ja026691b; Lazo ND, 1998, BIOCHEMISTRY-US, V37, P1731, DOI 10.1021/bi971016d; LeMaster DM, 1996, J AM CHEM SOC, V118, P9255, DOI 10.1021/ja960877r; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Sabate R, 2007, J MOL BIOL, V370, P768, DOI 10.1016/j.jmb.2007.05.014; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sen A, 2007, J BIOL CHEM, V282, P5545, DOI 10.1074/jbc.M611464200; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Siemer AB, 2006, J BIOMOL NMR, V34, P75, DOI 10.1007/s10858-005-5582-7; Siemer AB, 2006, J AM CHEM SOC, V128, P13224, DOI 10.1021/ja063639x; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tycko R, 2006, PROTEIN PEPTIDE LETT, V13, P229, DOI 10.2174/092986606775338470; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	37	789	800	0	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2008	319	5869					1523	1526		10.1126/science.1151839	http://dx.doi.org/10.1126/science.1151839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339938				2022-12-24	WOS:000253943800038
J	Coop, G; Wen, XQ; Ober, C; Pritchard, JK; Przeworski, M				Coop, Graham; Wen, Xiaoquan; Ober, Carole; Pritchard, Jonathan K.; Przeworski, Molly			High-resolution mapping of crossovers reveals extensive variation in fine-scale recombination patterns among humans	SCIENCE			English	Article							MEIOTIC RECOMBINATION; HUMAN GENOME; HUMAN MALES; EVOLUTION; HOTSPOT; RATES; MAP; POPULATIONS; CHIMPANZEES; COMPLEX	Recombination plays a crucial role in meiosis, ensuring the proper segregation of chromosomes. Recent linkage disequilibrium ( LD) and sperm- typing studies suggest that recombination rates vary tremendously across the human genome, with most events occurring in narrow "hotspots." To examine variation in fine- scale recombination patterns among individuals, we used dense, genome- wide single- nucleotide polymorphism data collected in nuclear families to localize crossovers with high spatial resolution. This analysis revealed that overall recombination hotspot usage is similar in males and females, with individual hotspots often active in both sexes. Across the genome, roughly 60% of crossovers occurred in hotspots inferred from LD studies. Notably, however, we found extensive and heritable variation among both males and females in the proportion of crossovers occurring in these hotspots.	[Coop, Graham; Wen, Xiaoquan; Ober, Carole; Pritchard, Jonathan K.; Przeworski, Molly] Univ Chicago, Dept Human Genet, Cummings Life Sci Ctr, Chicago, IL 60637 USA; [Ober, Carole] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Coop, G (corresponding author), Univ Chicago, Dept Human Genet, Cummings Life Sci Ctr, 920 E 58th St, Chicago, IL 60637 USA.	gcoop@uchicago.edu; pritch@uchicago.edu; mfp@uchicago.edu		Ober, Carole/0000-0003-4626-9809; Coop, Graham/0000-0001-8431-0302; Wen, Xiaoquan/0000-0001-8990-2737	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056399, R43HL056533, R44HL056533] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083098] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002772, HG002772] Funding Source: Medline; NHLBI NIH HHS [HL56533, HL56399] Funding Source: Medline; NICHD NIH HHS [HD21244] Funding Source: Medline; NIGMS NIH HHS [GM83098] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cheung VG, 2007, AM J HUM GENET, V80, P526, DOI 10.1086/512131; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2004, CYTOGENET GENOME RES, V107, P249, DOI 10.1159/000080602; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Lenormand T, 2003, GENETICS, V163, P811; Lynn A, 2004, ANNU REV GENOM HUM G, V5, P317, DOI 10.1146/annurev.genom.4.070802.110217; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Ptak SE, 2004, PLOS BIOL, V2, P849, DOI 10.1371/journal.pbio.0020155; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; Vallente RU, 2006, CHROMOSOMA, V115, P241, DOI 10.1007/s00412-006-0058-4; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Yu J, 1996, AM J HUM GENET, V59, P1186	31	274	281	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1395	1398		10.1126/science.1151851	http://dx.doi.org/10.1126/science.1151851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18239090				2022-12-24	WOS:000253712900045
J	Szemenyei, H; Hannon, M; Long, JA				Szemenyei, Heidi; Hannon, Mike; Long, Jeff A.			TOPLESS mediates auxin-dependent transcriptional repression during Arabidopsis embryogenesis	SCIENCE			English	Article							BOX PROTEIN TIR1; AUX/IAA PROTEINS; GENE FAMILY; EXPRESSION; ENCODES; GROUCHO; MOTIF; AXIS	The transcriptional response to auxin is critical for root and vascular development during Arabidopsis embryogenesis. Auxin induces the degradation of AUXIN/ INDOLE- 3- ACETIC ACID ( AUX/ IAA) transcriptional repressors, freeing their binding partners, the AUXIN RESPONSE FACTOR ( ARF) proteins, which can activate transcription of auxin response genes. We show that TOPLESS ( TPL) can physically interact with IAA12/ BODENLOS ( IAA12/ BDL) through an ETHYLENE RESPONSE FACTOR ( ERF) - associated amphiphilic repression ( EAR) motif. TPL can repress transcription in vivo and is required for IAA12/ BDL repressive activity. In addition, tpl- 1 can suppress the patterning defects of the bdl- 1 mutant. Direct interaction between TPL and ARF5/ MONOPTEROS, which is regulated by IAA12/ BDL, results in a loss- of- function arf5/ mp phenotype. These observations show that TPL is a transcriptional co- repressor and further our understanding of how auxin regulates transcription during plant development.	[Szemenyei, Heidi; Hannon, Mike; Long, Jeff A.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Szemenyei, Heidi; Hannon, Mike] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Long, JA (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	long@salk.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072764] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM072764, R01 GM072764] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BERLETH T, 1993, DEVELOPMENT, V118, P575; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fukaki H, 2006, PLANT J, V48, P380, DOI 10.1111/j.1365-313X.2006.02882.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Long JA, 2002, DEVELOPMENT, V129, P2797; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Wu KQ, 2002, PLANT PHYSIOL, V128, P30, DOI 10.1104/pp.010696	27	505	557	6	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1384	1386		10.1126/science.1151461	http://dx.doi.org/10.1126/science.1151461			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18258861				2022-12-24	WOS:000253712900042
J	Schwarz, UI; Ritchie, MD; Bradford, Y; Li, C; Dudek, SM; Frye-Anderson, A; Kim, RB; Roden, DM; Stein, CM				Schwarz, Ute I.; Ritchie, Marylyn D.; Bradford, Yuki; Li, Chun; Dudek, Scott M.; Frye-Anderson, Amy; Kim, Richard B.; Roden, Dan M.; Stein, C. Michael			Genetic determinants of response to warfarin during initial anticoagulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REDUCTASE COMPLEX SUBUNIT-1; DOSE REQUIREMENTS; ORAL ANTICOAGULATION; VKORC1 GENE; CYP2C9; THERAPY; POLYMORPHISMS; ASSOCIATION; VARIANTS; COMPLICATIONS	Background: Genetic variants of the enzyme that metabolizes warfarin, cytochrome P-450 2C9 (CYP2C9), and of a key pharmacologic target of warfarin, vitamin K epoxide reductase (VKORC1), contribute to differences in patients' responses to various warfarin doses, but the role of these variants during initial anticoagulation is not clear. Methods: In 297 patients starting warfarin therapy, we assessed CYP2C9 genotypes (CYP2C9 *1, *2, and *3), VKORC1 haplotypes (designated A and non-A), clinical characteristics, response to therapy (as determined by the international normalized ratio [INR]), and bleeding events. The study outcomes were the time to the first INR within the therapeutic range, the time to the first INR of more than 4, the time above the therapeutic INR range, the INR response over time, and the warfarin dose requirement. Results: As compared with patients with the non-A/non-A haplotype, patients with the A/A haplotype of VKORC1 had a decreased time to the first INR within the therapeutic range (P=0.02) and to the first INR of more than 4 (P=0.003). In contrast, the CYP2C9 genotype was not a significant predictor of the time to the first INR within the therapeutic range (P=0.57) but was a significant predictor of the time to the first INR of more than 4 (P=0.03). Both the CYP2C9 genotype and VKORC1 haplotype had a significant influence on the required warfarin dose after the first 2 weeks of therapy. Conclusions: Initial variability in the INR response to warfarin was more strongly associated with genetic variability in the pharmacologic target of warfarin, VKORC1, than with CYP2C9.	[Schwarz, Ute I.; Frye-Anderson, Amy; Kim, Richard B.; Roden, Dan M.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Schwarz, Ute I.; Frye-Anderson, Amy; Kim, Richard B.; Roden, Dan M.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Bradford, Yuki; Dudek, Scott M.] Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37212 USA; [Ritchie, Marylyn D.; Bradford, Yuki; Dudek, Scott M.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37212 USA; [Li, Chun] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Schwarz, UI (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.		Li, Chun/B-8388-2012; Kim, Richard/D-6971-2011; Li, Chun/R-1095-2019; Roden, Dan/ABD-5412-2021; Schwarz, Ute/G-2845-2011; Ritchie, Marylyn/C-1114-2012	Kim, Richard/0000-0001-8148-1632; Li, Chun/0000-0002-8819-2443; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065962, K24HL004012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM031304, U01GM061374] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL065962, U01-HL65962, K24 HL004012, HL04012] Funding Source: Medline; NIGMS NIH HHS [P01 GM031304, U01 GM061374, GM31304, U01-GM61374] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], MICR HEALTHC SER; Ansell J, 2005, CHEST, V127, P415; ANSELL J, 2004, CHEST S, V126, P3; Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beyth RJ, 2000, ANN INTERN MED, V133, P687, DOI 10.7326/0003-4819-133-9-200011070-00010; Cain D, 1997, J BIOL CHEM, V272, P29068, DOI 10.1074/jbc.272.46.29068; Carlquist JF, 2006, J THROMB THROMBOLYS, V22, P191, DOI 10.1007/s11239-006-9030-7; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Dickmann LJ, 2001, MOL PHARMACOL, V60, P382, DOI 10.1124/mol.60.2.382; Gage BF, 2004, THROMB HAEMOSTASIS, V91, P87, DOI 10.1160/TH03-06-0379; Gullov AL, 1999, ARCH INTERN MED, V159, P1322, DOI 10.1001/archinte.159.12.1322; Herman D, 2006, THROMB HAEMOSTASIS, V95, P782, DOI 10.1160/TH05-10-0678; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Lee SC, 2006, CLIN PHARMACOL THER, V79, P197, DOI 10.1016/j.clpt.2005.11.006; Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S; Li T, 2006, J MED GENET, V43, P740, DOI 10.1136/jmg.2005.040410; Lindh JD, 2005, CLIN PHARMACOL THER, V78, P540, DOI 10.1016/j.clpt.2005.08.006; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Margaglione M, 2000, THROMB HAEMOSTASIS, V84, P775; McMahan DA, 1998, J GEN INTERN MED, V13, P311, DOI 10.1046/j.1525-1497.1998.00096.x; Millican EA, 2007, BLOOD, V110, P1511, DOI 10.1182/blood-2007-01-069609; Peyvandi F, 2004, CLIN PHARMACOL THER, V75, P198, DOI 10.1016/j.clpt.2003.09.015; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; SullivanKlose TH, 1996, PHARMACOGENETICS, V6, P341, DOI 10.1097/00008571-199608000-00007; Takahashi H, 2004, CLIN PHARMACOL THER, V75, P376, DOI 10.1016/j.clpt.2004.01.007; Takahashi H, 2006, PHARMACOGENET GENOM, V16, P101, DOI 10.1097/01.fpc.0000184955.08453.a8; Vecsler M, 2006, THROMB HAEMOSTASIS, V95, P205, DOI 10.1160/TH05-06-0446; Veenstra DL, 2005, PHARMACOGENET GENOM, V15, P687, DOI 10.1097/01.fpc.0000174789.77614.68; Veenstra DL, 2005, CLIN PHARMACOL THER, V77, P353, DOI 10.1016/j.clpt.2005.01.019; Voora D, 2005, THROMB HAEMOSTASIS, V93, P700, DOI 10.1160/TH04-08-0542; Wadelius M, 2005, PHARMACOGENOMICS J, V5, P262, DOI 10.1038/sj.tpj.6500313; Xie HG, 2002, ADV DRUG DELIVER REV, V54, P1257, DOI 10.1016/S0169-409X(02)00076-5	37	440	481	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2008	358	10					999	1008		10.1056/NEJMoa0708078	http://dx.doi.org/10.1056/NEJMoa0708078			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JG	18322281	Green Accepted			2022-12-24	WOS:000253644700004
J	Ishii, KJ; Kawagoe, T; Koyama, S; Matsui, K; Kumar, H; Kawai, T; Uematsu, S; Takeuchi, O; Takeshita, F; Coban, C; Akira, S				Ishii, Ken J.; Kawagoe, Tatsukata; Koyama, Shohei; Matsui, Kosuke; Kumar, Himanshu; Kawai, Taro; Uematsu, Satoshi; Takeuchi, Osamu; Takeshita, Fumihiko; Coban, Cevayir; Akira, Shizuo			TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines	NATURE			English	Article							DENDRITIC CELLS; I INTERFERON; ACTIVATION; RECOGNITION; INDUCTION; INFECTION; MICE; VACCINATION; INFLUENZA; PATHWAY	Successful vaccines contain not only protective antigen(s) but also an adjuvant component that triggers innate immune activation and is necessary for their optimal immunogenicity(1,2). In the case of DNA vaccines(3), this consists of plasmid DNA; however, the adjuvant element( s) as well as its intra- and inter- cellular innate immune signalling pathway( s) leading to the encoded antigen- specific T- and B- cell responses remain unclear. Here we demonstrate in vivo that TANK- binding kinase 1 ( TBK1), a non- canonical I kappa B kinase, mediates the adjuvant effect of DNA vaccines and is essential for its immunogenicity in mice. Plasmid-DNA- activated, TBK1- dependent signalling and the resultant type- I interferon receptor- mediated signalling was required for induction of antigen- specific B and T cells, which occurred even in the absence of innate immune signalling through a well known CpG DNA sensor - Toll- like receptor 9 ( TLR9) or Z- DNA binding protein 1 ( ZBP1, also known as DAI, which was recently reported as a potential B- form DNA sensor(4)). Moreover, bone- marrow-transfer experiments revealed that TBK1- mediated signalling in haematopoietic cells was critical for the induction of antigenspecific B and CD4(+) T cells, whereas in non- haematopoietic cells TBK1 was required for CD8(+) T- cell induction. These data suggest that TBK1 is a key signalling molecule for DNA- vaccine- induced immunogenicity, by differentially controlling DNA- activated innate immune signalling through haematopoietic and nonhaematopoietic cells.	[Ishii, Ken J.; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, ERATO, Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; [Ishii, Ken J.] Osaka Univ, Dept Mol Protozool, Suita, Osaka 5650871, Japan; [Ishii, Ken J.; Kawagoe, Tatsukata; Koyama, Shohei; Kumar, Himanshu; Kawai, Taro; Uematsu, Satoshi; Takeuchi, Osamu; Coban, Cevayir; Akira, Shizuo] Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Kawagoe, Tatsukata; Koyama, Shohei; Matsui, Kosuke; Kumar, Himanshu; Kawai, Taro; Uematsu, Satoshi; Takeuchi, Osamu; Coban, Cevayir; Akira, Shizuo] Osaka Univ, Dept Host Def, Suita, Osaka 5650871, Japan; [Coban, Cevayir; Akira, Shizuo] Osaka Univ, Century Ctr Excellence COE 21, Combined Program Microbiol & Immunol, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Takeshita, Fumihiko] Yokohama City Univ, Dept Mol Biodef Res, Grad Sch Med, Kanagawa 2360004, Japan; [Koyama, Shohei] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan	Japan Science & Technology Agency (JST); Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Yokohama City University; Tohoku University	Ishii, KJ (corresponding author), Osaka Univ, ERATO, Japan Sci & Technol Agcy, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kenishii@biken.osaka-u.ac.jp; sakira@biken.osaka-u.ac.jp	Ishii, Ken J/B-1685-2012; Kumar, Himanshu/A-8070-2010; Takeuchi, Osamu/AAG-9359-2019; Coban, Cevayir/B-2129-2012; Takeuchi, Osamu/D-6007-2011; Koyama, Shohei/AAU-4113-2021; Akira, Shizuo/C-3134-2009; COBAN, Cevayir/P-1928-2019; Kumar, Himanshu/J-4494-2012	Ishii, Ken J/0000-0002-6728-3872; Takeuchi, Osamu/0000-0002-1260-6232; Koyama, Shohei/0000-0002-6897-9417; COBAN, Cevayir/0000-0002-4467-7799; Kumar, Himanshu/0000-0001-5246-2694; Kawai, Taro/0000-0001-7510-4662				Babiuk S, 2004, IMMUNOLOGY, V113, P114, DOI 10.1111/j.1365-2567.2004.01938.x; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Condon C, 1996, NAT MED, V2, P1122, DOI 10.1038/nm1096-1122; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishii KJ, 2005, EUR J IMMUNOL, V35, P2397, DOI 10.1002/eji.200425795; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Sasaki S, 2002, J VIROL, V76, P6652, DOI 10.1128/JVI.76.13.6652-6659.2002; Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeshita F, 2006, J VIROL, V80, P6218, DOI 10.1128/JVI.00121-06; Tudor D, 2005, VACCINE, V23, P1258, DOI 10.1016/j.vaccine.2004.09.001; Ulmer JB, 2006, TRENDS MOL MED, V12, P216, DOI 10.1016/j.molmed.2006.03.007; Wang RB, 2001, P NATL ACAD SCI USA, V98, P10817, DOI 10.1073/pnas.181123498; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463	30	471	506	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					725	U6		10.1038/nature06537	http://dx.doi.org/10.1038/nature06537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18256672				2022-12-24	WOS:000252929500043
J	Minamino, T; Namba, K				Minamino, Tohru; Namba, Keiichi			Distinct roles of the FliI ATPase and proton motive force in bacterial flagellar protein export	NATURE			English	Article							III SECRETION; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; CATALYTIC CYCLE; COMPONENTS; APPARATUS; OLIGOMERIZATION; SPECIFICITY; SIMILARITY; REGULATOR	Translocation of many soluble proteins across cell membranes occurs in an ATPase- driven manner. For construction of the bacterial flagellum responsible for motility, most of the components are exported by the flagellar protein export apparatus(1,2). The FliI ATPase is required for this export(3), and its ATPase activity is regulated by FliH(4); however, it is unclear how the chemical energy derived from ATP hydrolysis is used for the export process. Here we report that flagellar proteins of Salmonella enterica serovar Typhimurium are exported even in the absence of FliI. A fliH fliI double null mutant was weakly motile. Certain mutations in FlhA or FlhB, which form the core of the export gate, substantially improved protein export and motility of the double null mutant. Furthermore, proton motive force was essential for the export process. These results suggest that the FliH - FliI complex facilitates only the initial entry of export substrates into the gate, with the energy of ATP hydrolysis being used to disassemble and release the FliH - FliI complex from the protein about to be exported. The rest of the successive unfolding/ translocation process of the substrates is driven by proton motive force.	[Minamino, Tohru; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Minamino, Tohru; Namba, Keiichi] JST, ICORP, Dynam NanoMachine Project, Suita, Osaka 5650871, Japan	Osaka University; Japan Science & Technology Agency (JST)	Namba, K (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	keiichi@fbs.osaka-u.ac.jp	Namba, Keiichi/A-9406-2016					AIZAWA S, 1985, J BACTERIOL, V161, P836, DOI 10.1128/JB.161.3.836-849.1985; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Aldridge P, 2003, MOL MICROBIOL, V49, P1333, DOI 10.1046/j.1365-2958.2003.03637.x; Auvray F, 2002, J MOL BIOL, V318, P941, DOI 10.1016/S0022-2836(02)00172-9; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; EICHELBERG K, 1994, J BACTERIOL, V176, P4501, DOI 10.1128/JB.176.15.4501-4510.1994; Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981; GALPERIN MY, 1982, FEBS LETT, V143, P319, DOI 10.1016/0014-5793(82)80125-7; Gonzalez-Pedrajo B, 2002, MOL MICROBIOL, V45, P967, DOI 10.1046/j.1365-2958.2002.03047.x; Hirano T, 2003, J BACTERIOL, V185, P2485, DOI 10.1128/JB.185.8.2485-2492.2003; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; Karlinsey JE, 2006, J BACTERIOL, V188, P103, DOI 10.1128/JB.188.1.103-114.2006; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; Lane MC, 2006, J BIOL CHEM, V281, P508, DOI 10.1074/jbc.M507238200; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 2004, J MOL MICROB BIOTECH, V7, P5, DOI 10.1159/000077865; Minamino T, 2003, J BACTERIOL, V185, P3983, DOI 10.1128/JB.185.13.3983-3988.2003; Minamino T, 2006, J MOL BIOL, V360, P510, DOI 10.1016/j.jmb.2006.05.010; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; Pallen MJ, 2006, PROTEIN SCI, V15, P935, DOI 10.1110/ps.051958806; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; VOGLER AP, 1991, J BACTERIOL, V173, P3564, DOI 10.1128/jb.173.11.3564-3572.1991; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P255; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	34	219	221	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					485	U12		10.1038/nature06449	http://dx.doi.org/10.1038/nature06449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216858	Bronze			2022-12-24	WOS:000252554100049
J	Neil, SJD; Zang, T; Bieniasz, PD				Neil, Stuart J. D.; Zang, Trinity; Bieniasz, Paul D.			Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu	NATURE			English	Article							VIRUS TYPE-1 VPU; PROTEIN; RAFT; CD4; ENDOCYTOSIS; EXPRESSION; CELLS; GENE; NEF; GAG	Human cells possess an antiviral activity that inhibits the release of retrovirus particles, and other enveloped virus particles, and is antagonized by the HIV- 1 accessory protein, Vpu. This antiviral activity can be constitutively expressed or induced by interferon-alpha, and it consists of protein- based tethers, which we term 'tetherins', that cause retention of fully formed virions on infected cell surfaces. Using deductive constraints and gene expression analyses, we identify CD317 ( also called BST2 or HM1.24), a membrane protein of previously unknown function, as a tetherin. Specifically, CD317 expression correlated with, and induced, a requirement for Vpu during HIV- 1 and murine leukaemia virus particle release. Furthermore, in cells where HIV- 1 virion release requires Vpu expression, depletion of CD317 abolished this requirement. CD317 caused retention of virions on cell surfaces and, after endocytosis, in CD317- positive compartments. Vpu co- localized with CD317 and inhibited these effects. Inhibition of Vpu function and consequent mobilization of tetherin's antiviral activity is a potential therapeutic strategy in HIV/AIDS.	[Neil, Stuart J. D.; Zang, Trinity; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Neil, Stuart J. D.; Zang, Trinity; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, New York, NY 10016 USA	Rockefeller University; Rockefeller University	Bieniasz, PD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 1st Ave, New York, NY 10016 USA.	pbienias@adarc.org		Neil, Stuart/0000-0003-3306-5831				Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; GERAGHTY RJ, 1994, J MED PRIMATOL, V23, P146, DOI 10.1111/j.1600-0684.1994.tb00115.x; GOTO T, 1994, BLOOD, V84, P1922; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; Harila K, 2006, J VIROL, V80, P3765, DOI 10.1128/JVI.80.8.3765-3772.2006; Harila K, 2007, VIROLOGY, V369, P299, DOI 10.1016/j.virol.2007.08.009; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; STREBEL K, 1989, J VIROL, V63, P3784, DOI 10.1128/JVI.63.9.3784-3791.1989; TERWILLIGER EF, 1989, P NATL ACAD SCI USA, V86, P5163, DOI 10.1073/pnas.86.13.5163; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992	22	1375	1429	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					425	U1		10.1038/nature06553	http://dx.doi.org/10.1038/nature06553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18200009	Bronze			2022-12-24	WOS:000252554100036
J	Jaillon, O; Bouhouche, K; Gout, JF; Aury, JM; Noel, B; Saudemont, B; Nowacki, M; Serrano, V; Porcel, BM; Segurens, B; Le Mouel, A; Lepere, G; Schachter, V; Betermier, M; Cohen, J; Wincker, P; Sperling, L; Duret, L; Meyer, E				Jaillon, Olivier; Bouhouche, Khaled; Gout, Jean-Francois; Aury, Jean-Marc; Noel, Benjamin; Saudemont, Baptiste; Nowacki, Mariusz; Serrano, Vincent; Porcel, Betina M.; Segurens, Beatrice; Le Mouel, Anne; Lepere, Gersende; Schachter, Vincent; Betermier, Mireille; Cohen, Jean; Wincker, Patrick; Sperling, Linda; Duret, Laurent; Meyer, Eric			Translational control of intron splicing in eukaryotes	NATURE			English	Article							MESSENGER-RNA DECAY; NONSENSE-MEDIATED DECAY; PROTEIN-SYNTHESIS; GENOME BROWSER; INTERFERENCE; RECOGNITION	Most eukaryotic genes are interrupted by non- coding introns that must be accurately removed from pre- messenger RNAs to produce translatable mRNAs(1). Splicing is guided locally by short conserved sequences, but genes typically contain many potential splice sites, and the mechanisms specifying the correct sites remain poorly understood. In most organisms, short introns recognized by the intron definition mechanism(2) cannot be efficiently predicted solely on the basis of sequence motifs(3). In multicellular eukaryotes, long introns are recognized through exon definition(2) and most genes produce multiple mRNA variants through alternative splicing(4). The nonsense- mediated mRNA decay(5,6) ( NMD) pathway may further shape the observed sets of variants by selectively degrading those containing premature termination codons, which are frequently produced in mammals(7,8). Here we show that the tiny introns of the ciliate Paramecium tetraurelia are under strong selective pressure to cause premature termination of mRNA translation in the event of intron retention, and that the same bias is observed among the short introns of plants, fungi and animals. By knocking down the two P. tetraurelia genes encoding UPF1, a protein that is crucial in NMD, we show that the intrinsic efficiency of splicing varies widely among introns and that NMD activity can significantly reduce the fraction of unspliced mRNAs. The results suggest that, independently of alternative splicing, species with large intron numbers universally rely on NMD to compensate for suboptimal splicing efficiency and accuracy.	[Bouhouche, Khaled; Saudemont, Baptiste; Nowacki, Mariusz; Serrano, Vincent; Le Mouel, Anne; Lepere, Gersende; Meyer, Eric] Ecole Normale Super, Genet Mol Lab, F-75005 Paris, France; [Jaillon, Olivier; Aury, Jean-Marc; Noel, Benjamin; Porcel, Betina M.; Segurens, Beatrice; Schachter, Vincent; Wincker, Patrick] Genoscope CEA, F-91057 Evry, France; [Jaillon, Olivier; Aury, Jean-Marc; Noel, Benjamin; Porcel, Betina M.; Schachter, Vincent; Wincker, Patrick] CNRS, UMR 8030, F-91057 Evry, France; [Jaillon, Olivier; Aury, Jean-Marc; Noel, Benjamin; Porcel, Betina M.; Schachter, Vincent; Wincker, Patrick] Univ Evry, F-91057 Evry, France; [Bouhouche, Khaled; Saudemont, Baptiste; Nowacki, Mariusz; Serrano, Vincent; Le Mouel, Anne; Lepere, Gersende; Meyer, Eric] CNRS, UMR 8541, F-75005 Paris, France; [Bouhouche, Khaled; Betermier, Mireille; Cohen, Jean; Sperling, Linda] CNRS, Ctr Genet Mol, UPR 2167, F-91198 Gif Sur Yvette, France; [Bouhouche, Khaled; Betermier, Mireille; Cohen, Jean; Sperling, Linda] Univ Paris 11, F-91405 Orsay, France; [Bouhouche, Khaled; Betermier, Mireille; Cohen, Jean; Sperling, Linda] Univ Paris 06, F-75005 Paris, France; [Gout, Jean-Francois; Duret, Laurent] Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Meyer, E (corresponding author), Ecole Normale Super, Genet Mol Lab, 46 Rue Ulm, F-75005 Paris, France.	emeyer@biologie.ens.fr	Sperling, Linda/C-9734-2014; Nowacki, Mariusz/E-4485-2011; Bouhouche, khaled/AGR-4456-2022; Aury, Jean-Marc/N-1621-2019; Jaillon, Olivier/GRY-6287-2022	Nowacki, Mariusz/0000-0003-4894-2905; Aury, Jean-Marc/0000-0003-1718-3010; Porcel, Betina/0000-0003-0169-5302; Sperling, Linda/0000-0002-7772-4774; Betermier, Mireille/0000-0002-5407-6292; Gout, Jean-Francois/0000-0002-4549-5647; Duret, Laurent/0000-0003-2836-3463; Meyer, Eric/0000-0002-3161-8597; lepere, gersende/0000-0002-4609-7587; Noel, Benjamin/0000-0002-5830-3253				Arciga-Reyes L, 2006, PLANT J, V47, P480, DOI 10.1111/j.1365-313X.2006.02802.x; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Brogna S, 2002, MOL CELL, V10, P93, DOI 10.1016/S1097-2765(02)00565-8; Buhler M, 2002, EMBO REP, V3, P646, DOI 10.1093/embo-reports/kvf129; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Dahlberg JE, 2004, CURR OPIN CELL BIOL, V16, P335, DOI 10.1016/j.ceb.2004.03.006; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Galvani A, 2002, TRENDS GENET, V18, P11, DOI 10.1016/S0168-9525(01)02548-3; Garnier O, 2004, MOL CELL BIOL, V24, P7370, DOI 10.1128/MCB.24.17.7370-7379.2004; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Iborra FJ, 2004, J CELL SCI, V117, P5713, DOI 10.1242/jcs.01538; Iborra FJ, 2004, J CELL SCI, V117, P899, DOI 10.1242/jcs.00933; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Maquat LE, 2002, GENE DEV, V16, P1743, DOI 10.1101/gad.1014502; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Miriami E, 2004, RNA, V10, P1, DOI 10.1261/rna.5112704; Mohn F, 2005, RNA, V11, P147, DOI 10.1261/rna.7182905; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; Nathanson L, 2003, RNA, V9, P9, DOI 10.1261/rna.2990203; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; RUSSELL CB, 1994, NUCLEIC ACIDS RES, V22, P1221, DOI 10.1093/nar/22.7.1221; Skouri F, 1997, MOL BIOL CELL, V8, P1063; Wachtel C, 2004, RNA, V10, P1740, DOI 10.1261/rna.7480804; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wang J, 2002, SCIENCE, V297, P108, DOI 10.1126/science.1069757; [No title captured]; [No title captured]; [No title captured]	39	164	172	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					359	U15		10.1038/nature06495	http://dx.doi.org/10.1038/nature06495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202663	Green Published			2022-12-24	WOS:000252432100055
J	Rothlisberger, D; Khersonsky, O; Wollacott, AM; Jiang, L; DeChancie, J; Betker, J; Gallaher, JL; Althoff, EA; Zanghellini, A; Dym, O; Albeck, S; Houk, KN; Tawfik, DS; Baker, D				Rothlisberger, Daniela; Khersonsky, Olga; Wollacott, Andrew M.; Jiang, Lin; DeChancie, Jason; Betker, Jamie; Gallaher, Jasmine L.; Althoff, Eric A.; Zanghellini, Alexandre; Dym, Orly; Albeck, Shira; Houk, Kendall N.; Tawfik, Dan S.; Baker, David			Kemp elimination catalysts by computational enzyme design	NATURE			English	Article							PHYSICAL ORGANIC-CHEMISTRY; PROTON-TRANSFER; ANTIBODY; PROTEIN; EVOLUTION; BENZISOXAZOLES; SELECTION; DENSITY; DECOMPOSITION	The design of new enzymes for reactions not catalysed by naturally occurring biocatalysts is a challenge for protein engineering and is a critical test of our understanding of enzyme catalysis. Here we describe the computational design of eight enzymes that use two different catalytic motifs to catalyse the Kemp elimination - a model reaction for proton transfer from carbon - with measured rate enhancements of up to 10 5 and multiple turnovers. Mutational analysis confirms that catalysis depends on the computationally designed active sites, and a high- resolution crystal structure suggests that the designs have close to atomic accuracy. Application of in vitro evolution to enhance the computational designs produced a >200-fold increase in k(cat)/K-m (k(cat)/K-m of 2,600 M(-1)s(-1) and k(cat)/k(uncat) of >10(6)). These results demonstrate the power of combining computational protein design with directed evolution for creating new enzymes, and we anticipate the creation of a wide range of useful new catalysts in the future.	[Rothlisberger, Daniela; Wollacott, Andrew M.; Jiang, Lin; Althoff, Eric A.; Zanghellini, Alexandre; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Betker, Jamie; Gallaher, Jasmine L.; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Khersonsky, Olga; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Dym, Orly; Albeck, Shira] Weizmann Inst Sci, Israel Struct Proteom Ctr, IL-76100 Rehovot, Israel; [DeChancie, Jason; Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Weizmann Institute of Science; Weizmann Institute of Science; University of California System; University of California Los Angeles	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dan.tawfik@weizmann.ac.il; dabaker@u.washington.edu	Baker, David/K-8941-2012; Jiang, Lin/G-1575-2010	Baker, David/0000-0001-7896-6217; 	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abecassis V, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e88; Barlow M, 2002, GENETICS, V160, P823; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; CASEY ML, 1973, J ORG CHEM, V38, P2294, DOI 10.1021/jo00953a006; Cesaro-Tadic S, 2003, NAT BIOTECHNOL, V21, P679, DOI 10.1038/nbt828; Chica RA, 2005, CURR OPIN BIOTECH, V16, P378, DOI 10.1016/j.copbio.2005.06.004; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Debler EW, 2005, P NATL ACAD SCI USA, V102, P4984, DOI 10.1073/pnas.0409207102; Frisch M., 2016, GAUSSIAN 16 REVISION; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Hollfelder F, 2000, J AM CHEM SOC, V122, P1022, DOI 10.1021/ja993471y; Hollfelder F, 1997, J AM CHEM SOC, V119, P9578, DOI 10.1021/ja971970y; Hollfelder F, 1996, NATURE, V383, P60, DOI 10.1038/383060a0; Hu YF, 2004, J AM CHEM SOC, V126, P8197, DOI 10.1021/ja0490727; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; KEMP DS, 1973, J AM CHEM SOC, V95, P6670, DOI 10.1021/ja00801a024; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Misura KMS, 2004, J MOL BIOL, V342, P651, DOI 10.1016/j.jmb.2004.07.038; Na J, 1996, J AM CHEM SOC, V118, P6462, DOI 10.1021/ja953550j; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Press WH., 2002, NUMERICAL RECIPES C, V2; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; THORN SN, 1995, NATURE, V373, P228, DOI 10.1038/373228a0; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; Vartanian JP, 1996, NUCLEIC ACIDS RES, V24, P2627, DOI 10.1093/nar/24.14.2627; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; 1994, ACTA CRYSTALLOGR, V50, P760	34	904	934	8	364	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2008	453	7192					190	U4		10.1038/nature06879	http://dx.doi.org/10.1038/nature06879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18354394	Bronze			2022-12-24	WOS:000255592400032
J	Towers, M; Mahood, R; Yin, YL; Tickle, C				Towers, Matthew; Mahood, Ruth; Yin, Yili; Tickle, Cheryll			Integration of growth and specification in chick wing digit-patterning	NATURE			English	Article							SONIC-HEDGEHOG; CELL-CYCLE; LIMB BUD; POSITIONAL INFORMATION; ANTEROPOSTERIOR AXIS; VALPROIC ACID	In the classical model of chick wing digit- patterning(1), the polarizing region - a group of cells at the posterior margin of the early bud - produces a morphogen gradient, now known to be based on Sonic hedgehog (Shh)(2,3), that progressively specifies anteroposterior positional identities in the posterior digit- forming region(4). Here we add an integral growth component to this model by showing that Shh- dependent proliferation of prospective digit progenitor cells is essential for specifying the complete pattern of digits across the anteroposterior axis. Inhibiting Shh signalling in early wing buds reduced anteroposterior expansion, and posterior digits were lost because all prospective digit precursors formed anterior structures. Inhibiting proliferation also irreversibly reduced anteroposterior expansion, but instead anterior digits were lost because all prospective digit precursors formed posterior structures. When proliferation recovered in such wings, Shh transcription was maintained for longer than normal, suggesting that duration of Shh expression is controlled by a mechanism that measures proliferation. Rescue experiments confirmed that Shh- dependent proliferation controls digit number during a discrete time- window in which Shh- dependent specification normally occurs. Our findings that Shh signalling has dual functions that can be temporally uncoupled have implications for understanding congenital and evolutionary digit reductions.	[Towers, Matthew; Mahood, Ruth; Yin, Yili; Tickle, Cheryll] Univ Dundee, Dept Dev & Cell Biol, Dundee DD1 5EH, Scotland	University of Dundee	Tickle, C (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	cat24@bath.ac.uk		Towers, Matthew/0000-0003-2189-4536	MRC [G9806660] Funding Source: UKRI; Medical Research Council [G9806660] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALBERCH P, 1983, J EMBRYOL EXP MORPH, V76, P177; Alessandri JL, 2000, ARCH PEDIATRIE, V7, P637, DOI 10.1016/S0929-693X(00)80132-3; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; COOKE J, 1980, NATURE, V287, P697, DOI 10.1038/287697a0; Davey MG, 2006, GENE DEV, V20, P1365, DOI 10.1101/gad.369106; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; GABRIEL ML, 1946, J EXP ZOOL, V101, P339, DOI 10.1002/jez.1401010304; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; NIETO A, 1996, METHOD CELL BIOL, P219; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Ohsugi K, 1997, DEV BIOL, V189, P13, DOI 10.1006/dbio.1997.8665; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ros MA, 2003, DEVELOPMENT, V130, P527, DOI 10.1242/dev.00245; Roy S, 2002, J CELL SCI, V115, P4393, DOI 10.1242/jcs.00158; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; SHARONY R, 1993, PRENATAL DIAG, V13, P909, DOI 10.1002/pd.1970131005; SMITH JC, 1979, J EMBRYOL EXP MORPH, V52, P105; SMITH JC, 1981, J EMBRYOL EXP MORPH, V63, P127; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; SUMMERBELL D, 1981, J EMBRYOL EXP MORPH, V63, P161; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; Vargesson N, 1997, DEVELOPMENT, V124, P1909; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yang Y, 1997, DEVELOPMENT, V124, P4393; ZWILLING E, 1956, J EXP ZOOL, V132, P219, DOI 10.1002/jez.1401320203	30	157	159	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2008	452	7189					882	U7		10.1038/nature06718	http://dx.doi.org/10.1038/nature06718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18354396				2022-12-24	WOS:000255026000050
J	Kucharski, R; Maleszka, J; Foret, S; Maleszka, R				Kucharski, R.; Maleszka, J.; Foret, S.; Maleszka, R.			Nutritional control of reproductive status in honeybees via DNA methylation	SCIENCE			English	Article							EPIGENETIC REGULATION; GENE-EXPRESSION; SYSTEM; PLASTICITY; GROWTH; BEE	Fertile queens and sterile workers are alternative forms of the adult female honeybee that develop from genetically identical larvae following differential feeding with royal jelly. We show that silencing the expression of DNA methyltransferase Dnmt3, a key driver of epigenetic global reprogramming, in newly hatched larvae led to a royal jelly- like effect on the larval developmental trajectory; the majority of Dnmt3 small interfering RNA- treated individuals emerged as queens with fully developed ovaries. Our results suggest that DNA methylation in Apis is used for storing epigenetic information, that the use of that information can be differentially altered by nutritional input, and that the flexibility of epigenetic modifications underpins, profound shifts in developmental fates, with massive implications for reproductive and behavioral status.	[Kucharski, R.; Maleszka, J.; Foret, S.; Maleszka, R.] Australian Natl Univ, Arc Ctr Mol Genet & Dev, Res Sch Biol Sci, Canberra, ACT 0200, Australia	Australian National University	Maleszka, R (corresponding author), Australian Natl Univ, Arc Ctr Mol Genet & Dev, Res Sch Biol Sci, Canberra, ACT 0200, Australia.	maleszka@rsbs.anu.edu.au	Maleszka, Ryszard/A-6078-2008; Blow, joe/C-8616-2009; Foret, Sylvain/C-7661-2011	Maleszka, Ryszard/0000-0003-1855-555X; Kucharski, Robert/0000-0002-1708-1877				Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Burdge GC, 2007, BRIT J NUTR, V97, P1036, DOI 10.1017/S0007114507682920; COLHOUN EH, 1960, NATURE, V188, P854, DOI 10.1038/188854a0; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Evans JSO, 2000, INT J INORG MATER, V2, P1; Fry CJ, 2002, SCIENCE, V295, P1847, DOI 10.1126/science.1070260; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Maindonald J, 2007, DATA ANAL GRAPHICS U; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Nelson, 1915, EMBRYOLOGY HONEYBEE; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Schaefer M, 2007, BIOESSAYS, V29, P208, DOI 10.1002/bies.20548; SHUEL R. W., 1960, INSECTES SOCIAUX, V7, P265, DOI 10.1007/BF02224497; ULRICH GM, 1983, CELL TISSUE RES, V230, P49, DOI 10.1007/BF00216026; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WEAVER N, 1957, J ECON ENTOMOL, V50, P759, DOI 10.1093/jee/50.6.759; WEAVER NEVIN, 1957, ANN ENT SOC AMER, V50, P283; West-Eberhard Mary Jane, 2003, pi; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; WILSON EO, 1979, P AM PHILOS SOC, V123, P204	28	752	806	16	342	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2008	319	5871					1827	1830		10.1126/science.1153069	http://dx.doi.org/10.1126/science.1153069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18339900				2022-12-24	WOS:000254394000047
J	Mongillo, G; Barak, O; Tsodyks, M				Mongillo, Gianluigi; Barak, Omri; Tsodyks, Misha			Synaptic theory of working memory	SCIENCE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; NEURAL-NETWORKS; PERSISTENT ACTIVITY; RECURRENT NETWORKS; THETA-OSCILLATIONS; CALCIUM; PLASTICITY; SYNAPSES; DYNAMICS	It is usually assumed that enhanced spiking activity in the form of persistent reverberation for several seconds is the neural correlate of working memory. Here, we propose that working memory is sustained by calcium- mediated synaptic facilitation in the recurrent connections of neocortical networks. In this account, the presynaptic residual calcium is used as a buffer that is loaded, refreshed, and read out by spiking activity. Because of the long time constants of calcium kinetics, the refresh rate can be low, resulting in a mechanism that is metabolically efficient and robust. The duration and stability of working memory can be regulated by modulating the spontaneous activity in the network.	[Barak, Omri; Tsodyks, Misha] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Mongillo, Gianluigi] Ecole Normale Super, Grp Neural Theory, Dept Etud Cognit, F-75231 Paris, France; [Mongillo, Gianluigi] Coll France, F-75231 Paris, France	Weizmann Institute of Science; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; PSL Research University Paris; College de France	Tsodyks, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	misha@weizmann.ac.il	tsodyks, misha/J-4430-2013	Mongillo, Gianluigi/0000-0002-6885-9394; Barak, Omri/0000-0002-7894-6344; Tsodyks, Misha/0000-0002-5661-4349				AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bertram R, 1996, J NEUROPHYSIOL, V75, P1919, DOI 10.1152/jn.1996.75.5.1919; Brunel N, 2003, CEREB CORTEX, V13, P1151, DOI 10.1093/cercor/bhg096; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hebb Donald O., 1949, ORG BEHAV; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HORN D, 1989, PHYS REV A, V40, P1036, DOI 10.1103/PhysRevA.40.1036; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Loebel A, 2002, J COMPUT NEUROSCI, V13, P111, DOI 10.1023/A:1020110223441; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rainer G, 2002, EUR J NEUROSCI, V15, P1244, DOI 10.1046/j.1460-9568.2002.01958.x; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Tsodyks M, 2000, J NEUROSCI, V20; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Volman V, 2007, PHYS BIOL, V4, P91, DOI 10.1088/1478-3975/4/2/003; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	34	667	672	4	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2008	319	5869					1543	1546		10.1126/science.1150769	http://dx.doi.org/10.1126/science.1150769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273PI	18339943				2022-12-24	WOS:000253943800044
J	Brock, MV; Hooker, CM; Ota-Machida, E; Han, Y; Guo, MZ; Ames, S; Glockner, S; Piantadosi, S; Gabrielson, E; Pridham, G; Pelosky, K; Belinsky, SA; Yang, SC; Baylin, SB; Herman, JG				Brock, Malcolm V.; Hooker, Craig M.; Ota-Machida, Emi; Han, Yu; Guo, Mingzhou; Ames, Stephen; Gloeckner, Sabine; Piantadosi, Steven; Gabrielson, Edward; Pridham, Genevieve; Pelosky, Kristen; Belinsky, Steven A.; Yang, Stephen C.; Baylin, Stephen B.; Herman, James G.			DNA methylation markers and early recurrence in stage I lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE PROMOTER HYPERMETHYLATION; COLORECTAL-CANCER; LYMPH-NODES; ABERRANT METHYLATION; MULTIPLE GENES; TUMORS; ASSOCIATION; P16(INK4A); RESECTION; PROFILE	Background: Despite optimal and early surgical treatment of non-small-cell lung cancer (NSCLC), many patients die of recurrent NSCLC. We investigated the association between gene methylation and recurrence of the tumor. Methods: Fifty-one patients with stage I NSCLC who underwent curative resection but who had a recurrence within 40 months after resection (case patients) were matched on the basis of age, NSCLC stage, sex, and date of surgery to 116 patients with stage I NSCLC who underwent curative resection but who did not have a recurrence within 40 months after resection (controls). We investigated whether the methylation of seven genes in tumor and lymph nodes was associated with tumor recurrence. Results: In a multivariate model, promoter methylation of the cyclin-dependent kinase inhibitor 2A gene p16, the H-cadherin gene CDH13, the Ras association domain family 1 gene RASSF1A, and the adenomatous polyposis coli gene APC in tumors and in histologically tumor-negative lymph nodes was associated with tumor recurrence, independently of NSCLC stage, age, sex, race, smoking history, and histologic characteristics of the tumor. Methylation of the promoter regions of p16 and CDH13 in both tumor and mediastinal lymph nodes was associated with an odds ratio of recurrent cancer of 15.50 in the original cohort and an odds ratio of 25.25 when the original cohort was combined with an independent validation cohort of 20 patients with stage I NSCLC. Conclusions: Methylation of the promoter region of the four genes in patients with stage I NSCLC treated with curative intent by means of surgery is associated with early recurrence.	[Brock, Malcolm V.; Hooker, Craig M.; Ota-Machida, Emi; Han, Yu; Guo, Mingzhou; Ames, Stephen; Gloeckner, Sabine; Piantadosi, Steven; Gabrielson, Edward; Pridham, Genevieve; Pelosky, Kristen; Yang, Stephen C.; Baylin, Stephen B.; Herman, James G.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Belinsky, Steven A.] Lovelace Resp Res Inst, Albuquerque, NM USA	Johns Hopkins University; Johns Hopkins Medicine; Lovelace Respiratory Research Institute	Brock, MV (corresponding author), Johns Hopkins Med Inst, 600 N Wolfe St,Blalock 240, Baltimore, MD 21287 USA.	mabrock@jhmi.edu			NATIONAL CANCER INSTITUTE [P50CA058184] Funding Source: NIH RePORTER; NCI NIH HHS [CA058184-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Belinsky SA, 2006, CANCER RES, V66, P3338, DOI 10.1158/0008-5472.CAN-05-3408; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Brock MV, 2004, ANN THORAC SURG, V77, P271, DOI 10.1016/S0003-4975(03)01470-X; Brock MV, 2003, CLIN CANCER RES, V9, P2912; Esteller M, 2000, NEW ENGL J MED, V343, P1740; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2001, CANCER RES, V61, P3225; Ettinger D S, 1996, Oncology (Williston Park), V10, P81; Ginsberg Robert J., 1995, Annals of Thoracic Surgery, V60, P615, DOI 10.1016/0003-4975(95)00537-U; Gu J, 2006, CLIN CANCER RES, V12, P7329, DOI 10.1158/1078-0432.CCR-06-0894; Guo MZ, 2006, CLIN CANCER RES, V12, P4515, DOI 10.1158/1078-0432.CCR-05-2858; Harden SV, 2003, CLIN CANCER RES, V9, P1370; Hellman S, 1997, NEW ENGL J MED, V337, P996, DOI 10.1056/NEJM199710023371408; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hoffman PC, 2000, LANCET, V355, P1280; House MG, 2003, J GASTROINTEST SURG, V7, P1004, DOI 10.1016/j.gassur.2003.08.002; Johnson ZA, 2001, XENOTRANSPLANTATION, V8, P9; Kollermann J, 2003, EUR UROL, V44, P533, DOI 10.1016/S0302-2838(03)00361-0; Lu C, 2004, J CLIN ONCOL, V22, P4575, DOI 10.1200/JCO.2004.01.091; Machida EO, 2006, CANCER RES, V66, P6210, DOI 10.1158/0008-5472.CAN-05-4447; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; MOUNTAIN CF, 1986, CHEST, V89, pS225, DOI 10.1378/chest.89.4.225S; Pellise M, 2004, CLIN CANCER RES, V10, P4444, DOI 10.1158/1078-0432.CCR-03-0600; RIETHMULLER G, 1992, CURR OPIN IMMUNOL, V4, P647, DOI 10.1016/0952-7915(92)90041-C; Safar AM, 2007, ARCH PATHOL LAB MED, V131, P936; Sanchez-Cespedes M, 1999, CLIN CANCER RES, V5, P2450; Toyooka KO, 2001, CANCER RES, V61, P4556; Toyooka S, 2001, MOL CANCER THER, V1, P61; van Engeland M, 2003, CANCER RES, V63, P3133; van Engeland M, 2002, ONCOGENE, V21, P3792, DOI 10.1038/sj.onc.1205466; Wang J, 2004, CLIN CANCER RES, V10, P6119, DOI 10.1158/1078-0432.CCR-04-0652; Zhu JJG, 1999, NEUROSURGERY, V45, P409, DOI 10.1097/00006123-199908000-00049	35	435	465	2	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2008	358	11					1118	1128		10.1056/NEJMoa0706550	http://dx.doi.org/10.1056/NEJMoa0706550			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	272RK	18337602				2022-12-24	WOS:000253877200005
J	Frost, A; Perera, R; Roux, A; Spasov, K; Destaing, O; Egelman, EH; De Camilli, P; Unger, VM				Frost, Adam; Perera, Rushika; Roux, Aurelien; Spasov, Krasimir; Destaing, Olivier; Egelman, Edward H.; De Camilli, Pietro; Unger, Vinzenz M.			Structural basis of membrane invagination by F-BAR domains	CELL			English	Article							CLATHRIN-COATED PITS; ACTIN CYTOSKELETON; CRYSTAL-STRUCTURES; DYNAMIN; CURVATURE; PROTEINS; VISUALIZATION; RECONSTRUCTION; CONSTRICTION; AGGREGATION	BAR superfamily domains shape membranes through poorly understood mechanisms. We solved structures of F-BAR modules bound to flat and curved bilayers using electron (cryo) microscopy. We show that membrane tubules form when F-BARs polymerize into helical coats that are held together by lateral and tip-to-tip interactions. On gel-state membranes or after mutation of residues along the lateral interaction surface, F-BARs adsorb onto bilayers via surfaces other than their concave face. We conclude that membrane binding is separable from membrane bending, and that imposition of the module's concave surface forces fluid-phase bilayers to bend locally. Furthermore, exposure of the domain's lateral interaction surface through a change in orientation serves as the crucial trigger for assembly of the helical coat and propagation of bilayer bending. The geometric constraints and sequential assembly of the helical lattice explain how F-BAR and classical BAR domains segregate into distinct microdomains, and provide insight into the spatial regulation of membrane invagination.	[Frost, Adam; Spasov, Krasimir; Unger, Vinzenz M.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Perera, Rushika; Roux, Aurelien; Destaing, Olivier; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Frost, Adam; De Camilli, Pietro; Unger, Vinzenz M.] Yale Univ, Sch Med, Interdept Neurosci Program, New Haven, CT 06510 USA; [Roux, Aurelien; Destaing, Olivier; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Roux, Aurelien; Destaing, Olivier; De Camilli, Pietro] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Roux, Aurelien; Destaing, Olivier; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; [Egelman, Edward H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; University of Virginia	Unger, VM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 208024, New Haven, CT 06520 USA.	vinzenz.unger@yale.edu	destaing, olivier/M-3802-2013; Roux, Aurelien/AAU-1262-2021; Egelman, Edward H/A-2488-2009; Roux, Aurelien R/G-9541-2013	Roux, Aurelien R/0000-0002-6088-0711; destaing, olivier/0000-0001-7622-3700; Frost, Adam/0000-0003-2231-2577; Egelman, Edward/0000-0003-4844-5212	NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, R01GM071590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024101, P30DA018343] Funding Source: NIH RePORTER; NCI NIH HHS [CA46128, P01 CA046128] Funding Source: Medline; NCRR NIH HHS [P41 RR017573, P41 RR17573] Funding Source: Medline; NIBIB NIH HHS [R01 EB001567, EB001567] Funding Source: Medline; NIDA NIH HHS [P30 DA018343, DA024101, R21 DA024101-01, R21 DA024101] Funding Source: Medline; NIDDK NIH HHS [P30 DK045735, DK45735] Funding Source: Medline; NIGMS NIH HHS [R01 GM071590-02, R01 GM071590, R01 GM071590-03, 5T32GM07205, T32 GM007205, GM071590] Funding Source: Medline; PHS HHS [NCRR 19895-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Brett TJ, 2006, CURR OPIN CELL BIOL, V18, P395, DOI 10.1016/j.ceb.2006.06.014; Bruinsma R, 1996, CURR OPIN SOLID ST M, V1, P401, DOI 10.1016/S1359-0286(96)80032-5; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Le Goff L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.018101; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Rodriguez Y, 2007, BIOPHYS J, V92, P3071, DOI 10.1529/biophysj.106.089078; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Wang LG, 2006, P NATL ACAD SCI USA, V103, P18528, DOI 10.1073/pnas.0608714103; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	47	405	408	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					807	817		10.1016/j.cell.2007.12.041	http://dx.doi.org/10.1016/j.cell.2007.12.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329367	Green Accepted, Bronze			2022-12-24	WOS:000253818000018
J	Ventura, A; Young, AG; Winslow, MM; Lintault, L; Meissner, A; Erkeland, SJ; Newman, J; Bronson, RT; Crowley, D; Stone, JR; Jaenisch, R; Sharp, PA; Jacks, T				Ventura, Andrea; Young, Amanda G.; Winslow, Monte M.; Lintault, Laura; Meissner, Alex; Erkeland, Stefan J.; Newman, Jamie; Bronson, Roderick T.; Crowley, Denise; Stone, James R.; Jaenisch, Rudolf; Sharp, Phillip A.; Jacks, Tyler			Targeted deletion reveals essential and overlapping functions of the miR-17 similar to 92 family of miRNA clusters	CELL			English	Article							MESSENGER-RNA; LUNG CANCERS; MICE LACKING; BCL-2 FAMILY; MICRORNAS; LET-7; GENE; BIM; EXPRESSION; MIR-17-92	miR-17 similar to 92, miR-106b similar to 25, and miR-106a similar to 363 belong to a family of highly conserved miRNA clusters. Amplification and overexpression of miR-17 similar to 92 is observed in human cancers, and its oncogenic properties have been confirmed in a mouse model of B cell lymphoma. Here we show that mice deficient for miR17 similar to 92 die shortly after birth with lung hypoplasia and a ventricular septal defect. The miR-17 similar to 92 cluster is also essential for B cell development. Absence of miR-17 similar to 92 leads to increased levels of the proapoptotic protein Bim and inhibits B cell development at the pro-Bto pre-B transition. Furthermore, while ablation of miR-106b similar to 25 or miR-106a similar to 363 has no obvious phenotypic consequences, compound mutant embryos lacking both miR-106b similar to 25 and miR-17 similar to 92 die at midgestation. These results provide key insights into the physiologic functions of this family of microRNAs and suggest a link between the oncogenic properties of miR-17 similar to 92 and its functions during B lymphopoiesis and lung development.	[Ventura, Andrea; Young, Amanda G.; Winslow, Monte M.; Lintault, Laura; Newman, Jamie; Crowley, Denise; Sharp, Phillip A.; Jacks, Tyler] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Meissner, Alex; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Erkeland, Stefan J.] Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands; [Bronson, Roderick T.] Tufts Univ, Sch Vet, Dept Biomed Sci, North Grafton, MA USA; [Stone, James R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02114 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Erasmus University Rotterdam; Erasmus MC; Tufts University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.	tjacks@mit.edu	Ventura, Andrea/F-1789-2011	Ventura, Andrea/0000-0003-4320-9907; Erkeland, Stefan/0000-0002-1019-7957; Young, Amanda/0000-0002-2199-1873	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA042063-220012, P30 CA014051-34, P30-CA14051, P01 CA042063, P30 CA014051, P01 CA042063-21A10012, 2-PO1-CA42063-21, P30 CA014051-36, P30 CA014051-35] Funding Source: Medline; NIAID NIH HHS [U19 AI056900] Funding Source: Medline; NIGMS NIH HHS [R01 GM034277, R01-GM34277] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA042063, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chen JN, 2000, TRENDS GENET, V16, P383, DOI 10.1016/S0168-9525(00)02075-8; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LU J, 2005, IN PRESS NATURE; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Martensson IL, 2007, CURR OPIN IMMUNOL, V19, P137, DOI 10.1016/j.coi.2007.02.006; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Novotny GW, 2007, CELL DEATH DIFFER, V14, P879, DOI 10.1038/sj.cdd.4402090; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sakata Y, 2002, P NATL ACAD SCI USA, V99, P16197, DOI 10.1073/pnas.252648999; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Webb S, 1998, CIRC RES, V82, P645, DOI 10.1161/01.RES.82.6.645; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	52	1255	1346	2	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					875	886		10.1016/j.cell.2008.02.019	http://dx.doi.org/10.1016/j.cell.2008.02.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329372	Green Accepted, Bronze			2022-12-24	WOS:000253818000023
J	Fan, WW; Waymire, KG; Narula, N; Li, P; Rocher, C; Coskun, PE; Vannan, MA; Narula, J; MacGregor, GR; Wallace, DC				Fan, Weiwei; Waymire, Katrina G.; Narula, Navneet; Li, Peng; Rocher, Christophe; Coskun, Pinar E.; Vannan, Mani A.; Narula, Jagat; MacGregor, Grant R.; Wallace, Douglas C.			A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations	SCIENCE			English	Article							FOLLICLE-STIMULATING-HORMONE; ADAPTIVE SELECTION; APOPTOSIS; GENE; DNA	The majority of mitochondrial DNA ( mtDNA) mutations that cause human disease are mild to moderately deleterious, yet many random mtDNA mutations would be expected to be severe. To determine the fate of the more severe mtDNA mutations, we introduced mtDNAs containing two mutations that affect oxidative phosphorylation into the female mouse germ line. The severe ND6 mutation was selectively eliminated during oogenesis within four generations, whereas the milder COI mutation was retained throughout multiple generations even though the offspring consistently developed mitochondrial myopathy and cardiomyopathy. Thus, severe mtDNA mutations appear to be selectively eliminated from the female germ line, thereby minimizing their impact on population fitness.	[Fan, Weiwei; Waymire, Katrina G.; Rocher, Christophe; Coskun, Pinar E.; MacGregor, Grant R.; Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; [Fan, Weiwei; Waymire, Katrina G.; Rocher, Christophe; Coskun, Pinar E.; Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Narula, Navneet] Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA; [Li, Peng; Vannan, Mani A.; Narula, Jagat] Univ Calif Irvine, Div Cardiol, Dept Med, Irvine, CA 92697 USA; [MacGregor, Grant R.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [MacGregor, Grant R.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; [Wallace, Douglas C.] Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92697 USA; [Wallace, Douglas C.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wallace, DC (corresponding author), Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.	dwallace@uci.edu	Vannan, Mani/AAQ-5992-2020; Fan, Weiwei/B-3782-2010	Rocher, Christophe/0000-0003-1859-9704	NIA NIH HHS [AG13154, AG16573, AG24373] Funding Source: Medline; NICHD NIH HHS [HD45913, U01 HD045913-04, U01 HD045913-01, U01 HD045913-03, U01 HD045913-02] Funding Source: Medline; NIDDK NIH HHS [DK73691] Funding Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016573, R01AG024373, R01AG013154] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Acin-Perez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Levy SE, 1999, TRANSGENIC RES, V8, P137, DOI 10.1023/A:1008967412955; MACGREGOR GR, 2006, EMBRYONIC STEM CELLS, P72; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597; TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242; Trounce I, 1996, SOMAT CELL MOLEC GEN, V22, P81, DOI 10.1007/BF02374379; Tsai-Turton M, 2006, ENDOCRINOLOGY, V147, P1224, DOI 10.1210/en.2005-1281; Wallace D. C., 2007, EMERY RIMOINS PRINCI, V1, P194; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955	19	321	329	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2008	319	5865					958	962		10.1126/science.1147786	http://dx.doi.org/10.1126/science.1147786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276892	Green Accepted			2022-12-24	WOS:000253165700048
J	Ramagopalan, SV; Ebers, GC				Ramagopalan, Sreeram V.; Ebers, George C.			Genes for multiple sclerosis	LANCET			English	Editorial Material							GENOME-WIDE ASSOCIATION; INTERLEUKIN-7 RECEPTOR; RISK LOCI; LINKAGE; SUSCEPTIBILITY; REGIONS		[Ramagopalan, Sreeram V.; Ebers, George C.] Wellcome Trust Ctr Human Genet, Oxford, England; [Ramagopalan, Sreeram V.; Ebers, George C.] John Radcliffe Hosp, Univ Dept Clin Neurol, Oxford OX3 9DU, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Ebers, GC (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	george.ebers@clneuro.ox.ac.uk		Ebers, George/0000-0003-4771-4177				Akesson E, 2003, J NEUROIMMUNOL, V143, P31, DOI 10.1016/j.jneuroim.2003.08.008; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Herrera BM, 2006, GENES IMMUN, V7, P366, DOI 10.1038/sj.gene.6364308; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Oturai A, 1999, ANN NEUROL, V46, P612, DOI 10.1002/1531-8249(199910)46:4<612::AID-ANA9>3.3.CO;2-N; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	12	35	36	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2008	371	9609					283	285		10.1016/S0140-6736(08)60145-2	http://dx.doi.org/10.1016/S0140-6736(08)60145-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254VQ	18294983				2022-12-24	WOS:000252616500008
J	Ditzen, M; Pellegrino, M; Vosshall, LB				Ditzen, Mathias; Pellegrino, Maurizio; Vosshall, Leslie B.			Insect odorant receptors are molecular targets of the insect repellent DEET	SCIENCE			English	Article							AEDES-AEGYPTI; DROSOPHILA-ANTENNA; MEMBRANE TOPOLOGY; IN-VIVO; MOSQUITO; MALARIA; DIPTERA; CULICIDAE; OLFACTION; BEHAVIOR	DEET (N,N-diethyl- meta- toluamide) is the world's most widely used topical insect repellent, with broad effectiveness against most insects. Its mechanism of action and molecular target remain unknown. Here, we show that DEET blocks electrophysiological responses of olfactory sensory neurons to attractive odors in Anopheles gambiae and Drosophila melanogaster. DEET inhibits behavioral attraction to food odors in Drosophila, and this inhibition requires the highly conserved olfactory co- receptor OR83b. DEET inhibits odor- evoked currents mediated by the insect odorant receptor complex, comprising a ligand- binding subunit and OR83b. We conclude that DEET masks host odor by inhibiting subsets of heteromeric insect odorant receptors that require the OR83b co- receptor. The identification of candidate molecular targets for the action of DEET may aid in the design of safer and more effective insect repellents.	[Ditzen, Mathias; Pellegrino, Maurizio; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA	Rockefeller University	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie@mail.rockefeller.edu		Vosshall, Leslie/0000-0002-6060-8099	NIDCD NIH HHS [DC008600] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008600] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Carroll JF, 2005, MED VET ENTOMOL, V19, P101, DOI 10.1111/j.0269-283X.2005.00559.x; DAVIS EE, 1975, J COMP PHYSIOL, V96, P223, DOI 10.1007/BF00612696; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; GILBERT IH, 1955, J ECON ENTOMOL, V48, P741, DOI 10.1093/jee/48.6.741; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Klun JA, 2006, J MED ENTOMOL, V43, P34, DOI 10.1603/0022-2585(2006)043[0034:RADEOS]2.0.CO;2; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; MCCABE ET, 1954, J ORG CHEM, V19, P493, DOI 10.1021/jo01369a003; MCIVER SB, 1981, J MED ENTOMOL, V18, P357, DOI 10.1093/jmedent/18.5.357; Moore S. J., 2004, TRADITIONAL MED PLAN, P343; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; Rowland M, 2004, TROP MED INT HEALTH, V9, P343, DOI 10.1046/j.1365-3156.2003.01183.x; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; SCHRECK CE, 1970, J ECON ENTOMOL, V63, P1576, DOI 10.1093/jee/63.5.1576; TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Xue RD, 2007, EXP PARASITOL, V116, P201, DOI 10.1016/j.exppara.2006.12.011; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	27	239	274	4	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2008	319	5871					1838	1842		10.1126/science.1153121	http://dx.doi.org/10.1126/science.1153121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279ZF	18339904				2022-12-24	WOS:000254394000050
J	Kong, A; Thorleifsson, G; Stefansson, H; Masson, G; Helgason, A; Gudbjartsson, DF; Jonsdottir, GM; Gudjonsson, SA; Sverrisson, S; Thorlacius, T; Jonasdottir, A; Hardarson, GA; Palsson, ST; Frigge, ML; Gulcher, JR; Thorsteinsdottir, U; Stefansson, K				Kong, Augustine; Thorleifsson, Gudmar; Stefansson, Hreinn; Masson, Gisli; Helgason, Agnar; Gudbjartsson, Daniel F.; Jonsdottir, Gudrun M.; Gudjonsson, Sigurjon A.; Sverrisson, Sverrir; Thorlacius, Theodora; Jonasdottir, Aslaug; Hardarson, Gudmundur A.; Palsson, Stefan T.; Frigge, Michael L.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Stefansson, Kari			Sequence variants in the RNF212 gene associate with genome-wide recombination rate	SCIENCE			English	Article							MEIOTIC RECOMBINATION; HUMAN MALES; MEIOSIS; MAP; HUMANS	The genome- wide recombination rate varies between individuals, but the mechanism controlling this variation in humans has remained elusive. A genome- wide search identified sequence variants in the 4p16.3 region correlated with recombination rate in both males and females. These variants are located in the RNF212 gene, a putative ortholog of the ZHP- 3 gene that is essential for recombinations and chiasma formation in Caenorhabditis elegans. It is noteworthy that the haplotype formed by two single- nucleotide polymorphisms ( SNPs) associated with the highest recombination rate in males is associated with a low recombination rate in females. Consequently, if the frequency of the haplotype changes, the average recombination rate will increase for one sex and decrease for the other, but the sex- averaged recombination rate of the population can stay relatively constant.	[Kong, Augustine; Thorleifsson, Gudmar; Stefansson, Hreinn; Masson, Gisli; Helgason, Agnar; Gudbjartsson, Daniel F.; Jonsdottir, Gudrun M.; Gudjonsson, Sigurjon A.; Sverrisson, Sverrir; Thorlacius, Theodora; Jonasdottir, Aslaug; Hardarson, Gudmundur A.; Palsson, Stefan T.; Frigge, Michael L.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet Inc, IS-101 Reykjavik, Iceland		Kong, A (corresponding author), deCODE Genet Inc, IS-101 Reykjavik, Iceland.	kong@decode.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015	Helgason, Agnar/0000-0002-8545-3767; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Kong, Augustine/0000-0001-8193-5438; Stefansson, Hreinn/0000-0002-9331-6666; Gudbjartsson, Daniel/0000-0002-5222-9857				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Carrington M, 2004, TRENDS GENET, V20, P196, DOI 10.1016/j.tig.2004.02.006; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Costa Y, 2007, CHROMOSOME RES, V15, P579, DOI 10.1007/s10577-007-1142-1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 2004, CYTOGENET GENOME RES, V107, P249, DOI 10.1159/000080602; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jantsch V, 2004, MOL CELL BIOL, V24, P7998, DOI 10.1128/MCB.24.18.7998-8006.2004; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Sun F, 2006, HUM MOL GENET, V15, P2376, DOI 10.1093/hmg/ddl162; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	25	137	144	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2008	319	5868					1398	1401		10.1126/science.1152422	http://dx.doi.org/10.1126/science.1152422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	270HW	18239089				2022-12-24	WOS:000253712900046
J	Dixit, R; Ross, JL; Goldman, YE; Holzbaur, ELF				Dixit, Ram; Ross, Jennifer L.; Goldman, Yale E.; Holzbaur, Erika L. F.			Differential regulation of dynein and kinesin motor proteins by tau	SCIENCE			English	Article							CYTOPLASMIC DYNEIN; ALZHEIMERS-DISEASE; MICROTUBULES; TRANSPORT; NEURODEGENERATION; VESICLES	Dynein and kinesin motor proteins transport cellular cargoes toward opposite ends of microtubule tracks. In neurons, microtubules are abundantly decorated with microtubule- associated proteins ( MAPs) such as tau. Motor proteins thus encounter MAPs frequently along their path. To determine the effects of tau on dynein and kinesin motility, we conducted single- molecule studies of motor proteins moving along tau- decorated microtubules. Dynein tended to reverse direction, whereas kinesin tended to detach at patches of bound tau. Kinesin was inhibited at about a tenth of the tau concentration that inhibited dynein, and the microtubule- binding domain of tau was sufficient to inhibit motor activity. The differential modulation of dynein and kinesin motility suggests that MAPs can spatially regulate the balance of microtubule- dependent axonal transport.	[Dixit, Ram; Ross, Jennifer L.; Goldman, Yale E.; Holzbaur, Erika L. F.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Dixit, Ram; Ross, Jennifer L.; Goldman, Yale E.; Holzbaur, Erika L. F.] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Holzbaur, ELF (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu	Ross, Jennifer L/D-7208-2012	Ross, Jennifer L/0000-0002-4838-3798	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048661] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01 AR051174, P01 AR051174-050002, P01-AR-051174] Funding Source: Medline; NIGMS NIH HHS [R01 GM048661, GM-48661, R01 GM048661-16] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Andreadis A, 2006, PROG MOLEC, V44, P89; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Black MM, 1996, J NEUROSCI, V16, P3601; BRAAK H, 1994, ACTA NEUROPATHOL, V87, P554; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Kempf M, 1996, J NEUROSCI, V16, P5583; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Trinczek B, 1999, J CELL SCI, V112, P2355; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Wang ZH, 1999, CELL STRUCT FUNCT, V24, P373, DOI 10.1247/csf.24.373	20	684	706	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1086	1089		10.1126/science.1152993	http://dx.doi.org/10.1126/science.1152993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18202255	Green Accepted			2022-12-24	WOS:000253311700042
J	Nakashiba, T; Young, JZ; McHugh, TJ; Buhl, DL; Tonegawa, S				Nakashiba, Toshiaki; Young, Jennie Z.; McHugh, Thomas J.; Buhl, Derek L.; Tonegawa, Susumu			Transgenic inhibition of synaptic transmission reveals role of CA3 output in hippocampal learning	SCIENCE			English	Article							NMDA RECEPTORS; ENTORHINAL CORTEX; NOVELTY DETECTION; IN-VIVO; MEMORY; NEURONS; STORAGE; RECALL; INACTIVATION; SUPPRESSION	The hippocampus is an area of the brain involved in learning and memory. It contains parallel excitatory pathways referred to as the trisynaptic pathway ( which carries information as follows: entorhinal cortex --> dentate gyrus --> CA3 --> CA1 --> entorhinal cortex) and the monosynaptic pathway ( entorhinal cortex --> CA1 --> entorhinal cortex). We developed a generally applicable tetanus toxin - based method for transgenic mice that permits inducible and reversible inhibition of synaptic transmission and applied it to the trisynaptic pathway while preserving transmission in the monosynaptic pathway. We found that synaptic output from CA3 in the trisynaptic pathway is dispensable and the short monosynaptic pathway is sufficient for incremental spatial learning. In contrast, the full trisynaptic pathway containing CA3 is required for rapid one- trial contextual learning, for pattern completion based memory recall, and for spatial tuning of CA1 cells.	[Nakashiba, Toshiaki; Young, Jennie Z.; McHugh, Thomas J.; Buhl, Derek L.; Tonegawa, Susumu] MIT, Dept Biol, RIKEN MIT Neurosci Res Ctr, Howard Hughes Med Inst,Picower Inst Learning & Me, Cambridge, MA 02139 USA; [Nakashiba, Toshiaki; Young, Jennie Z.; McHugh, Thomas J.; Buhl, Derek L.; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, Dept Biol, RIKEN MIT Neurosci Res Ctr, Howard Hughes Med Inst,Picower Inst Learning & Me, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu	McHugh, Thomas J/A-6693-2010; McHugh, Thomas/M-6159-2019; Buhl, Derek/AAV-3911-2021	McHugh, Thomas J/0000-0002-1243-5189; McHugh, Thomas/0000-0002-1243-5189; Buhl, Derek/0000-0003-4433-7150	NIMH NIH HHS [R01-MH078821, P50-MH58880] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078821, P50MH058880] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kumaran D, 2007, HIPPOCAMPUS, V17, P735, DOI 10.1002/hipo.20326; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nishimura-Akiyoshi S, 2007, P NATL ACAD SCI USA, V104, P14801, DOI 10.1073/pnas.0706919104; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Roozendaal B, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn766; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	34	345	347	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 29	2008	319	5867					1260	1264		10.1126/science.1151120	http://dx.doi.org/10.1126/science.1151120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18218862				2022-12-24	WOS:000253530600049
J	Tanaka, S; Kerfeld, CA; Sawaya, MR; Cai, F; Heinhorst, S; Cannon, GC; Yeates, TO				Tanaka, Shiho; Kerfeld, Cheryl A.; Sawaya, Michael R.; Cai, Fei; Heinhorst, Sabine; Cannon, Gordon C.; Yeates, Todd O.			Atomic-level models of the bacterial carboxysome shell	SCIENCE			English	Article							THIOBACILLUS-NEAPOLITANUS; POLYHEDRAL BODIES; ORGANELLES; CYANOBACTERIA; HOMOLOGS; PROTEINS; REVEALS; VIRUSES	The carboxysome is a bacterial microcompartment that functions as a simple organelle by sequestering enzymes involved in carbon fixation. The carboxysome shell is roughly 800 to 1400 angstroms in diameter and is assembled from several thousand protein subunits. Previous studies have revealed the three- dimensional structures of hexameric carboxysome shell proteins, which self- assemble into molecular layers that most likely constitute the facets of the polyhedral shell. Here, we report the three- dimensional structures of two proteins of previously unknown function, CcmL and OrfA ( or CsoS4A), from the two known classes of carboxysomes, at resolutions of 2.4 and 2.15 angstroms. Both proteins assemble to form pentameric structures whose size and shape are compatible with formation of vertices in an icosahedral shell. Combining these pentamers with the hexamers previously elucidated gives two plausible, preliminary atomic models for the carboxysome shell.	[Tanaka, Shiho; Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy Inst Genom & Proteom, Los Angeles, CA 90095 USA; [Kerfeld, Cheryl A.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Cai, Fei; Heinhorst, Sabine; Cannon, Gordon C.] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; University of Southern Mississippi	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu		Yeates, Todd/0000-0001-5709-9839				Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; ENGLISH RS, 1994, MOL MICROBIOL, V12, P647, DOI 10.1111/j.1365-2958.1994.tb01052.x; GANTT E, 1969, J BACTERIOL, V97, P1486, DOI 10.1128/JB.97.3.1486-1493.1969; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Heinhorst S., 2006, COMPLEX INTRACELLULA, P141, DOI [10.1007/7171_023, DOI 10.1007/7171_023]; Huiskonen JT, 2007, P NATL ACAD SCI USA, V104, P6666, DOI 10.1073/pnas.0608625104; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; SHIVELY JM, 1991, CAN J BOT, V69, P957, DOI 10.1139/b91-123; SHIVELY JM, 1973, J BACTERIOL, V116, P1405, DOI 10.1128/JB.116.3.1405-1411.1973; Shively JM, 2001, CURR OPIN MICROBIOL, V4, P301, DOI 10.1016/S1369-5274(00)00207-1; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; STEWART PL, 1991, CELL, V67, P145, DOI 10.1016/0092-8674(91)90578-M; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Wunderlich Z, 2004, PROTEINS, V56, P181, DOI 10.1002/prot.20091	26	292	300	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2008	319	5866					1083	1086		10.1126/science.1151458	http://dx.doi.org/10.1126/science.1151458			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292340				2022-12-24	WOS:000253311700041
J	Harjes, CE; Rocheford, TR; Bai, L; Brutnell, TP; Kandianis, CB; Sowinski, SG; Stapleton, AE; Vallabhaneni, R; Williams, M; Wurtzel, ET; Yan, JB; Buckler, ES				Harjes, Carlos E.; Rocheford, Torbert R.; Bai, Ling; Brutnell, Thomas P.; Kandianis, Catherine Bermudez; Sowinski, Stephen G.; Stapleton, Ann E.; Vallabhaneni, Ratnakar; Williams, Mark; Wurtzel, Eleanore T.; Yan, Jianbing; Buckler, Edward S.			Natural genetic variation in lycopene epsilon cyclase tapped for maize biofortification	SCIENCE			English	Article							VITAMIN-A-DEFICIENCY; LINKAGE DISEQUILIBRIUM; Y1 GENE; CAROTENOIDS; BETA; FORTIFICATION; BIOSYNTHESIS; REVEALS	Dietary vitamin A deficiency causes eye disease in 40 million children each year and places 140 to 250 million at risk for health disorders. Many children in sub- Saharan Africa subsist on maize- based diets. Maize displays considerable natural variation for carotenoid composition, including vitamin A precursors alpha-carotene, beta-carotene, and beta-cryptoxanthin. Through association analysis, linkage mapping, expression analysis, and mutagenesis, we show that variation at the lycopene epsilon cyclase (lcyE) locus alters flux down alpha-carotene versus beta-carotene branches of the carotenoid pathway. Four natural lcyE polymorphisms explained 58% of the variation in these two branches and a threefold difference in provitamin A compounds. Selection of favorable lcyE alleles with inexpensive molecular markers will now enable developing- country breeders to more effectively produce maize grain with higher provitamin A levels.	[Rocheford, Torbert R.; Kandianis, Catherine Bermudez] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Harjes, Carlos E.; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Bai, Ling; Brutnell, Thomas P.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Sowinski, Stephen G.; Williams, Mark] DuPont Crop Genet Res, Wilmington, DE 19880 USA; [Stapleton, Ann E.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28403 USA; [Vallabhaneni, Ratnakar; Wurtzel, Eleanore T.] CUNY Herbert H Lehman Coll, Dept Biol Sci, Bronx, NY 10468 USA; [Vallabhaneni, Ratnakar; Wurtzel, Eleanore T.] CUNY Grad Sch & Univ Ctr, New York, NY 10016 USA; [Yan, Jianbing] CIMMYT, Mexico City 06600, DF, Mexico; [Buckler, Edward S.] ARS, USDA, Plant Soil & Nutr Res Unit, Ithaca, NY 14853 USA; [Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA	University of Illinois System; University of Illinois Urbana-Champaign; Cornell University; Cornell University; Boyce Thompson Institute for Plant Research; DuPont; University of North Carolina; University of North Carolina Wilmington; City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) Graduate School; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); United States Department of Agriculture (USDA); Cornell University	Rocheford, TR (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	trochefo@uiuc.edu; esb33@cornell.edu	Buckler, Edward/L-7651-2019; Brutnell, Thomas/M-2840-2013; Buckler, Edward/GPS-4932-2022	Buckler, Edward/0000-0002-3100-371X; Brutnell, Thomas/0000-0002-3581-8211; Wurtzel, Eleanore/0000-0002-9186-3260; Stapleton, Ann/0000-0001-7242-2673	NIGMS NIH HHS [SC1 GM081160-02, SC1 GM081160-01, S06-GM08225, SC1 GM081160] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008225, SC1GM081160] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asins MJ, 2002, PLANT BREEDING, V121, P281, DOI 10.1046/j.1439-0523.2002.730285.x; Buckner B, 1996, GENETICS, V143, P479; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.2307/3870254; Dary O, 2002, J NUTR, V132, p2927S, DOI 10.1093/jn/132.9.2927S; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Diretto G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-13; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Graham RD, 2001, ADV AGRON, V70, P77, DOI 10.1016/S0065-2113(01)70004-1; Howe JA, 2006, J NUTR, V136, P2562, DOI 10.1093/jn/136.10.2562; Li FQ, 2007, PLANT PHYSIOL, V144, P1181, DOI 10.1104/PP.107.098996; Li S, 2007, J AGR FOOD CHEM, V55, P10744, DOI 10.1021/jf071815v; Low JW, 2007, J NUTR, V137, P1320; Matthews PD, 2008, CHEM FUNCT PROP FOOD, P347; Mora JO, 2003, J NUTR, V133, p2990S, DOI 10.1093/jn/133.9.2990S; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; Pecker I, 1996, PLANT MOL BIOL, V30, P807, DOI 10.1007/BF00019013; Pogson B, 1996, PLANT CELL, V8, P1627, DOI 10.1105/tpc.8.9.1627; Pogson BJ, 2000, PHILOS T ROY SOC B, V355, P1395, DOI 10.1098/rstb.2000.0701; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; STEVENS RA, IN PRESS FOOD POLICY; Underwood BA, 2004, J NUTR, V134, p231S, DOI 10.1093/jn/134.1.231S; van Lieshout M, 2005, AM J CLIN NUTR, V81, P943, DOI 10.1093/ajcn/81.4.943; West CE, 2000, NUTR REV, V58, P341, DOI 10.1111/j.1753-4887.2000.tb01831.x; Wong JC, 2004, THEOR APPL GENET, V108, P349, DOI 10.1007/s00122-003-1436-4; YU B, 2007, TRANSGENIC RES, DOI DOI 10.1007/S11248; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	27	533	577	0	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					330	333		10.1126/science.1150255	http://dx.doi.org/10.1126/science.1150255			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202289	Green Accepted			2022-12-24	WOS:000252436200038
J	Yin, P; Choi, HMT; Calvert, CR; Pierce, NA				Yin, Peng; Choi, Harry M. T.; Calvert, Colby R.; Pierce, Niles A.			Programming biomolecular self-assembly pathways	NATURE			English	Article							DNA; DESIGN; HYBRIDIZATION; DEVICES; ENZYME; TRACK; FUEL	In nature, self- assembling and disassembling complexes of proteins and nucleic acids bound to a variety of ligands perform intricate and diverse dynamic functions. In contrast, attempts to rationally encode structure and function into synthetic amino acid and nucleic acid sequences have largely focused on engineering molecules that self- assemble into prescribed target structures, rather than on engineering transient system dynamics(1,2). To design systems that perform dynamic functions without human intervention, it is necessary to encode within the biopolymer sequences the reaction pathways by which self- assembly occurs. Nucleic acids show promise as a design medium for engineering dynamic functions, including catalytic hybridization(3-6), triggered self- assembly(7) and molecular computation(8,9). Here, we program diverse molecular self- assembly and disassembly pathways using a 'reaction graph' abstraction to specify complementarity relationships between modular domains in a versatile DNA hairpin motif. Molecular programs are executed for a variety of dynamic functions: catalytic formation of branched junctions, autocatalytic duplex formation by a cross- catalytic circuit, nucleated dendritic growth of a binary molecular 'tree', and autonomous locomotion of a bipedal walker.	[Yin, Peng; Choi, Harry M. T.; Calvert, Colby R.; Pierce, Niles A.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Yin, Peng] CALTECH, Dept Comp Sci, Pasadena, CA 91125 USA; [Pierce, Niles A.] CALTECH, Dept Appl & Computat Math, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Pierce, NA (corresponding author), CALTECH, Dept Bioengn, Pasadena, CA 91125 USA.	niles@caltech.edu	Pierce, Niles A/F-6535-2010	Choi, Harry/0000-0002-1530-0773				Asbury CL, 2005, CURR OPIN CELL BIOL, V17, P89, DOI 10.1016/j.ceb.2004.12.002; Bath J, 2005, ANGEW CHEM INT EDIT, V44, P4358, DOI 10.1002/anie.200501262; Bois JS, 2005, NUCLEIC ACIDS RES, V33, P4090, DOI 10.1093/nar/gki721; Butterfoss GL, 2006, ANNU REV BIOPH BIOM, V35, P49, DOI 10.1146/annurev.biophys.35.040405.102046; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Dirks RM, 2004, NUCLEIC ACIDS RES, V32, P1392, DOI 10.1093/nar/gkh291; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Feldkamp U, 2006, ANGEW CHEM INT EDIT, V45, P1856, DOI 10.1002/anie.200502358; Flamm C, 2000, RNA, V6, P325, DOI 10.1017/S1355838200992161; Green SJ, 2006, BIOPHYS J, V91, P2966, DOI 10.1529/biophysj.106.084681; Hansma HG, 1996, BIOPHYS J, V70, P1933, DOI 10.1016/S0006-3495(96)79757-6; Lee DH, 1996, NATURE, V382, P525, DOI 10.1038/382525a0; Levy M, 2003, P NATL ACAD SCI USA, V100, P6416, DOI 10.1073/pnas.1130145100; Li YG, 2004, NAT MATER, V3, P38, DOI 10.1038/nmat1045; Paul N, 2002, P NATL ACAD SCI USA, V99, P12733, DOI 10.1073/pnas.202471099; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Robertson A, 2000, CHEM SOC REV, V29, P141, DOI 10.1039/a803602k; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Seelig G, 2006, J AM CHEM SOC, V128, P12211, DOI 10.1021/ja0635635; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Tian Y, 2005, ANGEW CHEM INT EDIT, V44, P4355, DOI 10.1002/anie.200500703; Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102; Venkataraman S, 2007, NAT NANOTECHNOL, V2, P490, DOI 10.1038/nnano.2007.225; VONKIEDROWSKI G, 1986, ANGEW CHEM INT EDIT, V25, P932, DOI 10.1002/anie.198609322; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yin P, 2004, ANGEW CHEM INT EDIT, V43, P4906, DOI 10.1002/anie.200460522; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532	32	1062	1119	59	912	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					318	U4		10.1038/nature06451	http://dx.doi.org/10.1038/nature06451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202654				2022-12-24	WOS:000252432100046
J	Schones, DE; Cui, KR; Cuddapah, S; Roh, TY; Barski, A; Wang, ZB; Wei, G; Zhao, KJ				Schones, Dustin E.; Cui, Kairong; Cuddapah, Suresh; Roh, Tae-Young; Barski, Artem; Wang, Zhibin; Wei, Gang; Zhao, Keji			Dynamic regulation of nucleosome positioning in the human genome	CELL			English	Article							EMBRYONIC STEM-CELLS; HISTONE H2A VARIANT; RNA-POLYMERASE; DEVELOPMENTAL REGULATORS; SACCHAROMYCES-CEREVISIAE; STRUCTURAL-ANALYSIS; CHROMATIN-STRUCTURE; SWI/SNF COMPLEX; IN-VIVO; WIDE	The positioning of nucleosomes with respect to DNA plays an important role in regulating transcription. However, nucleosome mapping has been performed for only limited genomic regions in humans. We have generated genome-wide maps of nucleosome positions in both resting and activated human CD4(+) T cells by direct sequencing of nucleosome ends using the Solexa high-throughput sequencing technique. We find that nucleosome phasing relative to the transcription start sites is directly correlated to RNA polymerase II (Pol II) binding. Furthermore, the first nucleosome downstream of a start site exhibits differential positioning in active and silent genes. TCR signaling induces extensive nucleosome reorganization in promoters and enhancers to allow transcriptional activation or repression. Our results suggest that H2A.Z-containing and modified nucleosomes are preferentially lost from the -1 nucleosome position. Our data provide a comprehensive view of the nucleosome landscape and its dynamic regulation in the human genome.	[Schones, Dustin E.; Cui, Kairong; Cuddapah, Suresh; Roh, Tae-Young; Barski, Artem; Wang, Zhibin; Wei, Gang; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	Cuddapah, Suresh/AAU-4288-2021; Wei, Gang/A-3291-2011	Cuddapah, Suresh/0000-0002-4556-2029; Roh, Tae-Young/0000-0001-5833-0844; Barski, Artem/0000-0002-1861-5316	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005801, ZICHL006018, ZIAHL005801] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AFFYMETRIX I, 2002, STAT ALGORITHMS DESC; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Gutierrez JL, 2007, EMBO J, V26, P730, DOI 10.1038/sj.emboj.7601524; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kornberg RD, 2002, CURR OPIN GENET DEV, V12, P249, DOI 10.1016/S0959-437X(02)00293-9; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Langst G, 1997, NUCLEIC ACIDS RES, V25, P511, DOI 10.1093/nar/25.3.511; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; OwenHughes T, 1996, SCIENCE, V273, P513, DOI 10.1126/science.273.5274.513; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Whitehouse I, 2006, NAT STRUCT MOL BIOL, V13, P633, DOI 10.1038/nsmb1111; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	66	981	1023	1	102	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					887	898		10.1016/j.cell.2008.02.022	http://dx.doi.org/10.1016/j.cell.2008.02.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329373	Bronze			2022-12-24	WOS:000253818000024
J	Dick, IE; Tadross, MR; Liang, HY; Tay, LH; Yang, WJ; Yue, DT				Dick, Ivy E.; Tadross, Michael R.; Liang, Haoya; Tay, Lai Hock; Yang, Wanjun; Yue, David T.			A modular switch for spatial Ca2+ selectivity in the calmodulin regulation of Ca-V channels	NATURE			English	Article							GATED CALCIUM-CHANNEL; CA2+-DEPENDENT INACTIVATION; BETA-SUBUNIT; FACILITATION; MECHANISMS; EXPRESSION; REVEALS; GAMMA; FRET	Ca2+/ calmodulin- dependent regulation of voltage- gated Ca(V)1 - 2 Ca2+ channels shows extraordinary modes of spatial Ca2+ decoding and channel modulation(1-6), vital for many biological functions(6-9). A single calmodulin ( CaM) molecule associates constitutively with the channel's carboxy- terminal tail(3,10-13), and Ca2+ binding to the C- terminal and N- terminal lobes of CaM can each induce distinct channel regulations(2,14). As expected from close channel proximity, the C- lobe responds to the roughly 100-mu M Ca2+ pulses driven by the associated channel(15,16), a behaviour defined as 'local Ca2+ selectivity'. Conversely, all previous observations have indicated that the N- lobe somehow senses the far weaker signals from distant Ca2+ sources(2,3,17,18). This 'global Ca2+ selectivity' satisfies a general signalling requirement, enabling a resident molecule to remotely sense cellular Ca2+ activity, which would otherwise be overshadowed by Ca2+ entry through the host channel(5,6). Here we show that the spatial Ca2+ selectivity of N- lobe CaM regulation is not invariably global but can be switched by a novel Ca2+/CaM- binding site within the amino terminus of channels ( NSCaTE, for N- terminal spatial Ca2+ transforming element). Native Ca(V)2.2 channels lack this element and show N- lobe regulation with a global selectivity. On the introduction of NSCaTE into these channels, spatial Ca2+ selectivity transforms from a global to local profile. Given this effect, we examined Ca(V)1.2/ Ca(V)1.3 channels, which naturally contain NSCaTE, and found that their N- lobe selectivity is indeed local. Disruption of this element produces a global selectivity, confirming the native function of NSCaTE. Thus, differences in spatial selectivity between advanced Ca(V)1 and Ca(V)2 channel isoforms are explained by the presence or absence of NSCaTE. Beyond functional effects, the position of NSCaTE on the channel's amino terminus indicates that CaM can bridge the amino terminus and carboxy terminus of channels. Finally, the modularity of NSCaTE offers practical means for understanding the basis of global Ca2+ selectivity(19).	[Dick, Ivy E.; Tadross, Michael R.; Liang, Haoya; Tay, Lai Hock; Yang, Wanjun; Yue, David T.] Johns Hopkins Univ, Sch Med, Calcium Signals Lab, Dept Biomed Engn, Baltimore, MD 21205 USA; [Dick, Ivy E.; Tadross, Michael R.; Liang, Haoya; Tay, Lai Hock; Yang, Wanjun; Yue, David T.] Johns Hopkins Univ, Sch Med, Calcium Signals Lab, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Calcium Signals Lab, Dept Biomed Engn, Ross Bldg,Room 713,720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu		Dick, Ivy/0000-0002-7253-6846	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL076795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000023, P30DC005211] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL076795] Funding Source: Medline; NIDCD NIH HHS [T32 DC000023, P30 DC005211] Funding Source: Medline; NIMH NIH HHS [R01 MH065531] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Agler HL, 2005, NEURON, V46, P891, DOI 10.1016/j.neuron.2005.05.011; Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Bootman MD, 2001, J CELL SCI, V114, P2213; Chaudhuri D, 2007, J GEN PHYSIOL, V129, P385, DOI 10.1085/jgp.200709749; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Dunlap K, 2007, J GEN PHYSIOL, V129, P379, DOI 10.1085/jgp.200709786; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; EVANS J, 2003, BIOPHYS J A S, V84; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; KINCAID RL, 1988, METHOD ENZYMOL, V159, P605; Kobrinsky E, 2003, J BIOL CHEM, V278, P5021, DOI 10.1074/jbc.M211254200; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Song LS, 1998, J PHYSIOL-LONDON, V512, P677, DOI 10.1111/j.1469-7793.1998.677bd.x; Stratton J, 2004, BIOPHYS J, V86, p317A; TADROSS MR, 2007, BIOPHYS J A S, V354; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Toescu EC, 2007, AGING CELL, V6, P267, DOI 10.1111/j.1474-9726.2007.00296.x; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; WEI XY, 1991, J BIOL CHEM, V266, P21943; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; YANG PS, 2007, BIOPHYS J A S, V354	38	185	192	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					830	U9		10.1038/nature06529	http://dx.doi.org/10.1038/nature06529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18235447	Green Accepted, Green Published			2022-12-24	WOS:000253191400043
J	Fuerst, PG; Koizumi, A; Masland, RH; Burgess, RW				Fuerst, Peter G.; Koizumi, Amane; Masland, Richard H.; Burgess, Robert W.			Neurite arborization and mosaic spacing in the mouse retina require DSCAM	NATURE			English	Article							CELL-ADHESION MOLECULE; HOMOPHILIC INTERCELLULAR-ADHESION; AXON GUIDANCE; DROSOPHILA DSCAM; SELF-AVOIDANCE; DIVERSITY; NEURONS; SPECIFICITY; BINDING; SYSTEM	To establish functional circuitry, retinal neurons occupy spatial domains by arborizing their processes, which requires the self-avoidance of neurites from an individual cell, and by spacing their cell bodies, which requires positioning the soma and establishing a zone within which other cells of the same type are excluded(1). The mosaic patterns of distinct cell types form independently and overlap. The cues that direct these processes in the vertebrate retina are not known(2,3). Here we show that some types of retinal amacrine cells from mice with a spontaneous mutation in Down syndrome cell adhesion molecule ( Dscam), a gene encoding an immunoglobulin- superfamily member adhesion molecule(4,5), have defects in the arborization of processes and in the spacing of cell bodies. In the mutant retina, cells that would normally express Dscam have hyperfasciculated processes, preventing them from creating an orderly arbor. Also, their cell bodies are randomly distributed or pulled into clumps rather than being regularly spaced mosaics. Our results indicate that mouse DSCAM mediates isoneuronal self- avoidance for arborization and heteroneuronal self- avoidance within specific cell types to prevent fasciculation and to preserve mosaic spacing. These functions are analogous to those of Drosophila DSCAM ( ref. 6) and DSCAM2 ( ref. 7). DSCAM may function similarly in other regions of the mammalian nervous system, and this role may extend to other members of the mammalian Dscam gene family.	[Fuerst, Peter G.; Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Koizumi, Amane; Masland, Richard H.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Jackson Laboratory; Harvard University; Massachusetts General Hospital	Burgess, RW (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	robert.burgess@jax.org	Koizumi, Amane/E-7771-2011	Burgess, Robert/0000-0002-9229-3407; Koizumi, Amane/0000-0003-1177-0185	NATIONAL EYE INSTITUTE [R03EY016031, F32EY015966] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY015966-02, R03 EY016031-03, F32 EY015966, R03 EY016031] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Galli-Resta L, 2000, DEVELOPMENT, V127, P1509; GalliResta L, 1997, J NEUROSCI, V17, P7831; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Novelli E, 2005, PROG BRAIN RES, V147, P141, DOI 10.1016/S0079-6123(04)47011-3; Raven MA, 2003, J COMP NEUROL, V461, P123, DOI 10.1002/cne.10693; Resta V, 2005, DEVELOPMENT, V132, P2873, DOI 10.1242/dev.01855; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Yimlamai D, 2005, DEV BIOL, V279, P44, DOI 10.1016/j.ydbio.2004.12.001; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	28	210	213	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					470	U8		10.1038/nature06514	http://dx.doi.org/10.1038/nature06514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216855	Green Accepted, Bronze			2022-12-24	WOS:000252554100046
J	Mangale, VS; Hirokawa, KE; Satyaki, PRV; Gokulchandran, N; Chikbire, S; Subramanian, L; Shetty, AS; Martynoga, B; Paul, J; Mai, MV; Li, YQ; Flanagan, LA; Tole, S; Monuki, ES				Mangale, Vishakha S.; Hirokawa, Karla E.; Satyaki, Prasad R. V.; Gokulchandran, Nandini; Chikbire, Satyadeep; Subramanian, Lakshmi; Shetty, Ashwin S.; Martynoga, Ben; Paul, Jolly; Mai, Mark V.; Li, Yuqing; Flanagan, Lisa A.; Tole, Shubha; Monuki, Edwin S.			Lhx2 selector activity specifies cortical identity and suppresses hippocampal organizer fate	SCIENCE			English	Article							CAJAL-RETZIUS CELLS; CEREBRAL-CORTEX; DENTATE GYRUS; MOUSE HIPPOCAMPUS; GRANULE CELLS; EXPRESSION; DORSAL; GENE; DROSOPHILA; FOREBRAIN	The earliest step in creating the cerebral cortex is the specification of neuroepithelium to a cortical fate. Using mouse genetic mosaics and timed inactivations, we demonstrated that Lhx2 acts as a classic selector gene and essential intrinsic determinant of cortical identity. Lhx2 selector activity is restricted to an early critical period when stem cells comprise the cortical neuroepithelium, where it acts cell- autonomously to specify cortical identity and suppress alternative fates in a spatially dependent manner. Laterally, Lhx2 null cells adopt antihem identity, whereas medially they become cortical hem cells, which can induce and organize ectopic hippocampal fields. In addition to providing functional evidence for Lhx2 selector activity, these findings show that the cortical hem is a hippocampal organizer.	[Mangale, Vishakha S.; Satyaki, Prasad R. V.; Gokulchandran, Nandini; Chikbire, Satyadeep; Subramanian, Lakshmi; Shetty, Ashwin S.; Martynoga, Ben; Paul, Jolly; Tole, Shubha] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Hirokawa, Karla E.; Monuki, Edwin S.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Mai, Mark V.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA; [Li, Yuqing] Univ Alabama Birmingham, Sch Med, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Flanagan, Lisa A.; Monuki, Edwin S.] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA	Tata Institute of Fundamental Research (TIFR); University of California System; University of California Irvine; Swarthmore College; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Irvine	Tole, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	stole@tifr.res.in; emonuki@uci.edu	Li, Yuqing/AAR-9383-2021; Mangale, Vishakha/AAQ-6403-2021; Li, Yuqing/G-1596-2011; shetty, Ashwin/AAV-3956-2021	Li, Yuqing/0000-0003-1211-5529; Li, Yuqing/0000-0003-1211-5529; shetty, Ashwin/0000-0002-2812-7674; Monuki, Edwin/0000-0001-5130-781X; Subramanian, Lakshmi/0000-0002-3504-4455; Mai, Mark/0000-0003-0346-5818; Hirokawa, Karla/0000-0002-9954-5515	NIA NIH HHS [AG23583, K01 AG023583] Funding Source: Medline; NIMH NIH HHS [MH02029, K08 MH002029] Funding Source: Medline; NINDS NIH HHS [NS07444, NS053511, T32 NS007444] Funding Source: Medline; Wellcome Trust [056684/Z/99/Z] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ando H, 2005, DEV BIOL, V287, P456, DOI 10.1016/j.ydbio.2005.09.023; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Badea TC, 2003, J NEUROSCI, V23, P2314; Bagri A, 2002, DEVELOPMENT, V129, P4249; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; Bryja V, 2005, STEM CELLS, V23, P965, DOI 10.1634/stemcells.2004-0174; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Cheng X, 2006, J NEUROSCI, V26, P7640, DOI 10.1523/JNEUROSCI.0714-06.2006; Currle DS, 2005, DEVELOPMENT, V132, P3549, DOI 10.1242/dev.01915; DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B; Galceran J, 2000, DEVELOPMENT, V127, P469; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Gotz M, 1996, NEURON, V16, P551, DOI 10.1016/S0896-6273(00)80074-4; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hebert JM, 2002, NEURON, V35, P1029, DOI 10.1016/S0896-6273(02)00900-5; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Jin XL, 2000, BIOCHEM BIOPH RES CO, V270, P978, DOI 10.1006/bbrc.2000.2532; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Muzio L, 2005, J NEUROSCI, V25, P4435, DOI 10.1523/JNEUROSCI.4804-04.2005; Nagy A, 2003, MANIPULATING MOUSE E, P453; Porter FD, 1997, DEVELOPMENT, V124, P2935; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; RICKMANN M, 1987, J COMP NEUROL, V264, P449, DOI 10.1002/cne.902640403; Rincon-Limas DE, 1999, P NATL ACAD SCI USA, V96, P2165, DOI 10.1073/pnas.96.5.2165; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Shinozaki K, 2004, MECH DEVELOP, V121, P475, DOI 10.1016/j.mod.2004.03.013; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 1997, DEVELOPMENT, V124, P3765; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tole S, 2001, J NEUROSCI, V21, P1580, DOI 10.1523/JNEUROSCI.21-05-01580.2001; Tole S, 1997, DEVELOPMENT, V124, P4959; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209; Zhao CJ, 2006, BRAIN RES, V1077, P48, DOI 10.1016/j.brainres.2006.01.042; Zhou CJ, 2004, J NEUROSCI, V24, P121, DOI 10.1523/JNEUROSCI.4071-03.2004	44	234	237	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					304	309		10.1126/science.1151695	http://dx.doi.org/10.1126/science.1151695			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18202285	Green Accepted			2022-12-24	WOS:000252436200030
J	Harada, Y; Takagaki, Y; Sunagawa, M; Saito, T; Yamada, L; Taniguchi, H; Shoguchi, E; Sawada, H				Harada, Yoshito; Takagaki, Yuhei; Sunagawa, Masahiko; Saito, Takako; Yamada, Lixy; Taniguchi, Hisaaki; Shoguchi, Eiichi; Sawada, Hitoshi			Mechanism of self-sterility in a hermaphroditic chordate	SCIENCE			English	Article							SEA-URCHIN SPERM; CIONA-INTESTINALIS; PHYSIOLOGICAL PROBLEMS; ACROSOMAL REGION; CATION CHANNEL; FERTILIZATION; PROTEIN; RECOGNITION; INCOMPATIBILITY; DISCRIMINATION	Hermaphroditic organisms avoid inbreeding by a system of self- incompatibility ( SI). A primitive chordate ( ascidian) Ciona intestinalis is an example of such an organism, but the molecular mechanism underlying its SI system is not known. Here, we show that the SI system is governed by two gene loci that act cooperatively. Each locus contains a tightly linked pair of polycystin 1- related receptor ( s- Themis) and fibrinogen- like ligand ( v- Themis) genes, the latter of which is located in the first intron of s- Themis but transcribed in the opposite direction. These genes may encode male- and female- side self- recognition molecules. The SI system of C. intestinalis has a similar framework to that of flowering plants but utilizing different molecules.	[Harada, Yoshito; Takagaki, Yuhei; Sunagawa, Masahiko; Saito, Takako; Sawada, Hitoshi] Nagoya Univ, Sugashima Marine Biol Lab, Grad Sch Sci, Toba 5170004, Japan; [Yamada, Lixy; Taniguchi, Hisaaki] Univ Tokushima, Div Dis Proteom, Inst Enzyme Res, Tokushima 7708503, Japan; [Shoguchi, Eiichi] Kyoto Univ, Dept Zool, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	Nagoya University; Tokushima University; Kyoto University	Harada, Y (corresponding author), Nagoya Univ, Sugashima Marine Biol Lab, Grad Sch Sci, Toba 5170004, Japan.	yharada@bio.nagoya-u.ac.jp; hsawada@bio.nagoya-u.ac.jp	Taniguchi, Hisaaki/I-9171-2012	Saito, Takako/0000-0002-3969-9192				Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; BOOKBINDER LH, 1995, SCIENCE, V269, P86, DOI 10.1126/science.7604284; Casselton LA, 2002, HEREDITY, V88, P142, DOI 10.1038/sj.hdy.6800035; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; Delmas P, 2004, CELL, V118, P145, DOI 10.1016/j.cell.2004.07.007; DESANTIS R, 1991, MOL REPROD DEV, V29, P47, DOI 10.1002/mrd.1080290108; Gao ZQ, 2003, CURR BIOL, V13, P2175, DOI 10.1016/j.cub.2003.11.053; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Inaba K, 2002, MOL REPROD DEV, V62, P431, DOI 10.1002/mrd.10131; Jiang D, 2005, BIOL BULL-US, V209, P107, DOI 10.2307/3593128; KAWAMURA K, 1987, DEV GROWTH DIFFER, V29, P627; Kierszenbaum AL, 2004, MOL REPROD DEV, V67, P385, DOI 10.1002/mrd.20042; Kim JH, 2007, GENOME RES, V17, P1101, DOI 10.1101/gr.5894107; Mengerink KJ, 2002, J BIOL CHEM, V277, P943, DOI 10.1074/jbc.M109673200; Morgan TH, 1942, J EXP ZOOL, V90, P199, DOI 10.1002/jez.1400900205; Morgan TH, 1944, J EXP ZOOL, V95, P37, DOI 10.1002/jez.1400950105; Morgan TH, 1939, J EXP ZOOL, V80, P19, DOI 10.1002/jez.1400800103; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; Murabe N, 2002, ZOOL SCI, V19, P527, DOI 10.2108/zsj.19.527; Neill AT, 2004, MOL REPROD DEV, V67, P472, DOI 10.1002/mrd.20033; Nyholm SV, 2006, IMMUNITY, V25, P163, DOI 10.1016/j.immuni.2006.04.011; ROSATI F, 1978, EXP CELL RES, V112, P111, DOI 10.1016/0014-4827(78)90531-1; Sawada H, 2004, P NATL ACAD SCI USA, V101, P15615, DOI 10.1073/pnas.0401928101; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Uyenoyama MK, 2005, NEW PHYTOL, V165, P63, DOI 10.1111/j.1469-8137.2004.01246.x	27	90	91	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					548	550		10.1126/science.1152488	http://dx.doi.org/10.1126/science.1152488			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18356489	Green Published			2022-12-24	WOS:000255249300055
J	Dunn, CW; Hejnol, A; Matus, DQ; Pang, K; Browne, WE; Smith, SA; Seaver, E; Rouse, GW; Obst, M; Edgecombe, GD; Sorensen, MV; Haddock, SHD; Schmidt-Rhaesa, A; Okusu, A; Kristensen, RM; Wheeler, WC; Martindale, MQ; Giribet, G				Dunn, Casey W.; Hejnol, Andreas; Matus, David Q.; Pang, Kevin; Browne, William E.; Smith, Stephen A.; Seaver, Elaine; Rouse, Greg W.; Obst, Matthias; Edgecombe, Gregory D.; Sorensen, Martin V.; Haddock, Steven H. D.; Schmidt-Rhaesa, Andreas; Okusu, Akiko; Kristensen, Reinhardt Mobjerg; Wheeler, Ward C.; Martindale, Mark Q.; Giribet, Gonzalo			Broad phylogenomic sampling improves resolution of the animal tree of life	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BAYESIAN-INFERENCE; ARTHROPODS; EUKARYOTES; ECDYSOZOA; EVOLUTION; SELECTION; POSITION; DATABASE; CLADE	Long-held ideas regarding the evolutionary relationships among animals have recently been upended by sometimes controversial hypotheses based largely on insights from molecular data(1,2). These new hypotheses include a clade of moulting animals (Ecdysozoa)(3) and the close relationship of the lophophorates to molluscs and annelids (Lophotrochozoa)(4). Many relationships remain disputed, including those that are required to polarize key features of character evolution, and support for deep nodes is often low. Phylogenomic approaches, which use data from many genes, have shown promise for resolving deep animal relationships, but are hindered by a lack of data from many important groups. Here we report a total of 39.9 Mb of expressed sequence tags from 29 animals belonging to 21 phyla, including 11 phyla previously lacking genomic or expressed-sequence-tag data. Analysed in combination with existing sequences, our data reinforce several previously identified clades that split deeply in the animal tree (including Protostomia, Ecdysozoa and Lophotrochozoa), unambiguously resolve multiple long-standing issues for which there was strong conflicting support in earlier studies with less data (such as velvet worms rather than tardigrades as the sister group of arthropods(5)), and provide molecular support for the monophyly of molluscs, a group long recognized by morphologists. In addition, we find strong support for several new hypotheses. These include a clade that unites annelids (including sipunculans and echiurans) with nemerteans, phoronids and brachiopods, molluscs as sister to that assemblage, and the placement of ctenophores as the earliest diverging extant multicellular animals. A single origin of spiral cleavage (with subsequent losses) is inferred from well-supported nodes. Many relationships between a stable subset of taxa find strong support, and a diminishing number of lineages remain recalcitrant to placement on the tree.	[Dunn, Casey W.; Hejnol, Andreas; Matus, David Q.; Pang, Kevin; Browne, William E.; Seaver, Elaine; Martindale, Mark Q.] Univ Hawaii, Kewalo Marine Lab, PBRC, Honolulu, HI 96813 USA; [Smith, Stephen A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Rouse, Greg W.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Obst, Matthias] Kristineberg Marine Res Stn, S-45034 Fiskebackskil, Sweden; [Edgecombe, Gregory D.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Sorensen, Martin V.] Univ Copenhagen, Ancient DNA & Evolut Grp, Inst Biol, DK-2100 Copenhagen, Denmark; [Haddock, Steven H. D.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Schmidt-Rhaesa, Andreas] Univ Hamburg, Museum Zool, D-20146 Hamburg, Germany; [Okusu, Akiko] Simmons Coll, Dept Biol, Boston, MA 02115 USA; [Kristensen, Reinhardt Mobjerg] Univ Copenhagen, Zool Museum, DK-2100 Copenhagen, Denmark; [Wheeler, Ward C.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Giribet, Gonzalo] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Giribet, Gonzalo] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Hawaii System; Yale University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Natural History Museum London; University of Copenhagen; Monterey Bay Aquarium Research Institute; University of Hamburg; Simmons University; University of Copenhagen; American Museum of Natural History (AMNH); Harvard University; Harvard University	Dunn, CW (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, 80 Waterman St, Providence, RI 02912 USA.	casey_dunn@brown.edu	Rouse, Greg W/F-2611-2010; Smith, Stephen/B-3451-2010; Smith, Stephen/AAE-8623-2019; Rouse, Gregory/AAW-1494-2021; Browne, William E./AAV-4035-2021; Browne, William E/D-4267-2013; Sørensen, Martin V/A-8852-2013; Hejnol, Andreas/C-5577-2012; Kristensen, Reinhardt M/A-8772-2013; Matus, David/E-9972-2010; Giribet, Gonzalo/P-1086-2015	Rouse, Greg W/0000-0001-9036-9263; Smith, Stephen/0000-0003-2035-9531; Rouse, Gregory/0000-0001-9036-9263; Browne, William E./0000-0001-8200-6489; Browne, William E/0000-0001-8200-6489; Sørensen, Martin V/0000-0002-0377-0276; Hejnol, Andreas/0000-0003-2196-8507; Kristensen, Reinhardt M/0000-0001-9549-1188; Matus, David/0000-0002-1570-5025; Edgecombe, Gregory/0000-0002-9591-8011; Giribet, Gonzalo/0000-0002-5467-8429; Dunn, Casey/0000-0003-0628-5150				Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Baurain D, 2007, MOL BIOL EVOL, V24, P6, DOI 10.1093/molbev/msl137; Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Freeman G, 2002, DEV BIOL, V252, P301, DOI 10.1006/dbio.2002.0854; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Giribet G, 2002, MOL PHYLOGENET EVOL, V24, P345, DOI 10.1016/S1055-7903(02)00206-3; Giribet G, 2000, SYST BIOL, V49, P539, DOI 10.1080/10635159950127385; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; MORRIS SC, 1995, PHILOS T ROY SOC B, V347, P305, DOI 10.1098/rstb.1995.0029; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Parkinson J, 2004, BIOINFORMATICS, V20, P1398, DOI 10.1093/bioinformatics/bth101; Philip GK, 2005, MOL BIOL EVOL, V22, P1175, DOI 10.1093/molbev/msi102; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Philippe H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000717; Philippe H, 2006, TRENDS ECOL EVOL, V21, P614, DOI 10.1016/j.tree.2006.08.004; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Schmidt-Rhaesa A, 2001, ZOOL ANZ, V240, P549, DOI 10.1078/0044-5231-00066; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Telford MJ, 2005, MOL BIOL EVOL, V22, P1129, DOI 10.1093/molbev/msi099; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorley JL, 1999, J THEOR BIOL, V200, P343, DOI 10.1006/jtbi.1999.0999; Van Dongen S, 2000, THESIS U UTRECHT NET; VANDONGEN S, 2000, INSR0010 STICHT MATH	41	1430	1479	9	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2008	452	7188					745	U5		10.1038/nature06614	http://dx.doi.org/10.1038/nature06614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18322464				2022-12-24	WOS:000254792500044
J	Huh, JH; Bauer, MJ; Hsieh, TF; Fischer, RL				Huh, Jin Hoe; Bauer, Matthew J.; Hsieh, Tzung-Fu; Fischer, Robert L.			Cellular programming of plant gene imprinting	CELL			English	Review							MEDEA POLYCOMB GENE; INDEPENDENT SEED DEVELOPMENT; DNA GLYCOSYLASE/LYASE ROS1; ENDOSPERM DEVELOPMENT; ARABIDOPSIS-THALIANA; GROUP PROTEINS; FEMALE GAMETOPHYTE; FERTILIZATION; METHYLATION; EXPRESSION	Gene imprinting, the differential expression of maternal and paternal alleles, independently evolved in mammals and in flowering plants. A unique feature of flowering plants is a double-fertilization event in which the sperm fertilize not only the egg, which forms the embryo, but also the central cell, which develops into the endosperm (an embryo-supporting tissue). The distinctive mechanisms of gene imprinting in the endosperm, which involve DNA demethylation and histone methylation, begin in the central cell and sperm prior to fertilization. Flowering plants might have coevolved double fertilization and imprinting to prevent parthenogenetic development of the endosperm.	[Huh, Jin Hoe; Bauer, Matthew J.; Hsieh, Tzung-Fu; Fischer, Robert L.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Fischer, RL (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	rfischer@berkeley.edu		Bauer, Matthew/0000-0002-1242-0665; Hsieh, Tzung-Fu/0000-0001-7584-3721	NIGMS NIH HHS [R01-GM069415] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069415] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams S, 2000, DEVELOPMENT, V127, P2493; Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Berger E., 2007, V8, P91, DOI 10.1007/7089_2007_111; Bicknell RA, 2004, PLANT CELL, V16, pS228, DOI 10.1105/tpc.017921; BIRCHLER JA, 1993, ANNU REV GENET, V27, P181, DOI 10.1146/annurev.ge.27.120193.001145; Brown R. C., 2007, V8, P1, DOI 10.1007/7089_2007_106; Brown RC, 2003, PROTOPLASMA, V222, P167, DOI 10.1007/s00709-003-0010-x; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; Choi Y, 2004, P NATL ACAD SCI USA, V101, P7481, DOI 10.1073/pnas.0402328101; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Danilevskaya ON, 2003, PLANT CELL, V15, P425, DOI 10.1105/tpc.006759; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Dilkes BP, 2004, PLANT CELL, V16, P3174, DOI 10.1105/tpc.104.161230; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Friedman WE, 2006, NATURE, V441, P337, DOI 10.1038/nature04690; Friedman WE, 2001, CR ACAD SCI III-VIE, V324, P559, DOI 10.1016/S0764-4469(01)01326-9; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guitton AE, 2004, DEVELOPMENT, V131, P2971, DOI 10.1242/dev.01168; Gutierrez-Marcos JF, 2006, NAT GENET, V38, P876, DOI 10.1038/ng1828; Haerizadeh F, 2006, SCIENCE, V313, P496, DOI 10.1126/science.1125526; HAIG D, 1991, PHILOS T ROY SOC B, V333, P1, DOI 10.1098/rstb.1991.0057; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hermon P, 2007, PLANT MOL BIOL, V64, P387, DOI 10.1007/s11103-007-9160-0; Iwakawa H, 2006, PLANT J, V45, P819, DOI 10.1111/j.1365-313X.2005.02643.x; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Jost JP, 2001, NUCLEIC ACIDS RES, V29, P4452, DOI 10.1093/nar/29.21.4452; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Katz A, 2004, PLANT J, V37, P707, DOI 10.1111/j.1365-313X.2003.01996.x; Kawabe A, 2007, CURR BIOL, V17, P1885, DOI 10.1016/j.cub.2007.09.051; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kinoshita T, 2001, P NATL ACAD SCI USA, V98, P14156, DOI 10.1073/pnas.241507798; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Le BH, 2007, PLANT PHYSIOL, V144, P562, DOI 10.1104/pp.107.100362; Leroy O, 2007, DEVELOPMENT, V134, P3639, DOI 10.1242/dev.009027; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; McVean GT, 1997, P ROY SOC B-BIOL SCI, V264, P739, DOI 10.1098/rspb.1997.0105; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Nguyen H, 2000, PROTOPLASMA, V212, P99, DOI 10.1007/BF01279351; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Nowack MK, 2007, NATURE, V447, P312, DOI 10.1038/nature05770; Ohad N, 1999, PLANT CELL, V11, P407, DOI 10.1105/tpc.11.3.407; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Penterman J, 2007, PLANT PHYSIOL, V145, P1549, DOI 10.1104/pp.107.107730; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Scott RJ, 2006, CYTOGENET GENOME RES, V113, P53, DOI 10.1159/000090815; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Singh MB, 2007, BIOESSAYS, V29, P1124, DOI 10.1002/bies.20660; Skinner DJ, 2004, PLANT CELL, V16, pS32, DOI 10.1105/tpc.015933; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Spillane C, 2007, NATURE, V448, P349, DOI 10.1038/nature05984; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; UNG, 2006, NAT GENET, V38, P706; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	80	117	125	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					735	744		10.1016/j.cell.2008.02.018	http://dx.doi.org/10.1016/j.cell.2008.02.018			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329361	Bronze			2022-12-24	WOS:000253818000012
J	Tice, JA; Cummings, SR; Smith-Bindman, R; Ichikawa, L; Barlow, WE; Kerlikowske, K				Tice, Jeffrey A.; Cummings, Steven R.; Smith-Bindman, Rebecca; Ichikawa, Laura; Barlow, William E.; Kerlikowske, Karla			Using clinical factors and mammographic breast density to estimate breast cancer risk: Development and validation of a new predictive model	ANNALS OF INTERNAL MEDICINE			English	Article							PARENCHYMAL PATTERNS; ETHNIC-GROUPS; SCREENING MAMMOGRAPHY; FAMILY-HISTORY; WOMEN; CHEMOPREVENTION; PERFORMANCE; TAMOXIFEN; ACCURACY; MARKER	Background: Current models for assessing breast cancer risk are complex and do not include breast density, a strong risk factor for breast cancer that is routinely reported with mammography. Objective: To develop and validate an easy-to-use breast cancer risk prediction model that includes breast density. Design: Empirical model based on Surveillance, Epidemiology, and End Results incidence, and relative hazards from a prospective cohort. Setting: Screening mammography sites participating in the Breast Cancer Surveillance Consortium. Patients: 1 095 484 women undergoing mammography who had no previous diagnosis of breast cancer. Measurements: Self-reported age, race or ethnicity, family history of breast cancer, and history of breast biopsy. Community radiologists rated breast density by using 4 Breast Imaging Reporting and Data System categories. Results: During 5.3 years of follow-up, invasive breast cancer was diagnosed in 14 766 women. The breast density model was well calibrated overall ( expected-observed ratio, 1.03 [ 95% CI, 0.99 to 1.06]) and in racial and ethnic subgroups. It had modest discriminatory accuracy ( concordance index, 0.66 [ CI, 0.65 to 0.67]). Women with low-density mammograms had 5-year risks less than 1.67% unless they had a family history of breast cancer and were older than age 65 years. Limitation: The model has only modest ability to discriminate between women who will develop breast cancer and those who will not. Conclusion: A breast cancer prediction model that incorporates routinely reported measures of breast density can estimate 5-year risk for invasive breast cancer. Its accuracy needs to be further evaluated in independent populations before it can be recommended for clinical use.	[Tice, Jeffrey A.] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA; Univ Washington, Seattle, WA 98195 USA	University of California System; University of California San Francisco; University of Washington; University of Washington Seattle	Tice, JA (corresponding author), Univ Calif San Francisco, Dept Med, Div Gen Internal Med, 1701 Divisadero St,Suite 554, San Francisco, CA 94143 USA.	jtice@medicine.ucsf.edu		Tice, Jeffrey/0000-0002-9857-2028	NATIONAL CANCER INSTITUTE [U01CA086076, U01CA063731, U01CA069976, U01CA070013, U01CA086082, U01CA063740, U01CA070040, U01CA063736, K07CA086032, K24CA125036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K12AR047659] Funding Source: NIH RePORTER; NCI NIH HHS [U01CA70013, U01CA69976, U01CA63736, U01 CA086082, U01CA70040, K07 CA086032-01, U01 CA063740, U01CA63731, 01CA63740, U01 CA063731, K24 CA125036, U01 CA069976, K07 CA086032, U01CA86082, U01 CA063736, U01 CA070013, U01CA86076, U01 CA086076, U01 CA070040, K07 CA086032-02] Funding Source: Medline; NIAMS NIH HHS [K12 AR47659, K12 AR047659] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AM CANC SOC, 2007, CANC FACTS FIG 2007; Armstrong K, 2006, ARCH INTERN MED, V166, P2260, DOI 10.1001/archinte.166.20.2260; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Boyd NF, 2002, BRIT J CANCER, V87, P876, DOI 10.1038/sj.bjc.6600537; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; CLAUS EB, 1993, BREAST CANCER RES TR, V28, P115, DOI 10.1007/BF00666424; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; D'Orsi C, 2003, BREAST IMAGING REPOR; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Freedman AN, 2005, JNCI-J NATL CANCER I, V97, P715, DOI 10.1093/jnci/dji128; Freedman AN, 2003, JNCI-J NATL CANCER I, V95, P526, DOI 10.1093/jnci/95.7.526; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2007, J NATL CANCER I, V99, P1782, DOI 10.1093/jnci/djm223; Guo YP, 2001, CANCER EPIDEM BIOMAR, V10, P243; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hawes D, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1408; Kaplan CP, 2006, CANCER EPIDEM BIOMAR, V15, P162, DOI 10.1158/1055-9965.EPI-04-0758; Kerlikowske K, 1998, J NATL CANCER I, V90, P1801, DOI 10.1093/jnci/90.23.1801; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Kerlikowske K, 2007, J NATL CANCER I, V99, P386, DOI 10.1093/jnci/djk066; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V53, P1; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; Martin KE, 2006, RADIOLOGY, V240, P656, DOI 10.1148/radiol.2402041947; Nicholson BT, 2006, ACAD RADIOL, V13, P1143, DOI 10.1016/j.acra.2006.06.005; OZA AM, 1993, EPIDEMIOL REV, V15, P196, DOI 10.1093/oxfordjournals.epirev.a036105; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rockhill B, 2003, J CLIN EPIDEMIOL, V56, P856, DOI 10.1016/S0895-4356(03)00124-0; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; SAFTLAS AF, 1989, AM J EPIDEMIOL, V129, P518, DOI 10.1093/oxfordjournals.aje.a115163; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Shepherd JA, 2006, MED PHYS, V33, P1490, DOI 10.1118/1.2193691; Shepherd JA, 2005, TECHNOL CANCER RES T, V4, P173, DOI 10.1177/153303460500400206; Sickles EA, 2005, RADIOLOGY, V235, P775, DOI 10.1148/radiol.2353040738; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Tchou J, 2004, CANCER-AM CANCER SOC, V100, P1800, DOI 10.1002/cncr.20205; Tice JA, 2005, BREAST CANCER RES TR, V94, P115, DOI 10.1007/s10549-005-5152-4; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Vachon CM, 2007, CANCER EPIDEM BIOMAR, V16, P43, DOI 10.1158/1055-9965.EPI-06-0738; van Gils CH, 1998, J EPIDEMIOL COMMUN H, V52, P267, DOI 10.1136/jech.52.4.267; van Gils CH, 1998, EUR J EPIDEMIOL, V14, P315, DOI 10.1023/A:1007423824675; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; WARNER E, 1992, CANCER DETECT PREV, V16, P67; WOLFE JN, 1987, AM J ROENTGENOL, V148, P1087, DOI 10.2214/ajr.148.6.1087	55	368	376	2	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2008	148	5					337	W75		10.7326/0003-4819-148-5-200803040-00004	http://dx.doi.org/10.7326/0003-4819-148-5-200803040-00004			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268SX	18316752	Green Accepted			2022-12-24	WOS:000253600800002
J	Santorelli, LA; Thompson, CRL; Villegas, E; Svetz, J; Dinh, C; Parikh, A; Sucgang, R; Kuspa, A; Strassmann, JE; Queller, DC; Shaulsky, G				Santorelli, Lorenzo A.; Thompson, Christopher R. L.; Villegas, Elizabeth; Svetz, Jessica; Dinh, Christopher; Parikh, Anup; Sucgang, Richard; Kuspa, Adam; Strassmann, Joan E.; Queller, David C.; Shaulsky, Gad			Facultative cheater mutants reveal the genetic complexity of cooperation in social amoebae	NATURE			English	Article							DICTYOSTELIUM-DISCOIDEUM; MYXOCOCCUS-XANTHUS; MECHANISM; EVOLUTION; BACTERIUM; DNA	Cooperation is central to many major transitions in evolution, including the emergence of eukaryotic cells, multicellularity and eusociality(1). Cooperation can be destroyed by the spread of cheater mutants that do not cooperate but gain the benefits of cooperation from others(1,2). However, cooperation can be preserved if cheaters are facultative, cheating others but cooperating among themselves(2). Several cheater mutants have been studied before, but no study has attempted a genome- scale investigation of the genetic opportunities for cheating. Here we describe such a screen in a social amoeba and show that cheating is multifaceted by revealing cheater mutations in well over 100 genes of diverse types. Many of these mutants cheat facultatively, producing more than their fair share of spores in chimaeras, but cooperating normally when clonal. These findings indicate that phenotypically stable cooperative systems may nevertheless harbour genetic conflicts. The opportunities for evolutionary moves and countermoves in such conflicts may select for the involvement of multiple pathways and numerous genes.	[Santorelli, Lorenzo A.; Kuspa, Adam; Strassmann, Joan E.; Queller, David C.; Shaulsky, Gad] Rice Univ, Dept Ecol & Evolut Biol, Houston, TX 77005 USA; [Thompson, Christopher R. L.; Villegas, Elizabeth; Svetz, Jessica; Parikh, Anup; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dinh, Christopher; Sucgang, Richard; Kuspa, Adam] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Parikh, Anup; Shaulsky, Gad] Baylor Coll Med, Grad Program Struct Computat Biol & Mol Biophys, Houston, TX 77030 USA	Rice University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Shaulsky, G (corresponding author), Rice Univ, Dept Ecol & Evolut Biol, Houston, TX 77005 USA.	gadi@bcm.tmc.edu		Santorelli, Lorenzo/0000-0002-8392-801X; Strassmann, Joan/0000-0003-0638-8440; Kuspa, Adam/0000-0002-9156-149X; Shaulsky, Gad/0000-0002-0532-0551	MRC [G0400103] Funding Source: UKRI; Medical Research Council [G0400103] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Chen GK, 2004, DEVELOPMENT, V131, P2619, DOI 10.1242/dev.01151; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Ennis HL, 2000, P NATL ACAD SCI USA, V97, P3292, DOI 10.1073/pnas.050005097; Fiegna F, 2005, PLOS BIOL, V3, P1980, DOI 10.1371/journal.pbio.0030370; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Greig D, 2004, P ROY SOC B-BIOL SCI, V271, pS25, DOI 10.1098/rsbl.2003.0083; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; JERMYN KA, 1989, NATURE, V340, P144, DOI 10.1038/340144a0; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Kibler K, 2003, DEV BIOL, V259, P193, DOI 10.1016/S0012-1606(03)00204-5; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; KUSPA A, 1992, P NATL ACAD SCI USA, V89, P8803, DOI 10.1073/pnas.89.18.8803; Maynard Smith John., 1995, MAJOR TRANSITION EVO; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; SHAULSKY G, 1995, P NATL ACAD SCI USA, V92, P5660, DOI 10.1073/pnas.92.12.5660; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; STERNFELD J, 1982, DEV BIOL, V93, P111, DOI 10.1016/0012-1606(82)90244-5; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Thompson CRL, 2004, DEVELOPMENT, V131, P513, DOI 10.1242/dev.00939; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103	28	104	104	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2008	451	7182					1107	U7		10.1038/nature06558	http://dx.doi.org/10.1038/nature06558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18272966				2022-12-24	WOS:000253453600042
J	Ebert, BL; Pretz, J; Bosco, J; Chang, CY; Tamayo, P; Galili, N; Raza, A; Root, DE; Attar, E; Ellis, SR; Golub, TR				Ebert, Benjamin L.; Pretz, Jennifer; Bosco, Jocelyn; Chang, Cindy Y.; Tamayo, Pablo; Galili, Naomi; Raza, Azra; Root, David E.; Attar, Eyal; Ellis, Steven R.; Golub, Todd R.			Identification of RPS14 as a 5q(-) syndrome gene by RNA interference screen	NATURE			English	Article							CANCER; DELETION	Somatic chromosomal deletions in cancer are thought to indicate the location of tumour suppressor genes, by which a complete loss of gene function occurs through biallelic deletion, point mutation or epigenetic silencing, thus fulfilling Knudson's two- hit hypothesis(1). In many recurrent deletions, however, such biallelic inactivation has not been found. One prominent example is the 5q(-) syndrome, a subtype of myelodysplastic syndrome characterized by a defect in erythroid differentiation(2). Here we describe an RNA-mediated interference ( RNAi)- based approach to discovery of the 5q(-) disease gene. We found that partial loss of function of the ribosomal subunit protein RPS14 phenocopies the disease in normal haematopoietic progenitor cells, and also that forced expression of RPS14 rescues the disease phenotype in patient- derived bone marrow cells. In addition, we identified a block in the processing of pre- ribosomal RNA in RPS14- deficient cells that is functionally equivalent to the defect in Diamond- Blackfan anaemia, linking the molecular pathophysiology of the 5q(-) syndrome to a congenital syndrome causing bone marrow failure. These results indicate that the 5q(-) syndrome is caused by a defect in ribosomal protein function and suggest that RNAi screening is an effective strategy for identifying causal haploinsufficiency disease genes.	[Ebert, Benjamin L.; Pretz, Jennifer; Bosco, Jocelyn; Chang, Cindy Y.; Tamayo, Pablo; Root, David E.; Golub, Todd R.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Ebert, Benjamin L.; Pretz, Jennifer; Bosco, Jocelyn; Chang, Cindy Y.; Tamayo, Pablo; Root, David E.; Golub, Todd R.] Harvard Univ, Cambridge, MA 02142 USA; [Ebert, Benjamin L.; Golub, Todd R.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Ebert, Benjamin L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, Boston, MA 02115 USA; [Galili, Naomi; Raza, Azra] Univ Massachusetts, Sch Med, Div Hematol Oncol, Worcester, MA 01655 USA; [Attar, Eyal] Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02114 USA; [Ellis, Steven R.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; University of Louisville; Howard Hughes Medical Institute	Golub, TR (corresponding author), MIT, Broad Inst, Cambridge, MA 02142 USA.	golub@broad.mit.edu			NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945, R01HL079583, K08HL078818] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32 CA009172] Funding Source: Medline; NHLBI NIH HHS [K08 HL078818, R01 HL082945, R01 HL079583] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Ebert BL, 2005, BLOOD, V105, P4620, DOI 10.1182/blood-2004-08-3313; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; FIYGARE J, 2007, BLOOD, V109, P860; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Giagounidis AAN, 2006, CLIN CANCER RES, V12, P5, DOI 10.1158/1078-0432.CCR-05-1437; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; Horrigan SK, 2000, BLOOD, V95, P2372, DOI 10.1182/blood.V95.7.2372.007k20_2372_2377; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Liu JM, 2006, BLOOD, V107, P4583, DOI 10.1182/blood-2005-12-4831; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; QUESENBERRY PJ, 2005, WILLIAMS HEMATOLOGY, P153; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; RAZA A, 1995, BLOOD, V86, P268, DOI 10.1182/blood.V86.1.268.bloodjournal861268; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; VANDENBERGHE H, 1974, NATURE, V251, P437, DOI 10.1038/251437a0; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	28	670	700	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					335	U7		10.1038/nature06494	http://dx.doi.org/10.1038/nature06494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202658	Green Submitted, Green Accepted			2022-12-24	WOS:000252432100050
J	Roll-Mecak, A; Vale, RD				Roll-Mecak, Antonina; Vale, Ronald D.			Structural basis of microtubule severing by the hereditary spastic paraplegia protein spastin	NATURE			English	Article							ATP-DEPENDENT OLIGOMERIZATION; DISASSEMBLES MICROTUBULES; ALPHA-TUBULIN; KATANIN; RECOGNITION; SCATTERING; HOMOLOG; BINDING; INVIVO; DOMAIN	Spastin, the most common locus for mutations in hereditary spastic paraplegias(1), and katanin are related microtubule- severing AAA ATPases(2-6) involved in constructing neuronal(7-10) and non-centrosomal(7,11) microtubule arrays and in segregating chromosomes(12,13). The mechanism by which spastin and katanin break and destabilize microtubules is unknown, in part owing to the lack of structural information on these enzymes. Here we report the X- ray crystal structure of the Drosophila spastin AAA domain and provide a model for the active spastin hexamer generated using small- angle X- ray scattering combined with atomic docking. The spastin hexamer forms a ring with a prominent central pore and six radiating arms that may dock onto the microtubule. Helices unique to the microtubule- severing AAA ATPases surround the entrances to the pore on either side of the ring, and three highly conserved loops line the pore lumen. Mutagenesis reveals essential roles for these structural elements in the severing reaction. Peptide and antibody inhibition experiments further show that spastin may dismantle microtubules by recognizing specific features in the carboxy- terminal tail of tubulin. Collectively, our data support a model in which spastin pulls the C terminus of tubulin through its central pore, generating a mechanical force that destabilizes tubulin- tubulin interactions within the microtubule lattice. Our work also provides insights into the structural defects in spastin that arise from mutations identified in hereditary spastic paraplegia patients.	[Roll-Mecak, Antonina; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Roll-Mecak, Antonina; Vale, Ronald D.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu		Roll-Mecak, Antonina/0000-0003-2621-7307	Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [K99 NS057934-01, K99 NS057934-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS057934] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Burk DH, 2001, PLANT CELL, V13, P807, DOI 10.1105/tpc.13.4.807; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Fonknechten N, 2000, HUM MOL GENET, V9, P637, DOI 10.1093/hmg/9.4.637; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Guinier  A., 1995, SMALL ANGLE SCATTERI; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lu CG, 2004, MOL BIOL CELL, V15, P142, DOI 10.1091/mbc.E03-06-0418; Matsushita-Ishiodori Y, 2007, BIOCHEM BIOPH RES CO, V359, P157, DOI 10.1016/j.bbrc.2007.05.086; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; RODRIGUEZ JA, 1979, BIOCHEM BIOPH RES CO, V89, P893, DOI 10.1016/0006-291X(79)91862-X; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2006, J CELL BIOL, V175, P849, DOI 10.1083/jcb.200611149; Salinas S, 2005, J NEUROCHEM, V95, P1411, DOI 10.1111/j.1471-4159.2005.03472.x; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Srayko M, 2000, GENE DEV, V14, P1072; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tarrade A, 2006, HUM MOL GENET, V15, P3544, DOI 10.1093/hmg/ddl431; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WEHLAND J, 1983, J CELL BIOL, V97, P1467, DOI 10.1083/jcb.97.5.1467; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Wood JD, 2006, HUM MOL GENET, V15, P2763, DOI 10.1093/hmg/ddl212; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011	34	232	241	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					363	U16		10.1038/nature06482	http://dx.doi.org/10.1038/nature06482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202664	Green Accepted			2022-12-24	WOS:000252432100056
J	Zhai, RG; Zhang, F; Hiesinger, PR; Cao, Y; Haueter, CM; Bellen, HJ				Zhai, R. Grace; Zhang, Fan; Hiesinger, P. Robin; Cao, Yu; Haueter, Claire M.; Bellen, Hugo J.			NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration	NATURE			English	Article							WALLERIAN DEGENERATION; AXON DEGENERATION; NERVOUS-SYSTEM; WLD(S); MICE; MODEL; BIOSYNTHESIS; AGGREGATION; DROSOPHILA; DISEASE	Neurodegeneration can be triggered by genetic or environmental factors. Although the precise cause is often unknown, many neurodegenerative diseases share common features such as protein aggregation and age dependence. Recent studies in Drosophila have uncovered protective effects of NAD synthase nicotinamide mononucleotide adenylyltransferase ( NMNAT) against activity-induced neurodegeneration and injury- induced axonal degeneration(1,2). Here we show that NMNAT overexpression can also protect against spinocerebellar ataxia 1 ( SCA1)- induced neurodegeneration, suggesting a general neuroprotective function of NMNAT. It protects against neurodegeneration partly through a proteasome-mediated pathway in a manner similar to heat- shock protein 70 ( Hsp70). NMNAT displays chaperone function both in biochemical assays and cultured cells, and it shares significant structural similarity with known chaperones. Furthermore, it is upregulated in the brain upon overexpression of poly- glutamine expanded protein and recruited with the chaperone Hsp70 into protein aggregates. Our results implicate NMNAT as a stress- response protein that acts as a chaperone for neuronal maintenance and protection. Our studies provide an entry point for understanding how normal neurons maintain activity, and offer clues for the common mechanisms underlying different neurodegenerative conditions.	[Zhai, R. Grace; Zhang, Fan] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Zhai, R. Grace; Hiesinger, P. Robin; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zhai, R. Grace; Cao, Yu; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	University of Miami; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Zhai, RG (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	gzhai@med.miami.edu; hbellen@bcm.edu	Zhai, R. Grace/AGZ-3936-2022; Zhang, Fan/E-4333-2010	Bellen, Hugo/0000-0001-5992-5989; Zhang, Fan/0000-0002-0744-673X; Zhai, Rong/0000-0002-7599-1430	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [P30 HD024064-20, P30 HD024064] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Chang ZY, 1996, J BIOL CHEM, V271, P7218, DOI 10.1074/jbc.271.12.7218; Conforti L, 2007, CELL DEATH DIFFER, V14, P116, DOI 10.1038/sj.cdd.4401944; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Ferri A, 2003, CURR BIOL, V13, P669, DOI 10.1016/S0960-9822(03)00206-9; Gillingwater TH, 2004, J CEREBR BLOOD F MET, V24, P62, DOI 10.1097/01.WCB.0000095798.98378.34; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; Holm L, 1997, STRUCTURE, V5, P165, DOI 10.1016/S0969-2126(97)00176-7; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Jia HQ, 2007, NEUROSCI LETT, V413, P46, DOI 10.1016/j.neulet.2006.11.067; Kubo Y, 1999, J MOL BIOL, V286, P447, DOI 10.1006/jmbi.1998.2465; Li JZ, 2003, STRUCTURE, V11, P323, DOI 10.1016/S0969-2126(03)00030-3; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; LUDWIN SK, 1992, J NEUROL SCI, V109, P140, DOI 10.1016/0022-510X(92)90160-M; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; RIBCHESTER RR, 1995, EUR J NEUROSCI, V7, P1641, DOI 10.1111/j.1460-9568.1995.tb01159.x; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sajadi A, 2004, CURR BIOL, V14, P326, DOI 10.1016//j.cub.2004.01.053; Samsam M, 2003, J NEUROSCI, V23, P2833; Sousa MC, 2001, STRUCTURE, V9, P1135, DOI 10.1016/S0969-2126(01)00680-3; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	30	159	170	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 17	2008	452	7189					887	U8		10.1038/nature06721	http://dx.doi.org/10.1038/nature06721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288ZY	18344983	Green Accepted			2022-12-24	WOS:000255026000051
J	Pohl, C; Jentsch, S				Pohl, Christian; Jentsch, Stefan			Final stages of cytokinesis and midbody ring formation are controlled by BRUCE	CELL			English	Article							KINESIN-LIKE PROTEIN; NUCLEAR-LOCALIZATION; UBIQUITIN LIGASE; CELL-DIVISION; MITOTIC EXIT; APOPTOSIS; COMPLETION; EXOCYST; ENZYME; PROTEOLYSIS	Cytokinesis involves the formation of a cleavage furrow, followed by abscission, the cutting of the midbody channel, the final bridge between dividing cells. Recently, the midbody ring became known as central for abscission, but its regulation remains enigmatic. Here, we identify BRUCE, a 528 kDa multifunctional protein, which processes ubiquitin-conjugating activity, as a major regulator of abscission. During cytokinesis, BRUCE moves from the vesicular system to the midbody ring and serves as a platform for the membrane delivery machinery and mitotic regulators. Depletion of BRUCE in cell cultures causes defective abscission and cytokinesis-associated apoptosis, accompanied by a block of vesicular targeting and defective formation of the midbody and the midbody ring. Notably, ubiquitin relocalizes from midbody microtubules to the midbody ring during cytokinesis, and depletion of BRUCE disrupts this process. We propose that BRUCE coordinates multiple steps required for abscission and that ubiquitylation may be a crucial trigger.	[Pohl, Christian; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de	Pohl, Christian/D-4700-2011					Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Flemming W., 1891, ARCH MIKROSK ANAT, V37, P685, DOI [DOI 10.1007/BF02954311, 10.1007/BF02954311]; GRENFELL SJ, 1994, BIOCHEM J, V300, P701, DOI 10.1042/bj3000701; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kuriyama R, 2002, J CELL BIOL, V156, P783, DOI 10.1083/jcb.200109090; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu XQ, 2007, BIOCHEM BIOPH RES CO, V353, P960, DOI 10.1016/j.bbrc.2006.12.142; Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004; Matuliene J, 2002, MOL BIOL CELL, V13, P1832, DOI 10.1091/mbc.01-10-0504; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Pines J, 2005, NAT CELL BIOL, V7, P731, DOI 10.1038/ncb0805-731; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Row PE, 2007, J BIOL CHEM, V282, P30929, DOI 10.1074/jbc.M704009200; Samuel T, 2005, CANCER RES, V65, P210; Schmidt K, 2004, CURR BIOL, V14, P1002, DOI 10.1016/j.cub.2004.05.044; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; Verhagen AM, 2001, GENOME BIOL, V2; WOJCIK C, 1995, EUR J CELL BIOL, V68, P191; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yu XZ, 2007, EUR J CELL BIOL, V86, P25, DOI 10.1016/j.ejcb.2006.10.002	36	133	150	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2008	132	5					832	845		10.1016/j.cell.2008.01.012	http://dx.doi.org/10.1016/j.cell.2008.01.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329369	Bronze			2022-12-24	WOS:000253818000020
J	Gollisch, T; Meister, M				Gollisch, Tim; Meister, Markus			Rapid neural coding in the retina with relative spike latencies	SCIENCE			English	Article							GANGLION-CELLS; RECEPTIVE-FIELD; CONTRAST; ORGANIZATION; INFORMATION; RESPONSES; PATTERN; CODE	Natural vision is a highly dynamic process. Frequent body, head, and eye movements constantly bring new images onto the retina for brief periods, challenging our understanding of the neural code for vision. We report that certain retinal ganglion cells encode the spatial structure of a briefly presented image in the relative timing of their first spikes. This code is found to be largely invariant to stimulus contrast and robust to noisy fluctuations in response latencies. Mechanistically, the observed response characteristics result from different kinetics in two retinal pathways ("ON" and "OFF") that converge onto ganglion cells. This mechanism allows the retina to rapidly and reliably transmit new spatial information with the very first spikes emitted by a neural population.	[Gollisch, Tim; Meister, Markus] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Gollisch, Tim; Meister, Markus] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Meister, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	meister@fas.harvard.edu		Meister, Markus/0000-0003-2136-6506; Gollisch, Tim/0000-0003-3998-533X	NATIONAL EYE INSTITUTE [R01EY014737] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014737] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; ASHMORE JF, 1980, NATURE, V288, P84, DOI 10.1038/288084a0; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Burkhardt DA, 1998, VISUAL NEUROSCI, V15, P219, DOI 10.1017/S0952523898152021; Chase SM, 2007, P NATL ACAD SCI USA, V104, P5175, DOI 10.1073/pnas.0610368104; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; DEMONASTERIO FM, 1978, J NEUROPHYSIOL, V41, P1435, DOI 10.1152/jn.1978.41.6.1435; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Geffen MN, 2007, PLOS BIOL, V5, P640, DOI 10.1371/journal.pbio.0050065; Greschner M, 2006, J NEUROPHYSIOL, V96, P2845, DOI 10.1152/jn.01131.2005; Hare WA, 1996, J NEUROPHYSIOL, V76, P2005, DOI 10.1152/jn.1996.76.3.2005; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Kara P, 2003, J NEUROSCI, V23, P8547; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Menz MD, 2003, NAT NEUROSCI, V6, P59, DOI 10.1038/nn986; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Reich DS, 2001, J NEUROPHYSIOL, V85, P1039, DOI 10.1152/jn.2001.85.3.1039; Roska B, 2003, NAT NEUROSCI, V6, P600, DOI 10.1038/nn1061; Sawtell NB, 2005, CURR OPIN NEUROBIOL, V15, P437, DOI 10.1016/j.conb.2005.06.006; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; WERNER C, 1985, ZOOL JAHRB ALLG ZOOL, V89, P359; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002	30	408	454	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2008	319	5866					1108	1111		10.1126/science.1149639	http://dx.doi.org/10.1126/science.1149639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264SW	18292344				2022-12-24	WOS:000253311700048
J	Merideth, MA; Gordon, LB; Clauss, S; Sachdev, V; Smith, ACM; Perry, MB; Brewer, CC; Zalewski, C; Kim, HJ; Solomon, B; Brooks, BP; Gerber, LH; Turner, ML; Domingo, DL; Hart, TC; Graf, J; Reynolds, JC; Gropman, A; Yanovski, JA; Gerhard-Herman, M; Collins, FS; Nabel, EG; Cannon, RO; Gahl, WA; Introne, WJ				Merideth, Melissa A.; Gordon, Leslie B.; Clauss, Sarah; Sachdev, Vandana; Smith, Ann C. M.; Perry, Monique B.; Brewer, Carmen C.; Zalewski, Christopher; Kim, H. Jeffrey; Solomon, Beth; Brooks, Brian P.; Gerber, Lynn H.; Turner, Maria L.; Domingo, Demetrio L.; Hart, Thomas C.; Graf, Jennifer; Reynolds, James C.; Gropman, Andrea; Yanovski, Jack A.; Gerhard-Herman, Marie; Collins, Francis S.; Nabel, Elizabeth G.; Cannon, Richard O., III; Gahl, William A.; Introne, Wendy J.			Phenotype and course of Hutchinson-Gilford progeria syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							6-MINUTE WALK TEST; MUTANT LAMIN-A; CARDIOVASCULAR RISK; INHIBITING FARNESYLATION; AMERICAN-SOCIETY; CHILDREN; DISEASE; PROTEIN; ECHOCARDIOGRAPHY; ATHEROSCLEROSIS	Background: Hutchinson-Gilford progeria syndrome is a rare, sporadic, autosomal dominant syndrome that involves premature aging, generally leading to death at approximately 13 years of age due to myocardial infarction or stroke. The genetic basis of most cases of this syndrome is a change from glycine GGC to glycine GGT in codon 608 of the lamin A (LMNA) gene, which activates a cryptic splice donor site to produce abnormal lamin A; this disrupts the nuclear membrane and alters transcription. Methods: We enrolled 15 children between 1 and 17 years of age, representing nearly half of the world's known patients with Hutchinson-Gilford progeria syndrome, in a comprehensive clinical protocol between February 2005 and May 2006. Results: Clinical investigations confirmed sclerotic skin, joint contractures, bone abnormalities, alopecia, and growth impairment in all 15 patients; cardiovascular and central nervous system sequelae were also documented. Previously unrecognized findings included prolonged prothrombin times, elevated platelet counts and serum phosphorus levels, measured reductions in joint range of motion, low-frequency conductive hearing loss, and functional oral deficits. Growth impairment was not related to inadequate nutrition, insulin unresponsiveness, or growth hormone deficiency. Growth hormone treatment in a few patients increased height growth by 10% and weight growth by 50%. Cardiovascular studies revealed diminishing vascular function with age, including elevated blood pressure, reduced vascular compliance, decreased ankle-brachial indexes, and adventitial thickening. Conclusions: Establishing the detailed phenotype of Hutchinson-Gilford progeria syndrome is important because advances in understanding this syndrome may offer insight into normal aging. Abnormal lamin A (progerin) appears to accumulate with aging in normal cells. (ClinicalTrials.gov number, NCT00365092.).	[Merideth, Melissa A.; Smith, Ann C. M.; Gropman, Andrea; Collins, Francis S.; Gahl, William A.; Introne, Wendy J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Merideth, Melissa A.] NIH, Intramural Off Rare Dis, Bethesda, MD 20892 USA; [Sachdev, Vandana; Nabel, Elizabeth G.; Cannon, Richard O., III] NHLBI, Bethesda, MD 20892 USA; [Perry, Monique B.; Solomon, Beth] NIH, Dept Rehabil Med, Bethesda, MD 20892 USA; [Reynolds, James C.] NIH, Dept Nucl Med, Ctr Clin, Bethesda, MD 20892 USA; [Brewer, Carmen C.; Zalewski, Christopher; Kim, H. Jeffrey] Natl Inst Deafness & Other Communicat Disorders, Bethesda, MD USA; [Brooks, Brian P.] NEI, Bethesda, MD 20892 USA; NCI, Bethesda, MD 20892 USA; [Domingo, Demetrio L.; Hart, Thomas C.] Natl Inst Dent & Craniofacial Res, Bethesda, MD USA; [Yanovski, Jack A.] NICHHD, Bethesda, MD 20892 USA; [Gordon, Leslie B.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Clauss, Sarah; Gropman, Andrea] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Smith, Ann C. M.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Gerber, Lynn H.] George Mason Univ, Ctr Chron Illness & Disabil, Fairfax, VA 22030 USA; [Gerhard-Herman, Marie] Brigham & Womens Hosp, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Brown University; Children's National Health System; Georgetown University; George Mason University; Harvard University; Brigham & Women's Hospital	Gahl, WA (corresponding author), NHGRI, NIH, Bldg 10,Rm 10C-103, Bethesda, MD 20892 USA.	bgahl@helix.nih.gov	SMITH, ANN C.M./C-1122-2008; Gordon, Leslie B./AAJ-5793-2021	Yanovski, Jack/0000-0001-8542-1637; Gerber, Lynn/0000-0001-7525-680X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200352, ZIAHG200305, Z01HG200334, Z01HG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000064] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HD999999, Z01 HD000641-12] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		CALLOWAY DH, 1971, J NUTR, V101, P205, DOI 10.1093/jn/101.2.205; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; CAPELL BC, 2006, 56 ANN M AM SOC HUM, P18; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; CHARNAS LR, 1991, NEW ENGL J MED, V324, P1318, DOI 10.1056/NEJM199105093241904; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; CUMMING GR, 1978, AM J CARDIOL, V41, P69, DOI 10.1016/0002-9149(78)90134-0; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; *FOOD NUTR BOARD, 2005, DIET REF INT EN CARB, P168; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gordon LB, 2005, J PEDIATR-US, V146, P336, DOI 10.1016/j.jpeds.2004.10.064; Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; HAGG U, 1985, ANGLE ORTHOD, V55, P93; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Kieran MW, 2007, PEDIATRICS, V120, P834, DOI 10.1542/peds.2007-1356; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lin MR, 2004, J AM GERIATR SOC, V52, P1343, DOI 10.1111/j.1532-5415.2004.52366.x; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Mazereeuw-Hautier J, 2007, BRIT J DERMATOL, V156, P1308, DOI 10.1111/j.1365-2133.2007.07897.x; Meyer AA, 2006, PEDIATRICS, V117, P1560, DOI 10.1542/peds.2005-2140; Mora S, 1998, CALCIFIED TISSUE INT, V63, P369, DOI 10.1007/s002239900542; Muchir A, 2004, PHYSIOLOGY, V19, P309, DOI 10.1152/physiol.00022.2004; Roman MJ, 2006, J AM SOC ECHOCARDIOG, V19, P943, DOI 10.1016/j.echo.2006.04.020; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; SINGH G, 1994, ARTHRITIS RHEUM, V37, P1761, DOI 10.1002/art.1780371209; Stehbens WE, 1999, CARDIOVASC PATHOL, V8, P29, DOI 10.1016/S1054-8807(98)00023-4; Stehbens WE, 2001, CARDIOVASC PATHOL, V10, P133, DOI 10.1016/S1054-8807(01)00069-2; STEINBERG AH, 1957, ARCH DIS CHILD, V32, P401, DOI 10.1136/adc.32.165.401; van Rijn RR, 2003, EUR RADIOL, V13, P700, DOI 10.1007/s00330-002-1676-8; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968	42	440	453	0	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2008	358	6					592	604		10.1056/NEJMoa0706898	http://dx.doi.org/10.1056/NEJMoa0706898			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259CJ	18256394	Green Accepted			2022-12-24	WOS:000252916400006
J	Michishita, E; McCord, RA; Berber, E; Kioi, M; Padilla-Nash, H; Damian, M; Cheung, P; Kusumoto, R; Kawahara, TLA; Barrett, JC; Chang, HY; Bohr, VA; Ried, T; Gozani, O; Chua, KF				Michishita, Eriko; McCord, Ronald A.; Berber, Elisabeth; Kioi, Mitomu; Padilla-Nash, Hesed; Damian, Mara; Cheung, Peggie; Kusumoto, Rika; Kawahara, Tiara L. A.; Barrett, J. Carl; Chang, Howard Y.; Bohr, Vilhelm A.; Ried, Thomas; Gozani, Or; Chua, Katrin F.			SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin	NATURE			English	Article							PROTECTS HUMAN TELOMERES; WERNER-SYNDROME CELLS; S-PHASE; DYSFUNCTIONAL TELOMERES; SYNDROME FIBROBLASTS; GENOMIC INSTABILITY; MAMMALIAN TELOMERES; DNA-DAMAGE; SENESCENCE; TRF2	The Sir2 deacetylase regulates chromatin silencing and lifespan in Saccharomycescerevisiae(1,2). In mice, deficiency for the Sir2 family member SIRT6 leads to a shortened lifespan and a premature ageing- like phenotype(3). However, the molecular mechanisms of SIRT6 function are unclear. SIRT6 is a chromatin- associated protein(3), but no enzymatic activity of SIRT6 at chromatin has yet been detected, and the identity of physiological SIRT6 substrates is unknown. Here we show that the human SIRT6 protein is an NAD(+)-dependent, histone H3 lysine 9 ( H3K9) deacetylase that modulates telomeric chromatin. SIRT6 associates specifically with telomeres, and SIRT6 depletion leads to telomere dysfunction with end- to- end chromosomal fusions and premature cellular senescence. Moreover, SIRT6- depleted cells exhibit abnormal telomere structures that resemble defects observed in Werner syndrome, a premature ageing disorder(4,5). At telomeric chromatin, SIRT6 deacetylates H3K9 and is required for the stable association of WRN, the factor that is mutated in Werner syndrome(4,5). We propose that SIRT6 contributes to the propagation of a specialized chromatin state at mammalian telomeres, which in turn is required for proper telomere metabolism and function. Our findings constitute the first identification of a physiological enzymatic activity of SIRT6, and link chromatin regulation by SIRT6 to telomere maintenance and a human premature ageing syndrome.	[Michishita, Eriko; McCord, Ronald A.; Berber, Elisabeth; Damian, Mara; Chua, Katrin F.] Stanford Univ, Dept Med, Div Endocrinol Gerontol & Metab, Sch Med, Stanford, CA 94305 USA; [Kioi, Mitomu] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Cheung, Peggie; Gozani, Or] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Kawahara, Tiara L. A.; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA; [Michishita, Eriko; McCord, Ronald A.; Berber, Elisabeth; Damian, Mara; Chua, Katrin F.] VA Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA; [Padilla-Nash, Hesed; Ried, Thomas] NCI, Genet Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Barrett, J. Carl] NCI, Lab Biosyst & Canc, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Kusumoto, Rika; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	Stanford University; Stanford University; Stanford University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chua, KF (corresponding author), Stanford Univ, Dept Med, Div Endocrinol Gerontol & Metab, Sch Med, Stanford, CA 94305 USA.	kfchua@stanford.edu	Bohr, Vilhelm/AAP-5931-2020; Gozani, Or P/I-6157-2013	Kioi, Mitomu/0000-0002-7981-3340; Gozani, Or/0000-0002-1365-4463	NIA NIH HHS [K08 AG028961-03, K08 AG028961, R01 AG028867-03, R01 AG028867] Funding Source: Medline; NIGMS NIH HHS [R01 GM079641-02, R01 GM079641] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG028961, R01AG028867, Z01AG000726] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ariyoshi K, 2007, J RADIAT RES, V48, P219, DOI 10.1269/jrr.07017; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Cheng WH, 2007, EXP GERONTOL, V42, P871, DOI 10.1016/j.exger.2007.04.011; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Multani AS, 2007, J CELL SCI, V120, P713, DOI 10.1242/jcs.03397; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Padilla-Nash HM, 2001, GENE CHROMOSOME CANC, V30, P349, DOI 10.1002/gcc.1101; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; TAKEUCHI F, 1982, EXP GERONTOL, V17, P473, DOI 10.1016/S0531-5565(82)80009-0; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630	32	779	830	3	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 27	2008	452	7186					492	U16		10.1038/nature06736	http://dx.doi.org/10.1038/nature06736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18337721	Green Accepted			2022-12-24	WOS:000254341300036
J	Jones, KE; Patel, NG; Levy, MA; Storeygard, A; Balk, D; Gittleman, JL; Daszak, P				Jones, Kate E.; Patel, Nikkita G.; Levy, Marc A.; Storeygard, Adam; Balk, Deborah; Gittleman, John L.; Daszak, Peter			Global trends in emerging infectious diseases	NATURE			English	Article							PUBLIC-HEALTH; RISK-FACTORS; HOST-RANGE; EMERGENCE; ECOLOGY	Emerging infectious diseases (EIDs) are a significant burden on global economies and public health(1-3). Their emergence is thought to be driven largely by socio- economic, environmental and ecological factors(1-9), but no comparative study has explicitly analysed these linkages to understand global temporal and spatial patterns of EIDs. Here we analyse a database of 335 EID 'events' (origins of EIDs) between 1940 and 2004, and demonstrate non-random global patterns. EID events have risen significantly over time after controlling for reporting bias, with their peak incidence (in the 1980s) concomitant with the HIV pandemic. EID events are dominated by zoonoses (60.3% of EIDs): the majority of these (71.8%) originate in wildlife (for example, severe acute respiratory virus, Ebola virus), and are increasing significantly over time. We find that 54.3% of EID events are caused by bacteria or rickettsia, reflecting a large number of drug- resistant microbes in our database. Our results confirm that EID origins are significantly correlated with socio- economic, environmental and ecological factors, and provide a basis for identifying regions where new EIDs are most likely to originate (emerging disease 'hotspots'). They also reveal a substantial risk of wildlife zoonotic and vector-borne EIDs originating at lower latitudes where reporting effort is low. We conclude that global resources to counter disease emergence are poorly allocated, with the majority of the scientific and surveillance effort focused on countries from where the next important EID is least likely to originate.	[Patel, Nikkita G.; Daszak, Peter] Wildlife Trust, Consortium Conservat Med, Beijing 100011, Peoples R China; [Jones, Kate E.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Levy, Marc A.; Storeygard, Adam; Balk, Deborah] Columbia Univ, Ctr Int Earth Sci Informat Network, Palisades, NY 10964 USA; [Gittleman, John L.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	Zoological Society of London; Columbia University; University System of Georgia; University of Georgia	Daszak, P (corresponding author), Wildlife Trust, Consortium Conservat Med, 460 W 34th St,17th Floor, Beijing 100011, Peoples R China.	daszak@conservationmedicine.org	Patel, Nikkita/GRJ-5319-2022; Jones, Kate/Y-3317-2019; Levy, Marc A/K-3557-2015; Levy, Marc/F-6183-2010; Storeygard, Adam/H-2633-2017	Jones, Kate/0000-0001-5231-3293; Levy, Marc A/0000-0002-1111-2222; Balk, Deborah/0000-0002-9028-7898; Patel, Nikkita/0000-0001-6300-6731	FIC NIH HHS [R01 TW005869] Funding Source: Medline; NIAID NIH HHS [R01 AI079231] Funding Source: Medline; NICHD NIH HHS [T32 HD007338] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007338] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079231] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Binder S, 1999, SCIENCE, V284, P1311, DOI 10.1126/science.284.5418.1311; BURKE DS, 1998, PATHOLOGY EMERGING I, P00001; [CIAT CIESIN], 2005, GRIDD POP WORLD VERS; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; *ESRI, 2005, DAT MAPS VERS 9 1; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Houghton J. T., 2001, CLIMATE CHANGE 2001; IIASA/FAO, 2000, GLOB AGR EC ZON GAEZ; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310; Lederberg J., 1992, I MED US COMMITTEE; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Morse Stephen S., 1993, P10; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; R Development Core Team. R, 2005, LANG ENV STAT COMP R; Rogers DJ, 2003, NAT REV MICROBIOL, V1, P231, DOI 10.1038/nrmicro776; SECHREST W, 2003, GLOBAL DIVERSITY END; Smolinsky M.S., 2003, MICROBIAL THREATS HL; *SPSS INC, 2006, SPSS WIND VERS 12 0; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	29	4114	4278	82	2605	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2008	451	7181					990	U4		10.1038/nature06536	http://dx.doi.org/10.1038/nature06536			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288193	Green Published, Bronze			2022-12-24	WOS:000253313100048
J	Gruber, N; Galloway, JN				Gruber, Nicolas; Galloway, James N.			An Earth-system perspective of the global nitrogen cycle	NATURE			English	Article							CARBON-CYCLE; DENITRIFICATION; TERRESTRIAL	With humans having an increasing impact on the planet, the interactions between the nitrogen cycle, the carbon cycle and climate are expected to become an increasingly important determinant of the Earth system.	[Gruber, Nicolas] ETH, Inst Biogeochem & Pollutant Dynam, Environm Phys Grp, CH-8092 Zurich, Switzerland; [Galloway, James N.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Virginia	Gruber, N (corresponding author), ETH, Inst Biogeochem & Pollutant Dynam, Environm Phys Grp, Univ Str 16, CH-8092 Zurich, Switzerland.	nicolas.gruber@env.ethz.ch	Gruber, Nicolas/B-7013-2009; Galloway, James N/C-2769-2013	Gruber, Nicolas/0000-0002-2085-2310; Galloway, James N/0000-0001-7676-8698				Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; [Anonymous], [No title captured]; AUSTIN AT, 2003, INTERACTIONS MAJOR B; Ramos JBE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002898; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Codispoti LA., 2006, BIOGEOSCI DISCUSS, V3, P1203, DOI DOI 10.5194/BGD-3-1203-2006; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fluckiger J, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002122; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; GRUBER N, IN PRESS NITROGEN MA, pCH1; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Rabalais NN, 2002, AMBIO, V31, P102, DOI 10.1579/0044-7447-31.2.102; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Sarmiento JL, 2002, PHYS TODAY, V55, P30, DOI 10.1063/1.1510279; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444	23	1928	2110	153	1662	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					293	296		10.1038/nature06592	http://dx.doi.org/10.1038/nature06592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202647	Bronze			2022-12-24	WOS:000252432100039
J	Brass, AL; Dykxhoorn, DM; Benita, Y; Yan, N; Engelman, A; Xavier, RJ; Lieberman, J; Elledge, SJ				Brass, Abraham L.; Dykxhoorn, Derek M.; Benita, Yair; Yan, Nan; Engelman, Alan; Xavier, Ramnik J.; Lieberman, Judy; Elledge, Stephen J.			Identification of host proteins required for HIV infection through a functional genomic screen	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; N-LINKED GLYCOSYLATION; ENDOPLASMIC-RETICULUM; NUCLEAR IMPORT; SNARE TLG1P; LATE GOLGI; COMPLEX; GLYCOPROTEINS; TRANSPORT; CXCR4	HIV- 1 exploits multiple host proteins during infection. We performed a large- scale small interfering RNA screen to identify host factors required by HIV- 1 and identified more than 250 HIV- dependency factors ( HDFs). These proteins participate in a broad array of cellular functions and implicate new pathways in the viral life cycle. Further analysis revealed previously unknown roles for retrograde Golgi transport proteins ( Rab6 and Vps53) in viral entry, a karyopherin ( TNPO3) in viral integration, and the Mediator complex ( Med28) in viral transcription. Transcriptional analysis revealed that HDF genes were enriched for high expression in immune cells, suggesting that viruses evolve in host cells that optimally perform the functions required for their life cycle. This effort illustrates the power with which RNA interference and forward genetics can be used to expose the dependencies of human pathogens such as HIV, and in so doing identify potential targets for therapy.	[Brass, Abraham L.; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Brigham & Womens Hosp,Dept Genet,Ctr Genet & Geno, Boston, MA 02115 USA; [Brass, Abraham L.; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Dykxhoorn, Derek M.; Yan, Nan; Lieberman, Judy] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Dykxhoorn, Derek M.; Yan, Nan; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Benita, Yair; Xavier, Ramnik J.] Harvard Univ, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Engelman, Alan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Aids, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Brigham & Womens Hosp,Dept Genet,Ctr Genet & Geno, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Dykxhoorn, Derek M/D-1357-2015; Abrams, William R/A-5782-2008; Lieberman, Judy/A-2717-2015; Benita, Yair/E-3094-2012		Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [U19-AI056900, P30 AI060354, AI062773, AI052014] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561-13, P30 DK040561] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773, R01AI052014, U19AI056900, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allemand E, 2002, MOL BIOL CELL, V13, P2436, DOI 10.1091/mbc.E02-02-0102; Ashida H, 2006, J BIOL CHEM, V281, P896, DOI 10.1074/jbc.M511311200; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; BLOUGH HA, 1986, BIOCHEM BIOPH RES CO, V141, P33, DOI 10.1016/S0006-291X(86)80330-8; Chabot DJ, 2000, J VIROL, V74, P4404, DOI 10.1128/JVI.74.9.4404-4413.2000; Conde R, 2003, YEAST, V20, P1189, DOI 10.1002/yea.1032; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Erkmann JA, 2005, MOL BIOL CELL, V16, P2960, DOI 10.1091/mbc.E04-11-1023; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Luo ZL, 2003, J BIOL CHEM, V278, P791, DOI 10.1074/jbc.M209120200; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Murray JL, 2005, J VIROL, V79, P11742, DOI 10.1128/JVI.79.18.11742-11751.2005; Nehete PN, 2002, ANTIVIR RES, V56, P233, DOI 10.1016/S0166-3542(02)00130-4; Puri A, 2004, AIDS, V18, P849, DOI 10.1097/00002030-200404090-00002; Quenneville NR, 2006, MOL BIOL CELL, V17, P1859, DOI 10.1091/mbc.E05-11-1002; Sabri N, 2007, J CELL BIOL, V178, P557, DOI 10.1083/jcb.200612135; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Siniossoglou S, 2002, J BIOL CHEM, V277, P48318, DOI 10.1074/jbc.M209428200; Siniossoglou S, 2001, EMBO J, V20, P5991, DOI 10.1093/emboj/20.21.5991; Ungar D, 2006, TRENDS CELL BIOL, V16, P113, DOI 10.1016/j.tcb.2005.12.004; Wang JB, 2004, VIROLOGY, V324, P140, DOI 10.1016/j.virol.2004.03.005; Wolk T, 2006, MED MICROBIOL IMMUN, V195, P165, DOI 10.1007/s00430-006-0016-z	35	1101	1155	2	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					921	926		10.1126/science.1152725	http://dx.doi.org/10.1126/science.1152725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18187620				2022-12-24	WOS:000253165700037
J	Parelho, V; Hadjur, S; Spivakov, M; Leleu, M; Sauer, S; Gregson, HC; Jarmuz, A; Canzonetta, C; Webster, Z; Nesterova, T; Cobb, BS; Yokomori, K; Dillon, N; Aragon, L; Fisher, AG; Merkenschiager, M				Parelho, Vania; Hadjur, Suzana; Spivakov, Mikhail; Leleu, Marion; Sauer, Stephan; Gregson, Heather C.; Jarmuz, Adam; Canzonetta, Claudia; Webster, Zoe; Nesterova, Tatyana; Cobb, Bradley S.; Yokomori, Kyoko; Dillon, Niall; Aragon, Luis; Fisher, Amanda G.; Merkenschiager, Matthias			Cohesins functionally associate with CTCF on mammalian chromosome arms	CELL			English	Article							SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; ENHANCER-BLOCKING ACTIVITY; NIPPED-B; GENE-EXPRESSION; HUMAN HOMOLOG; SMC PROTEINS; CELL-CYCLE; ACTIVATION; INSULATOR	Cohesins mediate sister chromatid cohesion, which is essential for chromosome segregation and postreplicative DNA repair. In addition, cohesins appear to regulate gene expression and enhancer-promoter interactions. These noncanonical functions remained unexplained because knowledge of cohesin-binding sites and functional interactors in metazoans was lacking. We show that the distribution of cohesins on mammalian chromosome arms is not driven by transcriptional activity, in contrast to S. cerevisiae. Instead, mammalian cohesins occupy a subset of DNase I hypersensitive sites, many of which contain sequence motifs resembling the consensus for CTCF, a DNA-binding protein with enhancer blocking function and boundary-element activity. We find cohesins at most CTCF sites and show that CTCF is required for cohesin localization to these sites. Recruitment by CTCF suggests a rationale for noncanonical cohesin functions and, because CTCF binding is sensitive to DNA methylation, allows cohesin positioning to integrate DNA sequence and epigenetic state.	[Parelho, Vania; Hadjur, Suzana; Spivakov, Mikhail; Leleu, Marion; Sauer, Stephan; Webster, Zoe; Cobb, Bradley S.; Fisher, Amanda G.; Merkenschiager, Matthias] Univ London Imperial Coll Sci Technol & Med, Lymphocyte Dev Grp, London W12 0NN, England; [Jarmuz, Adam; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, Cell Cycle Grp, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Gene Regulat & Chromatin Grp, London W12 0NN, England; [Nesterova, Tatyana] Univ London Imperial Coll Sci Technol & Med, Dev Epigenet Grp, MRC Clin Sci Ctr, London W12 0NN, England; [Gregson, Heather C.; Yokomori, Kyoko] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of California System; University of California Irvine	Merkenschiager, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Lymphocyte Dev Grp, Du Cane Rd, London W12 0NN, England.	matthias.merkenschlager@csc.mrc.ac.uk		Merkenschlager, Matthias/0000-0003-2889-3288; Spivakov, Mikhail/0000-0002-0383-3943; Nesterova, Tatyana/0000-0001-7740-4386; Canzonetta, Claudia/0000-0002-8928-5537	Medical Research Council [MC_U120027516, MC_U120074328, MC_U120036884] Funding Source: Medline; NIGMS NIH HHS [GM59150] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059150] Funding Source: NIH RePORTER; MRC [MC_U120036884, MC_U120027516, MC_U120074328] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Dorsett D, 2007, CHROMOSOMA, V116, P1, DOI 10.1007/s00412-006-0072-6; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; GROVES T, 1995, J IMMUNOL, V154, P5011; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Lau A, 2002, GENE DEV, V16, P2935, DOI 10.1101/gad.764102; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lehmann AR, 2005, DNA REPAIR, V4, P309, DOI 10.1016/j.dnarep.2004.07.009; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lundgren M, 2000, CELL, V103, P733, DOI 10.1016/S0092-8674(00)00177-X; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Recillas-Targa F, 1999, P NATL ACAD SCI USA, V96, P14354, DOI 10.1073/pnas.96.25.14354; Rollins RA, 1999, GENETICS, V152, P577; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Sabbattini P, 2005, SEMIN IMMUNOL, V17, P121, DOI 10.1016/j.smim.2005.01.004; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	49	656	674	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					422	433		10.1016/j.cell.2008.01.011	http://dx.doi.org/10.1016/j.cell.2008.01.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18237772	Green Accepted, Bronze			2022-12-24	WOS:000253180700017
J	Han, MH; Hwang, SI; Roy, DB; Lundgren, DH; Price, JV; Ousman, SS; Fernald, GH; Gerlitz, B; Robinson, WH; Baranzini, SE; Grinnell, BW; Raine, CS; Sobel, RA; Han, DK; Steinman, L				Han, May H.; Hwang, Sun-Il; Roy, Dolly B.; Lundgren, Deborah H.; Price, Jordan V.; Ousman, Shalina S.; Fernald, Guy Haskin; Gerlitz, Bruce; Robinson, William H.; Baranzini, Sergio E.; Grinnell, Brian W.; Raine, Cedric S.; Sobel, Raymond A.; Han, David K.; Steinman, Lawrence			Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; ALPHA-B-CRYSTALLIN; PROTEIN-C; PLAQUE; CHROMATOGRAPHY; PATHOGENESIS; ASTROCYTES; ACTIVATION; ANTIBODIES; SEPSIS	Understanding the neuropathology of multiple sclerosis ( MS) is essential for improved therapies. Therefore, identification of targets specific to pathological types of MS may have therapeutic benefits. Here we identify, by laser- capture microdissection and proteomics, proteins unique to three major types of MS lesions: acute plaque, chronic active plaque and chronic plaque. Comparative proteomic profiles identified tissue factor and protein C inhibitor within chronic active plaque samples, suggesting dysregulation of molecules associated with coagulation. In vivo administration of hirudin or recombinant activated protein C reduced disease severity in experimental autoimmune encephalomyelitis and suppressed Th1 and Th17 cytokines in astrocytes and immune cells. Administration of mutant forms of recombinant activated protein C showed that both its anticoagulant and its signalling functions were essential for optimal amelioration of experimental autoimmune encephalomyelitis. A proteomic approach illuminated potential therapeutic targets selective for specific pathological stages of MS and implicated participation of the coagulation cascade.	[Han, May H.; Price, Jordan V.; Ousman, Shalina S.; Steinman, Lawrence] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Robinson, William H.] Stanford Univ, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA; [Hwang, Sun-Il; Lundgren, Deborah H.; Han, David K.] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Ctr Vasc Biol, Farmington, CT 06030 USA; [Roy, Dolly B.] Northridge Neurol Ctr, Northridge, CA 91325 USA; [Fernald, Guy Haskin; Baranzini, Sergio E.] Univ Calif San Francisco, Sch Dent, Dept Neurol, San Francisco, CA 94143 USA; [Gerlitz, Bruce; Grinnell, Brian W.] Eli Lilly & Co, Lilly Res Lab, Lilly Corp Ctr, Biotechnol Discovery Res, Indianapolis, IN 46285 USA; [Raine, Cedric S.] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Sobel, Raymond A.] Dept Pathol Neuropathol, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Connecticut; University of California System; University of California San Francisco; Eli Lilly; Yeshiva University; Albert Einstein College of Medicine	Steinman, L (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	steinman@stanford.edu	Baranzini, Sergio/A-9422-2013	Baranzini, Sergio/0000-0003-0067-194X; Sobel, Raymond/0000-0002-0477-9002; Robinson, William/0000-0003-4385-704X; Hwang, Sunil/0000-0003-0600-3694; Steinman, Lawrence/0000-0002-2437-2250	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Bagnato C, 2007, MOL CELL PROTEOMICS, V6, P1088, DOI 10.1074/mcp.M600259-MCP200; Benito C, 2007, J NEUROSCI, V27, P2396, DOI 10.1523/JNEUROSCI.4814-06.2007; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; de Kleijn ED, 2003, CRIT CARE MED, V31, P1839, DOI 10.1097/01.CCM.0000072121.61120.D8; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Esmon CT, 2004, MATURITAS, V47, P305, DOI 10.1016/j.maturitas.2003.10.015; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gerlitz B, 1996, J BIOL CHEM, V271, P22285, DOI 10.1074/jbc.271.37.22285; Greenfield EA, 2006, J NEUROSCI RES, V83, P415, DOI 10.1002/jnr.20748; GRINNELL BW, 2007, CRIT CARE MED S, V35; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hwang SI, 2006, MOL CELL PROTEOMICS, V5, P1131, DOI 10.1074/mcp.M500162-MCP200; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kagitani-Shimono K, 2006, NEUROPATH APPL NEURO, V32, P64, DOI 10.1111/j.1365-2990.2005.00690.x; Kirichuk VF, 2003, ZH NEVROPATOL PSIKH, P34; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Laterre PF, 2005, CRIT CARE MED, V33, P952, DOI 10.1097/01.CCM.0000162381.24074.D7; LIDER O, 1989, J CLIN INVEST, V83, P752, DOI 10.1172/JCI113953; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lundgren DH, 2003, MOL CELL PROTEOMICS, V2, P1164, DOI 10.1074/mcp.M300059-MCP200; MASCHMEYER J, 1961, Bull Los Angel Neuro Soc, V26, P165; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Platten M, 2006, SCIENCE, V311, P954; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Riewald M, 2002, TRENDS CARDIOVAS MED, V12, P149, DOI 10.1016/S1050-1738(02)00153-6; Rubinsztein DC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-229; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; Song XH, 1999, CIRCULATION, V100, P1528, DOI 10.1161/01.CIR.100.14.1528; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Wekerle H, 2005, NEUROL SCI, V26, pS1, DOI 10.1007/s10072-005-0386-9; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	38	422	441	0	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1076	U2		10.1038/nature06559	http://dx.doi.org/10.1038/nature06559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18278032				2022-12-24	WOS:000253453600035
J	Yoo, SD; Cho, YH; Tena, G; Xiong, Y; Sheen, J				Yoo, Sang-Dong; Cho, Young-Hee; Tena, Guillaume; Xiong, Yan; Sheen, Jen			Dual control of nuclear EIN3 by bifurcate MAPK cascades in C2H4 signalling	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; ETHYLENE-RESPONSE PATHWAY; F-BOX PROTEINS; FUNCTIONAL-ANALYSIS; ARABIDOPSIS; STRESS; UBIQUITIN; CTR1; ETR1; ETHYLENE-INSENSITIVE3	A principal question in MAP kinase ( MAPK/ MPK) cascade signalling is how similar components dictate different specificity in the information- processing machineries from yeast to humans and plants. In Arabidopsis, how MPK3/ 6modulates distinct outputs in diverse signal transduction pathways remains elusive. By combining systematic cellular and genetic screens, here we uncover a previously unexpected MKK9 - MPK3/ MPK6 cascade promoting ethylene- insensitive 3 ( EIN3)- mediated transcription in ethylene signalling. The mkk9 mutant exhibits a broad spectrum of moderate ethylene- insensitive phenotypes, and translocated MKK9 governs nuclear signalling downstream of receptors. Breaking a linear model and conventional MAPK signalling, ethylene inactivates the negative regulator constitutive triple response 1 ( CTR1, a Raf- like MAPK kinase kinase ( MAPKKK)) to activate the positive MKK9 - MPK3/ 6 cascade. The bifurcate and antagonistic CTR1 and MKK9 pathways are both critical in determining ethylene- signalling specificity through two MAPK phosphorylation sites with opposite effects on EIN3 stability. The results suggest a new paradigm for linking intertwined MAPK cascades to control quantitative responses and specificity in signalling networks.	[Yoo, Sang-Dong; Cho, Young-Hee; Tena, Guillaume; Xiong, Yan; Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Yoo, Sang-Dong; Cho, Young-Hee; Tena, Guillaume; Xiong, Yan; Sheen, Jen] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheen, J (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	yoo@molbio.mgh.harvard.edu; sheen@molbio.mgh.harvard.edu		Xiong, Yan/0000-0003-0676-8267; Tena, Guillaume/0000-0001-8652-905X	NIGMS NIH HHS [R01 GM070567, R01 GM060493] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060493, R01GM070567] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alonso JM, 2004, SCIENCE, V306, P1513, DOI 10.1126/science.1104812; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Burch-Smith TM, 2006, PLANT PHYSIOL, V142, P21, DOI 10.1104/pp.106.084624; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Ecker JR, 2004, PLANT CELL, V16, P3169, DOI 10.1105/tpc.104.161210; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Larsen PB, 2001, PLANT PHYSIOL, V125, P1061, DOI 10.1104/pp.125.2.1061; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; NELJUBOV DN, 1901, BEIH BOT CENTRALBH, V10, P129; Novikova GV, 2000, FEBS LETT, V474, P29, DOI 10.1016/S0014-5793(00)01565-9; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Raman M, 2003, CURR BIOL, V13, pR886, DOI 10.1016/j.cub.2003.10.053; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	50	362	404	11	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					789	U1		10.1038/nature06543	http://dx.doi.org/10.1038/nature06543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273012	Green Accepted, Bronze			2022-12-24	WOS:000253191400034
J	Schnell, JR; Chou, JJ				Schnell, Jason R.; Chou, James J.			Structure and mechanism of the M2 proton channel of influenza A virus	NATURE			English	Article							ION-CHANNEL; MEMBRANE-PROTEIN; AMANTADINE; LOCALIZATION; COUPLINGS; ALIGNMENT; SEQUENCE; REVEALS; FORMS; DRUG	The integral membrane protein M2 of influenza virus forms pH-gated proton channels in the viral lipid envelope(1). The low pH of an endosome activates the M2 channel before haemagglutinin-mediated fusion. Conductance of protons acidifies the viral interior and thereby facilitates dissociation of the matrix protein from the viral nucleoproteins - a required process for unpacking of the viral genome(2). In addition to its role in release of viral nucleoproteins, M2 in the trans- Golgi network ( TGN) membrane prevents premature conformational rearrangement of newly synthesized haemagglutinin during transport to the cell surface by equilibrating the pH of the TGN with that of the host cell cytoplasm(3). Inhibiting the proton conductance of M2 using the anti- viral drug amantadine or rimantadine inhibits viral replication(4-7). Here we present the structure of the tetrameric M2 channel in complex with rimantadine, determined by NMR. In the closed state, four tightly packed transmembrane helices define a narrow channel, in which a 'tryptophan gate' is locked by intermolecular interactions with aspartic acid. A carboxy- terminal, amphipathic helix oriented nearly perpendicular to the transmembrane helix forms an inward- facing base. Lowering the pH destabilizes the transmembrane helical packing and unlocks the gate, admitting water to conduct protons, whereas the C- terminal base remains intact, preventing dissociation of the tetramer. Rimantadine binds at four equivalent sites near the gate on the lipid- facing side of the channel and stabilizes the closed conformation of the pore. Drug-resistance mutations are predicted to counter the effect of drug binding by either increasing the hydrophilicity of the pore or weakening helix - helix packing, thus facilitating channel opening.	[Schnell, Jason R.; Chou, James J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Chou, JJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	james_chou@hms.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344	NIAID NIH HHS [R01 AI067438-02, R01 AI067438-03, R01 AI067438-01A1, R01 AI067438] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067438] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDRICH PE, 1971, J MED CHEM, V14, P535, DOI 10.1021/jm00288a019; ALLERHAN.A, 1966, J CHEM PHYS, V45, P902, DOI 10.1063/1.1727703; Astrahan P, 2004, PROTEINS, V55, P251, DOI 10.1002/prot.20018; BAX A, 1994, METHOD ENZYMOL, V239, P79; Betakova T, 2005, J GEN VIROL, V86, P181, DOI 10.1099/vir.0.80358-0; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Chizhmakov IV, 1996, J PHYSIOL-LONDON, V494, P329, DOI 10.1113/jphysiol.1996.sp021495; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; CIAMPOR F, 1992, VIROLOGY, V188, P14, DOI 10.1016/0042-6822(92)90730-D; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Kukol A, 1999, J MOL BIOL, V286, P951, DOI 10.1006/jmbi.1998.2512; Lamb R. A., 1994, RECEPTOR MEDIATED VI, P303; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; MacKenzie KR, 1996, J BIOMOL NMR, V7, P256; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; PINTO LH, 1995, TRENDS MICROBIOL, V3, P271, DOI 10.1016/S0966-842X(00)88942-8; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Subczynski WK, 1998, J PHARM SCI-US, V87, P1249, DOI 10.1021/js970381n; SUGRUE RJ, 1990, VIROLOGY, V179, P51, DOI 10.1016/0042-6822(90)90272-S; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; SVENSSON TH, 1973, EUR J PHARMACOL, V23, P232, DOI 10.1016/0014-2999(73)90088-5; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Tobler K, 1999, J VIROL, V73, P9695, DOI 10.1128/JVI.73.12.9695-9701.1999; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Wang JF, 2004, BIOCHEM BIOPH RES CO, V324, P212, DOI 10.1016/j.bbrc.2004.09.039; Wang JF, 2001, PROTEIN SCI, V10, P2241, DOI 10.1110/ps.17901; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	39	857	891	7	286	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					591	U12		10.1038/nature06531	http://dx.doi.org/10.1038/nature06531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18235503	Green Accepted			2022-12-24	WOS:000252739900046
J	Lee, KPK; Dey, M; Neculai, D; Cao, C; Dever, TE; Sicheri, F				Lee, Kenneth P. K.; Dey, Madhusudan; Neculai, Dante; Cao, Chune; Dever, Thomas E.; Sicheri, Frank			Structure of the dual enzyme ire1 reveals the basis for catalysis and regulation in nonconventional RNA splicing	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; TRANSMEMBRANE PROTEIN; 2-5A-DEPENDENT RNASE; KINASE-ACTIVITY; ACTIVATION; CLEAVAGE	Ire1 is an ancient transmembrane sensor of ER stress with dual protein kinase and ribonuclease activities. In response to ER stress, Ire1 catalyzes the splicing of target mRNAs in a spliceosome-independent manner. We have determined the crystal structure of the dual catalytic region of Ire1at 2.4 angstrom resolution, revealing the fusion of a domain, which we term the KEN domain, to the protein kinase domain. Dimerization of the kinase domain composes a large catalytic surface on the KEN domain which carries out ribonuclease function. We further show that signal induced trans-autophosphorylation of the kinase domain permits unfettered binding of nucleotide, which in turn promotes dimerization to compose the ribonuclease active site. Comparison of Ire1 to a topologically disparate ribonuclease reveals the convergent evolution of their catalytic mechanism. These findings provide a basis for understanding the mechanism of action of RNaseL and other pseudokinases, which represent 10% of the human kinome.	[Lee, Kenneth P. K.; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Syst Biol, Toronto, ON M5G 1X5, Canada; [Lee, Kenneth P. K.; Neculai, Dante; Sicheri, Frank] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; [Dey, Madhusudan; Cao, Chune; Dever, Thomas E.] Natl Inst Child Hlth & Human Dev, Lab Gene Regulat & Dev, Bethesda, MD 20892 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sicheri, F (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sicheri@mshri.on.ca	Neculai, Dante/M-2884-2013; Longo, Kenneth A/A-5631-2010; Dever, Thomas/GSE-0966-2022; Neculai, Dante/A-9923-2011; Sicheri, Frank/F-8856-2013	Neculai, Dante/0000-0001-8887-9168; Dever, Thomas/0000-0001-7120-9678	Intramural NIH HHS [Z01 HD001010-13] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001010] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Debreczeni JE, 2003, ACTA CRYSTALLOGR D, V59, P393, DOI 10.1107/S0907444902020917; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; DONG BH, 1994, J BIOL CHEM, V269, P14153; Dong BH, 2001, RNA, V7, P361, DOI 10.1017/S1355838201002230; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080; Gay LM, 2006, J MOL BIOL, V360, P409, DOI 10.1016/j.jmb.2006.05.015; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Greenstein AE, 2007, J BIOL CHEM, V282, P11427, DOI 10.1074/jbc.M610193200; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kimata Y, 2004, J CELL BIOL, V167, P445, DOI 10.1083/jcb.200405153; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Mori K, 2003, TRAFFIC, V4, P519, DOI 10.1034/j.1600-0854.2003.00112.x; MORI K, 1993, CELL, V74, P743; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Xue S, 2006, SCIENCE, V312, P906, DOI 10.1126/science.1126629; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	41	253	268	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					89	100		10.1016/j.cell.2007.10.057	http://dx.doi.org/10.1016/j.cell.2007.10.057			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191223	Bronze, Green Accepted			2022-12-24	WOS:000253427600018
J	Kaminsky, R; Ducray, P; Jung, M; Clover, R; Rufener, L; Bouvier, J; Weber, SS; Wenger, A; Wieland-Berghausen, S; Goebel, T; Gauvry, N; Pautrat, F; Skripsky, T; Froelich, O; Komoin-Oka, C; Westlund, B; Sluder, A; Maser, P				Kaminsky, Ronald; Ducray, Pierre; Jung, Martin; Clover, Ralph; Rufener, Lucien; Bouvier, Jacques; Weber, Sandra Schorderet; Wenger, Andre; Wieland-Berghausen, Susanne; Goebel, Thomas; Gauvry, Noelle; Pautrat, Francois; Skripsky, Thomas; Froelich, Olivier; Komoin-Oka, Clarisse; Westlund, Bethany; Sluder, Ann; Maeser, Pascal			A new class of anthelmintics effective against drug-resistant nematodes	NATURE			English	Article							HAEMONCHUS-CONTORTUS; IVERMECTIN; EFFICACY; SUBUNITS	Anthelmintic resistance in human and animal pathogenic helminths has been spreading in prevalence and severity to a point where multidrug resistance against the three major classes of anthelmintics - the benzimidazoles, imidazothiazoles and macrocyclic lactones - has become a global phenomenon in gastrointestinal nematodes of farm animals. Hence, there is an urgent need for an anthelmintic with a new mode of action. Here we report the discovery of the amino- acetonitrile derivatives ( AADs) as a new chemical class of synthetic anthelmintics and describe the development of drug candidates that are efficacious against various species of livestock- pathogenic nematodes. These drug candidates seem to have a novel mode of action involving a unique, nematode- specific clade of acetylcholine receptor subunits. The AADs are well tolerated and of low toxicity to mammals, and overcome existing resistances to the currently available anthelmintics.	[Kaminsky, Ronald; Jung, Martin; Rufener, Lucien; Bouvier, Jacques; Weber, Sandra Schorderet; Wenger, Andre; Froelich, Olivier] Novartis Ctr Rech Sante Animale, CH-1566 St Aubin, Switzerland; [Ducray, Pierre; Wieland-Berghausen, Susanne; Goebel, Thomas; Gauvry, Noelle; Pautrat, Francois; Skripsky, Thomas] Novartis Anim Hlth Inc, CH-4002 Basel, Switzerland; [Clover, Ralph; Westlund, Bethany; Sluder, Ann] Cambria Biosci, Woburn, MA 01801 USA; [Rufener, Lucien; Maeser, Pascal] Lab Cent Vet Bingerville, Lanada, Cote Ivoire	Novartis; Novartis	Kaminsky, R (corresponding author), Novartis Ctr Rech Sante Animale, CH-1566 St Aubin, Switzerland.	ronald.kaminsky@novartis.com	Sluder, Ann/AAS-3102-2020	Maser, Pascal/0000-0003-3122-1941				Anderson P, 1995, METHOD CELL BIOL, V48, P31; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P231, DOI 10.1179/000349804225003253; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Besier B, 2007, TRENDS PARASITOL, V23, P21, DOI 10.1016/j.pt.2006.11.004; BOISVENUE RJ, 1983, VET PARASITOL, V13, P341, DOI 10.1016/0304-4017(83)90050-X; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; DeClercq D, 1997, AM J TROP MED HYG, V57, P25, DOI 10.4269/ajtmh.1997.57.25; Fleming JT, 1997, J NEUROSCI, V17, P5843; Geerts S, 2000, CLIN MICROBIOL REV, V13, P207, DOI 10.1128/CMR.13.2.207-222.2000; Jackson F, 2000, PARASITOLOGY, V120, pS95, DOI 10.1017/S0031182099005740; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P129, DOI 10.1007/s10158-007-0049-z; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Mongan NP, 2002, PROTEIN SCI, V11, P1162, DOI 10.1110/ps.3040102; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Rand James B, 2007, WormBook, P1; Ruaud AF, 2006, DEVELOPMENT, V133, P2211, DOI 10.1242/dev.02392; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treinin M, 1998, P NATL ACAD SCI USA, V95, P15492, DOI 10.1073/pnas.95.26.15492; VANWYK JA, 1988, VET REC, V123, P226, DOI 10.1136/vr.123.9.226; Waller PJ, 1997, VET PARASITOL, V72, P391, DOI 10.1016/S0304-4017(97)00107-6; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; WOOD IB, 1995, VET PARASITOL, V58, P181, DOI 10.1016/0304-4017(95)00806-2	23	361	417	9	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2008	452	7184					176	U19		10.1038/nature06722	http://dx.doi.org/10.1038/nature06722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	273JG	18337814				2022-12-24	WOS:000253925600032
J	Vandermeer, J; Perfecto, I; Philpott, SM				Vandermeer, John; Perfecto, Ivette; Philpott, Stacy M.			Clusters of ant colonies and robust criticality in a tropical agroecosystem	NATURE			English	Article							SELF-ORGANIZATION; PATTERN; SCALE; MUTUALISM; PREY	Although sometimes difficult to measure at large scales, spatial pattern is important in natural biological spaces as a determinant of key ecological properties such as species diversity, stability, resiliency and others(1-6). Here we demonstrate, at a large spatial scale, that a common species of tropical arboreal ant forms clusters of nests through a combination of local satellite colony formation and density- dependent control by natural enemies, mainly a parasitic fly. Cluster sizes fall off as a power law consistent with a so-called robust critical state(7). This endogenous cluster formation at a critical state is a unique example of an insect population forming a non- random pattern at a large spatial scale. Furthermore, because the species is a keystone of a larger network that contributes to the ecosystem function of pest control, this is an example of how spatial dynamics at a large scale can affect ecosystem service at a local level.	[Vandermeer, John] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Vandermeer, John; Perfecto, Ivette] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Philpott, Stacy M.] Univ Toledo, Dept Environm Sci, Toledo, OH 43606 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; University of Toledo	Vandermeer, J (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Kraus Nat Sci Bldg, Ann Arbor, MI 48109 USA.	jvander@umich.edu	Philpott, Stacy/M-3486-2019; Philpott, Stacy M/F-2330-2011	Philpott, Stacy/0000-0002-8338-3806; Philpott, Stacy M/0000-0002-8338-3806				Ball P., 1999, SELF MADE TAPESTRY P; CZARAN T, 1992, TRENDS ECOL EVOL, V7, P38, DOI 10.1016/0169-5347(92)90103-I; Durrett R, 1998, THEOR POPUL BIOL, V53, P30, DOI 10.1006/tpbi.1997.1338; FORMAN RTT, 1987, LANDSCAPE ECOLOGY; Gurney WSC, 2000, B MATH BIOL, V62, P61, DOI 10.1006/bulm.1999.0130; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Maron JL, 1997, SCIENCE, V278, P1619, DOI 10.1126/science.278.5343.1619; Pascual M, 2005, TRENDS ECOL EVOL, V20, P88, DOI 10.1016/j.tree.2004.11.012; Pascual M, 2002, PHILOS T ROY SOC B, V357, P657, DOI 10.1098/rstb.2001.0983; PERFECTO I, IN PRESS ECOLOGY; Perfecto I, 2006, AGR ECOSYST ENVIRON, V117, P218, DOI 10.1016/j.agee.2006.04.007; Philpott SM, 2004, OIKOS, V105, P141, DOI 10.1111/j.0030-1299.2004.12889.x; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Roy Manojit, 2003, Complexity, V8, P19, DOI 10.1002/cplx.10096; TURNER SJ, 1990, ECOL STUD, V82, P17; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432; VANDERMEER J, UNPUB J AGR SCI; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595	20	93	97	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					457	U3		10.1038/nature06477	http://dx.doi.org/10.1038/nature06477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216853	Bronze, Green Published			2022-12-24	WOS:000252554100043
J	Yeung, T; Gilbert, GE; Shi, J; Silvius, J; Kapus, A; Grinstein, S				Yeung, Tony; Gilbert, Gary E.; Shi, Jialan; Silvius, John; Kapus, Andras; Grinstein, Sergio			Membrane phosphatidylserine regulates surface charge and protein localization	SCIENCE			English	Article							PLASMA-MEMBRANE; ELECTROSTATIC SWITCH; BINDING; LACTADHERIN; ASSOCIATION; APOPTOSIS; K-RAS4B; DOMAIN	Electrostatic interactions with negatively charged membranes contribute to the subcellular targeting of proteins with polybasic clusters or cationic domains. Although the anionic phospholipid phosphatidylserine is comparatively abundant, its contribution to the surface charge of individual cellular membranes is unknown, partly because of the lack of reagents to analyze its distribution in intact cells. We developed a biosensor to study the subcellular distribution of phosphatidylserine and found that it binds the cytosolic leaflets of the plasma membrane, as well as endosomes and lysosomes. The negative charge associated with the presence of phosphatidylserine directed proteins with moderately positive charge to the endocytic pathway. More strongly cationic proteins, normally associated with the plasma membrane, relocalized to endocytic compartments when the plasma membrane surface charge decreased on calcium influx.	[Yeung, Tony; Grinstein, Sergio] Hosp Sick Children, Div Cell Biol, Toronto, ON M5G 1X8, Canada; [Gilbert, Gary E.; Shi, Jialan] Harvard Univ, Dept Vet Affairs, Brigham & Womens Hosp, Dept Med,VA Boston Healthcare Syst,Sch Med, Boston, MA 02115 USA; [Silvius, John] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Kapus, Andras] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Sheng Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Kapus, Andras] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; McGill University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Grinstein, S (corresponding author), Hosp Sick Children, Div Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sga@sickkids.ca		Shi, Jialan/0000-0001-5642-5436; Yeung, Tony/0000-0002-1970-5751				Andersen MH, 2000, BIOCHEMISTRY-US, V39, P6200, DOI 10.1021/bi992221r; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; GILBERT GE, 1990, J BIOL CHEM, V265, P815; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Leventis R, 1998, BIOCHEMISTRY-US, V37, P7640, DOI 10.1021/bi973077h; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	17	728	752	5	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2008	319	5860					210	213		10.1126/science.1152066	http://dx.doi.org/10.1126/science.1152066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249RC	18187657				2022-12-24	WOS:000252246400043
J	Lim, J; Crespo-Barreto, J; Jafar-Nejad, P; Bowman, AB; Richman, R; Hill, DE; Orr, HT; Zoghbi, HY				Lim, Janghoo; Crespo-Barreto, Juan; Jafar-Nejad, Paymaan; Bowman, Aaron B.; Richman, Ronald; Hill, David E.; Orr, Harry T.; Zoghbi, Huda Y.			Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1	NATURE			English	Article							BULBAR MUSCULAR-ATROPHY; MOTOR-NEURON DEGENERATION; TRANSGENIC MOUSE MODEL; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; IN-VIVO; TRINUCLEOTIDE REPEAT; INTERACTION NETWORK; MICE; ATAXIN-1	Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease caused by expansion of a glutamine-encoding repeat in ataxin 1 (ATXN1). In all known polyglutamine diseases, the glutamine expansion confers toxic functions onto the protein; however, the mechanism by which this occurs remains enigmatic, in light of the fact that the mutant protein apparently maintains interactions with its usual partners. Here we show that the expanded polyglutamine tract differentially affects the function of the host protein in the context of different endogenous protein complexes. Polyglutamine expansion in ATXN1 favours the formation of a particular protein complex containing RBM17, contributing to SCA1 neuropathology by means of a gain-of-function mechanism. Concomitantly, polyglutamine expansion attenuates the formation and function of another protein complex containing ATXN1 and capicua, contributing to SCA1 through a partial loss-of-function mechanism. This model provides mechanistic insight into the molecular pathogenesis of SCA1 as well as other polyglutamine diseases.	[Lim, Janghoo; Jafar-Nejad, Paymaan; Bowman, Aaron B.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Crespo-Barreto, Juan; Zoghbi, Huda Y.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Richman, Ronald; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Hill, David E.] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Hill, David E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Hill, David E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Orr, Harry T.] Univ Minnesota, Inst Human Genet, Dept Biochem Biophys & Mol Biol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu	Hill, David E/B-6617-2011	Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349; Bowman, Aaron/0000-0001-8728-3346	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [P30 HD024064, P30 HD024064-19] Funding Source: Medline; NINDS NIH HHS [R01 NS027699-19, R01 NS027699] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chaouki AS, 2006, PLOS GENET, V2, P1974, DOI 10.1371/journal.pgen.0020178; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kiehl TR, 2006, BIOCHEM BIOPH RES CO, V339, P17, DOI 10.1016/j.bbrc.2005.10.186; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li AM, 2007, EMBO J, V26, P2777, DOI 10.1038/sj.emboj.7601726; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; McManamny P, 2002, HUM MOL GENET, V11, P2103, DOI 10.1093/hmg/11.18.2103; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sampath J, 2003, AM J PATHOL, V163, P1781, DOI 10.1016/S0002-9440(10)63538-9; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Thomas PS, 2006, HUM MOL GENET, V15, P2225, DOI 10.1093/hmg/ddl148; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Van Broeck B, 2007, NEURODEGENER DIS, V4, P349, DOI 10.1159/000105156; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	43	234	237	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 10	2008	452	7188					713	U1		10.1038/nature06731	http://dx.doi.org/10.1038/nature06731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285QY	18337722	Green Accepted			2022-12-24	WOS:000254792500037
J	Dinsdale, EA; Edwards, RA; Hall, D; Angly, F; Breitbart, M; Brulc, JM; Furlan, M; Desnues, C; Haynes, M; Li, LL; McDaniel, L; Moran, MA; Nelson, KE; Nilsson, C; Olson, R; Paul, J; Brito, BR; Ruan, YJ; Swan, BK; Stevens, R; Valentine, DL; Thurber, RV; Wegley, L; White, BA; Rohwer, F				Dinsdale, Elizabeth A.; Edwards, Robert A.; Hall, Dana; Angly, Florent; Breitbart, Mya; Brulc, Jennifer M.; Furlan, Mike; Desnues, Christelle; Haynes, Matthew; Li, Linlin; McDaniel, Lauren; Moran, Mary Ann; Nelson, Karen E.; Nilsson, Christina; Olson, Robert; Paul, John; Brito, Beltran Rodriguez; Ruan, Yijun; Swan, Brandon K.; Stevens, Rick; Valentine, David L.; Thurber, Rebecca Vega; Wegley, Linda; White, Bryan A.; Rohwer, Forest			Functional metagenomic profiling of nine biomes	NATURE			English	Article							MICROBIAL ECOLOGY; GENOME; DIVERSITY; EVOLUTION; COMMUNITY; DATABASE; VIRUSES; BACTERIOPHAGES; BACTERIA; ARCHAEA	Microbial activities shape the biogeochemistry of the planet(1,2) and macroorganism health(3). Determining the metabolic processes performed by microbes is important both for understanding and for manipulating ecosystems ( for example, disruption of key processes that lead to disease, conservation of environmental services, and so on). Describing microbial function is hampered by the inability to culture most microbes and by high levels of genomic plasticity. Metagenomic approaches analyse microbial communities to determine the metabolic processes that are important for growth and survival in any given environment. Here we conduct a metagenomic comparison of almost 15 million sequences from 45 distinct microbiomes and, for the first time, 42 distinct viromes and show that there are strongly discriminatory metabolic profiles across environments. Most of the functional diversity was maintained in all of the communities, but the relative occurrence of metabolisms varied, and the differences between metagenomes predicted the biogeochemical conditions of each environment. The magnitude of the microbial metabolic capabilities encoded by the viromes was extensive, suggesting that they serve as a repository for storing and sharing genes among their microbial hosts and influence global evolutionary and metabolic processes.	[Dinsdale, Elizabeth A.; Edwards, Robert A.; Hall, Dana; Angly, Florent; Furlan, Mike; Desnues, Christelle; Haynes, Matthew; Li, Linlin; Brito, Beltran Rodriguez; Thurber, Rebecca Vega; Wegley, Linda; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Edwards, Robert A.; Rohwer, Forest] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Angly, Florent; Brito, Beltran Rodriguez] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Dinsdale, Elizabeth A.] Flinders Univ S Australia, Sch Biol Sci, Bedford Pk, SA 5042, Australia; [Edwards, Robert A.; Olson, Robert; Stevens, Rick] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [Breitbart, Mya; McDaniel, Lauren; Paul, John] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Brulc, Jennifer M.; White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Moran, Mary Ann] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Nelson, Karen E.] J Craig Venter Inst, Rockville, MD 20850 USA; [Nilsson, Christina; Ruan, Yijun] Genome Inst Singapore, Singapore 138672, Singapore; [Swan, Brandon K.; Valentine, David L.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; Flinders University South Australia; United States Department of Energy (DOE); Argonne National Laboratory; State University System of Florida; University of South Florida; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University System of Georgia; University of Georgia; J. Craig Venter Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California Santa Barbara	Dinsdale, EA (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	elizabeth_dinsdale@hotmail.com	Li, Linlin/E-3335-2010; Martinez, Octavio/B-7375-2009; Angly, Florent E/A-7717-2011; Edwards, Robert/Q-1691-2019; Desnues, Christelle/ABG-2910-2021; Moran, Mary Ann/B-6939-2012; Swan, Brandon K/O-9824-2018; Valentine, David/E-5594-2012; Breitbart, Mya/B-1366-2009; Desnues, Christelle/B-1383-2010; Rohwer, Forest/AAC-5315-2019	Angly, Florent E/0000-0002-8999-0738; Edwards, Robert/0000-0001-8383-8949; Desnues, Christelle/0000-0002-2178-0355; Swan, Brandon K/0000-0003-0465-1444; Breitbart, Mya/0000-0003-3210-2899; Desnues, Christelle/0000-0002-2178-0355; dinsdale, elizabeth/0000-0002-2177-203X; Moran, Mary Ann/0000-0002-0702-8167; Rohwer, Forest/0000-0003-1548-5429; Valentine, David/0000-0001-5914-9107				Aksnes A, 2006, AQUACULTURE, V261, P1102, DOI 10.1016/j.aquaculture.2006.07.038; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Davis BM, 2002, MOBILE DNA-UK, P1040, DOI [10.1128/9781555817954.ch45, DOI 10.1128/9781555817954.CH45]; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dunbar J, 2000, APPL ENVIRON MICROB, V66, P2943, DOI 10.1128/AEM.66.7.2943-2950.2000; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Gunn MR, 2007, MOL ECOL NOTES, V7, P393, DOI 10.1111/j.1471-8286.2007.01696.x; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Iwanicka-Nowicka R, 2007, J BACTERIOL, V189, P1675, DOI 10.1128/JB.00592-06; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; MEYER F, UNPUB BMC BIOINF; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Sano E, 2004, APPL ENVIRON MICROB, V70, P5842, DOI 10.1128/AEM.70.10.5842-5846.2004; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065	36	644	661	6	310	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 3	2008	452	7187					629	U8		10.1038/nature06810	http://dx.doi.org/10.1038/nature06810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282KR	18337718				2022-12-24	WOS:000254567200045
J	Kay, KN; Naselaris, T; Prenger, RJ; Gallant, JL				Kay, Kendrick N.; Naselaris, Thomas; Prenger, Ryan J.; Gallant, Jack L.			Identifying natural images from human brain activity	NATURE			English	Article							HUMAN VISUAL-CORTEX; BOLD FMRI; ORIENTATION; STRIATE; AREAS; RECONSTRUCTION; REPRESENTATION; FREQUENCY; RESPONSES; PATTERNS	A challenging goal in neuroscience is to be able to read out, or decode, mental content from brain activity. Recent functional magnetic resonance imaging ( fMRI) studies have decoded orientation(1,2), position(3) and object category(4,5) from activity in visual cortex. However, these studies typically used relatively simple stimuli ( for example, gratings) or images drawn from fixed categories ( for example, faces, houses), and decoding was based on previous measurements of brain activity evoked by those same stimuli or categories. To overcome these limitations, here we develop a decoding method based on quantitative receptive- field models that characterize the relationship between visual stimuli and fMRI activity in early visual areas. These models describe the tuning of individual voxels for space, orientation and spatial frequency, and are estimated directly from responses evoked by natural images. We show that these receptive- field models make it possible to identify, from a large set of completely novel natural images, which specific image was seen by an observer. Identification is not a mere consequence of the retinotopic organization of visual areas; simpler receptive- field models that describe only spatial tuning yield much poorer identification performance. Our results suggest that it may soon be possible to reconstruct a picture of a person's visual experience from measurements of brain activity alone.	[Kay, Kendrick N.; Gallant, Jack L.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Naselaris, Thomas; Gallant, Jack L.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Prenger, Ryan J.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gallant, JL (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	gallant@berkeley.edu	Gallant, Jack L/C-4426-2011; Kay, Kendrick/A-4344-2009	Kay, Kendrick/0000-0001-6604-9155	NATIONAL EYE INSTITUTE [R01EY019684] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY019684] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Hansen KA, 2004, NEUROIMAGE, V23, P233, DOI 10.1016/j.neuroimage.2004.05.012; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2004, P NATL ACAD SCI USA, V101, P4286, DOI 10.1073/pnas.0307948101; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Lee TS, 1996, IEEE T PATTERN ANAL, V18, P959, DOI 10.1109/34.541406; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Olman CA, 2004, VISION RES, V44, P669, DOI 10.1016/j.visres.2003.10.022; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Sasaki Y, 2006, NEURON, V51, P661, DOI 10.1016/j.neuron.2006.07.021; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	30	747	798	7	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					352	U7		10.1038/nature06713	http://dx.doi.org/10.1038/nature06713			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18322462	Green Accepted			2022-12-24	WOS:000254117400047
J	Cokus, SJ; Feng, SH; Zhang, XY; Chen, ZG; Merriman, B; Haudenschild, CD; Pradhan, S; Nelson, SF; Pellegrini, M; Jacobsen, SE				Cokus, Shawn J.; Feng, Suhua; Zhang, Xiaoyu; Chen, Zugen; Merriman, Barry; Haudenschild, Christian D.; Pradhan, Sriharsa; Nelson, Stanley F.; Pellegrini, Matteo; Jacobsen, Steven E.			Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning	NATURE			English	Article							5-METHYLCYTOSINE RESIDUES; EPIGENETIC INHERITANCE; NUCLEOSOMAL STRUCTURE; GENES	Cytosine DNA methylation is important in regulating gene expression and in silencing transposons and other repetitive sequences(1,2). Recent genomic studies in Arabidopsis thaliana have revealed that many endogenous genes are methylated either within their promoters or within their transcribed regions, and that gene methylation is highly correlated with transcription levels(3-5). However, plants have different types of methylation controlled by different genetic pathways, and detailed information on the methylation status of each cytosine in any given genome is lacking. To this end, we generated a map at single- base- pair resolution of methylated cytosines for Arabidopsis, by combining bisulphite treatment of genomic DNA with ultra- high- throughput sequencing using the Illumina 1G Genome Analyser and Solexa sequencing technology(6). This approach, termed BS- Seq, unlike previous microarray- based methods, allows one to sensitively measure cytosine methylation on a genome- wide scale within specific sequence contexts. Here we describe methylation on previously inaccessible components of the genome and analyse the DNA methylation sequence composition and distribution. We also describe the effect of various DNA methylation mutants on genome- wide methylation patterns, and demonstrate that our newly developed library construction and computational methods can be applied to large genomes such as that of mouse.	[Cokus, Shawn J.; Feng, Suhua; Zhang, Xiaoyu; Pellegrini, Matteo; Jacobsen, Steven E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Chen, Zugen; Merriman, Barry; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Haudenschild, Christian D.] Illumina Inc, Hayward, CA 94545 USA; [Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Illumina; New England Biolabs	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	matteop@mcdb.ucla.edu; jacobsen@ucla.edu	Christian, Haudenschild C/D-1602-2009; Zhang, xiaoyu/GXA-3206-2022; Nelson, Stanley F/D-4771-2009; Hu, Ruogu/B-2203-2008; jia, xu/A-8386-2016	Nelson, Stanley F/0000-0002-2082-3114; Pellegrini, Matteo/0000-0001-9355-9564	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; BERS EP, 1992, PLANT MOL BIOL, V20, P1089, DOI 10.1007/BF00028895; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Dieguez MJ, 1998, MOL GEN GENET, V259, P207, DOI 10.1007/s004380050806; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fulnecek J, 1998, MOL GEN GENET, V259, P133, DOI 10.1007/s004380050798; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; MEYER P, 1994, EMBO J, V13, P2084, DOI 10.1002/j.1460-2075.1994.tb06483.x; NGERNPRASIRTSIRI J, 1988, P NATL ACAD SCI USA, V85, P4750, DOI 10.1073/pnas.85.13.4750; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Vershinin AV, 1998, PLANT MOL BIOL, V36, P149, DOI 10.1023/A:1005912822671; Zhang X, 2006, COLD SPRING HARB SYM, V71, P439, DOI 10.1101/sqb.2006.71.047; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	26	1561	1662	7	354	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 13	2008	452	7184					215	219		10.1038/nature06745	http://dx.doi.org/10.1038/nature06745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273JG	18278030	Green Accepted			2022-12-24	WOS:000253925600040
J	Lohmueller, KE; Indap, AR; Schmidt, S; Boyko, AR; Hernandez, RD; Hubisz, MJ; Sninsky, JJ; White, TJ; Sunyaev, SR; Nielsen, R; Clark, AG; Bustamante, CD				Lohmueller, Kirk E.; Indap, Amit R.; Schmidt, Steffen; Boyko, Adam R.; Hernandez, Ryan D.; Hubisz, Melissa J.; Sninsky, John J.; White, Thomas J.; Sunyaev, Shamil R.; Nielsen, Rasmus; Clark, Andrew G.; Bustamante, Carlos D.			Proportionally more deleterious genetic variation in European than in African populations	NATURE			English	Article							BRAIN SIZE; MUTATIONS; SELECTION; EVOLUTION; GENOME	Quantifying the number of deleterious mutations per diploid human genome is of crucial concern to both evolutionary and medical geneticists(1-3). Here we combine genome- wide polymorphism data from PCR- based exon resequencing, comparative genomic data across mammalian species, and protein structure predictions to estimate the number of functionally consequential singlenucleotide polymorphisms (SNPs) carried by each of 15 African American (AA) and 20 European American (EA) individuals. We find that AAs show significantly higher levels of nucleotide heterozygosity than do EAs for all categories of functional SNPs considered, including synonymous, non- synonymous, predicted 'benign', predicted 'possibly damaging' and predicted 'probably damaging' SNPs. This result is wholly consistent with previous work showing higher overall levels of nucleotide variation in African populations than in Europeans(4). EA individuals, in contrast, have significantly more genotypes homozygous for the derived allele at synonymous and non- synonymous SNPs and for the damaging allele at ` probably damaging' SNPs than AAs do. For SNPs segregating only in one population or the other, the proportion of non-synonymous SNPs is significantly higher in the EA sample (55.4%) than in the AA sample (47.0%; P < 2.33 X 10(-37)). We observe a similar proportional excess of SNPs that are inferred to be 'probably damaging' (15.9% in EA; 12.1% in AA; P < 3.33 X 10(-11)). Using extensive simulations, we show that this excess proportion of segregating damaging alleles in Europeans is probably a consequence of a bottleneck that Europeans experienced at about the time of the migration out of Africa.	[Lohmueller, Kirk E.; Indap, Amit R.; Boyko, Adam R.; Hernandez, Ryan D.; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Lohmueller, Kirk E.; Boyko, Adam R.; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Schmidt, Steffen] Max Planck Inst Dev Biol, Dept Biochem, D-72076 Tubingen, Germany; [Hubisz, Melissa J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Sninsky, John J.; White, Thomas J.] Celera Diagnost, Alameda, CA 94592 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Nielsen, Rasmus] Univ Copenhagen, Ctr Comparat Genom, Dept Biol, DK-2100 Copenhagen O, Denmark	Cornell University; Cornell University; Max Planck Society; University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Copenhagen	Bustamante, CD (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Biotechnol Bldg, Ithaca, NY 14853 USA.	cdb28@cornell.edu	Nielsen, Rasmus/D-4405-2009; Pepper, John W/O-1662-2013	Nielsen, Rasmus/0000-0003-0513-6591; Pepper, John W/0000-0001-9888-0437; Schmidt, Steffen/0000-0001-9077-6010; Indap, Amit/0000-0002-3322-4735; Hubisz, Melissa/0000-0002-9561-6830; Clark, Andrew/0000-0001-7159-8511; Bustamante, Carlos D./0000-0002-4187-7920	NHGRI NIH HHS [R01 HG003229, R01 HG003229-03] Funding Source: Medline; NHLBI NIH HHS [R01 HL072904] Funding Source: Medline; NIGMS NIH HHS [P50 GM065509-070006, P50 GM065509] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072904] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM065509] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Fay JC, 2001, GENETICS, V158, P1227; Hernandez RD, 2007, MOL BIOL EVOL, V24, P1792, DOI 10.1093/molbev/msm108; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kere J, 2001, ANNU REV GENOM HUM G, V2, P103, DOI 10.1146/annurev.genom.2.1.103; KONDRASHOV AS, 1995, J THEOR BIOL, V175, P583, DOI 10.1006/jtbi.1995.0167; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MULLER HJ, 1950, AM J HUM GENET, V2, P111; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Slatkin M, 2004, AM J HUM GENET, V75, P282, DOI 10.1086/423146; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Travis JMJ, 2007, MOL BIOL EVOL, V24, P2334, DOI 10.1093/molbev/msm167; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	30	286	291	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					994	U5		10.1038/nature06611	http://dx.doi.org/10.1038/nature06611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288194	Bronze, Green Accepted			2022-12-24	WOS:000253313100049
J	Helgason, A; Palsson, S; Guobjartsson, DF; Kristjansson, P; Stefansson, K				Helgason, Agnar; Palsson, Snaebjoern; Guobjartsson, Daniel F.; Kristjansson, Porour; Stefansson, Kari			An association between the kinship and fertility of human couples	SCIENCE			English	Article							CONSANGUINEOUS MARRIAGES; POPULATION; MORTALITY	Previous studies have reported that related human couples tend to produce more children than unrelated couples but have been unable to determine whether this difference is biological or stems from socioeconomic variables. Our results, drawn from all known couples of the Icelandic population born between 1800 and 1965, show a significant positive association between kinship and fertility, with the greatest reproductive success observed for couples related at the level of third and fourth cousins. Owing to the relative socioeconomic homogeneity of Icelanders, and the observation of highly significant differences in the fertility of couples separated by very fine intervals of kinship, we conclude that this association is likely to have a biological basis.	[Helgason, Agnar; Palsson, Snaebjoern; Guobjartsson, Daniel F.; Kristjansson, Porour; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Helgason, Agnar] Univ Iceland, Dept Anthropol, IS-101 Reykjavik, Iceland; [Palsson, Snaebjoern] Univ Iceland, Dept Biol, IS-101 Reykjavik, Iceland; [Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	University of Iceland; University of Iceland; University of Iceland	Helgason, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	agnar@decode.is	Stefansson, Kari/AAE-7187-2019; Palsson, Snaebjorn/J-9113-2012; Helgason, Agnar/K-1522-2015	Helgason, Agnar/0000-0002-8545-3767; Palsson, Snaebjorn/0000-0002-4297-3500; Gudbjartsson, Daniel/0000-0002-5222-9857				AlHusain M, 1997, ANN TROP PAEDIATR, V17, P155; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; BITTLES AH, 1993, INT J EPIDEMIOL, V22, P463, DOI 10.1093/ije/22.3.463; Bittles AH, 2002, ANN HUM BIOL, V29, P111, DOI 10.1080/03014460110075657; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; EDYAL GB, 2003, DEMOGRAPHIC TRENDS I; GUNNLAUGSSON GA, 1993, J FAM HIST, V18, P315, DOI 10.1177/036319909301800403; GUNNLAUGSSON GA, 1997, SAGA SAMFELAG PAETTI; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hussain R, 2004, J HEALTH POPUL NUTR, V22, P1; Ober C, 1999, AM J HUM GENET, V64, P225, DOI 10.1086/302198; PHILIPPE P, 1974, HUM BIOL, V46, P405; Schull WJ, 1965, EFFECTS INBREEDING J; Villegas MJB, 2006, ANN HUM BIOL, V33, P330, DOI 10.1080/03014460600627529; Watkins K, 2006, HUMAN DEV REPORT	15	105	106	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2008	319	5864					813	816		10.1126/science.1150232	http://dx.doi.org/10.1126/science.1150232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18258915				2022-12-24	WOS:000252963000062
J	Seidel, HS; Rockman, MV; Kruglyak, L				Seidel, Hannah S.; Rockman, Matthew V.; Kruglyak, Leonid			Widespread genetic incompatibility in C. elegans maintained by balancing selection	SCIENCE			English	Article							EFFECT SELFISH GENES; CAENORHABDITIS-ELEGANS; LINKAGE DISEQUILIBRIUM; NATURAL-POPULATIONS; MEIOTIC DRIVE; POLYMORPHISM; SEGREGATION; RESISTANCE; DISTORTION; DYNAMICS	Natural selection is expected to eliminate genetic incompatibilities from interbreeding populations. We have discovered a globally distributed incompatibility in the primarily selfing species Caenorhabditis elegans that has been maintained despite its negative consequences for fitness. Embryos homozygous for a naturally occurring deletion of the zygotically acting gene zeel- 1 arrest if their sperm parent carries an incompatible allele of a second, paternal- effect locus, peel- 1. The two interacting loci are tightly linked, with incompatible alleles occurring in linkage disequilibrium in two common haplotypes. These haplotypes exhibit elevated sequence divergence, and population genetic analyses of this region indicate that natural selection is preserving both haplotypes in the population. Our data suggest that long- term maintenance of a balanced polymorphism has permitted the incompatibility to persist despite gene flow across the rest of the genome.	[Seidel, Hannah S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Seidel, HS (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	hseidel@princeton.edu; mrockman@princeton.edu; leonid@genomics.princeton.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG004321-01, R01 HG004321] Funding Source: Medline; NIGMS NIH HHS [GM071508] Funding Source: Medline; NIMH NIH HHS [R37 MH059520] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahringer J., 2006, REVERSE GENETICS; Atlan A, 1997, EVOLUTION, V51, P1886, DOI 10.1111/j.1558-5646.1997.tb05111.x; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; BEEMAN RW, 1992, SCIENCE, V256, P89, DOI 10.1126/science.1566060; Beeman RW, 1999, HEREDITY, V82, P529, DOI 10.1038/sj.hdy.6885150; Browning H, 1996, DEVELOPMENT, V122, P391; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Cutter AD, 2006, GENETICS, V172, P171, DOI 10.1534/genetics.105.048207; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Fishman L, 2005, GENETICS, V169, P347, DOI 10.1534/genetics.104.032789; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gonczy P., 2005, ASYMMETRIC CELL DIVI; Haber M, 2005, MOL BIOL EVOL, V22, P160, DOI 10.1093/molbev/msh264; Hodgkin J, 1997, GENETICS, V146, P149; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; L'Hernault S. W, 2006, SPERMATOGENESIS, DOI 10. 1895/wormbook. 1. 85. 1; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Orr HA, 2005, GENETICS, V169, P671, DOI 10.1534/genetics.104.033274; Reed FA, 2005, EVOLUTION, V59, P1280, DOI 10.1111/j.0014-3820.2005.tb01778.x; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Sivasundar A, 2005, CURR BIOL, V15, P1598, DOI 10.1016/j.cub.2005.08.034; Sivasundar A, 2003, GENETICS, V163, P147; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Thomas JH, 2006, GENETICS, V172, P127, DOI 10.1534/genetics.104.040030; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Vasudevan S, 2007, EMBO REP, V8, P279, DOI 10.1038/sj.embor.7400895; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	34	180	187	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2008	319	5863					589	594		10.1126/science.1151107	http://dx.doi.org/10.1126/science.1151107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18187622	Green Accepted			2022-12-24	WOS:000252772000032
J	Horsley, V; Aliprantis, AO; Polak, L; Glimcher, LH; Fuchs, E				Horsley, Valerie; Aliprantis, Antonios O.; Polak, Lisa; Glimcher, Laurie H.; Fuchs, Elaine			NFATc1 balances quiescence and proliferation of skin stem cells	CELL			English	Article							HAIR FOLLICLE MORPHOGENESIS; CYCLOSPORINE-A; BETA-CATENIN; HUMAN KERATINOCYTES; TRANSIENT ACTIVATION; EPIDERMAL STEM; GROWTH; DIFFERENTIATION; CALCINEURIN; INHIBITION	Quiescent adult stem cells reside in specialized niches where they become activated to proliferate and differentiate during tissue homeostasis and injury. How stem cell quiescence is governed is poorly understood. We report here that NFATc1 is preferentially expressed by hair follicle stem cells in their niche, where its expression is activated by BMP signaling upstream and it acts downstream to transcriptionally repress CDK4 and maintain stem cell quiescence. As stem cells become activated during hair growth, NFATc1 is downregulated, relieving CDK4 repression and activating proliferation. When calcineurin/NFATc1 signaling is suppressed, pharmacologically or via complete or conditional NFATc1 gene ablation, stem cells are activated prematurely, resulting in precocious follicular growth. Our findings may explain why patients receiving cyclosporine A for immunosuppressive therapy display excessive hair growth, and unveil a functional role for calcium-NFATc1-CDK4 circuitry in governing stem cell quiescence.	[Horsley, Valerie; Polak, Lisa; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA; [Aliprantis, Antonios O.; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Infect Dis & Immunol, Boston, MA 02115 USA; [Aliprantis, Antonios O.; Glimcher, Laurie H.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Aliprantis, Antonios O.; Glimcher, Laurie H.] Harvard Univ, Sch Med, Boston, MA USA	Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Fuchs, E (corresponding author), Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NIAID NIH HHS [U19 AI031541, AI31541, P01 AI031541] Funding Source: Medline; NIAMS NIH HHS [R01-AR31737, K99 AR054775, R01 AR031737-25, K99-AR054775, R01 AR031737, R01 AR050452] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031541, P01AI031541, U01AI031541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737, R01AR050452, K99AR054775] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Al-Daraji WI, 2002, J INVEST DERMATOL, V118, P779, DOI 10.1046/j.1523-1747.2002.01709.x; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Canning MT, 2006, J MOL HISTOL, V37, P285, DOI 10.1007/s10735-006-9034-9; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Gafter-Gvili A, 2004, ARCH DERMATOL RES, V296, P265, DOI 10.1007/s00403-004-0516-x; Gafter-Gvili A, 2003, AM J PHYSIOL-CELL PH, V284, pC1593, DOI 10.1152/ajpcell.00537.2002; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hennings H, 1980, Curr Probl Dermatol, V10, P3; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Karashima T, 1996, J DERMATOL SCI, V12, P246, DOI 10.1016/0923-1811(95)00480-7; Kaufman CK, 2002, MOL CELL BIOL, V22, P4293, DOI 10.1128/MCB.22.12.4293-4308.2002; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Maurer M, 1997, AM J PATHOL, V150, P1433; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Pan MG, 2007, J IMMUNOL, V178, P4315, DOI 10.4049/jimmunol.178.7.4315; PAUS R, 1994, AM J PATHOL, V144, P719; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; SAWADA M, 1987, LAB INVEST, V56, P684; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yamamoto S, 1994, J Dermatol Sci, V7 Suppl, pS47, DOI 10.1016/0923-1811(94)90035-3; Yarosh DB, 2005, J INVEST DERMATOL, V125, P1020, DOI 10.1111/j.0022-202X.2005.23858.x; Yu BD, 2003, P NATL ACAD SCI USA, V100, P14881, DOI 10.1073/pnas.2431391100; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544; Zhang JY, 2005, J CELL BIOL, V168, P561, DOI 10.1083/jcb.200411060; Zhou B, 2002, J BIOL CHEM, V277, P10704, DOI 10.1074/jbc.M107068200	62	315	334	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					299	310		10.1016/j.cell.2007.11.047	http://dx.doi.org/10.1016/j.cell.2007.11.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243104	Bronze, Green Accepted			2022-12-24	WOS:000253427700015
J	Jelluma, N; Brenkman, AB; van den Broek, NJF; Cruijsen, CWA; van Osch, MHJ; Lens, SMA; Medema, RH; Kops, GJPL				Jelluma, Nannette; Brenkman, Arjan B.; van den Broek, Niels J. F.; Cruijsen, Carin W. A.; van Osch, Maria H. J.; Lens, Susanne M. A.; Medema, Rene H.; Kops, Geert J. P. L.			Mps1 phosphorylates borealin to control aurora B activity and chromosome alignment	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; SMALL-MOLECULE INHIBITOR; POLO-LIKE KINASE-1; KINETOCHORE LOCALIZATION; PASSENGER COMPLEX; PROTEIN-KINASE; CENP-E; MICROTUBULE DYNAMICS; INCENP; BUB1	Maintenance of chromosomal stability relies on coordination between various processes that are critical for proper chromosome segregation in mitosis. Here we show that monopolar spindle 1 (Mps1) kinase, which is essential for the mitotic checkpoint, also controls correction of improper chromosome attachments. We report that Borealin/DasraB, a member of the complex that regulates the Aurora B kinase, is directly phosphorylated by Mps1 on residues that are crucial for Aurora B activity and chromosome alignment. As a result, cells lacking Mps1 kinase activity fail to efficiently align chromosomes due to impaired Aurora B function at centromeres, leaving improper attachments uncorrected. Strikingly, Borealin/DasraB bearing phosphomimetic mutations restores Aurora B activity and alignment in Mps1-depleted cells. Mps1 thus coordinates attachment error correction and checkpoint signaling, two crucial responses to unproductive chromosome attachments.	[Jelluma, Nannette; Cruijsen, Carin W. A.; Lens, Susanne M. A.; Medema, Rene H.; Kops, Geert J. P. L.] UMC Utrecht, Expt Oncol Lab, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands; [Jelluma, Nannette; Brenkman, Arjan B.; van den Broek, Niels J. F.; van Osch, Maria H. J.; Kops, Geert J. P. L.] UMC Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; [Jelluma, Nannette; Brenkman, Arjan B.; van den Broek, Niels J. F.; van Osch, Maria H. J.; Kops, Geert J. P. L.] UMC Utrecht, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Kops, GJPL (corresponding author), UMC Utrecht, Expt Oncol Lab, Dept Med Oncol, Universiteitsweg 100, NL-3584 CG Utrecht, Netherlands.	g.j.p.l.kops@umcutrecht.nl	Medema, Rene H/G-5415-2011; Medema, Rene H/E-2981-2013	Medema, Rene/0000-0002-6754-0381; Kops, Geert/0000-0003-3555-5295				Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; CHEESEMAN IM, 2005, SCI STKE, V266, pPL1; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; Draviam VM, 2007, NAT CELL BIOL, V9, P556, DOI 10.1038/ncb1569; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Khodjakov A, 2003, J CELL BIOL, V160, P671, DOI 10.1083/jcb.200208143; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Meraldi P, 2005, EMBO J, V24, P1621, DOI 10.1038/sj.emboj.7600641; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Schutz AR, 1998, MOL BIOL CELL, V9, P759, DOI 10.1091/mbc.9.4.759; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanenbaum ME, 2006, EMBO J, V25, P45, DOI 10.1038/sj.emboj.7600916; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	60	206	222	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2008	132	2					233	246		10.1016/j.cell.2007.11.046	http://dx.doi.org/10.1016/j.cell.2007.11.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IM	18243099	Bronze			2022-12-24	WOS:000253427700010
J	Feng, SH; Martinez, C; Gusmaroli, G; Wang, Y; Zhou, JL; Wang, F; Chen, LY; Yu, L; Iglesias-Pedraz, JM; Kircher, S; Schafer, E; Fu, XD; Fan, LM; Deng, XW				Feng, Suhua; Martinez, Cristina; Gusmaroli, Giuliana; Wang, Yu; Zhou, Junli; Wang, Feng; Chen, Liying; Yu, Lu; Iglesias-Pedraz, Juan M.; Kircher, Stefan; Schaefer, Eberhard; Fu, Xiangdong; Fan, Liu-Min; Deng, Xing Wang			Coordinated regulation of Arabidopsis thaliana development by light and gibberellins	NATURE			English	Article							PHYTOCHROME INTERACTING FACTOR-3; TRANSCRIPTION FACTOR; SEED-GERMINATION; PROTEIN; PIF3; AFFINITY; DEGRADATION; RECEPTOR; PATHWAY; BINDING	Light and gibberellins ( GAs) mediate many essential and partially overlapping plant developmental processes. DELLA proteins are GA- signalling repressors that block GA- induced development(1). GA induces degradation of DELLA proteins via the ubiquitin/ proteasome pathway(2), but light promotes accumulation of DELLA proteins by reducing GA levels(3). It was proposed that DELLA proteins restrain plant growth largely through their effect on gene expression(4,5). However, the precise mechanism of their function in coordinating GA signalling and gene expression remains unknown. Here we characterize a nuclear protein interaction cascade mediating transduction of GA signals to the activity regulation of a light- responsive transcription factor. In the absence of GA, nuclear- localized DELLA proteins accumulate to higher levels, interact with phytochrome- interacting factor 3 ( PIF3, a bHLH- type transcription factor) and prevent PIF3 from binding to its target gene promoters and regulating gene expression, and therefore abrogate PIF3- mediated light control of hypocotyl elongation. In the presence of GA, GID1 proteins ( GA receptors) elevate their direct interaction with DELLA proteins in the nucleus, trigger DELLA protein's ubiquitination and proteasome- mediated degradation, and thus release PIF3 from the negative effect of DELLA proteins.	[Feng, Suhua; Martinez, Cristina; Gusmaroli, Giuliana; Deng, Xing Wang] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Feng, Suhua; Zhou, Junli; Wang, Feng; Chen, Liying; Yu, Lu; Deng, Xing Wang] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Wang, Yu; Fan, Liu-Min; Deng, Xing Wang] Peking Univ, Coll Life Sci, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, Beijing 100871, Peoples R China; [Wang, Yu; Fan, Liu-Min; Deng, Xing Wang] Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China; [Iglesias-Pedraz, Juan M.] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, E-28049 Madrid, Spain; [Kircher, Stefan; Schaefer, Eberhard] Univ Freiburg, Inst Biol Bot 2, D-79104 Freiburg, Germany; [Fu, Xiangdong] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100080, Peoples R China	Yale University; National Institute of Biological Sciences, Beijing; Peking University; Peking University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Freiburg; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Deng, XW (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	xingwang.deng@yale.edu	Iglesias-Pedraz, Juan Manuel/U-7205-2017; Pedraz, Juan Manuel Iglesias/AAH-6067-2019; Hernandez, Cristina Martinez/L-1703-2014; Deng, Xing Wang/ABF-4107-2020; Iglesias Pedraz, Juan Manuel/AAH-6075-2019	Iglesias-Pedraz, Juan Manuel/0000-0003-0070-8116; Hernandez, Cristina Martinez/0000-0001-7061-062X; Iglesias Pedraz, Juan Manuel/0000-0003-0070-8116; Kircher, Stefan/0000-0002-8351-567X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047850, R01GM047850] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM047850, R01 GM047850-12, R37 GM047850, R37 GM047850-17] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achard P, 2007, PLANT PHYSIOL, V143, P1163, DOI 10.1104/pp.106.092254; Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Alabadi D, 2004, PLANT PHYSIOL, V134, P1050, DOI 10.1104/pp.103.035451; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Feng SH, 2004, PLANT CELL, V16, P1870, DOI 10.1105/tpc.021949; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Fu XD, 2004, PLANT CELL, V16, P1406, DOI 10.1105/tpc.021386; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Itoh H, 2003, TRENDS PLANT SCI, V8, P492, DOI 10.1016/j.tplants.2003.08.002; Jiao YL, 2005, PLANT CELL, V17, P3239, DOI 10.1105/tpc.105.035840; Kim JY, 2003, PLANT CELL, V15, P2399, DOI 10.1105/tpc.014498; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Oh E, 2004, PLANT CELL, V16, P3045, DOI 10.1105/tpc.104.025163; Park E, 2004, PLANT CELL PHYSIOL, V45, P968, DOI 10.1093/pcp/pch125; Penfield S, 2005, CURR BIOL, V15, P1998, DOI 10.1016/j.cub.2005.11.010; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Zhu YX, 2000, P NATL ACAD SCI USA, V97, P13419, DOI 10.1073/pnas.230433797	32	724	804	12	280	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					475	U9		10.1038/nature06448	http://dx.doi.org/10.1038/nature06448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216856	Green Accepted, Bronze			2022-12-24	WOS:000252554100047
J	Hill, MM; Bastiani, M; Luetterforst, R; Kirkham, M; Kirkham, A; Nixon, SJ; Walser, P; Abankwa, D; Oorschot, VMJ; Martin, S; Hancock, JF; Parton, RG				Hill, Michelle M.; Bastiani, Michele; Luetterforst, Robert; Kirkham, Matthew; Kirkham, Annika; Nixon, Susan J.; Walser, Piers; Abankwa, Daniel; Oorschot, Viola M. J.; Martin, Sally; Hancock, John F.; Parton, Robert G.			PTRF-Cavin, a conserved cytoplasmic protein required for Caveola formation and function	CELL			English	Article							PLASMA-MEMBRANE; BINDING PROTEIN; GOLGI-COMPLEX; MEDIATED ENDOCYTOSIS; CELL-SURFACE; MICE SHOW; CHOLESTEROL; EXPRESSION; MUSCLE; TRAFFICKING	Caveolae are abundant cell-surface organelles involved in lipid regulation and endocytosis. We used comparative proteomics to identify PTRF ( also called Cav-p60, Cavin) as a putative caveolar coat protein. PTRF-Cavin selectively associates with mature caveolae at the plasma membrane but not Golgi-localized caveolin. In prostate cancer PC3 cells, and during development of zebrafish notochord, lack of PTRF-Cavin expression correlates with lack of caveolae, and caveolin resides on flat plasma membrane. Expression of PTRF-Cavin in PC3 cells is sufficient to cause formation of caveolae. Knockdown of PTRF-Cavin reduces caveolae density, both in mammalian cells and in the zebrafish. Caveolin remains on the plasma membrane in PTRF-Cavin knockdown cells but exhibits increased lateral mobility and accelerated lysosomal degradation. We conclude that PTRF-Cavin is required for caveola formation and sequestration of mobile caveolin into immobile caveolae.	[Hill, Michelle M.; Bastiani, Michele; Luetterforst, Robert; Kirkham, Matthew; Kirkham, Annika; Nixon, Susan J.; Walser, Piers; Abankwa, Daniel; Oorschot, Viola M. J.; Martin, Sally; Hancock, John F.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Michelle M.; Bastiani, Michele; Luetterforst, Robert; Kirkham, Matthew; Kirkham, Annika; Nixon, Susan J.; Walser, Piers; Oorschot, Viola M. J.; Martin, Sally; Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Parton, RG (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	r.parton@imb.uq.edu.au	Hill, Michelle Mei Chih/G-4417-2010; Parton, Robert G/C-5673-2009; Bastiani, Michele/J-1823-2014; Kirkham, Matthew/I-5458-2012; Martin, Sally/A-7150-2010; Nixon, Susan/D-4588-2017	Hill, Michelle Mei Chih/0000-0003-1134-0951; Parton, Robert G/0000-0002-7494-5248; Bastiani, Michele/0000-0001-6752-4157; Martin, Sally/0000-0001-9294-5404; Kirkham, Matthew/0000-0003-0920-5355; Abankwa, Daniel/0000-0003-2769-0745; Hancock, John/0000-0003-0542-4710; Nixon, Susan/0000-0003-0346-9683	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM066717-04, R01 GM066717] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; BURGENER R, 1990, BIOCHEM J, V269, P729, DOI 10.1042/bj2690729; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Fang PK, 2006, AM J PATHOL, V169, P2209, DOI 10.2353/ajpath.2006.060562; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Gustincich S, 1999, GENOMICS, V57, P120, DOI 10.1006/geno.1998.5733; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Hailstones D, 1998, J LIPID RES, V39, P369; Izumi Y, 1997, J BIOL CHEM, V272, P7381, DOI 10.1074/jbc.272.11.7381; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Monier S, 1996, FEBS LETT, V388, P143, DOI 10.1016/0014-5793(96)00519-4; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Nixon SJ, 2007, J CELL SCI, V120, P2151, DOI 10.1242/jcs.003830; Parolini I, 1999, J BIOL CHEM, V274, P25718, DOI 10.1074/jbc.274.36.25718; Parton RG, 2002, J BIOL CHEM, V277, P46769, DOI 10.1074/jbc.M205683200; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Vinten J, 2001, CELL TISSUE RES, V305, P99, DOI 10.1007/s004410100389; Vinten J, 2005, BBA-BIOMEMBRANES, V1717, P34, DOI 10.1016/j.bbamem.2005.09.013; Voldstedlund M, 2001, CELL TISSUE RES, V306, P265, DOI 10.1007/s004410100439; Voldstedlund M, 2003, ACTA PHYSIOL SCAND, V179, P179, DOI 10.1046/j.1365-201X.2003.01183.x; Wanaski SP, 2003, BIOCHEMISTRY-US, V42, P42, DOI 10.1021/bi012097n; WAY M, 1995, FEBS LETT, V376, P108, DOI 10.1016/0014-5793(95)01256-7; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004	38	510	521	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 11	2008	132	1					113	124		10.1016/j.cell.2007.11.042	http://dx.doi.org/10.1016/j.cell.2007.11.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191225	Bronze, Green Accepted			2022-12-24	WOS:000253427600020
J	Datta, SR; Vasconcelos, ML; Ruta, V; Luo, S; Wong, A; Demir, E; Flores, J; Balonze, K; Dickson, BJ; Axel, R				Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Ruta, Vanessa; Luo, Sean; Wong, Allan; Demir, Ebru; Flores, Jorge; Balonze, Karen; Dickson, Barry J.; Axel, Richard			The Drosophila pheromone cVA activates a sexually dimorphic neural circuit	NATURE			English	Article							MALE COURTSHIP BEHAVIOR; OLFACTORY SYSTEM; FRUITLESS GENE; NEURONS; PROTEIN; REPRESENTATION; ORGANIZATION; ORIENTATION; RESPONSES; BRAIN	Courtship is an innate sexually dimorphic behaviour that can be observed in naive animals without previous learning or experience, suggesting that the neural circuits that mediate this behaviour are developmentally programmed(1). In Drosophila, courtship involves a complex yet stereotyped array of dimorphic behaviours that are regulated by Fru(M), a male- specific isoform of the fruitless gene(2-5). Fru(M) is expressed in about 2,000 neurons in the fly brain, including three subpopulations of olfactory sensory neurons and projection neurons ( PNs). One set of Fru(+) olfactory neurons expresses the odorant receptor Or67d and responds to the male-specific pheromone cis- vaccenyl acetate ( cVA)(6-10). These neurons converge on the DA1 glomerulus in the antennal lobe. In males, activation of Or67d 1 neurons by cVA inhibits courtship of other males, whereas in females their activation promotes receptivity to other males(7). These observations pose the question of how a single pheromone acting through the same set of sensory neurons can elicit different behaviours in male and female flies. Anatomical or functional dimorphisms in this neural circuit might be responsible for the dimorphic behaviour. We therefore developed a neural tracing procedure that employs two- photon laser scanning microscopy to activate the photoactivatable green fluorescent protein(11). Here we show, using this technique, that the projections from the DA1 glomerulus to the protocerebrum are sexually dimorphic. We observe a male- specific axonal arbor in the lateral horn whose elaboration requires the expression of the transcription factor Fru(M) in DA1 projection neurons and other Fru(+) cells. The observation that cVA activates a sexually dimorphic circuit in the protocerebrum suggests a mechanism by which a single pheromone can elicit different behaviours in males and in females.	[Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Ruta, Vanessa; Luo, Sean; Wong, Allan; Flores, Jorge; Balonze, Karen; Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Datta, Sandeep Robert; Vasconcelos, Maria Luisa; Ruta, Vanessa; Luo, Sean; Wong, Allan; Flores, Jorge; Balonze, Karen; Axel, Richard] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; [Wong, Allan] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; [Wong, Allan] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Demir, Ebru; Dickson, Barry J.] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Columbia University; Columbia University; Howard Hughes Medical Institute; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ra27@columbia.edu	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Datta, Sandeep/0000-0002-8068-3862; Vasconcelos, Maria Luisa/0000-0001-6248-3667; Ruta, Vanessa/0000-0002-4963-2768; Axel, Richard/0000-0002-3141-4076	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; Cajal S., 1889, MANUAL HISTOLOGIA NO; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Heinrichs V, 1998, MOL CELL BIOL, V18, P450, DOI 10.1128/MCB.18.1.450; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Ito K, 1998, LEARN MEMORY, V5, P52; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	27	247	252	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2008	452	7186					473	477		10.1038/nature06808	http://dx.doi.org/10.1038/nature06808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	279FU	18305480				2022-12-24	WOS:000254341300032
J	Hunter, N				Hunter, Neil			Hop1 and the meiotic DNA-damage response	CELL			English	Editorial Material							STRAND BREAK REPAIR; BUDDING YEAST; MEK1 KINASE; CHECKPOINT; MEIOSIS; DOMAIN; RED1; RAD9	During the DNA-damage response, adaptor proteins mediate signaling between the PI3K-like sensor kinases, ATM and ATR, and serine/threonine effector kinases. Carballo et al. (2008) now show that the chromosomal protein Hop1 mediates PI3K-like kinase signaling during the repair of DNA double-strand breaks (DSBs) in meiosis.	[Hunter, Neil] Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hunter, N (corresponding author), Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA.	nhunter@ucdavis.edu						Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Wan LH, 2004, MOL BIOL CELL, V15, P11, DOI 10.1091/mbc.E03-07-0499; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Zhao H, 2004, J BIOL CHEM, V279, P53023, DOI 10.1074/jbc.M410449200	13	7	7	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					731	732		10.1016/j.cell.2008.02.026	http://dx.doi.org/10.1016/j.cell.2008.02.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329359	Bronze			2022-12-24	WOS:000253818000010
J	Keller, M; Ruegg, A; Werner, S; Beer, HD				Keller, Martin; Rueegg, Andreas; Werner, Sabine; Beer, Hans-Dietmar			Active caspase-1 is a regulator of unconventional protein secretion	CELL			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; MASS-SPECTROMETRIC PROTEOMICS; NONCLASSICAL SECRETION; INFLAMMATORY CASPASES; IL-1-BETA SECRETION; MICE DEFICIENT; GROWTH-FACTOR; ACTIVATION; CELLS; EXOCYTOSIS	Mammalian cells export most proteins by the endoplasmic reticulum/Golgi-dependent pathway. However, some proteins are secreted via unconventional, poorly understood mechanisms. The latter include the proinflammatory cytokines interleukin(IL)-1 beta, IL-18, and IL-33, which require activation by caspase-1 for biological activity. Caspase-1 itself is activated by innate immune complexes, the inflammasomes. Here we show that secretion of the leaderless proteins proIL-1 alpha, caspase-1, and fibroblast growth factor (FGF)-2 depends on caspase-1 activity. Although proIL-1 alpha and FGF-2 are not substrates of the protease, we demonstrated their physical interaction. Secretome analysis using iTRAQ proteomics revealed caspase-1-mediated secretion of other leaderless proteins with known or unknown extracellular functions. Strikingly, many of these proteins are involved in inflammation, cytoprotection, or tissue repair. These results provide evidence for an important role of caspase-1 in unconventional protein secretion. By this mechanism, stress-induced activation of caspase-1 directly links inflammation to cytoprotection, cell survival, and regenerative processes.	[Keller, Martin; Rueegg, Andreas; Werner, Sabine; Beer, Hans-Dietmar] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Beer, HD (corresponding author), ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland.	dietmar.beer@cell.biol.ethz.ch		Werner, Sabine/0000-0001-7397-8710; Beer, Hans-Dietmar/0000-0002-8085-713X				Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; BROADLEY KN, 1989, LAB INVEST, V61, P571; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chang JW, 2006, BIOCHEM BIOPH RES CO, V345, P118, DOI 10.1016/j.bbrc.2006.04.073; Cleves AE, 1997, CURR BIOL, V7, pR318, DOI 10.1016/S0960-9822(06)00148-5; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; Danielsen EM, 2003, BIOCHEMISTRY-US, V42, P14670, DOI 10.1021/bi0355239; Di Quinzio MKW, 2007, AUST NZ J OBSTET GYN, V47, P9, DOI 10.1111/j.1479-828X.2006.00671.x; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Donaldson VH, 1998, P ASSOC AM PHYSICIAN, V110, P140; Faure AV, 2002, EXP CELL RES, V276, P79, DOI 10.1006/excr.2002.5512; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Haendeler J, 2006, ANTIOXID REDOX SIGN, V8, P1723, DOI 10.1089/ars.2006.8.1723; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Heidtmann HH, 1997, CLIN EXP METASTAS, V15, P368, DOI 10.1023/A:1018494020001; Huang CM, 2006, PROTEOMICS, V6, P5805, DOI 10.1002/pmic.200600163; Huang CM, 2006, PROTEOMICS, V6, P6107, DOI 10.1002/pmic.200600287; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lanza A, 2006, INT J IMMUNOPATH PH, V19, P399, DOI 10.1177/039463200601900216; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Lolis E, 2003, EXPERT OPIN THER TAR, V7, P153, DOI 10.1517/14728222.7.2.153; Lorusso A, 2006, EMBO J, V25, P5443, DOI 10.1038/sj.emboj.7601419; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Mee JB, 2005, J INVEST DERMATOL, V124, P1267, DOI 10.1111/j.0022-202X.2005.23684.x; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Munding C, 2006, CELL DEATH DIFFER, V13, P1938, DOI 10.1038/sj.cdd.4401896; Nakamura H, 2006, SEMIN CANCER BIOL, V16, P444, DOI 10.1016/j.semcancer.2006.09.001; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; RUBARTELLI A, 1995, CANCER RES, V55, P675; Rubartelli Anna, 2005, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V4, P133, DOI 10.2174/1568014053507104; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Zhao WQ, 2003, J BIOL CHEM, V278, P4205, DOI 10.1074/jbc.M210545200	53	670	699	0	83	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 7	2008	132	5					818	831		10.1016/j.cell.2007.12.040	http://dx.doi.org/10.1016/j.cell.2007.12.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VY	18329368	Bronze			2022-12-24	WOS:000253818000019
J	Soetikno, RM; Kaltenbach, T; Rouse, RV; Park, W; Maheshwari, A; Sato, T; Matsui, S; Friedland, S				Soetikno, Roy M.; Kaltenbach, Tonya; Rouse, Robert V.; Park, Walter; Maheshwari, Anamika; Sato, Tohru; Matsui, Suzanne; Friedland, Shai			Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INCREASED RISK; LESIONS; SURVEILLANCE; ADENOMAS; CANCER; COLON; COLONOSCOPY; GUIDELINES; RESECTION; UPDATE	Context Colorectal cancer is the second leading cause of cancer death in the United States. Prevention has focused on the detection and removal of polypoid neoplasms. Data are limited on the significance of nonpolypoid colorectal neoplasms ( NP- CRNs). Objectives To determine the prevalence of NP- CRNs in a veterans hospital population and to characterize their association with colorectal cancer. Design, Setting, and Patients Cross- sectional study at a veterans hospital in California with 1819 patients undergoing elective colonoscopy from July 2003 to June 2004. Main Outcome Measures Endoscopic appearance, location, size, histology, and depth of invasion of neoplasms. Results The overall prevalence of NP- CRNs was 9.35% ( 95% confidence interval [ 95% CI], 8.05%- 10.78%; n= 170). The prevalence of NP- CRNs in the subpopulations for screening, surveillance, and symptoms was 5.84% ( 95% CI, 4.13%- 8.00%; n= 36), 15.44% ( 95% CI, 12.76%- 18.44%; n= 101), and 6.01% ( 95% CI, 4.17%-8.34%; n= 33), respectively. The overall prevalence of NP- CRNs with in situ or submucosal invasive carcinoma was 0.82% ( 95% CI, 0.46%- 1.36%; n= 15); in the screening population, the prevalence was 0.32% ( 95% CI, 0.04%- 1.17%; n= 2). Overall, NP- CRNs were more likely to contain carcinoma ( odds ratio, 9.78; 95% CI, 3.93-24.4) than polypoid lesions, irrespective of the size. The positive size- adjusted association of NP- CRNs with in situ or submucosal invasive carcinoma was also observed in subpopulations for screening ( odds ratio, 2.01; 95% CI, 0.27- 15.3) and surveillance ( odds ratio, 63.7; 95% CI, 9.41- 431). The depressed type had the highest risk ( 33%). Nonpolypoid colorectal neoplasms containing carcinoma were smaller in diameter as compared with the polypoid ones ( mean [ SD] diameter, 15.9 [ 10.2] mm vs 19.2 [ 9.6] mm, respectively). The procedure times did not change appreciably as compared with historical controls. Conclusion In this group of veteran patients, NP- CRNs were relatively common lesions diagnosed during routine colonoscopy and had a greater association with carcinoma compared with polypoid neoplasms, irrespective of size.	[Soetikno, Roy M.; Kaltenbach, Tonya; Rouse, Robert V.; Park, Walter; Maheshwari, Anamika; Sato, Tohru; Matsui, Suzanne; Friedland, Shai] Vet Affairs Palo Alto Hlth Care Syst, Gastroenterol Sect, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Soetikno, RM (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Gastroenterol Sect, 3801 Miranda Ave,GI-111, Palo Alto, CA 94304 USA.	soetikno@earthlink.net		Park, Walter/0000-0001-8187-4188				Fidler JL, 2002, ABDOM IMAGING, V27, P292, DOI 10.1007/s00261-001-0171-z; Fujii T, 2001, ENDOSCOPY, V33, P1036; Fujii T, 1998, ENDOSCOPY, V30, P437, DOI 10.1055/s-2007-1001304; Hamilton SR, 2000, WHO CLASSIFICATION T; Hiraoka S, 2006, GASTROENTEROLOGY, V131, P379, DOI 10.1053/j.gastro.2006.04.027; Hurlstone DP, 2003, AM J GASTROENTEROL, V98, P2543, DOI 10.1016/S0002-9270(03)00664-6; Iishi H, 1996, GASTROINTEST ENDOSC, V44, P594, DOI 10.1016/S0016-5107(96)70015-9; JARAMILLO E, 1995, GASTROINTEST ENDOSC, V42, P114, DOI 10.1016/S0016-5107(95)70066-8; Kaltenbach T, 2007, GASTROINTEST ENDOSC, V65, P857, DOI 10.1016/j.gie.2006.11.035; Kronborg O, 2006, SCAND J GASTROENTERO, V41, P737, DOI 10.1080/00365520500442666; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Kudo S, 2000, WORLD J SURG, V24, P1081, DOI 10.1007/s002680010154; Kudo S., 1996, EARLY COLORECTAL CAN; Lieberman D, 2006, NEW ENGL J MED, V355, P2588, DOI 10.1056/NEJMe068254; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Matsui T, 2000, WORLD J SURG, V24, P1022, DOI 10.1007/s002680010153; MATSUI T, 2005, GASTROENTEROLOGIC EN, V47, P227; Nosho K, 2005, BRIT J CANCER, V92, P1193, DOI 10.1038/sj.bjc.6602442; O'Brien MJ, 2004, CLIN GASTROENTEROL H, V2, P905, DOI 10.1016/S1542-3565(04)00392-1; Park SH, 2007, AM J ROENTGENOL, V188, P953, DOI 10.2214/AJR.06.0436; Pickhardt PJ, 2004, AM J ROENTGENOL, V183, P1343, DOI 10.2214/ajr.183.5.1831343; Rembacken BJ, 2001, ENDOSCOPY, V33, P709, DOI 10.1055/s-2001-16224; Rembacken BJ, 2000, LANCET, V355, P1211, DOI 10.1016/S0140-6736(00)02086-9; Rex DK, 2006, GASTROENTEROLOGY, V130, P1865, DOI 10.1053/j.gastro.2006.03.013; Saitoh Y, 1998, GASTROINTEST ENDOSC, V48, P362, DOI 10.1016/S0016-5107(98)70004-5; Saitoh Y, 2001, GASTROENTEROLOGY, V120, P1657, DOI 10.1053/gast.2001.24886; Soetikno R, 2006, GASTROENTEROLOGY, V130, P566, DOI 10.1053/j.gastro.2005.12.006; SOETIKNO RM, 2004, DIAGNOSIS FLAT DEPRE; Tsuda S, 2002, GUT, V51, P550, DOI 10.1136/gut.51.4.550; Van Gelder RE, 2004, GASTROENTEROLOGY, V127, P41, DOI 10.1053/j.gastro.2004.03.055; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; [No title captured]	35	441	457	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2008	299	9					1027	1035		10.1001/jama.299.9.1027	http://dx.doi.org/10.1001/jama.299.9.1027			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269JH	18319413	Bronze			2022-12-24	WOS:000253644800020
J	Jakobsson, M; Scholz, SW; Scheet, P; Gibbs, JR; VanLiere, JM; Fung, HC; Szpiech, ZA; Degnan, JH; Wang, K; Guerreiro, R; Bras, JM; Schymick, JC; Hernandez, DG; Traynor, BJ; Simon-Sanchez, J; Matarin, M; Britton, A; van de Leemput, J; Rafferty, I; Bucan, M; Cann, HM; Hardy, JA; Rosenberg, NA; Singleton, AB				Jakobsson, Mattias; Scholz, Sonja W.; Scheet, Paul; Gibbs, J. Raphael; VanLiere, Jenna M.; Fung, Hon-Chung; Szpiech, Zachary A.; Degnan, James H.; Wang, Kai; Guerreiro, Rita; Bras, Jose M.; Schymick, Jennifer C.; Hernandez, Dena G.; Traynor, Bryan J.; Simon-Sanchez, Javier; Matarin, Mar; Britton, Angela; van de Leemput, Joyce; Rafferty, Ian; Bucan, Maja; Cann, Howard M.; Hardy, John A.; Rosenberg, Noah A.; Singleton, Andrew B.			Genotype, haplotype and copy-number variation in worldwide human populations	NATURE			English	Article							HUMAN GENOME; LINKAGE DISEQUILIBRIUM; GENETIC-STRUCTURE; POLYMORPHISMS; DISTANCE; AFRICA; MODEL	Genome-wide patterns of variation across individuals provide a powerful source of data for uncovering the history of migration, range expansion, and adaptation of the human species. However, high-resolution surveys of variation in genotype, haplotype and copy number have generally focused on a small number of population groups(1-3). Here we report the analysis of high-quality genotypes at 525,910 single-nucleotide polymorphisms ( SNPs) and 396 copy-number-variable loci in a worldwide sample of 29 populations. Analysis of SNP genotypes yields strongly supported fine-scale inferences about population structure. Increasing linkage disequilibrium is observed with increasing geographic distance from Africa, as expected under a serial founder effect for the out-of-Africa spread of human populations. New approaches for haplotype analysis produce inferences about population structure that complement results based on unphased SNPs. Despite a difference from SNPs in the frequency spectrum of the copy-number variants (CNVs) detected-including a comparatively large number of CNVs in previously unexamined populations from Oceania and the Americas-the global distribution of CNVs largely accords with population structure analyses for SNP data sets of similar size. Our results produce new inferences about inter-population variation, support the utility of CNVs in human population-genetic research, and serve as a genomic resource for human-genetic studies in diverse worldwide populations.	[Jakobsson, Mattias; Scheet, Paul; VanLiere, Jenna M.; Szpiech, Zachary A.; Degnan, James H.; Rosenberg, Noah A.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Jakobsson, Mattias; Degnan, James H.; Rosenberg, Noah A.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Scheet, Paul; Rosenberg, Noah A.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Scholz, Sonja W.; Gibbs, J. Raphael; Fung, Hon-Chung; Guerreiro, Rita; Bras, Jose M.; Schymick, Jennifer C.; Hernandez, Dena G.; Traynor, Bryan J.; Simon-Sanchez, Javier; Matarin, Mar; Britton, Angela; van de Leemput, Joyce; Rafferty, Ian; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Scholz, Sonja W.; Gibbs, J. Raphael; van de Leemput, Joyce; Hardy, John A.] UCL, Dept Mol Neurosci, London WC1N 3BG, England; [Scholz, Sonja W.; Gibbs, J. Raphael; van de Leemput, Joyce; Hardy, John A.] UCL, Reta Lila Weston Inst Neurol Studies, Inst Neurol, London WC1N 3BG, England; [Fung, Hon-Chung] Chang Gung Mem Hosp, Dept Neurol, Taipei 10591, Taiwan; [Fung, Hon-Chung] Chang Gung Univ, Coll Med, Taipei 10591, Taiwan; [Wang, Kai; Bucan, Maja] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Guerreiro, Rita; Bras, Jose M.] Univ Coimbra, Fac Med, Ctr Neurosci & Cell Biol, P-3004504 Coimbra, Portugal; [Schymick, Jennifer C.] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England; [Traynor, Bryan J.] Natl Inst Neurol Disorders & Stroke, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Simon-Sanchez, Javier] CSIC, Unidad Genet Mol, Dept Genom & Proteom, Inst Biomed Valencia, Valencia 46010, Spain; [Cann, Howard M.] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France; [Singleton, Andrew B.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; Chang Gung Memorial Hospital; Chang Gung University; University of Pennsylvania; Universidade de Coimbra; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Foundation Jean Dausset-CEPH; University of Virginia	Rosenberg, NA (corresponding author), Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA.	rnoah@umich.edu; singleta@mail.nih.gov	Singleton, Andrew B/C-3010-2009; Hardy, John/C-2451-2009; Scholz, Sonja W./R-5524-2017; Traynor, Bryan J/G-5690-2010; Matarin, Mar/F-1771-2016; Bras, Jose/D-3366-2009; Scholz, Sonja/AAN-6601-2021; Jakobsson, Mattias/A-6116-2011; Guerreiro, Rita J L/A-1327-2011; Degnan, James/A-4489-2008; Bras, Jose MT/A-1428-2011; Gibbs, J. Raphael/A-3984-2010	Hardy, John/0000-0002-3122-0423; Scholz, Sonja W./0000-0002-6623-0429; Matarin, Mar/0000-0002-4717-5735; Scholz, Sonja/0000-0002-6623-0429; Jakobsson, Mattias/0000-0001-7840-7853; Gibbs, J. Raphael/0000-0002-6985-0658; van de Leemput, Joyce/0000-0003-1903-7295; Simon Sanchez, Javier/0000-0001-5141-5829; Rosenberg, Noah/0000-0002-1829-8664; Guerreiro, Rita/0000-0001-5879-3486; Bras, Jose/0000-0001-8186-0333; Canzoniero, Jenna/0000-0003-1084-6918	NATIONAL INSTITUTE ON AGING [Z01AG000932, ZIAAG000932] Funding Source: NIH RePORTER; MRC [G0701075] Funding Source: UKRI; Intramural NIH HHS Funding Source: Medline; Medical Research Council [MR/K01417X/1, G0701075] Funding Source: Medline; NHGRI NIH HHS [T32 HG000040] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bastos-Rodrigues L, 2006, ANN HUM GENET, V70, P658, DOI 10.1111/j.1469-1809.2006.00287.x; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Cann HM, 2002, SCIENCE, V296, P261; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Eberle MA, 2006, PLOS GENET, V2, P1319, DOI 10.1371/journal.pgen.0020142; Falush D, 2003, GENETICS, V164, P1567; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McVean GAT, 2002, GENETICS, V162, P987; Need AC, 2006, NAT GENET, V38, P1227, DOI 10.1038/ng1106-1227; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sabatti C, 2002, GENETICS, V160, P1707; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	30	623	638	2	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2008	451	7181					998	1003		10.1038/nature06742	http://dx.doi.org/10.1038/nature06742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264TK	18288195	Green Published			2022-12-24	WOS:000253313100050
J	Hanyu-Nakamura, K; Sonobe-Nojima, H; Tanigawa, A; Lasko, P; Nakamura, A				Hanyu-Nakamura, Kazuko; Sonobe-Nojima, Hiroko; Tanigawa, Akie; Lasko, Paul; Nakamura, Akira			Drosophila Pgc protein inhibits P-TEFb recruitment to chromatin in primordial germ cells	NATURE			English	Article							RNA-POLYMERASE-II; HEAT-SHOCK; C-ELEGANS; TRANSCRIPTION ELONGATION; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; NONCODING RNA; HIV-1 TAT; IN-VIVO; KINASE	Germ cells are the only cells that transmit genetic information to the next generation, and they therefore must be prevented from differentiating inappropriately into somatic cells(1). A common mechanism by which germline progenitors are protected from differentiation- inducing signals is a transient and global repression of RNA polymerase II ( RNAPII)- dependent transcription(1). In both Drosophila and Caenorhabditis elegans embryos, the repression of messenger RNA transcription during germ cell specification correlates with an absence of phosphorylation of Ser 2 residues in the carboxy- terminal domain of RNAPII ( hereafter called CTD)(2), a critical modification for transcriptional elongation(3). Here we show that, in Drosophila embryos, a small protein encoded by polar granule component ( pgc) is essential for repressing CTD Ser 2 phosphorylation in newly formed pole cells, the germline progenitors. Ectopic Pgc expression in somatic cells is sufficient to repress CTD Ser 2 phosphorylation. Furthermore, Pgc interacts, physically and genetically, with positive transcription elongation factor b ( P- TEFb), the CTD Ser 2 kinase complex, and prevents its recruitment to transcription sites. These results indicate that Pgc is a cell- type- specific P- TEFb inhibitor that has a fundamental role in Drosophila germ cell specification. In C. elegans embryos, PIE- 1 protein segregates to germline blastomeres, and is thought to repress mRNA transcription through interaction with P- TEFb(4-7). Thus, inhibition of P- TEFb is probably a common mechanism during germ cell specification in the disparate organisms C. elegans and Drosophila.	[Hanyu-Nakamura, Kazuko; Sonobe-Nojima, Hiroko; Tanigawa, Akie; Nakamura, Akira] RIKEN, Ctr Dev Biol, Lab Germline Dev, Kobe, Hyogo 6500047, Japan; [Lasko, Paul] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	RIKEN; McGill University	Nakamura, A (corresponding author), RIKEN, Ctr Dev Biol, Lab Germline Dev, Kobe, Hyogo 6500047, Japan.	akiran@cdb.riken.jp	Lasko, Paul/C-6761-2014; Nakamura, Akira/V-6869-2019	Lasko, Paul/0000-0002-4037-3501; Nakamura, Akira/0000-0001-6506-9146	NICHD NIH HHS [R01 HD036631, R01 HD036631-10] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036631] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Deshpande G, 2004, DEVELOPMENT, V131, P1247, DOI 10.1242/dev.01004; Eissenberg JC, 2007, MOL GENET GENOMICS, V277, P101, DOI 10.1007/s00438-006-0164-2; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Lis JT, 2000, GENE DEV, V14, P792; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Nakamura A, 1996, SCIENCE, V274, P2075, DOI 10.1126/science.274.5295.2075; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Peng JM, 1998, J BIOL CHEM, V273, P13855, DOI 10.1074/jbc.273.22.13855; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	33	149	153	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2008	451	7179					730	U7		10.1038/nature06498	http://dx.doi.org/10.1038/nature06498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HD	18200011	Green Accepted			2022-12-24	WOS:000252929500044
J	Wong, KM; Suchard, MA; Huelsenbeck, JP				Wong, Karen M.; Suchard, Marc A.; Huelsenbeck, John P.			Alignment uncertainty and genomic analysis	SCIENCE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SACCHAROMYCES GENOMES; PHYLOGENY ESTIMATION; DNA-SEQUENCES; SELECTION; ELEMENTS; GENES	The statistical methods applied to the analysis of genomic data do not account for uncertainty in the sequence alignment. Indeed, the alignment is treated as an observation, and all of the subsequent inferences depend on the alignment being correct. This may not have been too problematic for many phylogenetic studies, in which the gene is carefully chosen for, among other things, ease of alignment. However, in a comparative genomics study, the same statistical methods are applied repeatedly on thousands of genes, many of which will be difficult to align. Using genomic data from seven yeast species, we show that uncertainty in the alignment can lead to several problems, including different alignment methods resulting in different conclusions.	[Huelsenbeck, John P.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Wong, Karen M.] Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; [Suchard, Marc A.] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA 90095 USA	University of California System; University of California Berkeley; University of California System; University of California San Diego; University of California System; University of California Los Angeles	Huelsenbeck, JP (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	johnh@berkeley.edu	Suchard, Marc A/A-9703-2008; Huelsenbeck, John P/C-6398-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069801] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069801, GM-069801] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GRAYBEAL A, 1994, SYST BIOL, V43, P174, DOI 10.2307/2413460; Hein J, 2003, P NATL ACAD SCI USA, V100, P14960, DOI 10.1073/pnas.2036252100; Holmes I, 2001, BIOINFORMATICS, V17, P803, DOI 10.1093/bioinformatics/17.9.803; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; LAKE JA, 1991, MOL BIOL EVOL, V8, P378; Lutzoni F, 2000, SYST BIOL, V49, P628, DOI 10.1080/106351500750049743; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Mugridge NB, 2000, MOL BIOL EVOL, V17, P1842, DOI 10.1093/oxfordjournals.molbev.a026285; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Redelings BD, 2005, SYST BIOL, V54, P401, DOI 10.1080/10635150590947041; Redelings BD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-40; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Stoye J, 1998, GENE, V211, pGC45, DOI 10.1016/S0378-1119(98)00097-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORNE JL, 1991, J MOL EVOL, V33, P114, DOI 10.1007/BF02193625; Yang ZH, 2000, GENETICS, V155, P431	23	261	264	4	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2008	319	5862					473	476		10.1126/science.1151532	http://dx.doi.org/10.1126/science.1151532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254HB	18218900				2022-12-24	WOS:000252576600041
J	Heimann, M; Reichstein, M				Heimann, Martin; Reichstein, Markus			Terrestrial ecosystem carbon dynamics and climate feedbacks	NATURE			English	Article							TEMPERATURE; SOIL; DECOMPOSITION	Recent evidence suggests that, on a global scale, terrestrial ecosystems will provide a positive feedback in a warming world, albeit of uncertain magnitude.	[Heimann, Martin; Reichstein, Markus] Max Planck Inst Biogeochem, D-07745 Jena, Germany	Max Planck Society	Heimann, M (corresponding author), Max Planck Inst Biogeochem, Hans Knoll Str 10, D-07745 Jena, Germany.	martin.heimann@bgc-jena.mpg.de	Reichstein, Markus/A-7494-2011; Heimann, Martin/H-7807-2016	Reichstein, Markus/0000-0001-5736-1112; Heimann, Martin/0000-0001-6296-5113				Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Farquhar GD, 2003, SCIENCE, V299, P1997, DOI 10.1126/science.1080681; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; KHVOROSTYANOV DV, IN PRESS TELLUS; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reichstein M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027880; Sabine CL, 2004, SCOPE SER, V62, P17; SAIESKA SR, 2003, SCIENCE, V302, P1554; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Wahlen M., 2001, EXCHANGES ATMOSPHERI; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X	18	996	1096	46	750	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2008	451	7176					289	292		10.1038/nature06591	http://dx.doi.org/10.1038/nature06591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202646	Bronze			2022-12-24	WOS:000252432100038
J	Schatton, T; Murphy, GF; Frank, NY; Yamaura, K; Waaga-Gasser, AM; Gasser, M; Zhan, Q; Jordan, S; Duncan, LM; Weishaupt, C; Fuhlbrigge, RC; Kupper, TS; Sayegh, MH; Frank, MH				Schatton, Tobias; Murphy, George F.; Frank, Natasha Y.; Yamaura, Kazuhiro; Waaga-Gasser, Ana Maria; Gasser, Martin; Zhan, Qian; Jordan, Stefan; Duncan, Lyn M.; Weishaupt, Carsten; Fuhlbrigge, Robert C.; Kupper, Thomas S.; Sayegh, Mohamed H.; Frank, Markus H.			Identification of cells initiating human melanomas	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; MALIGNANT-MELANOMA; STEM-CELLS; CANCER-CELLS; EXPRESSION; CHEMORESISTANCE; GENE	Tumour- initiating cells capable of self- renewal and differentiation, which are responsible for tumour growth, have been identified in human haematological malignancies(1,2) and solid cancers(3-6). If such minority populations are associated with tumour progression in human patients, specific targeting of tumour- initiating cells could be a strategy to eradicate cancers currently resistant to systemic therapy. Here we identify a subpopulation enriched for human malignant- melanoma- initiating cells ( MMIC) defined by expression of the chemoresistance mediator ABCB5 ( refs 7, 8) and show that specific targeting of this tumorigenic minority population inhibits tumour growth. ABCB5(+) tumour cells detected in human melanoma patients show a primitive molecular phenotype and correlate with clinical melanoma progression. In serial human- to-mouse xenotransplantation experiments, ABCB5(+) melanoma cells possess greater tumorigenic capacity than ABCB5(-) bulk populations and re- establish clinical tumour heterogeneity. In vivo genetic lineage tracking demonstrates a specific capacity of ABCB5(+) sub-populations for self- renewal and differentiation, because ABCB5(+) cancer cells generate both ABCB5(+) and ABCB5(-) progeny, whereas ABCB5(-) tumour populations give rise, at lower rates, exclusively to ABCB5(-) cells. In an initial proof- of- principle analysis, designed to test the hypothesis that MMIC are also required for growth of established tumours, systemic administration of a monoclonal antibody directed at ABCB5, shown to be capable of inducing antibody- dependent cell- mediated cytotoxicity in ABCB5(+) MMIC, exerted tumour- inhibitory effects. Identification of tumour- initiating cells with enhanced abundance in more advanced disease but susceptibility to specific targeting through a defining chemoresistance determinant has important implications for cancer therapy.	[Schatton, Tobias; Frank, Natasha Y.; Yamaura, Kazuhiro; Jordan, Stefan; Sayegh, Mohamed H.; Frank, Markus H.] Childrens Hosp, Transplantat Res Ctr, Boston, MA 02115 USA; [Schatton, Tobias; Murphy, George F.; Frank, Natasha Y.; Yamaura, Kazuhiro; Zhan, Qian; Jordan, Stefan; Sayegh, Mohamed H.; Frank, Markus H.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Frank, Natasha Y.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Waaga-Gasser, Ana Maria; Gasser, Martin] Univ Wurzburg, Dept Surg, D-97080 Wurzburg, Germany; [Duncan, Lyn M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Weishaupt, Carsten; Fuhlbrigge, Robert C.; Kupper, Thomas S.] Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Wurzburg; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Frank, MH (corresponding author), Childrens Hosp, Transplantat Res Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	mfrank@rics.bwh.harvard.edu	Schatton, Tobias/N-9898-2018; Jordan, Stefan/AAI-1073-2021; Jordan, Stefan/G-6243-2011; Jordan, Stefan/AAH-8261-2021; Frank, Markus/O-1625-2014	Schatton, Tobias/0000-0003-1386-680X; Jordan, Stefan/0000-0001-9330-1715; Jordan, Stefan/0000-0001-9330-1715; Jordan, Stefan/0000-0001-9330-1715; Sayegh, Mohamed/0000-0002-2847-588X; Frank, Markus/0000-0002-1312-0488	NATIONAL CANCER INSTITUTE [R01CA113796] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS051349] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA113796-01A1, R01 CA113796] Funding Source: Medline; NHLBI NIH HHS [R01 HL084815, R01 HL084815-17] Funding Source: Medline; NIAMS NIH HHS [P30 AR042689-159006, P30 AR042689] Funding Source: Medline; NINDS NIH HHS [K08 NS051349] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arce C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000098; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; FLORENES VA, 1994, CANCER RES, V54, P354; Frank NY, 2006, J CELL BIOL, V175, P99, DOI 10.1083/jcb.200511036; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Hazenbos WLW, 1998, J IMMUNOL, V161, P3026; Hendrix MJC, 2003, ONCOGENE, V22, P3070, DOI 10.1038/sj.onc.1206447; Huang Y, 2004, CANCER RES, V64, P4294, DOI 10.1158/0008-5472.CAN-03-3884; Kanazawa J, 2000, CANCER IMMUNOL IMMUN, V49, P253, DOI 10.1007/s002620000101; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Klein WM, 2007, MODERN PATHOL, V20, P102, DOI 10.1038/modpathol.3800720; KROESEN BJ, 1992, J IMMUNOL METHODS, V156, P47, DOI 10.1016/0022-1759(92)90009-I; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rahmanto YS, 2007, CARCINOGENESIS, V28, P2172, DOI 10.1093/carcin/bgm096; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; van Kempen LCLT, 2000, AM J PATHOL, V156, P769, DOI 10.1016/S0002-9440(10)64943-7	30	1061	1128	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2008	451	7176					345	U11		10.1038/nature06489	http://dx.doi.org/10.1038/nature06489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252FJ	18202660	Green Accepted			2022-12-24	WOS:000252432100052
J	Brouhard, GJ; Stear, JH; Noetzel, TL; Al-Bassam, J; Kinoshita, K; Harrison, SC; Howard, J; Hyman, AA				Brouhard, Gary J.; Stear, Jeffrey H.; Noetzel, Tim L.; Al-Bassam, Jawdat; Kinoshita, Kazuhisa; Harrison, Stephen C.; Howard, Jonathon; Hyman, Anthony A.			XMAP215 is a processive microtubule polymerase	CELL			English	Article							XENOPUS EGG EXTRACTS; SPINDLE POLE ORGANIZATION; PLUS-END; FISSION YEAST; STRUCTURAL BASIS; ATP HYDROLYSIS; PROTEIN; DYNAMICS; ACTIN; TUBULIN	Fast growth of microtubules is essential for rapid assembly of the microtubule cytoskeleton during cell proliferation and differentiation. XMAP215 belongs to a conserved family of proteins that promote microtubule growth. To determine how XMAP215 accelerates growth, we developed a single-molecule assay to visualize directly XMAP215-GFP interacting with dynamic microtubules. XMAP215 binds free tubulin in a 1: 1 complex that interacts with the microtubule lattice and targets the ends by a diffusion-facilitated mechanism. XMAP215 persists at the plus end for many rounds of tubulin subunit addition in a form of "tip tracking.'' These results show that XMAP215 is a processive polymerase that directly catalyzes the addition of up to 25 tubulin dimers to the growing plus end. Under some circumstances XMAP215 can also catalyze the reverse reaction, namely microtubule shrinkage. The similarities between XMAP215 and formins, actin polymerases, suggest that processive tip tracking is a common mechanism for stimulating the growth of cytoskeletal polymers.	[Brouhard, Gary J.; Stear, Jeffrey H.; Noetzel, Tim L.; Howard, Jonathon; Hyman, Anthony A.] Max Planck Inst Mol Cell Bio & Genet, Dresden, Germany; [Al-Bassam, Jawdat; Harrison, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kinoshita, Kazuhisa] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan	Max Planck Society; Harvard University; Harvard Medical School; Kyoto University	Howard, J (corresponding author), Max Planck Inst Mol Cell Bio & Genet, Dresden, Germany.	howard@mpi-cbg.de; hyman@mpi-cbg.de	Hyman, Tony/F-1923-2011; Howard, Jonathon/D-4229-2011; Hyman, Anthony A/B-3917-2017; Brouhard, Gary/AAZ-7789-2021; Howard, Jonathon/J-7492-2016	Howard, Jonathon/0000-0003-0086-1196; Hyman, Anthony A/0000-0003-3664-154X; Howard, Jonathon/0000-0003-0086-1196; Kinoshita, Kazuhisa/0000-0002-0882-4296; Stear, Jeffrey/0000-0002-2255-8297	NIAMS NIH HHS [R01 AR040593, R01 AR040593-10, R01 AR40593] Funding Source: Medline; NIGMS NIH HHS [F32 GM074723-01A1, F32 GM078023-01] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074723, F32GM078023] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; Ashford AJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P205; Brittle AL, 2005, EMBO J, V24, P1387, DOI 10.1038/sj.emboj.7600629; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Cassimeris L, 2001, J CELL SCI, V114, P3025; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; Gard DL, 2004, INT REV CYTOL, V239, P179, DOI 10.1016/S0074-7696(04)39004-2; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hestermann A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-24; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; HOWARD J, 1993, METHOD CELL BIOL, V39, P105, DOI 10.1016/S0091-679X(08)60164-8; Howard J., 2001, MECH MOTOR PROTEINS; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kinoshita K, 2002, TRENDS CELL BIOL, V12, P267, DOI 10.1016/S0962-8924(02)02295-X; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; Niethammer P, 2007, PLOS BIOL, V5, P190, DOI 10.1371/journal.pbio.0050029; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Parsons SF, 1997, CELL MOTIL CYTOSKEL, V36, P1; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Sato M, 2007, NATURE, V447, P334, DOI 10.1038/nature05773; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Severin F, 2001, J CELL BIOL, V153, P435, DOI 10.1083/jcb.153.2.435; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Srayko M, 2003, CURR BIOL, V13, P1506, DOI 10.1016/S0960-9822(03)00597-9; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Vasquez RJ, 1999, CELL MOTIL CYTOSKEL, V43, P310, DOI 10.1002/(SICI)1097-0169(1999)43:4<310::AID-CM4>3.3.CO;2-A; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128	57	361	365	5	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2008	132	1					79	88		10.1016/j.cell.2007.11.043	http://dx.doi.org/10.1016/j.cell.2007.11.043			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	266IL	18191222	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000253427600017
J	Parisien, M; Major, F				Parisien, Marc; Major, Francois			The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data	NATURE			English	Article							SECONDARY STRUCTURE PREDICTION; ISOSTERICITY MATRICES; ESCHERICHIA-COLI; MESSENGER-RNA; INDUCED FIT; 5-S RNA; RECOGNITION; ELEMENT; PROTEIN; HIV-1	The classical RNA secondary structure model considers A.U and G.U Watson - Crick as well as G.U wobble base pairs. Here we substitute it for a new one, in which sets of nucleotide cyclic motifs define RNA structures. This model allows us to unify all base pairing energetic contributions in an effective scoring function to tackle the problem of RNA folding. We show how pipelining two computer algorithms based on nucleotide cyclic motifs, MC- Fold and MC- Sym, reproduces a series of experimentally determined RNA three- dimensional structures from the sequence. This demonstrates how crucial the consideration of all base- pairing interactions is in filling the gap between sequence and structure. We use the pipeline to define rules of precursor microRNA folding in double helices, despite the presence of a number of presumed mismatches and bulges, and to propose a new model of the human immunodeficiency virus- 1-1 frame- shifting element.	[Parisien, Marc; Major, Francois] Univ Montreal, IRIC, Dept Comp Sci & Operat Res, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Major, F (corresponding author), Univ Montreal, IRIC, Dept Comp Sci & Operat Res, POB 6128,Downtown Stn, Montreal, PQ H3C 3J7, Canada.	francois.major@umontreal.ca		Parisien, Marc/0000-0003-2924-5960				Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRUNEL C, 1991, J MOL BIOL, V221, P293; Clery A, 2007, NUCLEIC ACIDS RES, V35, P1868, DOI 10.1093/nar/gkm066; DAS R, 2007, P NATL ACAD SCI US; Dima RI, 2005, J MOL BIOL, V347, P53, DOI 10.1016/j.jmb.2004.12.012; Do CB, 2006, BIOINFORMATICS, V22, pE90, DOI 10.1093/bioinformatics/btl246; Gaudin C, 2005, J MOL BIOL, V349, P1024, DOI 10.1016/j.jmb.2005.04.045; Gesteland R., 2006, RNA WORLD, V3rd edn. Cold Spring Harbor; Giedroc DP, 2000, J MOL BIOL, V298, P167, DOI 10.1006/jmbi.2000.3668; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JAFFREY SR, 1993, NUCLEIC ACIDS RES, V21, P4627, DOI 10.1093/nar/21.19.4627; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kondo J, 2006, NUCLEIC ACIDS RES, V34, P676, DOI 10.1093/nar/gkj467; Lee BM, 2006, J MOL BIOL, V357, P275, DOI 10.1016/j.jmb.2005.12.010; LEIPUVIENE R, IN PRESS CELL MOL LI; Lemieux S, 2006, NUCLEIC ACIDS RES, V34, P2340, DOI 10.1093/nar/gkl120; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; LEONTIS NB, 1986, BIOCHEMISTRY-US, V25, P3916, DOI 10.1021/bi00361a027; Lescoute A, 2005, NUCLEIC ACIDS RES, V33, P2395, DOI 10.1093/nar/gki535; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; MAJOR F, 1991, SCIENCE, V253, P1255, DOI 10.1126/science.1716375; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; Mathews DH, 2006, J MOL BIOL, V359, P526, DOI 10.1016/j.jmb.2006.01.067; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; PERRET V, 1990, BIOCHIMIE, V72, P735, DOI 10.1016/0300-9084(90)90158-D; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; Shankar N, 2006, BIOCHEMISTRY-US, V45, P11776, DOI 10.1021/bi0605787; Shapiro BA, 2007, CURR OPIN STRUC BIOL, V17, P157, DOI 10.1016/j.sbi.2007.03.001; SIERZPUTOWSKAGRACZ H, 1995, NUCLEIC ACIDS RES, V23, P146, DOI 10.1093/nar/23.1.146; Staple DW, 2005, J MOL BIOL, V349, P1011, DOI 10.1016/j.jmb.2005.03.038; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575	40	563	585	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2008	452	7183					51	55		10.1038/nature06684	http://dx.doi.org/10.1038/nature06684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	269SZ	18322526				2022-12-24	WOS:000253671900044
J	Halpern, BS; Walbridge, S; Selkoe, KA; Kappel, CV; Micheli, F; D'Agrosa, C; Bruno, JF; Casey, KS; Ebert, C; Fox, HE; Fujita, R; Heinemann, D; Lenihan, HS; Madin, EMP; Perry, MT; Selig, ER; Spalding, M; Steneck, R; Watson, R				Halpern, Benjamin S.; Walbridge, Shaun; Selkoe, Kimberly A.; Kappel, Carrie V.; Micheli, Fiorenza; D'Agrosa, Caterina; Bruno, John F.; Casey, Kenneth S.; Ebert, Colin; Fox, Helen E.; Fujita, Rod; Heinemann, Dennis; Lenihan, Hunter S.; Madin, Elizabeth M. P.; Perry, Matthew T.; Selig, Elizabeth R.; Spalding, Mark; Steneck, Robert; Watson, Reg			A global map of human impact on marine ecosystems	SCIENCE			English	Article							COASTAL; FISHERIES; BIODIVERSITY; CONSERVATION; OCEAN; WORLD; AQUACULTURE; DEPLETION; HOTSPOTS; THREATS	The management and conservation of the world's oceans require synthesis of spatial data on the distribution and intensity of human activities and the overlap of their impacts on marine ecosystems. We developed an ecosystem- specific, multiscale spatial model to synthesize 17 global data sets of anthropogenic drivers of ecological change for 20 marine ecosystems. Our analysis indicates that no area is unaffected by human influence and that a large fraction ( 41%) is strongly affected by multiple drivers. However, large areas of relatively little human impact remain, particularly near the poles. The analytical process and resulting maps provide flexible tools for regional and global efforts to allocate conservation resources; to implement ecosystem- based management; and to inform marine spatial planning, education, and basic research.	[Halpern, Benjamin S.; Walbridge, Shaun; Selkoe, Kimberly A.; Kappel, Carrie V.; Ebert, Colin; Perry, Matthew T.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Selkoe, Kimberly A.] Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Micheli, Fiorenza] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [D'Agrosa, Caterina] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Bruno, John F.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA; [Casey, Kenneth S.; Selig, Elizabeth R.] NOAA, Natl Oceanog Data Ctr, Silver Spring, MD 20910 USA; [Fox, Helen E.] World Wildlife Fund, Conservat Sci Program, Washington, DC 20037 USA; [Fujita, Rod] Environm Def, Oakland, CA 94618 USA; [Heinemann, Dennis] Ocean Conservancy, Washington, DC 20006 USA; [Lenihan, Hunter S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Madin, Elizabeth M. P.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Selig, Elizabeth R.] Univ N Carolina, Curriculum Ecol, Chapel Hill, NC 27599 USA; [Spalding, Mark] Nature Conservancy, Conservat Strategies Div, Newmarket CB8 8AW, Suffolk, England; [Steneck, Robert] Univ Maine, Darling Marine Ctr, Sch Marine Sci, Walpole, ME 04353 USA; [Watson, Reg] Univ British Columbia, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	National Center for Ecological Analysis & Synthesis; Stanford University; Wildlife Conservation Society; University of North Carolina; University of North Carolina Chapel Hill; National Oceanic Atmospheric Admin (NOAA) - USA; World Wildlife Fund; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of North Carolina; University of North Carolina Chapel Hill; University of Maine System; University of Maine Orono; University of British Columbia	Halpern, BS (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St, Santa Barbara, CA 93101 USA.	halpern@nceas.ucsb.edu; selkoe@nceas.ucsb.edu	Casey, Kenneth S/D-4065-2013; Fox, Helen E/C-3543-2009; Watson, Reg A/F-4850-2012; Kappel, Carrie Vanessa/B-9534-2009; Langhamer, Olivia/J-3425-2012; Spalding, Mark/GVU-0739-2022	Casey, Kenneth S/0000-0002-6052-7117; Watson, Reg A/0000-0001-7201-8865; Kappel, Carrie Vanessa/0000-0003-2507-8042; Heinemann, Dennis/0000-0002-1434-2445; Fox, Helen/0000-0002-0541-7484; Micheli, Fiorenza/0000-0002-6865-1438; Spalding, Mark/0000-0001-9456-4533				AIROLDI L, 2007, ANN REV OCEANOGR MAR, V45, P347; BAN N, 2007, AQUAT CONSERV MAR FR, V16; Beck MW, 2001, AQUAT CONSERV, V11, P235, DOI 10.1002/aqc.449; BRYANT D, 1998, RISK MAP BASED INDIC; Clarke A, 2003, ENVIRON CONSERV, V30, P1, DOI 10.1017/S0376892903000018; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Dalton R, 2004, NATURE, V431, P502, DOI 10.1038/431502a; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; HALPERN BS, 2008, OCEAN COAST MANAGE; Islam MS, 2004, MAR POLLUT BULL, V48, P624, DOI 10.1016/j.marpolbul.2003.12.004; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Overland JE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030808; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; *POC, 2003, AM LIV OC CHART COUR; Price ARG, 2002, MAR ECOL PROG SER, V241, P23, DOI 10.3354/meps241023; Reid W.V, 2005, MILLENNIUM ECOSYSTEM; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; *US COMM OC POL, 2004, OC BLUEPR 21 CENT; Vander Schaaf D., 2006, CONSERVATION ASSESSM; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Witherell D, 2000, ICES J MAR SCI, V57, P771, DOI 10.1006/jmsc.2000.0719	34	4045	4208	103	2525	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2008	319	5865					948	952		10.1126/science.1149345	http://dx.doi.org/10.1126/science.1149345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	262RM	18276889				2022-12-24	WOS:000253165700045
J	Liu, M; Duke, JL; Richter, DJ; Vinuesa, CG; Goodnow, CC; Kleinstein, SH; Schatz, DG				Liu, Man; Duke, Jamie L.; Richter, Daniel J.; Vinuesa, Carola G.; Goodnow, Christopher C.; Kleinstein, Steven H.; Schatz, David G.			Two levels of protection for the B cell genome during somatic hypermutation	NATURE			English	Article							INDUCED CYTIDINE DEAMINASE; CLASS SWITCH RECOMBINATION; GENE-EXPRESSION; C-MYC; AID; IG; TRANSLOCATIONS; IMMUNOGLOBULIN; MUTATION; PROTOONCOGENES	Somatic hypermutation introduces point mutations into immunoglobulin genes in germinal centre B cells during an immune response. The reaction is initiated by cytosine deamination by the activation- induced deaminase ( AID) and completed by error- prone processing of the resulting uracils by mismatch and base excision repair factors(1). Somatic hypermutation represents a threat to genome integrity(2) and it is not known how the B cell genome is protected from the mutagenic effects of somatic hypermutation nor how often these protective mechanisms fail. Here we show, by extensive sequencing of murine B cell genes, that the genome is protected by two distinct mechanisms: selective targeting of AID and gene- specific, high- fidelity repair of AID- generated uracils. Numerous genes linked to B cell tumorigenesis, including Myc, Pim1, Pax5, Ocab ( also called Pou2af1), H2afx, Rhoh and Ebf1, are deaminated by AID but escape acquisition of most mutations through the combined action of mismatch and base excision repair. However, approximately 25% of expressed genes analysed were not fully protected by either mechanism and accumulated mutations in germinal centre B cells. Our results demonstrate that AID acts broadly on the genome, with the ultimate distribution of mutations determined by a balance between high- fidelity and error- prone DNA repair.	[Liu, Man; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Duke, Jamie L.; Kleinstein, Steven H.] Yale Univ, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06511 USA; [Richter, Daniel J.] MIT, Broad Inst, Cambridge, MA 02141 USA; [Richter, Daniel J.] Harvard Univ, Cambridge, MA 02141 USA; [Vinuesa, Carola G.; Goodnow, Christopher C.] Australian Natl Univ, Div Immunol & Genet, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Goodnow, Christopher C.] Australian Phenom Facil, Canberra, ACT 2601, Australia; [Schatz, David G.] Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Australian National University; John Curtin School of Medical Research; Howard Hughes Medical Institute	Schatz, DG (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.	david.schatz@yale.edu	Schatz, David/A-6748-2013; Goodnow, Christopher C/V-8108-2018; Vinuesa, Carola G/B-1108-2010	Schatz, David/0000-0002-5669-1176; Goodnow, Christopher C/0000-0001-5296-6155; Vinuesa, Carola G/0000-0001-9799-0298; Duke, Jamie/0000-0002-4768-0846; Richter, Daniel/0000-0002-9238-5571				Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Auer RL, 2005, GENE CHROMOSOME CANC, V43, P1, DOI 10.1002/gcc.20159; Bindra RS, 2007, CANCER LETT, V252, P93, DOI 10.1016/j.canlet.2006.12.011; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Duquette ML, 2007, CANCER RES, V67, P2586, DOI 10.1158/0008-5472.CAN-06-2419; Epeldegui M, 2007, MOL IMMUNOL, V44, P934, DOI 10.1016/j.molimm.2006.03.018; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; HUANG XQ, 1994, COMPUT APPL BIOSCI, V10, P227; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Parsa JY, 2007, MOL IMMUNOL, V44, P567, DOI 10.1016/j.molimm.2006.02.003; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Poltoratsky V, 2007, DNA REPAIR, V6, P244, DOI 10.1016/j.dnarep.2006.10.003; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631; Rosenberg Brad R, 2007, Adv Immunol, V94, P215, DOI 10.1016/S0065-2776(06)94007-3; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shen HM, 2000, INT IMMUNOL, V12, P1085, DOI 10.1093/intimm/12.7.1085; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Wang CL, 2004, P NATL ACAD SCI USA, V101, P7352, DOI 10.1073/pnas.0402009101; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Yu D, 2008, IMMUNOL CELL BIOL, V86, P3, DOI 10.1038/sj.icb.7100123	48	449	460	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2008	451	7180					841	U11		10.1038/nature06547	http://dx.doi.org/10.1038/nature06547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273020				2022-12-24	WOS:000253191400045
J	Liu, X; Wang, L; Zhao, KH; Thompson, PR; Hwang, Y; Marmorstein, R; Cole, PA				Liu, Xin; Wang, Ling; Zhao, Kehao; Thompson, Paul R.; Hwang, Yousang; Marmorstein, Ronen; Cole, Philip A.			The structural basis of protein acetylation by the p300/CBP transcriptional coactivator	NATURE			English	Article							HISTONE ACETYLTRANSFERASE ACTIVITY; CBP; INHIBITORS; CANCER; CELLS; HAT; MUTATIONS; ROLES; PCAF; GENE	The transcriptional coactivator p300/ CBP ( CREBBP) is a histone acetyltransferase ( HAT) that regulates gene expression by acetylating histones and other transcription factors. Dysregulation of p300/ CBP HAT activity contributes to various diseases including cancer(1-4). Sequence alignments, enzymology experiments and inhibitor studies on p300/ CBP have led to contradictory results about its catalytic mechanism and its structural relation to the Gcn5/ PCAF and MYST HATs(5-9). Here we describe a high- resolution X- ray crystal structure of a semi- synthetic heterodimeric p300 HAT domain in complex with a bi- substrate inhibitor, Lys- CoA. This structure shows that p300/ CBP is a distant cousin of other structurally characterized HATs, but reveals several novel features that explain the broad substrate specificity and preference for nearby basic residues. Based on this structure and accompanying biochemical data, we propose that p300/ CBP uses an unusual 'hitandrun' ( Theorell - Chance) catalytic mechanism that is distinct from other characterized HATs. Several disease- associated mutations can also be readily accounted for by the p300 HAT structure. These studies pave the way for new epigenetic therapies involving modulation of p300/ CBP HAT activity.	[Liu, Xin; Zhao, Kehao; Marmorstein, Ronen] Wistar Inst Anat & Biol, Program Gene Express & Regulat, Philadelphia, PA 19104 USA; [Liu, Xin; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Wang, Ling; Thompson, Paul R.; Hwang, Yousang; Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	The Wistar Institute; University of Pennsylvania; Johns Hopkins University	Marmorstein, R (corresponding author), Wistar Inst Anat & Biol, Program Gene Express & Regulat, 3601 Spruce St, Philadelphia, PA 19104 USA.	marmor@wistar.org; pcole@jhmi.edu						Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Cebrat M, 2003, BIOORGAN MED CHEM, V11, P3307, DOI 10.1016/S0968-0896(03)00265-7; Davidson SM, 2005, CHEMBIOCHEM, V6, P162, DOI 10.1002/cbic.200400246; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Goodman RH, 2000, GENE DEV, V14, P1553; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Hwang Y, 2007, ANGEW CHEM INT EDIT, V46, P7621, DOI 10.1002/anie.200702485; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Karanam B, 2007, BIOCHEMISTRY-US, V46, P8207, DOI 10.1021/bi7000054; Kishimoto M, 2005, CLIN CANCER RES, V11, P512; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Marmorstein R, 2001, J MOL BIOL, V311, P433, DOI 10.1006/jmbi.2001.4859; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; Muraoka M, 1996, ONCOGENE, V12, P1565; Murata T, 2001, HUM MOL GENET, V10, P1071, DOI 10.1093/hmg/10.10.1071; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Qiao YF, 2006, SCIENCE, V311, P1293, DOI 10.1126/science.1122224; Scheibner KA, 2002, J BIOL CHEM, V277, P18118, DOI 10.1074/jbc.M200595200; Segel I.H., 1975, ENZYME KINETICS; Stimson L, 2005, MOL CANCER THER, V4, P1521, DOI 10.1158/1535-7163.MCT-05-0135; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Varier RA, 2006, CURR PHARM DESIGN, V12, P1975, DOI 10.2174/138161206777442092; Yuan LWC, 2002, ONCOGENE, V21, P2253, DOI 10.1038/sj.onc.1205283; Zheng YJ, 2005, J AM CHEM SOC, V127, P17182, DOI 10.1021/ja0558544; Zheng YJ, 2004, METHOD ENZYMOL, V376, P188; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	30	304	316	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2008	451	7180					846	850		10.1038/nature06546	http://dx.doi.org/10.1038/nature06546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	263BA	18273021				2022-12-24	WOS:000253191400046
J	Sims, DW; Southall, EJ; Humphries, NE; Hays, GC; Bradshaw, CJA; Pitchford, JW; James, A; Ahmed, MZ; Brierley, AS; Hindell, MA; Morritt, D; Musyl, MK; Righton, D; Shepard, ELC; Wearmouth, VJ; Wilson, RP; Witt, MJ; Metcalfe, JD				Sims, David W.; Southall, Emily J.; Humphries, Nicolas E.; Hays, Graeme C.; Bradshaw, Corey J. A.; Pitchford, Jonathan W.; James, Alex; Ahmed, Mohammed Z.; Brierley, Andrew S.; Hindell, Mark A.; Morritt, David; Musyl, Michael K.; Righton, David; Shepard, Emily L. C.; Wearmouth, Victoria J.; Wilson, Rory P.; Witt, Matthew J.; Metcalfe, Julian D.			Scaling laws of marine predator search behaviour	NATURE			English	Article							PATTERNS; ZOOPLANKTON; MOVEMENTS; SUCCESS	Many free- ranging predators have to make foraging decisions with little, if any, knowledge of present resource distribution and availability(1). The optimal search strategy they should use to maximize encounter rates with prey in heterogeneous natural environments remains a largely unresolved issue in ecology(1-3). Levy walks(4) are specialized random walks giving rise to fractal movement trajectories that may represent an optimal solution for searching complex landscapes(5). However, the adaptive significance of this putative strategy in response to natural prey distributions remains untested(6,7). Here we analyse over a million movement displacements recorded from animal- attached electronic tags to show that diverse marine predators - sharks, bony fishes, sea turtles and penguins - exhibit Levy- walk- like behaviour close to a theoretical optimum(2). Prey density distributions also display Levy- like fractal patterns, suggesting response movements by predators to prey distributions. Simulations show that predators have higher encounter rates when adopting Levy- type foraging in natural- like prey fields compared with purely random landscapes. This is consistent with the hypothesis that observed search patterns are adapted to observed statistical patterns of the landscape. This may explain why Levy- like behaviour seems to be widespread among diverse organisms(3), from microbes(8) to humans(9), as a `rule' that evolved in response to patchy resource distributions.	[Sims, David W.; Southall, Emily J.; Humphries, Nicolas E.; Wearmouth, Victoria J.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [Sims, David W.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Sch Biol Sci, Plymouth PL4 8AA, Devon, England; [Ahmed, Mohammed Z.] Univ Plymouth, Sch Comp Commun & Elect, Plymouth PL4 8AA, Devon, England; [Hays, Graeme C.; Shepard, Emily L. C.; Wilson, Rory P.] Univ Coll Swansea, Dept Biol Sci, Inst Environm Sustainabil, Swansea SA2 8PP, W Glam, Wales; [Bradshaw, Corey J. A.] Charles Darwin Univ, Sch Environm Res, Darwin, NT 0909, Australia; [Pitchford, Jonathan W.; James, Alex] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Pitchford, Jonathan W.; James, Alex] Univ York, York Ctr Complex Syst Anal, York YO10 5YW, N Yorkshire, England; [James, Alex] Univ Canterbury, Dept Math & Stat, Christchurch 1, New Zealand; [Brierley, Andrew S.] Univ St Andrews, Gatty Marine Lab, Sch Biol, St Andrews KY16 8LB, Fife, Scotland; [Hindell, Mark A.] Univ Tasmania, Sch Zool, Hobart, Tas 7001, Australia; [Morritt, David] Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Musyl, Michael K.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Pelag Fisheries Res Programme, Kewalo Res Facil,NOAA Fisheries, Honolulu, HI 96814 USA; [Righton, David; Metcalfe, Julian D.] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft NR33 0HT, Suffolk, England; [Witt, Matthew J.] Univ Exeter, Ctr Ecol & Conservat, Cornwall TR10 9EZ, England	Marine Biological Association United Kingdom; University of Plymouth; University of Plymouth; Swansea University; Charles Darwin University; University of York - UK; University of York - UK; University of Canterbury; University of St Andrews; University of Tasmania; University of London; Royal Holloway University London; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa; Centre for Environment Fisheries & Aquaculture Science; University of Exeter	Sims, DW (corresponding author), Marine Biol Assoc United Kingdom Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England.	dws@mba.ac.uk	Witt, Matthew/V-3318-2018; Humphries, Nick/AAE-7170-2019; Brierley, Andrew S/G-8019-2011; Hindell, Mark A/K-1131-2013; Witt, Matthew J/C-2279-2008; SOUTHALL, EMILY J/AGP-5395-2022; Ahmed, Mohammed/T-5898-2019; Bradshaw, Corey J.A./A-1311-2008; Righton, David/D-6140-2013; Hindell, Mark A/C-8368-2013	Witt, Matthew/0000-0002-9498-5378; Humphries, Nick/0000-0003-3741-1594; Brierley, Andrew S/0000-0002-6438-6892; SOUTHALL, EMILY J/0000-0001-7246-278X; Bradshaw, Corey J.A./0000-0002-5328-7741; Shepard, Emily/0000-0001-7325-6398; Righton, David/0000-0001-8643-3672; Hindell, Mark/0000-0002-7823-7185; Hays, Graeme/0000-0002-3314-8189; Sims, David/0000-0002-0916-7363; James, Alex/0000-0002-1543-7139	NERC [mba010004] Funding Source: UKRI; Natural Environment Research Council [mba010004, NER/A/S/2003/00302, NER/G/S/2001/00012, NER/A/S/2001/01053, NER/A/S/2001/01251] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bartumeus F, 2007, FRACTALS, V15, P151, DOI 10.1142/S0218348X07003460; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; BRADSHAW CJA, UNPUB J ANIM ECOL; Brierley AS, 2006, LIMNOL OCEANOGR-METH, V4, P18, DOI 10.4319/lom.2006.4.18; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; CHATFIELD C, 1996, NATL TIME SERIES; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; MACKAS DL, 1979, SCIENCE, V204, P62, DOI 10.1126/science.204.4388.62; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; McMahon CR, 2006, GLOBAL CHANGE BIOL, V12, P1330, DOI 10.1111/j.1365-2486.2006.01174.x; Myers AE, 2006, MAR ECOL PROG SER, V322, P259, DOI 10.3354/meps322259; Perry G, 1997, TRENDS ECOL EVOL, V12, P360, DOI 10.1016/S0169-5347(97)01097-5; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; RUSSELL RW, 1992, LANDSCAPE ECOL, V7, P195, DOI 10.1007/BF00133310; Schuster FL, 1996, J EUKARYOT MICROBIOL, V43, P150, DOI 10.1111/j.1550-7408.1996.tb04496.x; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Steele JH, 1989, LANDSCAPE ECOL, V3, P185, DOI 10.1007/BF00131537; Stephens D.W., 1986, pi; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Viswanathan GM, 2000, PHYSICA A, V282, P1, DOI 10.1016/S0378-4371(00)00071-6	31	681	685	7	376	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2008	451	7182					1098	U5		10.1038/nature06518	http://dx.doi.org/10.1038/nature06518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	266RB	18305542				2022-12-24	WOS:000253453600040
J	Silva, J; Smith, A				Silva, Jose; Smith, Austin			Capturing pluripotency	CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; LINEAGE-COMMITMENT; MOUSE DEVELOPMENT; X-INACTIVATION; ES CELLS; EPIBLAST; NANOG; DIFFERENTIATION; MAINTENANCE	In this Essay, we argue that pluripotent epiblast founder cells in the embryo and embryonic stem (ES) cells in culture represent the ground state for a mammalian cell, signified by freedom from developmental specification or epigenetic restriction and capacity for autonomous self-replication. We speculate that cell-to-cell variation may be integral to the ES cell condition, safe-guarding self-renewal while continually presenting opportunities for lineage specification.	[Silva, Jose; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Silva, Jose; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	Smith, A (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England.	ags39@cscr.cam.ac.uk	Silva, Jose C R/X-5140-2019; Silva, Jose/G-1920-2014	Silva, Jose C R/0000-0001-5487-1117; Silva, Jose/0000-0001-5487-1117; Smith, Austin/0000-0002-3029-4682	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G19/38] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Smith A, 2005, CELL, V123, P757, DOI 10.1016/j.cell.2005.11.012; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; STEVENS LC, 1983, TERATOCARCINOMA STEM, V10; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Wang ZD, 2004, DEV BIOL, V275, P192, DOI 10.1016/j.ydbio.2004.06.026; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	34	344	363	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 22	2008	132	4					532	536		10.1016/j.cell.2008.02.006	http://dx.doi.org/10.1016/j.cell.2008.02.006			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	271VX	18295569	Green Published, Bronze			2022-12-24	WOS:000253817900011
J	Yamagata, M; Sanes, JR				Yamagata, Masahito; Sanes, Joshua R.			Dscam and Sidekick proteins direct lamina-specific synaptic connections in vertebrate retina	NATURE			English	Article							CELL-ADHESION MOLECULE; HOMOPHILIC INTERCELLULAR-ADHESION; CHOLINE-ACETYLTRANSFERASE; MAMMALIAN RETINA; DROSOPHILA DSCAM; AXON GUIDANCE; DIVERSITY; SYSTEM; TRANSPOSITION; SEGREGATION	Synaptic circuits in the retina transform visual input gathered by photoreceptors into messages that retinal ganglion cells ( RGCs) send to the brain. Processes of retinal interneurons ( amacrine and bipolar cells) form synapses on dendrites of RGCs in the inner plexiform layer ( IPL). The IPL is divided into at least 10 parallel sublaminae; subsets of interneurons and RGCs arborize and form synapses in just one or a few of them(1-3). These lamina- specific circuits determine the visual features to which RGC subtypes respond(3-5). Here we show that four closely related immunoglobulin superfamily ( IgSF) adhesion molecules - Dscam ( Down's syndrome cell adhesion molecule), DscamL ( refs 6 - 9), Sidekick- 1 and Sidekick- 2 ( ref. 10) - are expressed in chick by non- overlapping subsets of interneurons and RGCs that form synapses in distinct IPL sublaminae. Moreover, each protein is concentrated within the appropriate sublaminae and each mediates homophilic adhesion. Loss- and gain- of- function studies in vivo indicate that these IgSF members participate in determining the IPL sublaminae in which synaptic partners arborize and connect. Thus, vertebrate Dscams, like Drosophila Dscams(11-19), play roles in neural connectivity. Together, our results on Dscams and Sidekicks suggest the existence of an IgSF code for laminar specificity in retina and, by implication, in other parts of the central nervous system.	[Yamagata, Masahito; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Yamagata, Masahito; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Sanes, JR (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu	Yamagata, Masahito/H-6695-2016	Yamagata, Masahito/0000-0001-8193-2931				Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Cajal SR., 1893, CELLULE, V9, P119; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hughes SH, 2004, FOLIA BIOL-PRAGUE, V50, P107; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; JOHNSON CD, 1986, J NEUROCHEM, V46, P968, DOI 10.1111/j.1471-4159.1986.tb13064.x; Kidd T, 2007, NEURON, V54, P350, DOI 10.1016/j.neuron.2007.04.018; Li X, 2001, MOL GENET GENOMICS, V266, P190, DOI 10.1007/s004380100525; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Pang JJ, 2002, J NEUROSCI, V22, P4693, DOI 10.1523/JNEUROSCI.22-11-04693.2002; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPIRA AW, 1987, J COMP NEUROL, V260, P526, DOI 10.1002/cne.902600406; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wohrn JCP, 1998, J COMP NEUROL, V396, P20; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2006, MOL CELL NEUROSCI, V33, P296, DOI 10.1016/j.mcn.2006.08.001; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Yimlamai D, 2005, DEV BIOL, V279, P44, DOI 10.1016/j.ydbio.2004.12.001; Zeng Y, 2005, METHOD ENZYMOL, V392, P371, DOI 10.1016/S0076-6879(04)92022-8; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	33	294	301	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2008	451	7177					465	U6		10.1038/nature06469	http://dx.doi.org/10.1038/nature06469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18216854	Bronze			2022-12-24	WOS:000252554100045
J	Pearce, A; Law, C; Elliman, D; Cole, TJ; Bedford, H				Pearce, Anna; Law, Catherine; Elliman, David; Cole, Tim J.; Bedford, Helen		Millennium Cohort Study Child Hlth	Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; IMMUNIZATION; CHILDREN; EXPENDITURES; INFECTIONS; ATTITUDES; COVERAGE; ENGLAND; RECORDS	Objectives To estimate uptake of the combined measles, mumps, and rubella vaccine (MMR) and single antigen vaccines and explore factors associated with uptake and reasons for not using MMR. Design Nationally representative cohort study. Setting Children born in the UK, 2000-2. Participants 14 578 children for whom data on immunisation were available. Main outcome measures Immunisation status at 3 years defined as "immunised with MMR," "immunised with at least one single antigen vaccine," and "unimmunised." Results 88.6% (13 013) were immunised with MMR and 5.2% (634) had received at least one single antigen vaccine. Children were more likely to be unimmunised if they lived in a household with other children (risk ratio 1.74, 95% confidence interval 1.35 to 2.25, for those living with three or more) or a tone parent (1.31, 1.07 to 1.60) or if their mother was under 20 (1.41, 1.08 to 1.85) or over 34 at cohort child's birth (reaching 2.34, 1.20 to 3.23, for >= 40), more highly educated (1.41, 1.05 to 1.89, for a degree), not employed (1.43, 1.12 to 1.82), or self employed (1.71, 1.18 to 2.47). Use of single vaccines increased with household income (reaching 2.98, 2.05 to 4.32, for incomes of >=52 pound 000 ((euro)69 750, $102 190)), maternal age (reaching 3.04, 2.05 to 4.50, for >= 40), and education (reaching 3.15, 1.78 to 5.58, for a degree). Children were less likely to have received single vaccines if they lived with other children (reaching 0.14, 0.07 to 0.29, for three or more), had mothers who were Indian (0.50, 0.25 to 0.99), Pakistani or Bangladeshi (0.13, 0.04 to 0.39), or black (0.31, 0.14 to 0.64), or aged under 25 (reaching 0.14, 0.05 to 0.36, for 14-19). Nearly three quarters (74.4%, 1110) of parents who did not immunise with MMR made a "conscious decision" not to immunise. Conclusions Although MMR uptake in this cohort is high, a substantial proportion of children remain susceptible to avoidable infection, largely because parents consciously decide not to immunise. Social differentials in uptake could be used to inform targeted interventions to promote uptake.	[Pearce, Anna; Law, Catherine; Cole, Tim J.; Bedford, Helen] UCL, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth, London WC1N 1EH, England; [Elliman, David] Great Ormond St Hosp Sick Children, Childrens Populat Hlth Unit, London WC1N 3JH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Bedford, H (corresponding author), UCL, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth, London WC1N 1EH, England.	h.bedford@ich.ucl.ac.uk	Law, Catherine/A-1353-2009; Pearce, Anna/C-1272-2010; Cole, Tim J/B-7883-2008; Elliman, David/AAK-4595-2020	Pearce, Anna/0000-0003-0085-5263; Cole, Tim J/0000-0001-5711-8200; Law, Catherine/0000-0002-1777-9386; Rahi, Jugnoo/0000-0002-5718-9209	Medical Research Council [G9827821] Funding Source: Medline; Department of Health Funding Source: Medline; MRC [G9827821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AbdelSalam HHM, 2004, CLIN PEDIATR, V43, P83, DOI 10.1177/000992280404300111; BOOY R, 2006, CLIN EVID, V15, P1; Casiday R, 2006, VACCINE, V24, P177, DOI 10.1016/j.vaccine.2005.07.063; Cassell JA, 2006, PUBLIC HEALTH, V120, P783, DOI 10.1016/j.puhe.2006.03.011; *COMM DIS SURV CTR, 1995, CDR WKLY, V5, P301; *CTR LONG STUD, MILL COH STUD SURV D; Demicheli V, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub2; Department of Health, 2004, NHS IMM STAT ENGL 20; DEVLIN NJ, 1993, NEW ZEAL MED J, V106, P126; Evans M, 2001, BRIT J GEN PRACT, V51, P904; Flynn M, 2004, BRIT J GEN PRACT, V54, P526; Friederichs V, 2006, ARCH DIS CHILD, V91, P465, DOI 10.1136/adc.2005.085944; Goldacre B, 2007, BRIT MED J, V335, P126, DOI 10.1136/bmj.39280.447419.59; Hadjikoumi I, 2006, ARCH DIS CHILD, V91, P621, DOI 10.1136/adc.2005.088898; Harrington P M, 2000, Ir Med J, V93, P239; Health Protection Agency, 2003, CDR WKLY, V91, P465; *HLTH PROT AG, MEASL NOT CONF CAS E; *HLTH PROT AG, 2007, HLTH PROT REP, V1; *HLTH PROT AG, 2004, CDR WKLY         JUL, V14; *HLTH PROT AG, 2004, CDR WKLY         JAN, V14; *HLTH PROT AG, 2004, CDR WKLY         OCT, V14; *HLTH PROT AG, 2004, CDR WKLY         APR, V14; HORTON R, 2004, MMR SCI FICTION; JEFFERIES S, 1991, J PUBLIC HEALTH MED, V13, P312; Lamden K, 2004, Commun Dis Public Health, V7, P388; Li J, 1993, Health Trends, V25, P16; LI J, 1993, BRIT MED J, V307, P168, DOI 10.1136/bmj.307.6897.168; Lyratzopoulos G, 2002, Commun Dis Public Health, V5, P305; MCKINNEY PA, 1991, J PUBLIC HEALTH MED, V13, P13, DOI 10.1093/oxfordjournals.pubmed.a042571; Middleton E, 2003, BMJ-BRIT MED J, V326, P854, DOI 10.1136/bmj.326.7394.854; Plewis I, 2004, MILLENNIUM COHORT ST; Plewis I, 2006, MILLENNIUM COHORT ST; Salisbury D, 2006, IMMUNISATION INFECT, V3rd; SHARLAND M, 1997, COMMUN DIS REP CDR R, V7, pR196; Simpson L, 2005, AMBUL PEDIATR, V5, P6, DOI 10.1367/A04-119R.1; Smith A, 2007, VACCINE, V25, P3996, DOI 10.1016/j.vaccine.2007.02.071; Sonnenberg P, 2007, ARCH DIS CHILD, V92, P786, DOI 10.1136/adc.2006.109223; Speers Tammy, 2004, Commun Med, V1, P171; Suarez L, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e3; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wright JA, 2006, EUR J PUBLIC HEALTH, V16, P137, DOI 10.1093/eurpub/cki194	41	110	112	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2008	336	7647					754	757		10.1136/bmj.39489.590671.25	http://dx.doi.org/10.1136/bmj.39489.590671.25			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284JW	18309964	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000254703700031
J	Westbrook, TF; Hu, G; Ang, XLL; Mulligan, P; Pavlova, NN; Liang, A; Leng, YM; Maehr, R; Shi, Y; Harper, JW; Elledge, SJ				Westbrook, Thomas F.; Hu, Guang; Ang, Xiaolu L.; Mulligan, Peter; Pavlova, Natalya N.; Liang, Anthony; Leng, Yumei; Maehr, Rene; Shi, Yang; Harper, J. Wade; Elledge, Stephen J.			SCF beta-TRCP controls oncogenic transformation and neural differentiation through REST degradation	NATURE			English	Article							RESTRICTIVE SILENCER FACTOR; UBIQUITIN-LIGASE COMPLEX; BOX PROTEIN BETA-TRCP1; EMBRYONIC STEM-CELLS; F-BOX; IN-VITRO; EXPRESSION; GENES; TRANSCRIPTION; PRECURSORS	The RE1- silencing transcription factor ( REST, also known as NRSF) is a master repressor of neuronal gene expression and neuronal programmes in non- neuronal lineages(1-3). Recently, REST was identified as a human tumour suppressor in epithelial tissues(4), suggesting that its regulation may have important physiological and pathological consequences. However, the pathways controlling REST have yet to be elucidated. Here we show that REST is regulated by ubiquitin- mediated proteolysis, and use an RNA interference ( RNAi) screen to identify a Skp1- Cul1- F- box protein complex containing the F- box protein beta- TRCP ( SCF beta-TRCP) as an E3 ubiquitin ligase responsible for REST degradation. beta- TRCP binds and ubiquitinates REST and controls its stability through a conserved phospho- degron. During neural differentiation, REST is degraded in a beta-TRCP- dependent manner. beta- TRCP is required for proper neural differentiation only in the presence of REST, indicating that beta- TRCP facilitates this process through degradation of REST. Conversely, failure to degrade REST attenuates differentiation. Furthermore, we find that beta-TRCP overexpression, which is common in human epithelial cancers, causes oncogenic transformation of human mammary epithelial cells and that this pathogenic function requires REST degradation. Thus, REST is a key target in beta- TRCP- driven transformation and the beta- TRCP - REST axis is a new regulatory pathway controlling neurogenesis.	[Westbrook, Thomas F.; Hu, Guang; Pavlova, Natalya N.; Liang, Anthony; Leng, Yumei; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; [Ang, Xiaolu L.; Mulligan, Peter; Shi, Yang; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Maehr, Rene] Harvard Univ, Dept Stem Cell & Regenerat Biol, Howard Hughes Med Inst, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Harvard Partners Ctr Genet & Genom, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu; selledge@genetics.med.harvard.edu	Hu, Guang/E-7474-2016; Cambronne, Xiaolu Ang/GRY-7149-2022	Hu, Guang/0000-0003-0437-4723; Cambronne, Xiaolu Ang/0000-0002-3547-448X; Harper, Jeffrey/0000-0002-6944-7236; Mulligan, Peter/0000-0003-0737-2328	Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [R01 AG011085-16, R01 AG011085] Funding Source: Medline; NIGMS NIH HHS [R01 GM054137, R01 GM054137-13, R01 GM071004] Funding Source: Medline; NINDS NIH HHS [F31 NS054507-01, F31 NS054507] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004, R01GM054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Fuller GN, 2005, MOL CANCER THER, V4, P343; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kudo Y, 2004, MOL CELL BIOL, V24, P8184, DOI 10.1128/MCB.24.18.8184-8194.2004; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Saitoh T, 2001, INT J ONCOL, V18, P959; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Su XH, 2006, MOL CELL BIOL, V26, P1666, DOI 10.1128/MCB.26.5.1666-1678.2006; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	27	246	254	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2008	452	7185					370	U11		10.1038/nature06780	http://dx.doi.org/10.1038/nature06780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276BX	18354483	Green Accepted			2022-12-24	WOS:000254117400051
J	Takeda, S; Gapper, C; Kaya, H; Bell, E; Kuchitsu, K; Dolan, L				Takeda, Seiji; Gapper, Catherine; Kaya, Hidetaka; Bell, Elizabeth; Kuchitsu, Kazuyuki; Dolan, Liam			Local positive feedback regulation determines cell shape in root hair cells	SCIENCE			English	Article							NADPH OXIDASE; TIP GROWTH; INHIBITOR; PROTEIN	The specification and maintenance of growth sites are tightly regulated during cell morphogenesis in all organisms. ROOT HAIR DEFECTIVE 2 reduced nicotinamide adenine dinucleotide phosphate ( RHD2 NADPH) oxidase - derived reactive oxygen species ( ROS) stimulate a Ca2+ influx into the cytoplasm that is required for root hair growth in Arabidopsis thaliana. We found that Ca2+, in turn, activated the RHD2 NADPH oxidase to produce ROS at the growing point in the root hair. Together, these components could establish a means of positive feedback regulation that maintains an active growth site in expanding root hair cells. Because the location and stability of growth sites predict the ultimate form of a plant cell, our findings demonstrate how a positive feedback mechanism involving RHD2, ROS, and Ca2+ can determine cell shape.	[Takeda, Seiji; Gapper, Catherine; Bell, Elizabeth; Dolan, Liam] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Kaya, Hidetaka; Kuchitsu, Kazuyuki] Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba 2788510, Japan; [Kaya, Hidetaka; Kuchitsu, Kazuyuki] Tokyo Univ Sci, Dept Appl Biol Sci, Chiba 2788510, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Tokyo University of Science; Tokyo University of Science	Dolan, L (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk	Kuchitsu, Kazuyuki/G-3024-2013	Kuchitsu, Kazuyuki/0000-0001-8854-0375; Dolan, Liam/0000-0003-1206-7096; Kaya, Hidetaka/0000-0003-4711-8236; Takeda, Seiji/0000-0003-0183-7390	Natural Environment Research Council [NE/C510732/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/B/04498] Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Bibikova TN, 1999, PLANT J, V17, P657, DOI 10.1046/j.1365-313X.1999.00415.x; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Lee SH, 2006, PLANT CELL, V18, P1604, DOI 10.1105/tpc.105.035972; LIU CM, 1978, J BIOL CHEM, V253, P5892; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Ringli C, 2002, PLANT PHYSIOL, V129, P1464, DOI 10.1104/pp.005777; Samaj J, 2006, TRENDS PLANT SCI, V11, P594, DOI 10.1016/j.tplants.2006.10.002; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Webb M, 2002, DEVELOPMENT, V129, P123; Wymer CL, 1997, PLANT J, V12, P427, DOI 10.1046/j.1365-313X.1997.12020427.x; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449	22	374	393	7	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 29	2008	319	5867					1241	1244		10.1126/science.1152505	http://dx.doi.org/10.1126/science.1152505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267SX	18309082				2022-12-24	WOS:000253530600043
J	Zheng, SL; Sun, JL; Wiklund, F; Smith, S; Stattin, P; Li, G; Adami, HO; Hsu, FC; Zhu, Y; Balter, K; Kader, AK; Turner, AR; Liu, WN; Bleecker, ER; Meyers, DA; Duggan, D; Carpten, JD; Chang, BL; Isaacs, WB; Xu, JF; Gronberg, H				Zheng, S. Lilly; Sun, Jielin; Wiklund, Fredrik; Smith, Shelly; Stattin, Par; Li, Ge; Adami, Hans-Olov; Hsu, Fang-Chi; Zhu, Yi; Balter, Katarina; Kader, A. Karim; Turner, Aubrey R.; Liu, Wennuan; Bleecker, Eugene R.; Meyers, Deborah A.; Duggan, David; Carpten, John D.; Chang, Bao-Li; Isaacs, William B.; Xu, Jianfeng; Gronberg, Henrik			Cumulative association of five genetic variants with prostate cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHROMOSOME 8Q24; RISK LOCUS; COMMON	Background Single-nucleotide polymorphisms (SNPs) in five chromosomal regions -- three at 8q24 and one each at 17q12 and 17q24.3 -- have been associated with prostate cancer. Each SNP has only a moderate association, but when SNPs are combined, the association may be stronger. Methods We evaluated 16 SNPs from five chromosomal regions in a Swedish population (2893 subjects with prostate cancer and 1781 control subjects) and assessed the individual and combined association of the SNPs with prostate cancer. Results Multiple SNPs in each of the five regions were associated with prostate cancer in single SNP analysis. When the most significant SNP from each of the five regions was selected and included in a multivariate analysis, each SNP remained significant after adjustment for other SNPs and family history. Together, the five SNPs and family history were estimated to account for 46% of the cases of prostate cancer in the Swedish men we studied. The five SNPs plus family history had a cumulative association with prostate cancer (P for trend, 3.93x10(-28)). In men who had any five or more of these factors associated with prostate cancer, the odds ratio for prostate cancer was 9.46 (P=1.29x10(-8)), as compared with men without any of the factors. The cumulative effect of these variants and family history was independent of serum levels of prostate-specific antigen at diagnosis. Conclusions SNPs in five chromosomal regions plus a family history of prostate cancer have a cumulative and significant association with prostate cancer.	[Zheng, S. Lilly; Sun, Jielin; Smith, Shelly; Li, Ge; Hsu, Fang-Chi; Zhu, Yi; Turner, Aubrey R.; Liu, Wennuan; Bleecker, Eugene R.; Meyers, Deborah A.; Chang, Bao-Li; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genome, Winston Salem, NC 27157 USA; [Hsu, Fang-Chi] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Kader, A. Karim] Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, Winston Salem, NC 27157 USA; [Wiklund, Fredrik; Adami, Hans-Olov; Balter, Katarina; Gronberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Stattin, Par] Univ Umea Hosp, Dept Urol, S-90185 Umea, Sweden; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Duggan, David; Carpten, John D.] Translat Genom Res Inst, Phoenix, AZ USA; [Isaacs, William B.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Karolinska Institutet; Umea University; Harvard University; Harvard T.H. Chan School of Public Health; Translational Genomics Research Institute; Johns Hopkins University; Johns Hopkins Medicine	Xu, JF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genome, Med Ctr Blvd, Winston Salem, NC 27157 USA.	wisaacs@jhmi.edu; jxu@wfubmc.edu			NCI NIH HHS [PC051264, CA95052, CA58236, CA112517, CA105055, CA106523] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095052, R01CA112517, R01CA105055, P50CA058236, R01CA106523] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; GUNDMUNDSSON J, 2007, NAT GENET, V39, P977; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Johns LE, 2003, BJU INT, V91, P789, DOI 10.1046/j.1464-410X.2003.04232.x; LILIENFELD AM, 1980, FDN EPIDEMIOLOGY, P301; Lindstrom S, 2006, CANCER RES, V66, P11077, DOI 10.1158/0008-5472.CAN-06-3024; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Severi G, 2007, CANCER EPIDEM BIOMAR, V16, P610, DOI 10.1158/1055-9965.EPI-06-0872; Suuriniemi M, 2007, CANCER EPIDEM BIOMAR, V16, P809, DOI 10.1158/1055-9965.EPI-06-1049; Wang L, 2007, CANCER RES, V67, P2944, DOI 10.1158/0008-5472.CAN-06-3186; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zheng SL, 2007, JNCI-J NATL CANCER I, V99, P1525, DOI 10.1093/jnci/djm169	16	496	509	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2008	358	9					910	919		10.1056/NEJMoa075819	http://dx.doi.org/10.1056/NEJMoa075819			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266JD	18199855	Bronze			2022-12-24	WOS:000253430200006
J	Sakaue-Sawano, A; Kurokawa, H; Morimura, T; Hanyu, A; Hama, H; Osawa, H; Kashiwagi, S; Fukami, K; Miyata, T; Miyoshi, H; Imamura, T; Ogawa, M; Masai, H; Miyawaki, A				Sakaue-Sawano, Asako; Kurokawa, Hiroshi; Morimura, Toshifumi; Hanyu, Aki; Hama, Hiroshi; Osawa, Hatsuki; Kashiwagi, Saori; Fukami, Kiyoko; Miyata, Takaki; Miyoshi, Hiroyuki; Imamura, Takeshi; Ogawa, Masaharu; Masai, Hisao; Miyawaki, Atsushi			Visualizing spatiotemporal dynamics of multicellular cell-cycle progression	CELL			English	Article							TO-MESENCHYMAL TRANSITION; LICENSING FACTOR CDT1; DNA-REPLICATION; FLUORESCENT PROTEINS; UBIQUITIN LIGASES; NEURONS ARISE; S-PHASE; DEGRADATION; GEMININ; PCNA	The cell-cycle transition from G(1) to S phase has been difficult to visualize. We have harnessed antiphase oscillating proteins that mark cell-cycle transitions in order to develop genetically encoded fluorescent probes for this purpose. These probes effectively label individual G, phase nuclei red and those in S/G(2)/M phases green. We were able to generate cultured cells and transgenic mice constitutively expressing the cell-cycle probes, in which every cell nucleus exhibits either red or green fluorescence. We performed time-lapse imaging to explore the spatiotemporal patterns of cell-cycle dynamics during the epithelial-mesenchymal transition of cultured cells, the migration and differentiation of neural progenitors in brain slices, and the development of tumors across blood vessels in live mice. These mice and cell lines will serve as model systems permitting unprecedented spatial and temporal resolution to help us better understand how the cell cycle is coordinated with various biological events.	[Sakaue-Sawano, Asako; Kurokawa, Hiroshi; Hama, Hiroshi; Osawa, Hatsuki; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct & Dynam, Wako, Saitama 3510198, Japan; [Morimura, Toshifumi; Kashiwagi, Saori; Ogawa, Masaharu] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Culture Dev, Wako, Saitama 3510198, Japan; [Sakaue-Sawano, Asako; Miyawaki, Atsushi] JST, ERATO, Wako, Saitama 3510198, Japan; [Kurokawa, Hiroshi; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo 1920392, Japan; [Hanyu, Aki; Miyata, Takaki] Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, Tokyo 1358550, Japan; [Miyata, Takaki] Nagoya Univ, Grad Sch Med, Dept Anat & Cell Biol, Syowa Ku, Aichi 4668550, Japan; [Miyoshi, Hiroyuki] RIKEN Tsukuba Inst, BioResource Ctr, Subteam Manipulat Cell Fate, Tsukuba, Ibaraki 3050074, Japan; [Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Gen Dynam Project, Bunkyo Ku, Tokyo 1138613, Japan	RIKEN; RIKEN; Japan Science & Technology Agency (JST); Tokyo University of Pharmacy & Life Sciences; Japanese Foundation for Cancer Research; Nagoya University; RIKEN; Tokyo Metropolitan Institute of Medical Science	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct & Dynam, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.jp	Miyawaki, Atsushi/K-3569-2014; Miyoshi, Hiroyuki/G-9808-2013; MIYATA, TAKAKI/I-7066-2014	Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390				Ang X. L., 2004, SCI STKE, V242, ppe31; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Easwaran HP, 2005, CELL CYCLE, V4, P453, DOI 10.4161/cc.4.3.1525; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hoffman RM, 2005, CURR TOP DEV BIOL, V70, P121, DOI 10.1016/S0070-2153(05)70006-5; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kisielewska J, 2005, BIOL CELL, V97, P221; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2002, J NEUROSCI RES, V69, P861, DOI 10.1002/jnr.10335; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Nurse P, 1998, NAT MED, V4, P1103, DOI 10.1038/2594; Piek E, 1999, J CELL SCI, V112, P4557; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Spella M, 2007, NEUROSCIENCE, V147, P373, DOI 10.1016/j.neuroscience.2007.03.050; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yang M, 2003, P NATL ACAD SCI USA, V100, P14259, DOI 10.1073/pnas.2436101100; Yang Y, 2006, ONCOGENE, V25, P7235, DOI 10.1038/sj.onc.1209712; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365; Zhang GJ, 2004, NAT MED, V10, P643, DOI 10.1038/nm1047	47	1413	1437	10	230	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2008	132	3					487	498		10.1016/j.cell.2007.12.033	http://dx.doi.org/10.1016/j.cell.2007.12.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	262XD	18267078	Bronze			2022-12-24	WOS:000253180700022
J	Braithwaite, RS; Roberts, MS; Chang, CCH; Goetz, MB; Gibert, CL; Rodrigue-Barradas, MC; Shechter, S; Schaefer, A; Nucifora, K; Koppenhaver, R; Justice, AC				Braithwaite, R. Scott; Roberts, Mark S.; Chang, Chung Chou H.; Goetz, Matthew Bidwell; Gibert, Cynthia L.; Rodrigue-Barradas, Maria C.; Shechter, Steven; Schaefer, Andrew; Nucifora, Kimberly; Koppenhaver, Robert; Justice, Amy C.			Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: A decision model	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; INFECTION; COHORT; RESISTANCE; OUTCOMES; ADULTS	Background: The optimal threshold for initiating HIV treatment is unclear. Objective: To compare different thresholds for initiating HIV treatment. Design: A validated computer simulation was used to weigh important harms from earlier initiation of antiretroviral therapy (toxicity, side effects, and resistance accumulation) against important benefits (decreased HIV-related mortality). Data Sources: Veterans Aging Cohort Study (5742 HIV-infected patients and 11 484 matched uninfected controls) and published reports. Target Population: Individuals with newly diagnosed chronic HIV infection and varying viral loads (10 000, 30 000, 100 000, and 300 000 copies/mL) and ages (30, 40, and 50 years). Time Horizon: Unlimited. Perspective: Societal. Intervention: Alternative thresholds for initiating antiretroviral therapy (CD4 counts of 200, 350, and 500 cells/mm(3)). Outcome Measures: Life-years and quality-adjusted life-years (QALYs). Results of Base-Case Analysis: Although the simulation was biased against earlier treatment initiation because it used an upper-bound assumption for therapy-related toxicity, earlier treatment increased life expectancy and QALYs at age 30 years regardless of viral load (life expectancies with CD4 initiation thresholds of 500, 350, and 200 cells/mm(3) were 18.2 years, 17.6 years, and 17.2 years, respectively, for a viral load of 10 000 copies/mL and 17.3 years, 15.9 years, and 14.5 years, respectively, for a viral load of 300000 copies/mL), and increased life expectancies at age 40 years if viral loads were greater than 30000 copies/mL (life expectancies were 12.5 years, 12.0 years, and 11.4 years, respectively, for a viral load of 300000 copies/mL). Results of Sensitivity Analysis: Findings favoring early treatment were generally robust. Limitations: Results favoring later treatment may not be valid. The findings may not be generalizable to women. Conclusion: This simulation suggests that earlier initiation of combination antiretroviral therapy is often favored compared with current recommendations.	[Braithwaite, R. Scott] Yale Univ, West Haven, CT 06516 USA; Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA; George Washington Univ, Washington, DC USA; Vet Affairs Med Ctr, Washington, DC 20422 USA; Baylor Coll Med, Houston, TX 77030 USA; Michael E DeBakey VA Med Ctr, Houston, TX USA; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; Baylor College of Medicine; University of British Columbia	Braithwaite, RS (corresponding author), Yale Univ, 950 Campbell Ave, West Haven, CT 06516 USA.	Ronald.Braithwaite@va.gov	Goetz, Matthew Bidwell/GPX-4090-2022	Braithwaite, Ronald Scott/0000-0001-7067-3655; Goetz, Matthew/0000-0003-4542-992X	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA014483, U10AA013566] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NIAAA NIH HHS [U10 AA013566, U10 AA013566-07, 2U10 AA13566, K23 AA14483-01, K23 AA014483] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Braithwaite RS, 2006, J ANTIMICROB CHEMOTH, V58, P1036, DOI 10.1093/jac/dkl386; Braithwaite RS, 2007, VALUE HEALTH, V10, P204, DOI 10.1111/j.1524-4733.2007.00170.x; Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; BRAITHWAITE RS, IN PRESS VALUE HLTH; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74; Hertogs K, 2000, AIDS, V14, P1203, DOI 10.1097/00002030-200006160-00018; *HIV HCV COINF STU, 2003, J ACQ IMMUN DEF SYND, V32, P259; *HIV OUTP STUD HOP, 2002, LANCET, V360, P1747; *HIV OUTP STUD INV, 2003, ANN INTERN MED, V138, P620; HO DD, 1995, NEW ENGL J MED, V333, P450, DOI 10.1056/NEJM199508173330710; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; Justice AC, 2006, MED CARE, V44, pS13, DOI 10.1097/01.mlr.0000223741.02074.66; Lane HC, 2003, ANN INTERN MED, V138, P680, DOI 10.7326/0003-4819-138-8-200304150-00018; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Mocroft A, 2004, J INFECT DIS, V190, P1947, DOI 10.1086/425424; *PAN CLIN PRACT TR, 2006, GUID US ANT AG HIV 1; Phillips AN, 2003, AIDS, V17, P1863, DOI 10.1097/00002030-200309050-00004; Plana M, 2000, AIDS, V14, P1921, DOI 10.1097/00002030-200009080-00007; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, ARCH INTERN MED, V162, P2478, DOI 10.1001/archinte.162.21.2478; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Sterling TR, 2003, J INFECT DIS, V188, P1659, DOI 10.1086/379741; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; Walensky RP, 2002, JAIDS-J ACQ IMM DEF, V31, P27, DOI 10.1097/00126334-200209010-00004; 2002, AIDS, V16, P1371	30	43	43	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2008	148	3					178	185		10.7326/0003-4819-148-3-200802050-00004	http://dx.doi.org/10.7326/0003-4819-148-3-200802050-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258DX	18252681	Green Accepted			2022-12-24	WOS:000252849700002
J	Gale, EAM; Alberti, G; Zimmet, PZ				Gale, Edwin A. M.; Alberti, George; Zimmet, P. Z.			Should we dump the metabolic syndrome?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gale, Edwin A. M.] Univ Bristol, Southmead Hosp, Med Sch Unit, Bristol BS10 5NB, Avon, England; [Alberti, George] St Marys Hosp, Dept Endocrinol & Metab, London, England; [Alberti, George] Univ London Imperial Coll Sci Technol & Med, London, England; [Zimmet, P. Z.] Int Diabet Inst, Melbourne, Vic, Australia	Southmead Hospital; University of Bristol; Imperial College London; Imperial College London	Gale, EAM (corresponding author), Univ Bristol, Southmead Hosp, Med Sch Unit, Bristol BS10 5NB, Avon, England.	Edwin.Gale@bristol.ac.uk; george.alberti@ncl.ac.uk	Zimmet, Paul/O-8486-2019	Zimmet, Paul/0000-0003-0627-0776					0	55	59	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 22	2008	336	7645					640	641		10.1136/bmj.39477.500197.AD	http://dx.doi.org/10.1136/bmj.39477.500197.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280RH	18356231	Green Published			2022-12-24	WOS:000254443400022
J	Service, RF				Service, Robert F.			Structural biology - Protein structure initiative: Phase 3 or phase out	SCIENCE			English	News Item								The production-line approach to finding protein structures is rapidly filling up databases. The determination of structures of various proteins has come a long way, from structuring of the protein GroEL to the various proteins discovered so far. The cost involved in determining the X-ray crystal structures has also increases simultaneously. Protein Structure Initiative (PSI), a big- science project funded by the U. S. National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH) in Bethesda, Maryland. PSI is involved in protein structure determination.											0	13	14	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2008	319	5870					1610	1613		10.1126/science.319.5870.1610	http://dx.doi.org/10.1126/science.319.5870.1610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276VR	18356502				2022-12-24	WOS:000254172300011
J	Basham, P; Luik, J; Jeffery, RW; Sherwood, NE				Basham, Patrick; Luik, John; Jeffery, R. W.; Sherwood, N. E.			Is the obesity epidemic exaggerated?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Basham, Patrick] Johns Hopkins Univ, Washington, DC 20036 USA; [Jeffery, R. W.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Sherwood, N. E.] HealthPartners Res Fdn, Minneapolis, MN 55440 USA	Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; HealthPartners Institute for Education & Research	Basham, P (corresponding author), Johns Hopkins Univ, 1717 Massachusetts Ave NW, Washington, DC 20036 USA.	patrickbasham@gmail.com; jefferyrw@gmail.com	Basham, Patrick/AAR-9496-2021	Sherwood, Nancy/0000-0002-3365-9018	NCI NIH HHS [CA116849] Funding Source: Medline; NIDDK NIH HHS [DK50456] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))			0	49	49	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 2	2008	336	7638					244	245		10.1136/bmj.39458.480764.AD	http://dx.doi.org/10.1136/bmj.39458.480764.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	261TM	18244993	Green Published			2022-12-24	WOS:000253102900032
J	Britton, J; Macara, AW				Britton, John; Macara, Alexander W.			Should doctors advocate snus and other nicotine replacements?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Britton, John] City Hosp, Nottingham NG5 1PB, England; [Macara, Alexander W.] Natl Heart Forum, Bristol, Avon, England	University of Nottingham	Britton, J (corresponding author), City Hosp, Clin Sci Bldg, Nottingham NG5 1PB, England.	j.britton@virgin.net; alexandermacara@yahoo.co.uk							0	19	19	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 16	2008	336	7640					358	359		10.1136/bmj.39479.427477.AD	http://dx.doi.org/10.1136/bmj.39479.427477.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268AP	18276711	Green Published			2022-12-24	WOS:000253550600036
J	Rehm, J; Fischer, B; McKeganey, N				Rehm, Juergen; Fischer, Benedikt; McKeganey, Neil			Should heroin be prescribed to heroin misusers?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rehm, Juergen; Fischer, Benedikt] Ctr Addict & Mental Hlth, Toronto, ON M5S 2S1, Canada; [Fischer, Benedikt] Univ Victoria, Ctr Addict Res British Columbia, Victoria, BC V8W 2Y2, Canada; [McKeganey, Neil] Univ Glasgow, Glasgow G11 6PW, Lanark, Scotland	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Victoria; University of Glasgow	Rehm, J (corresponding author), Ctr Addict & Mental Hlth, Toronto, ON M5S 2S1, Canada.	jtrehm@aol.com; n.mckeganey@lbss.gla.ac.uk	Rem, Jürgen/H-1309-2011	Fischer, B/0000-0002-2186-4030					0	12	12	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 12	2008	336	7635					70	71		10.1136/bmj.39421.593692.94	http://dx.doi.org/10.1136/bmj.39421.593692.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	18187720	Green Accepted, Green Published			2022-12-24	WOS:000252494800024
